{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests as req\n",
    "import string \n",
    "from bs4 import BeautifulSoup\n",
    "import pandas as pd\n",
    "import pypdf as pdf\n",
    "import re\n",
    "from io import BytesIO"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\project_work_its\\CosmeticIngredientReview.py:26: GuessedAtParserWarning: No parser was explicitly specified, so I'm using the best available HTML parser for this system (\"html.parser\"). This usually isn't a problem, but if you run this code on another system, or in a different virtual environment, it may use a different parser and behave differently.\n",
      "\n",
      "The code that caused this warning is on line 26 of the file c:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\project_work_its\\CosmeticIngredientReview.py. To get rid of this warning, pass the additional argument 'features=\"html.parser\"' to the BeautifulSoup constructor.\n",
      "\n",
      "  page = BeautifulSoup(web_page.text)\n"
     ]
    }
   ],
   "source": [
    "import PyPDF2 as pdf\n",
    "\n",
    "\n",
    "chiave=('1,2,4-Trihydroxybenzene', '1,2,4-Trihydroxybenzene')\n",
    "cir.get_source(chiave,database)\n",
    "source = req.get(database[chiave][1],stream=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['5d55d919-245e-ee11-be6f-00224824e39e',\n",
       " 'https://cir-reports.cir-safety.org/view-attachment?id=a1152e70-abec-b78c-b63e-a52bba62a429',\n",
       " '2024']"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "database[chiave]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "response = req.get('https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6')\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "87\n",
      "Snippet 1:\n",
      "Status:    Final Report   Release Date:   October 22 , 201 5 Panel Date:   September 21 -22, 201 5                 The 20 15 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A . Hill, Ph.D. ; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and \n",
      "\n",
      "Snippet 2:\n",
      "e under the intended conditions of use in cosmetics . The Panel was concerned about the presence of alkylating and other agents that are used to modify polysaccharide gums in cosmetics.  Industry should use good manufacturing practices to limit impur ities.  INTRODUCTION    The safety of 106 polysaccharide gums (see Table s 1 and 2 ) as used in cosmetics is reviewed in this safety assessment.  The p\n",
      "\n",
      "Snippet 3:\n",
      "   Regardless of how they are structured, all of  the “moieties” that comprise the molecular structures of these ingredients are polymers composed of monosaccharides.   Although these  ingredients could be categorized in  multiple ways , all of these ingredients fall into two predominate categories, modified  and unmodified .  The ingredients in the Modified subgroup have  been further subdivided in\n",
      "\n",
      "Snippet 4:\n",
      "ns are listed in Table 2.   As a group , polysaccharide gums comprise polymers of simple saccharide monom ers.  Their substantial molecular sizes suggest that skin penetration of these ingredients would be unlikely.   Thus, these ingredients are unlikely to have significant systemic accessibility and any major decomposition products are likely to be simple sacc harides .   In addition, the Panel  ha\n",
      "\n",
      "Snippet 5:\n",
      "haride g ums are each naturally derived materials that comprise polysaccharides obtained from plants or algae.  Their substantial molecular sizes suggest that skin penetration of these ingredients would be unlikely.  While, for t he sake of clarity a nd organizatio n, these ingredients can be sub divided into categories such as linear, branched, cylic, modified, and unmodified, these moieties repres\n",
      "\n",
      "Snippet 6:\n",
      "entration of 0.34%.  Additionally, polysaccharide gums are used in powders  at concentrations up to 33% (tapioca starch).  Becaus e polysaccharide gums are used in products that are sprayed , they could possibly be inhaled.  In practice, 95% to 99% of the droplets/particles released from cosmetic sprays have aerodynamic equivalent dia meters >10 µm, with propellant sprays yielding a gr eater fractio\n",
      "\n",
      "Snippet 7:\n",
      "n of droplets/particles below 1 0 µm, compared with pump sprays .20,21,22,23  Therefore, mo st droplets/particles incidentally inhaled from cosmetic sprays would be deposited in the nasopharyngeal and bronchial regions and would not be respirable (i.e., they would not enter the l ungs) to any appreciable amount.20,21 There is some evi dence indicating that de\n",
      "\n",
      "Snippet 8:\n",
      "recognized that there is variability in medical conditions among infants requiring formulas for special medical purposes that contain the higher levels of carrageenan, and noted that these infants would normally be under medical supervision.  A summary of the discussion on which the Committee’s conclusion is based is summarized in the Repeated Dose Toxicity -Oral section of this report .   Inulin   \n",
      "\n",
      "Snippet 9:\n",
      ", cough drops, and candy lozenges.28  Sterculia Urens Gum    Sterculia urens  gum has the following uses in food:  formulation aid, stabilizer and thickener, and emulsifier and emulsifier salt.31  World Health Organization (WHO) reports affirming the safety of karaya gum as a food additive are available.32,33  Cyclic   Cyclodextrin    Cyclodextrins have been used to solubilize drugs in aqueous vehic\n",
      "\n",
      "Snippet 10:\n",
      "ered 14C-β-cyclodextrin.  The authors suggested, based on the results of this study, that the rate -determining step in β -cyclodextrin absorption is the enzymatic hydrolysis of β -cyclodextrin to yield linear dextrins, which are rapidly  hydrolyzed to maltose and glucose.37  Human   Branched - Unmodified   Starch Acetate   The pharmacokinetics of starch acetate (acetyl starch) and hydroxyethyl star\n",
      "\n",
      "Snippet 11:\n",
      "ch was studied using 2 groups of 16 surgical patients  (18 to 70 years old) .38  Patients in one group were initially infused intravenously ( i.v.) with 15 mL/kg of a 6% acetyl starch solution , and then  up to a maximal dos ing volume  of 1,000 mL/kg,  over a 30 -minute pe\n",
      "\n",
      "Snippet 12:\n",
      "um      Five male volunteers were involved in a study in which 24-h urine samples were collect ed prior to, and following, the ingestion  of 10 g karaya gum for 15 days.39  Total gum intake was 10 -fold greater than the  approved average daily intake ( ADI) of 0-12.5 mg/kg body weight .  The detection limit for rhamnose in the urine was 0.2 µg; however, rhamnose was not detected in any of the urine \n",
      "\n",
      "Snippet 13:\n",
      "specimens.   The authors noted that if 1% of the rhamnose in 10 g karaya gum appeared in the 24 -h urine specimens, it would have been detected.  Furthermore, the results of this study confirmed that dietary gum karaya i s neither digested nor degraded by enteric bacteria, and is not absorbed to any significant extent in t\n",
      "\n",
      "Snippet 14:\n",
      "he digestive tract.     Tapioca Starch   Ten men  (29 to 41 years old) participated in an oral exposure study.40 Blood was collected after a 12 -h fast. Tapioca starch (30 g) containing 0.1 g aspartame was d issolved in 150 L  of water, and  the solution or dispersion \n",
      "\n",
      "Snippet 15:\n",
      "n  of Thy  1.2 expression on the surface of the thymocytes. ANK -102 was classified as an immunosuppressive polysaccharide .   Potas sium Carrageenan    Male Sprague -Dawley rats (8 animals, 7 weeks old) were injected i.p. with potassium carrageenan (50 mg in 5 ml PBS).50  The control group received a single injection of PBS (0.5 ml).  At 3 weeks post -injection, serum levels of IgM, IgG and slow α \n",
      "\n",
      "Snippet 16:\n",
      "ted systemic immune responses after immunization.  Further processing reduced immunogenicity, although there was no evidence that systemic  immunity    to complex polysaccharide antigen  responses could be completely abolished  by processing or purification. Karaya  gum caused considerable footpad swelling when injected  intradermally.   Human   Branched - Modified   Propylene Glycol Alginate   Foll\n",
      "\n",
      "Snippet 17:\n",
      "f ACF, and 2.5% carrageenan promoted the growth of ACF in rats.  In another study, carrageenan (up to 5% in the diet) did not possess promoting activity for colorectal carcinogenesis in rats.  It should also be noted  that 5% carrageenan in the diet increased colonic cell proliferation in rats, but that it was concluded that this response was probably adaptive, and would not contribute to the increa\n",
      "\n",
      "Snippet 18:\n",
      "l Irritation and Sensitization   Skin irritation and sensitization studies on polysaccharide  gums are summarized in Table 12.  The results of animal and human tests indicate that these gums can be mild skin irritants, but are non -sensitizers.  Phototoxicity   Branched - Modified   Sodium Hydrolyzed Potato Starch Dodecenylsuccinate    The phototoxicity of a sodium hydrolyzed potato starch dodecenyl\n",
      "\n",
      "Snippet 19:\n",
      "was reported for each patient.  It was also noted that n o severe side effects were recorded during the trial.  Case Reports   Linear Polysaccharides and Their Salts  Calcium Alginate     A 50 -year-old woman was referred for treatment after the discovery of adenoid cystic carcinoma in an excised  left submandibular gland.57 Treatment involved clearing  the left submandibular fossa, and selective ne\n",
      "\n",
      "Snippet 20:\n",
      "e bleeding.   After an extended period , the pack was reported to have stimulated  a foreign body reaction which, on a computed tomogram,  mimicked a  recurrence of the tumo r.  Alginate  A 52 -year-old general practitioner  injected 0.1 ml of an alginate solution into the  deep dermis of her left arm.58 Ten days later, she observed a small pink nodule at the injection  site; a bluish papule  was ob\n",
      "\n",
      "Snippet 21:\n",
      "ons.59  The 40% incidence of this disfiguring effect  was considered high .    Sodium Carrageenan    Within minutes of receiving a barium enema solution that contained sodium carrageenan, a 26 -year-old female had an anaphylactic reaction associated with the following signs/symptoms:60  abdominal cramps, mild generalized pruritus, generalized urticaria, hypotension, transient loss of consciousness, \n",
      "\n",
      "Snippet 22:\n",
      " powder form, was placed in one eye of each of 6 New Zealand White rabbits (5 males, 1 female).66  Iritis was observed in 1 of 6 rabbits, and the reaction had cleared by 24 h post -administration.  Mild conjunctival irritation was observed in all 6 rabbits, and reactions had cleared by 48 h post -administration.  There was no evidence of corneal opacity  or abnormal physical signs in any of the anim\n",
      "\n",
      "Snippet 23:\n",
      "od, opacity was measured by passing visible light from an opacitometer through the cornea and on to the surface of a light sensor.  It was noted that a clear cornea unchanged by the test substance would allow light to pass through and be detected by the sensor.  Opaque corneas would produce light scattering (Tyndall effect) and reduced detection that is proportional to the degree of ocular damage. A\n",
      "\n",
      "Snippet 24:\n",
      "e required for the test substance to reduce tissue viability by 50% (ET 50).   An ET 50 > 4 h (non -irritant) was reported for the eye gel.  The positive control, Triton X -100, was classified as a mild irritant ( ET 50 = 28.8 minutes).   Branched – Modified   Hydroxypropyltrimonium Hydrolyzed Corn Starch   The ocular irritation potential of hydroxyp ropyltrimonium hydrolyzed corn starch was evaluat\n",
      "\n",
      "Snippet 25:\n",
      "abbit ocular irritation test.  The test substance (0.3 ml) w as administered to the CAM at concentrations of 5%, 10%, and 15%.  Results indicated that hydroxypropyltrimonium hydrolyzed corn starch would have practically no irritation potential in vivo .  It was noted that the CAM results at 5%, 10%, and 15% are equiv alent to Draize test results for the test substance at concentrations of 10%, 20%, \n",
      "\n",
      "Snippet 26:\n",
      "The concentration of konjac flour that caused a 50% decrease in the respiratory rate (RD 50) was 110 mg/m3.        A study was performed to investigate whether exposure to food grade konjac flour  could produce respiratory hypersensitivity.78  The composition of the sample tested was in agreement wi th Food Chemical Codex  specifications of <8% protein, >75% carbohydrate, and <5% ash.  Groups of mal\n",
      "\n",
      "Snippet 27:\n",
      "Polysaccharides and Their Salts  Carrageenan    Local  muscle inflammation was induced by injecting  carrageenan (10 mg/kg)  into the right tibialis  anterior muscle in 22 healthy ARC mice  (6 weeks old) .84  The contralateral muscle  was injected with sterile isotonic sali ne, and the muscles were  removed after 24 h for measurement of contractile function and  cytokine concentration. Carrageenan s\n",
      "\n",
      "Snippet 28:\n",
      "Additionally,    polysaccharide gums are used in cosmetic products (powders) at concentrations up to 33% (tapioca starch).  Because polysaccharide gums are used in products that are sprayed , they could possibly be inhaled.   Maltodextrin, t he most frequently used cosmetic ingredient reviewed in this safety assessment, is prepared as a white powder or concentrated solution by partial hydrolysis of \n",
      "\n",
      "Snippet 29:\n",
      "otato starch dodec enylsuccinate and corn-starch modified), 2,000 mg/kg corn starch modified, 2,000 mg/kg dextrin palmitate, 2,000 mg/kg dextrin myristate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  > 5,000 mg/kg body weigh t (rats) have been reported for glucomannan.   In acute dermal toxicity studies on corn starch modified, potato starch modifi\n",
      "\n",
      "Snippet 30:\n",
      "ed, dextrin myristate, and dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were reported for glu comannan in an acute dermal toxicity study involving rabbits.   Repeated dose oral toxicity studies on the following wer\n",
      "\n",
      "Snippet 31:\n",
      " rats), and sterculia urens gum (5 g/kg/day, rats; 7% in diet, rats).  Sodium alginate was nephrotoxic in mice, but results for starch acetate were of little, if any, toxicological significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were no remarkable findings in control rats dosed with inulin.  There were no toxicologically significant finding\n",
      "\n",
      "Snippet 32:\n",
      "starch modified) was mildly irritating to the skin of rabbits.  At a dose of 2,000 mg/kg in an acute dermal toxicity study, corn starch modified (30% solids in distilled water) was cla ssified as a mild skin irritant in rabbits.    Skin irritation was not obser ved in albino guinea pigs patch -tested with 100% carboxymethyl inulin. Erythema and edema were observed in an acute dermal toxicity study i\n",
      "\n",
      "Snippet 33:\n",
      "ds slurry of calcium starch isododecenylsuccinate (considered    structurally similar to sodium  hydrolyzed potato starch dodec enylsuccinate and corn -starch modified) was classified as a probable mild irritant in a 21 day cumulative skin irrit ation study involving 23 human subjects.   Algae exopolysaccharides (1%) did not cause skin irritation or sensitization in an HRIPT involving 50 subjects.  \n",
      "\n",
      "Snippet 34:\n",
      "er, feeding  with the test substance (calcium salt) at dietary concentrations up to 5% prior to mating in a three -generation feeding study, no specific external, skeletal, or soft -tissue anomaly could be correlated with dosage.  In a study in which calcium carrageenan  was fed at dietary concentrations up to 1.8% prior to mating, during breeding, and throughout gestation, lactation, and post -wean\n",
      "\n",
      "Snippet 35:\n",
      "ne ingredient to one subgroup of polysaccahrides, of which that ingredient or analog is a member.     The substantial molecular sizes of many of these polysaccharides suggest that skin penetration would be unlikely.   Specifically, the percutaneous absorption of 14C-2-hydroxypropyl -β-cyclodextrin through intact hairless mouse skin  was extremely low, i.e., approximately 0.02% of the amount applied \n",
      "\n",
      "Snippet 36:\n",
      "oducts that are sprayed or in powder form and agreed t hat, based on likely airborne particle size distributions and concentrations in the breathing zone and ingredient use , incidental inhalation would not lead to local respiratory effects or systemic effects.    The Panel expressed concern about pesticide resi dues and heavy metals that may be present in ingredients  txhat are derived from plants \n",
      "\n",
      "Snippet 37:\n",
      ".  They stressed that the cosmetics industry should continue to use current good manufacturing practices (cGMPs) to limit impurities.   The Panel also agreed that the same  suggestion is applicable to alkylating and other agents (e.g., haloethylaminop\n",
      "\n",
      "Snippet 38:\n",
      "yzed Triticum Spelta Starch * Hydrolyzed Wheat Starch   *Not reported to be in current use. Were ingredients in this group not in current use to be used in the future, the expectation is that they would be used in product categories and at concentrations comparable to others in this group.       Table 1 .  Names, CAS Registry Numbers, Definitions and Idealized Structures of the Polysaccharide Gums.1\n",
      "\n",
      "Snippet 39:\n",
      " is adjusted between 7 and 8 with alkaline (triethanolamine; sodium hydroxide solution, potassium hydroxide solution).  The sodium dextrin octenylsuccinate manufactured according to this method is so ld as a liquid. Method 3:  Dextrin solution and octenylsuccinic anhydr ide are esterified, whereby the pH value is adjusted between 7 and 8 with sodium hydroxide solution.  The solution is then dried.12\n",
      "\n",
      "Snippet 40:\n",
      "ride Gums  Starch Hydroxypropyltrimonium Chloride   Form:  Clear to slightly hazy liquid (clear in 1:5 water solution) .109   Dry Substance  (%) 31 -33.109   Color, Gardner: ≤ 2.5.109   Odor:  Very mild; slightly sweet .109   pH @ 20°C: 3.5-4.5.109    Method of Manufacture:  The starting materials for the production of starch hydroxypropyltrimonium chloride are:  oxidized starch and the catio nic re\n",
      "\n",
      "Snippet 41:\n",
      "f ~ 15,000 Da.35  Furthermore , according to another source, the molecular weight of poligeenan is in the range of 10,000 to 20,000 Da.141   Inulin  According to the Food Chemicals Codex , inulin should contain no more than the following: 1 mg/kg lead, 0.2% ash, and 15% (combined) of monosaccharides (as fructose and glucose) and disaccharides (as sucrose), calculated on the dried basis.115   Linear \n",
      "\n",
      "Snippet 42:\n",
      "t of quantification (i.e.,10 µg/kg) and  research pesticides at a concentration < the limit of quantification (i.e., 10 ng/g).  Maltode xtrin  According to the Food Chemicals Codex , maltodextrin should contain no more than the following:  0.5 mg/kg lead, 0.0025% sulfur dioxide, 1% maltodextrins produced from high -amylose starches, and 0.5% all other types of maltodextrins.115   Branched - Unmodifi\n",
      "\n",
      "Snippet 43:\n",
      "ing male and female rats (number and strain not stated).  An LC50 of  > 0.0015 mg/l was reported.151   Oral  Branched - Unmodified  Glucomannan:   Male and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:  appearance, behavior, body weight changes, occult blood in the urine and feces, or macroscopic findings.152   Glucomannan\n",
      "\n",
      "Snippet 44:\n",
      "  (in konjac flour) : Male and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151   Sterculia Urens Gum:  Vehicle: corn oil.  5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other toxic effects .153    Branched - Modified  Calcium Starch Isododecenylsuccinate : Material structurally similar to this gum tested. 5 m\n",
      "\n",
      "Snippet 45:\n",
      "ale and 5 female Wistar albino rats. OECD Guideline 401 test protocol.  Dosing followed by 14 -day observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154    Corn Starch Modified:  Vehicle: distilled water. 5 male and 5 female Wistar albino r ats.  Organisation for Economic Co -operation and Development (OECD) 401 pr\n",
      "\n",
      "Snippet 46:\n",
      "otocol. 14 -day observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66  Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67  Dextrin Palmitate: Rats (number and strain not stated).  LD 50 > 2,000 mg/kg body weight.68,69  Potato Starch Modified:   30% aqueous solution. Albino rats (5 males, 5 \n",
      "\n",
      "Snippet 47:\n",
      "females). OECD 401 protocol.  14 -day observation period.  Soft stool  (1 female); and no other signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155   Stearoyl Inulin: Rats (number and strain not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72  Dermal  Branched  - Unmodified  Glucomannan  (\n",
      "\n",
      "Snippet 48:\n",
      "in konjac flour) : Male and female rabbits (number and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151  Branched  - Modified  Carboxymethyl Inulin: 31.1% aqueous carboxymethyl inulin. 10 adult Dunkin –Hartley albino guinea pigs (4 weeks old). Maximization test. No mortal\n",
      "\n",
      "Snippet 49:\n",
      "rn starch modified (Amaze® [28 -1890]) in distilled water (30% solids). 5 male and 5 female New Zealand White rabbits.  OECD 402 protocol.  14 -day observation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66   Dextrin Myristate:   Rats (number and strain not stated).  Occlusive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67  Dextrin Palmitate: \n",
      "\n",
      "Snippet 50:\n",
      "  Rats (number and strain not stated).  Occlusive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69  Potato Starch Modified: 10 rats (strain n ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155   Potato Starch Modified:  18.5% solids aqueou\n",
      "\n",
      "Snippet 51:\n",
      " per cm2 was not stated.   Very slight to slight erythema/edema at application sites (all animals); reactions had cleared by 72 h.   S igns of local irritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70   Intravenous  Linear Polysaccharides and Their Salts  Carrageenan and Potassium Carrageenan:   ι-carrageenan (one subtype of carrageenan with a specific number and posit\n",
      "\n",
      "Snippet 52:\n",
      "mpound.158        Table 7 . Acute Toxicity Studies on Polysaccharide Gums      Intrapleural  Linear Polysaccharides and Their Salts  Carrageenan:   Groups of 6 adult female Balb/c mice (6 to 7 weeks old). One group  received  single intrapleural injection of 0.1 ml sterile saline (0.9% NaCl) and λ -carrageenan ( one subtype of carrageenan with a specific number and position of sulfate groups on the \n",
      "\n",
      "Snippet 53:\n",
      "injected with carrageenan and killed at 4 months, 3 were deemed inappropriate f or morphometry because of developing fibrosis, abscesses and/or emphysematous bullae in the lung s.  Thus, the lungs (mild to severe erythema observed) of the remaining 5 animals injected with carrageenan and of the 5 control rabbits killed at 4 months were prepared for morphometric analysis.  Scattered  infiltration of \n",
      "\n",
      "Snippet 54:\n",
      "hematology or clinical chemistry parameters, or on organ weights or ophthalmic, macroscopic or microscopic findings. Gast rointestinal tract appeared normal in detailed histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647 mg/kg/day in females).113    Carrageenan:  kappa/lambda -carrageenan (from C. crispus  or  G. \n",
      "\n",
      "Snippet 55:\n",
      "ere  not accompanied by degenerative changes or changes in kidney weight, and were considered non -toxic and suggestive of an adaptive response. No remarkable findings in control rats fed basal diet. NOAEL =  4. 4 g/kg/day.163 Ghatti Gum: Ghatti gum concentrations of 0, 0.5, 1.5 and 5%. Groups of Sprague -Dawley rat s (10 males/group, 10 females/group). Dietary feeding (in basal diet) for at least 90 d\n",
      "\n",
      "Snippet 56:\n",
      "n d females.  2 of 10 females in 5% ghatti gum group had a single colon ulcer, with associated acute inflammation.  Ulcers were considered  sporadic occurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044 and 3309 mg/kg/day, respectively.164 Ghatti Gum:  5% Ghatti gum. Groups of 20 female Sprague -Dawley rats. Dietary feeding  for  at least\n",
      "\n",
      "Snippet 57:\n",
      "sal  diet. Statistically significant alterations in clinical chemistry we re  considered sporadic and unrelated to treatment. Feed consumption among treated and control groups  similar for each sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164  Glucomannan:  10% konjac (plant consisting mostly of glucomannan). Groups of four male Sprague -Dawley rats were fe\n",
      "\n",
      "Snippet 58:\n",
      "n of toxicity.165,166        Table 8 . Repeated  Dose Toxicity Studies on Polysaccharide Gums   Branched - Unmodified   Glucomannan:  2.5%, 5%, or 10% refined konjac meal.   Groups of 12 five -week -old Sprague -Dawley rats of each sex .  Feeding with  either a normal basal diet, a hypercholesterolaemic diet (control diet containing 1% cholesterol), or one of three test diets.  Because refin ed konj\n",
      "\n",
      "Snippet 59:\n",
      "there was less thickening of the aortic wall.  These changes were related to less senescence in the treated group than in the control group.   No evidence of treatment -related pathological changes.  NOAEL = 1% konjac meal, equivalent to an intake of 500 mg/kg body weight per day.165   Pectin and Solanum Tuberosum (Potato) Starch:   Test diets containing 5% or 10% pectin -derived acidic oligosaccharide\n",
      "\n",
      "Snippet 60:\n",
      "ia of the transitional epithelium was observed in the kidney.  Administration of pAOS at dietary levels up to 10% (equivalent to 7.1 g/kg bo dy weight/day) did not reveal any relevant effects that could be attributed to the ingestion of acidic oligosaccharides.168  Starch Acetate:  55% Starch acetate (a chemically modified potato starch) in diet.  Mice (75 males and 75 females per test substance). F\n",
      "\n",
      "Snippet 61:\n",
      "ales)   did not cause toxicity.170      Table 8 . Repeated  Dose Toxicity Studies on Polysaccharide Gums  Oral - Human  Branched - Unmodified  Sterculia Urens Gum:  5 male volunteers (30 to 56 years old).  Ingestion of sterculia urens gum (10.5 g in diet) daily for 21 days. No toxicity or significant effects on plasma biochemistry, hematological indices, or urinalysis parameters were noted.171   Bra\n",
      "\n",
      "Snippet 62:\n",
      "s in hematologic test parameters, but these findi ngs were within historical control ranges for this strain of rat.  Signs of systemic toxicity not observed at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body weight/day.155   Potato Starch Modified:   10% solids aqueous solution. New Zealand albino rabbits (10 males and 10 females) tested; 20 rabbits (controls).  Applied to skin under a\n",
      "\n",
      "Snippet 63:\n",
      " Osborne -Mendel rats  Three -generation study. Feeding with 0.5, 1, 2.5, or 5% in diet 12 weeks prior to mating  In F 2c and F 3c litters, no specific external, skeletal, or soft -tissue  anomaly could be correlated with dosage .62  Calcium Carrageenan  Sprague -Dawley rats (number not stated)  Feeding with 0.45, 0.9, or 1.8% in diet prior to mating, during breeding, and throughout gestation, lacta\n",
      "\n",
      "Snippet 64:\n",
      "y and PCNA served as markers of cell proliferation. No increase in PCNA -positive cells. Increased thymidine kinase levels observed only in the 5% ι-carrageenan dietary group, corresponding to a 4 -fold increase  in colonic cell proliferation .183 Carrageenan :  ι-carrageenan.  F344 rats. Feeding in diet for 64 days, followed by 28 -day recovery period.  During recovery period, proliferating cells r\n",
      "\n",
      "Snippet 65:\n",
      "eturned to level similar to  those in rats fed control diet.  Results suggest that the quantitative changes in cell proliferation were probably adaptive, and would not contribute to an increased risk of colon neoplasia.183  Carrageenan :  0.1, 5, 15, and 25% carrageenan. Groups of 5 male and 5 female mice of two strains. Feeding in the diet for lifespan.  Add i\n",
      "\n",
      "Snippet 66:\n",
      "t native (undegraded) carrageenan is carcinogenic to experimental animals, and, in the absence of epidemi ological  data, that no evaluation of the carcinogenicity of native carra geenan in humans could be made.92 Inulin : Inulin -enriched diet (10% w/w).  Group of 10 to 15 Min/+ mice (has heterozygous mutation in the Apc gene, resulting in the truncated  Apc protein and development of numerous inte\n",
      "\n",
      "Snippet 67:\n",
      "les).  Application to skin  (2,000 mg/kg); dose per cm2 not stated.  Dermal reactions either absent or classified as barely perceptible at 24 -h and 48-h readings, and absent at the 74 -h reading.  Mild skin irritant (primary irritation index = 0.25).66  Corn Starch Modified:   Corn Starch Modified (up to 30%).  20 guinea pigs (strain not stated; 10 males, 10 females).  Maximization test (OECD proto\n",
      "\n",
      "Snippet 68:\n",
      "ial layer effects ranged from none to glazing with peeling and cracking.   50% w/v slurry caused milder reactions (cu mulative irritation score = 50.6).  Both test materials classified  as probable mild irritants under normal use conditions.63,64,210 Branched - Modified   Sodium Hydrolyzed Potato Starch Dodecenylsuccinate:   Cleanser containing 10 wt% sodium hydrolyzed potato starch dodecenylsuccina\n",
      "\n",
      "Snippet 69:\n",
      "te. 227 subjects (18 to 69 years old; 165 females, 62 males). HRIPT. During induction, occlusive patch containing ~ 0.2 g of the test material was applied to the back (area of application site not stated) for 24 h. week non -treatment p\n",
      "\n",
      "Snippet 70:\n",
      "r).  Substances  that damage this enzyme inhibit reduction of the tetrazolium salt.   Undiluted test substance (100 µl) added to millicells containing EpiDermTM samples;  time at which % viability would be 50% (ET 50) estimated.   Mild irritant  (ET 50 = 18.1h).213          References    1.  Nikitakis, J. and Breslawec H. P. International Cosmetic Ingredient Dictionary and Handbook. 14 ed. Washingto\n",
      "\n",
      "Snippet 71:\n",
      "n, DC: Personal Care Products Council, 2014.   2.  Johnson, W. Jr. Bergfeld W. F. Belsito D. V. Marks J. G. Jr. Shank R. C. Slaga T. J. Snyder P. W. Klaassen C. D. Liebler D. C. Hill R. A. and Andersen F. A. 2012. Final Report on the safety assessment of galactomannans. Unpu\n",
      "\n",
      "Snippet 72:\n",
      "blished report. Washington: Cosmetic Ingredient Review.    3.  Fiume, M. M. Heldreth B. A. Bergfeld W. F. Belsito D. V. Hill  R. A. Klaassen C. D. Liebler D. C. Marks J. G. Jr. Shank R. C. Slaga T. J. Snyder P. W. and Andersen F. A. 2012. Final safety assessment of microbial polysaccharide gums as \n",
      "\n",
      "Snippet 73:\n",
      "87;6(1):1 -22.   5.  Andersen, F. A. Annual review of cosmetic ingredient safety assessments - 2004/2005. Astragalus gummifer gum. International Journal of Toxicology .  2006;25(2):1 -89.   6.  Bergfeld, W. F. Belsito D. V. Snyder P. W. Klaassen C. D. Marks J. G. Jr. Shank R. C. Slaga T. J. and Andersen F. A. Final report on the safety assessment of aloe andongensis extract, aloe andongens is leaf j\n",
      "\n",
      "Snippet 74:\n",
      " polysacc harides, aloe barbadensis leaf water, aloe ferox leaf extract, aloe ferox leaf juice, and aloe ferox leaf juice extract. International Journal of Toxicology .  2007;26(2):1 -50.   7.  Bergfeld, W. F. Belsito D. V. Snyder P. W. Klaassen C. D. Marks J. G. Jr. Shank R. C. Slaga T. J. and Andersen F. A. Amended final report on the safety assessment of oryza sativa (rice) bran oil, oryza sativa\n",
      "\n",
      "Snippet 75:\n",
      "ydrolyzed rice bran extract, hydrolyzed rice bran protein, hydrolyzed rice extract, and hydrolyzed rice protein. International Journal of Toxicology .  2006;25(2):91 -120.   8.  Andersen, F. A. Bergfeld W. F. Belsito D. V. Klaassen C. D. Marks J. G. Jr. Shank R. C. Slaga T. J. and Snyder P. W. Final report of the safety assessment of cosmetic ingredients derived from zea mays (corn). Intern ational \n",
      "\n",
      "Snippet 76:\n",
      "Journal of Toxicology .  2011;30(1):17S -39S.   9.  Bergfeld, W. F. Belsito D. V. Snyder P. W. Klaassen C. D. Marks J. G. Jr. Shank R. C. Slaga T. J. and Andersen F. A. Final report on the safety assessment of acacia catechu gum, acacia concinna frui t extract\n",
      "\n",
      "Snippet 77:\n",
      "flower wax, acacia farnesiana gum, acacia senegal extract, acacia senegal gum, and acacia senegal gum extract. Interna tional Journal of Toxicology .  2005;24(3):75 -118.   10.  Johnson, W. Jr. Bergfeld W. F. Belsito D. V. Marks J. G. Jr. Shank R. C. Slaga T. J. Snyder P. W. Klaassen C. D. and Andersen F. A. Final report of the amended safety assessment of glyceryl laurate, glyceryl laurate SE, glyc\n",
      "\n",
      "Snippet 78:\n",
      "earate/acetate, glyceryl stearate/maleate, glyceryl tallowate, glyceryl thiopropionate, and glyceryl undecylenate. International Journal of Toxicology .  2006;25(2):55 -94.   11.  Becker, L. C. Bergfeld W. F. Belsito D. V. Klaassen C. D. Marks J. G. Jr. Shank R. C. Slaga T. J. Snyder P. W. and Andersen F. A. Final report of the safety assessment of hyaluronic acid, potassium  hyaluronate, and sodium\n",
      "\n",
      "Snippet 79:\n",
      "to starch dodecenylsuccinate. Unpublished data submitted by the Personal Care Products Council on 4 -8-2015. 2015.  pp.1   20.  Rothe H, Fautz R, Gerber E, Neumann L, Rettinger K, Schuh W, and Gronewold C . Special aspects of cosmetic spray safety evaluations: Principles on inhalation risk assessment. Toxicol Lett .  2011;205(2):97 -104.  PM:21669261.   21.  Bremmer HJ, Prud'homme de Lodder LCH, and\n",
      "\n",
      "Snippet 80:\n",
      " Hammack T. S. and Andrews W. H. Methods for the recovery of Salmonella  spp. from carboxymethylcellulose gum, gum ghatti, and gelatin. Journal of AOAC International .  1998;81(4):721 -726.   29.  World Health Organization. Joint FAO/WHO Expert Committee on Food Additives. Seventy -ninth meeting. Geneva, 17 -26 June 2014. Summary and Conclusions. Carrageenan for use in infant formula and formula for\n",
      "\n",
      "Snippet 81:\n",
      "FDA). Everything added to food in the United States (EAFUS). Listing of specific substances affirmed as GRAS . Karaya gum (sterculia gum). 21CFR:184.1349. www.fda.gov .  Last Updated  2014.   32.  World Health Organization (WHO). Seventeenth Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series No. 539. FAO Nutrition Meeting S eries No. 53. Geneva: World Health \n",
      "\n",
      "Snippet 82:\n",
      "Organization, 1974.   33.  World Health Organization (WHO). Evaluation of certain food additives and contaminants, JECFA 27. Technical Report Series No. 696. Geneva: World Health Organization, 1983.   34.  Loftsson, T. Hrei nsdottir D. and Masson M. Evaluation of cyclodextrin solubilization of drugs. Internatioinal Journal of Pharmaceuticals .  2005;302(1 -2):18 -28.  \n",
      "\n",
      "Snippet 83:\n",
      "Y. Kouzuki Y. Taniguchi K. Matsuda H. Arima H. and Tsuchiya S. Effect of 2-hydroxypropyl --cyclodextrin on percutaneous absorption of methyl paraben. J.Pharm.Pharmacol.   1995;47:897 -900.   42.  World Health Organization (WHO). Toxicological evaluation of certain food additives and contaminants. ß -Cyclodextrin. The forty -first meeting of the Joint FAO/WHO Expert Committee on Food Additives. WHO \n",
      "\n",
      "Snippet 84:\n",
      "Food Additiv e Series 32. 1993.  pp.173 -193. Geneva: World Health Organization.   43.  Olivier, P. Verwaerde F. and Hedges A. R. Subchronic tocicity of orally administered ß -cyclodextrin in rats. J.Am.Coll.Toxicol.   1991;10:407 -419.   44.  Bellringer, M. \n",
      "\n",
      "Snippet 85:\n",
      ". H. and Szejtli J. Pharmacokinetics and toxicology of cyclodextrins. Chapter: 3. Szejtli, J. and Szente L. In: Proc. of the 8th Int. Symposium on Cyclodextrins .  1996:33 -45.  46.  Perrin, J. H. Field F. P. Hansen D. A. Mufson R. A. and Torosian G. ß-cyclodextrin as an aid to peritoneal dialysis. Renal toxicity of ß -cyclodextrin in the rat.  Res.Commun.Chem.P athol.Pharmacol.   1978;19:373 -376. \n",
      "\n",
      "Snippet 86:\n",
      "omatous reaction after injection of a new resorbable filler Novabel. Am.J.Dermatopathol .  2011;33(7):710 -711.   59.  Schuller -Petrovic, S. Pavlovic M. D. Schuller S. s. Schuller -Lukic B. and Neuhold N. Early granulomatous foreign body reactions to a novel alginate dermal filler: the system's failure? JEADV .  2011;27:121 -123.   60.  Tarlo, S.  M. Dolovich J. and Listgarten C. Anaphylaxis to car\n",
      "\n",
      "Snippet 87:\n",
      "iauffreti J. Y. Martini M. C. Gonnet J. F. and Soulet G. Safety evaluation of gums and thickeners used in  cosmetic formulations. International Journal of Cosmetic Science .  1982;4:53 -66.   62.  World Health Organization. Safety evaluation of certain food additives. Carrageenan. Prepared by the fifty -first meeting of the Joint FAO/WHO Expert Committee of Food Additives (JECFA). WHO Food Additives\n",
      "\n",
      "Snippet 88:\n",
      "rs .  2011;8 6(4):1739 -1744.   104.  Elworthy, P. H. and George T. M. The molecular properties of ghatti gum: A naturally occurring polyelectrolyte. J.Pharm.Pharmacol.   1963;15:781 -793.   105.  World Health Organization (WHO). Toxicological evaluation of certain food a dditives and contaminants. Konjac flour.  World Health Organization (WHO) Food Additives Series 32. 1993. http://www.inchem.org/d\n",
      "\n",
      "Snippet 89:\n",
      "ride). Composition, product specifications, and technical data sheet. https:// www.lubrizol.com/PersonalCare/Products/Sensomer/CI -50.html .  Last Updated  2014. Date Accessed 10 -22-2014.   110.  Gould, S and Scott R. C. 2 -Hydroxy -ß-cyclodextrin (HP -ß-CD): A toxicology review. Food and Chemical Toxicology .  2005;43:1451 -1459.   111.  Toyoda, K. Sjhoda T. Uneyama C. Takada K. and Takahashi M. C\n",
      "\n",
      "Snippet 90:\n",
      "h Institute. Study of mutagenic effects of sterculia gum (karaya), FDA No. 71 -17.  NTIS Report No. PB221823. 1972.  pp.1 -91.   154.  MB Research Laboratories, Inc. Single dose oral toxicity in rats/LD 50 in rats.  Test article # 73 -8050.  Unpublished data submitted by AkzoNobel on 4 -14-2014. 1996.  pp.1 -5.   155.  Austrialian Government Department of Health. National Industrial Chemicals Notificat\n",
      "\n",
      "Snippet 91:\n",
      "pot, R. R. Davis J. Moser G. Giri D. K . and Hayashi S. Evaluation of 90 -day oral rat toxicity studies on the food additive, gum ghatti.  Food and Chemical Toxicology .  2012;51:215 -224.   165.  World Health Organization (WHO). Toxicological evaluation of certain food additives. Konjac flour. WHO  Food Additive Series 37. 1996. http://www.inchem.org/documents/jecfa/jecmono/v37je04.htm .  Last Upda\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def sorting_func(el):\n",
    "    return el[0].split(' ')[0]\n",
    "\n",
    "response = req.get('https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6')\n",
    "\n",
    "\n",
    "file = BytesIO(response.content)\n",
    "pdf_text=pdf.PdfReader(file)\n",
    "print(len(pdf_text.pages))\n",
    "text = ''.join([x.extract_text() for x in pdf_text.pages])\n",
    "text = text.replace('\\n','').replace('\\r','')\n",
    "pattern = r'(.{0,200})(\\bNOAEL|LD50|LD 50|LD\\b)(.{0,200})'\n",
    "values = re.findall(pattern,text,re.IGNORECASE)\n",
    "results = [\"\".join(match) for match in values]\n",
    "for i, snippet in enumerate(results):\n",
    "    print(f\"Snippet {i+1}:\\n{snippet}\\n\")\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "87\n"
     ]
    }
   ],
   "source": [
    "def sorting_func(el):\n",
    "    return el[0].split(' ')[0]\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "with open('pdf.txt','rb') as file:\n",
    "    pdf_text=pdf.PdfReader(file)\n",
    "    print(len(pdf_text.pages))\n",
    "    text = ''.join([x.extract_text() for x in pdf_text.pages])\n",
    "    text = text.replace('\\n','').replace('\\r','')\n",
    "    pattern = r'([\\.][^.!?]*?\\bLD50|LD 50\\b[^.!?]*[.!?])'\n",
    "    values = re.findall(pattern,text,re.IGNORECASE)\n",
    "    final_values = []\n",
    "    for i in range(len(values)):\n",
    "        value_pattern = r'\\b\\d+\\s*.g/kg\\s*bw\\b'\n",
    "        noael = re.findall(value_pattern,values[i])\n",
    "        if noael:\n",
    "            if len(noael) == 1:\n",
    "                final_values.append((noael[0],values[i]))\n",
    "            else:\n",
    "                for el in noael:\n",
    "                    final_values.append((el,values[i]))\n",
    "\n",
    "    final_values.sort(key=sorting_func)\n",
    "    \n",
    "    for el in final_values:\n",
    "        print(el)\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "dataframe = pd.DataFrame({'Nome comune':[],\n",
    "                                  'Nome INCI': [],\n",
    "                                  'stem_pdf_link':[],\n",
    "                                  'full_pdf_link':[],\n",
    "                                  'NOAEL':[],\n",
    "                                  'LD50':[]})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "ename": "ValueError",
     "evalue": "All arrays must be of the same length",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mValueError\u001b[0m                                Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[21], line 1\u001b[0m\n\u001b[1;32m----> 1\u001b[0m df \u001b[38;5;241m=\u001b[39m \u001b[43mcir\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43maggiorna_database\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m      3\u001b[0m df\u001b[38;5;241m.\u001b[39mhead()\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\project_work_its\\CosmeticIngredientReview.py:32\u001b[0m, in \u001b[0;36maggiorna_database\u001b[1;34m()\u001b[0m\n\u001b[0;32m     29\u001b[0m         diz[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mNome INCI\u001b[39m\u001b[38;5;124m'\u001b[39m]\u001b[38;5;241m.\u001b[39mappend(el[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mpcpc_ciringredientname\u001b[39m\u001b[38;5;124m'\u001b[39m])\n\u001b[0;32m     30\u001b[0m         diz[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mstem_pdf_link\u001b[39m\u001b[38;5;124m'\u001b[39m]\u001b[38;5;241m.\u001b[39mappend(url_base\u001b[38;5;241m+\u001b[39mel[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mpcpc_ingredientid\u001b[39m\u001b[38;5;124m'\u001b[39m])\n\u001b[1;32m---> 32\u001b[0m dataframe \u001b[38;5;241m=\u001b[39m \u001b[43mpd\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mDataFrame\u001b[49m\u001b[43m(\u001b[49m\u001b[43mdiz\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m     33\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m dataframe\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\pandas\\core\\frame.py:778\u001b[0m, in \u001b[0;36mDataFrame.__init__\u001b[1;34m(self, data, index, columns, dtype, copy)\u001b[0m\n\u001b[0;32m    772\u001b[0m     mgr \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_init_mgr(\n\u001b[0;32m    773\u001b[0m         data, axes\u001b[38;5;241m=\u001b[39m{\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mindex\u001b[39m\u001b[38;5;124m\"\u001b[39m: index, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mcolumns\u001b[39m\u001b[38;5;124m\"\u001b[39m: columns}, dtype\u001b[38;5;241m=\u001b[39mdtype, copy\u001b[38;5;241m=\u001b[39mcopy\n\u001b[0;32m    774\u001b[0m     )\n\u001b[0;32m    776\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(data, \u001b[38;5;28mdict\u001b[39m):\n\u001b[0;32m    777\u001b[0m     \u001b[38;5;66;03m# GH#38939 de facto copy defaults to False only in non-dict cases\u001b[39;00m\n\u001b[1;32m--> 778\u001b[0m     mgr \u001b[38;5;241m=\u001b[39m \u001b[43mdict_to_mgr\u001b[49m\u001b[43m(\u001b[49m\u001b[43mdata\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mindex\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mcolumns\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mdtype\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mdtype\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mcopy\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcopy\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtyp\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mmanager\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    779\u001b[0m \u001b[38;5;28;01melif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(data, ma\u001b[38;5;241m.\u001b[39mMaskedArray):\n\u001b[0;32m    780\u001b[0m     \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mnumpy\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mma\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m mrecords\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\pandas\\core\\internals\\construction.py:503\u001b[0m, in \u001b[0;36mdict_to_mgr\u001b[1;34m(data, index, columns, dtype, typ, copy)\u001b[0m\n\u001b[0;32m    499\u001b[0m     \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m    500\u001b[0m         \u001b[38;5;66;03m# dtype check to exclude e.g. range objects, scalars\u001b[39;00m\n\u001b[0;32m    501\u001b[0m         arrays \u001b[38;5;241m=\u001b[39m [x\u001b[38;5;241m.\u001b[39mcopy() \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mhasattr\u001b[39m(x, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mdtype\u001b[39m\u001b[38;5;124m\"\u001b[39m) \u001b[38;5;28;01melse\u001b[39;00m x \u001b[38;5;28;01mfor\u001b[39;00m x \u001b[38;5;129;01min\u001b[39;00m arrays]\n\u001b[1;32m--> 503\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43marrays_to_mgr\u001b[49m\u001b[43m(\u001b[49m\u001b[43marrays\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mcolumns\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mindex\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mdtype\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mdtype\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtyp\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtyp\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mconsolidate\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcopy\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\pandas\\core\\internals\\construction.py:114\u001b[0m, in \u001b[0;36marrays_to_mgr\u001b[1;34m(arrays, columns, index, dtype, verify_integrity, typ, consolidate)\u001b[0m\n\u001b[0;32m    111\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m verify_integrity:\n\u001b[0;32m    112\u001b[0m     \u001b[38;5;66;03m# figure out the index, if necessary\u001b[39;00m\n\u001b[0;32m    113\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m index \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[1;32m--> 114\u001b[0m         index \u001b[38;5;241m=\u001b[39m \u001b[43m_extract_index\u001b[49m\u001b[43m(\u001b[49m\u001b[43marrays\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    115\u001b[0m     \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m    116\u001b[0m         index \u001b[38;5;241m=\u001b[39m ensure_index(index)\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\pandas\\core\\internals\\construction.py:677\u001b[0m, in \u001b[0;36m_extract_index\u001b[1;34m(data)\u001b[0m\n\u001b[0;32m    675\u001b[0m lengths \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mlist\u001b[39m(\u001b[38;5;28mset\u001b[39m(raw_lengths))\n\u001b[0;32m    676\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mlen\u001b[39m(lengths) \u001b[38;5;241m>\u001b[39m \u001b[38;5;241m1\u001b[39m:\n\u001b[1;32m--> 677\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mValueError\u001b[39;00m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mAll arrays must be of the same length\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m    679\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m have_dicts:\n\u001b[0;32m    680\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mValueError\u001b[39;00m(\n\u001b[0;32m    681\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mMixing dicts with non-Series may lead to ambiguous ordering.\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[0;32m    682\u001b[0m     )\n",
      "\u001b[1;31mValueError\u001b[0m: All arrays must be of the same length"
     ]
    }
   ],
   "source": [
    "df = cir.aggiorna_database()\n",
    "\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[19], line 1\u001b[0m\n\u001b[1;32m----> 1\u001b[0m df \u001b[38;5;241m=\u001b[39m \u001b[43mcir\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43maggiorna_database\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m      3\u001b[0m df\u001b[38;5;241m.\u001b[39mhead()\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\project_work_its\\CosmeticIngredientReview.py:23\u001b[0m, in \u001b[0;36maggiorna_database\u001b[1;34m()\u001b[0m\n\u001b[0;32m     13\u001b[0m diz \u001b[38;5;241m=\u001b[39m {\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mNome comune\u001b[39m\u001b[38;5;124m'\u001b[39m:[],\n\u001b[0;32m     14\u001b[0m         \u001b[38;5;124m'\u001b[39m\u001b[38;5;124mNome INCI\u001b[39m\u001b[38;5;124m'\u001b[39m: [],\n\u001b[0;32m     15\u001b[0m         \u001b[38;5;124m'\u001b[39m\u001b[38;5;124mstem_pdf_link\u001b[39m\u001b[38;5;124m'\u001b[39m:[],\n\u001b[0;32m     16\u001b[0m         \u001b[38;5;124m'\u001b[39m\u001b[38;5;124mfull_pdf_link\u001b[39m\u001b[38;5;124m'\u001b[39m:[],\n\u001b[0;32m     17\u001b[0m         \u001b[38;5;124m'\u001b[39m\u001b[38;5;124mNOAEL\u001b[39m\u001b[38;5;124m'\u001b[39m:[],\n\u001b[0;32m     18\u001b[0m         \u001b[38;5;124m'\u001b[39m\u001b[38;5;124mLD50\u001b[39m\u001b[38;5;124m'\u001b[39m:[]}\n\u001b[0;32m     21\u001b[0m \u001b[38;5;28;01mfor\u001b[39;00m i \u001b[38;5;129;01min\u001b[39;00m \u001b[38;5;28mrange\u001b[39m(\u001b[38;5;241m1\u001b[39m,\u001b[38;5;241m3\u001b[39m):\n\u001b[1;32m---> 23\u001b[0m     table \u001b[38;5;241m=\u001b[39m \u001b[43mreq\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mget\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;124;43mf\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;132;43;01m{\u001b[39;49;00m\u001b[43mrequest\u001b[49m\u001b[38;5;132;43;01m}\u001b[39;49;00m\u001b[38;5;132;43;01m{\u001b[39;49;00m\u001b[43mi\u001b[49m\u001b[38;5;132;43;01m}\u001b[39;49;00m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43mheaders\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mheader\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m     24\u001b[0m     table \u001b[38;5;241m=\u001b[39m table\u001b[38;5;241m.\u001b[39mjson()\n\u001b[0;32m     26\u001b[0m     \u001b[38;5;28;01mfor\u001b[39;00m el \u001b[38;5;129;01min\u001b[39;00m table[\u001b[38;5;124m'\u001b[39m\u001b[38;5;124mresults\u001b[39m\u001b[38;5;124m'\u001b[39m]:\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\requests\\api.py:73\u001b[0m, in \u001b[0;36mget\u001b[1;34m(url, params, **kwargs)\u001b[0m\n\u001b[0;32m     62\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21mget\u001b[39m(url, params\u001b[38;5;241m=\u001b[39m\u001b[38;5;28;01mNone\u001b[39;00m, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs):\n\u001b[0;32m     63\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124mr\u001b[39m\u001b[38;5;124;03m\"\"\"Sends a GET request.\u001b[39;00m\n\u001b[0;32m     64\u001b[0m \n\u001b[0;32m     65\u001b[0m \u001b[38;5;124;03m    :param url: URL for the new :class:`Request` object.\u001b[39;00m\n\u001b[1;32m   (...)\u001b[0m\n\u001b[0;32m     70\u001b[0m \u001b[38;5;124;03m    :rtype: requests.Response\u001b[39;00m\n\u001b[0;32m     71\u001b[0m \u001b[38;5;124;03m    \"\"\"\u001b[39;00m\n\u001b[1;32m---> 73\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mrequest\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mget\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mparams\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mparams\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\requests\\api.py:59\u001b[0m, in \u001b[0;36mrequest\u001b[1;34m(method, url, **kwargs)\u001b[0m\n\u001b[0;32m     55\u001b[0m \u001b[38;5;66;03m# By using the 'with' statement we are sure the session is closed, thus we\u001b[39;00m\n\u001b[0;32m     56\u001b[0m \u001b[38;5;66;03m# avoid leaving sockets open which can trigger a ResourceWarning in some\u001b[39;00m\n\u001b[0;32m     57\u001b[0m \u001b[38;5;66;03m# cases, and look like a memory leak in others.\u001b[39;00m\n\u001b[0;32m     58\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m sessions\u001b[38;5;241m.\u001b[39mSession() \u001b[38;5;28;01mas\u001b[39;00m session:\n\u001b[1;32m---> 59\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43msession\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mrequest\u001b[49m\u001b[43m(\u001b[49m\u001b[43mmethod\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mmethod\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43murl\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\requests\\sessions.py:589\u001b[0m, in \u001b[0;36mSession.request\u001b[1;34m(self, method, url, params, data, headers, cookies, files, auth, timeout, allow_redirects, proxies, hooks, stream, verify, cert, json)\u001b[0m\n\u001b[0;32m    584\u001b[0m send_kwargs \u001b[38;5;241m=\u001b[39m {\n\u001b[0;32m    585\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mtimeout\u001b[39m\u001b[38;5;124m\"\u001b[39m: timeout,\n\u001b[0;32m    586\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mallow_redirects\u001b[39m\u001b[38;5;124m\"\u001b[39m: allow_redirects,\n\u001b[0;32m    587\u001b[0m }\n\u001b[0;32m    588\u001b[0m send_kwargs\u001b[38;5;241m.\u001b[39mupdate(settings)\n\u001b[1;32m--> 589\u001b[0m resp \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43msend\u001b[49m\u001b[43m(\u001b[49m\u001b[43mprep\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43msend_kwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    591\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m resp\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\requests\\sessions.py:703\u001b[0m, in \u001b[0;36mSession.send\u001b[1;34m(self, request, **kwargs)\u001b[0m\n\u001b[0;32m    700\u001b[0m start \u001b[38;5;241m=\u001b[39m preferred_clock()\n\u001b[0;32m    702\u001b[0m \u001b[38;5;66;03m# Send the request\u001b[39;00m\n\u001b[1;32m--> 703\u001b[0m r \u001b[38;5;241m=\u001b[39m \u001b[43madapter\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43msend\u001b[49m\u001b[43m(\u001b[49m\u001b[43mrequest\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    705\u001b[0m \u001b[38;5;66;03m# Total elapsed time of the request (approximately)\u001b[39;00m\n\u001b[0;32m    706\u001b[0m elapsed \u001b[38;5;241m=\u001b[39m preferred_clock() \u001b[38;5;241m-\u001b[39m start\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\requests\\adapters.py:667\u001b[0m, in \u001b[0;36mHTTPAdapter.send\u001b[1;34m(self, request, stream, timeout, verify, cert, proxies)\u001b[0m\n\u001b[0;32m    664\u001b[0m     timeout \u001b[38;5;241m=\u001b[39m TimeoutSauce(connect\u001b[38;5;241m=\u001b[39mtimeout, read\u001b[38;5;241m=\u001b[39mtimeout)\n\u001b[0;32m    666\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m--> 667\u001b[0m     resp \u001b[38;5;241m=\u001b[39m \u001b[43mconn\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43murlopen\u001b[49m\u001b[43m(\u001b[49m\n\u001b[0;32m    668\u001b[0m \u001b[43m        \u001b[49m\u001b[43mmethod\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrequest\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mmethod\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    669\u001b[0m \u001b[43m        \u001b[49m\u001b[43murl\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    670\u001b[0m \u001b[43m        \u001b[49m\u001b[43mbody\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrequest\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mbody\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    671\u001b[0m \u001b[43m        \u001b[49m\u001b[43mheaders\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mrequest\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mheaders\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    672\u001b[0m \u001b[43m        \u001b[49m\u001b[43mredirect\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[0;32m    673\u001b[0m \u001b[43m        \u001b[49m\u001b[43massert_same_host\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[0;32m    674\u001b[0m \u001b[43m        \u001b[49m\u001b[43mpreload_content\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[0;32m    675\u001b[0m \u001b[43m        \u001b[49m\u001b[43mdecode_content\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mFalse\u001b[39;49;00m\u001b[43m,\u001b[49m\n\u001b[0;32m    676\u001b[0m \u001b[43m        \u001b[49m\u001b[43mretries\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mmax_retries\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    677\u001b[0m \u001b[43m        \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtimeout\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    678\u001b[0m \u001b[43m        \u001b[49m\u001b[43mchunked\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mchunked\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    679\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    681\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m (ProtocolError, \u001b[38;5;167;01mOSError\u001b[39;00m) \u001b[38;5;28;01mas\u001b[39;00m err:\n\u001b[0;32m    682\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mConnectionError\u001b[39;00m(err, request\u001b[38;5;241m=\u001b[39mrequest)\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\urllib3\\connectionpool.py:793\u001b[0m, in \u001b[0;36mHTTPConnectionPool.urlopen\u001b[1;34m(self, method, url, body, headers, retries, redirect, assert_same_host, timeout, pool_timeout, release_conn, chunked, body_pos, preload_content, decode_content, **response_kw)\u001b[0m\n\u001b[0;32m    790\u001b[0m response_conn \u001b[38;5;241m=\u001b[39m conn \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m release_conn \u001b[38;5;28;01melse\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[0;32m    792\u001b[0m \u001b[38;5;66;03m# Make the request on the HTTPConnection object\u001b[39;00m\n\u001b[1;32m--> 793\u001b[0m response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_make_request\u001b[49m\u001b[43m(\u001b[49m\n\u001b[0;32m    794\u001b[0m \u001b[43m    \u001b[49m\u001b[43mconn\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    795\u001b[0m \u001b[43m    \u001b[49m\u001b[43mmethod\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    796\u001b[0m \u001b[43m    \u001b[49m\u001b[43murl\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    797\u001b[0m \u001b[43m    \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtimeout_obj\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    798\u001b[0m \u001b[43m    \u001b[49m\u001b[43mbody\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mbody\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    799\u001b[0m \u001b[43m    \u001b[49m\u001b[43mheaders\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mheaders\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    800\u001b[0m \u001b[43m    \u001b[49m\u001b[43mchunked\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mchunked\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    801\u001b[0m \u001b[43m    \u001b[49m\u001b[43mretries\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mretries\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    802\u001b[0m \u001b[43m    \u001b[49m\u001b[43mresponse_conn\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mresponse_conn\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    803\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpreload_content\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpreload_content\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    804\u001b[0m \u001b[43m    \u001b[49m\u001b[43mdecode_content\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mdecode_content\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    805\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mresponse_kw\u001b[49m\u001b[43m,\u001b[49m\n\u001b[0;32m    806\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    808\u001b[0m \u001b[38;5;66;03m# Everything went great!\u001b[39;00m\n\u001b[0;32m    809\u001b[0m clean_exit \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mTrue\u001b[39;00m\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\urllib3\\connectionpool.py:537\u001b[0m, in \u001b[0;36mHTTPConnectionPool._make_request\u001b[1;34m(self, conn, method, url, body, headers, retries, timeout, chunked, response_conn, preload_content, decode_content, enforce_content_length)\u001b[0m\n\u001b[0;32m    535\u001b[0m \u001b[38;5;66;03m# Receive the response from the server\u001b[39;00m\n\u001b[0;32m    536\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m--> 537\u001b[0m     response \u001b[38;5;241m=\u001b[39m \u001b[43mconn\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mgetresponse\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    538\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m (BaseSSLError, \u001b[38;5;167;01mOSError\u001b[39;00m) \u001b[38;5;28;01mas\u001b[39;00m e:\n\u001b[0;32m    539\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_raise_timeout(err\u001b[38;5;241m=\u001b[39me, url\u001b[38;5;241m=\u001b[39murl, timeout_value\u001b[38;5;241m=\u001b[39mread_timeout)\n",
      "File \u001b[1;32mc:\\Users\\LucaGiovagnoli\\github\\personal_projects\\project_work_its\\pw_01\\Lib\\site-packages\\urllib3\\connection.py:466\u001b[0m, in \u001b[0;36mHTTPConnection.getresponse\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    463\u001b[0m \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mresponse\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m HTTPResponse\n\u001b[0;32m    465\u001b[0m \u001b[38;5;66;03m# Get the response from http.client.HTTPConnection\u001b[39;00m\n\u001b[1;32m--> 466\u001b[0m httplib_response \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43msuper\u001b[39;49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mgetresponse\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    468\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m    469\u001b[0m     assert_header_parsing(httplib_response\u001b[38;5;241m.\u001b[39mmsg)\n",
      "File \u001b[1;32m~\\AppData\\Local\\Programs\\Python\\Python312\\Lib\\http\\client.py:1428\u001b[0m, in \u001b[0;36mHTTPConnection.getresponse\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m   1426\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m   1427\u001b[0m     \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m-> 1428\u001b[0m         \u001b[43mresponse\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mbegin\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m   1429\u001b[0m     \u001b[38;5;28;01mexcept\u001b[39;00m \u001b[38;5;167;01mConnectionError\u001b[39;00m:\n\u001b[0;32m   1430\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mclose()\n",
      "File \u001b[1;32m~\\AppData\\Local\\Programs\\Python\\Python312\\Lib\\http\\client.py:331\u001b[0m, in \u001b[0;36mHTTPResponse.begin\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    329\u001b[0m \u001b[38;5;66;03m# read until we get a non-100 response\u001b[39;00m\n\u001b[0;32m    330\u001b[0m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[1;32m--> 331\u001b[0m     version, status, reason \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_read_status\u001b[49m\u001b[43m(\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    332\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m status \u001b[38;5;241m!=\u001b[39m CONTINUE:\n\u001b[0;32m    333\u001b[0m         \u001b[38;5;28;01mbreak\u001b[39;00m\n",
      "File \u001b[1;32m~\\AppData\\Local\\Programs\\Python\\Python312\\Lib\\http\\client.py:292\u001b[0m, in \u001b[0;36mHTTPResponse._read_status\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    291\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m_read_status\u001b[39m(\u001b[38;5;28mself\u001b[39m):\n\u001b[1;32m--> 292\u001b[0m     line \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mstr\u001b[39m(\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfp\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mreadline\u001b[49m\u001b[43m(\u001b[49m\u001b[43m_MAXLINE\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m+\u001b[39;49m\u001b[43m \u001b[49m\u001b[38;5;241;43m1\u001b[39;49m\u001b[43m)\u001b[49m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124miso-8859-1\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[0;32m    293\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mlen\u001b[39m(line) \u001b[38;5;241m>\u001b[39m _MAXLINE:\n\u001b[0;32m    294\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m LineTooLong(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mstatus line\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n",
      "File \u001b[1;32m~\\AppData\\Local\\Programs\\Python\\Python312\\Lib\\socket.py:707\u001b[0m, in \u001b[0;36mSocketIO.readinto\u001b[1;34m(self, b)\u001b[0m\n\u001b[0;32m    705\u001b[0m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[0;32m    706\u001b[0m     \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m--> 707\u001b[0m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_sock\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mrecv_into\u001b[49m\u001b[43m(\u001b[49m\u001b[43mb\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m    708\u001b[0m     \u001b[38;5;28;01mexcept\u001b[39;00m timeout:\n\u001b[0;32m    709\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_timeout_occurred \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mTrue\u001b[39;00m\n",
      "File \u001b[1;32m~\\AppData\\Local\\Programs\\Python\\Python312\\Lib\\ssl.py:1252\u001b[0m, in \u001b[0;36mSSLSocket.recv_into\u001b[1;34m(self, buffer, nbytes, flags)\u001b[0m\n\u001b[0;32m   1248\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m flags \u001b[38;5;241m!=\u001b[39m \u001b[38;5;241m0\u001b[39m:\n\u001b[0;32m   1249\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mValueError\u001b[39;00m(\n\u001b[0;32m   1250\u001b[0m           \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mnon-zero flags not allowed in calls to recv_into() on \u001b[39m\u001b[38;5;132;01m%s\u001b[39;00m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;241m%\u001b[39m\n\u001b[0;32m   1251\u001b[0m           \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m\u001b[38;5;18m__class__\u001b[39m)\n\u001b[1;32m-> 1252\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mread\u001b[49m\u001b[43m(\u001b[49m\u001b[43mnbytes\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mbuffer\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m   1253\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m   1254\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28msuper\u001b[39m()\u001b[38;5;241m.\u001b[39mrecv_into(buffer, nbytes, flags)\n",
      "File \u001b[1;32m~\\AppData\\Local\\Programs\\Python\\Python312\\Lib\\ssl.py:1104\u001b[0m, in \u001b[0;36mSSLSocket.read\u001b[1;34m(self, len, buffer)\u001b[0m\n\u001b[0;32m   1102\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[0;32m   1103\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m buffer \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[1;32m-> 1104\u001b[0m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_sslobj\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mread\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mlen\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mbuffer\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m   1105\u001b[0m     \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[0;32m   1106\u001b[0m         \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_sslobj\u001b[38;5;241m.\u001b[39mread(\u001b[38;5;28mlen\u001b[39m)\n",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "df = cir.aggiorna_database()\n",
    "\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Nome comune</th>\n",
       "      <th>Nome INCI</th>\n",
       "      <th>page_link</th>\n",
       "      <th>pdf_link</th>\n",
       "      <th>NOAEL</th>\n",
       "      <th>LD50</th>\n",
       "      <th>Data</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1,10-Decanediol</td>\n",
       "      <td>1,10-Decanediol</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1,2,4-Trihydroxybenzene</td>\n",
       "      <td>1,2,4-Trihydroxybenzene</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1,2-Butanediol</td>\n",
       "      <td>1,2-Butanediol</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1,2-Hexanediol</td>\n",
       "      <td>1,2-Hexanediol</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1,4-Butanediol</td>\n",
       "      <td>1,4-Butanediol</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7782</th>\n",
       "      <td>Zingiber Officinale (Ginger) Root Oil</td>\n",
       "      <td>Zingiber Officinale (Ginger) Root Oil</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7783</th>\n",
       "      <td>Zingiber Officinale (Ginger) Root Powder</td>\n",
       "      <td>Zingiber Officinale (Ginger) Root Powder</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7784</th>\n",
       "      <td>Zingiber Officinale (Ginger) Water</td>\n",
       "      <td>Zingiber Officinale (Ginger) Water</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7785</th>\n",
       "      <td>Zirconium Silicate</td>\n",
       "      <td>Zirconium Silicate</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7786</th>\n",
       "      <td>Zirconium Silicate</td>\n",
       "      <td>Zirconium Silicate</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>7787 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                   Nome comune  \\\n",
       "0                              1,10-Decanediol   \n",
       "1                      1,2,4-Trihydroxybenzene   \n",
       "2                               1,2-Butanediol   \n",
       "3                               1,2-Hexanediol   \n",
       "4                               1,4-Butanediol   \n",
       "...                                        ...   \n",
       "7782     Zingiber Officinale (Ginger) Root Oil   \n",
       "7783  Zingiber Officinale (Ginger) Root Powder   \n",
       "7784        Zingiber Officinale (Ginger) Water   \n",
       "7785                        Zirconium Silicate   \n",
       "7786                        Zirconium Silicate   \n",
       "\n",
       "                                     Nome INCI  \\\n",
       "0                              1,10-Decanediol   \n",
       "1                      1,2,4-Trihydroxybenzene   \n",
       "2                               1,2-Butanediol   \n",
       "3                               1,2-Hexanediol   \n",
       "4                               1,4-Butanediol   \n",
       "...                                        ...   \n",
       "7782     Zingiber Officinale (Ginger) Root Oil   \n",
       "7783  Zingiber Officinale (Ginger) Root Powder   \n",
       "7784        Zingiber Officinale (Ginger) Water   \n",
       "7785                        Zirconium Silicate   \n",
       "7786                        Zirconium Silicate   \n",
       "\n",
       "                                              page_link  pdf_link  NOAEL  \\\n",
       "0     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "1     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "2     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "3     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "4     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "...                                                 ...       ...    ...   \n",
       "7782  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "7783  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "7784  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "7785  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "7786  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "\n",
       "      LD50  Data  \n",
       "0        0     0  \n",
       "1        0     0  \n",
       "2        0     0  \n",
       "3        0     0  \n",
       "4        0     0  \n",
       "...    ...   ...  \n",
       "7782     0     0  \n",
       "7783     0     0  \n",
       "7784     0     0  \n",
       "7785     0     0  \n",
       "7786     0     0  \n",
       "\n",
       "[7787 rows x 7 columns]"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "url_base = 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id='\n",
    "request = 'https://cir-reports.cir-safety.org/FetchCIRReports/?&pagingcookie=%26lt%3bcookie%20page%3d%26quot%3b1%26quot%3b%26gt%3b%26lt%3bpcpc_name%20last%3d%26quot%3bPEG-50%20Stearate%26quot%3b%20first%3d%26quot%3b1%2c10-Decanediol%26quot%3b%20%2f%26gt%3b%26lt%3bpcpc_ingredientidname%20last%3d%26quot%3bPEG-50%20Stearate%26quot%3b%20first%3d%26quot%3b1%2c10-Decanediol%26quot%3b%20%2f%26gt%3b%26lt%3bpcpc_cirrelatedingredientsid%20last%3d%26quot%3b%7bC223037E-F278-416D-A287-2007B9671D0C%7d%26quot%3b%20first%3d%26quot%3b%7b940AF697-52B5-4A3A-90A6-B9DB30EF4A7E%7d%26quot%3b%20%2f%26gt%3b%26lt%3b%2fcookie%26gt%3b&page='\n",
    "header = {'User-Agent':'Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/125.0.0.0 Safari/537.36'}\n",
    "diz = {'Nome comune':[],\n",
    "            'Nome INCI': [],\n",
    "            'page_link':[],\n",
    "            'pdf_link':[],\n",
    "            'NOAEL':[],\n",
    "            'LD50':[],\n",
    "            'Data':[]}\n",
    "\n",
    "    \n",
    "for i in range(1,3):\n",
    "\n",
    "    table = req.get(f'{request}{i}',headers=header)\n",
    "    table = table.json()\n",
    "\n",
    "    for el in table['results']:\n",
    "\n",
    "        diz['Nome comune'].append(el['pcpc_ingredientname'])\n",
    "        diz['Nome INCI'].append(el['pcpc_ciringredientname'])\n",
    "        diz['page_link'].append(url_base+el['pcpc_ingredientid'])\n",
    "        diz['pdf_link'].append(0)\n",
    "        diz['NOAEL'].append(0)\n",
    "        diz['LD50'].append(0)\n",
    "        diz['Data'].append(0)\n",
    "\n",
    "dataframe = pd.DataFrame(diz)\n",
    "dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Nome comune</th>\n",
       "      <th>Nome INCI</th>\n",
       "      <th>page_link</th>\n",
       "      <th>pdf_link</th>\n",
       "      <th>NOAEL</th>\n",
       "      <th>LD50</th>\n",
       "      <th>Data</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1,10-Decanediol</td>\n",
       "      <td>1,10-Decanediol</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1,2,4-Trihydroxybenzene</td>\n",
       "      <td>1,2,4-Trihydroxybenzene</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1,2-Butanediol</td>\n",
       "      <td>1,2-Butanediol</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1,2-Hexanediol</td>\n",
       "      <td>1,2-Hexanediol</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1,4-Butanediol</td>\n",
       "      <td>1,4-Butanediol</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7781</th>\n",
       "      <td>Zingiber Officinale (Ginger) Root Juice</td>\n",
       "      <td>Zingiber Officinale (Ginger) Root Juice</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7782</th>\n",
       "      <td>Zingiber Officinale (Ginger) Root Oil</td>\n",
       "      <td>Zingiber Officinale (Ginger) Root Oil</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7783</th>\n",
       "      <td>Zingiber Officinale (Ginger) Root Powder</td>\n",
       "      <td>Zingiber Officinale (Ginger) Root Powder</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7784</th>\n",
       "      <td>Zingiber Officinale (Ginger) Water</td>\n",
       "      <td>Zingiber Officinale (Ginger) Water</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7785</th>\n",
       "      <td>Zirconium Silicate</td>\n",
       "      <td>Zirconium Silicate</td>\n",
       "      <td>https://cir-reports.cir-safety.org/cir-ingredi...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6238 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                   Nome comune  \\\n",
       "0                              1,10-Decanediol   \n",
       "1                      1,2,4-Trihydroxybenzene   \n",
       "2                               1,2-Butanediol   \n",
       "3                               1,2-Hexanediol   \n",
       "4                               1,4-Butanediol   \n",
       "...                                        ...   \n",
       "7781   Zingiber Officinale (Ginger) Root Juice   \n",
       "7782     Zingiber Officinale (Ginger) Root Oil   \n",
       "7783  Zingiber Officinale (Ginger) Root Powder   \n",
       "7784        Zingiber Officinale (Ginger) Water   \n",
       "7785                        Zirconium Silicate   \n",
       "\n",
       "                                     Nome INCI  \\\n",
       "0                              1,10-Decanediol   \n",
       "1                      1,2,4-Trihydroxybenzene   \n",
       "2                               1,2-Butanediol   \n",
       "3                               1,2-Hexanediol   \n",
       "4                               1,4-Butanediol   \n",
       "...                                        ...   \n",
       "7781   Zingiber Officinale (Ginger) Root Juice   \n",
       "7782     Zingiber Officinale (Ginger) Root Oil   \n",
       "7783  Zingiber Officinale (Ginger) Root Powder   \n",
       "7784        Zingiber Officinale (Ginger) Water   \n",
       "7785                        Zirconium Silicate   \n",
       "\n",
       "                                              page_link  pdf_link  NOAEL  \\\n",
       "0     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "1     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "2     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "3     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "4     https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "...                                                 ...       ...    ...   \n",
       "7781  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "7782  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "7783  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "7784  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "7785  https://cir-reports.cir-safety.org/cir-ingredi...         0      0   \n",
       "\n",
       "      LD50  Data  \n",
       "0        0     0  \n",
       "1        0     0  \n",
       "2        0     0  \n",
       "3        0     0  \n",
       "4        0     0  \n",
       "...    ...   ...  \n",
       "7781     0     0  \n",
       "7782     0     0  \n",
       "7783     0     0  \n",
       "7784     0     0  \n",
       "7785     0     0  \n",
       "\n",
       "[6238 rows x 7 columns]"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataframe.drop_duplicates('Nome comune',inplace=True)\n",
    "\n",
    "dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "chiave = 'Zirconium Silicate'\n",
    "\n",
    "ingrediente = dataframe.loc[dataframe['Nome comune'] == chiave].index()\n",
    "page = dataframe['page_link'].iloc[ingrediente]\n",
    "web_page = req.get(page)\n",
    "page = BeautifulSoup(web_page.text)\n",
    "righe = page.find_all('tr')       \n",
    "report = righe[1].a['href']\n",
    "final_url = url_base + report[report.index('/')+1:]\n",
    "database[chiave].append(final_url)\n",
    "date = righe[1].find_all('td')[-1]\n",
    "date = date.text[-4:]\n",
    "database[chiave].append(date)\n",
    "return database[chiave][1]'''\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "import redis\n",
    "import requests as req\n",
    "\n",
    "\n",
    "r = redis.Redis(\n",
    "    host='redis-11492.c300.eu-central-1-1.ec2.redns.redis-cloud.com',\n",
    "    port = 11492,\n",
    "    password='0ssFnSEhNJ6Hn7JVtznKkpOuAD1ffdtR',\n",
    "    decode_responses=True\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5715\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['Ingredient:Acrylates/Lauryl Methacrylate/Tridecyl Methacrylate Crosspolymer',\n",
       " 'Ingredient:Ceramide NS Dilaurate',\n",
       " 'Ingredient:Camellia Sinensis Leaf',\n",
       " 'Ingredient:Glyceryl Tripalmate/Palm Kernelate/Olivate/Macadamiate/Rapeseedate',\n",
       " 'Ingredient:Hydrogenated Wheat Germ Oil Unsaponifiables',\n",
       " 'Ingredient:Hydrolyzed Fucus Vesiculosus Extract',\n",
       " 'Ingredient:Mesophyllum Lichenoides Extract',\n",
       " 'Ingredient:C12-13 Alketh-3 (Formerly C12-13 Pareth-3)',\n",
       " 'Ingredient:C12-13 Pareth-7',\n",
       " 'Ingredient:PEG/PPG-6/2 Propylheptyl Ether',\n",
       " 'Ingredient:Polyglyceryl-6 Myristate',\n",
       " 'Ingredient:Heptylundecyl Hydroxystearate',\n",
       " 'Ingredient:Citrus Tangelo Fruit Juice',\n",
       " 'Ingredient:Calcium Aspartate',\n",
       " 'Ingredient:Glycine Max (Soybean) Callus Culture Extract',\n",
       " 'Ingredient:Polyglyceryl-3 Soyate/Shea Butterate',\n",
       " 'Ingredient:Polyglyceryl-3 Ricinoleate',\n",
       " 'Ingredient:Cystine',\n",
       " 'Ingredient:Sodium Stearoyl Lactylate',\n",
       " 'Ingredient:Cystoseira Amentacea/Caespitosa/Branchycarpa Extract',\n",
       " 'Ingredient:PEG-35 Hydrogenated Castor Oil',\n",
       " 'Ingredient:Helianthus Annuus (Sunflower) Seed Oil Unsaponifiables',\n",
       " 'Ingredient:PEG/PPG-8/2 Propylheptyl Ether',\n",
       " 'Ingredient:Cetyl Isononanoate',\n",
       " 'Ingredient:Ceramide 1',\n",
       " 'Ingredient:PEG-32 Distearate',\n",
       " 'Ingredient:Glyceryl Oleate/Elaidate',\n",
       " 'Ingredient:Glycol Ditallowate',\n",
       " 'Ingredient:Hydrogenated Ethylhexyl Olivate',\n",
       " 'Ingredient:PEG-5 Isononanoate',\n",
       " 'Ingredient:PEG-9 Dimethicone',\n",
       " 'Ingredient:Coconut Oil Decyl Esters',\n",
       " 'Ingredient:Isostearyl Isostearate',\n",
       " 'Ingredient:Octoxynol-25',\n",
       " 'Ingredient:Carbomer-934',\n",
       " 'Ingredient:PEG-5 Tsubakiate Glycerides',\n",
       " 'Ingredient:Potassium Hydrogenated Cocoate',\n",
       " 'Ingredient:Polyglyceryl-20 Hexacaprylate',\n",
       " 'Ingredient:Camellia Sinensis Leaf Water',\n",
       " 'Ingredient:Phytosteryl Caprylate/Caprate',\n",
       " 'Ingredient:Behenic Acid',\n",
       " 'Ingredient:PEG-5 Stearamine',\n",
       " 'Ingredient:Porphyra Umbilicalis Extract',\n",
       " 'Ingredient:Arabinose',\n",
       " 'Ingredient:Lauryl Lactate',\n",
       " 'Ingredient:Potassium Cellulose Succinate',\n",
       " 'Ingredient:Citrus Limon (Lemon) Flower/Leaf/Stem Oil',\n",
       " 'Ingredient:Calcium Disodium EDTA',\n",
       " 'Ingredient:C11-12 Isoparaffin',\n",
       " 'Ingredient:Citrus Aurantifolia (Lime) Seed Oil Unsaponifiables',\n",
       " 'Ingredient:Potassium Hydrogenated Palmate',\n",
       " 'Ingredient:Citrus Aurantium Dulcis (Orange) Peel Wax',\n",
       " 'Ingredient:Sargassum Filipendula Extract',\n",
       " 'Ingredient:Nonoxynol-9',\n",
       " 'Ingredient:Lupine Amino Acids',\n",
       " 'Ingredient:Sodium Trideceth Sulfate',\n",
       " 'Ingredient:PPG-2 C9-11 Alketh-8 (Formerly PPG-2 C9-11 Pareth-8)',\n",
       " 'Ingredient:PEG-30 Soy Sterol',\n",
       " 'Ingredient:PEG-75 Soy Glycerides',\n",
       " 'Ingredient:Citrus Natsudaidai Peel Extract',\n",
       " 'Ingredient:C12-15 Pareth-4',\n",
       " 'Ingredient:Polyoxymethylene Melamine',\n",
       " 'Ingredient:PPG-5 Lanolin Alcohol Ether',\n",
       " 'Ingredient:Polyglyceryl-2 Tetraisostearate',\n",
       " 'Ingredient:Sodium Myristoyl Isethionate',\n",
       " 'Ingredient:Rosa Canina Fruit',\n",
       " 'Ingredient:PEG-6 Hydrogenated Castor Oil',\n",
       " 'Ingredient:Butylene/Ethylene/Propylene Copolymer',\n",
       " 'Ingredient:Ethylhexyl Olivate',\n",
       " 'Ingredient:Dimethoxysilyl Ethylenediaminopropyl Dimethicone',\n",
       " 'Ingredient:Ethyl Benzoate',\n",
       " 'Ingredient:Diisodecyl Adipate',\n",
       " 'Ingredient:Citrus Iyo Peel Oil',\n",
       " 'Ingredient:Acrylates/Methacrylamide Copolymer',\n",
       " 'Ingredient:Acrylates/Steareth-20 Methacrylate Crosspolymer',\n",
       " 'Ingredient:Propylene Glycol Dicaprylate/Dicaprate',\n",
       " 'Ingredient:Rosa Damascena Bud Extract',\n",
       " 'Ingredient:C30-50 Alketh-40 (Formerly C30-50 Pareth-40)',\n",
       " 'Ingredient:Oleic/Linoleic Triglyceride',\n",
       " 'Ingredient:Hydrolyzed Fucus Vesiculosus Protein',\n",
       " 'Ingredient:Bis-Methoxy PEG-10 Dimethyl MEA/HDI/Bis-PEG-10 Dimethicone Copolymer',\n",
       " 'Ingredient:PEG-60 Lanolin',\n",
       " 'Ingredient:Sodium Tocopheryl Phosphate',\n",
       " 'Ingredient:Diisobutyl Sodium Sulfosuccinate',\n",
       " 'Ingredient:Benzophenone-8',\n",
       " 'Ingredient:Polystyrene',\n",
       " 'Ingredient:PEG-2 Oleamine',\n",
       " 'Ingredient:Hordeum Vulgare Stem Water',\n",
       " 'Ingredient:Ceteth-17',\n",
       " 'Ingredient:PPG-2 C12-15 Alketh-6 (Formerly PPG-2 C12-15 Pareth-6)',\n",
       " 'Ingredient:Methylene Chloride',\n",
       " 'Ingredient:Panax Ginseng Root Water',\n",
       " 'Ingredient:PPG-2-Ceteth-20',\n",
       " 'Ingredient:Pectin',\n",
       " 'Ingredient:PEG-30 Hydrogenated Castor Oil',\n",
       " 'Ingredient:Sodium Oxidized Starch Acetate/Succinate',\n",
       " 'Ingredient:Borage Seed Oil PEG-8 Esters',\n",
       " 'Ingredient:Pyrus Malus (Apple) Fruit Water',\n",
       " 'Ingredient:Pikea Robusta Extract',\n",
       " 'Ingredient:Acacia Senegal Gum Extract',\n",
       " 'Ingredient:PPG-2 C9-11 Alketh-5 (Formerly PPG-2 C9-11 Pareth-5)',\n",
       " 'Ingredient:Oatamidopropyl Dimethylamine',\n",
       " 'Ingredient:Polyglyceryl-6 Caprate',\n",
       " 'Ingredient:Myreth-4',\n",
       " 'Ingredient:PPG-2-Deceth-60',\n",
       " 'Ingredient:Cucumis Sativus (Cucumber) Seed Oil',\n",
       " 'Ingredient:Caprylic/Capric Glycerides Polyglyceryl-10 Esters',\n",
       " 'Ingredient:Human Umbilical Extract',\n",
       " 'Ingredient:Cetearyl Behenate',\n",
       " 'Ingredient:Rhamnose',\n",
       " 'Ingredient:PEG-14 Laurate',\n",
       " 'Ingredient:Sodium Acrylates/Acrolein Copolymer',\n",
       " 'Ingredient:PEG-23M',\n",
       " 'Ingredient:Sodium Lauroyl Silk Amino Acids',\n",
       " 'Ingredient:Potassium Tallate',\n",
       " 'Ingredient:Pyrus Malus (Apple) Fruit Extract',\n",
       " 'Ingredient:Dioscorea Villosa (Wild Yam) Root Extract',\n",
       " 'Ingredient:Phytic Acid',\n",
       " 'Ingredient:Bis-Phenylisopropyl Phenylisopropyl Dimethicone/Vinyl Dimethicone Crosspolymer',\n",
       " 'Ingredient:Potassium Chlorate',\n",
       " 'Ingredient:Dioctyl Dimer Dilinoleate',\n",
       " 'Ingredient:Lauryl Myristate',\n",
       " 'Ingredient:C11-13 Alketh-10 (Formerly C11-13 Pareth-10)',\n",
       " 'Ingredient:Olea Europaea (Olive) Fruit',\n",
       " 'Ingredient:Citrus Grandis (Grapefruit) Leaf Extract',\n",
       " 'Ingredient:L-Ascorbic Acid',\n",
       " 'Ingredient:Hydrogenated Sweet Almond Oil',\n",
       " 'Ingredient:Serine',\n",
       " 'Ingredient:PEG-60 Almond Glycerides',\n",
       " 'Ingredient:Helianthus Annuus (Sunflower) Seed Oil',\n",
       " 'Ingredient:Isopropyl Arachidate',\n",
       " 'Ingredient:PPG-4 Oleth-10 Dimethicone',\n",
       " 'Ingredient:C14-15 Pareth-12',\n",
       " 'Ingredient:Nonoxynol-20',\n",
       " 'Ingredient:Citrus Paradisi (Grapefruit) Fruit Water',\n",
       " 'Ingredient:Rosa Rubiginosa Seed Oil Polyglyceryl-6 Esters',\n",
       " 'Ingredient:Polyglyceryl-6 Heptacaprylate',\n",
       " 'Ingredient:Salvia Officinalis (Sage) Flower/Leaf/Stem Juice',\n",
       " 'Ingredient:Hydrogenated Coconut Acid',\n",
       " 'Ingredient:Laureth-23',\n",
       " 'Ingredient:PPG-10 Lanolin Alcohol Ether',\n",
       " 'Ingredient:Hydrolyzed Spongin',\n",
       " 'Ingredient:Methyl Lactate',\n",
       " 'Ingredient:Polyglyceryl-10 Isostearate',\n",
       " 'Ingredient:Acrylamide/Sodium Acrylate Copolymer',\n",
       " 'Ingredient:Sodium Sesameseedate',\n",
       " 'Ingredient:Ceramide 6 II',\n",
       " 'Ingredient:Ricinoleic/Caproic/Caprylic/Capric Triglyceride',\n",
       " 'Ingredient:Ammonium Laureth Sulfate',\n",
       " 'Ingredient:Citrus Aurantium Sinensis Peel Extract',\n",
       " 'Ingredient:Cottonseed Glyceride',\n",
       " 'Ingredient:PVP/VA/Vinyl Propionate Copolymer',\n",
       " 'Ingredient:Cocos Nucifera (Coconut) Shell Powder',\n",
       " 'Ingredient:2,4-Diaminophenoxyethanol HCl',\n",
       " 'Ingredient:C12-14 Sec-Alketh-9 (Formerly C12-14 Sec-Pareth-9)',\n",
       " 'Ingredient:Behenyl Alcohol',\n",
       " 'Ingredient:PEG/PPG-16/2 Dimethicone',\n",
       " 'Ingredient:Polyglyceryl-3 Pentaolivate',\n",
       " 'Ingredient:Sodium Cocoyl Taurate',\n",
       " 'Ingredient:PEG-7 Tallow Amine',\n",
       " 'Ingredient:Glycine Soja (Soybean) Seed Powder',\n",
       " 'Ingredient:m-Aminophenol',\n",
       " 'Ingredient:PEG-15 Jojoba Alcohol',\n",
       " 'Ingredient:Citrus Grandis (Grapefruit) Fruit Extract',\n",
       " 'Ingredient:HDI/Di-C12-14 Alkyl Tartrate/Hydrogenated Dilinoleyl Alcohol Copolymer',\n",
       " 'Ingredient:Isostearyl Myristate',\n",
       " 'Ingredient:PEG-35 Castor Oil',\n",
       " 'Ingredient:PEG/PPG-8/26 Dimethicone',\n",
       " 'Ingredient:Hydrogenated Phosphatidylcholine',\n",
       " 'Ingredient:Calcium Potassium Carbomer',\n",
       " 'Ingredient:Magnesium Alginate',\n",
       " 'Ingredient:Hydrolyzed Ginseng Root Extract',\n",
       " 'Ingredient:Panax Quinquefolium Root Extract',\n",
       " 'Ingredient:PEG/PPG-5/2 Methacrylate/Methacrylic Acid Crosspolymer',\n",
       " 'Ingredient:Ethylhexyl Oleate',\n",
       " 'Ingredient:PEG-75 Sorbitan Laurate',\n",
       " 'Ingredient:Citrus Limon (Lemon) Peel',\n",
       " 'Ingredient:C11-13 Alketh-6 (Formerly C11-13 Pareth-6)',\n",
       " 'Ingredient:Punica Granatum Seed Extract',\n",
       " 'Ingredient:PEG-60 Glyceryl Diisostearate',\n",
       " 'Ingredient:Glycine Soja (Soybean) Protein',\n",
       " 'Ingredient:Quaternium-90 Bentonite',\n",
       " 'Ingredient:PPG-2-Deceth-15',\n",
       " 'Ingredient:Cetearyl Ethylhexanoate',\n",
       " 'Ingredient:Myristyl Salicylate',\n",
       " 'Ingredient:Ceteareth-22',\n",
       " 'Ingredient:Potassium Xylenesulfonate',\n",
       " 'Ingredient:C12-15 Alketh-10 (Formerly C12-15 Pareth-10)',\n",
       " 'Ingredient:Disperse Blue 1',\n",
       " 'Ingredient:PEG-7 Olive Glycerides',\n",
       " 'Ingredient:Poloxamer 335',\n",
       " 'Ingredient:Decyl Oleate',\n",
       " 'Ingredient:PEG-75 Shea Butter Glycerides',\n",
       " 'Ingredient:Polyglyceryl-20 Octaisononanoate',\n",
       " 'Ingredient:Pichia Heedii Extract',\n",
       " 'Ingredient:Sargassum Vulgare Extract',\n",
       " 'Ingredient:Magnesium Oleth Sulfate',\n",
       " 'Ingredient:PEG-6 Distearate',\n",
       " 'Ingredient:Mink Oil PEG-13 Esters',\n",
       " 'Ingredient:Hydrogenated Talloweth-12',\n",
       " 'Ingredient:Magnesium Palmitoyl Glutamate',\n",
       " 'Ingredient:Glucosamine HCl',\n",
       " 'Ingredient:Equisetum Arvense Powder',\n",
       " 'Ingredient:Dihexyl Sodium Sulfosuccinate',\n",
       " 'Ingredient:Peanut Acid',\n",
       " 'Ingredient:Beheneth-10',\n",
       " 'Ingredient:Polyurethane-28',\n",
       " 'Ingredient:Diheptylundecyl Adipate',\n",
       " 'Ingredient:Potassium Hydroxide',\n",
       " 'Ingredient:PEG/PPG-8/3 Diisostearate',\n",
       " 'Ingredient:Argan Oil PEG-8 Esters',\n",
       " 'Ingredient:Aluminum Lanolate',\n",
       " 'Ingredient:Glycereth-26',\n",
       " 'Ingredient:Propylene Glycol Diethylhexanoate',\n",
       " 'Ingredient:Potassium Linoleate',\n",
       " 'Ingredient:PPG-2-Laureth-5',\n",
       " 'Ingredient:Sodium Malate',\n",
       " 'Ingredient:Citrus Aurantifolia (Lime) Fruit Water',\n",
       " 'Ingredient:PPG-40 Butyl Ether',\n",
       " 'Ingredient:C12-14 Sec-Alketh-12 (Formerly C12-14 Sec-Pareth-12)',\n",
       " 'Ingredient:Olea Europaea (Olive) Fruit Juice',\n",
       " 'Ingredient:Polyacrylate-5',\n",
       " 'Ingredient:PEG-70 Hydrogenated Lanolin',\n",
       " 'Ingredient:Disodium Laureth-6 Sulfosuccinate',\n",
       " 'Ingredient:Acrylates/Dimethiconol Acrylate Copolymer',\n",
       " 'Ingredient:Hexyldecyl Ethylhexanoate',\n",
       " 'Ingredient:Distarch Phosphate Acetate',\n",
       " 'Ingredient:Hydrogenated Olive Oil',\n",
       " 'Ingredient:Calcium Undecylenate',\n",
       " 'Ingredient:Potassium C12-14 Alkyl Phosphate',\n",
       " 'Ingredient:Castor Oil Polyglyceryl-6 Esters',\n",
       " 'Ingredient:p-Hydroxyanisole',\n",
       " 'Ingredient:Phosphatidylserine',\n",
       " 'Ingredient:Phaseolus Radiatus Seed Starch',\n",
       " 'Ingredient:Dimethicone/Lauryl Dimethicone/Bis-Vinyldimethicone Crosspolymer',\n",
       " 'Ingredient:Adipic Acid Dihydrazide',\n",
       " 'Ingredient:C30-50 Pareth-10',\n",
       " 'Ingredient:PEG-80 Glyceryl Cocoate',\n",
       " 'Ingredient:Ceteareth-28',\n",
       " 'Ingredient:Octyldodecyl Benzoate',\n",
       " 'Ingredient:Ammonium Styrene/Acrylates Copolymer',\n",
       " 'Ingredient:Porphyra Yezoensis Extract',\n",
       " 'Ingredient:Polyvinyl Acetate',\n",
       " 'Ingredient:Aphanothece Sacrum Exopolysaccharides',\n",
       " 'Ingredient:Ammonium Coco-Sulfate',\n",
       " 'Ingredient:PEG-10 Polydimethylsiloxyethyl Dimethicone/Bis-Vinyl Dimethicone Crosspolymer',\n",
       " 'Ingredient:Arachidyl Glycol',\n",
       " 'Ingredient:Potassium Polyphosphate',\n",
       " 'Ingredient:Sorbeth-20 Beeswax',\n",
       " 'Ingredient:Cholesteryl Nonanoate',\n",
       " 'Ingredient:Euterpe Oleracea Seed Powder',\n",
       " 'Ingredient:Polyglyceryl-10 Tridecanoate',\n",
       " 'Ingredient:Aminomethyl Propanol',\n",
       " 'Ingredient:Lauroyl Collagen Amino Acids',\n",
       " 'Ingredient:Butyl Glycolate',\n",
       " 'Ingredient:Aluminum Hydroxide',\n",
       " 'Ingredient:Arginine HCl',\n",
       " 'Ingredient:Acrylamide/Ammonium Acrylate Copolymer',\n",
       " 'Ingredient:Hydrogenated Castor Oil Behenyl Esters',\n",
       " 'Ingredient:Sodium Cocoyl Barley Amino Acids',\n",
       " 'Ingredient:Polyglyceryl-5 Hexastearate',\n",
       " 'Ingredient:Poly C10-30 Alkyl Acrylate',\n",
       " 'Ingredient:Isooctyl Caprylate/Caprate',\n",
       " 'Ingredient:Nylon-12',\n",
       " 'Ingredient:Olea Europaea (Olive) Sap Extract',\n",
       " 'Ingredient:Myristyl Betaine',\n",
       " 'Ingredient:Polyglyceryl-10 Palmate',\n",
       " 'Ingredient:Citrus Tankan Fruit Extract',\n",
       " 'Ingredient:Capryloyl Salicylic Acid',\n",
       " 'Ingredient:Isohexyl Caprate',\n",
       " 'Ingredient:C20-40 Alketh-3 (Formerly C20-40 Pareth-3)',\n",
       " 'Ingredient:Kappaphycus Alvarezii Extract',\n",
       " 'Ingredient:Sodium Acrylate/Acryloyldimethyltaurate/Dimethylacrylamide Crosspolymer',\n",
       " 'Ingredient:Sesamidopropyl Betaine',\n",
       " 'Ingredient:Magnesium Citrate',\n",
       " 'Ingredient:Dimethicone Crosspolymer',\n",
       " 'Ingredient:Polyglyceryl-10 Heptahydroxystearate',\n",
       " 'Ingredient:Citrus Reticulata (Tangerine) Leaf Oil',\n",
       " 'Ingredient:Peanutamide MEA',\n",
       " 'Ingredient:Potassium Alginate',\n",
       " 'Ingredient:Oleth-9',\n",
       " 'Ingredient:Sodium Acrylate/Acrolein Copolymer',\n",
       " 'Ingredient:Achillea Millefolium Extract',\n",
       " 'Ingredient:Caesalpinia Spinosa Gum',\n",
       " 'Ingredient:Polyglyceryl-10 Pentastearate',\n",
       " 'Ingredient:N-Phenyl-p-Phenylenediamine',\n",
       " 'Ingredient:Butoxyethyl Acetate',\n",
       " 'Ingredient:Sodium Tridecylbenzenesulfonate',\n",
       " 'Ingredient:PEG-20 Hydrogenated Castor Oil Isostearate',\n",
       " 'Ingredient:PEG-50 Castor Oil',\n",
       " 'Ingredient:PEG-75 Cocoa Butter Glycerides',\n",
       " 'Ingredient:Decyl Myristate',\n",
       " 'Ingredient:PEG-10 Sorbitan Laurate',\n",
       " 'Ingredient:Citrus Aurantium Dulcis (Orange) Seed Oil',\n",
       " 'Ingredient:Histidine HCl',\n",
       " 'Ingredient:PVM/MA Copolymer',\n",
       " 'Ingredient:Citrus Madurensis Fruit Extract',\n",
       " 'Ingredient:Candelilla Wax',\n",
       " 'Ingredient:Ammonium Thioglycolate',\n",
       " 'Ingredient:PPG-26/HDI Copolymer',\n",
       " 'Ingredient:PEG-20 Lanolin',\n",
       " 'Ingredient:Palmitoyl Silk Amino Acids',\n",
       " 'Ingredient:PEG-33',\n",
       " 'Ingredient:Polyglyceryl-10 Behenate/Eicosadioate',\n",
       " 'Ingredient:PEG-20 Castor Oil',\n",
       " 'Ingredient:PEG-40 Jojoba Alcohol',\n",
       " 'Ingredient:Citrus Aurantium Amara (Bitter Orange) Fruit Extract',\n",
       " 'Ingredient:C11-13 Alketh-9 (Formerly C11-13 Pareth-9)',\n",
       " 'Ingredient:Glyceryl Citrate/Lactate/Linoleate/Oleate',\n",
       " 'Ingredient:PEG-40 Soy Sterol',\n",
       " 'Ingredient:Propyl Acetate',\n",
       " 'Ingredient:Myristoyl Ethyltrimonium Methosulfate',\n",
       " 'Ingredient:Polyglyceryl-10 Myristate',\n",
       " 'Ingredient:Apricot Kernel Amino Acids',\n",
       " 'Ingredient:Avena Sativa (Oat) Leaf/Stalk Extract',\n",
       " 'Ingredient:3-Nitro-p-Hydroxyethylaminophenol',\n",
       " 'Ingredient:Laminaria Japonica Extract',\n",
       " 'Ingredient:Amino Bispropyl Dimethicone',\n",
       " 'Ingredient:Methyl Glycolate',\n",
       " 'Ingredient:Hazel (Corylus Avellana) Extract',\n",
       " 'Ingredient:Aluminum Isostearates/Myristates',\n",
       " 'Ingredient:Citrus Aurantium Dulcis (Orange) Peel Oil',\n",
       " 'Ingredient:Hydrogenated Palm/Palm Kernel Oil PEG-6 Esters',\n",
       " 'Ingredient:Coconut Acid',\n",
       " 'Ingredient:Rapeseed Oil PEG-20 Esters',\n",
       " 'Ingredient:Dimethyl Behenamine',\n",
       " 'Ingredient:Cetyl Myristate',\n",
       " 'Ingredient:Beta-Sitosteryl Acetate',\n",
       " 'Ingredient:Nitrocellulose',\n",
       " 'Ingredient:Citrus Aurantium Dulcis (Orange) Seed Extract',\n",
       " 'Ingredient:Polysorbate 81',\n",
       " 'Ingredient:PEG-18 Castor Oil Dioleate',\n",
       " 'Ingredient:PEG-32 Dioleate',\n",
       " 'Ingredient:Hydrolyzed Triticum Spelta Starch',\n",
       " 'Ingredient:Laureth-40',\n",
       " 'Ingredient:Melaleuca Alternifolia (Tea Tree) Flower/Leaf/Stem Oil',\n",
       " 'Ingredient:2-Amino-6-Chloro-4-Nitrophenol Hydrochloride',\n",
       " 'Ingredient:Polyglyceryl-6 Palmitate/Succinate',\n",
       " 'Ingredient:Oleth-30',\n",
       " 'Ingredient:Aloe Arborescens Leaf Protoplasts',\n",
       " 'Ingredient:Fumaric Acid',\n",
       " 'Ingredient:Bassia Latifolia Seed Butter',\n",
       " 'Ingredient:C12-14 Sec-Pareth-50',\n",
       " 'Ingredient:Mentha Piperita (Peppermint) Leaf Juice',\n",
       " 'Ingredient:Glycereth-8',\n",
       " 'Ingredient:6-Amino-o-Cresol',\n",
       " 'Ingredient:Citrus Aurantifolia (Lime) Peel Powder',\n",
       " 'Ingredient:PEG-32',\n",
       " 'Ingredient:PPG-2-Ceteth-1',\n",
       " 'Ingredient:Eisenia Arborea Extract',\n",
       " 'Ingredient:C11-15 Pareth-3',\n",
       " 'Ingredient:Cyclopentasiloxane',\n",
       " 'Ingredient:Hydrolyzed Human Placental Protein',\n",
       " 'Ingredient:Citrullus Lanatus (Watermelon) Seed Oil',\n",
       " 'Ingredient:Acetyl Glutamine',\n",
       " 'Ingredient:C12-18 Acid Triglyceride',\n",
       " 'Ingredient:Isopropyl Isostearate',\n",
       " 'Ingredient:PEG-7 Hydrogenated Castor Oil',\n",
       " 'Ingredient:Polyglyceryl-2 Oleate',\n",
       " 'Ingredient:Ascophyllum Nodosum Powder',\n",
       " 'Ingredient:PEG-2 Diisononanoate',\n",
       " 'Ingredient:Isomalt',\n",
       " 'Ingredient:Dicetyl Phosphate',\n",
       " 'Ingredient:PPG-17-Buteth-17',\n",
       " 'Ingredient:Acrylates Crosspolymer-4',\n",
       " 'Ingredient:Nonoxynol-120',\n",
       " 'Ingredient:Phospholipids',\n",
       " 'Ingredient:p-Cresol',\n",
       " 'Ingredient:Ethoxyethanol Acetate',\n",
       " 'Ingredient:Melaleuca Alternifolia (Tea Tree) Leaf Oil',\n",
       " 'Ingredient:C11-21 Alketh-3 (Formerly C11-21 Pareth-3)',\n",
       " 'Ingredient:Aleurites Moluccana Seed Oil',\n",
       " 'Ingredient:Luffa Cylindrica Seed Oil',\n",
       " 'Ingredient:Hydrogenated Poly(C6-20 Olefin)',\n",
       " 'Ingredient:Cellulose Gum',\n",
       " 'Ingredient:Calcium Xylenesulfonate',\n",
       " 'Ingredient:Coconut Oil MIPA Amides',\n",
       " 'Ingredient:Ammonium C12-15 Pareth Sulfate',\n",
       " 'Ingredient:Erucyl Oleate',\n",
       " 'Ingredient:C22-24 Pareth-33',\n",
       " 'Ingredient:Isopropyl Oleate',\n",
       " 'Ingredient:Ammonium Hydrolyzed Collagen',\n",
       " 'Ingredient:PPG-6 Trideceth-8',\n",
       " 'Ingredient:Sorbeth-60 Tetrastearate',\n",
       " 'Ingredient:Potassium Olivate/Sunflowerseedate',\n",
       " 'Ingredient:Sodium Myristoyl Glutamate',\n",
       " 'Ingredient:Potassium Carbomer',\n",
       " 'Ingredient:Dichlorophene',\n",
       " 'Ingredient:Lauryl Polydimethylsiloxyethyl Dimethicone/Bis-Vinyldimethicone Crosspolymer',\n",
       " 'Ingredient:PPG-1-Ceteth-10',\n",
       " 'Ingredient:Sodium Methyl Myristoyl Taurate',\n",
       " 'Ingredient:Glycol Dipalmate/Palm Kernelate/Olivate/Macadamiate',\n",
       " 'Ingredient:Hydrolyzed Shea Seedcake Extract',\n",
       " 'Ingredient:Avocado Oil Propylene Glycol Esters',\n",
       " 'Ingredient:Citrus Hassaku/Natsudaidai Peel Powder',\n",
       " 'Ingredient:Sodium Lauryl Phosphate',\n",
       " 'Ingredient:Polyglyceryl-2 Distearate',\n",
       " 'Ingredient:MEA-Lauryl Sulfate',\n",
       " 'Ingredient:PEG-220',\n",
       " 'Ingredient:Salvia Officinalis (Sage) Leaf Extract',\n",
       " 'Ingredient:Perfluorononyl Dimethicone/Methicone/Amodimethicone Crosspolymer',\n",
       " 'Ingredient:Dimethyl Glutarate',\n",
       " 'Ingredient:Cyanidium Caldarium Extract',\n",
       " 'Ingredient:Palmamide DEA',\n",
       " 'Ingredient:Centella Asiatica Leaf Water',\n",
       " 'Ingredient:C20-40 Pareth-24',\n",
       " 'Ingredient:Polyglyceryl-6 Tetrabehenate',\n",
       " 'Ingredient:Cellobiose Octanonanoate',\n",
       " 'Ingredient:PEG-40 Sorbitan Stearate',\n",
       " 'Ingredient:Porphyridium Cruentum Culture Conditioned Media',\n",
       " 'Ingredient:Hydroxypropyl Methylcellulose',\n",
       " 'Ingredient:Disodium C12-15 Alketh Sulfosuccinate (Formerly Disodium C12-15 Pareth Sulfosuccinate)',\n",
       " 'Ingredient:Sodium Methyl Palmitoyl Taurate',\n",
       " 'Ingredient:Polyglyceryl-10 Tricocoate',\n",
       " 'Ingredient:Acrylates/Methoxy PEG-15 Methacrylate Copolymer',\n",
       " 'Ingredient:HC Yellow No. 4',\n",
       " 'Ingredient:MEA-Hydrolyzed Silk',\n",
       " 'Ingredient:PPG-2 Methyl Ether',\n",
       " 'Ingredient:Citrus Clementina Peel Oil',\n",
       " 'Ingredient:Anhydroglucitol',\n",
       " 'Ingredient:Poloxamer 122',\n",
       " 'Ingredient:Galactoarabinan',\n",
       " 'Ingredient:Palmaria Palmata Powder',\n",
       " 'Ingredient:Glyceryl Linoleate',\n",
       " 'Ingredient:Octyldodecyl Myristate',\n",
       " 'Ingredient:Lauramide DEA',\n",
       " 'Ingredient:Cocoyl Glutamic Acid',\n",
       " 'Ingredient:Astragalus Gummifer Gum',\n",
       " 'Ingredient:Methoxy PEG-11 Methoxy PPG-24 Dimethicone',\n",
       " 'Ingredient:Punica Granatum Fruit/Sucrose Ferment Filtrate',\n",
       " 'Ingredient:Polyurethane-42',\n",
       " 'Ingredient:Crotonic Acid/Vinyl C8-12 Isoalkyl Esters/VA/Bis-Vinyldimethicone Crosspolymer',\n",
       " 'Ingredient:Euterpe Edulis Juice Extract',\n",
       " 'Ingredient:Dicetyl Ether',\n",
       " 'Ingredient:Meadowfoamamidopropyl Betaine',\n",
       " 'Ingredient:Apricotamidopropyl Betaine',\n",
       " 'Ingredient:Polyglyceryl-6 Palmitate',\n",
       " 'Ingredient:Salvia Officinalis (Sage) Leaf Powder',\n",
       " 'Ingredient:HC Blue No. 2',\n",
       " 'Ingredient:Bis-PEG/PPG-20/5 PEG/PPG-20/5 Dimethicone',\n",
       " 'Ingredient:Isosteareth-12',\n",
       " 'Ingredient:Laneth-60',\n",
       " 'Ingredient:Oleth-20',\n",
       " 'Ingredient:C10-13 Isoalkane (Formerly C10-13 Isoparaffin)',\n",
       " 'Ingredient:Ammonium Cumenesulfonate',\n",
       " 'Ingredient:Ammonium Carbonate',\n",
       " 'Ingredient:Euterpe Oleracea Fruit Oil',\n",
       " 'Ingredient:Citrus Junos Fruit Juice',\n",
       " 'Ingredient:Lanolin Oil',\n",
       " 'Ingredient:Poloxamer 284',\n",
       " 'Ingredient:Methyl Glucose Sesquilaurate',\n",
       " 'Ingredient:Citrus Iyo Fruit Water',\n",
       " 'Ingredient:PPG-8-Deceth-6',\n",
       " 'Ingredient:C12-14 Sec-Pareth-12',\n",
       " 'Ingredient:Disodium Cocoamphodiacetate',\n",
       " 'Ingredient:PEG-50 Stearamide',\n",
       " 'Ingredient:Rosa Canina Bud Extract',\n",
       " 'Ingredient:Polyperfluoroethoxymethoxy Difluoroethyl PEG Ether',\n",
       " 'Ingredient:Hydroxypropyl Guar',\n",
       " 'Ingredient:Porphyridium Purpureum Extract',\n",
       " 'Ingredient:PPG-8-Ceteth-5',\n",
       " 'Ingredient:Propylene Glycol Dicaproate',\n",
       " 'Ingredient:Boron Nitride',\n",
       " 'Ingredient:PEG-65 Hydrogenated Castor Oil',\n",
       " 'Ingredient:Cycloheptasiloxane',\n",
       " 'Ingredient:Basic Yellow 87',\n",
       " 'Ingredient:Bis-Diglyceryl Polyacyladipate-1',\n",
       " 'Ingredient:Glycyrrhiza Inflata Root Extract',\n",
       " 'Ingredient:Oleoyl Tyrosine',\n",
       " 'Ingredient:Prunus Domestica Seed Oil',\n",
       " 'Ingredient:Polyglyceryl-10 Dodecacaprylate',\n",
       " 'Ingredient:Lauryl Glycol',\n",
       " 'Ingredient:Simmondsia Chinensis (Jojoba) Seed Oil',\n",
       " 'Ingredient:DEA-C12-15 Alkyl Sulfate',\n",
       " 'Ingredient:Octyldecyl Oleate',\n",
       " 'Ingredient:PPG-6 C12-18 Pareth-11',\n",
       " 'Ingredient:N-Phenyl-p-Phenylenediamine Sulfate',\n",
       " 'Ingredient:Mentha Piperita (Peppermint) Oil',\n",
       " 'Ingredient:PEG-175 Diisostearate',\n",
       " 'Ingredient:Equisetum Arvense Leaf Powder',\n",
       " 'Ingredient:Avocado Oil',\n",
       " 'Ingredient:Polybutylene Terephthalate',\n",
       " 'Ingredient:Hydrogenated Cottonseed Oil',\n",
       " 'Ingredient:Carnitine PCA',\n",
       " 'Ingredient:Polyurethane-70',\n",
       " 'Ingredient:Carya Illinoensis (Pecan) Seed Oil',\n",
       " 'Ingredient:Glyceryl Dibehenate',\n",
       " 'Ingredient:Neopentyl Glycol Dicaprylate/Dicaprate',\n",
       " 'Ingredient:Diisononyl Adipate',\n",
       " 'Ingredient:Acrylates/C12-22 Alkyl Methacrylate Copolymer',\n",
       " 'Ingredient:C12-18 Alkyl Glucoside',\n",
       " 'Ingredient:Oryza Sativa (Rice) Germ Powder',\n",
       " 'Ingredient:Linoleamidopropyl Dimethylamine',\n",
       " 'Ingredient:PEG-20 Hydrogenated Castor Oil Laurate',\n",
       " 'Ingredient:Malus Domestica Fruit Cell Culture Extract',\n",
       " 'Ingredient:Peanut Glycerides',\n",
       " 'Ingredient:Butyl Ester of PVM/MA Copolymer',\n",
       " 'Ingredient:PPG-9 Diethylmonium Chloride',\n",
       " 'Ingredient:Potassium Palmitate',\n",
       " 'Ingredient:C14-15 Pareth-11',\n",
       " 'Ingredient:Sodium Oleoyl Isethionate',\n",
       " 'Ingredient:Isosteareth-22',\n",
       " 'Ingredient:Salvia Officinalis (Sage) Flower/Leaf/Stem Water',\n",
       " 'Ingredient:Palm Oil Polyglyceryl-3 Esters',\n",
       " 'Ingredient:Polyacrylate-14',\n",
       " 'Ingredient:Avena Sativa (Oat) Kernel Flour',\n",
       " 'Ingredient:Sodium Acrylates Crosspolymer-2',\n",
       " 'Ingredient:Poly(C30-45 Olefin)',\n",
       " 'Ingredient:Humulus Lupulus (Hops) Extract',\n",
       " 'Ingredient:Hydroxypropyl Methylcellulose Acetate/Succinate',\n",
       " 'Ingredient:Octyl Stearate',\n",
       " 'Ingredient:PEG-4 Dicocoate',\n",
       " 'Ingredient:Polyglyceryl-10 Pentalinoleate',\n",
       " 'Ingredient:Raphanus Sativus (Radish) Root Powder',\n",
       " 'Ingredient:Laneth-50',\n",
       " 'Ingredient:PPG-6-Deceth-9',\n",
       " 'Ingredient:PPG-4-Deceth-6',\n",
       " 'Ingredient:Diisobutyl Glutarate',\n",
       " 'Ingredient:PEG-5 Soy Sterol',\n",
       " 'Ingredient:Coceth-3',\n",
       " 'Ingredient:C12-15 Pareth-10',\n",
       " 'Ingredient:Hordeum Vulgare Leaf/Stem Powder',\n",
       " 'Ingredient:C12-16 Pareth-7',\n",
       " 'Ingredient:Lauryl Acrylate Crosspolymer',\n",
       " 'Ingredient:Glyceryl Ethylhexanoate',\n",
       " 'Ingredient:Corallina Officinalis Thallus Extract',\n",
       " 'Ingredient:Behentrimonium Methosulfate',\n",
       " 'Ingredient:Pentaerythrityl Tetralaurate',\n",
       " 'Ingredient:HEMA',\n",
       " 'Ingredient:Hydrolyzed Grape Skin',\n",
       " 'Ingredient:Malva Sylvestris (Mallow) Oil',\n",
       " 'Ingredient:Di-t-Butylhydroquinone',\n",
       " 'Ingredient:PEG-22 Tallow Amine',\n",
       " 'Ingredient:Polyglyceryl-2 Laurate',\n",
       " 'Ingredient:Octyldodecyl Stearate',\n",
       " 'Ingredient:Cetearyl Isononanoate',\n",
       " 'Ingredient:Benzalkonium Sepiolite',\n",
       " 'Ingredient:Fragaria Virginiana (Strawberry) Seed Oil',\n",
       " 'Ingredient:Ammonium Myreth Sulfate',\n",
       " 'Ingredient:Citrus Tachibana/Reticulata Peel Oil',\n",
       " 'Ingredient:Citrus Grandis (Grapefruit) Fruit/Peel Water',\n",
       " 'Ingredient:Cetyl Palmitate',\n",
       " 'Ingredient:Citrus Nobilis (Mandarin Orange)',\n",
       " 'Ingredient:Isodecyl Salicylate',\n",
       " 'Ingredient:Ceteareth-17',\n",
       " 'Ingredient:Octyldodeceth-5',\n",
       " 'Ingredient:Octyldodecyl Safflowerate',\n",
       " 'Ingredient:Ecklonia Maxima Extract',\n",
       " 'Ingredient:Potassium Carbonate',\n",
       " 'Ingredient:Glycine Soja (Soybean) Sterols',\n",
       " 'Ingredient:Saccharina Japonica Extract',\n",
       " 'Ingredient:DEA-Myristate',\n",
       " 'Ingredient:Alcohol Denat.',\n",
       " 'Ingredient:PEG-50 Sorbitol Hexaoleate',\n",
       " 'Ingredient:1,4-Butanediol/Succinic Acid/Adipic Acid/HDI Copolymer',\n",
       " 'Ingredient:Cichorium Intybus (Chicory) Root Oligosaccharides',\n",
       " 'Ingredient:C14-15 Pareth-4',\n",
       " 'Ingredient:Octyldodecyl Stearoyl Stearate',\n",
       " 'Ingredient:Diisopropyl Adipate',\n",
       " 'Ingredient:Citrus Tachibana/Reticulata Peel Powder',\n",
       " 'Ingredient:Citrus Depressa Flower Water',\n",
       " 'Ingredient:Retinyl Palmitate',\n",
       " 'Ingredient:Coceth-7',\n",
       " 'Ingredient:Dimethiconol Panthenol',\n",
       " 'Ingredient:Hydrogenated Orange Seed Oil',\n",
       " 'Ingredient:Sodium C10-15 Pareth Sulfate',\n",
       " 'Ingredient:Almondamidopropyl Betaine',\n",
       " 'Ingredient:PEG-25 Soy Sterol',\n",
       " 'Ingredient:Myreth-10',\n",
       " 'Ingredient:Avena Sativa (Oat) Seed Extract',\n",
       " 'Ingredient:Humulus Lupulus (Hops) Flower Extract',\n",
       " 'Ingredient:Glycolic Acid',\n",
       " 'Ingredient:Acrylates/C10-30 Alkyl Methacrylate Copolymer',\n",
       " 'Ingredient:PPG-4-Deceth-4',\n",
       " 'Ingredient:Ricinoleamidopropyl Dimethylamine',\n",
       " 'Ingredient:PEG-4 Cocamine',\n",
       " 'Ingredient:Hydrogenated Styrene/Isoprene Copolymer',\n",
       " 'Ingredient:C9-11 Pareth-3',\n",
       " 'Ingredient:Nonoxynol-70',\n",
       " 'Ingredient:PPG-30 Butyl Ether',\n",
       " 'Ingredient:DEA-Cocoamphodipropionate',\n",
       " 'Ingredient:Gelidium Pulchrum Protein',\n",
       " 'Ingredient:Hydroxystearamide MEA',\n",
       " 'Ingredient:Citrus Aurantifolia (Lime) Peel Water',\n",
       " 'Ingredient:2-Amino-5-Nitrophenol',\n",
       " 'Ingredient:PEG-50 Hydrogenated Tallow Amine',\n",
       " 'Ingredient:Glyceryl Allyl Ether',\n",
       " 'Ingredient:Piper Methysticum Root Extract',\n",
       " 'Ingredient:Glyceryl Caprate',\n",
       " 'Ingredient:Methylbenzethonium Chloride',\n",
       " 'Ingredient:Glyceryl Hydrogenated Rapeseedate',\n",
       " 'Ingredient:Cucumis Sativus (Cucumber) Fruit Water',\n",
       " 'Ingredient:Sodium p-Chloro-m-Cresol',\n",
       " 'Ingredient:Butyl Benzoate',\n",
       " 'Ingredient:PEG-8 Diisostearate',\n",
       " 'Ingredient:Dimethyl Adipate',\n",
       " 'Ingredient:Glycine Max (Soybean) Leaf Cell Extract',\n",
       " 'Ingredient:Citrus Aurantium Dulcis (Orange) Peel Extract',\n",
       " 'Ingredient:Corallina Officinalis Powder',\n",
       " 'Ingredient:Hippophae Rhamnoides Oil',\n",
       " 'Ingredient:Ethylene/Methacrylate Copolymer',\n",
       " 'Ingredient:Glyceryl Sesquioleate',\n",
       " 'Ingredient:Polyglyceryl-6 Oleate',\n",
       " 'Ingredient:Hydrolyzed Corn Starch Hydroxyethyl Ether',\n",
       " 'Ingredient:Polyglyceryl-4 Laurate',\n",
       " 'Ingredient:Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone',\n",
       " 'Ingredient:Quaternium-18',\n",
       " 'Ingredient:Acrylamide',\n",
       " 'Ingredient:Pyrus Malus (Apple) Leaf Extract',\n",
       " 'Ingredient:Polyglyceryl-10 Hexaerucate',\n",
       " 'Ingredient:Poloxamer 184',\n",
       " 'Ingredient:PEG-7 Methyl Ether',\n",
       " 'Ingredient:Dimethiconol Sal Butterate',\n",
       " 'Ingredient:Sodium Hydrolyzed Potato Starch Dodecenylsuccinate',\n",
       " 'Ingredient:Butyrospermum Parkii (Shea) Butter Extract',\n",
       " 'Ingredient:Glyceryl Isotridecanoate/Stearate/Adipate',\n",
       " 'Ingredient:Glyceryl Hydrogenated Rosinate',\n",
       " 'Ingredient:Hydrolyzed Corn Protein',\n",
       " 'Ingredient:Sarcodiotheca Gaudichaudii Extract',\n",
       " 'Ingredient:Hydrolyzed Sulfonated Keratin',\n",
       " 'Ingredient:Sodium Acrylate/Vinyl Alcohol Copolymer',\n",
       " 'Ingredient:PPG-2-Isodeceth-25',\n",
       " 'Ingredient:Ricinoleamidopropyl Betaine',\n",
       " 'Ingredient:Sodium Styrene/Acrylates Copolymer',\n",
       " 'Ingredient:Canarium Indicum Seed Oil',\n",
       " 'Ingredient:Arginine',\n",
       " 'Ingredient:Sodium Acetylated Hyaluronate',\n",
       " 'Ingredient:SD Alcohol 39-C',\n",
       " 'Ingredient:Citrus Unshiu Leaf Extract',\n",
       " 'Ingredient:Polyglyceryl-15 Diisostearate',\n",
       " 'Ingredient:Calcium PCA',\n",
       " 'Ingredient:Glycine Max (Soybean) Sprout Extract',\n",
       " 'Ingredient:Clay',\n",
       " 'Ingredient:Benzophenone-5',\n",
       " 'Ingredient:PEG-8 Distearate',\n",
       " 'Ingredient:Polyurethane-18',\n",
       " 'Ingredient:Isostearamide MIPA',\n",
       " 'Ingredient:Diethyl Phthalate',\n",
       " 'Ingredient:Cucumis Sativus (Cucumber) Fruit Extract',\n",
       " 'Ingredient:Human Placental Enzymes',\n",
       " 'Ingredient:SD Alcohol 40-B',\n",
       " 'Ingredient:Polyurethane-11',\n",
       " 'Ingredient:Pentetic Acid',\n",
       " 'Ingredient:Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       " 'Ingredient:Hexacosyl Glycol',\n",
       " 'Ingredient:MEA-Cocoate',\n",
       " 'Ingredient:p-Phenylenediamine Sulfate',\n",
       " 'Ingredient:Simmondsia Chinensis (Jojoba) Seed Wax',\n",
       " 'Ingredient:Polyglyceryl-8 Oleate',\n",
       " 'Ingredient:Disperse Black 9',\n",
       " 'Ingredient:Malva Sylvestris (Mallow) Flower/Leaf/Stem Extract',\n",
       " 'Ingredient:Citrus Depressa Peel Extract',\n",
       " 'Ingredient:Capryloyl Pea Amino Acids',\n",
       " 'Ingredient:DM Hydantoin',\n",
       " 'Ingredient:PEG/PPG-22/22 Butyl Ether Dimethicone',\n",
       " 'Ingredient:Propylene Glycol Laurate',\n",
       " 'Ingredient:Hydroxycapric Acid',\n",
       " 'Ingredient:Chondrus Crispus Powder',\n",
       " 'Ingredient:Polyglyceryl-10 Caprylate',\n",
       " 'Ingredient:2-Bromo-2-Nitropropane-1,3-Diol',\n",
       " 'Ingredient:Corn Starch Modified',\n",
       " 'Ingredient:Palmitic/Stearic Triglyceride',\n",
       " 'Ingredient:Palm Kernelamidopropyl Betaine',\n",
       " 'Ingredient:Ceteth-10',\n",
       " 'Ingredient:Lauryl Stearate',\n",
       " 'Ingredient:m-Cresol',\n",
       " 'Ingredient:Rhizobian Gum',\n",
       " 'Ingredient:Eucalyptus Globulus Leaf',\n",
       " 'Ingredient:Disodium Phosphate',\n",
       " 'Ingredient:Glyceryl Oleate',\n",
       " 'Ingredient:Citrus Paradisi (Grapefruit) Peel Extract',\n",
       " 'Ingredient:Adansonia Digitata Seed Oil PEG-8 Esters',\n",
       " 'Ingredient:Methoxy PEG/PPG-25/4 Dimethicone',\n",
       " 'Ingredient:Ammonium Sulfite',\n",
       " 'Ingredient:Oleyl Oleate',\n",
       " 'Ingredient:PPG-18 Butyl Ether',\n",
       " 'Ingredient:Potassium Camelliate',\n",
       " 'Ingredient:C12-13 Alketh-10 (Formerly C12-13 Pareth-10)',\n",
       " 'Ingredient:Citrus Aurantium Amara (Bitter Orange) Leaf/Twig Extract',\n",
       " 'Ingredient:Hypericum Perforatum Flower/Leaf/Stem Extract',\n",
       " 'Ingredient:Acrylates/Beheneth-25 Methacrylate Copolymer',\n",
       " 'Ingredient:Octyl Dodecanol',\n",
       " 'Ingredient:Cocos Nucifera (Coconut) Flower Nectar Extract',\n",
       " 'Ingredient:Disodium Oleyl Phosphate',\n",
       " 'Ingredient:PEG/PPG-3/6 Dimethyl Ether',\n",
       " 'Ingredient:PEG-12',\n",
       " 'Ingredient:Silk',\n",
       " 'Ingredient:Propylene Glycol Myristate',\n",
       " 'Ingredient:Lithium Stearate',\n",
       " 'Ingredient:Octyldodeceth-20',\n",
       " 'Ingredient:Sodium Cottonseedamphoacetate',\n",
       " 'Ingredient:Shea Butteramide/Castoramide DEA',\n",
       " 'Ingredient:Sodium Paraben',\n",
       " 'Ingredient:Hydrogenated Grapefruit Seed Oil Unsaponifiables',\n",
       " 'Ingredient:Hydroxy Tetramethylpiperidine Oxide',\n",
       " 'Ingredient:Lessonia Nigrescens Extract',\n",
       " 'Ingredient:DEA-C12-13 Alkyl Sulfate',\n",
       " 'Ingredient:Acrylamide/Sodium Acryloyldimethyltaurate Copolymer',\n",
       " 'Ingredient:Polysorbate 61',\n",
       " 'Ingredient:Hydroxypropyltrimonium Maltodextrin Crosspolymer',\n",
       " 'Ingredient:Polyglyceryl-10 Tetradecanedioate',\n",
       " 'Ingredient:Citrus Junos Seed Oil',\n",
       " 'Ingredient:PEG-55',\n",
       " 'Ingredient:Deceth-10',\n",
       " 'Ingredient:Glyceryl Collagenate',\n",
       " 'Ingredient:HC Orange No. 1',\n",
       " 'Ingredient:Scutellaria Baicalensis Root Powder',\n",
       " 'Ingredient:Ethanolamine HCl',\n",
       " 'Ingredient:Methyl Methacrylate/Glycol Dimethacrylate Crosspolymer',\n",
       " 'Ingredient:Hydrogenated Poly(C6-14 Olefin)',\n",
       " 'Ingredient:Hydrolyzed Soy Starch',\n",
       " 'Ingredient:Octoxynol-5',\n",
       " 'Ingredient:Poloxamer 123',\n",
       " 'Ingredient:Cetyl Dimethylbutyl Ether',\n",
       " 'Ingredient:Melaleuca Alternifolia (Tea Tree) Leaf Powder',\n",
       " 'Ingredient:Decyltetradeceth-20',\n",
       " 'Ingredient:Hydrogenated Apricot Oil Unsaponifiables',\n",
       " 'Ingredient:Capryl Dimethicone',\n",
       " 'Ingredient:C12-13 Pareth-5',\n",
       " 'Ingredient:Ammonia',\n",
       " 'Ingredient:Ethylparaben',\n",
       " 'Ingredient:Cetearyl Palmitate',\n",
       " 'Ingredient:Diisostearyl Sebacate',\n",
       " 'Ingredient:PPG-2 Butyl Ether',\n",
       " 'Ingredient:Cocos Nucifera (Coconut) Fruit/Fruit Juice Extract',\n",
       " 'Ingredient:Cyclohexasiloxane',\n",
       " 'Ingredient:Cyclohexyl Methacrylate/Ethylhexyl Methacrylate Copolymer',\n",
       " 'Ingredient:Avena Sativa (Oat) Kernel Protein',\n",
       " 'Ingredient:Sodium Cocoyl Isethionate',\n",
       " 'Ingredient:o-Cymen-5-ol',\n",
       " 'Ingredient:Capryloyl Silk Amino Acids',\n",
       " 'Ingredient:Polyurethane-5',\n",
       " 'Ingredient:Ceteareth-40',\n",
       " 'Ingredient:Sodium Myreth Sulfate',\n",
       " 'Ingredient:2-Methyl-5-Hydroxyethylaminophenol',\n",
       " 'Ingredient:PPG-1-Ceteth-5',\n",
       " 'Ingredient:Pisum Sativum (Pea) Protein',\n",
       " 'Ingredient:Polyacrylate-2',\n",
       " 'Ingredient:Lecithinamide DEA',\n",
       " 'Ingredient:Shea oleine',\n",
       " 'Ingredient:Glyceryl Diricinoleate',\n",
       " 'Ingredient:Acetylated Lanolin',\n",
       " 'Ingredient:Acetyl Proline',\n",
       " 'Ingredient:Cystoseira Balearica Extract',\n",
       " 'Ingredient:PEG-40 Sorbitan Tetraoleate',\n",
       " 'Ingredient:PTFE',\n",
       " 'Ingredient:C15-18 Glycol',\n",
       " 'Ingredient:Hydrogenated Peach Kernel Oil',\n",
       " 'Ingredient:Sodium Decyl Sulfate',\n",
       " 'Ingredient:Magnesium Lanolate',\n",
       " 'Ingredient:Carnitine Hydroxycitrate',\n",
       " 'Ingredient:Lactose',\n",
       " 'Ingredient:PEG/PPG-15/15 Dimethicone',\n",
       " 'Ingredient:Polypropylene Terephthalate',\n",
       " 'Ingredient:Fucose',\n",
       " 'Ingredient:MIPA-Myristate',\n",
       " 'Ingredient:Sodium Lauraminopropionate',\n",
       " 'Ingredient:Ceramide AS',\n",
       " 'Ingredient:Glyceryl Undecylenate',\n",
       " 'Ingredient:Lauryl Dimethicone PEG-15 Crosspolymer',\n",
       " 'Ingredient:Malus domestica (apple ) seed oil (synonym of Pyrus Malus (Apple) Seed Oil)',\n",
       " 'Ingredient:PEG/PPG-27/9 Butyl Ether Dimethicone',\n",
       " 'Ingredient:Quaternium-15',\n",
       " 'Ingredient:Chondrus Crispus Extract',\n",
       " 'Ingredient:Sodium Lactate',\n",
       " 'Ingredient:PPG-2-Isodeceth-18',\n",
       " 'Ingredient:Cetyl Babassuate',\n",
       " 'Ingredient:Nylon-11',\n",
       " 'Ingredient:Methoxy PEG-17/Methoxy PEG-11/HDI Isocyanurate Trimer Crosspolymer',\n",
       " 'Ingredient:Lauramine Oxide',\n",
       " 'Ingredient:Butene/Propylene Copolymer',\n",
       " 'Ingredient:Polyglyceryl-3 Di-Hydroxystearate',\n",
       " 'Ingredient:PEG-3 Distearate',\n",
       " 'Ingredient:C16-22 Acid Amide MEA',\n",
       " 'Ingredient:Sodium Myristyl Sulfate',\n",
       " 'Ingredient:PPG-3-Isodeceth-1',\n",
       " 'Ingredient:Sodium Dehydroacetate',\n",
       " 'Ingredient:PVP/VA/Itaconic Acid Copolymer',\n",
       " 'Ingredient:Corylus Rostrata (Hazelnut) Seed Extract',\n",
       " 'Ingredient:Adansonia Digitata Seed Oil',\n",
       " 'Ingredient:Diisobutyl Adipate',\n",
       " 'Ingredient:Citrus Grandis (Grapefruit) Fruit Water',\n",
       " 'Ingredient:Laminaria Digitata Powder',\n",
       " 'Ingredient:Lauric/Palmitic/Oleic Triglyceride',\n",
       " 'Ingredient:Methenamine',\n",
       " 'Ingredient:C16-17 Alkyl Benzoate',\n",
       " 'Ingredient:Isocetyl Myristate',\n",
       " 'Ingredient:Dibehenyl Fumarate',\n",
       " 'Ingredient:Citrus Junos Fruit Water',\n",
       " 'Ingredient:C12-14 Sec-Pareth-8',\n",
       " 'Ingredient:1-Naphthol',\n",
       " 'Ingredient:Isostearamidopropyl Dimethylamine',\n",
       " 'Ingredient:Glycyrrhiza Glabra (Licorice) Rhizome/Root',\n",
       " 'Ingredient:Isopropylidenediphenyl Bisglycidyl Methacrylate',\n",
       " 'Ingredient:C10-12 Isoalkane (Formerly C10-12 Isoparaffin)',\n",
       " 'Ingredient:Aloe Barbadensis Leaf',\n",
       " 'Ingredient:PPG-4-Ceteth-5',\n",
       " 'Ingredient:Diethylhexyl Adipate',\n",
       " 'Ingredient:Borage Seed Oil Polyglyceryl-6 Esters',\n",
       " 'Ingredient:Ethyl Myristate',\n",
       " 'Ingredient:Disodium Laureth-12 Sulfosuccinate',\n",
       " 'Ingredient:Pyrocatechol',\n",
       " 'Ingredient:Hexyldecyl Oleate',\n",
       " 'Ingredient:Polyquaternium-53',\n",
       " 'Ingredient:PPG-14-Deceth-6',\n",
       " 'Ingredient:Citrus Nobilis (Mandarin Orange) Peel Extract',\n",
       " 'Ingredient:Propylene Glycol Isodeceth-4',\n",
       " 'Ingredient:Phytosteryl Linoleate/Linolenate',\n",
       " 'Ingredient:Hydrogenated Lard Glycerides',\n",
       " 'Ingredient:Locust Bean Hydroxypropyltrimonium Chloride',\n",
       " 'Ingredient:Retinol',\n",
       " 'Ingredient:Quassin',\n",
       " 'Ingredient:Potassium Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       " 'Ingredient:Citrus Grandis (Grapefruit) Peel Extract',\n",
       " 'Ingredient:PEG-2 Sorbitan Isostearate',\n",
       " 'Ingredient:Bisabolol',\n",
       " 'Ingredient:Rosa Centifolia Leaf Cell Extract',\n",
       " 'Ingredient:Bis-PEG-8 Dimethicone',\n",
       " 'Ingredient:C12-15 Pareth-3',\n",
       " 'Ingredient:Humulus Lupulus (Hops) Stem Extract',\n",
       " 'Ingredient:Octyldodecyl Glucoside',\n",
       " 'Ingredient:Polyglyceryl-2 Tetrabehenate/Macadamiate/Sebacate',\n",
       " 'Ingredient:Calcium/Sodium PVM/MA Copolymer',\n",
       " 'Ingredient:Dimethiconol/Methylsilanol/Silicate Crosspolymer',\n",
       " 'Ingredient:Carica Papaya (Papaya) Fruit Extract',\n",
       " 'Ingredient:2,4-Diaminophenol Dihydrochloride',\n",
       " 'Ingredient:Polyglyceryl-10 Trilaurate',\n",
       " 'Ingredient:Humulus Lupulus (Hops) Oil',\n",
       " 'Ingredient:Nonoxynol-10',\n",
       " 'Ingredient:Polyglyceryl-5 Tristearate',\n",
       " 'Ingredient:Rubus Idaeus (Raspberry) Seed Oil',\n",
       " 'Ingredient:Rice Bran Acid',\n",
       " 'Ingredient:Coconut Flower Sugar',\n",
       " 'Ingredient:Hydrolyzed Wheat Gluten',\n",
       " 'Ingredient:Potassium Sorbate',\n",
       " 'Ingredient:PEG-15 Hydrogenated Lanolin',\n",
       " 'Ingredient:Cetyl Ricinoleate',\n",
       " 'Ingredient:Dodecylhexadecyltrimonium Chloride',\n",
       " 'Ingredient:Lauramide MIPA',\n",
       " 'Ingredient:Hordeum Distichon (Barley) Seed Flour',\n",
       " 'Ingredient:PPG-1-Deceth-7',\n",
       " 'Ingredient:Collodion',\n",
       " 'Ingredient:Methacrylic Acid/PEG-6 Methacrylate/PEG-6 Dimethacrylate Crosspolymer',\n",
       " 'Ingredient:Hordeum Vulgare Root Extract',\n",
       " 'Ingredient:Hydrolyzed Beta-Glucan',\n",
       " 'Ingredient:Myristyl Sultaine',\n",
       " 'Ingredient:PEG-44 Sorbitan Laurate',\n",
       " 'Ingredient:PPG-9 Butyl Ether',\n",
       " 'Ingredient:PEG-60 Hydrogenated Castor Oil Triisostearate',\n",
       " 'Ingredient:Propylene Glycol Alginate',\n",
       " 'Ingredient:Dimethicone PEG-7 Phosphate',\n",
       " 'Ingredient:Behenyl Methacrylate/Perfluorooctylethyl Methacrylate Copolymer',\n",
       " 'Ingredient:Polyperfluoroethoxymethoxy Difluorohydroxyethyl Ether',\n",
       " 'Ingredient:Babassu Oil Polyglyceryl-4 Esters',\n",
       " 'Ingredient:Citrus Aurantium Dulcis (Orange) Peel Powder',\n",
       " 'Ingredient:Ethyl Lactate',\n",
       " 'Ingredient:Sodium Cocoyl/Hydrogenated Tallow Glutamate',\n",
       " 'Ingredient:Polyglyceryl-2 Diisostearate',\n",
       " 'Ingredient:Propylene Glycol Diundecanoate',\n",
       " 'Ingredient:Ceramide NS',\n",
       " 'Ingredient:Brucine Sulfate',\n",
       " 'Ingredient:Polyurethane-35',\n",
       " 'Ingredient:PEG-50 Hydrogenated Castor Oil Triisostearate',\n",
       " 'Ingredient:Ceteth-23',\n",
       " 'Ingredient:Chimyl Stearate',\n",
       " 'Ingredient:Ceteth-18',\n",
       " 'Ingredient:Citrus Unshiu Fruit Powder',\n",
       " 'Ingredient:Mango Seed Oil PEG-70 Esters',\n",
       " 'Ingredient:Zea Mays (Corn) Seed Flour',\n",
       " 'Ingredient:Hydrogenated Jojoba Oil',\n",
       " 'Ingredient:Juniperus Phoenicea Gum Extract',\n",
       " 'Ingredient:PEG-9 Polydimethylsiloxyethyl Dimethicone',\n",
       " 'Ingredient:PEG-6 Methyl Ether Dimethicone',\n",
       " 'Ingredient:Sodium Caprate',\n",
       " 'Ingredient:Bis-PEG-4 Dimethicone',\n",
       " 'Ingredient:Glucose Pentaacetate',\n",
       " 'Ingredient:Polyurethane-25',\n",
       " 'Ingredient:Glyceryl Palmitate Lactate',\n",
       " 'Ingredient:Octoxynol-40',\n",
       " 'Ingredient:Octyldodecyl Olivate',\n",
       " 'Ingredient:Olea Europaea (Olive) Bud Extract',\n",
       " 'Ingredient:Poloxamer 124',\n",
       " 'Ingredient:Nonoxynol-44',\n",
       " 'Ingredient:Sodium Polymethacrylate',\n",
       " 'Ingredient:Arctium Lappa Seed Oil',\n",
       " 'Ingredient:Linseed Oil PEG-8 Esters',\n",
       " 'Ingredient:Polyurethane-16',\n",
       " 'Ingredient:Lactic Yeasts',\n",
       " 'Ingredient:Isopropyl Cresols',\n",
       " 'Ingredient:Pelargonic Acid',\n",
       " 'Ingredient:Magnesium Salicylate',\n",
       " 'Ingredient:Calcium Starch Octenylsuccinate',\n",
       " 'Ingredient:Polyglyceryl-3 Dioleate',\n",
       " 'Ingredient:Hordeum Vulgare Seed Extract',\n",
       " 'Ingredient:Potassium Dodecylbenzenesulfonate',\n",
       " 'Ingredient:Polyurethane-13',\n",
       " 'Ingredient:Ceteareth-2',\n",
       " 'Ingredient:Basic Yellow 57',\n",
       " 'Ingredient:Laureth-12',\n",
       " 'Ingredient:p-Chloro-m-Cresol',\n",
       " 'Ingredient:Gelidium Amansii Oligosaccharides',\n",
       " 'Ingredient:Pyrus Malus (Apple) Pectin Extract',\n",
       " 'Ingredient:Polyquaternium-51',\n",
       " 'Ingredient:Lactoglobulin',\n",
       " 'Ingredient:PEG-40 Hydrogenated Castor Oil Laurate',\n",
       " 'Ingredient:Dextran Hydroxypropyltrimonium Chloride',\n",
       " 'Ingredient:Sodium Decylbenzenesulfonate',\n",
       " 'Ingredient:Polyglyceryl-10 Decaoleate',\n",
       " 'Ingredient:Di-C16-18 Alkyl Dimer Dilinoleate',\n",
       " 'Ingredient:Nylon-12/6/66 Copolymer',\n",
       " 'Ingredient:PEG-75 Lanolin Oil',\n",
       " 'Ingredient:Cetyl Dimethicone',\n",
       " 'Ingredient:Decylene Glycol',\n",
       " 'Ingredient:Polyquaternium-14',\n",
       " 'Ingredient:Polydecene',\n",
       " 'Ingredient:Sodium Coceth Sulfate',\n",
       " 'Ingredient:Gelatin',\n",
       " 'Ingredient:Hectorite',\n",
       " 'Ingredient:Glyceryl Arachidate',\n",
       " 'Ingredient:Octyl Palmitate',\n",
       " 'Ingredient:Potassium Paraben',\n",
       " 'Ingredient:Ginkgo Biloba Root Extract',\n",
       " 'Ingredient:Sodium Palmitoyl Sarcosinate',\n",
       " 'Ingredient:Polyglyceryl-6 Tetraoleate',\n",
       " 'Ingredient:Chlorphenesin',\n",
       " 'Ingredient:Saccharomyces Ferment',\n",
       " 'Ingredient:Polyglyceryl-20 Heptadecabehenate/Laurate',\n",
       " 'Ingredient:Glyceryl Distearate',\n",
       " 'Ingredient:Linseed Acid',\n",
       " 'Ingredient:Disodium C12-14 Sec-Pareth-9 Sulfosuccinate',\n",
       " 'Ingredient:Bis-PEG/PPG-15/5 Dimethicone',\n",
       " 'Ingredient:Butyl Acrylate/Styrene Copolymer',\n",
       " 'Ingredient:Aluminum Distearate',\n",
       " 'Ingredient:Sodium C12-13 Alketh Sulfate (Formerly Sodium C12-13 Pareth Sulfate)',\n",
       " 'Ingredient:Ethylene/Acrylic Acid Copolymer',\n",
       " 'Ingredient:Polyglyceryl-2 Sesquioleate',\n",
       " 'Ingredient:Glycol Dimethacrylate Crosspolymer',\n",
       " 'Ingredient:Macadamia Ternifolia Seed Oil',\n",
       " 'Ingredient:Sodium C12-14 Olefin Sulfonate',\n",
       " 'Ingredient:Glycine Soja (Soybean) Sprout Extract',\n",
       " 'Ingredient:Polypentaerythrityl Terephthalate',\n",
       " 'Ingredient:5-Amino-4-Chloro-o-Cresol HCl',\n",
       " 'Ingredient:Poloxamer 105',\n",
       " 'Ingredient:Myreth-3',\n",
       " 'Ingredient:Hydrolyzed Rhizobian Gum',\n",
       " 'Ingredient:Citrus Limon (Lemon) Seed Oil',\n",
       " 'Ingredient:PEG/PPG-27/14 Dimethyl Ether',\n",
       " 'Ingredient:Citrus Limon (Lemon) Leaf Extract',\n",
       " 'Ingredient:Propanediol Diisostearate',\n",
       " 'Ingredient:PPG-2-Ceteth-10',\n",
       " 'Ingredient:Glyceryl/Sorbitol Oleate/Hydroxystearate',\n",
       " 'Ingredient:Isostearyl Linoleate',\n",
       " 'Ingredient:Dimethyl Phthalate',\n",
       " 'Ingredient:C12-14 Sec-Alketh-30 (Formerly C12-14 Sec-Pareth-30)',\n",
       " 'Ingredient:Polyurethane-33',\n",
       " 'Ingredient:Ghatti Gum',\n",
       " 'Ingredient:Shea Butteramidopropyl Betaine',\n",
       " 'Ingredient:Rosa Centifolia Extract',\n",
       " 'Ingredient:C14-18 Alkyl Ethylhexanoate',\n",
       " 'Ingredient:Aluminum Stearate',\n",
       " 'Ingredient:Acacia Dealbata',\n",
       " 'Ingredient:Behenamide DEA',\n",
       " 'Ingredient:Hordeum Vulgare Leaf Extract',\n",
       " 'Ingredient:Citrus Jabara Peel Water',\n",
       " 'Ingredient:Portulaca Oleracea Flower/Leaf/Stem Extract',\n",
       " 'Ingredient:Sodium Myristoyl Sarcosinate',\n",
       " 'Ingredient:PPG-6-Laureth-3',\n",
       " 'Ingredient:Hydrolyzed Candida Bombicola Extract',\n",
       " 'Ingredient:Polyphosphorylcholine Glycol Acrylate',\n",
       " 'Ingredient:Myristyl Acetate',\n",
       " 'Ingredient:Kluyveromyces Extract',\n",
       " 'Ingredient:Butyrospermum Parkii (Shea) Nut Shell Powder',\n",
       " 'Ingredient:HC Red No. 1',\n",
       " 'Ingredient:C12-14 Sec-Pareth-40',\n",
       " 'Ingredient:Hydrolyzed Corallina Officinalis',\n",
       " 'Ingredient:Polyglyceryl-5 Triisostearate',\n",
       " 'Ingredient:Acacia Farnesiana Flower Wax',\n",
       " 'Ingredient:Acrylates/Stearyl Methacrylate/VP Copolymer',\n",
       " 'Ingredient:Euphorbia Cerifera (Candelilla) Wax',\n",
       " 'Ingredient:Polyglyceryl-10 Pentaoleate',\n",
       " 'Ingredient:PEG-160 Sorbitan Triisostearate',\n",
       " 'Ingredient:Calcium Dodecylbenzenesulfonate',\n",
       " 'Ingredient:Punica Granatum Fruit Extract',\n",
       " 'Ingredient:PPG-1-Deceth-6',\n",
       " 'Ingredient:PEG-11 Methyl Ether Dimethicone',\n",
       " 'Ingredient:Phytosteryl Hydroxystearate',\n",
       " 'Ingredient:Isodecyl Ethylhexanoate',\n",
       " 'Ingredient:PEG-10 Hydrogenated Lanolin',\n",
       " 'Ingredient:Erucyl Erucate',\n",
       " 'Ingredient:Polyurethane-68',\n",
       " 'Ingredient:PEG-20 Dilaurate',\n",
       " 'Ingredient:Dihydrocholesteryl Nonanoate',\n",
       " 'Ingredient:Oleyl Linoleate',\n",
       " 'Ingredient:Isolaureth-3',\n",
       " 'Ingredient:Ammonium Polyacrylate',\n",
       " 'Ingredient:Propanediol Dipelargonate',\n",
       " 'Ingredient:Rosmarinus Officinalis (Rosemary) Water',\n",
       " 'Ingredient:Polyglyceryl-20 Docosabehenate/Isostearate',\n",
       " 'Ingredient:Polyglyceryl-10 Pentahydroxystearate',\n",
       " 'Ingredient:Polyquaternium-10',\n",
       " ...]"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chiavi =r.keys(pattern='Ingredient:*')\n",
    "print(len(chiavi))\n",
    "chiavi"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5673\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=188da513-3deb-4a0c-8b92-1337fa58e115'"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ingredienti = r.lrange('list:ingredients',0,-1)\n",
    "print(len(ingredienti))\n",
    "r.get(f'Ingredient:{ingredienti[347]}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "ingredienti = ['Zirconium silicate','Zirconium','ZAZA']\n",
    "\n",
    "for ingrediente in ingredienti:\n",
    "\n",
    "    r.rpush('list:ingredients',ingrediente)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Sodium Myristoyl Sarcosinate', 'Zirconium silicate', 'Zirconium', 'ZAZA']"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r.lrange('list:ingredients',-4,-1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4\n"
     ]
    }
   ],
   "source": [
    "import json\n",
    "\n",
    "with open(\"hsdb database.json\",'r')as file:\n",
    "\n",
    "    lista = json.load(file)\n",
    "    print(lista['Annotations']['TotalPages'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Morpholine\n",
      "Ammonia\n",
      "Isobutane\n",
      "Isopentane\n",
      "L-Ascorbic Acid\n",
      "n-Butane\n",
      "1,4-Butanediol\n",
      "2,3-Butanediol\n"
     ]
    }
   ],
   "source": [
    "ingredienti = r.lrange('list:ingredients',0,-1)\n",
    "\n",
    "pubchem = []\n",
    "\n",
    "for el in lista['Annotations']['Annotation']:\n",
    "    if el['Name'] in ingredienti:\n",
    "        pubchem.append(el)\n",
    "\n",
    "for el in pubchem:\n",
    "    print(el['Name'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "'list' object has no attribute 'split'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mAttributeError\u001b[0m                            Traceback (most recent call last)",
      "Cell \u001b[1;32mIn[49], line 78\u001b[0m\n\u001b[0;32m     76\u001b[0m \u001b[38;5;66;03m# Example usage\u001b[39;00m\n\u001b[0;32m     77\u001b[0m url \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m'\u001b[39m\u001b[38;5;124mhttps://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6\u001b[39m\u001b[38;5;124m'\u001b[39m  \u001b[38;5;66;03m# Replace with actual PDF URL\u001b[39;00m\n\u001b[1;32m---> 78\u001b[0m df \u001b[38;5;241m=\u001b[39m \u001b[43mmain\u001b[49m\u001b[43m(\u001b[49m\u001b[43murl\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m     79\u001b[0m \u001b[38;5;28mprint\u001b[39m(df)\n",
      "Cell \u001b[1;32mIn[49], line 67\u001b[0m, in \u001b[0;36mmain\u001b[1;34m(url)\u001b[0m\n\u001b[0;32m     64\u001b[0m search_terms \u001b[38;5;241m=\u001b[39m [\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mNOAEL\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mLD50\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mLD 50\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mLD\u001b[39m\u001b[38;5;124m\"\u001b[39m]\n\u001b[0;32m     66\u001b[0m \u001b[38;5;66;03m# Step 4: Capture surrounding text\u001b[39;00m\n\u001b[1;32m---> 67\u001b[0m contexts \u001b[38;5;241m=\u001b[39m \u001b[43mcapture_surrounding_text\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtext\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43msearch_terms\u001b[49m\u001b[43m)\u001b[49m\n\u001b[0;32m     69\u001b[0m \u001b[38;5;66;03m# Step 5: Build DataFrame\u001b[39;00m\n\u001b[0;32m     70\u001b[0m df \u001b[38;5;241m=\u001b[39m build_dataframe(contexts)\n",
      "Cell \u001b[1;32mIn[49], line 40\u001b[0m, in \u001b[0;36mcapture_surrounding_text\u001b[1;34m(text, search_terms)\u001b[0m\n\u001b[0;32m     37\u001b[0m match_end \u001b[38;5;241m=\u001b[39m match_start \u001b[38;5;241m+\u001b[39m \u001b[38;5;28mlen\u001b[39m(match_text)\n\u001b[0;32m     39\u001b[0m \u001b[38;5;66;03m# Get 10 words before and after the match\u001b[39;00m\n\u001b[1;32m---> 40\u001b[0m start_idx \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mmax\u001b[39m(\u001b[38;5;241m0\u001b[39m, \u001b[38;5;28mlen\u001b[39m(\u001b[43mwords\u001b[49m\u001b[43m[\u001b[49m\u001b[43m:\u001b[49m\u001b[43mmatch_start\u001b[49m\u001b[43m]\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43msplit\u001b[49m()) \u001b[38;5;241m-\u001b[39m \u001b[38;5;241m10\u001b[39m)\n\u001b[0;32m     41\u001b[0m end_idx \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mlen\u001b[39m(words[:match_end]\u001b[38;5;241m.\u001b[39msplit()) \u001b[38;5;241m+\u001b[39m \u001b[38;5;241m10\u001b[39m\n\u001b[0;32m     43\u001b[0m context_words \u001b[38;5;241m=\u001b[39m words[start_idx:end_idx]\n",
      "\u001b[1;31mAttributeError\u001b[0m: 'list' object has no attribute 'split'"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import pdfplumber\n",
    "import re\n",
    "import pandas as pd\n",
    "import io\n",
    "\n",
    "def fetch_pdf(url):\n",
    "    response = requests.get(url)\n",
    "    response.raise_for_status()  # Ensure the request was successful\n",
    "    return response.content\n",
    "\n",
    "def extract_text_from_pdf(pdf_content):\n",
    "    text = \"\"\n",
    "    with pdfplumber.open(io.BytesIO(pdf_content)) as pdf:\n",
    "        for page in pdf.pages:\n",
    "            page_text = page.extract_text()\n",
    "            if page_text:\n",
    "                text += page_text\n",
    "    return text\n",
    "\n",
    "def capture_surrounding_text(text, search_terms):\n",
    "    # Define the regex pattern to match the terms followed by a numerical value and unit\n",
    "    pattern = r'\\b(?:{})\\b(?:(?!\\b(?:{})\\b).)*?(\\d+\\.?\\d* ?(?:mg/kg|mg|g/kg|g|µg/kg|µg|kg))'.format('|'.join(search_terms), '|'.join(search_terms))\n",
    "    \n",
    "    # Find all matches\n",
    "    matches = re.finditer(pattern, text, re.IGNORECASE | re.DOTALL)\n",
    "    \n",
    "    result_contexts = []\n",
    "    for match in matches:\n",
    "        match_text = match.group()\n",
    "        \n",
    "        # Split the text into words\n",
    "        words = text.split()\n",
    "        \n",
    "        # Find the starting and ending index of the match in words list\n",
    "        match_start = text.find(match_text)\n",
    "        match_end = match_start + len(match_text)\n",
    "        \n",
    "        # Get 10 words before and after the match\n",
    "        start_idx = max(0, len(words[:match_start].split()) - 10)\n",
    "        end_idx = len(words[:match_end].split()) + 10\n",
    "        \n",
    "        context_words = words[start_idx:end_idx]\n",
    "        context = ' '.join(context_words)\n",
    "        \n",
    "        result_contexts.append((match.group(1), context))\n",
    "    \n",
    "    return result_contexts\n",
    "\n",
    "def build_dataframe(contexts):\n",
    "    data = {'values': [val for val, _ in contexts],\n",
    "            'context': [ctx for _, ctx in contexts]}\n",
    "    df = pd.DataFrame(data)\n",
    "    return df\n",
    "\n",
    "def main(url):\n",
    "    # Step 1: Fetch PDF\n",
    "    pdf_content = fetch_pdf(url)\n",
    "    \n",
    "    # Step 2: Extract text from PDF\n",
    "    text = extract_text_from_pdf(pdf_content)\n",
    "    \n",
    "    # Step 3: Define search terms\n",
    "    search_terms = [\"NOAEL\", \"LD50\", \"LD 50\", \"LD\"]\n",
    "    \n",
    "    # Step 4: Capture surrounding text\n",
    "    contexts = capture_surrounding_text(text, search_terms)\n",
    "    \n",
    "    # Step 5: Build DataFrame\n",
    "    df = build_dataframe(contexts)\n",
    "    \n",
    "    return df\n",
    "\n",
    "\n",
    "\n",
    "# Example usage\n",
    "url = 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6'  # Replace with actual PDF URL\n",
    "df = main(url)\n",
    "print(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'and the same was true for rats dosed with 5, 000 mg/kg potato starch modified, 5,000 mg/kg calcium starch isododecenylsuccinate (considered'"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['context'][4]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: dified), 2,000 mg/kg corn starch modified, 2,000 mg/kg dextrin palmitate, 2,000 mg/kg dextrin \n",
      "myristate, or 2,000 mg/kg stearoyl inulin.  Acute oralLD50values of  > 2,800 mg/kg body weight (mice) and  > \n",
      "5,000 mg/kg body weight (rats) have been reported for glucomannan. \n",
      "\n",
      "In acute dermal toxicity stud\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: ies on corn starch modified, potato starch modified, dextrin myristate, and \n",
      "\n",
      "dextrin palmitate, anLD50of  > 2,000 mg/kg (rats) was reported.  The same results were reported for glucomannan \n",
      "in an acute dermal toxicity study involving rabbits.  \n",
      "\n",
      "Repeat\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: d).  An LC50 of  > 0.0015 mg/l was reported.151   \n",
      "\n",
      "Branched - Unmodified \n",
      "\n",
      "Oral \n",
      "\n",
      "Glucomannan:  Male and female mice (number and strain not stated).LD50> 2,800 mg/kg body weight.  No abnormalities with respect to the following:  \n",
      "appearance, behavior, body weight changes, occult blood in the urine and\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: feces, or macroscopic findings.152   \n",
      "\n",
      "Glucomannan (in konjac flour): Male and female rats (number and strain not stated.LD50> 5,000 mg/kg body weight.151  \n",
      "\n",
      "Sterculia Urens Gum:  Vehicle: corn oil.  5 fasted male Sprague-Dawley rats.   LD50 > 10,000 mg/kg body weight. Trans\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: male and 5 female Wistar albino rats. OECD Guideline 401 \n",
      "test protocol.  Dosing followed by 14-day observation period.  No abnormal systemic signs.LD50> 5,000 mg/kg body weight.63,64,154    \n",
      "\n",
      "Corn Starch Modified: Vehicle: distilled water. 5 male and 5 female Wistar albino rats.  Organisation for Eco\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: nomic Co-operation and Development \n",
      "(OECD) 401 protocol. 14-day observation period.  Alopecia  in one animal.LD50> 2,000 mg/kg body weight.66  \n",
      "\n",
      "Dextrin Myristate: Rats (number and strain not stated). LD50 > 2,000 mg/kg body weight.67  \n",
      "\n",
      "Dextrin Palmitate: Rats (\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: number and strain not stated).LD50> 2,000 mg/kg body weight.68,69  \n",
      "\n",
      "Potato Starch Modified:   30% aqueous solution. Albino rats (5 males, 5 females). OECD 401 protocol.  14-day observ\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: ation period.  Soft stool  (1 \n",
      "female); and no other signs. Body weight changes at necropsy  normal.LD50> 5,000 mg/kg body weight.70,155  \n",
      "\n",
      "Stearoyl Inulin: Rats (number and strain not stated).   Protocol not stated. LD50  > 2,000 mg/kg body weight.71,72\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: Branched  - Unmodified \n",
      "\n",
      "Dermal \n",
      "\n",
      "Glucomannan (in konjac flour): Male and female rabbits (number and strain not stated).  Protocol not stated.LD50> 2,000 mg/kg body weight.151  \n",
      "\n",
      "Branched  - Modified \n",
      "\n",
      "Carboxymethyl Inulin: 31.1% aqueous carboxymethyl inulin. 10 adult Dunkin–Hartley albino guine\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: ed water (30% solids). 5 male and 5 female New Zealand White rabbits.  \n",
      "OECD 402 protocol.  14-day observation period. Nine of 10 rabbits survived.LD50> 2,000 mg/kg body weight.66   \n",
      "\n",
      "Dextrin Myristate:  Rats (number and strain not stated).  Occlusive dressing technique (details not included).  LD50\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: > 2,000 mg/kg body weight.67  \n",
      "\n",
      "Dextrin Palmitate:  Rats (number and strain not stated).  Occlusive dressing technique (details not included).LD50> 2,000 mg/kg body weight.68,69  \n",
      "\n",
      "Potato Starch Modified: 10 rats (strain not specified). OECD 402 test guideline.  LD50  > 2,000 mg/kg body weight.1\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: rythema/edema at application sites (all animals); reactions had cleared by 72 h.   Signs of local \n",
      "irritation may have been due to mechanical trauma.LD50> 2,000 mg/kg body weight.70   \n",
      "\n",
      "Linear Polysaccharides and Their Salts \n",
      "\n",
      "Intravenous \n",
      "\n",
      "Carrageenan and Potassium Carrageenan:  ι-carrageenan (one sub\n",
      "--------------------------------------------------\n",
      "Keyword: LD\n",
      "Value: 50\n",
      "Context: um (karaya), FDA No. 71-\n",
      "\n",
      "17.  NTIS Report No. PB221823. 1972.  pp.1-91.  \n",
      "\n",
      "  154.   MB Research Laboratories, Inc. Single dose oral toxicity in rats/LD50in rats.  Test article # 73-\n",
      "\n",
      "8050. Unpublished data submitted by AkzoNobel on 4-14-2014. 1996.  pp.1-5.  \n",
      "\n",
      "  155.   Austrialian Government Department\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "import io\n",
    "import re\n",
    "from pdfminer.high_level import extract_text\n",
    "from urllib.parse import urlparse\n",
    "\n",
    "def download_pdf(url):\n",
    "    response = requests.get(url)\n",
    "    return io.BytesIO(response.content)\n",
    "\n",
    "def extract_text_from_pdf(pdf_file):\n",
    "    return extract_text(pdf_file)\n",
    "\n",
    "def find_keywords_and_values(text):\n",
    "    pattern = r'(.{0,150})(NOAEL|LD50|LD)\\s*(\\d+(?:[.,]\\d+)?)\\s*(.{0,150})'\n",
    "    matches = re.finditer(pattern, text, re.IGNORECASE | re.DOTALL)\n",
    "    \n",
    "    results = []\n",
    "    for match in matches:\n",
    "        before, keyword, value, after = match.groups()\n",
    "        results.append({\n",
    "            'keyword': keyword,\n",
    "            'value': value,\n",
    "            'context': before.strip() + keyword + value + after.strip()\n",
    "        })\n",
    "    \n",
    "    return results\n",
    "\n",
    "def main(url):\n",
    "    try:\n",
    "        pdf_file = download_pdf(url)\n",
    "        text = extract_text_from_pdf(pdf_file)\n",
    "        results = find_keywords_and_values(text)\n",
    "        \n",
    "        if results:\n",
    "            for result in results:\n",
    "                print(f\"Keyword: {result['keyword']}\")\n",
    "                print(f\"Value: {result['value']}\")\n",
    "                print(f\"Context: {result['context']}\")\n",
    "                print('-' * 50)\n",
    "        else:\n",
    "            print(\"No matching keywords and values found.\")\n",
    "    \n",
    "    except Exception as e:\n",
    "        print(f\"An error occurred: {str(e)}\")\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    pdf_url = 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6'\n",
    "    if not urlparse(pdf_url).scheme:\n",
    "        pdf_url = \"http://\" + pdf_url\n",
    "    main(pdf_url)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "<>:33: SyntaxWarning: invalid escape sequence '\\d'\n",
      "<>:33: SyntaxWarning: invalid escape sequence '\\d'\n",
      "C:\\Users\\LucaGiovagnoli\\AppData\\Local\\Temp\\ipykernel_15080\\168236810.py:33: SyntaxWarning: invalid escape sequence '\\d'\n",
      "  value = re.match('(\\d+(?:[.,]\\d+)\\s*.g\\/Kg[\\s*\\/.*\\/d.*]*)',line,re.IGNORECASE)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[('rats).  Sodium alginate was nephrotoxic in mice, but results for starch acetate were of little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were ', None), ('clinical chemistry parameters, or on organ weights or ophthalmic, macroscopic or microscopic findings. Gast rointestinal tract appeared normal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647 ', None), ('changes or changes in kidney weight, and were considered non -toxic and suggestive of an adaptive response. No remarkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163 ', None), ('alterations in clinical chemistry we re  considered sporadic and unrelated to treatment. Feed consumption among treated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164  ', None), ('parameters supported these findings.  Decreased organ weights and differences in hematologic test parameters, but these findi ngs were within historical  control ranges for this strain of rat.  Signs of systemic toxicity not observed at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body ', None)]\n",
      "[]\n"
     ]
    }
   ],
   "source": [
    "def extract_text_from_pdf_url(url):\n",
    "    try:\n",
    "        response = requests.get(url)\n",
    "        if response.status_code == 200:\n",
    "            pdf_data = BytesIO(response.content)\n",
    "            text_pages = []\n",
    "            document = pdf.PdfReader(pdf_data)\n",
    "            for page_num in range(len(document.pages)):\n",
    "                try:\n",
    "                    page = document.pages[page_num]\n",
    "                    page_text = page.extract_text()\n",
    "                    if page_text:\n",
    "                        text_pages.append((page_text, page_num + 1))\n",
    "                    \n",
    "                except Exception as e:\n",
    "                    pass\n",
    "            return text_pages\n",
    "        \n",
    "    except Exception as e:\n",
    "        pass\n",
    "\n",
    "def extract_noael_and_ld50(text_pages):\n",
    "    noael_pattern = re.compile(r'(.*?NOAEL.*?\\d+\\.?\\d*\\s*[a-zA-Z/]+.*?(\\.|$))', re.IGNORECASE)\n",
    "    ld50_pattern = re.compile(r'(.*?LD50.*?\\d+\\.?\\d*\\s*[a-zA-Z/]+.*?(\\.|$))', re.IGNORECASE)\n",
    "    \n",
    "    noael_matches = []\n",
    "    ld50_matches = []\n",
    "    \n",
    "    for text, page_num in text_pages:\n",
    "        lines = text.split(\"\\n\")\n",
    "        for i, line in enumerate(lines):\n",
    "            if re.search(noael_pattern, line):\n",
    "                value = re.match('(\\d+(?:[.,]\\d+)\\s*.g\\/Kg[\\s*\\/.*\\/d.*]*)',line,re.IGNORECASE)\n",
    "                previous_line = lines[i - 1] if i > 0 else \"\"\n",
    "                formatted_match = f\"{previous_line} {line}\"\n",
    "                noael_matches.append((formatted_match, value))\n",
    "            if re.search(ld50_pattern, line):\n",
    "                previous_line = lines[i - 1] if i > 0 else \"\"\n",
    "                formatted_match = f\"{previous_line} {line}\"\n",
    "                ld50_matches.append((formatted_match, page_num))\n",
    "    \n",
    "    return noael_matches, ld50_matches\n",
    "\n",
    "pages = extract_text_from_pdf_url(url)\n",
    "noaels,ld50s = extract_noael_and_ld50(pages)\n",
    "print(noaels)\n",
    "print(ld50s)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of pages: 87\n",
      "Total count: 0\n"
     ]
    }
   ],
   "source": [
    "url = 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6'\n",
    "response = req.get(url)\n",
    "text = BytesIO(response.content)\n",
    "\n",
    "reader = pdf.PdfReader(text)\n",
    "print(f\"Number of pages: {len(reader.pages)}\")\n",
    "\n",
    "# Inizializza il conteggio\n",
    "count = 0\n",
    "\n",
    "# Itera su ogni pagina\n",
    "for i in range(len(reader.pages)):\n",
    "    page = reader.pages[i]\n",
    "    text = page.extract_text()\n",
    "    \n",
    "    # Debug: Stampa il testo estratto per la pagina corrente\n",
    "    ##print(f\"--- Page {i + 1} ---\")\n",
    "    ##print(text[:500])  # Print the first 500 characters for a quick check\n",
    "    ##print(\"--------------------\")\n",
    "\n",
    "    # Converti il testo in minuscolo e rimuovi caratteri speciali\n",
    "    text = text.lower()\n",
    "    text = re.sub(r'\\s+', ' ', text)  # Rimuovi spazi extra\n",
    "\n",
    "    # Definisci l'espressione regolare che copre tutte le varianti\n",
    "    pattern = r\"ld\\s*50\\s*(?:s)?\\s*(.+?)\\s*mg/kg\\s*bw\"\n",
    "\n",
    "    # Trova tutte le occorrenze che corrispondono al pattern\n",
    "    matches = re.findall(pattern, text, flags=re.IGNORECASE)\n",
    "    \n",
    "    # Aggiorna il conteggio e stampa i match\n",
    "    if matches:\n",
    "        count += len(matches)\n",
    "        print(f\"Matches on page {i + 1}: {matches}\")\n",
    "        print(f\"Counts on page {i + 1}: {count}\")\n",
    "\n",
    "print(f\"Total count: {count}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['ridge of the stomach. The authors noted that analogousstructures do not exist in humans. Study results indicated a noobserved effect level (NOEL) of 50 mg/kg/d, and a no observedadverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi-city. The NOAEL was based on the findings (irritation) in thestomach, likely due to local irritation effects.341,2-Butanediol. In an 8-week oral study, groups of rat', 'erved in females thatreceived 1000 mg/kg doses. N o observable effect levels(NOELs) for repeat dose toxicity were 1000 mg/kg/d (males)and 200 mg/kg/d (females). The no observable adverse effectlevel (NOAEL) was 200 mg/kg body weight/day in thisstudy.35According to a summary of data provided by Dow ChemicalCompany, the administration of large (unspecified) doses of1,2-butanediol to rats caused irritatio', 'thelial hyperpla sia remained in the animalspreviously dosed with 1000 mg/kg/d, but the severity and inci-dence of this finding after the treatment period was largelyreversible. Both the NOEL and the NOAEL in this study was100 mg/kg body weight/d.36Pentylene glycol. Pentylene glycol was administered orallyto rats, intermittently over a 28-week period. A TDLo of2450mg/kg was reported.30Propylene glycol.', 's were killed on day 4 oflactation. Neither effects on reproduction (copulation, implan-tation, pregnancy, parturition, or lactation) nor developmentaltoxicity effects on offspring were observed. The NOAEL was1000 mg/kg for parental animals and the F 1generation.35Theestimated dose of low concern (EDCL) for this study wascalculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/dand a reproductive toxicit', 'y on >98 %caprylyl glycol (Dermosoft Octiol). The NOAELwas based on the findings of irritation on the pars nonglandularisand limiting ridge of the stomach; analogous structures do notexist in man. An NOAEL of 100 mg/kg/d was reported for ratsin a 28-day oral toxicity study on decylene glycol (SymClariol).Short-term oral administration of 1,2-butanediol to rats yieldedan NOAEL of 200 mg/kg/d. Reportedly', 'glycol to the skin of rabbits did not result in skin irritation, andresults were negative for 1,2-hexanediol (10 %to 100%)i nt h emouse local lymph node assay for evaluating sensitizationpotential.An NOAEL of 1000 mg/kg for reproductive/developmentaltoxicity has been reported for 1,2-butanediol in rats dosedorally. In a prenatal developmental toxicity study involvingrats, an NOEL of 300 mg/kg was repor']\n",
      "['tional Journal of Toxicology 31(Supplement 2)organs were observed in 3160 and 4640 mg/kg dose groups.Surviving animals recovered within 24 hours, and 215 mg/kgwas the nontoxic dose in this study. The LD50', ' values of 2240(males) and 2200 (females) were reported.In another study (OECD 423 test procedure) involving rats,the LD50 for caprylyl glycol was >2500 mg/kg.27,1,2-Butanediol. An acute oral LD50', ' mg/kg wasreported for 1,2-butanediol in a study involving female Swissalbino mice/ICR.28Study details were not provided. Accordingto a data summary available from Dow Chemical Company, theacute oral LD50', 'ediol). The following acute oralLD50 values have been reported for pentylene glycol: 1.2700Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits);and 5200 mg/kg (guinea pigs).30Stearyl glycol. An LD50', ' of >5000 mg/kg was reported for ratsdosed orally with stearyl glycol.30C15-18 glycol. The acute oral toxicity of C15-18 glycol wasevaluated using adult male Sprague-Dawley rats, and an LD50', 'of >20.0 g/kg body weight was reported.5Propylene glycol. The 24-hour oral LD50', 'LD', 'oxiceffects.21Details relating to the test procedure were not pro-vided; however, it was presumed that neat material was tested.Decylene glycol. In an acute dermal toxicity study invol-ving rats, the LD50', ' for decylene glycol (SymClariol) was>2000 mg/kg.27Propylene glycol. The dermal LD50', 'l).31Groups of 6 adult female, ICR Swiss albino mice wereinjected ip with increasing doses of 1,2-butanediol (geometricfactor of 1.2) in distilled water (injection volume ¼0.01 mL/gbody weight). Mean LD50', ' values and 95 %confidence limitswere calculated from cumulative mortality curves at 24 hoursand 144 hours. The following values were reported for 1,2-butanediol: 24-hour LD50', ' of 66.5 mmol/kg ( *5.99 g/kg) and144-hour LD50', 'LD', 'exceptthe high-dose mice survived 6 days after dosing. Signs of toxi-city, such as lethargy and ruffled hair coats, were not observedin the 2600 and 5200 groups.2IntravenousPropylene glycol. Acute iv LD50', 's of 6.2 mL/kg (rats) and 6.4mL/kg (mice) have been reported for PG. In other parenteraltoxicity studies, acute intramuscular (im) LD50 (20 g/kg rats)and acute subcutaneous (sc) LD50', 'rs to an atmosphere saturated with 1,2-butanediol. Acuteoral toxicity data on caprylyl glycol and other 1,2-glycols forwhich data are available suggest that death would occur atrelatively high doses (LD50', 'e blood vessels, and kidney dam-age in rats. Overt toxic effects were not observed in ethanol-dependent rats dosed orally with 2.74 g/kg 1,2-butanediol.The available data suggest that 1,2-butanediol (LD50', 'ared, caprylyl glycol had the lowest ED 3value (1.5mmole/kg), suggesting that its intoxication potency (ie, abilityto induce ataxia) was greatest. In an acute dermal toxicity studyinvolving rats, the LD50', 'LD', 'LD']\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>LD50</th>\n",
       "      <th>Contesto</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2.74 g/kg</td>\n",
       "      <td>e blood vessels, and kidney dam-age in rats. O...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5.99 g/kg</td>\n",
       "      <td>of 66.5 mmol/kg ( *5.99 g/kg) and144-hour LD50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>20.0 g/kg body weight</td>\n",
       "      <td>of &gt;20.0 g/kg body weight was reported.5Propyl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>20 g/kg</td>\n",
       "      <td>s of 6.2 mL/kg (rats) and 6.4mL/kg (mice) have...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2000 mg/kg</td>\n",
       "      <td>for decylene glycol (SymClariol) was&gt;2000 mg/...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                     LD50                                           Contesto\n",
       "0              2.74 g/kg   e blood vessels, and kidney dam-age in rats. O...\n",
       "1               5.99 g/kg     of 66.5 mmol/kg ( *5.99 g/kg) and144-hour LD50\n",
       "2  20.0 g/kg body weight   of >20.0 g/kg body weight was reported.5Propyl...\n",
       "3                20 g/kg   s of 6.2 mL/kg (rats) and 6.4mL/kg (mice) have...\n",
       "4              2000 mg/kg   for decylene glycol (SymClariol) was>2000 mg/..."
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def sorting_func(el):\n",
    "    num = ''\n",
    "    for char in el[0]:\n",
    "        if char.isnumeric():\n",
    "            num = num+char\n",
    "        else:\n",
    "            break\n",
    "             \n",
    "    return int(num)\n",
    "\n",
    "\n",
    "fonte = 'https://cir-reports.cir-safety.org/view-attachment/?id=9862ac6b-8e74-ec11-8943-0022482f06a6'\n",
    "\n",
    "response = req.get(fonte)\n",
    "file = BytesIO(response.content)            \n",
    "pdf_text=pdf.PdfReader(file)\n",
    "text = ''.join([x.extract_text() for x in pdf_text.pages])\n",
    "text = text.replace('\\n','').replace('\\r','')\n",
    "noael_pattern = r'(.{0,200}\\bNOAEL\\b.{0,200})'\n",
    "ld50_pattern = r'(.{0,200}\\bLD50|LD|LD\\s*50\\b.{0,200})'\n",
    "noael_values = re.findall(noael_pattern,text)\n",
    "print(noael_values)\n",
    "ld50_values = re.findall(ld50_pattern,text)\n",
    "print(ld50_values)\n",
    "ld50_final_values = []\n",
    "noael_final_values = []\n",
    "if noael_values:\n",
    "    for i in range(len(noael_values)):\n",
    "        noael_value_pattern = r'\\b\\d+\\s*[\\.,]*\\d*\\s*.g/kg[\\s*(bw|body weight)]*[\\/d.*]* \\b'\n",
    "        noael = re.findall(noael_value_pattern,noael_values[i])\n",
    "        if noael:\n",
    "            if len(noael) == 1:\n",
    "                noael_final_values.append((noael[0],noael_values[i]))\n",
    "            else:\n",
    "                for el in noael:\n",
    "                    noael_final_values.append((el,noael_values[i]))\n",
    "if ld50_values:\n",
    "    for i in range(len(ld50_values)):\n",
    "        ld50_value_pattern = r'\\b\\d+\\s*[\\.,]*\\d*\\s*.g/kg[\\s*bw|body\\s*weight]*\\b'\n",
    "        ld50 = re.findall(ld50_value_pattern,ld50_values[i])\n",
    "        if ld50:\n",
    "            if len(ld50) == 1:\n",
    "                ld50_final_values.append((ld50[0],ld50_values[i]))\n",
    "            else:\n",
    "                for el in ld50:\n",
    "                    ld50_final_values.append((el,ld50_values[i]))\n",
    "\n",
    "if noael_final_values:\n",
    "\n",
    "    noael_final_values.sort(key=sorting_func)\n",
    "    valori_noael = [x[0] for x in noael_final_values]\n",
    "    contesti_noael = [x[1] for x in noael_final_values]\n",
    "\n",
    "if ld50_final_values:\n",
    "    ld50_final_values.sort(key=sorting_func)\n",
    "    valori_ld50 = [x[0] for x in ld50_final_values]\n",
    "    contesti_ld50 = [x[1] for x in ld50_final_values]\n",
    "\n",
    "if noael_final_values:\n",
    "    noaels = pd.DataFrame({'NOAEL':valori_noael,'Contesto':contesti_noael})\n",
    "if ld50_final_values:\n",
    "    ld50s = pd.DataFrame({'LD50':valori_ld50,'Contesto':contesti_ld50})\n",
    "\n",
    "ld50s.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pymongo.mongo_client import MongoClient\n",
    "from pymongo.server_api import ServerApi\n",
    "\n",
    "\n",
    "uri = \"mongodb+srv://lucagiovagnoli:t7g^Fyi7zpN!Liw@ufs13.dsmvdrx.mongodb.net/?retryWrites=true&w=majority&appName=UFS13\"\n",
    "# Create a new client and connect to the server\n",
    "client = MongoClient(uri, server_api=ServerApi('1'))\n",
    "# Send a ping to confirm a successful connection\n",
    "    \n",
    "\n",
    "db = client['INCI']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "ingredienti = db.Ingredienti.find({},{\"_id\":0,\"Nome_comune\":1,\"INCI_name\":1})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['1,10-Decanediol',\n",
       " '1,2,4-Trihydroxybenzene',\n",
       " '1,2-Butanediol',\n",
       " '1,2-Hexanediol',\n",
       " '1,4-Butanediol',\n",
       " '1,4-Butanediol/Succinic Acid/Adipic Acid/HDI Copolymer',\n",
       " '1,5-Pentanediol',\n",
       " '10-Hydroxydecanoic Acid',\n",
       " '10-Hydroxystearic Acid',\n",
       " '1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate',\n",
       " '1-Naphthol',\n",
       " '2,3-Butanediol',\n",
       " '2,3-Naphthalenediol',\n",
       " '2,4-Diaminophenol',\n",
       " '2,4-Diaminophenol Dihydrochloride',\n",
       " '2,4-Diaminophenol HCl',\n",
       " '2,4-Diaminophenoxyethanol Dihydrochloride',\n",
       " '2,4-Diaminophenoxyethanol HCl',\n",
       " '2,4-Diaminophenoxyethanol Sulfate',\n",
       " '2-Amino-3-Hydroxypyridine',\n",
       " '2-Amino-3-Nitrophenol',\n",
       " '2-Amino-4-Hydroxyethylaminoanisole',\n",
       " '2-Amino-4-Hydroxyethylaminoanisole Sulfate',\n",
       " '2-Amino-4-Nitrophenol',\n",
       " '2-Amino-4-Nitrophenol Sulfate',\n",
       " '2-Amino-5-Nitrophenol',\n",
       " '2-Amino-6-Chloro-4-Nitrophenol',\n",
       " '2-Amino-6-Chloro-4-Nitrophenol Hydrochloride',\n",
       " '2-Bromo-2-Nitropropane-1,3-Diol',\n",
       " '2-Chloro-p-Phenylenediamine',\n",
       " '2-Chloro-p-Phenylenediamine Sulfate',\n",
       " '2-Ethoxy ethoxy ethyl methacrylate',\n",
       " '2-Methoxyethanol',\n",
       " '2-Methyl-5-Hydroxyethylaminophenol',\n",
       " '2-Methylresorcinol',\n",
       " '2-Nitro-p-Phenylenediamine',\n",
       " '2-Oleamido-1,3-Octadecanediol',\n",
       " '3-Methylamino-4-Nitrophenoxyethanol',\n",
       " '3-Nitro-p-Hydroxyethylaminophenol',\n",
       " '4-Amino-2-Hydroxytoluene',\n",
       " '4-Amino-2-Nitrophenol',\n",
       " '4-Amino-3-Nitrophenol',\n",
       " '4-Amino-m-Cresol',\n",
       " '4-Chloro-2-Aminophenol',\n",
       " '4-Chlororesorcinol',\n",
       " '4-Hydroxybenzoic Acid',\n",
       " '4-Hydroxypropylamino-3-Nitrophenol',\n",
       " '4-Methoxy-m-Phenylenediamine',\n",
       " '4-Methoxy-m-Phenylenediamine Sulfate',\n",
       " '4-Methoxy-m-Phenylenediamine-HCI',\n",
       " '4-Nitro-m-Phenylenediamine',\n",
       " '4-Nitro-o-Phenylenediamine',\n",
       " '5-Amino-4-Chloro-o-Cresol',\n",
       " '5-Amino-4-Chloro-o-Cresol HCl',\n",
       " '5-Amino-6-Chloro-o-Cresol',\n",
       " '5-Bromo-5-Nitro-1,3-Dioxane',\n",
       " '6-Amino-m-Cresol',\n",
       " '6-Amino-o-Cresol',\n",
       " '6-Hydroxyindole',\n",
       " 'Acacia Catechu',\n",
       " 'Acacia Catechu Gum',\n",
       " 'Acacia Concinna',\n",
       " 'Acacia Concinna Extract',\n",
       " 'Acacia Concinna Fruit Extract',\n",
       " 'Acacia Dealbata',\n",
       " 'Acacia Dealbata Extract',\n",
       " 'Acacia Dealbata Leaf Extract',\n",
       " 'Acacia Dealbata Leaf Wax',\n",
       " 'Acacia Decurrens',\n",
       " 'Acacia Decurrens Extract',\n",
       " 'Acacia Farnesiana',\n",
       " 'Acacia Farnesiana Extract',\n",
       " 'Acacia Farnesiana Flower Wax',\n",
       " 'Acacia Farnesiana Flower/Stem Extract',\n",
       " 'Acacia Farnesiana Gum',\n",
       " 'Acacia Senegal',\n",
       " 'Acacia Senegal Extract',\n",
       " 'Acacia Senegal Flower/Stem Extract',\n",
       " 'Acacia Senegal Gum',\n",
       " 'Acacia Senegal Gum Extract',\n",
       " 'Acetamide MEA',\n",
       " 'Acetic Acid',\n",
       " 'Acetic/Linoleic/Palmitic Triglyceride',\n",
       " 'Acetyl Arginine',\n",
       " 'Acetyl Carnitine',\n",
       " 'Acetyl Carnitine HCl',\n",
       " 'Acetyl Cysteine',\n",
       " 'Acetyl Glucosamine',\n",
       " 'Acetyl Glutamic Acid',\n",
       " 'Acetyl Glutamine',\n",
       " 'Acetyl Hexapeptide-8',\n",
       " 'Acetyl Hexapeptide-8 Amide',\n",
       " 'Acetyl Histidine',\n",
       " 'Acetyl Methionine',\n",
       " 'Acetyl Proline',\n",
       " 'Acetyl Tributyl Citrate',\n",
       " 'Acetyl Triethyl Citrate',\n",
       " 'Acetyl Triethylhexyl Citrate',\n",
       " 'Acetyl Trihexyl Citrate',\n",
       " 'Acetyl Trioctyl Citrate',\n",
       " 'Acetyl Tyrosine',\n",
       " 'Acetylated Lanolin',\n",
       " 'Acetylated Lanolin Alcohol',\n",
       " 'Achillea Millefolium Extract',\n",
       " 'Achillea Millefolium Flower Extract',\n",
       " 'Achillea Millefolium Flower/Leaf/Stem Extract',\n",
       " 'Acid Orange 3',\n",
       " 'Acid Violet 43',\n",
       " 'Acrylamide',\n",
       " 'Acrylamide/Ammonium Acrylate Copolymer',\n",
       " 'Acrylamide/Ethyltrimonium Chloride Acrylate/Ethalkonium Chloride Acrylate Copolymer',\n",
       " 'Acrylamide/Sodium Acrylate Copolymer',\n",
       " 'Acrylamide/Sodium Acryloyldimethyltaurate Copolymer',\n",
       " 'Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer',\n",
       " 'Acrylamidopropyltrimonium Chloride/Acrylamide Copolymer',\n",
       " 'Acrylamidopropyltrimonium Chloride/Acrylates Copolymer',\n",
       " 'Acrylates Copolymer',\n",
       " 'Acrylates Crosspolymer',\n",
       " 'Acrylates Crosspolymer-3',\n",
       " 'Acrylates Crosspolymer-4',\n",
       " 'Acrylates Crosspolymer-5',\n",
       " 'Acrylates/Acrylamide Copolymer',\n",
       " 'Acrylates/Ammonium Methacrylate Copolymer',\n",
       " 'Acrylates/Beheneth-25 Methacrylate Copolymer',\n",
       " 'Acrylates/Beheneth-25 Methacrylate/Steareth-30 Methacrylate Copolymer',\n",
       " 'Acrylates/Bis-Hydroxypropyl Dimethicone Crosspolymer',\n",
       " 'Acrylates/C10-30 Alkyl Acrylate Crosspolymer',\n",
       " 'Acrylates/C10-30 Alkyl Methacrylate Copolymer',\n",
       " 'Acrylates/C12-13 Alkyl Methacrylates/Methoxyethyl Acrylate Crosspolymer',\n",
       " 'Acrylates/C12-22 Alkyl Methacrylate Copolymer',\n",
       " 'Acrylates/C26-28 Olefin Copolymer',\n",
       " 'Acrylates/C5-8 Alkyl Acrylate Copolymer',\n",
       " 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer',\n",
       " 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer-2',\n",
       " 'Acrylates/Ceteth-20 Methacrylate Copolymer',\n",
       " 'Acrylates/Dimethiconol Acrylate Copolymer',\n",
       " 'Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       " 'Acrylates/Ethylhexyl Acrylate Crosspolymer',\n",
       " 'Acrylates/Ethylhexyl Acrylate/Glycidyl Methacrylate Crosspolymer',\n",
       " 'Acrylates/Ethylhexyl Acrylate/Styrene Copolymer',\n",
       " 'Acrylates/Hydroxyesters Acrylates Copolymer',\n",
       " 'Acrylates/Hydroxyethyl Acrylate/Lauryl Acrylate Copolymer',\n",
       " 'Acrylates/Hydroxyethyl Acrylate/Methoxyethyl Acrylate Copolymer',\n",
       " 'Acrylates/Laureth-25 Methacrylate Copolymer',\n",
       " 'Acrylates/Lauryl Methacrylate Copolymer',\n",
       " 'Acrylates/Lauryl Methacrylate/Tridecyl Methacrylate Crosspolymer',\n",
       " 'Acrylates/Methacrylamide Copolymer',\n",
       " 'Acrylates/Methoxy PEG-15 Methacrylate Copolymer',\n",
       " 'Acrylates/Methoxy PEG-23 Methacrylate Copolymer',\n",
       " 'Acrylates/Methoxy PEG-23 Methacrylate/Perfluorooctyl Ethyl Acrylate Copolymer',\n",
       " 'Acrylates/Methoxy PEG-4 Methacrylate Copolymer',\n",
       " 'Acrylates/Methoxy PEG-90 Methacrylate Crosspolymer',\n",
       " 'Acrylates/Octylacrylamide Copolymer',\n",
       " 'Acrylates/Palmeth-25 Acrylate Copolymer',\n",
       " 'Acrylates/PEG-4 Dimethacrylate Crosspolymer',\n",
       " 'Acrylates/Perfluorohexylethyl Methacrylate Copolymer',\n",
       " 'Acrylates/PVP Copolymer',\n",
       " 'Acrylates/Steareth-20 Methacrylate Copolymer',\n",
       " 'Acrylates/Steareth-20 Methacrylate Crosspolymer',\n",
       " 'Acrylates/Steareth-30 Methacrylate Copolymer',\n",
       " 'Acrylates/Steareth-50 Acrylate Copolymer',\n",
       " 'Acrylates/Stearyl Methacrylate Copolymer',\n",
       " 'Acrylates/Stearyl Methacrylate/VP Copolymer',\n",
       " 'Acrylates/t-Butylacrylamide Copolymer',\n",
       " 'Acrylates/VA Copolymer',\n",
       " 'Acrylates/VA Crosspolymer',\n",
       " 'Acrylates/Vinyl Isodecanoate Crosspolymer',\n",
       " 'Acrylates/Vinyl Neodecanoate Crosspolymer',\n",
       " 'Acrylates/VP Copolymer',\n",
       " 'Acrylic Acid/C12-22 Alkyl Acrylate Copolymer',\n",
       " 'Acrylic Acid/Phosphorylcholine Glycol Acrylate Crosspolymer',\n",
       " 'Acrylic Acid/Stearyl Acrylate Copolymer',\n",
       " 'Acrylic Acid/VP Crosspolymer',\n",
       " 'Acryloyloxypropyl Polysilsesquioxane',\n",
       " 'Actinidia Chinensis (Kiwi) Seed Oil',\n",
       " 'Adansonia Digitata Oil',\n",
       " 'Adansonia Digitata Seed Oil',\n",
       " 'Adansonia Digitata Seed Oil PEG-8 Esters',\n",
       " 'Adansonia Digitata Seed Oil Polyglyceryl-6 Esters',\n",
       " 'Adenosine',\n",
       " 'Adenosine Phosphate',\n",
       " 'Adenosine Triphosphate',\n",
       " 'Adipic Acid',\n",
       " 'Adipic Acid Dihydrazide',\n",
       " 'Adipic Acid/1,4-Butanediol/Terephthalate Copolymer',\n",
       " 'Adipic Acid/CHDM/MA/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       " 'Adipic Acid/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       " 'Agar',\n",
       " 'Agarose',\n",
       " 'Agarum Cribrosum Extract',\n",
       " 'Ahnfeltiopsis Concinna Extract',\n",
       " 'Alanine',\n",
       " 'Alaria Esculenta Extract',\n",
       " 'Alcaligenes Polysaccharides',\n",
       " 'Alcohol Denat.',\n",
       " 'Aldioxa',\n",
       " 'Aleurites Moluccana Seed Oil',\n",
       " 'Aleurites Moluccanus Bakoly Seed Oil',\n",
       " 'Algae Exopolysaccharides',\n",
       " 'Algin',\n",
       " 'Alginic Acid',\n",
       " 'Allantoin',\n",
       " 'Allantoin Ascorbate',\n",
       " 'Allantoin Biotin',\n",
       " 'Allantoin Galacturonic Acid',\n",
       " 'Allantoin Glycyrrhetinic Acid',\n",
       " 'Allantoin Panthenol',\n",
       " 'Allantoin Polygalacturonic Acid',\n",
       " 'Allyl Methacrylate/Glycol Dimethacryate Crosspolymer',\n",
       " 'Allyl Methacrylates Crosspolymer',\n",
       " 'Almond Meal',\n",
       " 'Almond Oil PEG-6 Esters',\n",
       " 'Almond Oil PEG-8 Esters',\n",
       " 'Almond Oil Propylene Glycol Esters',\n",
       " 'Almond Oil/Polyglyceryl-10 Esters',\n",
       " 'Almondamide DEA',\n",
       " 'Almondamidopropyl Betaine',\n",
       " 'Almondamidopropyl Dimethylamine',\n",
       " 'Aloe Andongensis Extract',\n",
       " 'Aloe Andongensis Leaf Extract',\n",
       " 'Aloe Andongensis Leaf Juice',\n",
       " 'Aloe Arborescens Leaf Extract',\n",
       " 'Aloe Arborescens Leaf Juice',\n",
       " 'Aloe Arborescens Leaf Protoplasts',\n",
       " 'Aloe Barbadensis Flower Extract',\n",
       " 'Aloe Barbadensis Leaf',\n",
       " 'Aloe Barbadensis Leaf Extract',\n",
       " 'Aloe Barbadensis Leaf Juice',\n",
       " 'Aloe Barbadensis Leaf Polysaccharides',\n",
       " 'Aloe Barbadensis Leaf Water',\n",
       " 'Aloe Ferox Leaf Extract',\n",
       " 'Aloe Ferox Leaf Juice',\n",
       " 'Aloe Ferox Leaf Juice Extract',\n",
       " 'Alumina',\n",
       " 'Alumina Magnesium Metasilicate',\n",
       " 'Aluminum Calcium Sodium Silicate',\n",
       " 'Aluminum Citrate',\n",
       " 'Aluminum Dilinoleate',\n",
       " 'Aluminum Dimyristate',\n",
       " 'Aluminum Distearate',\n",
       " 'Aluminum Hydroxide',\n",
       " 'Aluminum Iron Calcium Magnesium Germanium Silicates',\n",
       " 'Aluminum Iron Calcium Magnesium Zirconium Silicates',\n",
       " 'Aluminum Iron Silicates',\n",
       " 'Aluminum Isostearate',\n",
       " 'Aluminum Isostearates/Laurates/Palmitates',\n",
       " 'Aluminum Isostearates/Laurates/Stearates',\n",
       " 'Aluminum Isostearates/Myristates',\n",
       " 'Aluminum Isostearates/Palmitates',\n",
       " 'Aluminum Isostearates/Stearates',\n",
       " 'Aluminum Lanolate',\n",
       " 'Aluminum Myristate',\n",
       " 'Aluminum Myristates/Palmitates',\n",
       " 'Aluminum Silicate',\n",
       " 'Aluminum Starch Octenylsuccinate',\n",
       " 'Aluminum Stearate',\n",
       " 'Aluminum Stearates',\n",
       " 'Aluminum Tristearate',\n",
       " 'Amaranthus Hypochondriacus Seed Oil',\n",
       " 'Amino Bispropyl Dimethicone',\n",
       " 'Aminoethyl Propanediol',\n",
       " 'Aminomethyl Propanediol',\n",
       " 'Aminomethyl Propanol',\n",
       " 'Aminomethylpropanediol',\n",
       " 'Aminomethylpropanol',\n",
       " 'Aminopropyl Dimethicone',\n",
       " 'Ammonia',\n",
       " 'Ammonium Acrylates Copolymer',\n",
       " 'Ammonium Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       " 'Ammonium Acrylates/Methylstyrene/Styrene Copolymer',\n",
       " 'Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer',\n",
       " 'Ammonium Acryloyldimethyltaurate/Carboxyethyl Acrylate Crosspolymer',\n",
       " 'Ammonium Acryloyldimethyltaurate/Laureth-7 Methacrylate Copolymer',\n",
       " 'Ammonium Acryloyldimethyltaurate/Steareth-25 Methacrylate Crosspolymer',\n",
       " 'Ammonium Acryloyldimethyltaurate/Steareth-8 Methacrylate Copolymer',\n",
       " 'Ammonium Acryloyldimethyltaurate/Vinyl Formamide Copolymer',\n",
       " 'Ammonium Acryloyldimethyltaurate/VP Copolymer',\n",
       " 'Ammonium Alginate',\n",
       " 'Ammonium Bicarbonate',\n",
       " 'Ammonium Bisulfite',\n",
       " 'Ammonium C12-15 Pareth Sulfate',\n",
       " 'Ammonium Capryleth Sulfate',\n",
       " 'Ammonium Carbonate',\n",
       " 'Ammonium Caseinate',\n",
       " 'Ammonium Cocomonoglyceride Sulfate',\n",
       " 'Ammonium Coco-Sulfate',\n",
       " 'Ammonium Cocoyl Isethionate',\n",
       " 'Ammonium Cocoyl Sarcosinate',\n",
       " 'Ammonium Cumenesulfonate',\n",
       " 'Ammonium Dinonyl Sulfosuccinate',\n",
       " 'Ammonium Dodecylbenzenesulfonate',\n",
       " 'Ammonium Glycolate',\n",
       " 'Ammonium Glycyrrhizate',\n",
       " 'Ammonium Hydrolyzed Collagen',\n",
       " 'Ammonium Hydroxide',\n",
       " 'Ammonium Isostearate',\n",
       " 'Ammonium Lactate',\n",
       " 'Ammonium Laureth Sulfate',\n",
       " 'Ammonium Lauroyl Sarcosinate',\n",
       " 'Ammonium Lauryl Sulfate',\n",
       " 'Ammonium Myreth Sulfate',\n",
       " 'Ammonium Myristyl Sulfate',\n",
       " 'Ammonium Oleate',\n",
       " 'Ammonium Persulfate',\n",
       " 'Ammonium Phosphate',\n",
       " 'Ammonium Phosphatidyl Rapeseedate',\n",
       " 'Ammonium Polyacrylate',\n",
       " 'Ammonium Polyacryloyldimethyl Taurate',\n",
       " 'Ammonium Silver Zeolite',\n",
       " 'Ammonium Silver Zinc Aluminum Silicate',\n",
       " 'Ammonium Stearate',\n",
       " 'Ammonium Styrene/Acrylates Copolymer',\n",
       " 'Ammonium Styrene/Acrylates/Ethylhexyl Acrylate/Lauryl Acrylate Copolymer',\n",
       " 'Ammonium Sulfite',\n",
       " 'Ammonium Tallate',\n",
       " 'Ammonium Thioglycolate',\n",
       " 'Ammonium VA/Acrylates Copolymer',\n",
       " 'Ammonium Xylenesulfonate',\n",
       " 'Amodimethicone',\n",
       " 'Amodimethicone Hydroxystearate',\n",
       " 'AMP-Acrylates Copolymer',\n",
       " 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide Copolymer',\n",
       " 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide/Hydroxyethylacrylate Copolymer',\n",
       " 'Amyl Acetate',\n",
       " 'Amyl Benzoate',\n",
       " 'Amyl Cinnamal',\n",
       " 'Amyl Salicylate',\n",
       " 'Amylcinnamyl Alcohol',\n",
       " 'Amylodextrin',\n",
       " 'Amylopectin',\n",
       " 'Amylose',\n",
       " 'Anacardium Occidentale (Cashew) Seed Oil',\n",
       " 'Anhydrogalactose',\n",
       " 'Anhydroglucitol',\n",
       " 'Anhydroxylitol',\n",
       " 'Anthemis Nobilis Flower Extract',\n",
       " 'Anthemis Nobilis Flower Oil',\n",
       " 'Anthemis Nobilis Flower Powder',\n",
       " 'Anthemis Nobilis Flower Water',\n",
       " 'Aphanothece Sacrum Polysaccharide',\n",
       " 'Apricot Kernel Amino Acids',\n",
       " 'Apricot Kernel Oil PEG-40 Esters',\n",
       " 'Apricot Kernel Oil PEG-6 Esters',\n",
       " 'Apricot Kernel Oil PEG-8 Esters',\n",
       " 'Apricot Kernel Oil Polyglyceryl-10 Esters',\n",
       " 'Apricot Kernel Oil Polyglyceryl-3 Esters',\n",
       " 'Apricot Kernel Oil Polyglyceryl-4 Esters',\n",
       " 'Apricot Kernel Oil Polyglyceryl-5 Esters',\n",
       " 'Apricot Kernel Oil Polyglyceryl-6 Esters',\n",
       " 'Apricot Kernel Oil Propylene Glycol Esters',\n",
       " 'Apricotamide DEA',\n",
       " 'Apricotamidopropyl Betaine',\n",
       " 'Arabinose',\n",
       " 'Arabinoxylan',\n",
       " 'Arachideth-20',\n",
       " 'Arachidic Acid',\n",
       " 'Arachidonic Acid',\n",
       " 'Arachidyl Behenate',\n",
       " 'Arachidyl Erucate',\n",
       " 'Arachidyl Glucoside',\n",
       " 'Arachidyl Glycol',\n",
       " 'Arachidyl Propionate',\n",
       " 'Arachis Hypogaea (Peanut) Flour',\n",
       " 'Arachis Hypogaea (Peanut) Oil',\n",
       " 'Arctium Lappa Seed Oil',\n",
       " 'Argan Oil PEG-8 Esters',\n",
       " 'Argan Oil Polyglyceryl-6 Esters',\n",
       " 'Argania Spinosa Kernel Oil',\n",
       " 'Arginine',\n",
       " 'Arginine HCl',\n",
       " 'Arnica Montana',\n",
       " 'Arnica Montana Flower Extract',\n",
       " 'Ascophyllum Nodosum',\n",
       " 'Ascophyllum Nodosum Extract',\n",
       " 'Ascophyllum Nodosum Powder',\n",
       " 'Ascorbyl Dipalmitate',\n",
       " 'Ascorbyl Glucoside',\n",
       " 'Ascorbyl Isostearate',\n",
       " 'Ascorbyl Linoleate',\n",
       " 'Ascorbyl Palmitate',\n",
       " 'Ascorbyl Stearate',\n",
       " 'Ascorbyl Tetraisopalmitate',\n",
       " 'Ascorbyl Tocopheryl Acetate',\n",
       " 'Ascorbyl Tocopheryl Maleate',\n",
       " 'Asparagine',\n",
       " 'Asparagopsis Armata Extract',\n",
       " 'Aspartic Acid',\n",
       " 'Astragalus Gummifer Gum',\n",
       " 'Astrocaryum Murumuru Seed Butter',\n",
       " 'Astrocaryum Vulgare Oil Polyglyceryl-6 Esters',\n",
       " 'Atelocollagen',\n",
       " 'Attapulgite',\n",
       " 'Avena Sativa (Oat) Bran',\n",
       " 'Avena Sativa (Oat) Bran Extract',\n",
       " 'Avena Sativa (Oat) Flower/Leaf/Stem Juice',\n",
       " 'Avena Sativa (Oat) Kernel Extract',\n",
       " 'Avena Sativa (Oat) Kernel Flour',\n",
       " 'Avena Sativa (Oat) Kernel Meal',\n",
       " 'Avena Sativa (Oat) Kernel Oil',\n",
       " 'Avena Sativa (Oat) Kernel Protein',\n",
       " 'Avena Sativa (Oat) Leaf Extract',\n",
       " 'Avena Sativa (Oat) Leaf/Stalk Extract',\n",
       " 'Avena Sativa (Oat) Leaf/Stem Extract',\n",
       " 'Avena Sativa (Oat) Meal Extract',\n",
       " 'Avena Sativa (Oat) Meristem Cell Extract',\n",
       " 'Avena Sativa (Oat) Peptide',\n",
       " 'Avena Sativa (Oat) Protein Extract',\n",
       " 'Avena Sativa (Oat) Seed Extract',\n",
       " 'Avena Sativa (Oat) Seed Water',\n",
       " 'Avena Sativa (Oat) Sprout Oil',\n",
       " 'Avena Sativa (Oat) Starch',\n",
       " 'Avena Sativa (Oat) Straw Extract',\n",
       " 'Avocadamide DEA',\n",
       " 'Avocadamidopropyl Betaine',\n",
       " 'Avocadamidopropyl Dimethylamine',\n",
       " 'Avocado Oil',\n",
       " 'Avocado Oil PEG-11 Esters',\n",
       " 'Avocado Oil PEG-8 Esters',\n",
       " 'Avocado Oil Polyglyceryl-6 Esters',\n",
       " 'Avocado Oil Propylene Glycol Esters',\n",
       " 'Azelaic Acid',\n",
       " 'Azelamide MEA',\n",
       " 'Azulene',\n",
       " 'Babassu Acid',\n",
       " 'Babassu Oil Polyglyceryl-4 Esters',\n",
       " 'Babassu Oil Polyglyceryl-6 Esters',\n",
       " 'Babassuamide DEA',\n",
       " 'Babassuamide MEA',\n",
       " 'Babassuamidopropyl Betaine',\n",
       " 'Babassuamidopropyl Dimethylamine',\n",
       " 'Barium Sulfate',\n",
       " 'Basic Blue 7',\n",
       " 'Basic Blue 99',\n",
       " 'Basic Brown 17',\n",
       " 'Basic Red 76',\n",
       " 'Basic Violet 1',\n",
       " 'Basic Violet 3',\n",
       " 'Basic Violet 4',\n",
       " 'Basic Yellow 57',\n",
       " 'Basic Yellow 87',\n",
       " 'Bassia Butyracea Seed Butter',\n",
       " 'Bassia Latifolia Seed Butter',\n",
       " 'Batyl Alcohol',\n",
       " 'Batyl Isostearate',\n",
       " 'Batyl Stearate',\n",
       " 'Beeswax',\n",
       " 'Beeswax Acid',\n",
       " 'Behenamide DEA',\n",
       " 'Behenamide MEA',\n",
       " 'Behenamidopropyl Betaine',\n",
       " 'Behenamidopropyl Dimethylamine',\n",
       " 'Beheneth-10',\n",
       " 'Beheneth-15',\n",
       " 'Beheneth-2',\n",
       " 'Beheneth-20',\n",
       " 'Beheneth-25',\n",
       " 'Beheneth-30',\n",
       " 'Beheneth-5',\n",
       " 'Behenic Acid',\n",
       " 'Behenoxy Dimethicone',\n",
       " 'Behenoxy PEG-10 Dimethicone',\n",
       " 'Behentrimonium Chloride',\n",
       " 'Behentrimonium Methosulfate',\n",
       " 'Behenyl Alcohol',\n",
       " 'Behenyl Beeswax',\n",
       " 'Behenyl Behenate',\n",
       " 'Behenyl Benzoate',\n",
       " 'Behenyl Betaine',\n",
       " 'Behenyl Dimethicone/Bis-Vinyldimethicone Crosspolymer',\n",
       " 'Behenyl Erucate',\n",
       " 'Behenyl Isostearate',\n",
       " 'Behenyl Methacrylate/Perfluorooctylethyl Methacrylate Copolymer',\n",
       " 'Behenyl Methacrylate/t-Butyl Methacrylate Copolymer',\n",
       " 'Behenyl Olivate',\n",
       " 'Behenyl/Isostearyl Beeswax',\n",
       " 'Bentonite',\n",
       " 'Benzaldehyde',\n",
       " 'Benzalkonium Chloride',\n",
       " 'Benzalkonium Montmorillonite',\n",
       " 'Benzalkonium Sepiolite',\n",
       " 'Benzethonium Chloride',\n",
       " 'Benzoic Acid',\n",
       " 'Benzophenone-1',\n",
       " 'Benzophenone-10',\n",
       " 'Benzophenone-11',\n",
       " 'Benzophenone-12',\n",
       " 'Benzophenone-2',\n",
       " 'Benzophenone-3',\n",
       " 'Benzophenone-4',\n",
       " 'Benzophenone-5',\n",
       " 'Benzophenone-6',\n",
       " 'Benzophenone-8',\n",
       " 'Benzophenone-9',\n",
       " 'Benzoxiquine',\n",
       " 'Benzyl Alcohol',\n",
       " 'Benzyl Benzoate',\n",
       " 'Benzyl Salicylate',\n",
       " 'Benzylparaben',\n",
       " 'Bertholletia Excelsa Seed Oil',\n",
       " 'Bertholletia Excelsa Seed Oil PEG-8 Esters',\n",
       " 'Bertholletia Excelsa Seed Oil Polyglyceryl-6 Esters',\n",
       " 'Beta-Alanine Diacetic Acid',\n",
       " 'Beta-Glucan',\n",
       " 'Beta-Glucan Hydroxypropyltrimonium Chloride',\n",
       " 'Beta-Glucan Palmitate',\n",
       " 'Betaine',\n",
       " 'Betaphycus Gelatinum Extract',\n",
       " 'Beta-Sitosterol',\n",
       " 'Beta-Sitosteryl Acetate',\n",
       " 'BHA',\n",
       " 'BHT',\n",
       " 'Biosaccharide Gum-1',\n",
       " 'Biosaccharide Gum-2',\n",
       " 'Biosaccharide Gum-3',\n",
       " 'Biosaccharide Gum-4',\n",
       " 'Biosaccharide Gum-5',\n",
       " 'Biotin',\n",
       " 'Bis(Glyceryl Dimethacylate) Pyromellitate',\n",
       " 'Bis(Tripeptide-1) Copper Acetate',\n",
       " 'Bisabolol',\n",
       " 'Bis-C16-20 Isoalkoxy TMHDI/PEG-90 Copolymer',\n",
       " 'Bis-Cetyl/PEG-8 Cetyl PEG-8 Dimethicone',\n",
       " 'Bis-Diglyceryl Polyacyladipate-1',\n",
       " 'Bis-Diglyceryl Polyacyladipate-2',\n",
       " 'Bis-Hydroxyethoxypropyl Dimethicone',\n",
       " 'Bis-Hydroxyethyl Acrylate Poly(1,4-Butanediol)-9/TMHDI Copolymer',\n",
       " 'Bis-Isobutyl PEG/PPG-10/7/Dimethicone Copolymer',\n",
       " 'Bis-Isobutyl PEG-13/Dimethicone Copolymer',\n",
       " 'Bis-Isobutyl PEG-24/PPG-7/Dimethicone Copolymer',\n",
       " 'Bis-Isostearyl 1,4-Butanediol/HDI/Hydrogenated Dimer Dilinoleyl Alcohol Copolymer',\n",
       " 'Bis-Lauryl Cocaminopropylamine/HDI/PEG-100 Copolymer',\n",
       " 'Bis-Methoxy PEG-10 Dimethyl MEA/HDI/Bis-PEG-10 Dimethicone Copolymer',\n",
       " 'Bis-PEG/PPG-14/14 Dimethicone',\n",
       " 'Bis-PEG/PPG-15/5 Dimethicone',\n",
       " 'Bis-PEG/PPG-16/16 PEG/PPG-16/16 Dimethicone',\n",
       " 'Bis-PEG/PPG-18/6 Dimethicone',\n",
       " 'Bis-PEG/PPG-20/20 Dimethicone',\n",
       " 'Bis-PEG/PPG-20/5 PEG/PPG-20/5 Dimethicone',\n",
       " 'Bis-PEG-1 Dimethicone',\n",
       " 'Bis-PEG-10 Dimethicone',\n",
       " 'Bis-PEG-12 Dimethicone',\n",
       " 'Bis-PEG-12 Dimethicone Beeswax',\n",
       " 'Bis-PEG-12 Dimethicone Candelillate',\n",
       " 'Bis-PEG-15 Methyl Ether Dimethicone',\n",
       " 'Bis-PEG-20 Dimethicone',\n",
       " 'Bis-PEG-4 Dimethicone',\n",
       " 'Bis-PEG-8 Dimethicone',\n",
       " 'Bis-PEG-8 PEG-8 Dimethicone',\n",
       " 'Bis-Phenylisopropyl Phenylisopropyl Dimethicone/Vinyl Dimethicone Crosspolymer',\n",
       " 'Bis-Propylheptyl Carbonate',\n",
       " 'Bis-Stearoxy Dimethicone',\n",
       " 'Bis-Stearoxydimethylsilane',\n",
       " 'Bis-Stearoxyethyl Dimethicone',\n",
       " 'Bis-Vinyldimethicone Crosspolymer',\n",
       " 'Bis-Vinyldimethicone/Bis-Isobutyl PPG-20 Crosspolymer',\n",
       " 'Bis-Vinyldimethicone/PEG-10 Dimethicone Crosspolymer',\n",
       " 'Bis-Vinyldimethicone/PPG-20 Crosspolymer',\n",
       " 'Borage Seed Oil PEG-8 Esters',\n",
       " 'Borage Seed Oil Polyglyceryl-4 Esters',\n",
       " 'Borage Seed Oil Polyglyceryl-6 Esters',\n",
       " 'Borago Officinalis Seed Oil',\n",
       " 'Boric Acid',\n",
       " 'Boron Nitride',\n",
       " 'Botryocladia Occidentalis Extract',\n",
       " 'Brassica Campestris (Rapeseed) Oil Unsaponifiables',\n",
       " 'Brassica Campestris (Rapeseed) Seed Oil',\n",
       " 'Brassica Campestris (Rapeseed) Sterols',\n",
       " 'Brassica Napus Seed Oil',\n",
       " 'Brassica Oleracea Acephala Seed Oil',\n",
       " 'Brassica Oleracea Italica (Broccoli) Seed Oil',\n",
       " 'Brassicamidopropyl Dimethylamine',\n",
       " 'Brucine',\n",
       " 'Brucine Sulfate',\n",
       " 'Butane',\n",
       " 'Butene/Propylene Copolymer',\n",
       " 'Buteth-3',\n",
       " 'Butoxyethanol',\n",
       " 'Butoxyethyl Acetate',\n",
       " 'Butyl Acetate',\n",
       " 'Butyl Acrylate/Cyclohexyl Methacrylate Copolymer',\n",
       " 'Butyl Acrylate/Ethylhexyl Methacrylate Copolymer',\n",
       " 'Butyl Acrylate/Glycol Dimethacrylate Crosspolymer',\n",
       " 'Butyl Acrylate/Hydroxyethyl Methacrylate Copolymer',\n",
       " 'Butyl Acrylate/Isopropylacrylamide/PEG-18 Dimethacrylate Crosspolymer',\n",
       " 'Butyl Acrylate/Styrene Copolymer',\n",
       " 'Butyl Avocadate',\n",
       " 'Butyl Babassuate',\n",
       " 'Butyl Benzoate',\n",
       " 'Butyl Benzyl Phthalate',\n",
       " 'Butyl Ester of PVM/MA Copolymer',\n",
       " 'Butyl Ethyl Propanediol',\n",
       " 'Butyl Glucoside',\n",
       " 'Butyl Glycolate',\n",
       " 'Butyl Isostearate',\n",
       " 'Butyl Lactate',\n",
       " 'Butyl Methacrylate',\n",
       " 'Butyl Methacrylate/Acryoyloxy PG Methacrylate Copolymer',\n",
       " 'Butyl Myristate',\n",
       " 'Butyl Oleate',\n",
       " 'Butyl Stearate',\n",
       " 'Butyl Thioglycolate',\n",
       " 'Butylated Hydroxyanisole',\n",
       " 'Butylated PVP',\n",
       " 'Butyldimethicone Methacrylate/Methyl Methacrylate Crosspolymer',\n",
       " 'Butylene Glycol',\n",
       " 'Butylene Glycol Cocoate',\n",
       " 'Butylene Glycol Dicaprylate/Dicaprate',\n",
       " 'Butylene Glycol Diisononanoate',\n",
       " 'Butylene/Ethylene Copolymer',\n",
       " 'Butylene/Ethylene/Propylene Copolymer',\n",
       " 'Butylene/Ethylene/Styrene Copolymer',\n",
       " 'Butyloctyl Beeswax',\n",
       " 'Butyloctyl Behenate',\n",
       " 'Butyloctyl Benzoate',\n",
       " 'Butyloctyl Candelillate',\n",
       " 'Butyloctyl Cetearate',\n",
       " 'Butyloctyl Oleate',\n",
       " 'Butyloctyl Palmitate',\n",
       " 'Butyloctyl Salicylate',\n",
       " 'Butylparaben',\n",
       " 'Butyrospermum Parkii (Shea) Butter',\n",
       " 'Butyrospermum Parkii (Shea) Butter Extract',\n",
       " 'Butyrospermum Parkii (Shea) Butter Unsaponifiables',\n",
       " 'Butyrospermum Parkii (Shea) Nut Extract',\n",
       " 'Butyrospermum Parkii (Shea) Nut Shell Powder',\n",
       " 'Butyrospermum Parkii (Shea) Oil',\n",
       " 'Butyrospermum Parkii (Shea) Seedcake Extract',\n",
       " 'C10-11 Isoparaffin',\n",
       " 'C10-12 Isoparaffin',\n",
       " 'C10-13 Isoparaffin',\n",
       " 'C10-16 Alkyl Glucoside',\n",
       " 'C10-16 Pareth-1',\n",
       " 'C10-16 Pareth-2',\n",
       " 'C10-18 Triglycerides',\n",
       " 'C10-40 Isoalkyl Acid',\n",
       " 'C10-40 Isoalkyl Acid Octyldodecanol Esters',\n",
       " 'C10-40 Isoalkyl Acid Phytosterol Esters',\n",
       " 'C10-40 Isoalkyl Acid Triglyceride',\n",
       " 'C11-12 Isoparaffin',\n",
       " 'C11-13 Isoparaffin',\n",
       " 'C11-13 Pareth-10',\n",
       " 'C11-13 Pareth-6',\n",
       " 'C11-13 Pareth-9',\n",
       " 'C11-14 Isoparaffin',\n",
       " 'C11-15 Pareth-12',\n",
       " 'C11-15 Pareth-15',\n",
       " 'C11-15 Pareth-20',\n",
       " 'C11-15 Pareth-3',\n",
       " 'C11-15 Pareth-30',\n",
       " 'C11-15 Pareth-40',\n",
       " 'C11-15 Pareth-5',\n",
       " 'C11-15 Pareth-7',\n",
       " 'C11-15 Pareth-9',\n",
       " 'C11-15 Sec-Pareth-12',\n",
       " 'C11-21 Pareth-10',\n",
       " 'C11-21 Pareth-3',\n",
       " 'C12-13 Alkyl Ethylhexanoate',\n",
       " 'C12-13 Pareth-1',\n",
       " 'C12-13 Pareth-10',\n",
       " 'C12-13 Pareth-15',\n",
       " 'C12-13 Pareth-2',\n",
       " 'C12-13 Pareth-23',\n",
       " 'C12-13 Pareth-3',\n",
       " 'C12-13 Pareth-4',\n",
       " 'C12-13 Pareth-5',\n",
       " 'C12-13 Pareth-6',\n",
       " 'C12-13 Pareth-7',\n",
       " 'C12-13 Pareth-9',\n",
       " 'C12-14 Isoparaffin',\n",
       " 'C12-14 Pareth-11',\n",
       " 'C12-14 Pareth-12',\n",
       " 'C12-14 Pareth-3',\n",
       " 'C12-14 Pareth-5',\n",
       " 'C12-14 Pareth-7',\n",
       " 'C12-14 Pareth-9',\n",
       " 'C12-14 Sec-Pareth-12',\n",
       " 'C12-14 Sec-Pareth-15',\n",
       " 'C12-14 Sec-Pareth-20',\n",
       " 'C12-14 Sec-Pareth-3',\n",
       " 'C12-14 Sec-Pareth-30',\n",
       " 'C12-14 Sec-Pareth-40',\n",
       " 'C12-14 Sec-Pareth-5',\n",
       " 'C12-14 Sec-Pareth-50',\n",
       " 'C12-14 Sec-Pareth-7',\n",
       " 'C12-14 Sec-Pareth-8',\n",
       " 'C12-14 Sec-Pareth-9',\n",
       " 'C12-15 Alkyl Benzoate',\n",
       " 'C12-15 Alkyl Ethylhexanoate',\n",
       " 'C12-15 Alkyl Salicylate',\n",
       " 'C12-15 Pareth-10',\n",
       " 'C12-15 Pareth-11',\n",
       " 'C12-15 Pareth-12',\n",
       " 'C12-15 Pareth-2',\n",
       " 'C12-15 Pareth-3',\n",
       " 'C12-15 Pareth-4',\n",
       " 'C12-15 Pareth-5',\n",
       " 'C12-15 Pareth-7',\n",
       " 'C12-15 Pareth-9',\n",
       " 'C12-16 Pareth-5',\n",
       " 'C12-16 Pareth-7',\n",
       " 'C12-16 Pareth-9',\n",
       " 'C12-18 Acid Triglyceride',\n",
       " 'C12-18 Alkyl Glucoside',\n",
       " 'C12-20 Alkyl Glucoside',\n",
       " 'C12-20 Isoparaffin',\n",
       " 'C12-22 Alkyl Acrylate/Hydroxyethylacrylate Copolymer',\n",
       " 'C13-14 Isoparaffin',\n",
       " 'C13-15 Pareth-21',\n",
       " 'C13-16 Isoparaffin',\n",
       " 'C14-15 Dialkyl Carbonate',\n",
       " 'C14-15 Pareth-11',\n",
       " 'C14-15 Pareth-12',\n",
       " 'C14-15 Pareth-13',\n",
       " 'C14-15 Pareth-4',\n",
       " 'C14-15 Pareth-7',\n",
       " 'C14-15 Pareth-8',\n",
       " 'C14-18 Alkyl Ethylhexanoate',\n",
       " 'C14-18 Glycol',\n",
       " 'C14-28 Alkyl Acid',\n",
       " 'C14-28 Isoalkyl Acid',\n",
       " 'C14-30 Alkyl Beeswax',\n",
       " 'C15-18 Glycol',\n",
       " 'C15-35 Isoparaffin/Isoalkylcycloalkanes',\n",
       " 'C16-17 Alkyl Benzoate',\n",
       " 'C16-22 Acid Amide MEA',\n",
       " 'C16-36 Alkyl Stearate',\n",
       " 'C18-22 Hydroxyalkyl Hydroxypropyl Guar',\n",
       " 'C18-30 Glycol',\n",
       " 'C18-36 Acid Triglyceride',\n",
       " 'C18-38 Alkyl Beeswax',\n",
       " 'C18-38 Alkyl C24-54 Acid Ester',\n",
       " 'C18-70 Isoparaffin',\n",
       " 'C20-22 Alkyl Glucoside',\n",
       " 'C20-22 Alkyl Phosphate',\n",
       " 'C20-22 Pareth-30',\n",
       " 'C20-24 Alkyl Dimethicone',\n",
       " 'C20-24 Alkyl Methicone',\n",
       " 'C20-30 Glycol',\n",
       " 'C20-40 Alkyl Behenate',\n",
       " 'C20-40 Alkyl Stearate',\n",
       " 'C20-40 Isoparaffin',\n",
       " 'C20-40 Pareth-10',\n",
       " 'C20-40 Pareth-24',\n",
       " 'C20-40 Pareth-3',\n",
       " 'C20-40 Pareth-40',\n",
       " 'C20-40 Pareth-95',\n",
       " 'C22-24 Pareth-33',\n",
       " 'C24-28 Alkyl Dimethicone',\n",
       " 'C24-28 Alkyl Methicone',\n",
       " 'C26-28 Alkyl Dimethicone',\n",
       " 'C26-28 Alkyl Methicone',\n",
       " 'C26-28 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       " 'C30-45 Alkyl Cetearyl Dimethicone Crosspolymer',\n",
       " 'C30-45 Alkyl Dimethicone',\n",
       " 'C30-45 Alkyl Dimethicone/Polycyclohexene Oxide Crosspolymer',\n",
       " 'C30-45 Alkyl Methicone',\n",
       " 'C30-45 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       " 'C30-50 Alkyl Beeswax',\n",
       " 'C30-50 Alkyl Stearate',\n",
       " 'C30-50 Pareth-10',\n",
       " 'C30-50 Pareth-3',\n",
       " 'C30-50 Pareth-40',\n",
       " 'C30-60 Alkyl Dimethicone',\n",
       " 'C32 Alkyl Dimethicone',\n",
       " 'C32-36 Isoalkyl Acid',\n",
       " 'C32-36 Isoalkyl Stearate',\n",
       " 'C40-60 Alkyl Stearate',\n",
       " 'C40-60 Pareth-10',\n",
       " 'C40-60 Pareth-3',\n",
       " 'C4-18 Alkyl Methacrylate/Methacryloyloxyethyl Phosphorylcholine Copolymer',\n",
       " 'C4-24 Alkyl Dimethicone/Divinyldimethicone Crosspolymer',\n",
       " 'C4-5 Isoalkyl Cocoate',\n",
       " 'C4-6 Olefin/Styrene Copolymer',\n",
       " 'C5-6 Olefin/Styrene Copolymer',\n",
       " 'C6-14 Perfluoroalkylethyl Acrylate/HEMA Copolymer',\n",
       " 'C7-8 Isoparaffin',\n",
       " 'C8-10 Alkyl Ethyl Phosphate',\n",
       " 'C8-22 Alkyl Acrylates/Methacrylic Acid Crosspolymer',\n",
       " 'C8-9 Isoparaffin',\n",
       " 'C9-11 Isoparaffin',\n",
       " 'C9-11 Pareth-3',\n",
       " 'C9-11 Pareth-4',\n",
       " 'C9-11 Pareth-6',\n",
       " 'C9-11 Pareth-8',\n",
       " 'C9-12 Isoparaffin',\n",
       " 'C9-13 Isoparaffin',\n",
       " 'C9-14 Isoparaffin',\n",
       " 'C9-15 Alkyl Phosphate',\n",
       " 'C9-15 Pareth-8',\n",
       " 'C9-16 Isoparaffin',\n",
       " 'Caesalpinia Spinosa Gum',\n",
       " 'Caesalpinia Spinosa Hydroxypropyltrimonium Chloride',\n",
       " 'Caffeine',\n",
       " 'Calcium Acetate',\n",
       " 'Calcium Alginate',\n",
       " 'Calcium Aluminum Borosilicate',\n",
       " 'Calcium Ascorbate',\n",
       " 'Calcium Aspartate',\n",
       " 'Calcium Behenate',\n",
       " 'Calcium Benzoate',\n",
       " 'Calcium Carbonate',\n",
       " 'Calcium Carboxymethyl Cellulose',\n",
       " 'Calcium Carrageenan',\n",
       " 'Calcium Caseinate',\n",
       " 'Calcium Citrate',\n",
       " 'Calcium Dihydrogen Phosphate',\n",
       " 'Calcium Disodium EDTA',\n",
       " 'Calcium Dodecylbenzenesulfonate',\n",
       " 'Calcium Gluconate',\n",
       " 'Calcium Glycinate',\n",
       " 'Calcium Hydrolyzed Collagen',\n",
       " 'Calcium Hydroxide',\n",
       " 'Calcium Lactate',\n",
       " 'Calcium Laurate',\n",
       " 'Calcium Lauroyl Taurate',\n",
       " 'Calcium Magnesium Silicate',\n",
       " 'Calcium Myristate',\n",
       " 'Calcium Pantothenate',\n",
       " 'Calcium Paraben',\n",
       " 'Calcium PCA',\n",
       " 'Calcium Phosphate',\n",
       " 'Calcium Potassium Carbomer',\n",
       " 'Calcium Potassium Sodium Phosphate',\n",
       " 'Calcium Pyrophosphate',\n",
       " 'Calcium Salicylate',\n",
       " 'Calcium Silicate',\n",
       " 'Calcium Sodium Borosilicate',\n",
       " 'Calcium Starch Isododecenylsuccinate',\n",
       " 'Calcium Starch Octenylsuccinate',\n",
       " 'Calcium Stearate',\n",
       " 'Calcium Stearoyl Lactylate',\n",
       " 'Calcium Thioglycolate',\n",
       " 'Calcium Titanium Borosilicate',\n",
       " 'Calcium Undecylenate',\n",
       " 'Calcium Xylenesulfonate',\n",
       " 'Calcium/Sodium PVM/MA Copolymer',\n",
       " 'Calendula Officinalis',\n",
       " 'Calendula Officinalis Extract',\n",
       " 'Calendula Officinalis Flower',\n",
       " 'Calendula Officinalis Flower Extract',\n",
       " 'Calendula Officinalis Flower Oil',\n",
       " 'Calendula Officinalis Seed Oil',\n",
       " 'Calliblepharis Ciliata Extract',\n",
       " 'Camelina Sativa Seed Oil',\n",
       " 'Camellia Japonica Seed Oil',\n",
       " 'Camellia Kissi Seed Oil',\n",
       " 'Camellia Oleifera Seed Oil',\n",
       " 'Camellia Sinensis Catechins',\n",
       " 'Camellia Sinensis Flower Extract',\n",
       " 'Camellia Sinensis Flower/Leaf/Stem Juice',\n",
       " 'Camellia Sinensis Leaf',\n",
       " 'Camellia Sinensis Leaf Extract',\n",
       " 'Camellia Sinensis Leaf Oil',\n",
       " 'Camellia Sinensis Leaf Powder',\n",
       " 'Camellia Sinensis Leaf Water',\n",
       " 'Camellia Sinensis Root Extract',\n",
       " 'Camellia Sinensis Seed Extract',\n",
       " 'Camellia Sinensis Seed Oil',\n",
       " 'Camellia Sinensis Seed Powder',\n",
       " 'Camellia Sinensis Seedcoat Powder',\n",
       " 'Canarium Indicum Seed Oil',\n",
       " 'Candelilla Cera',\n",
       " 'Candelilla Wax',\n",
       " 'Candelilla/Jojoba/Rice Bran Polyglyceryl-3 Esters',\n",
       " 'Canola Oil',\n",
       " 'Canola Oil Unsaponifiables',\n",
       " 'Canola Sterols',\n",
       " 'Canolamidopropyl Betaine',\n",
       " 'Capramide DEA',\n",
       " 'Capric Acid',\n",
       " 'Capric/Lauric/Myristic/Oleic Triglyceride',\n",
       " 'Caproic Acid',\n",
       " 'Caprooyl Phytosphingosine',\n",
       " 'Caprooyl Sphingosine',\n",
       " 'Caproyl Sphingosine',\n",
       " 'Capryl Dimethicone',\n",
       " 'Capryl Sultaine',\n",
       " 'Capryl/Capramidopropyl Betaine',\n",
       " 'Capryleth-4',\n",
       " 'Capryleth-5',\n",
       " 'Caprylhydroxamic Acid',\n",
       " 'Caprylic Acid',\n",
       " 'Caprylic/Capric Glycerides Polyglyceryl-10 Esters',\n",
       " 'Caprylic/Capric Triglyceride',\n",
       " 'Caprylic/Capric/Coco Glycerides',\n",
       " 'Caprylic/Capric/Lauric Triglyceride',\n",
       " 'Caprylic/Capric/Linoleic Triglyceride',\n",
       " 'Caprylic/Capric/Myristic/Stearic Triglyceride',\n",
       " 'Caprylic/Capric/Palmitic/Stearic Triglyceride',\n",
       " 'Caprylic/Capric/Stearic Triglyceride',\n",
       " 'Capryloyl Collagen Amino Acids',\n",
       " 'Capryloyl Glycine',\n",
       " 'Capryloyl Gold of Pleasure Amino Acids',\n",
       " 'Capryloyl Keratin Amino Acids',\n",
       " 'Capryloyl Pea Amino Acids',\n",
       " 'Capryloyl Quinoa Amino Acids',\n",
       " 'Capryloyl Salicylic Acid',\n",
       " 'Capryloyl Salicylic Acid (ester)',\n",
       " 'Capryloyl Silk Amino Acids',\n",
       " 'Caprylyl Butyrate',\n",
       " 'Caprylyl Caprylate',\n",
       " 'Caprylyl Eicosenoate',\n",
       " 'Caprylyl Glucoside',\n",
       " 'Caprylyl Glyceryl Ether',\n",
       " 'Caprylyl Glycol',\n",
       " 'Caprylyl Glycol/Glycerin/Polyacrylic Acid Copolymer',\n",
       " 'Caprylyl Methicone',\n",
       " 'Caprylyl/Capryl Glucoside',\n",
       " 'Capsaicin',\n",
       " 'Capsicum Annuum Extract',\n",
       " 'Capsicum Annuum Fruit Extract',\n",
       " 'Capsicum Annuum Resin',\n",
       " 'Capsicum Annuum Root Powder',\n",
       " 'Capsicum Frutescens Fruit',\n",
       " 'Capsicum Frutescens Fruit Extract',\n",
       " 'Capsicum Frutescens Resin',\n",
       " 'Captan',\n",
       " 'Carapa Guaianensis Oil Polyglyceryl-6 Esters',\n",
       " 'Carbomer',\n",
       " 'Carbomer-910',\n",
       " 'Carbomer-934',\n",
       " 'Carbomer-934P',\n",
       " 'Carbomer-941',\n",
       " 'Carbomer-962',\n",
       " 'Carboxymethyl Cellulose Acetate Butyrate',\n",
       " 'Carboxymethyl Dextran',\n",
       " 'Carboxymethyl Hydroxyethylcellulose',\n",
       " 'Carboxymethyl Hydroxypropyl Guar',\n",
       " 'Carica Papaya (Papaya) Fruit',\n",
       " 'Carica Papaya (Papaya) Fruit Extract',\n",
       " 'Carica Papaya (Papaya) Fruit Juice',\n",
       " 'Carica Papaya (Papaya) Fruit Water',\n",
       " 'Carica Papaya (Papaya) Leaf Extract',\n",
       " 'Carica Papaya (Papaya) Seed Oil',\n",
       " 'Carnauba Wax',\n",
       " 'Carnitine',\n",
       " 'Carnitine HCl',\n",
       " 'Carnitine Hydroxycitrate',\n",
       " 'Carnitine PCA',\n",
       " 'Carrageenan',\n",
       " 'Carthamus Tinctorius (Safflower) Seed Oil',\n",
       " 'Carvacrol',\n",
       " 'Carya Illinoensis (Pecan) Seed Oil',\n",
       " 'Caryocar Brasiliense Fruit Oil',\n",
       " 'Casein',\n",
       " 'Casein Extract',\n",
       " 'Cassia Angustifolia Seed Polysaccharide',\n",
       " 'Cassia Gum',\n",
       " 'Cassia Hydroxypropyltrimonium Chloride',\n",
       " 'Castor Oil Phosphate',\n",
       " 'Castor Oil Polyglyceryl-6 Esters',\n",
       " 'Cellobiose Octanonanoate',\n",
       " 'Cellulose',\n",
       " 'Cellulose Acetate',\n",
       " 'Cellulose Acetate Butyrate',\n",
       " 'Cellulose Acetate Propionate',\n",
       " 'Cellulose Acetate Propionate Carboxylate',\n",
       " 'Cellulose Gum',\n",
       " 'Cellulose Succinate',\n",
       " 'Centella Asiatica Callus Culture',\n",
       " 'Centella Asiatica Extract',\n",
       " 'Centella Asiatica Flower/Leaf/Stem Extract',\n",
       " 'Centella Asiatica Leaf Cell Culture Extract',\n",
       " 'Centella Asiatica Leaf Extract',\n",
       " 'Centella Asiatica Leaf Water',\n",
       " 'Centella Asiatica Meristem Cell Culture',\n",
       " 'Centella Asiatica Meristem Cell Culture Extract',\n",
       " 'Centella Asiatica Root Extract',\n",
       " 'Ceramide 1',\n",
       " 'Ceramide 1 A',\n",
       " 'Ceramide 2',\n",
       " 'Ceramide 3',\n",
       " 'Ceramide 4',\n",
       " 'Ceramide 5',\n",
       " 'Ceramide 6 II',\n",
       " 'Ceramide AP',\n",
       " 'Ceramide AS',\n",
       " 'Ceramide EOP',\n",
       " 'Ceramide EOS',\n",
       " 'Ceramide NG',\n",
       " 'Ceramide NP',\n",
       " 'Ceramide NS',\n",
       " 'Ceramide NS Dilaurate',\n",
       " 'Ceramium Kondoi Extract',\n",
       " 'Ceramium Rubrum Extract',\n",
       " 'Ceratonia Siliqua (Carob) Gum',\n",
       " 'Ceresin',\n",
       " 'Ceteareth-10',\n",
       " 'Ceteareth-100',\n",
       " 'Ceteareth-11',\n",
       " 'Ceteareth-12',\n",
       " 'Ceteareth-13',\n",
       " 'Ceteareth-14',\n",
       " 'Ceteareth-15',\n",
       " 'Ceteareth-16',\n",
       " 'Ceteareth-17',\n",
       " 'Ceteareth-18',\n",
       " 'Ceteareth-2',\n",
       " 'Ceteareth-20',\n",
       " 'Ceteareth-22',\n",
       " ...]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ingredients = []\n",
    "for el in ingredienti:\n",
    "    ingredients.append(el[\"Nome_comune\"])\n",
    "    \n",
    "ingredients"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "6238"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(ingredients)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "None\n"
     ]
    }
   ],
   "source": [
    "oggetto = db.Ingredienti.find_one({\"Nome_comune\":\"Amyl Cinnamal\"},{\"_id\":0})[\"pdf_link\"]\n",
    "print(oggetto)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "def sorting_func(el):\n",
    "    num = ''\n",
    "    for char in el[0]:\n",
    "        if char.isnumeric():\n",
    "            num = num+char\n",
    "        else:\n",
    "            break\n",
    "             \n",
    "    return int(num)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from tqdm import tqdm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "not_values = []\n",
    "\n",
    "for ingredient in tqdm(ingredients[:100]):\n",
    "    url = db.Ingredienti.find_one({\"Nome_comune\":ingredient},{\"_id\":0})['pdf_link']\n",
    "    if url:\n",
    "        try:\n",
    "            response = req.get(url)\n",
    "            file = BytesIO(response.content)            \n",
    "            pdf_text=pdf.PdfReader(file)\n",
    "            print(len(pdf_text.pages))\n",
    "            text = ''.join([x.extract_text() for x in pdf_text.pages])\n",
    "            text = text.replace('\\n','').replace('\\r','')\n",
    "            noael_pattern = r'(.{0,100}\\bNOAEL\\b.{0,100})'\n",
    "            ld50_pattern = r'(.{0,100}\\bLD\\s*50\\b.{0,100})'\n",
    "            noael_values = re.findall(noael_pattern,text,re.IGNORECASE)\n",
    "            ld50_values = re.findall(ld50_pattern,text,re.IGNORECASE)\n",
    "            ld50_final_values = []\n",
    "            noael_final_values = []\n",
    "            if noael_values:\n",
    "                for i in range(len(noael_values)):\n",
    "                    noael_value_pattern = r'\\b\\d+\\s*[\\.,]*\\d*\\s*.g/kg[\\s*bw|body\\s*weight]*[\\/d.*]* \\b'\n",
    "                    noael = re.findall(noael_value_pattern,noael_values[i])\n",
    "                    if noael:\n",
    "                        if len(noael) == 1:\n",
    "                            noael_final_values.append((noael[0],noael_values[i]))\n",
    "                        else:\n",
    "                            for el in noael:\n",
    "                                noael_final_values.append((el,noael_values[i]))\n",
    "            if ld50_values:\n",
    "                for i in range(len(ld50_values)):\n",
    "                    ld50_value_pattern = r'\\b\\d+\\s*[\\.,]*\\d*\\s*.g/kg[\\s*bw|body\\s*weight]*\\b'\n",
    "                    ld50 = re.findall(ld50_value_pattern,ld50_values[i])\n",
    "                    if ld50:\n",
    "                        if len(ld50) == 1:\n",
    "                            ld50_final_values.append((ld50[0],ld50_values[i]))\n",
    "                        else:\n",
    "                            for el in ld50:\n",
    "                                ld50_final_values.append((el,ld50_values[i]))\n",
    "\n",
    "            if not noael_final_values and not ld50_final_values:\n",
    "                not_values.append(ingredient)\n",
    "            \n",
    "            if noael_final_values:\n",
    "\n",
    "                noael_final_values.sort(key=sorting_func,reverse=True)\n",
    "                valori_noael = [x[0] for x in noael_final_values]\n",
    "                contesti_noael = [x[1] for x in noael_final_values]\n",
    "\n",
    "            if ld50_final_values:\n",
    "                ld50_final_values.sort(key=sorting_func,reverse=True)\n",
    "                valori_ld50 = [x[0] for x in ld50_final_values]\n",
    "                contesti_ld50 = [x[1] for x in ld50_final_values]\n",
    "\n",
    "\n",
    "        except:\n",
    "            not_values.append(ingredient)\n",
    "    else:\n",
    "        not_values.append(ingredient)\n",
    "\n",
    "not_values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "24\n",
      "['500 mg/kg/d', '500 mg/kg/d']\n",
      "[' groups.  The no-observed -adverse- effect level (NOAEL) was determined to be greater than 500 mg/kg/d.     Chronic Toxicity Studies   Oral   Zingiber O', 'ay, via gavage, at doses up to 500  mg/kg/d.  The NOAEL was determined to be greater th an 500 mg/kg/d.  The potential chronic toxicity of a Zingiber  o']\n",
      "[]\n"
     ]
    }
   ],
   "source": [
    "not_values = []\n",
    "n_values =[]\n",
    "n_context = []\n",
    "\n",
    "ingredient = ingredients[6236]\n",
    "\n",
    "if ingredient:\n",
    "    url = db.Ingredienti.find_one({\"Nome_comune\":ingredient},{\"_id\":0})['pdf_link']\n",
    "    if url:\n",
    "        try:\n",
    "            response = req.get(url)\n",
    "            file = BytesIO(response.content)            \n",
    "            pdf_text=pdf.PdfReader(file)\n",
    "            print(len(pdf_text.pages))\n",
    "            text = ''.join([x.extract_text() for x in pdf_text.pages])\n",
    "            text = text.replace('\\n',' ').replace('\\r',' ')\n",
    "            noael_pattern = r'(.{0,50}\\bNOAEL\\b.{0,100}(\\b\\d+\\s*[\\.,]*\\d*\\s*.g/kg\\s*[\\s*bw|body\\s*weight]*\\s*/d[a-zA-Z]{0,3}\\b).{0,50})'\n",
    "            noael_values = re.finditer(noael_pattern,text)\n",
    "            if noael_values:\n",
    "                for el in noael_values:\n",
    "                    n_values.append(el.group(2))\n",
    "                    n_context.append(el.group(1))\n",
    "            else:\n",
    "                not_values.append(ingredient)\n",
    "        except:\n",
    "            print('fuck')\n",
    "            not_values.append(ingredient)\n",
    "\n",
    "print(n_values)\n",
    "print(n_context)\n",
    "print(not_values)\n",
    "\n",
    "                    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0\n"
     ]
    }
   ],
   "source": [
    "print(len(not_values))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "not_values = []\n",
    "l_values =[]\n",
    "l_context = []\n",
    "\n",
    "for ingredient in ingredients[:100]:\n",
    "    url = db.Ingredienti.find_one({\"Nome_comune\":ingredient},{\"_id\":0})['pdf_link']\n",
    "    if url:\n",
    "        try:\n",
    "            response = req.get(url)\n",
    "            file = BytesIO(response.content)            \n",
    "            pdf_text=pdf.PdfReader(file)\n",
    "            text = ''.join([x.extract_text() for x in pdf_text.pages])\n",
    "            text = text.replace('\\n',' ').replace('\\r',' ')\n",
    "            ld50_pattern = r'(.{0,50}\\bLD\\s*50\\b.{0,100}(\\b\\d+\\s*[\\.|,]*\\d*\\s*.g/kg[\\s*bw|body\\s*weight]*\\b).{0,50})'\n",
    "            ld50_values = re.findall(ld50_pattern,text)\n",
    "            if ld50_values:\n",
    "                pass\n",
    "            else:\n",
    "                not_values.append(ingredient)\n",
    "        except:\n",
    "            not_values.append(ingredient)\n",
    "\n",
    "\n",
    "print(len(not_values))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[]\n"
     ]
    }
   ],
   "source": [
    "for el in noael_values:\n",
    "    n_values.append(el.group(2))\n",
    "    n_context.append(el.group(1))\n",
    "\n",
    "print(len(not_values))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "https://pubchem.ncbi.nlm.nih.gov/compound/4510#section=Non-Human-Toxicity-Values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "200"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "response = req.get('https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/annotations/heading/JSON/?source=Hazardous%20Substances%20Data%20Bank%20(HSDB)&heading_type=Compound&heading=Non-Human%20Toxicity%20Values%20(Complete)&page=1')\n",
    "response.status_code\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'_id': ObjectId('668ed1556c1f2275d7294533'),\n",
       "  'Nome_comune': '1,10-Decanediol',\n",
       "  'INCI_name': '1,10-Decanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=940af697-52b5-4a3a-90a6-b9db30ef4a7e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294534'),\n",
       "  'Nome_comune': '1,2,4-Trihydroxybenzene',\n",
       "  'INCI_name': '1,2,4-Trihydroxybenzene',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d55d919-245e-ee11-be6f-00224824e39e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a1152e70-abec-b78c-b63e-a52bba62a429',\n",
       "  'pdf_date': 'June 04, 2024',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294535'),\n",
       "  'Nome_comune': '1,2-Butanediol',\n",
       "  'INCI_name': '1,2-Butanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7bf5d549-ac99-4282-a85f-603d8ecb185e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294536'),\n",
       "  'Nome_comune': '1,2-Hexanediol',\n",
       "  'INCI_name': '1,2-Hexanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=73f09bf1-26dd-4c2b-96f2-59e4285a3b2b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294537'),\n",
       "  'Nome_comune': '1,4-Butanediol',\n",
       "  'INCI_name': '1,4-Butanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ed04f7c6-4dde-4fe4-8ece-df05e25feecc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/8064',\n",
       "   'valori': ['LD50 Rat oral 1525 mg/kg',\n",
       "    'LD50 Rat oral 1550 mg/kg',\n",
       "    'LD50 Rat oral 1.78 g/kg',\n",
       "    'LD50 Rat (Sprague-Dawley, male) oral about 1350 mg/kg bw /from table/',\n",
       "    'LD50 Rat (Sprague-Dawley, female) oral 1670 mg/kg bw (95%confidence limits: 1420-2040 mg/kg bw) /from table/',\n",
       "    'LD50 Rat (albino, male) ip about 1000 mg/kg bw /from table/',\n",
       "    'LC50 Rat (Wistar) inhalation >5.1 mg/L/4 hr /from table/',\n",
       "    'LC50 Rat (Crl:CD BR, male) inhalation >15 mg/L/4 hr /from table/',\n",
       "    'LD50 Mouse oral 2062 mg/kg',\n",
       "    'LD50 Mouse oral 2.18 g/kg',\n",
       "    'LD50 Mouse ip 1660 mg/kg bw /from table/',\n",
       "    'LD50 Mouse sc 2000 mg/kg bw /from table/',\n",
       "    'LD50 Mouse iv 1000 mg/kg bw /from table/',\n",
       "    'LD50 Rabbit oral 2531 mg/kg bw /from table/',\n",
       "    'LD50 Guinea pig oral 1200 mg/kg bw /from table/'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 585\",\n",
       "    \"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 268\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V7 46\",\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.82 (10/1992).',\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.82 (10/1992).',\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.83 (10/1992).',\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.83 (10/1992).',\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.83 (10/1992).',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 585\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V7 46\",\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html',\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html',\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html',\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html',\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html']},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294538'),\n",
       "  'Nome_comune': '1,4-Butanediol/Succinic Acid/Adipic Acid/HDI Copolymer',\n",
       "  'INCI_name': '1,4-Butanediol/Succinic Acid/Adipic Acid/HDI Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=391468f9-9993-47ff-a4ec-163d6b451e65',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294539'),\n",
       "  'Nome_comune': '1,5-Pentanediol',\n",
       "  'INCI_name': '1,5-Pentanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=14283e30-c75a-47fb-bbb8-4291ecde468f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d729453a'),\n",
       "  'Nome_comune': '10-Hydroxydecanoic Acid',\n",
       "  'INCI_name': '10-Hydroxydecanoic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0f6c7436-9053-41e4-bd31-7f2ddbfc66ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d729453b'),\n",
       "  'Nome_comune': '10-Hydroxystearic Acid',\n",
       "  'INCI_name': '10-Hydroxystearic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e1a8f9e1-6aac-433d-a048-2c3a1061e97f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d729453c'),\n",
       "  'Nome_comune': '1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate',\n",
       "  'INCI_name': '1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e6bed57-49b8-4695-8eb7-44393eaf0252',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ef70343b-cd8c-e060-b172-3e84a17efffc',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):69-79, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d729453d'),\n",
       "  'Nome_comune': '1-Naphthol',\n",
       "  'INCI_name': '1-Naphthol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d729453e'),\n",
       "  'Nome_comune': '2,3-Butanediol',\n",
       "  'INCI_name': '2,3-Butanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ebf333ff-4031-4547-a832-4b98c2a3d386',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/262',\n",
       "   'valori': ['LD50 Mouse oral 5462 mg/kg', 'LD50 Mouse oral 9.0 mL/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 585\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V7 47\"]},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d729453f'),\n",
       "  'Nome_comune': '2,3-Naphthalenediol',\n",
       "  'INCI_name': '2,3-Naphthalenediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=03e8b18d-54a7-407c-a9bd-7762b7743d67',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8152792c-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 7(3):353-357, 1988',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294540'),\n",
       "  'Nome_comune': '2,4-Diaminophenol',\n",
       "  'INCI_name': '2,4-Diaminophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=89047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294541'),\n",
       "  'Nome_comune': '2,4-Diaminophenol Dihydrochloride',\n",
       "  'INCI_name': '2,4-Diaminophenol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fb4e11dd-5cfd-4c78-96ff-f0918920fc69',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294542'),\n",
       "  'Nome_comune': '2,4-Diaminophenol HCl',\n",
       "  'INCI_name': '2,4-Diaminophenol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8a047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294543'),\n",
       "  'Nome_comune': '2,4-Diaminophenoxyethanol Dihydrochloride',\n",
       "  'INCI_name': '2,4-Diaminophenoxyethanol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=668d2501-3f7f-4bb7-844c-442e511dae92',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4d65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 11, 2007',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294544'),\n",
       "  'Nome_comune': '2,4-Diaminophenoxyethanol HCl',\n",
       "  'INCI_name': '2,4-Diaminophenoxyethanol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9b2e0890-56f5-42dd-a488-a3780a93027e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4d65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 11, 2007',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294545'),\n",
       "  'Nome_comune': '2,4-Diaminophenoxyethanol Sulfate',\n",
       "  'INCI_name': '2,4-Diaminophenoxyethanol Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0c4e3782-5c83-42a3-8abe-425968594efc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4d65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 11, 2007',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294546'),\n",
       "  'Nome_comune': '2-Amino-3-Hydroxypyridine',\n",
       "  'INCI_name': '2-Amino-3-Hydroxypyridine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=23dc2b3d-2d85-46c5-94ae-c311fcc6c6e2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=657dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 2):91-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d7294547'),\n",
       "  'Nome_comune': '2-Amino-3-Nitrophenol',\n",
       "  'INCI_name': '2-Amino-3-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1b515eb4-7a2d-4ab6-8665-ceb0fadd5348',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d7294548'),\n",
       "  'Nome_comune': '2-Amino-4-Hydroxyethylaminoanisole',\n",
       "  'INCI_name': '2-Amino-4-Hydroxyethylaminoanisole',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=23efee15-ac8c-437f-a56e-8fa646f2e985',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=396dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):25-35, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d7294549'),\n",
       "  'Nome_comune': '2-Amino-4-Hydroxyethylaminoanisole Sulfate',\n",
       "  'INCI_name': '2-Amino-4-Hydroxyethylaminoanisole Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=baae8a82-cf0c-4654-8051-d87b2fc08c3a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=396dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):25-35, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454a'),\n",
       "  'Nome_comune': '2-Amino-4-Nitrophenol',\n",
       "  'INCI_name': '2-Amino-4-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=52eee821-092a-4a3d-9289-bc8757e609a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454b'),\n",
       "  'Nome_comune': '2-Amino-4-Nitrophenol Sulfate',\n",
       "  'INCI_name': '2-Amino-4-Nitrophenol Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=290b7d53-ab07-4921-bea8-1b0a917e2f7a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454c'),\n",
       "  'Nome_comune': '2-Amino-5-Nitrophenol',\n",
       "  'INCI_name': '2-Amino-5-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9df8e38c-ba50-4d72-a1c3-49d36257fc4c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454d'),\n",
       "  'Nome_comune': '2-Amino-6-Chloro-4-Nitrophenol',\n",
       "  'INCI_name': '2-Amino-6-Chloro-4-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f8f53e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454e'),\n",
       "  'Nome_comune': '2-Amino-6-Chloro-4-Nitrophenol Hydrochloride',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cc4914b4-29c6-4f50-a170-948f1b874969',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1a6dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 16(S1):131-143, 1997',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454f'),\n",
       "  'Nome_comune': '2-Bromo-2-Nitropropane-1,3-Diol',\n",
       "  'INCI_name': '2-Bromo-2-Nitropropane-1,3-Diol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7e75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294550'),\n",
       "  'Nome_comune': '2-Chloro-p-Phenylenediamine',\n",
       "  'INCI_name': '2-Chloro-p-Phenylenediamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=93047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294551'),\n",
       "  'Nome_comune': '2-Chloro-p-Phenylenediamine Sulfate',\n",
       "  'INCI_name': '2-Chloro-p-Phenylenediamine Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=94047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294552'),\n",
       "  'Nome_comune': '2-Ethoxy ethoxy ethyl methacrylate',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c2e8f24f-d285-ec11-8d21-000d3a98a506',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f876505d-1527-c1b5-9039-df537f4c8677',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):61-73, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294553'),\n",
       "  'Nome_comune': '2-Methoxyethanol',\n",
       "  'INCI_name': 'Methoxyethanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3a222a6f-9948-4aa2-88f3-e730210fdc7f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b6624b41-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 18(S2):53-67, 1999',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294554'),\n",
       "  'Nome_comune': '2-Methyl-5-Hydroxyethylaminophenol',\n",
       "  'INCI_name': '2-Methyl-5-Hydroxyethylaminophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294555'),\n",
       "  'Nome_comune': '2-Methylresorcinol',\n",
       "  'INCI_name': '2-Methylresorcinol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=30a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294556'),\n",
       "  'Nome_comune': '2-Nitro-p-Phenylenediamine',\n",
       "  'INCI_name': '2-Nitro-p-Phenylenediamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294557'),\n",
       "  'Nome_comune': '2-Oleamido-1,3-Octadecanediol',\n",
       "  'INCI_name': '2-Oleamido-1,3-Octadecanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d8aa33db-1156-4826-bffe-b495d07bb710',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d7294558'),\n",
       "  'Nome_comune': '3-Methylamino-4-Nitrophenoxyethanol',\n",
       "  'INCI_name': '3-Methylamino-4-Nitrophenoxyethanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6378aa15-7c0f-4f49-89d2-c2273df5b598',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4f106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 2):41-51, 2008',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d7294559'),\n",
       "  'Nome_comune': '3-Nitro-p-Hydroxyethylaminophenol',\n",
       "  'INCI_name': '3-Nitro-p-Hydroxyethylaminophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5ad921b3-8e2d-49dc-9249-318c36bfb86b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455a'),\n",
       "  'Nome_comune': '4-Amino-2-Hydroxytoluene',\n",
       "  'INCI_name': '4-Amino-2-Hydroxytoluene',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=21a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455b'),\n",
       "  'Nome_comune': '4-Amino-2-Nitrophenol',\n",
       "  'INCI_name': '4-Amino-2-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=62bbeb0a-3e10-49e0-b0e4-0ff55c2f638f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455c'),\n",
       "  'Nome_comune': '4-Amino-3-Nitrophenol',\n",
       "  'INCI_name': '4-Amino-3-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=77d5b990-0a17-40f9-afd3-bb0585e3e1dc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455d'),\n",
       "  'Nome_comune': '4-Amino-m-Cresol',\n",
       "  'INCI_name': '4-Amino-m-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7677eb23-40de-4c20-9975-071b204be829',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7b8f7c68-8baf-7096-93cc-8c18aaf27356',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455e'),\n",
       "  'Nome_comune': '4-Chloro-2-Aminophenol',\n",
       "  'INCI_name': '4-Chloro-2-Aminophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9957e9f9-7423-ef11-840b-0022482909f5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 23 (Suppl. 2):1-22, 2004',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455f'),\n",
       "  'Nome_comune': '4-Chlororesorcinol',\n",
       "  'INCI_name': '4-Chlororesorcinol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1af63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d7294560'),\n",
       "  'Nome_comune': '4-Hydroxybenzoic Acid',\n",
       "  'INCI_name': '4-Hydroxybenzoic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5ce58b93-04c3-4aa7-8a91-912227ba6f32',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl.1):5-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294561'),\n",
       "  'Nome_comune': '4-Hydroxypropylamino-3-Nitrophenol',\n",
       "  'INCI_name': '4-Hydroxypropylamino-3-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=232d97ca-a20a-4526-a3b4-aef5c9c55fb2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294562'),\n",
       "  'Nome_comune': '4-Methoxy-m-Phenylenediamine',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5fb7939c-df8d-4283-b9e9-45cef73759f3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fe6224f9-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 11(4):381-422, 1992',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294563'),\n",
       "  'Nome_comune': '4-Methoxy-m-Phenylenediamine Sulfate',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c1838f1d-ef27-46d0-9cdc-89a856dd2277',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fe6224f9-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 11(4):381-422, 1992',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294564'),\n",
       "  'Nome_comune': '4-Methoxy-m-Phenylenediamine-HCI',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5a08f95e-036f-4472-bdd9-125a27d6b69c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fe6224f9-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 11(4):381-422, 1992',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294565'),\n",
       "  'Nome_comune': '4-Nitro-m-Phenylenediamine',\n",
       "  'INCI_name': '4-Nitro-m-Phenylenediamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=34f197ac-c3bc-408a-8001-5c84e8983a5b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b177eaf5-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 11(4):489-495, 1992',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294566'),\n",
       "  'Nome_comune': '4-Nitro-o-Phenylenediamine',\n",
       "  'INCI_name': '4-Nitro-o-Phenylenediamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8d75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294567'),\n",
       "  'Nome_comune': '5-Amino-4-Chloro-o-Cresol',\n",
       "  'INCI_name': '5-Amino-4-Chloro-o-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c672931c-f7bd-ed11-83ff-00224824e39e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=022b1d54-27f0-61b3-84c9-84f8cd262808',\n",
       "  'pdf_date': 'December 05, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d7294568'),\n",
       "  'Nome_comune': '5-Amino-4-Chloro-o-Cresol HCl',\n",
       "  'INCI_name': '5-Amino-4-Chloro-o-Cresol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=12499228-f7bd-ed11-83ff-00224824e39e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=022b1d54-27f0-61b3-84c9-84f8cd262808',\n",
       "  'pdf_date': 'December 05, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d7294569'),\n",
       "  'Nome_comune': '5-Amino-6-Chloro-o-Cresol',\n",
       "  'INCI_name': '5-Amino-6-Chloro-o-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a73b31bd-e5bd-ed11-83ff-00224824e39e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=26b686af-79a6-00d2-bbb4-f77ce51f0ce0',\n",
       "  'pdf_date': 'June 13, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456a'),\n",
       "  'Nome_comune': '5-Bromo-5-Nitro-1,3-Dioxane',\n",
       "  'INCI_name': '5-Bromo-5-Nitro-1,3-Dioxane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9a047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456b'),\n",
       "  'Nome_comune': '6-Amino-m-Cresol',\n",
       "  'INCI_name': '6-Amino-m-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=42cc4d10-1777-ed11-81ab-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ed051618-c16f-5387-8646-4ab6e9cd2a5d',\n",
       "  'pdf_date': 'September 12, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456c'),\n",
       "  'Nome_comune': '6-Amino-o-Cresol',\n",
       "  'INCI_name': '6-Amino-o-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5274c358-1777-ed11-81ab-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9cf3627c-a53e-a518-85e7-cfa3eea92d6c',\n",
       "  'pdf_date': 'September 12, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456d'),\n",
       "  'Nome_comune': '6-Hydroxyindole',\n",
       "  'INCI_name': '6-Hydroxyindole',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0291cd73-e9cc-41c1-9d78-7e4d6709c538',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a97bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 3):24-35, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456e'),\n",
       "  'Nome_comune': 'Acacia Catechu',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=db49395b-e1d5-4f49-8cc4-9f46ff275907',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=20debc46-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 20, 1998',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456f'),\n",
       "  'Nome_comune': 'Acacia Catechu Gum',\n",
       "  'INCI_name': 'Acacia Catechu Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e80685b6-322c-486e-9e43-3a421fb955b4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294570'),\n",
       "  'Nome_comune': 'Acacia Concinna',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0a1aa0f9-b1b1-4a92-9e24-e4e97ff90a1b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294571'),\n",
       "  'Nome_comune': 'Acacia Concinna Extract',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=80c972a0-577a-4884-8c4d-211f29a098eb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=20debc46-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 20, 1998',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294572'),\n",
       "  'Nome_comune': 'Acacia Concinna Fruit Extract',\n",
       "  'INCI_name': 'Acacia Concinna Fruit Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=63514e63-6517-43ff-8566-457ed951e843',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294573'),\n",
       "  'Nome_comune': 'Acacia Dealbata',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3c1d642e-73a5-4144-baf6-8fe6f6743e57',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294574'),\n",
       "  'Nome_comune': 'Acacia Dealbata Extract',\n",
       "  'INCI_name': 'Acacia Dealbata Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1efa9d3d-2b0e-4305-a472-8f3ed4d9f87b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294575'),\n",
       "  'Nome_comune': 'Acacia Dealbata Leaf Extract',\n",
       "  'INCI_name': 'Acacia Dealbata Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ef6098d9-502e-4234-a969-25687ef8a07b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294576'),\n",
       "  'Nome_comune': 'Acacia Dealbata Leaf Wax',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=339c76f9-49a2-427b-9a12-41c915decd9d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294577'),\n",
       "  'Nome_comune': 'Acacia Decurrens',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=14ef418b-6d7e-4ae0-b6bb-0e4f84a42fd8',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d7294578'),\n",
       "  'Nome_comune': 'Acacia Decurrens Extract',\n",
       "  'INCI_name': 'Acacia Decurrens Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c86345ca-fd4d-4bac-a042-42176130b5d1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d7294579'),\n",
       "  'Nome_comune': 'Acacia Farnesiana',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dbef23d2-40df-4ee5-bb96-807712244b0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457a'),\n",
       "  'Nome_comune': 'Acacia Farnesiana Extract',\n",
       "  'INCI_name': 'Acacia Farnesiana Flower/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87a4cdfa-20ab-4975-9273-5beca3bc49b7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457b'),\n",
       "  'Nome_comune': 'Acacia Farnesiana Flower Wax',\n",
       "  'INCI_name': 'Acacia Farnesiana Flower Wax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e9cb237d-24be-4eb5-b805-3b645027ac0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457c'),\n",
       "  'Nome_comune': 'Acacia Farnesiana Flower/Stem Extract',\n",
       "  'INCI_name': 'Acacia Farnesiana Flower/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e9fa803-e3f3-4f15-9c77-9033aa06f91d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457d'),\n",
       "  'Nome_comune': 'Acacia Farnesiana Gum',\n",
       "  'INCI_name': 'Acacia Farnesiana Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=80aaf866-3f12-4ccc-981e-073036d2f860',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457e'),\n",
       "  'Nome_comune': 'Acacia Senegal',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e97a71cd-ec24-4e26-b6ae-324e7b597a54',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457f'),\n",
       "  'Nome_comune': 'Acacia Senegal Extract',\n",
       "  'INCI_name': 'Acacia Senegal Flower/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad4dc545-1d18-45a5-9c67-6972fbdf27a7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294580'),\n",
       "  'Nome_comune': 'Acacia Senegal Flower/Stem Extract',\n",
       "  'INCI_name': 'Acacia Senegal Flower/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a505f2cb-7603-446c-9ff0-95f468979a9f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294581'),\n",
       "  'Nome_comune': 'Acacia Senegal Gum',\n",
       "  'INCI_name': 'Acacia Senegal Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b78d3d8f-c353-ee11-be6f-002248227d1f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294582'),\n",
       "  'Nome_comune': 'Acacia Senegal Gum Extract',\n",
       "  'INCI_name': 'Acacia Senegal Gum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8472ffa1-c353-ee11-be6f-002248227d1f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294583'),\n",
       "  'Nome_comune': 'Acetamide MEA',\n",
       "  'INCI_name': 'Acetamide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a3047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294584'),\n",
       "  'Nome_comune': 'Acetic Acid',\n",
       "  'INCI_name': 'Acetic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5cd5b22a-d48b-4e6b-ba06-92c85d2060b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b8106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):112-136, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294585'),\n",
       "  'Nome_comune': 'Acetic/Linoleic/Palmitic Triglyceride',\n",
       "  'INCI_name': 'Acetic/Linoleic/Palmitic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b0e7571e-2d72-4a2b-a1c6-0c1428da9486',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294586'),\n",
       "  'Nome_comune': 'Acetyl Arginine',\n",
       "  'INCI_name': 'Acetyl Arginine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7a8d2616-7670-46df-9b4c-5e224499f733',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294587'),\n",
       "  'Nome_comune': 'Acetyl Carnitine',\n",
       "  'INCI_name': 'Acetyl Carnitine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e79446ba-83c8-4507-a04a-9d7a8d4075e9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d7294588'),\n",
       "  'Nome_comune': 'Acetyl Carnitine HCl',\n",
       "  'INCI_name': 'Acetyl Carnitine HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a0235c4e-aa25-4257-994b-686bde861d89',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d7294589'),\n",
       "  'Nome_comune': 'Acetyl Cysteine',\n",
       "  'INCI_name': 'Acetyl Cysteine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cadc1ba9-749d-4de4-bd97-cebefe529af3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458a'),\n",
       "  'Nome_comune': 'Acetyl Glucosamine',\n",
       "  'INCI_name': 'Acetyl Glucosamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=046461de-7246-4381-a99c-b6c6d15508bd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a70fc38-f9c8-b5a2-86f7-f3c19ae76f6a',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458b'),\n",
       "  'Nome_comune': 'Acetyl Glutamic Acid',\n",
       "  'INCI_name': 'Acetyl Glutamic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3bfe92a6-deed-4c0a-8a4c-33280d1f0b40',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458c'),\n",
       "  'Nome_comune': 'Acetyl Glutamine',\n",
       "  'INCI_name': 'Acetyl Glutamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=988d1c5e-68bd-4c7c-a76e-e066bb896953',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458d'),\n",
       "  'Nome_comune': 'Acetyl Hexapeptide-8',\n",
       "  'INCI_name': 'Acetyl Hexapeptide-8',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3bb45a94-6b17-4ecd-92dd-d76891fb4e65',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a1f5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458e'),\n",
       "  'Nome_comune': 'Acetyl Hexapeptide-8 Amide',\n",
       "  'INCI_name': 'Acetyl Hexapeptide-8 Amide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=11a45db9-41b3-44b0-8db2-084e1f511049',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a1f5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458f'),\n",
       "  'Nome_comune': 'Acetyl Histidine',\n",
       "  'INCI_name': 'Acetyl Histidine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ee6da64e-5b64-43ba-91b1-e62609a51de9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d7294590'),\n",
       "  'Nome_comune': 'Acetyl Methionine',\n",
       "  'INCI_name': 'Acetyl Methionine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=534aa127-804f-481e-9863-d3277a006853',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294591'),\n",
       "  'Nome_comune': 'Acetyl Proline',\n",
       "  'INCI_name': 'Acetyl Proline',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=035da07d-ea1d-402a-b2e0-f16258e79ddc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294592'),\n",
       "  'Nome_comune': 'Acetyl Tributyl Citrate',\n",
       "  'INCI_name': 'Acetyl Tributyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=672d8fff-b26b-4577-ab86-27c43d4f5910',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294593'),\n",
       "  'Nome_comune': 'Acetyl Triethyl Citrate',\n",
       "  'INCI_name': 'Acetyl Triethyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aeae8b8b-2e62-4c78-870d-9c3e7984d697',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294594'),\n",
       "  'Nome_comune': 'Acetyl Triethylhexyl Citrate',\n",
       "  'INCI_name': 'Acetyl Triethylhexyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b958b55b-4703-4ba2-acf1-774ca4417ff8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294595'),\n",
       "  'Nome_comune': 'Acetyl Trihexyl Citrate',\n",
       "  'INCI_name': 'Acetyl Trihexyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2af2fdea-7537-4272-a752-635c10f788e8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294596'),\n",
       "  'Nome_comune': 'Acetyl Trioctyl Citrate',\n",
       "  'INCI_name': 'Acetyl Triethylhexyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=025cc295-72dd-45a3-9159-451aa7850327',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294597'),\n",
       "  'Nome_comune': 'Acetyl Tyrosine',\n",
       "  'INCI_name': 'Acetyl Tyrosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1793fd51-fb71-4d14-8333-1793a70dbb09',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294598'),\n",
       "  'Nome_comune': 'Acetylated Lanolin',\n",
       "  'INCI_name': 'Acetylated Lanolin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ae345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fd11d33d-1cf7-f5c2-b131-d6a2e397b0c4',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d7294599'),\n",
       "  'Nome_comune': 'Acetylated Lanolin Alcohol',\n",
       "  'INCI_name': 'Acetylated Lanolin Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a5345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fd11d33d-1cf7-f5c2-b131-d6a2e397b0c4',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459a'),\n",
       "  'Nome_comune': 'Achillea Millefolium Extract',\n",
       "  'INCI_name': 'Achillea Millefolium Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e23f50e9-d948-4aa7-9a1a-fce28399835a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=234cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):5-15, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459b'),\n",
       "  'Nome_comune': 'Achillea Millefolium Flower Extract',\n",
       "  'INCI_name': 'Achillea Millefolium Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=44237a51-38bf-4df1-8911-12e57f49429e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=234cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):5-15, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459c'),\n",
       "  'Nome_comune': 'Achillea Millefolium Flower/Leaf/Stem Extract',\n",
       "  'INCI_name': 'Achillea Millefolium Flower/Leaf/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=de965a65-cfb0-4c0c-ba96-cd752c0e8fab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=234cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):5-15, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459d'),\n",
       "  'Nome_comune': 'Acid Orange 3',\n",
       "  'INCI_name': 'Acid Orange 3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4223bcbe-6044-4cec-8bea-457ba4d26c97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4437e464-5a8b-18fb-8bf4-15943e8a7823',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):10-11, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459e'),\n",
       "  'Nome_comune': 'Acid Violet 43',\n",
       "  'INCI_name': 'Acid Violet 43',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b8638a9d-fcb5-4029-98e1-82e6c2908824',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f6b7d52c-2d34-dab9-a522-21c81efb2a28',\n",
       "  'pdf_date': 'IJT 40(Suppl. 2):5-15, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459f'),\n",
       "  'Nome_comune': 'Acrylamide',\n",
       "  'INCI_name': 'Acrylamide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=428fb52a-b0b2-4e36-8faf-2632aea4c24c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=035b3c2f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 2):21-50, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d72945a0'),\n",
       "  'Nome_comune': 'Acrylamide/Ammonium Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Ammonium Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3a17189b-3eef-43e4-aba5-6222aab3847c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d72945a1'),\n",
       "  'Nome_comune': 'Acrylamide/Ethyltrimonium Chloride Acrylate/Ethalkonium Chloride Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Ethyltrimonium Chloride Acrylate/Ethalkonium Chloride Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5a3b92e1-42c0-4ac0-8f89-a9907f3a3c82',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a2'),\n",
       "  'Nome_comune': 'Acrylamide/Sodium Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Sodium Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=93dd8269-eea2-41a4-81ec-c2463fc16bb7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a3'),\n",
       "  'Nome_comune': 'Acrylamide/Sodium Acryloyldimethyltaurate Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Sodium Acryloyldimethyltaurate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4d4730f3-6fb1-4ce9-8b75-e0a5dc2f2ea9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a4'),\n",
       "  'Nome_comune': 'Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=84657cc6-7a06-4c45-82bd-b3ea37a0c6a9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a5'),\n",
       "  'Nome_comune': 'Acrylamidopropyltrimonium Chloride/Acrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylamidopropyltrimonium Chloride/Acrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=69286b2f-0555-404d-a3ff-2bb783c3803c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a6'),\n",
       "  'Nome_comune': 'Acrylamidopropyltrimonium Chloride/Acrylates Copolymer',\n",
       "  'INCI_name': 'Acrylamidopropyltrimonium Chloride/Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c9fa268d-a668-4928-b746-2cf43e1bf4e1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a7'),\n",
       "  'Nome_comune': 'Acrylates Copolymer',\n",
       "  'INCI_name': 'Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1212a6cb-8490-4f18-9539-11b8df473486',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a8'),\n",
       "  'Nome_comune': 'Acrylates Crosspolymer',\n",
       "  'INCI_name': 'Acrylates Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=769074f7-d148-4165-9000-2e15a0ca7a5e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a9'),\n",
       "  'Nome_comune': 'Acrylates Crosspolymer-3',\n",
       "  'INCI_name': 'Acrylates Crosspolymer-3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9650429d-f40e-408a-9d04-a6370c1873b9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945aa'),\n",
       "  'Nome_comune': 'Acrylates Crosspolymer-4',\n",
       "  'INCI_name': 'Acrylates Crosspolymer-4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=46103364-1153-400f-a88e-307ae1b6c604',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945ab'),\n",
       "  'Nome_comune': 'Acrylates Crosspolymer-5',\n",
       "  'INCI_name': 'Acrylates Crosspolymer-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=468c1d43-bd35-43c0-b0f2-50c7e04eab09',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945ac'),\n",
       "  'Nome_comune': 'Acrylates/Acrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylates/Acrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b7c19dab-0272-44ae-a1e7-165991cb0be6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945ad'),\n",
       "  'Nome_comune': 'Acrylates/Ammonium Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Ammonium Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=35d3d850-94b6-4319-924c-e4511fbf581f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945ae'),\n",
       "  'Nome_comune': 'Acrylates/Beheneth-25 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Beheneth-25 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3d97dc2c-110a-4611-8725-1b2b1ccc8831',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945af'),\n",
       "  'Nome_comune': 'Acrylates/Beheneth-25 Methacrylate/Steareth-30 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Beheneth-25 Methacrylate/Steareth-30 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=777434c1-4060-4d07-9206-925a1f7440ae',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945b0'),\n",
       "  'Nome_comune': 'Acrylates/Bis-Hydroxypropyl Dimethicone Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Bis-Hydroxypropyl Dimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a6f725ce-64ac-4171-89e5-6e639eeca3ae',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945b1'),\n",
       "  'Nome_comune': 'Acrylates/C10-30 Alkyl Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/C10-30 Alkyl Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=94871191-15c0-40f5-9a9d-062cee15f759',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945b2'),\n",
       "  'Nome_comune': 'Acrylates/C10-30 Alkyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/C10-30 Alkyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=79a05996-2f38-4133-b9d6-e5d4ed6b2b00',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945b3'),\n",
       "  'Nome_comune': 'Acrylates/C12-13 Alkyl Methacrylates/Methoxyethyl Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/C12-13 Alkyl Methacrylates/Methoxyethyl Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3778cbf4-879f-4a6e-8222-1c6f7d368c51',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b4'),\n",
       "  'Nome_comune': 'Acrylates/C12-22 Alkyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/C12-22 Alkyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d65231e-791f-441a-974b-74ab9eb614dd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b5'),\n",
       "  'Nome_comune': 'Acrylates/C26-28 Olefin Copolymer',\n",
       "  'INCI_name': 'Acrylates/C26-28 Olefin Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9be78183-875d-478c-af15-249e73b3d26e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b6'),\n",
       "  'Nome_comune': 'Acrylates/C5-8 Alkyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/C5-8 Alkyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=635a2b26-8d1c-4d6c-8ced-5a4bf874ae80',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b7'),\n",
       "  'Nome_comune': 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=228bbc84-c88f-481e-91de-8cbc009c3b9a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b8'),\n",
       "  'Nome_comune': 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer-2',\n",
       "  'INCI_name': 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=231453fb-9eac-43dd-a7a6-c86bb78e2c22',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b9'),\n",
       "  'Nome_comune': 'Acrylates/Ceteth-20 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Ceteth-20 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dcd4c8f7-738e-4813-8a7d-0f66bcd76e4e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945ba'),\n",
       "  'Nome_comune': 'Acrylates/Dimethiconol Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Dimethiconol Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=618d44d3-e129-4b39-bd0d-e4016e2746bb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0c62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):31-50, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945bb'),\n",
       "  'Nome_comune': 'Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c1c10569-94d3-483e-ab89-4269249a9cbb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945bc'),\n",
       "  'Nome_comune': 'Acrylates/Ethylhexyl Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Ethylhexyl Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c456442f-61fb-463d-8cf3-2e626b462c6b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945bd'),\n",
       "  'Nome_comune': 'Acrylates/Ethylhexyl Acrylate/Glycidyl Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Ethylhexyl Acrylate/Glycidyl Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87c65ea0-bd23-42ca-9a53-58f945edecc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945be'),\n",
       "  'Nome_comune': 'Acrylates/Ethylhexyl Acrylate/Styrene Copolymer',\n",
       "  'INCI_name': 'Acrylates/Ethylhexyl Acrylate/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ea780806-13d5-46c2-8ae6-748d63cb1168',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945bf'),\n",
       "  'Nome_comune': 'Acrylates/Hydroxyesters Acrylates Copolymer',\n",
       "  'INCI_name': 'Acrylates/Hydroxyesters Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=753ee939-0987-44b5-aa7a-9a401ff65f3a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945c0'),\n",
       "  'Nome_comune': 'Acrylates/Hydroxyethyl Acrylate/Lauryl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Hydroxyethyl Acrylate/Lauryl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f404648b-d131-4bcd-88ff-92f346fae829',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945c1'),\n",
       "  'Nome_comune': 'Acrylates/Hydroxyethyl Acrylate/Methoxyethyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Hydroxyethyl Acrylate/Methoxyethyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=be9209d2-9f72-4343-a13f-5a0bec9d7e9d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945c2'),\n",
       "  'Nome_comune': 'Acrylates/Laureth-25 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Laureth-25 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3bca4f0c-de86-41a6-95e2-1fba60cde34a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945c3'),\n",
       "  'Nome_comune': 'Acrylates/Lauryl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Lauryl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b11456c9-f919-4f65-8f75-e77fda6736cb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c4'),\n",
       "  'Nome_comune': 'Acrylates/Lauryl Methacrylate/Tridecyl Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Lauryl Methacrylate/Tridecyl Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e811004b-e2aa-4961-a5d5-6055f9343acd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c5'),\n",
       "  'Nome_comune': 'Acrylates/Methacrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methacrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f284ae0f-172c-4b8b-aee4-f643ec6a11ff',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c6'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-15 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-15 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=be3479ef-f62b-46eb-b535-20f6da215bc4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c7'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-23 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-23 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a09ab80-ec6f-48cb-8418-4a5cdc584e62',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c8'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-23 Methacrylate/Perfluorooctyl Ethyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-23 Methacrylate/Perfluorooctyl Ethyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff9154ac-278d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e821365b-edc8-8bc1-b1ed-7554f706933c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):144-161, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c9'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-4 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-4 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fefd51d8-1f19-485e-824c-5cdbe609090b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945ca'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-90 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-90 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa561e2a-eadb-4280-8e73-7033e9ae1f39',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945cb'),\n",
       "  'Nome_comune': 'Acrylates/Octylacrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylates/Octylacrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8183845a-d97f-4b01-9729-1435c4321b91',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945cc'),\n",
       "  'Nome_comune': 'Acrylates/Palmeth-25 Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Palmeth-25 Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f8da0eb4-ad2e-4cb7-a266-90d0cadd3a72',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945cd'),\n",
       "  'Nome_comune': 'Acrylates/PEG-4 Dimethacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/PEG-4 Dimethacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d2785572-6601-494a-9d15-863bd60f0a24',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945ce'),\n",
       "  'Nome_comune': 'Acrylates/Perfluorohexylethyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Perfluorohexylethyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b90e5db8-278d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e821365b-edc8-8bc1-b1ed-7554f706933c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):144-161, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945cf'),\n",
       "  'Nome_comune': 'Acrylates/PVP Copolymer',\n",
       "  'INCI_name': 'Acrylates/VP Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bf08a6f5-cdd3-4161-82c5-79415abfaf9b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d0'),\n",
       "  'Nome_comune': 'Acrylates/Steareth-20 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Steareth-20 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2834178b-eaf2-448a-92e1-9a20d6245081',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d1'),\n",
       "  'Nome_comune': 'Acrylates/Steareth-20 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Steareth-20 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4f10560c-61b0-4452-8120-abcef93b417d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d2'),\n",
       "  'Nome_comune': 'Acrylates/Steareth-30 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Steareth-30 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6efeb332-81d7-40b0-a934-f3e27f81d00d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d3'),\n",
       "  'Nome_comune': 'Acrylates/Steareth-50 Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Steareth-50 Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0ef65b89-4a8d-4350-b49e-3363a624870b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d4'),\n",
       "  'Nome_comune': 'Acrylates/Stearyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Stearyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d68ddcbc-56ee-4fed-b595-26645f6cb61a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d5'),\n",
       "  'Nome_comune': 'Acrylates/Stearyl Methacrylate/VP Copolymer',\n",
       "  'INCI_name': 'Acrylates/Stearyl Methacrylate/VP Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f9d53a94-568a-4dd8-9bda-55072521a896',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945d6'),\n",
       "  'Nome_comune': 'Acrylates/t-Butylacrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylates/t-Butylacrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5db655bf-766d-4017-a0e0-d35e546b4240',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945d7'),\n",
       "  'Nome_comune': 'Acrylates/VA Copolymer',\n",
       "  'INCI_name': 'Acrylates/VA Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c33a3e01-b9fc-4c17-b497-ad14ba3e8086',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945d8'),\n",
       "  'Nome_comune': 'Acrylates/VA Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/VA Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=25c9e4b8-e443-4186-a6e3-d9b2e20d346a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945d9'),\n",
       "  'Nome_comune': 'Acrylates/Vinyl Isodecanoate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Vinyl Isodecanoate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=610b1f10-7f99-4a4b-9b32-578eb261c6ec',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945da'),\n",
       "  'Nome_comune': 'Acrylates/Vinyl Neodecanoate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Vinyl Neodecanoate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e0d2d248-c54b-4818-9378-c1cf655ab55b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945db'),\n",
       "  'Nome_comune': 'Acrylates/VP Copolymer',\n",
       "  'INCI_name': 'Acrylates/VP Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bf63687d-30cb-4454-8a14-ed4fa0a10148',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945dc'),\n",
       "  'Nome_comune': 'Acrylic Acid/C12-22 Alkyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylic Acid/C12-22 Alkyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e37feccf-7802-4331-8e05-9b0d04c7bc6b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945dd'),\n",
       "  'Nome_comune': 'Acrylic Acid/Phosphorylcholine Glycol Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylic Acid/Phosphorylcholine Glycol Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6b89e7c7-1a27-4b60-8e46-c4d889c8809e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1000a48e-650c-6b92-a9dc-a53d51eea570',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945de'),\n",
       "  'Nome_comune': 'Acrylic Acid/Stearyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylic Acid/Stearyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3c698227-a57c-4ba4-875b-cd6da696f212',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945df'),\n",
       "  'Nome_comune': 'Acrylic Acid/VP Crosspolymer',\n",
       "  'INCI_name': 'Acrylic Acid/VP Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c32bf61c-e2f6-4b6a-aa74-c6bec87ef6a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e0'),\n",
       "  'Nome_comune': 'Acryloyloxypropyl Polysilsesquioxane',\n",
       "  'INCI_name': 'Acryloyloxypropyl Polysilsesquioxane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5e2b40c0-305a-4b5e-9086-fa80ef5e4196',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8b69a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e1'),\n",
       "  'Nome_comune': 'Actinidia Chinensis (Kiwi) Seed Oil',\n",
       "  'INCI_name': 'Actinidia Chinensis (Kiwi) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f3d8a5df-7ac0-4db3-aea1-d1c0f1571c84',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e2'),\n",
       "  'Nome_comune': 'Adansonia Digitata Oil',\n",
       "  'INCI_name': 'Adansonia Digitata Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e98f48fd-cfdb-4ac5-ab29-b328dd79e93b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e3'),\n",
       "  'Nome_comune': 'Adansonia Digitata Seed Oil',\n",
       "  'INCI_name': 'Adansonia Digitata Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa29c3ff-13da-4c08-8fd0-3f6d1c06a517',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e4'),\n",
       "  'Nome_comune': 'Adansonia Digitata Seed Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Adansonia Digitata Seed Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c6bd69b4-1790-4a50-aaa3-ac1f819b9d30',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e5'),\n",
       "  'Nome_comune': 'Adansonia Digitata Seed Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Adansonia Digitata Seed Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6f727652-9a25-40d2-a26f-a93952e357d7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e6'),\n",
       "  'Nome_comune': 'Adenosine',\n",
       "  'INCI_name': 'Adenosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=81b9c546-809b-4041-843e-4e9c8fbbecab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cd3b62ad-1279-3043-bf9f-58ee259b08ba',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):50-63, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e7'),\n",
       "  'Nome_comune': 'Adenosine Phosphate',\n",
       "  'INCI_name': 'Adenosine Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ee88ee88-f2d0-4513-bd4f-e665d8be72a4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cd3b62ad-1279-3043-bf9f-58ee259b08ba',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):50-63, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e8'),\n",
       "  'Nome_comune': 'Adenosine Triphosphate',\n",
       "  'INCI_name': 'Adenosine Triphosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c12e5d09-7c3c-4864-9572-b2ceb0f30a00',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cd3b62ad-1279-3043-bf9f-58ee259b08ba',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):50-63, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945e9'),\n",
       "  'Nome_comune': 'Adipic Acid',\n",
       "  'INCI_name': 'Adipic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fa017cd8-4eea-4122-b4a4-9e70508dfb0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d8d3785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl 1):5-76, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ea'),\n",
       "  'Nome_comune': 'Adipic Acid Dihydrazide',\n",
       "  'INCI_name': 'Adipic Acid Dihydrazide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=354028a6-8fad-4a26-8c85-4371b6d92c7f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d44621e7-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 13(3):154-156, 1994',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945eb'),\n",
       "  'Nome_comune': 'Adipic Acid/1,4-Butanediol/Terephthalate Copolymer',\n",
       "  'INCI_name': 'Adipic Acid/1,4-Butanediol/Terephthalate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=906bbed6-36ee-4a59-b512-853c01d0825d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9d4cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 3):36-47, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ec'),\n",
       "  'Nome_comune': 'Adipic Acid/CHDM/MA/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       "  'INCI_name': 'Adipic Acid/CHDM/MA/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f50a0ab5-9e83-4c2e-9af3-1b241645ae6f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=59efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):74-92, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ed'),\n",
       "  'Nome_comune': 'Adipic Acid/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       "  'INCI_name': 'Adipic Acid/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2010eb80-c416-4969-87b8-448ea41e8cdc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=59efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):74-92, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ee'),\n",
       "  'Nome_comune': 'Agar',\n",
       "  'INCI_name': 'Agar',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d655dd3-23ca-499c-9a9e-482e35cc7a8f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ef'),\n",
       "  'Nome_comune': 'Agarose',\n",
       "  'INCI_name': 'Agarose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e77d7fc3-7e9b-4074-b378-270642eccd15',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945f0'),\n",
       "  'Nome_comune': 'Agarum Cribrosum Extract',\n",
       "  'INCI_name': 'Agarum Cribrosum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=19795793-0662-4a93-a744-0f5aa2af8071',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f1'),\n",
       "  'Nome_comune': 'Ahnfeltiopsis Concinna Extract',\n",
       "  'INCI_name': 'Ahnfeltiopsis Concinna Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=28149688-a800-488d-be9c-ff9db8ce2cd9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f2'),\n",
       "  'Nome_comune': 'Alanine',\n",
       "  'INCI_name': 'Alanine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8cedbe8d-08c2-4137-9e7a-aa6bacad407f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f3'),\n",
       "  'Nome_comune': 'Alaria Esculenta Extract',\n",
       "  'INCI_name': 'Alaria Esculenta Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fd6dd27b-e907-4df6-b9d9-220d91289fb7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f4'),\n",
       "  'Nome_comune': 'Alcaligenes Polysaccharides',\n",
       "  'INCI_name': 'Alcaligenes Polysaccharides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4af28630-47d0-4efa-a026-e37bdb0162a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f5'),\n",
       "  'Nome_comune': 'Alcohol Denat.',\n",
       "  'INCI_name': 'Alcohol Denat.',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e809d27-c637-4a87-bdda-85b51475659f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=93ca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):1-43, 2008',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f6'),\n",
       "  'Nome_comune': 'Aldioxa',\n",
       "  'INCI_name': 'Aldioxa',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=651fc2ce-e6aa-484d-8b7e-103be09bebb1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a85227f3-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 12(3):237-242, 1993',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f7'),\n",
       "  'Nome_comune': 'Aleurites Moluccana Seed Oil',\n",
       "  'INCI_name': 'Aleurites Moluccanus Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a918aa5-cee0-40b6-b780-30fdc41317c3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f8'),\n",
       "  'Nome_comune': 'Aleurites Moluccanus Bakoly Seed Oil',\n",
       "  'INCI_name': 'Aleurites Moluccanus Bakoly Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=84fd3b42-7f30-4167-b235-576d28523dee',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f9'),\n",
       "  'Nome_comune': 'Algae Exopolysaccharides',\n",
       "  'INCI_name': 'Algae Exopolysaccharides (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=33d3a046-7fa6-476b-ae6c-e9b1389401c6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945fa'),\n",
       "  'Nome_comune': 'Algin',\n",
       "  'INCI_name': 'Algin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=88914979-370a-4582-a567-b2b58452d641',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945fb'),\n",
       "  'Nome_comune': 'Alginic Acid',\n",
       "  'INCI_name': 'Alginic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=82be7c0a-ed97-4d94-94c7-ecb28a5367cf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945fc'),\n",
       "  'Nome_comune': 'Allantoin',\n",
       "  'INCI_name': 'Allantoin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d3c2f751-f076-4f84-9d2d-22c14ee18ca2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945fd'),\n",
       "  'Nome_comune': 'Allantoin Ascorbate',\n",
       "  'INCI_name': 'Allantoin Ascorbate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4f51c5ed-4f98-4a25-a938-72959b10488a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945fe'),\n",
       "  'Nome_comune': 'Allantoin Biotin',\n",
       "  'INCI_name': 'Allantoin Biotin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=70c983e4-d5a4-4cdf-af07-427955ad8528',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945ff'),\n",
       "  'Nome_comune': 'Allantoin Galacturonic Acid',\n",
       "  'INCI_name': 'Allantoin Galacturonic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4163be75-6c3a-491f-a796-7a9dc6d85b6b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d7294600'),\n",
       "  'Nome_comune': 'Allantoin Glycyrrhetinic Acid',\n",
       "  'INCI_name': 'Allantoin Glycyrrhetinic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d5beaa0-0426-47a4-86df-f666584f386a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d7294601'),\n",
       "  'Nome_comune': 'Allantoin Panthenol',\n",
       "  'INCI_name': 'Allantoin Panthenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a319a3af-a43b-483a-9904-2e0f6cf8c92d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d7294602'),\n",
       "  'Nome_comune': 'Allantoin Polygalacturonic Acid',\n",
       "  'INCI_name': 'Allantoin Polygalacturonic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e786818f-4e12-46ae-829e-a49912b5d665',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d7294603'),\n",
       "  'Nome_comune': 'Allyl Methacrylate/Glycol Dimethacryate Crosspolymer',\n",
       "  'INCI_name': 'Allyl Methacrylate/Glycol Dimethacryate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=164b79c8-4ae4-4229-bb42-9a71b3e52fba',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294604'),\n",
       "  'Nome_comune': 'Allyl Methacrylates Crosspolymer',\n",
       "  'INCI_name': 'Allyl Methacrylates Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2c7cc7ce-155f-4d83-9eda-54e4bcd2bab2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294605'),\n",
       "  'Nome_comune': 'Almond Meal',\n",
       "  'INCI_name': 'Prunus Amygdalus Dulcis (Sweet Almond) Seed Meal',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a680b811-592c-408e-ab7a-7159cd0978f3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da627cd7-5592-4942-925d-fd85d7bf38c0',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):93-95, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294606'),\n",
       "  'Nome_comune': 'Almond Oil PEG-6 Esters',\n",
       "  'INCI_name': 'Almond Oil PEG-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=55a82e9b-9152-46b4-8d1c-7c3b0e6c4cc5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294607'),\n",
       "  'Nome_comune': 'Almond Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Almond Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ca3d17ec-0f39-4eaf-8f1d-3f80e35481ac',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294608'),\n",
       "  'Nome_comune': 'Almond Oil Propylene Glycol Esters',\n",
       "  'INCI_name': 'Almond Oil Propylene Glycol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a39c34b-80ea-4e9d-96ed-0fa61c1c8fa9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1c34b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294609'),\n",
       "  'Nome_comune': 'Almond Oil/Polyglyceryl-10 Esters',\n",
       "  'INCI_name': 'Almond Oil/Polyglyceryl-10 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=846189d1-e02d-435a-855e-fdf41004bf82',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d729460a'),\n",
       "  'Nome_comune': 'Almondamide DEA',\n",
       "  'INCI_name': 'Almondamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b0edbcd4-b6e1-4f0c-ae8e-c055798112f6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d729460b'),\n",
       "  'Nome_comune': 'Almondamidopropyl Betaine',\n",
       "  'INCI_name': 'Almondamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4e31d7de-4a7a-408a-82b7-07a85b430ebb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d729460c'),\n",
       "  'Nome_comune': 'Almondamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Almondamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f62991b7-8ba2-4287-b6f9-b903c842fc9b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d729460d'),\n",
       "  'Nome_comune': 'Aloe Andongensis Extract',\n",
       "  'INCI_name': 'Aloe Andongensis Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4b0c2173-2b26-4f7f-8df1-ac0e644879a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d729460e'),\n",
       "  'Nome_comune': 'Aloe Andongensis Leaf Extract',\n",
       "  'INCI_name': 'Aloe Andongensis Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a65f08f3-eee5-4ad9-8b7f-decd4aa569c9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d729460f'),\n",
       "  'Nome_comune': 'Aloe Andongensis Leaf Juice',\n",
       "  'INCI_name': 'Aloe Andongensis Leaf Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1e36623d-4158-4b2a-8990-b882c4a128ff',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294610'),\n",
       "  'Nome_comune': 'Aloe Arborescens Leaf Extract',\n",
       "  'INCI_name': 'Aloe Arborescens Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=549451e0-1646-4a1e-85cb-adb03d121e3b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294611'),\n",
       "  'Nome_comune': 'Aloe Arborescens Leaf Juice',\n",
       "  'INCI_name': 'Aloe Arborescens Leaf Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32aab4c3-228d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294612'),\n",
       "  'Nome_comune': 'Aloe Arborescens Leaf Protoplasts',\n",
       "  'INCI_name': 'Aloe Arborescens Leaf Protoplasts',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f79a30c7-4f4a-451e-8567-1e4049b20dca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294613'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Flower Extract',\n",
       "  'INCI_name': 'Aloe Barbadensis Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c41c0e5f-d1f2-4b02-970a-27aff7081330',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294614'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=78433939-0c86-4ee1-9fa7-9e308d101f80',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294615'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf Extract',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa484edd-97bd-4ff0-97dc-952ea3d7cb03',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d7294616'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf Juice',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=571c1793-4928-44d2-a3f7-0101187c0e31',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d7294617'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf Polysaccharides',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf Polysaccharides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e4792fe0-f563-46b8-b071-3e3eff5908c3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d7294618'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf Water',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=27539795-21e6-46b8-94ef-c615e569d120',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d7294619'),\n",
       "  'Nome_comune': 'Aloe Ferox Leaf Extract',\n",
       "  'INCI_name': 'Aloe Ferox Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2aac596c-44dd-4f35-a0f8-19d1d3a2eba8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461a'),\n",
       "  'Nome_comune': 'Aloe Ferox Leaf Juice',\n",
       "  'INCI_name': 'Aloe Ferox Leaf Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7a12bd9c-c842-4f7d-afb6-1475d42f487b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461b'),\n",
       "  'Nome_comune': 'Aloe Ferox Leaf Juice Extract',\n",
       "  'INCI_name': 'Aloe Ferox Leaf Juice Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=791e34d6-ab5b-4122-be8b-01fac6738c11',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461c'),\n",
       "  'Nome_comune': 'Alumina',\n",
       "  'INCI_name': 'Alumina',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eb66797c-8a8d-4553-90f9-e19a07311830',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cda7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):16-33, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461d'),\n",
       "  'Nome_comune': 'Alumina Magnesium Metasilicate',\n",
       "  'INCI_name': 'Magnesium Aluminometasilicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f90d327e-15f8-4127-b236-9d5540c2c6fb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461e'),\n",
       "  'Nome_comune': 'Aluminum Calcium Sodium Silicate',\n",
       "  'INCI_name': 'Aluminum Calcium Sodium Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=53910bac-1c13-40fc-8fbb-3dbc9255b184',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d729461f'),\n",
       "  'Nome_comune': 'Aluminum Citrate',\n",
       "  'INCI_name': 'Aluminum Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=efdc68db-1f75-4935-b03d-fa9aed18e105',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2b6dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl.2):16-46, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294620'),\n",
       "  'Nome_comune': 'Aluminum Dilinoleate',\n",
       "  'INCI_name': 'Aluminum Dilinoleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f1ab260b-e668-48df-9c7f-971f9469677b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294621'),\n",
       "  'Nome_comune': 'Aluminum Dimyristate',\n",
       "  'INCI_name': 'Aluminum Dimyristate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=486da2e0-a245-4e48-926f-32b046b5a4a6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294622'),\n",
       "  'Nome_comune': 'Aluminum Distearate',\n",
       "  'INCI_name': 'Aluminum Distearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7362ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294623'),\n",
       "  'Nome_comune': 'Aluminum Hydroxide',\n",
       "  'INCI_name': 'Aluminum Hydroxide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2fda9be6-efb8-4582-8bbe-01437d95bd0a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cda7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):16-33, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294624'),\n",
       "  'Nome_comune': 'Aluminum Iron Calcium Magnesium Germanium Silicates',\n",
       "  'INCI_name': 'Aluminum Iron Calcium Magnesium Germanium Silicates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=21a73c7c-1520-4cd3-90c3-fc6c0aba1c0e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294625'),\n",
       "  'Nome_comune': 'Aluminum Iron Calcium Magnesium Zirconium Silicates',\n",
       "  'INCI_name': 'Aluminum Iron Calcium Magnesium Zirconium Silicates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d197d0cb-8335-4278-a9e6-90368ef7e285',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294626'),\n",
       "  'Nome_comune': 'Aluminum Iron Silicates',\n",
       "  'INCI_name': 'Aluminum Iron Silicates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=30c6ca7a-1730-4f22-b6f3-963d61bf3733',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294627'),\n",
       "  'Nome_comune': 'Aluminum Isostearate',\n",
       "  'INCI_name': 'Aluminum Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=10a85454-0a80-49b7-9533-8dd452b388a4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d7294628'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Laurates/Palmitates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Laurates/Palmitates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=30d52b81-c8b7-42c1-a6e8-86829888a1bd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d7294629'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Laurates/Stearates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Laurates/Stearates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f30e4e63-1b3e-4fcc-b003-998a0d32aaa8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462a'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Myristates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Myristates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=077763a8-a91d-4d26-9841-bce5a1331367',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462b'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Palmitates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Palmitates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=68fefb27-3778-4b9b-b2a2-f2010055512d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462c'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Stearates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Stearates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ac2e3556-2997-4066-bff6-237e44422e2d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462d'),\n",
       "  'Nome_comune': 'Aluminum Lanolate',\n",
       "  'INCI_name': 'Aluminum Lanolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=df21c2f9-6c94-43ac-bd65-76321b4f0c02',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462e'),\n",
       "  'Nome_comune': 'Aluminum Myristate',\n",
       "  'INCI_name': 'Aluminum Myristate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=00daf653-a257-484f-b18f-9af9dc44d46f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462f'),\n",
       "  'Nome_comune': 'Aluminum Myristates/Palmitates',\n",
       "  'INCI_name': 'Aluminum Myristates/Palmitates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bc1b4575-a43a-4d39-beb9-179aa46bcaa6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d7294630'),\n",
       "  'Nome_comune': 'Aluminum Silicate',\n",
       "  'INCI_name': 'Aluminum Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3d7d0f1d-9fec-4e16-a6d8-5d03569dd083',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294631'),\n",
       "  'Nome_comune': 'Aluminum Starch Octenylsuccinate',\n",
       "  'INCI_name': 'Aluminum Starch Octenylsuccinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6ba180f2-2c58-4977-ab89-46ead971c089',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7096b815-7139-efe2-acb9-3bc9074e4412',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):12-13, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294632'),\n",
       "  'Nome_comune': 'Aluminum Stearate',\n",
       "  'INCI_name': 'Aluminum Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5662ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294633'),\n",
       "  'Nome_comune': 'Aluminum Stearates',\n",
       "  'INCI_name': 'Aluminum Stearates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9d3959d2-6511-49fd-8695-ff3d2bc42013',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294634'),\n",
       "  'Nome_comune': 'Aluminum Tristearate',\n",
       "  'INCI_name': 'Aluminum Tristearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5862ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294635'),\n",
       "  'Nome_comune': 'Amaranthus Hypochondriacus Seed Oil',\n",
       "  'INCI_name': 'Amaranthus Hypochondriacus Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3096551b-15e6-4e72-9ab2-4e00d80c8470',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294636'),\n",
       "  'Nome_comune': 'Amino Bispropyl Dimethicone',\n",
       "  'INCI_name': 'Amino Bispropyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a9f18b97-b08b-4c52-8a3b-0730ee0225ee',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294637'),\n",
       "  'Nome_comune': 'Aminoethyl Propanediol',\n",
       "  'INCI_name': 'Aminoethyl Propanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8889466b-7f21-49da-a7aa-5add6575936e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f74cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):5-18, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294638'),\n",
       "  'Nome_comune': 'Aminomethyl Propanediol',\n",
       "  'INCI_name': 'Aminomethyl Propanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2965e811-3a18-4aac-82cf-7a1374878b33',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f74cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):5-18, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294639'),\n",
       "  'Nome_comune': 'Aminomethyl Propanol',\n",
       "  'INCI_name': 'Aminomethyl Propanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c10e0af3-f349-4bd0-a3c2-4103a5031355',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=62ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 2):141-161, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463a'),\n",
       "  'Nome_comune': 'Aminomethylpropanediol',\n",
       "  'INCI_name': 'Aminomethyl Propanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9d35c8fb-1a9c-4b62-b51e-088bea417fea',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f74cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):5-18, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463b'),\n",
       "  'Nome_comune': 'Aminomethylpropanol',\n",
       "  'INCI_name': 'Aminomethyl Propanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b237c496-a701-4eed-807b-86594017017b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=62ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 2):141-161, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463c'),\n",
       "  'Nome_comune': 'Aminopropyl Dimethicone',\n",
       "  'INCI_name': 'Aminopropyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6532bfa4-8932-42dc-92c3-7b20d6ac40e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463d'),\n",
       "  'Nome_comune': 'Ammonia',\n",
       "  'INCI_name': 'Ammonia',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=099fb3ca-aa61-4668-b117-9b3bfd5a4d5d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e169a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 05, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/222',\n",
       "   'valori': ['LC50 Rabbit inhalation 7,050 mg/cu m/1 hr',\n",
       "    'LC50 Cat inhalation 746 mg/cu m (1064 ppm)/1 hr (Dynamic air flow)',\n",
       "    'LC50 Cat inhalation 7,050 mg/cu m (10,070 ppm)/1 hr  (Static conditions)',\n",
       "    'LC50 Rat inhalation 112 mg/L (16,000 ppm) for 15 min',\n",
       "    'LC50 Rat inhalation 71.9 mg/L (10,270 ppm) for 30 min',\n",
       "    'LC50 Rat inhalation 48.4 mg/L (6,190 ppm) for 60 min',\n",
       "    'LC50 Rat inhalation 7,600 mg/cu m (10,860 ppm)/2 hr',\n",
       "    'LC50 Rat inhalation 5,100 mg/cu m (7,285 ppm)/1 hr',\n",
       "    'LC50 Mouse inhalation 7,105 mg/cu m (10,150 ppm)/10 min',\n",
       "    'LC50 Mouse inhalation 3,360 mg/cu m (4,800 ppm)/1 hr',\n",
       "    'LC50 Mouse inhalation 3,310 mg/cu m (4,800 ppm)/2 hr',\n",
       "    'LD50 Rat oral 350 mg/kg',\n",
       "    'LD50 Mouse inhalation 4,837 ppm/1 hr'],\n",
       "   'fonti': ['Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.101 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.102 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.102 (1981)',\n",
       "    'HHS/ATSDR; Toxicological Profile for Ammonia p.71 (September 2004) TP126. Available from, as of May 24, 2016: https://www.atsdr.cdc.gov/toxprofiles/index.asp',\n",
       "    'HHS/ATSDR; Toxicological Profile for Ammonia p.71 (September 2004) TP126. Available from, as of May 24, 2016: https://www.atsdr.cdc.gov/toxprofiles/index.asp',\n",
       "    'HHS/ATSDR; Toxicological Profile for Ammonia p.71 (September 2004) TP126. Available from, as of May 24, 2016: https://www.atsdr.cdc.gov/toxprofiles/index.asp',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.102 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.102 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.103 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.103 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.103 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.103 (1981)',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 228\"]},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463e'),\n",
       "  'Nome_comune': 'Ammonium Acrylates Copolymer',\n",
       "  'INCI_name': 'Ammonium Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b13084c2-7a82-477b-918d-22df4ed1fdb4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463f'),\n",
       "  'Nome_comune': 'Ammonium Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Ammonium Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=40845776-2d5d-42d4-8671-e8c428d0cb31',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1746c1f2275d7294640'),\n",
       "  'Nome_comune': 'Ammonium Acrylates/Methylstyrene/Styrene Copolymer',\n",
       "  'INCI_name': 'Ammonium Acrylates/Methylstyrene/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2333ce62-c138-4a5e-b968-0e875bd2afec',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1746c1f2275d7294641'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eeddbd4e-b117-4b6a-9a4e-79f3e8868caa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294642'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Carboxyethyl Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Carboxyethyl Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2eea905e-b8c0-4af8-8785-c40dd89f4ce1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294643'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Laureth-7 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Laureth-7 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e3ddf022-cc0f-4036-9b24-0b3f07d98a5b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294644'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Steareth-25 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Steareth-25 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ead0cce2-7943-44e6-b34d-f04919f6fecc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294645'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Steareth-8 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Steareth-8 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6132638d-88b0-44be-963c-c5eb727ea875',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294646'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Vinyl Formamide Copolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Vinyl Formamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=af1f700a-a4f9-42d4-b5e0-726bdc5609e2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294647'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/VP Copolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/VP Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7f505b4b-124e-4e60-881a-2def10f5d795',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294648'),\n",
       "  'Nome_comune': 'Ammonium Alginate',\n",
       "  'INCI_name': 'Ammonium Alginate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c3dc0786-6554-479a-8d82-cea2d105433d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294649'),\n",
       "  'Nome_comune': 'Ammonium Bicarbonate',\n",
       "  'INCI_name': 'Ammonium Bicarbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2e9daa07-8899-4a84-9417-81dc50b74259',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d69e5a23-fad8-81e7-8ce9-48d464c919af',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):80-105, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d729464a'),\n",
       "  'Nome_comune': 'Ammonium Bisulfite',\n",
       "  'INCI_name': 'Ammonium Bisulfite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e6220e70-be6a-4ffb-b120-dacc4796b15b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=68b03823-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 22(Suppl. 2):63-88, 2003',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464b'),\n",
       "  'Nome_comune': 'Ammonium C12-15 Pareth Sulfate',\n",
       "  'INCI_name': 'Ammonium C12-15 Alketh Sulfate (Formerly Ammonium C12-15 Pareth Sulfate)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9c742790-8415-4c8d-b8d8-ef25fe3a0c38',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1dd4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):151-161, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464c'),\n",
       "  'Nome_comune': 'Ammonium Capryleth Sulfate',\n",
       "  'INCI_name': 'Ammonium Capryleth Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=806eb74c-d6ae-4b06-91e2-57834fedc786',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1dd4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):151-161, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464d'),\n",
       "  'Nome_comune': 'Ammonium Carbonate',\n",
       "  'INCI_name': 'Ammonium Carbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=220acad6-6a4e-4550-8822-80796447e6e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d69e5a23-fad8-81e7-8ce9-48d464c919af',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):80-105, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464e'),\n",
       "  'Nome_comune': 'Ammonium Caseinate',\n",
       "  'INCI_name': 'Ammonium Caseinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=abbbdcd6-09f5-4398-85a1-993ae20af4bd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a744d1db-21ea-4172-a676-d17332da9e6e',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):43-56, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464f'),\n",
       "  'Nome_comune': 'Ammonium Cocomonoglyceride Sulfate',\n",
       "  'INCI_name': 'Ammonium Cocomonoglyceride Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=25e76f3c-4d41-45cd-ba60-70b547070802',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=79ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 1):5-16, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294650'),\n",
       "  'Nome_comune': 'Ammonium Coco-Sulfate',\n",
       "  'INCI_name': 'Ammonium Coco-Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1312cc3b-7b6c-42e3-9fe7-065a451b1a81',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=12d4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):115-132, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294651'),\n",
       "  'Nome_comune': 'Ammonium Cocoyl Isethionate',\n",
       "  'INCI_name': 'Ammonium Cocoyl Isethionate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=16ede518-0683-4245-adef-d8fc73aa7c97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cd307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):5-16, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294652'),\n",
       "  'Nome_comune': 'Ammonium Cocoyl Sarcosinate',\n",
       "  'INCI_name': 'Ammonium Cocoyl Sarcosinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ffbe724f-a5a7-419c-bf98-98cb3abb0c08',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9eca7c04-56ee-1b53-ba7c-854f28363b44',\n",
       "  'pdf_date': 'IJT 40(Suppl. 2):117-133, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294653'),\n",
       "  'Nome_comune': 'Ammonium Cumenesulfonate',\n",
       "  'INCI_name': 'Ammonium Cumenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e5dba92f-b80c-4b64-bdb2-a1576af9ec86',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5ba16b53-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 3):270-283, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294654'),\n",
       "  'Nome_comune': 'Ammonium Dinonyl Sulfosuccinate',\n",
       "  'INCI_name': 'Ammonium Dinonyl Sulfosuccinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cd67ecb6-67f3-49ba-b9b4-653247d99cfa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7ca8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):34-46, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294655'),\n",
       "  'Nome_comune': 'Ammonium Dodecylbenzenesulfonate',\n",
       "  'INCI_name': 'Ammonium Dodecylbenzenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=34d93048-6526-4546-98de-7305ebedcdd1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=80307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 4):288-305, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294656'),\n",
       "  'Nome_comune': 'Ammonium Glycolate',\n",
       "  'INCI_name': 'Ammonium Glycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=01f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294657'),\n",
       "  'Nome_comune': 'Ammonium Glycyrrhizate',\n",
       "  'INCI_name': 'Ammonium Glycyrrhizate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d71cfddf-d1a0-4487-8496-3dcf6124a9f0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=49a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):79-112, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294658'),\n",
       "  'Nome_comune': 'Ammonium Hydrolyzed Collagen',\n",
       "  'INCI_name': 'Ammonium Hydrolyzed Collagen',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=71fdab00-b33e-480a-8d3e-b6f32e297e1e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=70af0ca6-3a32-ea93-85bf-c21e81f97048',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):21-42, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294659'),\n",
       "  'Nome_comune': 'Ammonium Hydroxide',\n",
       "  'INCI_name': 'Ammonium Hydroxide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aec980d8-8abe-4a50-93f7-8b30bda27def',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e169a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 05, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d729465a'),\n",
       "  'Nome_comune': 'Ammonium Isostearate',\n",
       "  'INCI_name': 'Ammonium Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e9775093-1054-464f-adb4-1340588fdab5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d729465b'),\n",
       "  'Nome_comune': 'Ammonium Lactate',\n",
       "  'INCI_name': 'Ammonium Lactate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=07f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d729465c'),\n",
       "  'Nome_comune': 'Ammonium Laureth Sulfate',\n",
       "  'INCI_name': 'Ammonium Laureth Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9c345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1dd4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):151-161, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d729465d'),\n",
       "  'Nome_comune': 'Ammonium Lauroyl Sarcosinate',\n",
       "  'INCI_name': 'Ammonium Lauroyl Sarcosinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b326d09c-9709-40f4-9f91-6aef70ffa3b4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9eca7c04-56ee-1b53-ba7c-854f28363b44',\n",
       "  'pdf_date': 'IJT 40(Suppl. 2):117-133, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d729465e'),\n",
       "  'Nome_comune': 'Ammonium Lauryl Sulfate',\n",
       "  'INCI_name': 'Ammonium Lauryl Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d729465f'),\n",
       "  'Nome_comune': 'Ammonium Myreth Sulfate',\n",
       "  'INCI_name': 'Ammonium Myreth Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d1c5648a-256b-4c90-aa2e-322a5c69afe6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1dd4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):151-161, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294660'),\n",
       "  'Nome_comune': 'Ammonium Myristyl Sulfate',\n",
       "  'INCI_name': 'Ammonium Myristyl Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=07ae8b83-aea3-4a54-a1a7-87ce930ab3ab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=12d4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):115-132, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294661'),\n",
       "  'Nome_comune': 'Ammonium Oleate',\n",
       "  'INCI_name': 'Ammonium Oleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e44dba44-980e-4b29-b074-8a0e24d141ff',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294662'),\n",
       "  'Nome_comune': 'Ammonium Persulfate',\n",
       "  'INCI_name': 'Ammonium Persulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a7152517-a7b9-4a0c-aaa6-1eb598c9e334',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b2769572-1904-d977-9587-1be4a26422ba',\n",
       "  'pdf_date': 'IJT 41(Suppl. 3):5-21, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294663'),\n",
       "  'Nome_comune': 'Ammonium Phosphate',\n",
       "  'INCI_name': 'Ammonium Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a117e391-6d24-494c-af87-c95bb19ad73b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294664'),\n",
       "  'Nome_comune': 'Ammonium Phosphatidyl Rapeseedate',\n",
       "  'INCI_name': 'Ammonium Phosphatidyl Rapeseedate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c177c35-9a47-48c4-9e71-fc7f882a0727',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1aefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 2):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294665'),\n",
       "  'Nome_comune': 'Ammonium Polyacrylate',\n",
       "  'INCI_name': 'Ammonium Polyacrylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=164d667f-a52e-458b-bfb9-a85742ff4328',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d7294666'),\n",
       "  'Nome_comune': 'Ammonium Polyacryloyldimethyl Taurate',\n",
       "  'INCI_name': 'Ammonium Polyacryloyldimethyl Taurate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=362bf41d-8ea3-43a4-bcd5-b8d99df63614',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d7294667'),\n",
       "  'Nome_comune': 'Ammonium Silver Zeolite',\n",
       "  'INCI_name': 'Ammonium Silver Zeolite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=effd64f1-8565-49db-946e-44604310bebc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5b047156-d323-2325-85e7-c654069ebcbd',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d7294668'),\n",
       "  'Nome_comune': 'Ammonium Silver Zinc Aluminum Silicate',\n",
       "  'INCI_name': 'Ammonium Silver Zinc Aluminum Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6bb630fc-6e91-4703-b007-66771137aaab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d7294669'),\n",
       "  'Nome_comune': 'Ammonium Stearate',\n",
       "  'INCI_name': 'Ammonium Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d62ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466a'),\n",
       "  'Nome_comune': 'Ammonium Styrene/Acrylates Copolymer',\n",
       "  'INCI_name': 'Ammonium Styrene/Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c4e73f01-1d3e-4baf-abec-de9b1b7090b5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466b'),\n",
       "  'Nome_comune': 'Ammonium Styrene/Acrylates/Ethylhexyl Acrylate/Lauryl Acrylate Copolymer',\n",
       "  'INCI_name': 'Ammonium Styrene/Acrylates/Ethylhexyl Acrylate/Lauryl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7887ab12-df19-45a2-b922-cbb9e981e8f1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466c'),\n",
       "  'Nome_comune': 'Ammonium Sulfite',\n",
       "  'INCI_name': 'Ammonium Sulfite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=97ba360d-91e3-465d-8ecd-6cc2e5fed437',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2ae51402-cfde-abc3-94fe-6b634e1851cc',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):110-114, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466d'),\n",
       "  'Nome_comune': 'Ammonium Tallate',\n",
       "  'INCI_name': 'Ammonium Tallate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c186f777-4039-4db3-84d5-71d4b80e175d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ce62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):252-258, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466e'),\n",
       "  'Nome_comune': 'Ammonium Thioglycolate',\n",
       "  'INCI_name': 'Ammonium Thioglycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3a6a7264-45ee-4d41-9438-42dbbf53b04a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=17a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 1):68-133, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d729466f'),\n",
       "  'Nome_comune': 'Ammonium VA/Acrylates Copolymer',\n",
       "  'INCI_name': 'Ammonium VA/Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b1c3c012-3c3c-4b0b-bde8-15954ac48db8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294670'),\n",
       "  'Nome_comune': 'Ammonium Xylenesulfonate',\n",
       "  'INCI_name': 'Ammonium Xylenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8fb06fb6-7680-4c19-bcf5-42ec6214fea3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5ba16b53-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 3):270-283, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294671'),\n",
       "  'Nome_comune': 'Amodimethicone',\n",
       "  'INCI_name': 'Amodimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=066bca27-d54a-48e4-85be-01e0111d5030',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294672'),\n",
       "  'Nome_comune': 'Amodimethicone Hydroxystearate',\n",
       "  'INCI_name': 'Amodimethicone Hydroxystearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=74a67b3b-3072-4ee0-9132-5f63709117e9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294673'),\n",
       "  'Nome_comune': 'AMP-Acrylates Copolymer',\n",
       "  'INCI_name': 'AMP-Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=80f47db3-98be-4c72-ae19-0a789e4e2456',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294674'),\n",
       "  'Nome_comune': 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide Copolymer',\n",
       "  'INCI_name': 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c7e4b0d1-81fb-4131-8bf9-6067e8c37f88',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294675'),\n",
       "  'Nome_comune': 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide/Hydroxyethylacrylate Copolymer',\n",
       "  'INCI_name': 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide/Hydroxyethylacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=64344123-668c-4428-b166-0985b50b6a58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294676'),\n",
       "  'Nome_comune': 'Amyl Acetate',\n",
       "  'INCI_name': 'Amyl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6bbf9814-d016-4269-b924-758a6e3b0c5e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=71fc240e-c88f-8e1a-8234-b421f7bb29ca',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):14-16, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294677'),\n",
       "  'Nome_comune': 'Amyl Benzoate',\n",
       "  'INCI_name': 'Amyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a45475d-aff1-4e35-8f59-908b2974bf23',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d7294678'),\n",
       "  'Nome_comune': 'Amyl Cinnamal',\n",
       "  'INCI_name': 'Amyl Cinnamal',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e5623c28-baaa-4b68-b3c6-8dc39b01c2cf',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'pdf_name': None,\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d7294679'),\n",
       "  'Nome_comune': 'Amyl Salicylate',\n",
       "  'INCI_name': 'Amyl Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=65374d82-1435-4047-96bb-1a1d708b462c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467a'),\n",
       "  'Nome_comune': 'Amylcinnamyl Alcohol',\n",
       "  'INCI_name': 'Amylcinnamyl Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=41dbb5e1-bc07-413c-aebd-1b9c58352d4a',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467b'),\n",
       "  'Nome_comune': 'Amylodextrin',\n",
       "  'INCI_name': 'Amylodextrin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aea4d1f6-626f-4c7e-87de-4fd7ef49414f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467c'),\n",
       "  'Nome_comune': 'Amylopectin',\n",
       "  'INCI_name': 'Amylopectin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e2a97d84-d244-4ec4-a1f5-99cb0b43ad54',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467d'),\n",
       "  'Nome_comune': 'Amylose',\n",
       "  'INCI_name': 'Amylose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66e9c906-bee6-4a31-a10b-b9ddff229f58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467e'),\n",
       "  'Nome_comune': 'Anacardium Occidentale (Cashew) Seed Oil',\n",
       "  'INCI_name': 'Anacardium Occidentale (Cashew) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f2f604d1-e9a6-47a1-8a71-1c30127dc38f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467f'),\n",
       "  'Nome_comune': 'Anhydrogalactose',\n",
       "  'INCI_name': 'Anhydrogalactose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=14a4533c-f918-4aea-b428-9f8ec2ebff50',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bbf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d7294680'),\n",
       "  'Nome_comune': 'Anhydroglucitol',\n",
       "  'INCI_name': 'Anhydroglucitol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=43e1184a-d0a9-4da4-8f1c-3f2ec7754ab6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bbf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294681'),\n",
       "  'Nome_comune': 'Anhydroxylitol',\n",
       "  'INCI_name': 'Anhydroxylitol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=51353f8c-c133-4916-b7f1-d8a34e0fdf8b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bbf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294682'),\n",
       "  'Nome_comune': 'Anthemis Nobilis Flower Extract',\n",
       "  'INCI_name': 'Anthemis Nobilis Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6dd207a7-6a90-40fb-9fb1-8ebab76cd5fc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6da8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):57-66, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294683'),\n",
       "  'Nome_comune': 'Anthemis Nobilis Flower Oil',\n",
       "  'INCI_name': 'Anthemis Nobilis Flower Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c9109158-8c09-4b25-a090-ed74c1d8b914',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6da8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):57-66, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294684'),\n",
       "  'Nome_comune': 'Anthemis Nobilis Flower Powder',\n",
       "  'INCI_name': 'Anthemis Nobilis Flower Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=31313ec7-35c1-4ac0-8203-6f917082c7c0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6da8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):57-66, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294685'),\n",
       "  'Nome_comune': 'Anthemis Nobilis Flower Water',\n",
       "  'INCI_name': 'Anthemis Nobilis Flower Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=188da513-3deb-4a0c-8b92-1337fa58e115',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6da8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):57-66, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294686'),\n",
       "  'Nome_comune': 'Aphanothece Sacrum Polysaccharide',\n",
       "  'INCI_name': 'Aphanothece Sacrum Exopolysaccharides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2dc61d4f-0fa9-4aef-a868-c457fece7516',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294687'),\n",
       "  'Nome_comune': 'Apricot Kernel Amino Acids',\n",
       "  'INCI_name': 'Apricot Kernel Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6b290c07-d2fa-4944-b4b9-0a726a6db918',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=de4bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):5-12, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294688'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil PEG-40 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil PEG-40 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=563b1f58-1e31-42d7-b7dd-7be8f752ed28',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294689'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil PEG-6 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil PEG-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b00988cb-e7ab-48ae-bd3d-29d5399c11a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d729468a'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a4f90314-9785-42fe-954e-32d6d5429820',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468b'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-10 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-10 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3727359b-05b0-42a9-a65d-5ab340609929',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468c'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-3 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-3 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=894d09b2-609d-4bf6-be75-2854cf40051d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468d'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-4 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-4 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=02e676eb-d425-48a6-b3e0-743cb00cfffb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468e'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-5 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-5 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bd157cec-4ec2-48f2-833c-467b3e5cc68c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468f'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5061fb85-4984-4f93-b6b7-7cfe7f6ea3ee',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294690'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Propylene Glycol Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Propylene Glycol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6810192b-07cc-42d7-9e0b-872ce29318ab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1c34b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294691'),\n",
       "  'Nome_comune': 'Apricotamide DEA',\n",
       "  'INCI_name': 'Apricotamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d0468d8f-15d3-42bf-8c1e-fdacc52a3c98',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294692'),\n",
       "  'Nome_comune': 'Apricotamidopropyl Betaine',\n",
       "  'INCI_name': 'Apricotamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=42a1d736-32de-464c-9d4f-7069b79e3a83',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294693'),\n",
       "  'Nome_comune': 'Arabinose',\n",
       "  'INCI_name': 'Arabinose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c702ea32-1e29-4d2c-9486-59e6dfa3ed17',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bbf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294694'),\n",
       "  'Nome_comune': 'Arabinoxylan',\n",
       "  'INCI_name': 'Arabinoxylan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=54053140-e6ed-4a67-b3e4-77bff34582a2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294695'),\n",
       "  'Nome_comune': 'Arachideth-20',\n",
       "  'INCI_name': 'Arachideth-20',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9453669d-8003-47fd-b8cb-251f90ef9415',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294696'),\n",
       "  'Nome_comune': 'Arachidic Acid',\n",
       "  'INCI_name': 'Arachidic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=02a22b02-14f1-42f4-bcac-315198c45490',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294697'),\n",
       "  'Nome_comune': 'Arachidonic Acid',\n",
       "  'INCI_name': 'Arachidonic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d151fe53-1c3a-4e7d-a14c-52ffe4979be8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6a9219ed-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 12(5):507-559, 1993',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294698'),\n",
       "  'Nome_comune': 'Arachidyl Behenate',\n",
       "  'INCI_name': 'Arachidyl Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5207cf12-607c-43ae-88b8-8ecf2d743617',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294699'),\n",
       "  'Nome_comune': 'Arachidyl Erucate',\n",
       "  'INCI_name': 'Arachidyl Erucate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=95609c74-2529-4a14-846d-fc885df836b0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d729469a'),\n",
       "  'Nome_comune': 'Arachidyl Glucoside',\n",
       "  'INCI_name': 'Arachidyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=751aba8f-ea4e-4a5a-a2a9-da2cf4b83d23',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d729469b'),\n",
       "  'Nome_comune': 'Arachidyl Glycol',\n",
       "  'INCI_name': 'Arachidyl Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=feb64da1-cd4d-4c98-9a74-b976bb4d8d2f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d729469c'),\n",
       "  'Nome_comune': 'Arachidyl Propionate',\n",
       "  'INCI_name': 'Arachidyl Propionate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4aa76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d729469d'),\n",
       "  'Nome_comune': 'Arachis Hypogaea (Peanut) Flour',\n",
       "  'INCI_name': 'Arachis Hypogaea (Peanut) Flour',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e61aac83-1195-4b2a-bc74-c600306d9402',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=072b261d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 20(S2):65-77, 2001',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d729469e'),\n",
       "  'Nome_comune': 'Arachis Hypogaea (Peanut) Oil',\n",
       "  'INCI_name': 'Arachis Hypogaea (Peanut) Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=36de9be4-3ada-489e-bd6c-bec25a11a67d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d729469f'),\n",
       "  'Nome_comune': 'Arctium Lappa Seed Oil',\n",
       "  'INCI_name': 'Arctium Lappa Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eead38f3-8e3b-4e8a-bc1b-ba36d66199a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a0'),\n",
       "  'Nome_comune': 'Argan Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Argan Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87e51260-213e-4f48-8938-57998e8e79b1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a1'),\n",
       "  'Nome_comune': 'Argan Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Argan Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8b5e5faf-ea89-4d71-86ae-39f392ace14b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a2'),\n",
       "  'Nome_comune': 'Argania Spinosa Kernel Oil',\n",
       "  'INCI_name': 'Argania Spinosa Kernel Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=93cfd974-764d-402e-a47d-9da840cc3586',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a3'),\n",
       "  'Nome_comune': 'Arginine',\n",
       "  'INCI_name': 'Arginine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2954191f-3508-4152-b8c1-3e3f95395f28',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a4'),\n",
       "  'Nome_comune': 'Arginine HCl',\n",
       "  'INCI_name': 'Arginine HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2f1d5b8f-ae6a-4cb0-a9d0-2dde5b1185b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a5'),\n",
       "  'Nome_comune': 'Arnica Montana',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7c4dc5a7-bf0d-42e0-8ada-f550ebe47a02',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d75e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 20(S2):1-11, 2001',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a6'),\n",
       "  'Nome_comune': 'Arnica Montana Flower Extract',\n",
       "  'INCI_name': 'Arnica Montana Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4d519c23-caaf-4bac-8a6f-2f7e891da178',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d75e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 20(S2):1-11, 2001',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a7'),\n",
       "  'Nome_comune': 'Ascophyllum Nodosum',\n",
       "  'INCI_name': 'Ascophyllum Nodosum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9d04ea69-f6c8-4ea0-930f-67b32f98587d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946a8'),\n",
       "  'Nome_comune': 'Ascophyllum Nodosum Extract',\n",
       "  'INCI_name': 'Ascophyllum Nodosum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f96de745-7ed3-454a-a91b-248d2005553b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946a9'),\n",
       "  'Nome_comune': 'Ascophyllum Nodosum Powder',\n",
       "  'INCI_name': 'Ascophyllum Nodosum Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=486fe4d1-3f1c-49ee-80c0-603e1fc59bd1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946aa'),\n",
       "  'Nome_comune': 'Ascorbyl Dipalmitate',\n",
       "  'INCI_name': 'Ascorbyl Dipalmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ae6a4b9f-d7a2-4a8d-8fdc-055074276753',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946ab'),\n",
       "  'Nome_comune': 'Ascorbyl Glucoside',\n",
       "  'INCI_name': 'Ascorbyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=49d62643-0ced-49c2-9a59-b61acbc4a694',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5bf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 15, 2020',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946ac'),\n",
       "  'Nome_comune': 'Ascorbyl Isostearate',\n",
       "  'INCI_name': 'Ascorbyl Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=da860c5c-e0b0-4edd-8b78-eb91c6900fb2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946ad'),\n",
       "  'Nome_comune': 'Ascorbyl Linoleate',\n",
       "  'INCI_name': 'Ascorbyl Linoleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8f2a3261-2e5a-43a9-b287-9cd15458d2a7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946ae'),\n",
       "  'Nome_comune': 'Ascorbyl Palmitate',\n",
       "  'INCI_name': 'Ascorbyl Palmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ac3df6b9-c2e4-4744-a905-5faba9de397e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946af'),\n",
       "  'Nome_comune': 'Ascorbyl Stearate',\n",
       "  'INCI_name': 'Ascorbyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ee22b3fd-1ff1-45e9-8f18-629378fe18fe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b0'),\n",
       "  'Nome_comune': 'Ascorbyl Tetraisopalmitate',\n",
       "  'INCI_name': 'Ascorbyl Tetraisopalmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=01b8e72e-5c2b-4cce-984a-6937c7c38a8d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b1'),\n",
       "  'Nome_comune': 'Ascorbyl Tocopheryl Acetate',\n",
       "  'INCI_name': 'Ascorbyl Tocopheryl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=693416fe-7b49-461e-830b-0856185a85fb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=297dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.2):61-94, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b2'),\n",
       "  'Nome_comune': 'Ascorbyl Tocopheryl Maleate',\n",
       "  'INCI_name': 'Ascorbyl Tocopheryl Maleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4eea394b-2a12-45a0-b7db-610d89ad8b97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=297dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.2):61-94, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b3'),\n",
       "  'Nome_comune': 'Asparagine',\n",
       "  'INCI_name': 'Asparagine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7f64cd4a-c0e9-4230-9d38-b1258cb62df8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b4'),\n",
       "  'Nome_comune': 'Asparagopsis Armata Extract',\n",
       "  'INCI_name': 'Asparagopsis Armata Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66421cde-4edd-4c80-816d-41829901a281',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b5'),\n",
       "  'Nome_comune': 'Aspartic Acid',\n",
       "  'INCI_name': 'Aspartic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4e99552f-6984-4d4f-8db1-1fe14156d2d7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b6'),\n",
       "  'Nome_comune': 'Astragalus Gummifer Gum',\n",
       "  'INCI_name': 'Astragalus Gummifer Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8875d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b7'),\n",
       "  'Nome_comune': 'Astrocaryum Murumuru Seed Butter',\n",
       "  'INCI_name': 'Astrocaryum Murumuru Seed Butter',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aec9b952-44f1-43bf-af01-792478851e7f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b8'),\n",
       "  'Nome_comune': 'Astrocaryum Vulgare Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Astrocaryum Vulgare Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=af655c65-a339-4497-b8ed-ff1eca3ddbef',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946b9'),\n",
       "  'Nome_comune': 'Atelocollagen',\n",
       "  'INCI_name': 'Atelocollagen',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1c51be99-7372-41a2-9500-4e58f858e35f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=70af0ca6-3a32-ea93-85bf-c21e81f97048',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):21-42, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946ba'),\n",
       "  'Nome_comune': 'Attapulgite',\n",
       "  'INCI_name': 'Attapulgite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0edc8dd2-ec14-4122-a9e8-63acb51a3bb8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d5fd5bfa-685d-6aab-94d5-67acbc8713fb',\n",
       "  'pdf_date': 'March 07, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946bb'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Bran',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Bran',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c69cc8c-8f05-4574-b5a0-f40e253c38d4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946bc'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Bran Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Bran Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=05b9cb1c-ddbe-4a71-840e-8898d1935ddd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946bd'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Flower/Leaf/Stem Juice',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Flower/Leaf/Stem Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a6cd2173-2fde-43ed-b987-7ade193c0231',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946be'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f17fb106-f944-46c1-94be-b0d3f658b4da',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946bf'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Flour',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Flour',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=feceda54-050a-4dea-9983-7971d3de5c58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946c0'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Meal',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Meal',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dcb14cb9-a5db-448b-865e-3488e1b3f69c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946c1'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Oil',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=99ae19e0-36a6-4174-ae4f-031c92dd2ee4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c2'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Protein',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Protein',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=320c61ba-a162-434a-ab34-a205f91add30',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c3'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Leaf Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d5349e4-b386-44f9-b3a6-7a2ed34504e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c4'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Leaf/Stalk Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Leaf/Stalk Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e6d27777-d7b5-4ed9-9c70-d7f0bd7c9f5d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c5'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Leaf/Stem Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Leaf/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ac89b733-abfe-49ae-80fa-8a8edd77b220',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c6'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Meal Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Meal Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d87ab2a3-161f-489d-89b0-99b3f36b47cc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c7'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Meristem Cell Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Meristem Cell Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=77b0b331-7801-4208-bdbb-4b18751455e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c8'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Peptide',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Peptide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=50f05bf0-41f2-4cd3-b52b-8bb69c9c38b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c9'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Protein Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Protein Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=18f95a50-1453-464a-915c-c46f44e4fc76',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946ca'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Seed Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Seed Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8501a96b-8af8-456a-86f8-329e2c2b8c4c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946cb'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Seed Water',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Seed Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67367937-85f4-4523-a765-c1f346faf5bb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946cc'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Sprout Oil',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Sprout Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bd484d97-d2b4-404b-815a-6a9dd0957dc0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946cd'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Starch',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Starch',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e059b355-7866-42d0-8a0a-f79f44c3abb2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946ce'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Straw Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Straw Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dcab5344-af35-4ac2-ab66-b9bdb5a74e82',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946cf'),\n",
       "  'Nome_comune': 'Avocadamide DEA',\n",
       "  'INCI_name': 'Avocadamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2988ca8b-dace-442b-9fd9-a224337cd471',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d0'),\n",
       "  'Nome_comune': 'Avocadamidopropyl Betaine',\n",
       "  'INCI_name': 'Avocadamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c1de33c-9ec0-4dda-a19f-abe4a3c640a0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d1'),\n",
       "  'Nome_comune': 'Avocadamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Avocadamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=57a0d67a-47d1-4f1c-87d0-c04927e32db4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d2'),\n",
       "  'Nome_comune': 'Avocado Oil',\n",
       "  'INCI_name': 'Persea Gratissima (Avocado) Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f3916e5b-2390-4e99-bdd2-7e29463be5c1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d3'),\n",
       "  'Nome_comune': 'Avocado Oil PEG-11 Esters',\n",
       "  'INCI_name': 'Avocado Oil PEG-11 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aca83640-557b-4add-ae95-72c22fb16fe3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d4'),\n",
       "  'Nome_comune': 'Avocado Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Avocado Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b8f27a03-0463-4d33-baad-0fea9086f57b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d5'),\n",
       "  'Nome_comune': 'Avocado Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Avocado Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2cb59cef-e3c7-4f55-80e3-2bdf377811b4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d6'),\n",
       "  'Nome_comune': 'Avocado Oil Propylene Glycol Esters',\n",
       "  'INCI_name': 'Avocado Oil Propylene Glycol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e94d4495-6eb3-4cf6-9a00-3a4412fb8bae',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1c34b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d7'),\n",
       "  'Nome_comune': 'Azelaic Acid',\n",
       "  'INCI_name': 'Azelaic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a8e9bfd6-d1f0-4a99-a5c0-344f5baa4863',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d8d3785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl 1):5-76, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d8'),\n",
       "  'Nome_comune': 'Azelamide MEA',\n",
       "  'INCI_name': 'Azelamide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9c6a068a-68ec-4923-bd59-4a970498f008',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=61a5d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):18-34, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d9'),\n",
       "  'Nome_comune': 'Azulene',\n",
       "  'INCI_name': 'Azulene',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=791185e2-2fed-4235-ad0a-9c6e6218652a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=62cf160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 18(S3):27-32, 1999',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946da'),\n",
       "  'Nome_comune': 'Babassu Acid',\n",
       "  'INCI_name': 'Babassu Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a4560db7-55c7-474d-b0fc-8454dd6db1a8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946db'),\n",
       "  'Nome_comune': 'Babassu Oil Polyglyceryl-4 Esters',\n",
       "  'INCI_name': 'Babassu Oil Polyglyceryl-4 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7bd0653b-8d64-4113-87e0-fddb4c667023',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946dc'),\n",
       "  'Nome_comune': 'Babassu Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Babassu Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b1fe1511-c3d6-4e1c-aa2c-0ffc58416769',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946dd'),\n",
       "  'Nome_comune': 'Babassuamide DEA',\n",
       "  'INCI_name': 'Babassuamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e754766f-b70c-4148-9663-716ba2522677',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946de'),\n",
       "  'Nome_comune': 'Babassuamide MEA',\n",
       "  'INCI_name': 'Babassuamide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8688d7a2-4584-4b08-8f3a-6209b95306d2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=61a5d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):18-34, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946df'),\n",
       "  'Nome_comune': 'Babassuamidopropyl Betaine',\n",
       "  'INCI_name': 'Babassuamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dfdfc59e-48d9-4819-9072-a1dfa74e71ed',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e0'),\n",
       "  'Nome_comune': 'Babassuamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Babassuamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a4ad126e-73f2-4ce5-893e-51750796dd7d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e1'),\n",
       "  'Nome_comune': 'Barium Sulfate',\n",
       "  'INCI_name': 'Barium Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=56a131dc-9e59-404a-a128-6c2a40bb2ece',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9c7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl3):5-11, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e2'),\n",
       "  'Nome_comune': 'Basic Blue 7',\n",
       "  'INCI_name': 'Basic Blue 7',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f098479e-5e32-ef11-8409-6045bdda3581',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=74c358f7-d495-3ba0-9f14-9032a7cc5b2a',\n",
       "  'pdf_date': 'June 24, 2024',\n",
       "  'pdf_name': 'Notice to Proceed without the Preparation of a Scientific Literature Review',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e3'),\n",
       "  'Nome_comune': 'Basic Blue 99',\n",
       "  'INCI_name': 'Basic Blue 99',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e3814c36-1977-ed11-81ab-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a0a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):51-63, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e4'),\n",
       "  'Nome_comune': 'Basic Brown 17',\n",
       "  'INCI_name': 'Basic Brown 17',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e56d1ea7-98db-4957-b68f-35c92ac66153',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7bf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e5'),\n",
       "  'Nome_comune': 'Basic Red 76',\n",
       "  'INCI_name': 'Basic Red 76',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=53e70981-bdc4-4c57-94cb-389672a6c6c9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7471582e-79fe-c5cc-890b-29d2a97bccd7',\n",
       "  'pdf_date': 'IJT 43(Suppl. 3):109-119, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e6'),\n",
       "  'Nome_comune': 'Basic Violet 1',\n",
       "  'INCI_name': 'Basic Violet 1',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a94906dc-175b-4585-a183-52b1b363c911',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a362e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):193-204, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e7'),\n",
       "  'Nome_comune': 'Basic Violet 3',\n",
       "  'INCI_name': 'Basic Violet 3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=477522d7-0959-4545-9265-236adccbb20a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a362e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):193-204, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946e8'),\n",
       "  'Nome_comune': 'Basic Violet 4',\n",
       "  'INCI_name': 'Basic Violet 4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f5a81bb4-1161-4069-830e-cc7ae6d73fbe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a362e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):193-204, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946e9'),\n",
       "  'Nome_comune': 'Basic Yellow 57',\n",
       "  'INCI_name': 'Basic Yellow 57',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1367622e-ee2f-428c-9e49-3da8c2092f78',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=815a45dd-8f24-6350-abc7-68b23eadcd69',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ea'),\n",
       "  'Nome_comune': 'Basic Yellow 87',\n",
       "  'INCI_name': 'Basic Yellow 87',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5283cca5-3f0c-ed11-82e5-000d3a9cc019',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=110d3b0e-b035-a1ac-a0ea-fe3ae3a7201a',\n",
       "  'pdf_date': 'March 07, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946eb'),\n",
       "  'Nome_comune': 'Bassia Butyracea Seed Butter',\n",
       "  'INCI_name': 'Bassia Butyracea Seed Butter',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1414f2c0-d378-46fb-b769-be6bf8a24aab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ec'),\n",
       "  'Nome_comune': 'Bassia Latifolia Seed Butter',\n",
       "  'INCI_name': 'Bassia Latifolia Seed Butter',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bb58dbb6-5b9d-4ecb-95ef-09287a2a4052',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ed'),\n",
       "  'Nome_comune': 'Batyl Alcohol',\n",
       "  'INCI_name': 'Batyl Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b30fdae8-64b8-4e8a-92d2-bfa0c4fa10e8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fb6cd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):5-21, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ee'),\n",
       "  'Nome_comune': 'Batyl Isostearate',\n",
       "  'INCI_name': 'Batyl Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e013a87-5ef6-43b7-8686-d7a1f1ee1dd9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ef'),\n",
       "  'Nome_comune': 'Batyl Stearate',\n",
       "  'INCI_name': 'Batyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1d001494-8799-45e4-a1ba-d55096ba167e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946f0'),\n",
       "  'Nome_comune': 'Beeswax',\n",
       "  'INCI_name': 'Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cb345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f1'),\n",
       "  'Nome_comune': 'Beeswax Acid',\n",
       "  'INCI_name': 'Beeswax Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4748b92a-0a84-4282-b92e-00cc914f6f64',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f2'),\n",
       "  'Nome_comune': 'Behenamide DEA',\n",
       "  'INCI_name': 'Behenamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff164f93-423c-487e-9f8c-e5369089b665',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f3'),\n",
       "  'Nome_comune': 'Behenamide MEA',\n",
       "  'INCI_name': 'Behenamide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff06816d-e69e-427b-90dd-fcc1a253a983',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=61a5d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):18-34, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f4'),\n",
       "  'Nome_comune': 'Behenamidopropyl Betaine',\n",
       "  'INCI_name': 'Behenamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0705da6d-0d53-4085-8744-fdb045fcf49c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f5'),\n",
       "  'Nome_comune': 'Behenamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Behenamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1a964f74-9934-4ab4-b026-dce544166be5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f6'),\n",
       "  'Nome_comune': 'Beheneth-10',\n",
       "  'INCI_name': 'Beheneth-10',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1c341831-09d0-4692-9a7c-6a3f89ab0c70',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f7'),\n",
       "  'Nome_comune': 'Beheneth-15',\n",
       "  'INCI_name': 'Beheneth-15',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=25a4cc23-77cd-4b89-b721-f26d4b89d390',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f8'),\n",
       "  'Nome_comune': 'Beheneth-2',\n",
       "  'INCI_name': 'Beheneth-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d760191-a831-4cc5-9626-de37b3a0ad63',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f9'),\n",
       "  'Nome_comune': 'Beheneth-20',\n",
       "  'INCI_name': 'Beheneth-20',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f6a07233-142f-4f24-acaf-00a0fe0da8f8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946fa'),\n",
       "  'Nome_comune': 'Beheneth-25',\n",
       "  'INCI_name': 'Beheneth-25',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=29078760-5b52-4f01-ae04-7785d81a1edc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946fb'),\n",
       "  'Nome_comune': 'Beheneth-30',\n",
       "  'INCI_name': 'Beheneth-30',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5e4bc8fd-74c4-468f-9068-c5ded224addd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946fc'),\n",
       "  'Nome_comune': 'Beheneth-5',\n",
       "  'INCI_name': 'Beheneth-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cac3fa48-5dc2-4fe1-93c7-449a25cd7bf8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946fd'),\n",
       "  'Nome_comune': 'Behenic Acid',\n",
       "  'INCI_name': 'Behenic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2547608c-8aaa-47ff-83b5-88ccef6a1752',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946fe'),\n",
       "  'Nome_comune': 'Behenoxy Dimethicone',\n",
       "  'INCI_name': 'Behenoxy Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=496e51ca-82ec-479b-8c65-48411855fa11',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946ff'),\n",
       "  'Nome_comune': 'Behenoxy PEG-10 Dimethicone',\n",
       "  'INCI_name': 'Behenoxy PEG-10 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0d88eee9-1e57-4b57-a655-7d673710bf80',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d7294700'),\n",
       "  'Nome_comune': 'Behentrimonium Chloride',\n",
       "  'INCI_name': 'Behentrimonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=216c134e-0a87-4f37-88ec-95b0de229bcb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d7294701'),\n",
       "  'Nome_comune': 'Behentrimonium Methosulfate',\n",
       "  'INCI_name': 'Behentrimonium Methosulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a0c8783a-823f-41de-82af-e139dff85561',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d7294702'),\n",
       "  'Nome_comune': 'Behenyl Alcohol',\n",
       "  'INCI_name': 'Behenyl Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=45a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d7294703'),\n",
       "  'Nome_comune': 'Behenyl Beeswax',\n",
       "  'INCI_name': 'Behenyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9be19c0f-6a42-4212-a1d0-8dcabec9339c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294704'),\n",
       "  'Nome_comune': 'Behenyl Behenate',\n",
       "  'INCI_name': 'Behenyl Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c5918593-a880-4ccc-910f-9ea9bde5f8a7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294705'),\n",
       "  'Nome_comune': 'Behenyl Benzoate',\n",
       "  'INCI_name': 'Behenyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5504a672-33f8-42de-ba76-e9839c11c4b8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294706'),\n",
       "  'Nome_comune': 'Behenyl Betaine',\n",
       "  'INCI_name': 'Behenyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff71e9e5-c717-4bf1-bb80-2c055a34e00f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4ca8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):28-46, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294707'),\n",
       "  'Nome_comune': 'Behenyl Dimethicone/Bis-Vinyldimethicone Crosspolymer',\n",
       "  'INCI_name': 'Behenyl Dimethicone/Bis-Vinyldimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ba4b8829-1156-4e40-9b26-340ce007ecea',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294708'),\n",
       "  'Nome_comune': 'Behenyl Erucate',\n",
       "  'INCI_name': 'Behenyl Erucate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2643c269-9ba5-4921-bdea-049a56132f23',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294709'),\n",
       "  'Nome_comune': 'Behenyl Isostearate',\n",
       "  'INCI_name': 'Behenyl Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fe83e9a6-60bd-4502-b67e-8cf908d1a44b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d729470a'),\n",
       "  'Nome_comune': 'Behenyl Methacrylate/Perfluorooctylethyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Behenyl Methacrylate/Perfluorooctylethyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1b51d9d0-278d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e821365b-edc8-8bc1-b1ed-7554f706933c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):144-161, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d729470b'),\n",
       "  'Nome_comune': 'Behenyl Methacrylate/t-Butyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Behenyl Methacrylate/t-Butyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4eb74c83-9c65-4423-80d6-e1d58a239f89',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d729470c'),\n",
       "  'Nome_comune': 'Behenyl Olivate',\n",
       "  'INCI_name': 'Behenyl Olivate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9320d319-ee15-47a9-b97b-74a80b72118b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d729470d'),\n",
       "  'Nome_comune': 'Behenyl/Isostearyl Beeswax',\n",
       "  'INCI_name': 'Behenyl/Isostearyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0821fbdc-26cd-435b-b22c-3375b38a59a9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d729470e'),\n",
       "  'Nome_comune': 'Bentonite',\n",
       "  'INCI_name': 'Bentonite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d6779b56-71f5-4b94-83aa-56fbe58b339a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d5fd5bfa-685d-6aab-94d5-67acbc8713fb',\n",
       "  'pdf_date': 'March 07, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d729470f'),\n",
       "  'Nome_comune': 'Benzaldehyde',\n",
       "  'INCI_name': 'Benzaldehyde',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=74924e88-ce11-ee11-8f6c-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2da63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 1):11-27, 2006',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294710'),\n",
       "  'Nome_comune': 'Benzalkonium Chloride',\n",
       "  'INCI_name': 'Benzalkonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=43a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294711'),\n",
       "  'Nome_comune': 'Benzalkonium Montmorillonite',\n",
       "  'INCI_name': 'Benzalkonium Montmorillonite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bdfd412a-e572-434f-a2b8-7d32aec50bad',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e553b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 01, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294712'),\n",
       "  'Nome_comune': 'Benzalkonium Sepiolite',\n",
       "  'INCI_name': 'Benzalkonium Sepiolite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=318cfc57-5bd0-4f12-a7d8-c0009c33c9f7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e553b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 01, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294713'),\n",
       "  'Nome_comune': 'Benzethonium Chloride',\n",
       "  'INCI_name': 'Benzethonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9d75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294714'),\n",
       "  'Nome_comune': 'Benzoic Acid',\n",
       "  'INCI_name': 'Benzoic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ebfc799c-8d0b-4433-b55c-2879d70aa3bb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6b62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):5-30, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294715'),\n",
       "  'Nome_comune': 'Benzophenone-1',\n",
       "  'INCI_name': 'Benzophenone-1',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=64345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294716'),\n",
       "  'Nome_comune': 'Benzophenone-10',\n",
       "  'INCI_name': 'Benzophenone-10',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=63c0f69c-f9f8-4676-98bc-481735687bbd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294717'),\n",
       "  'Nome_comune': 'Benzophenone-11',\n",
       "  'INCI_name': 'Benzophenone-11',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=58345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294718'),\n",
       "  'Nome_comune': 'Benzophenone-12',\n",
       "  'INCI_name': 'Benzophenone-12',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e57b6190-fc11-4f7b-beb2-6f6fb20ef37e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294719'),\n",
       "  'Nome_comune': 'Benzophenone-2',\n",
       "  'INCI_name': 'Benzophenone-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5b345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d729471a'),\n",
       "  'Nome_comune': 'Benzophenone-3',\n",
       "  'INCI_name': 'Benzophenone-3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d729471b'),\n",
       "  'Nome_comune': 'Benzophenone-4',\n",
       "  'INCI_name': 'Benzophenone-4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=62345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d729471c'),\n",
       "  'Nome_comune': 'Benzophenone-5',\n",
       "  'INCI_name': 'Benzophenone-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=63345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d729471d'),\n",
       "  'Nome_comune': 'Benzophenone-6',\n",
       "  'INCI_name': 'Benzophenone-6',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5e345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d729471e'),\n",
       "  'Nome_comune': 'Benzophenone-8',\n",
       "  'INCI_name': 'Benzophenone-8',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d729471f'),\n",
       "  'Nome_comune': 'Benzophenone-9',\n",
       "  'INCI_name': 'Benzophenone-9',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=60345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d7294720'),\n",
       "  'Nome_comune': 'Benzoxiquine',\n",
       "  'INCI_name': 'Benzoxiquine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=36c3974b-1ecf-46bf-bbb8-300b7216eaa3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d5a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 16(S1):117-122, 1997',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d7294721'),\n",
       "  'Nome_comune': 'Benzyl Alcohol',\n",
       "  'INCI_name': 'Benzyl Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=540c836b-b763-4f2f-9cd1-3daabf54abff',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6b62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):5-30, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d7294722'),\n",
       "  'Nome_comune': 'Benzyl Benzoate',\n",
       "  'INCI_name': 'Benzyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6c3ea246-7c07-4fbc-8484-eb7ce6009164',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6b62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):5-30, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d7294723'),\n",
       "  'Nome_comune': 'Benzyl Salicylate',\n",
       "  'INCI_name': 'Benzyl Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a6440801-5670-4209-bb1c-73eca2fff644',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=543ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294724'),\n",
       "  'Nome_comune': 'Benzylparaben',\n",
       "  'INCI_name': 'Benzylparaben',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2147d914-2c1d-473b-8178-37d49c53e31c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl.1):5-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294725'),\n",
       "  'Nome_comune': 'Bertholletia Excelsa Seed Oil',\n",
       "  'INCI_name': 'Bertholletia Excelsa Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=23a70782-ecab-4d49-a64f-4c22cbd27974',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294726'),\n",
       "  'Nome_comune': 'Bertholletia Excelsa Seed Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Bertholletia Excelsa Seed Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3b887d26-3e85-4ffe-9a82-55efecb418c8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294727'),\n",
       "  'Nome_comune': 'Bertholletia Excelsa Seed Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Bertholletia Excelsa Seed Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4e745e26-70e0-4030-bbe4-e4cb290fcf03',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294728'),\n",
       "  'Nome_comune': 'Beta-Alanine Diacetic Acid',\n",
       "  'INCI_name': 'Beta-Alanine Diacetic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2ee4fb99-4aad-47a0-8ff9-52c30ad099a9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=58aabee3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294729'),\n",
       "  'Nome_comune': 'Beta-Glucan',\n",
       "  'INCI_name': 'Beta-Glucan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cc4dcba5-7a50-4f37-8fe8-7a28a0e9a21a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d729472a'),\n",
       "  'Nome_comune': 'Beta-Glucan Hydroxypropyltrimonium Chloride',\n",
       "  'INCI_name': 'Beta-Glucan Hydroxypropyltrimonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=88f3bb35-78f7-4fff-a61a-9b12c06bdda4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d729472b'),\n",
       "  'Nome_comune': 'Beta-Glucan Palmitate',\n",
       "  'INCI_name': 'Beta-Glucan Palmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d27ee8b9-0a2d-4bf8-9dc6-a1ed7cb23876',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d729472c'),\n",
       "  'Nome_comune': 'Betaine',\n",
       "  'INCI_name': 'Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=42545615-7197-407c-91eb-4c7d708a7e52',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4ca8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):28-46, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d729472d'),\n",
       "  'Nome_comune': 'Betaphycus Gelatinum Extract',\n",
       "  'INCI_name': 'Betaphycus Gelatinum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c960d60-745d-4d92-91c1-b0027f316a7c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d729472e'),\n",
       "  'Nome_comune': 'Beta-Sitosterol',\n",
       "  'INCI_name': 'Beta-Sitosterol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=27563589-1a34-41bc-a8df-b6cd45affc83',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d729472f'),\n",
       "  'Nome_comune': 'Beta-Sitosteryl Acetate',\n",
       "  'INCI_name': 'Beta-Sitosteryl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2eaf8d90-b950-4850-a439-87e05f0b5bb5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294730'),\n",
       "  'Nome_comune': 'BHA',\n",
       "  'INCI_name': 'BHA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a575d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=138d48dd-b490-c938-8d57-f81ad33db764',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294731'),\n",
       "  'Nome_comune': 'BHT',\n",
       "  'INCI_name': 'BHT',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4fa9543a-9c8e-41ab-bfa5-de2f56d0e39c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=36412d37-a9e4-79a3-a2b0-5348e659547c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):17-19, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294732'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-1',\n",
       "  'INCI_name': 'Biosaccharide Gum-1',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=657b0252-d1ab-477a-ad0b-8f608effdd1b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294733'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-2',\n",
       "  'INCI_name': 'Biosaccharide Gum-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=180ee849-45dd-4c88-9ec5-2e2aa2dcc40f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294734'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-3',\n",
       "  'INCI_name': 'Biosaccharide Gum-3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e40f50ef-4208-40cd-8c43-3d1e66edfd2f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294735'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-4',\n",
       "  'INCI_name': 'Biosaccharide Gum-4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=db1dbfa8-c813-4830-a4c9-722143ee00c4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294736'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-5',\n",
       "  'INCI_name': 'Biosaccharide Gum-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0c0f3b68-48cc-4cdd-b680-63ff5e7d4d6c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d7294737'),\n",
       "  'Nome_comune': 'Biotin',\n",
       "  'INCI_name': 'Biotin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d4b4afe-da75-45e0-a56f-929bec060220',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=41404048-93dc-df74-aa5c-61ce594a4873',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):20-21, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d7294738'),\n",
       "  'Nome_comune': 'Bis(Glyceryl Dimethacylate) Pyromellitate',\n",
       "  'INCI_name': 'Bis-(Glyceryl Dimethacrylate) Pyromellitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dcfc94eb-527d-ec11-8d21-0022482f7740',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f876505d-1527-c1b5-9039-df537f4c8677',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):61-73, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d7294739'),\n",
       "  'Nome_comune': 'Bis(Tripeptide-1) Copper Acetate',\n",
       "  'INCI_name': 'Bis(Tripeptide-1) Copper Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b1385f95-f5c8-49c3-8558-534d9fd4c7d5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5a97bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl3):90-102, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473a'),\n",
       "  'Nome_comune': 'Bisabolol',\n",
       "  'INCI_name': 'Bisabolol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=19f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473b'),\n",
       "  'Nome_comune': 'Bis-C16-20 Isoalkoxy TMHDI/PEG-90 Copolymer',\n",
       "  'INCI_name': 'Bis-C16-20 Isoalkoxy TMHDI/PEG-90 Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e95e7bb9-9548-434f-8be2-69124c4ae996',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473c'),\n",
       "  'Nome_comune': 'Bis-Cetyl/PEG-8 Cetyl PEG-8 Dimethicone',\n",
       "  'INCI_name': 'Bis-Cetyl/PEG-8 Cetyl PEG-8 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e6000b64-c4a7-4343-8ec2-e6f419ef3bd2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473d'),\n",
       "  'Nome_comune': 'Bis-Diglyceryl Polyacyladipate-1',\n",
       "  'INCI_name': 'Bis-Diglyceryl Polyacyladipate-1',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a20cb463-815c-424d-8df8-544acce86dbe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bfa4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):56-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473e'),\n",
       "  'Nome_comune': 'Bis-Diglyceryl Polyacyladipate-2',\n",
       "  'INCI_name': 'Bis-Diglyceryl Polyacyladipate-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=08c02115-ea0f-496d-9bb8-c9a8dfd08c22',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bfa4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):56-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473f'),\n",
       "  'Nome_comune': 'Bis-Hydroxyethoxypropyl Dimethicone',\n",
       "  'INCI_name': 'Bis-Hydroxyethoxypropyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=17923d9c-f68e-4cfc-ba63-ec3891659a60',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294740'),\n",
       "  'Nome_comune': 'Bis-Hydroxyethyl Acrylate Poly(1,4-Butanediol)-9/TMHDI Copolymer',\n",
       "  'INCI_name': 'Bis-Hydroxyethyl Acrylate Poly(1,4-Butanediol)-9/TMHDI Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a68fc55-8758-4be0-ad53-7f90afa70ecb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294741'),\n",
       "  'Nome_comune': 'Bis-Isobutyl PEG/PPG-10/7/Dimethicone Copolymer',\n",
       "  'INCI_name': 'Bis-Isobutyl PEG/PPG-10/7/Dimethicone Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=98413d82-8b08-4a5f-8701-31b2076c03cd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294742'),\n",
       "  'Nome_comune': 'Bis-Isobutyl PEG-13/Dimethicone Copolymer',\n",
       "  'INCI_name': 'Bis-Isobutyl PEG-13/Dimethicone Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=99c68c58-b222-4562-88ec-cb0bac1185e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294743'),\n",
       "  'Nome_comune': 'Bis-Isobutyl PEG-24/PPG-7/Dimethicone Copolymer',\n",
       "  'INCI_name': 'Bis-Isobutyl PEG-24/PPG-7/Dimethicone Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2c904292-c7b1-4fbe-ad1f-f67174b5188d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294744'),\n",
       "  'Nome_comune': 'Bis-Isostearyl 1,4-Butanediol/HDI/Hydrogenated Dimer Dilinoleyl Alcohol Copolymer',\n",
       "  'INCI_name': 'Bis-Isostearyl 1,4-Butanediol/HDI/Hydrogenated Dimer Dilinoleyl Alcohol Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a3a72385-bda2-4a23-bf5f-19e36758e76d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294745'),\n",
       "  'Nome_comune': 'Bis-Lauryl Cocaminopropylamine/HDI/PEG-100 Copolymer',\n",
       "  'INCI_name': 'Bis-Lauryl Cocaminopropylamine/HDI/PEG-100 Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6fc5d2b4-b689-40d9-a587-55aad3a88cae',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294746'),\n",
       "  'Nome_comune': 'Bis-Methoxy PEG-10 Dimethyl MEA/HDI/Bis-PEG-10 Dimethicone Copolymer',\n",
       "  'INCI_name': 'Bis-Methoxy PEG-10 Dimethyl MEA/HDI/Bis-PEG-10 Dimethicone Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=172354ac-328e-46c0-b2ac-1ab8f3d27a9c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294747'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-14/14 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-14/14 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=755a460a-97a0-480c-a6c2-f8b3d77cc46f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294748'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-15/5 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-15/5 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bbe2a5c1-9d11-41d3-b2f2-531b1c04d338',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294749'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-16/16 PEG/PPG-16/16 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-16/16 PEG/PPG-16/16 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa1f3f0b-f4c9-473a-a4e4-4c02257c59f6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474a'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-18/6 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-18/6 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad2617a0-0494-4525-b1b4-6a3bb672df86',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474b'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-20/20 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-20/20 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=60da67c0-cff8-4990-8cae-0f1640391e92',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474c'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-20/5 PEG/PPG-20/5 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-20/5 PEG/PPG-20/5 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=24807d9d-3a95-4538-9a03-c8e0d3c31970',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474d'),\n",
       "  'Nome_comune': 'Bis-PEG-1 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-1 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c54769b5-7a80-4b1a-b05e-87c2b1dc133f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474e'),\n",
       "  'Nome_comune': 'Bis-PEG-10 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-10 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d15205ce-ffb7-4aa1-bd62-63165812bb4b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474f'),\n",
       "  'Nome_comune': 'Bis-PEG-12 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-12 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c4153969-7b25-4977-9aa2-75123500a3e2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1926c1f2275d7294750'),\n",
       "  'Nome_comune': 'Bis-PEG-12 Dimethicone Beeswax',\n",
       "  'INCI_name': 'Bis-PEG-12 Dimethicone Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d8bd5d1a-5008-4ba8-aa6d-84ae3fa49f58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1926c1f2275d7294751'),\n",
       "  'Nome_comune': 'Bis-PEG-12 Dimethicone Candelillate',\n",
       "  'INCI_name': 'Bis-PEG-12 Dimethicone Candelillate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87e0f306-79f6-4d5c-a8aa-aaf417e83700',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1926c1f2275d7294752'),\n",
       "  'Nome_comune': 'Bis-PEG-15 Methyl Ether Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-15 Methyl Ether Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d8d910a-79af-4301-b718-7063345f8c71',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1926c1f2275d7294753'),\n",
       "  'Nome_comune': 'Bis-PEG-20 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-20 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=807c2b18-b445-45d6-bdcd-61431404c136',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294754'),\n",
       "  'Nome_comune': 'Bis-PEG-4 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-4 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0fa1babe-9af3-4684-a8de-9690466f3e51',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294755'),\n",
       "  'Nome_comune': 'Bis-PEG-8 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-8 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1a72739f-0720-4726-85cc-2a48253ddb02',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294756'),\n",
       "  'Nome_comune': 'Bis-PEG-8 PEG-8 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-8 PEG-8 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=46f5a58d-3a12-449b-8965-2fbb237f7775',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294757'),\n",
       "  'Nome_comune': 'Bis-Phenylisopropyl Phenylisopropyl Dimethicone/Vinyl Dimethicone Crosspolymer',\n",
       "  'INCI_name': 'Bis-Phenylisopropyl Phenylisopropyl Dimethicone/Vinyl Dimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=60f67896-09e8-41ac-97a3-18464083c29d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294758'),\n",
       "  'Nome_comune': 'Bis-Propylheptyl Carbonate',\n",
       "  'INCI_name': 'Dipropylheptyl Carbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cc863345-1ed2-46eb-92b7-6482853ad3e7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5084a7bf-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 06, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294759'),\n",
       "  'Nome_comune': 'Bis-Stearoxy Dimethicone',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c894bdb-a142-4d38-8222-8a2543971027',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d729475a'),\n",
       "  'Nome_comune': 'Bis-Stearoxydimethylsilane',\n",
       "  'INCI_name': 'Bis-Stearoxydimethylsilane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=89d15e74-92a1-429b-a6ad-1dd909b93bc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3412a8b9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 06, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d729475b'),\n",
       "  'Nome_comune': 'Bis-Stearoxyethyl Dimethicone',\n",
       "  'INCI_name': 'Bis-Stearoxyethyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0b339c34-8a19-42cd-b2b1-2cf805383f43',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d729475c'),\n",
       "  'Nome_comune': 'Bis-Vinyldimethicone Crosspolymer',\n",
       "  'INCI_name': 'Bis-Vinyldimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad8441ce-9d43-48e0-8b0b-a1391380524a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1936c1f2275d729475d'),\n",
       "  'Nome_comune': 'Bis-Vinyldimethicone/Bis-Isobutyl PPG-20 Crosspolymer',\n",
       "  'INCI_name': 'Bis-Vinyldimethicone/Bis-Isobutyl PPG-20 Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3f385cf6-9766-4a24-8536-7976c883f9b0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d729475e'),\n",
       "  'Nome_comune': 'Bis-Vinyldimethicone/PEG-10 Dimethicone Crosspolymer',\n",
       "  'INCI_name': 'Bis-Vinyldimethicone/PEG-10 Dimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=019428e6-faea-4716-859f-6bfcb4757597',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d729475f'),\n",
       "  'Nome_comune': 'Bis-Vinyldimethicone/PPG-20 Crosspolymer',\n",
       "  'INCI_name': 'Bis-Vinyldimethicone/PPG-20 Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b3bfe02e-2c95-4b8f-b465-f5b4dfcbd2e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294760'),\n",
       "  'Nome_comune': 'Borage Seed Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Borage Seed Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e7d12c03-a794-429a-a342-93ab5cecf33a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294761'),\n",
       "  'Nome_comune': 'Borage Seed Oil Polyglyceryl-4 Esters',\n",
       "  'INCI_name': 'Borage Seed Oil Polyglyceryl-4 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b205fac8-d24a-40ee-9fff-ffea8ec661ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294762'),\n",
       "  'Nome_comune': 'Borage Seed Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Borage Seed Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6ce8da2b-3b37-4d21-8a06-a87dccb1cd06',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294763'),\n",
       "  'Nome_comune': 'Borago Officinalis Seed Oil',\n",
       "  'INCI_name': 'Borago Officinalis Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2d992197-eca4-48dd-bf7b-f279a1ce7555',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294764'),\n",
       "  'Nome_comune': 'Boric Acid',\n",
       "  'INCI_name': 'Boric Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a875d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294765'),\n",
       "  'Nome_comune': 'Boron Nitride',\n",
       "  'INCI_name': 'Boron Nitride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c302851a-c2d1-4622-b320-5ff2743a71fa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1897bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.3):53-60, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294766'),\n",
       "  'Nome_comune': 'Botryocladia Occidentalis Extract',\n",
       "  'INCI_name': 'Botryocladia Occidentalis Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4ddc8dd4-9719-4ac4-b41b-611460684f5c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d7294767'),\n",
       "  'Nome_comune': 'Brassica Campestris (Rapeseed) Oil Unsaponifiables',\n",
       "  'INCI_name': 'Brassica Campestris (Rapeseed) Oil Unsaponifiables',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e4241f2-0deb-4f84-840c-2c30f1d6d709',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d7294768'),\n",
       "  'Nome_comune': 'Brassica Campestris (Rapeseed) Seed Oil',\n",
       "  'INCI_name': 'Brassica Campestris (Rapeseed) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67818909-a7c2-400f-94ab-5be2869cb44d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d7294769'),\n",
       "  'Nome_comune': 'Brassica Campestris (Rapeseed) Sterols',\n",
       "  'INCI_name': 'Brassica Campestris (Rapeseed) Sterols',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d383a0f-6c51-4fe5-9767-6f78e75c4d01',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476a'),\n",
       "  'Nome_comune': 'Brassica Napus Seed Oil',\n",
       "  'INCI_name': 'Brassica Napus Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d9371a5-15e0-4a8d-89d6-c2b898a95548',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476b'),\n",
       "  'Nome_comune': 'Brassica Oleracea Acephala Seed Oil',\n",
       "  'INCI_name': 'Brassica Oleracea Acephala Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6533a822-40e3-4935-b063-c0d906e17d04',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476c'),\n",
       "  'Nome_comune': 'Brassica Oleracea Italica (Broccoli) Seed Oil',\n",
       "  'INCI_name': 'Brassica Oleracea Italica (Broccoli) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bc624334-9796-4f20-96c2-0586742c5c36',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476d'),\n",
       "  'Nome_comune': 'Brassicamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Brassicamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=671f9078-5b83-461f-85ec-39540a4b073f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476e'),\n",
       "  'Nome_comune': 'Brucine',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b388ce93-b53d-4e60-aeb6-a79f563f20ab',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476f'),\n",
       "  'Nome_comune': 'Brucine Sulfate',\n",
       "  'INCI_name': 'Brucine Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8900a5e9-172e-45ac-ac71-80934b91c95f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=93ca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):1-43, 2008',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294770'),\n",
       "  'Nome_comune': 'Butane',\n",
       "  'INCI_name': 'Butane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e1800789-ca53-ee11-be6f-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7457789c-652d-5ebc-9488-c792baa1ba9a',\n",
       "  'pdf_date': 'September 12, 2023',\n",
       "  'pdf_name': 'Re-evaluation - Report not opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294771'),\n",
       "  'Nome_comune': 'Butene/Propylene Copolymer',\n",
       "  'INCI_name': 'Butene/Propylene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=db6fc93a-fd98-4e8b-881b-501cc9285f33',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=32efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Supp. 2):59-90, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294772'),\n",
       "  'Nome_comune': 'Buteth-3',\n",
       "  'INCI_name': 'Buteth-3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b6dad73d-3207-4387-9954-843e2ef4d506',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=071ce85a-0f95-02b1-9531-587773c294f2',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):5-43, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294773'),\n",
       "  'Nome_comune': 'Butoxyethanol',\n",
       "  'INCI_name': 'Butoxyethanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d4345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294774'),\n",
       "  'Nome_comune': 'Butoxyethyl Acetate',\n",
       "  'INCI_name': 'Butoxyethyl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f8618e54-3623-4dda-bb5c-dd1ebbb6c20c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b8106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):112-136, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294775'),\n",
       "  'Nome_comune': 'Butyl Acetate',\n",
       "  'INCI_name': 'Butyl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4ca76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294776'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Cyclohexyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Cyclohexyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=934b8064-aed5-4892-8255-408a9770da18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294777'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Ethylhexyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Ethylhexyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=528b71a9-7cf5-4f76-8ee3-e06e8978a321',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294778'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Glycol Dimethacrylate Crosspolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Glycol Dimethacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c3d6f6fc-9ded-4c21-8266-5a0623d82002',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1976c1f2275d7294779'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Hydroxyethyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Hydroxyethyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=233a1269-10f9-4540-9156-1ab8df1cb5f1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477a'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Isopropylacrylamide/PEG-18 Dimethacrylate Crosspolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Isopropylacrylamide/PEG-18 Dimethacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=872e9050-2c25-4f6d-9151-494f16151fc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477b'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Styrene Copolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cfe822d6-5390-4039-95b5-48309f6f5e22',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477c'),\n",
       "  'Nome_comune': 'Butyl Avocadate',\n",
       "  'INCI_name': 'Butyl Avocadate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a7e7fb3b-ac89-45d9-99bf-c8c4eebd1138',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477d'),\n",
       "  'Nome_comune': 'Butyl Babassuate',\n",
       "  'INCI_name': 'Butyl Babassuate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a4ff9fc-f58e-4d12-b69b-8c94ec5c7a6f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477e'),\n",
       "  'Nome_comune': 'Butyl Benzoate',\n",
       "  'INCI_name': 'Butyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fd8ecd5c-bd9e-4902-ad11-86b183ae748b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477f'),\n",
       "  'Nome_comune': 'Butyl Benzyl Phthalate',\n",
       "  'INCI_name': 'Butyl Benzyl Phthalate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=18f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1976c1f2275d7294780'),\n",
       "  'Nome_comune': 'Butyl Ester of PVM/MA Copolymer',\n",
       "  'INCI_name': 'Butyl Ester of PVM/MA Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e39b8379-1d54-4861-87b5-017be2d10ab6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8c307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):128-144, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294781'),\n",
       "  'Nome_comune': 'Butyl Ethyl Propanediol',\n",
       "  'INCI_name': 'Butyl Ethyl Propanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=566006f4-4686-4e74-a8c8-6478b0de51ab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294782'),\n",
       "  'Nome_comune': 'Butyl Glucoside',\n",
       "  'INCI_name': 'Butyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2ff04713-2f57-4aea-bb6f-4e022b3affda',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294783'),\n",
       "  'Nome_comune': 'Butyl Glycolate',\n",
       "  'INCI_name': 'Butyl Glycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=06f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294784'),\n",
       "  'Nome_comune': 'Butyl Isostearate',\n",
       "  'INCI_name': 'Butyl Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=31d61bee-9fd0-4d8c-8ebf-2f7c578a7ecd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294785'),\n",
       "  'Nome_comune': 'Butyl Lactate',\n",
       "  'INCI_name': 'Butyl Lactate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0cf63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294786'),\n",
       "  'Nome_comune': 'Butyl Methacrylate',\n",
       "  'INCI_name': 'Butyl Methacrylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d33b9cfe-527d-ec11-8d21-0022482f7740',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f876505d-1527-c1b5-9039-df537f4c8677',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):61-73, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294787'),\n",
       "  'Nome_comune': 'Butyl Methacrylate/Acryoyloxy PG Methacrylate Copolymer',\n",
       "  'INCI_name': 'Butyl Methacrylate/Acryloyloxy PG Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b93d99e9-e7ce-42d1-8ccb-bd8699ee997f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294788'),\n",
       "  'Nome_comune': 'Butyl Myristate',\n",
       "  'INCI_name': 'Butyl Myristate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=811f3917-3182-4925-a279-57945bf66ab5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294789'),\n",
       "  'Nome_comune': 'Butyl Oleate',\n",
       "  'INCI_name': 'Butyl Oleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8e0fb056-0632-4eb4-b786-e1c73a7d31a6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478a'),\n",
       "  'Nome_comune': 'Butyl Stearate',\n",
       "  'INCI_name': 'Butyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dd345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478b'),\n",
       "  'Nome_comune': 'Butyl Thioglycolate',\n",
       "  'INCI_name': 'Butyl Thioglycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87452885-9341-4f70-89a3-243082bcf719',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=17a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 1):68-133, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478c'),\n",
       "  'Nome_comune': 'Butylated Hydroxyanisole',\n",
       "  'INCI_name': 'BHA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=565284ed-377d-4d33-aca7-eb205b0f8997',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=138d48dd-b490-c938-8d57-f81ad33db764',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478d'),\n",
       "  'Nome_comune': 'Butylated PVP',\n",
       "  'INCI_name': 'Butylated PVP',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8180c981-91e4-40d6-86fa-656dbfdfa710',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478e'),\n",
       "  'Nome_comune': 'Butyldimethicone Methacrylate/Methyl Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Butyldimethicone Methacrylate/Methyl Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bbe950e5-d42a-4861-9327-3ce4ab80cc60',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478f'),\n",
       "  'Nome_comune': 'Butylene Glycol',\n",
       "  'INCI_name': 'Butylene Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8f75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d7294790'),\n",
       "  'Nome_comune': 'Butylene Glycol Cocoate',\n",
       "  'INCI_name': 'Butylene Glycol Cocoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0c86f0ad-9bc5-4e03-b936-6398508d8b71',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=79ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 1):5-16, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d7294791'),\n",
       "  'Nome_comune': 'Butylene Glycol Dicaprylate/Dicaprate',\n",
       "  'INCI_name': 'Butylene Glycol Dicaprylate/Dicaprate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d2474879-6e6c-4da6-a2e6-d9856d35fbc5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8759a9c5-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 12, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1996c1f2275d7294792'),\n",
       "  'Nome_comune': 'Butylene Glycol Diisononanoate',\n",
       "  'INCI_name': 'Butylene Glycol Diisononanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=02c8475b-0146-4646-8615-5965537ebde9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8759a9c5-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 12, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294793'),\n",
       "  'Nome_comune': 'Butylene/Ethylene Copolymer',\n",
       "  'INCI_name': 'Butylene/Ethylene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=45c674ca-153b-4287-a339-3236540b5ba5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=32efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Supp. 2):59-90, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294794'),\n",
       "  'Nome_comune': 'Butylene/Ethylene/Propylene Copolymer',\n",
       "  'INCI_name': 'Butylene/Ethylene/Propylene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=58226157-aba4-42c3-8dd9-906605446ca7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=32efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Supp. 2):59-90, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294795'),\n",
       "  'Nome_comune': 'Butylene/Ethylene/Styrene Copolymer',\n",
       "  'INCI_name': 'Butylene/Ethylene/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4151c43e-a36d-4c90-917e-4165b00908db',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294796'),\n",
       "  'Nome_comune': 'Butyloctyl Beeswax',\n",
       "  'INCI_name': 'Butyloctyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8f7174f2-fe8c-4db6-b800-cb8780a4675a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294797'),\n",
       "  'Nome_comune': 'Butyloctyl Behenate',\n",
       "  'INCI_name': 'Butyloctyl Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0161d7c2-d6bc-498a-8184-69ad62ab2fd8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294798'),\n",
       "  'Nome_comune': 'Butyloctyl Benzoate',\n",
       "  'INCI_name': 'Butyloctyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1211a4b2-273e-46ab-90cf-42ea2c469a48',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294799'),\n",
       "  'Nome_comune': 'Butyloctyl Candelillate',\n",
       "  'INCI_name': 'Butyloctyl Candelillate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bdac2550-3bd0-48ce-9730-380e7b2574d9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d729479a'),\n",
       "  'Nome_comune': 'Butyloctyl Cetearate',\n",
       "  'INCI_name': 'Butyloctyl Cetearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67e208d5-efd0-44da-9627-966d438cae9c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d729479b'),\n",
       "  'Nome_comune': 'Butyloctyl Oleate',\n",
       "  'INCI_name': 'Butyloctyl Oleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e11cab95-65d2-433a-b672-771be2eaaee9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d729479c'),\n",
       "  'Nome_comune': 'Butyloctyl Palmitate',\n",
       "  'INCI_name': 'Butyloctyl Palmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3b195713-675c-409a-8178-3fc9ad3e7406',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d729479d'),\n",
       "  'Nome_comune': 'Butyloctyl Salicylate',\n",
       "  'INCI_name': 'Butyloctyl Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=51e405f7-eccf-454d-9e5a-53a352397bdf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d729479e'),\n",
       "  'Nome_comune': 'Butylparaben',\n",
       "  'INCI_name': 'Butylparaben',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bf95c8fe-94b2-428c-a243-127a9e275dca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl.1):5-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d729479f'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Butter',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Butter',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cbfd9ceb-3162-43bd-b07e-29cdb4479deb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a0'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Butter Extract',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Butter Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=06d3d739-d734-45eb-b960-ab8c7a662580',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a1'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Butter Unsaponifiables',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Butter Unsaponifiables',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c79fcac9-63f9-4b74-bff3-2ba5fcb85f6f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a2'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Nut Extract',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Nut Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b371c7f5-5fe1-4b68-af3b-97a9c2705caf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a3'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Nut Shell Powder',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Nut Shell Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ece5a6d0-3ebb-485a-baf9-391938d67df7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a4'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Oil',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3400cc9e-f3ac-4c35-8de6-5b607a67c9d7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a5'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Seedcake Extract',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Seedcake Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=096d0449-9e18-481a-a7a3-e9192bdff35d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a6'),\n",
       "  'Nome_comune': 'C10-11 Isoparaffin',\n",
       "  'INCI_name': 'C10-11 Isoalkane (Formerly C10-11 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=036f40a8-d75b-4435-9493-9643026d6862',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a7'),\n",
       "  'Nome_comune': 'C10-12 Isoparaffin',\n",
       "  'INCI_name': 'C10-12 Isoalkane (Formerly C10-12 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2b8254ae-d629-462b-bf97-b9a4cd9262d6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a8'),\n",
       "  'Nome_comune': 'C10-13 Isoparaffin',\n",
       "  'INCI_name': 'C10-13 Isoalkane (Formerly C10-13 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=79eea325-2c88-4ccb-818f-f528ab5063e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a9'),\n",
       "  'Nome_comune': 'C10-16 Alkyl Glucoside',\n",
       "  'INCI_name': 'C10-16 Alkyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ba099352-eb0d-4588-ab16-2d978247e56e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947aa'),\n",
       "  'Nome_comune': 'C10-16 Pareth-1',\n",
       "  'INCI_name': 'C10-16 Alketh-1 (Formerly C10-16 Pareth-1)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e145bb52-5323-4f3b-a03d-8f9a6742c381',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947ab'),\n",
       "  'Nome_comune': 'C10-16 Pareth-2',\n",
       "  'INCI_name': 'C10-16 Alketh-2 (Formerly C10-16 Pareth-2)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=917fed05-94a0-4782-b161-774c688cf1f3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947ac'),\n",
       "  'Nome_comune': 'C10-18 Triglycerides',\n",
       "  'INCI_name': 'C10-18 Triglycerides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=84a85e95-e6f6-4181-b7fe-283b241d021f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947ad'),\n",
       "  'Nome_comune': 'C10-40 Isoalkyl Acid',\n",
       "  'INCI_name': 'C10-40 Isoalkyl Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e62a513-fdc8-47d8-a8ef-661d2baef6d9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947ae'),\n",
       "  'Nome_comune': 'C10-40 Isoalkyl Acid Octyldodecanol Esters',\n",
       "  'INCI_name': 'C10-40 Isoalkyl Acid Octyldodecanol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dfa5ca17-d21e-43a5-90a7-4bd7424e6ef2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947af'),\n",
       "  'Nome_comune': 'C10-40 Isoalkyl Acid Phytosterol Esters',\n",
       "  'INCI_name': 'C10-40 Isoalkyl Acid Phytosterol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f96cefc1-5f8c-451f-a245-4346c31589bf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b0'),\n",
       "  'Nome_comune': 'C10-40 Isoalkyl Acid Triglyceride',\n",
       "  'INCI_name': 'C10-40 Isoalkyl Acid Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6e59b8df-f271-4a0b-b9ba-2784b8286b4c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b1'),\n",
       "  'Nome_comune': 'C11-12 Isoparaffin',\n",
       "  'INCI_name': 'C11-12 Isoalkane (Formerly C11-12 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3d977ec4-fda8-4db4-9fe7-569d72437816',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b2'),\n",
       "  'Nome_comune': 'C11-13 Isoparaffin',\n",
       "  'INCI_name': 'C11-13 Isoalkane (Formerly C11-13 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=79cee1ec-48f1-42e2-b7d9-f35c2af2201a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b3'),\n",
       "  'Nome_comune': 'C11-13 Pareth-10',\n",
       "  'INCI_name': 'C11-13 Alketh-10 (Formerly C11-13 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=001cc67a-424c-467b-89f4-9312df1f70b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b4'),\n",
       "  'Nome_comune': 'C11-13 Pareth-6',\n",
       "  'INCI_name': 'C11-13 Alketh-6 (Formerly C11-13 Pareth-6)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=973bde9a-0033-4c2f-aa1b-6246e1f42f41',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b5'),\n",
       "  'Nome_comune': 'C11-13 Pareth-9',\n",
       "  'INCI_name': 'C11-13 Alketh-9 (Formerly C11-13 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff5fe46f-8ffd-469d-8248-1c3d493a7d90',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b6'),\n",
       "  'Nome_comune': 'C11-14 Isoparaffin',\n",
       "  'INCI_name': 'C11-14 Isoalkane (Formerly C11-14 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bec0069d-1e3f-45e9-a2a4-1abc3ede1e7e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947b7'),\n",
       "  'Nome_comune': 'C11-15 Pareth-12',\n",
       "  'INCI_name': 'C11-15 Alketh-12 (Formerly C11-15 Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bca281de-5688-4b5b-b1d3-eb33c933d8d3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947b8'),\n",
       "  'Nome_comune': 'C11-15 Pareth-15',\n",
       "  'INCI_name': 'C11-15 Alketh-15 (Formerly C11-15 Pareth-15)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6c564534-6cd3-46a6-a6b2-fbbe2e06e825',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947b9'),\n",
       "  'Nome_comune': 'C11-15 Pareth-20',\n",
       "  'INCI_name': 'C11-15 Alketh-20 (Formerly C11-15 Pareth-20)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f801f709-52aa-43a2-8cb0-5ef439574dd1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947ba'),\n",
       "  'Nome_comune': 'C11-15 Pareth-3',\n",
       "  'INCI_name': 'C11-15 Alketh-3 (Formerly C11-15 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5fb2b1d7-2553-4244-b330-b6d6e4d895a2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947bb'),\n",
       "  'Nome_comune': 'C11-15 Pareth-30',\n",
       "  'INCI_name': 'C11-15 Alketh-30 (Formerly C11-15 Pareth-30)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=acfca8ec-87df-4d6e-8a8d-3fc64e0acb05',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947bc'),\n",
       "  'Nome_comune': 'C11-15 Pareth-40',\n",
       "  'INCI_name': 'C11-15 Alketh-40 (Formerly C11-15 Pareth-40)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3c5e4dcc-6e95-4b26-b261-4dfdfa0a8188',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947bd'),\n",
       "  'Nome_comune': 'C11-15 Pareth-5',\n",
       "  'INCI_name': 'C11-15 Alketh-5 (Formerly C11-15 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=14066adc-546b-4616-8f94-0e6786886ead',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947be'),\n",
       "  'Nome_comune': 'C11-15 Pareth-7',\n",
       "  'INCI_name': 'C11-15 Alketh-7 (Formerly C11-15 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e6768857-27cc-42b7-b1c9-d862588b1156',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947bf'),\n",
       "  'Nome_comune': 'C11-15 Pareth-9',\n",
       "  'INCI_name': 'C11-15 Alketh-9 (Formerly C11-15 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7094c8b1-2e08-4261-9e9f-414adf165b45',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947c0'),\n",
       "  'Nome_comune': 'C11-15 Sec-Pareth-12',\n",
       "  'INCI_name': 'C11-15 Sec-Alketh-12 (Formerly C11-15 Sec-Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e20d9ef9-6761-4a22-bd93-bdbfc456d5e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c1'),\n",
       "  'Nome_comune': 'C11-21 Pareth-10',\n",
       "  'INCI_name': 'C11-21 Alketh-10 (Formerly C11-21 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=90ffea43-f013-45bb-82e7-ed18ad15c331',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c2'),\n",
       "  'Nome_comune': 'C11-21 Pareth-3',\n",
       "  'INCI_name': 'C11-21 Alketh-3 (Formerly C11-21 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7c0f0941-d8b3-40a5-ba9b-62bff5719fc8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c3'),\n",
       "  'Nome_comune': 'C12-13 Alkyl Ethylhexanoate',\n",
       "  'INCI_name': 'C12-13 Alkyl Ethylhexanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b14283fd-b180-4cfd-b365-8d4209f3575a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9897bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.3):61-73, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c4'),\n",
       "  'Nome_comune': 'C12-13 Pareth-1',\n",
       "  'INCI_name': 'C12-13 Alketh-1 (Formerly C12-13 Pareth-1)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=197af9b4-3b20-4158-a272-713a49bf3403',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c5'),\n",
       "  'Nome_comune': 'C12-13 Pareth-10',\n",
       "  'INCI_name': 'C12-13 Alketh-10 (Formerly C12-13 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d267f919-1fc1-477a-a430-eebf6ccf80de',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c6'),\n",
       "  'Nome_comune': 'C12-13 Pareth-15',\n",
       "  'INCI_name': 'C12-13 Alketh-15 (Formerly C12-13 Pareth-15)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1e9d89da-edec-48ba-b434-ea5ff0adb8bb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c7'),\n",
       "  'Nome_comune': 'C12-13 Pareth-2',\n",
       "  'INCI_name': 'C12-13 Alketh-2 (Formerly C12-13 Pareth-2)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8ed4d216-a147-425c-a631-f68098e019f4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c8'),\n",
       "  'Nome_comune': 'C12-13 Pareth-23',\n",
       "  'INCI_name': 'C12-13 Alketh-23 (Formerly C12-13 Pareth-23)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bc8b6ffb-0c88-4e2e-8daa-fe5a0041f54d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c9'),\n",
       "  'Nome_comune': 'C12-13 Pareth-3',\n",
       "  'INCI_name': 'C12-13 Alketh-3 (Formerly C12-13 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=78b3a87d-2e72-4541-9569-88fedaa42331',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947ca'),\n",
       "  'Nome_comune': 'C12-13 Pareth-4',\n",
       "  'INCI_name': 'C12-13 Alketh-4 (Formerly C12-13 Pareth-4)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cb5b63f2-955d-41d3-b976-f6d077ccc253',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947cb'),\n",
       "  'Nome_comune': 'C12-13 Pareth-5',\n",
       "  'INCI_name': 'C12-13 Alketh-5 (Formerly C12-13 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fef34f6b-b76e-4911-904f-66867dedf937',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947cc'),\n",
       "  'Nome_comune': 'C12-13 Pareth-6',\n",
       "  'INCI_name': 'C12-13 Alketh-6 (Formerly C12-13 Pareth-6)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6bfbdf56-d635-4213-8b9c-2dc810919a78',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947cd'),\n",
       "  'Nome_comune': 'C12-13 Pareth-7',\n",
       "  'INCI_name': 'C12-13 Alketh-7 (Formerly C12-13 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c423a901-7ea5-405f-9f40-5e96b5c745b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947ce'),\n",
       "  'Nome_comune': 'C12-13 Pareth-9',\n",
       "  'INCI_name': 'C12-13 Alketh-9 (Formerly C12-13 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fb185a25-e39d-45ab-84d9-32d0c743cf3d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947cf'),\n",
       "  'Nome_comune': 'C12-14 Isoparaffin',\n",
       "  'INCI_name': 'C12-14 Isoalkane (Formerly C12-14 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=53860a81-369e-479d-aae9-14cda1099758',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947d0'),\n",
       "  'Nome_comune': 'C12-14 Pareth-11',\n",
       "  'INCI_name': 'C12-14 Alketh-11 (Formerly C12-14 Pareth-11)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8a645dff-c940-47ed-b3f7-7896897200a3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947d1'),\n",
       "  'Nome_comune': 'C12-14 Pareth-12',\n",
       "  'INCI_name': 'C12-14 Alketh-12 (Formerly C12-14 Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d6e9de3f-76eb-44ef-b952-839bb6f8201a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947d2'),\n",
       "  'Nome_comune': 'C12-14 Pareth-3',\n",
       "  'INCI_name': 'C12-14 Alketh-3 (Formerly C12-14 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1d9a3b62-419b-45e2-abc7-f77942389fa8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947d3'),\n",
       "  'Nome_comune': 'C12-14 Pareth-5',\n",
       "  'INCI_name': 'C12-14 Alketh-5 (Formerly C12-14 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d5c45459-97c4-4145-8da8-2b164de9acca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d4'),\n",
       "  'Nome_comune': 'C12-14 Pareth-7',\n",
       "  'INCI_name': 'C12-14 Alketh-7 (Formerly C12-14 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2d0a2026-e4b4-4f76-9549-9672d639d1f5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d5'),\n",
       "  'Nome_comune': 'C12-14 Pareth-9',\n",
       "  'INCI_name': 'C12-14 Alketh-9 (Formerly C12-14 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=94093418-2d63-4e20-ac5e-b788abc1c0de',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d6'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-12',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-12 (Formerly C12-14 Sec-Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9a32ec12-14b9-4c82-b404-1f8dffc67e8d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d7'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-15',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-15 (Formerly C12-14 Sec-Pareth-15)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f50003c9-adc4-4740-8172-6594a735a5cb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d8'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-20',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-20 (Formerly C12-14 Sec-Pareth-20)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fa793c7b-31e5-40ca-a71b-89e7cd69f18b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d9'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-3',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-3 (Formerly C12-14 Sec-Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=617c1136-baed-4d31-bbd3-094c26e0d2ca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947da'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-30',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-30 (Formerly C12-14 Sec-Pareth-30)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c7707b54-74c2-4f0b-bbfa-b92204da84ed',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947db'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-40',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-40 (Formerly C12-14 Sec-Pareth-40)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1ac4376a-1fd4-4fe1-b235-687864584d33',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947dc'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-5',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-5 (Formerly C12-14 Sec-Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c960d82-4cb5-4314-8b08-92576e9ae529',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947dd'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-50',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-50 (Formerly C12-14 Sec-Pareth-50)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a0beae96-d3c3-4771-8d44-3a7957a79177',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947de'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-7',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-7 (Formerly C12-14 Sec-Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4e1dc8c9-9829-4b75-9953-1acaa2149144',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947df'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-8',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-8 (Formerly C12-14 Sec-Pareth-8)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=af9dbfc8-b3c5-4e56-9066-b2d1cc0b90ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e0'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-9',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-9 (Formerly C12-14 Sec-Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a68dce9-a21c-459a-a2fd-2b31d5458402',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e1'),\n",
       "  'Nome_comune': 'C12-15 Alkyl Benzoate',\n",
       "  'INCI_name': 'C12-15 Alkyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ef996fe2-294a-4622-8c61-baa6a8ca360e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e2'),\n",
       "  'Nome_comune': 'C12-15 Alkyl Ethylhexanoate',\n",
       "  'INCI_name': 'C12-15 Alkyl Ethylhexanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ec23291f-3031-4514-8474-1803bbfbf5d5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9897bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.3):61-73, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e3'),\n",
       "  'Nome_comune': 'C12-15 Alkyl Salicylate',\n",
       "  'INCI_name': 'C12-15 Alkyl Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=73069494-dfe0-46ea-b6d8-08ce2dab4596',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e4'),\n",
       "  'Nome_comune': 'C12-15 Pareth-10',\n",
       "  'INCI_name': 'C12-15 Alketh-10 (Formerly C12-15 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8191ac85-df8d-4d24-ae7b-6eaf4565e2ad',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e5'),\n",
       "  'Nome_comune': 'C12-15 Pareth-11',\n",
       "  'INCI_name': 'C12-15 Alketh-11 (Formerly C12-15 Pareth-11)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=26c5c958-4195-4973-83b5-996e2b0af4ac',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e6'),\n",
       "  'Nome_comune': 'C12-15 Pareth-12',\n",
       "  'INCI_name': 'C12-15 Alketh-12 (Formerly C12-15 Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3347d339-e848-49e0-b627-7fc83c097e55',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947e7'),\n",
       "  'Nome_comune': 'C12-15 Pareth-2',\n",
       "  'INCI_name': 'C12-15 Alketh-2 (Formerly C12-15 Pareth-2)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3187c1e8-e31f-47a5-9574-5cd57f8fd28e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947e8'),\n",
       "  'Nome_comune': 'C12-15 Pareth-3',\n",
       "  'INCI_name': 'C12-15 Alketh-3 (Formerly C12-15 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8afe7629-85e2-4b23-b51c-6fc946a1d25b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947e9'),\n",
       "  'Nome_comune': 'C12-15 Pareth-4',\n",
       "  'INCI_name': 'C12-15 Alketh-4 (Formerly C12-15 Pareth-4)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=23650a51-85ef-4ba1-b3bd-2bd9328a610b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ea'),\n",
       "  'Nome_comune': 'C12-15 Pareth-5',\n",
       "  'INCI_name': 'C12-15 Alketh-5 (Formerly C12-15 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cb65b33e-51da-489f-ad85-3713f5031e41',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947eb'),\n",
       "  'Nome_comune': 'C12-15 Pareth-7',\n",
       "  'INCI_name': 'C12-15 Alketh-7 (Formerly C12-15 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6166763a-2949-4ce9-80d9-4d1dd70250d8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ec'),\n",
       "  'Nome_comune': 'C12-15 Pareth-9',\n",
       "  'INCI_name': 'C12-15 Alketh-9 (Formerly C12-15 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eaffb005-0c5f-4492-88d4-b44cad04d82b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ed'),\n",
       "  'Nome_comune': 'C12-16 Pareth-5',\n",
       "  'INCI_name': 'C12-16 Alketh-5 (Formerly C12-16 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1684b1a2-0fa3-44f9-89db-b906d19af242',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ee'),\n",
       "  'Nome_comune': 'C12-16 Pareth-7',\n",
       "  'INCI_name': 'C12-16 Alketh-7 (Formerly C12-16 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aebd5859-787a-417e-823f-a69de9be323c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ef'),\n",
       "  'Nome_comune': 'C12-16 Pareth-9',\n",
       "  'INCI_name': 'C12-16 Alketh-9 (Formerly C12-16 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=550b21b2-5116-4f19-b18e-fc0de1f97fd4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947f0'),\n",
       "  'Nome_comune': 'C12-18 Acid Triglyceride',\n",
       "  'INCI_name': 'C12-18 Acid Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7941147c-c487-4cb0-baaa-316a2dc64f5a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f1'),\n",
       "  'Nome_comune': 'C12-18 Alkyl Glucoside',\n",
       "  'INCI_name': 'C12-18 Alkyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1b51bc76-4ee3-43f3-a172-68cbe61108b9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f2'),\n",
       "  'Nome_comune': 'C12-20 Alkyl Glucoside',\n",
       "  'INCI_name': 'C12-20 Alkyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a9988a63-b0ed-4d6b-9f29-0a0f4a8237b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f3'),\n",
       "  'Nome_comune': 'C12-20 Isoparaffin',\n",
       "  'INCI_name': 'C12-20 Isoalkane (Formerly C12-20 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff4341ed-580b-4929-896f-5c8577432b34',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f4'),\n",
       "  'Nome_comune': 'C12-22 Alkyl Acrylate/Hydroxyethylacrylate Copolymer',\n",
       "  'INCI_name': 'C12-22 Alkyl Acrylate/Hydroxyethylacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a253bb75-9198-403e-b214-f3e92eaaf866',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f5'),\n",
       "  'Nome_comune': 'C13-14 Isoparaffin',\n",
       "  'INCI_name': 'C13-14 Isoalkane (Formerly C13-14 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7ebf05a3-727a-447d-b0bc-aecb3d1aadaa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f6'),\n",
       "  'Nome_comune': 'C13-15 Pareth-21',\n",
       "  'INCI_name': 'C13-15 Alketh-21 (Formerly C13-15 Pareth-21)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9b6a73e4-0ff3-49aa-afde-bc167a51b0fd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f7'),\n",
       "  'Nome_comune': 'C13-16 Isoparaffin',\n",
       "  'INCI_name': 'C13-16 Isoalkane (Formerly C13-16 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5fb995fd-d3ff-44e2-93c5-46e0974d867c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f8'),\n",
       "  'Nome_comune': 'C14-15 Dialkyl Carbonate',\n",
       "  'INCI_name': 'C14-15 Dialkyl Carbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a554974b-251d-4f43-9f1c-82ab5b53d8d1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5084a7bf-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 06, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f9'),\n",
       "  'Nome_comune': 'C14-15 Pareth-11',\n",
       "  'INCI_name': 'C14-15 Alketh-11 (Formerly C14-15 Pareth-11)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1fd38acd-4718-4509-8d59-e48badb6cae3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fa'),\n",
       "  'Nome_comune': 'C14-15 Pareth-12',\n",
       "  'INCI_name': 'C14-15 Alketh-12 (Formerly C14-15 Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a4a6f70-cd48-42e3-9008-031dbb3a0849',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fb'),\n",
       "  'Nome_comune': 'C14-15 Pareth-13',\n",
       "  'INCI_name': 'C14-15 Alketh-13 (Formerly C14-15 Pareth-13)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b9a6aa4b-2209-419d-80cb-34ad27c9fe5c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fc'),\n",
       "  'Nome_comune': 'C14-15 Pareth-4',\n",
       "  'INCI_name': 'C14-15 Alketh-4 (Formerly C14-15 Pareth-4)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=20eaca63-cf82-43a1-8c28-315051d2f8a9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fd'),\n",
       "  'Nome_comune': 'C14-15 Pareth-7',\n",
       "  'INCI_name': 'C14-15 Alketh-7 (Formerly C14-15 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b052dcce-8f02-4225-8750-80380249c9a2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fe'),\n",
       "  'Nome_comune': 'C14-15 Pareth-8',\n",
       "  'INCI_name': 'C14-15 Alketh-8 (Formerly C14-15 Pareth-8)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c896f605-b883-4530-94ff-7587ad4d365b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947ff'),\n",
       "  'Nome_comune': 'C14-18 Alkyl Ethylhexanoate',\n",
       "  'INCI_name': 'C14-18 Alkyl Ethylhexanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1f835e6c-30b5-4a38-8427-826f358702eb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9897bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.3):61-73, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d7294800'),\n",
       "  'Nome_comune': 'C14-18 Glycol',\n",
       "  'INCI_name': 'C14-18 Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a5b6da3f-67ac-4b97-837b-d93ec5dcb679',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d7294801'),\n",
       "  'Nome_comune': 'C14-28 Alkyl Acid',\n",
       "  'INCI_name': 'C14-28 Alkyl Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9a1ee188-71ba-4293-8074-bc338d5e4ea3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d7294802'),\n",
       "  'Nome_comune': 'C14-28 Isoalkyl Acid',\n",
       "  'INCI_name': 'C14-28 Isoalkyl Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a76f24fa-175a-41fe-8d45-d977d18176e1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d7294803'),\n",
       "  'Nome_comune': 'C14-30 Alkyl Beeswax',\n",
       "  'INCI_name': 'C14-30 Alkyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=424c9e29-a663-4a71-9e4f-c5e02f1edff6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294804'),\n",
       "  'Nome_comune': 'C15-18 Glycol',\n",
       "  'INCI_name': 'C15-18 Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c2d9b2c4-bd01-4539-b218-04404dd706bc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294805'),\n",
       "  'Nome_comune': 'C15-35 Isoparaffin/Isoalkylcycloalkanes',\n",
       "  'INCI_name': 'C15-35 Isoparaffin/Isoalkylcycloalkanes',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=068cafc4-72ae-408b-99a1-90c578402de1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294806'),\n",
       "  'Nome_comune': 'C16-17 Alkyl Benzoate',\n",
       "  'INCI_name': 'C16-17 Alkyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f2de6d4a-0373-420a-9404-5f90a75882ca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294807'),\n",
       "  'Nome_comune': 'C16-22 Acid Amide MEA',\n",
       "  'INCI_name': 'C16-22 Acid Amide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d09b980-5ade-4658-a79b-0cef556fbb08',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=61a5d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):18-34, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294808'),\n",
       "  'Nome_comune': 'C16-36 Alkyl Stearate',\n",
       "  'INCI_name': 'C16-36 Alkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bf1e7166-1a70-4918-8f1b-bfe27bd2ac7f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294809'),\n",
       "  'Nome_comune': 'C18-22 Hydroxyalkyl Hydroxypropyl Guar',\n",
       "  'INCI_name': 'C18-22 Hydroxyalkyl Hydroxypropyl Guar',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=30f24379-f467-446b-8ea9-4d3c68622720',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d729480a'),\n",
       "  'Nome_comune': 'C18-30 Glycol',\n",
       "  'INCI_name': 'C18-30 Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2080910f-f91a-47d8-b916-fed43ade2a70',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d729480b'),\n",
       "  'Nome_comune': 'C18-36 Acid Triglyceride',\n",
       "  'INCI_name': 'C18-36 Acid Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fc0bb560-ee0b-475a-89a6-88e283e1d8d9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d729480c'),\n",
       "  'Nome_comune': 'C18-38 Alkyl Beeswax',\n",
       "  'INCI_name': 'C18-38 Alkyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=08133edf-77a7-4937-8a8f-007ee4a636a6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d729480d'),\n",
       "  'Nome_comune': 'C18-38 Alkyl C24-54 Acid Ester',\n",
       "  'INCI_name': 'C18-38 Alkyl C24-54 Acid Ester',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ab3872bd-e462-43bb-88b0-b2b7a0228a5e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d729480e'),\n",
       "  'Nome_comune': 'C18-70 Isoparaffin',\n",
       "  'INCI_name': 'C18-70 Isoalkane (Formerly C18-70 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b60c6156-be48-45b7-a1b7-4c0ad78ca974',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d729480f'),\n",
       "  'Nome_comune': 'C20-22 Alkyl Glucoside',\n",
       "  'INCI_name': 'C20-22 Alkyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=71b50f56-441b-41d3-b913-ba3d8cbcd934',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294810'),\n",
       "  'Nome_comune': 'C20-22 Alkyl Phosphate',\n",
       "  'INCI_name': 'C20-22 Alkyl Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=370c32b6-ed35-49f2-9fc3-72b51ad9ab1a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=587dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):12-32, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294811'),\n",
       "  'Nome_comune': 'C20-22 Pareth-30',\n",
       "  'INCI_name': 'C20-22 Alketh-30 (Formerly C20-22 Pareth-30)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=21a89a70-f813-4384-b9e8-666592ea08ac',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294812'),\n",
       "  'Nome_comune': 'C20-24 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C20-24 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b5c0fb06-06aa-4c0f-9197-f6fa9d325783',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294813'),\n",
       "  'Nome_comune': 'C20-24 Alkyl Methicone',\n",
       "  'INCI_name': 'C20-24 Alkyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f9b17635-7ebd-40e9-868d-63ba25114da7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294814'),\n",
       "  'Nome_comune': 'C20-30 Glycol',\n",
       "  'INCI_name': 'C20-30 Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=180d8d02-099a-4d76-9588-07e1aa2bc74b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294815'),\n",
       "  'Nome_comune': 'C20-40 Alkyl Behenate',\n",
       "  'INCI_name': 'C20-40 Alkyl Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=45d295f5-8c99-401e-8843-8a1ea207c306',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294816'),\n",
       "  'Nome_comune': 'C20-40 Alkyl Stearate',\n",
       "  'INCI_name': 'C20-40 Alkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4dbd2a3b-c9d5-440d-a537-74cbdfe13670',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d7294817'),\n",
       "  'Nome_comune': 'C20-40 Isoparaffin',\n",
       "  'INCI_name': 'C20-40 Isoalkane (Formerly C20-40 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2636d1bd-2a6a-4c5f-9865-f598d44ee034',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d7294818'),\n",
       "  'Nome_comune': 'C20-40 Pareth-10',\n",
       "  'INCI_name': 'C20-40 Alketh-10 (Formerly C20-40 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa8ef3e2-c14d-4fe2-9ce3-96cda4575f60',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d7294819'),\n",
       "  'Nome_comune': 'C20-40 Pareth-24',\n",
       "  'INCI_name': 'C20-40 Alketh-24 (Formerly C20-40 Pareth-24)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d52fd315-a3f1-4674-b48e-1ca0075eb4e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481a'),\n",
       "  'Nome_comune': 'C20-40 Pareth-3',\n",
       "  'INCI_name': 'C20-40 Alketh-3 (Formerly C20-40 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=55502f15-64d7-4b14-b62b-cd59293d650c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481b'),\n",
       "  'Nome_comune': 'C20-40 Pareth-40',\n",
       "  'INCI_name': 'C20-40 Alketh-40 (Formerly C20-40 Pareth-40)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=81a9e9bb-526b-40be-92f3-c7c6fdf205b9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481c'),\n",
       "  'Nome_comune': 'C20-40 Pareth-95',\n",
       "  'INCI_name': 'C20-40 Alketh-95 (Formerly C20-40 Pareth-95)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=05cdbe06-19ad-4cde-b32d-88f84c9ed39b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481d'),\n",
       "  'Nome_comune': 'C22-24 Pareth-33',\n",
       "  'INCI_name': 'C22-24 Alketh-33 (Formerly C22-24 Pareth-33)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fb2c7dfc-b619-40b9-9a80-d5172324c90c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481e'),\n",
       "  'Nome_comune': 'C24-28 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C24-28 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=93e16fab-c4e9-4f2d-bed5-dffd70af4672',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481f'),\n",
       "  'Nome_comune': 'C24-28 Alkyl Methicone',\n",
       "  'INCI_name': 'C24-28 Alkyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=448c367c-a0a2-4952-b9f7-720bc54b315e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d7294820'),\n",
       "  'Nome_comune': 'C26-28 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C26-28 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a374646b-557a-44d9-842c-6d3aaf04398f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294821'),\n",
       "  'Nome_comune': 'C26-28 Alkyl Methicone',\n",
       "  'INCI_name': 'C26-28 Alkyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=397cfa71-18dd-44b2-b943-acc0f928fe4b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294822'),\n",
       "  'Nome_comune': 'C26-28 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       "  'INCI_name': 'C26-28 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cce4c69e-c7a7-40bc-b22c-062196c59cc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8b69a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294823'),\n",
       "  'Nome_comune': 'C30-45 Alkyl Cetearyl Dimethicone Crosspolymer',\n",
       "  'INCI_name': 'C30-45 Alkyl Cetearyl Dimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=97601953-51f6-436e-8f66-4c81c94faa75',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294824'),\n",
       "  'Nome_comune': 'C30-45 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C30-45 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8bf02639-c969-4840-99d4-548481bff40c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294825'),\n",
       "  'Nome_comune': 'C30-45 Alkyl Dimethicone/Polycyclohexene Oxide Crosspolymer',\n",
       "  'INCI_name': 'C30-45 Alkyl Dimethicone/Polycyclohexene Oxide Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=96cee631-a921-45f4-8487-ca1b4588fdb3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294826'),\n",
       "  'Nome_comune': 'C30-45 Alkyl Methicone',\n",
       "  'INCI_name': 'C30-45 Alkyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b2e535ec-2627-4000-b53b-39cdb03907da',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294827'),\n",
       "  'Nome_comune': 'C30-45 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       "  'INCI_name': 'C30-45 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c864c38-c4b6-4435-81cd-0efa0b6683a4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8b69a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294828'),\n",
       "  'Nome_comune': 'C30-50 Alkyl Beeswax',\n",
       "  'INCI_name': 'C30-50 Alkyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=16884307-3911-4093-a938-732467475c9d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294829'),\n",
       "  'Nome_comune': 'C30-50 Alkyl Stearate',\n",
       "  'INCI_name': 'C30-50 Alkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8bc82851-635b-474b-af2e-0d1d2c16fd77',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482a'),\n",
       "  'Nome_comune': 'C30-50 Pareth-10',\n",
       "  'INCI_name': 'C30-50 Alketh-10 (Formerly C30-50 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b9a75c31-c11c-4834-9142-cbbe64312362',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482b'),\n",
       "  'Nome_comune': 'C30-50 Pareth-3',\n",
       "  'INCI_name': 'C30-50 Alketh-3 (Formerly C30-50 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=04494971-6092-43ed-9c73-048f0b8308af',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482c'),\n",
       "  'Nome_comune': 'C30-50 Pareth-40',\n",
       "  'INCI_name': 'C30-50 Alketh-40 (Formerly C30-50 Pareth-40)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9755b85f-55ce-4062-8d3e-7b1cd92a6a2c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482d'),\n",
       "  'Nome_comune': 'C30-60 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C30-60 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3f24e15d-fe42-47d9-8006-e2790d5d0a58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482e'),\n",
       "  'Nome_comune': 'C32 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C32 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8b78c505-1383-42cd-893b-9b8f6f1c93f3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482f'),\n",
       "  'Nome_comune': 'C32-36 Isoalkyl Acid',\n",
       "  'INCI_name': 'C32-36 Isoalkyl Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d0ba4df-64cc-4ea2-8b7b-0409467b0396',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d7294830'),\n",
       "  'Nome_comune': 'C32-36 Isoalkyl Stearate',\n",
       "  'INCI_name': 'C32-36 Isoalkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ef64e407-c848-443c-b967-0266c0e2e8ec',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d7294831'),\n",
       "  'Nome_comune': 'C40-60 Alkyl Stearate',\n",
       "  'INCI_name': 'C40-60 Alkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=195fac04-916b-47b6-bc27-fddb8f37dba1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d7294832'),\n",
       "  'Nome_comune': 'C40-60 Pareth-10',\n",
       "  'INCI_name': 'C40-60 Alketh-10 (Formerly C40-60 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=466245ce-bec0-4ed9-9b5f-45c7ce983965',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d7294833'),\n",
       "  'Nome_comune': 'C40-60 Pareth-3',\n",
       "  'INCI_name': 'C40-60 Alketh-3 (Formerly C40-60 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d5fc0847-aedd-4dc0-8206-34e60c44df6c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294834'),\n",
       "  'Nome_comune': 'C4-18 Alkyl Methacrylate/Methacryloyloxyethyl Phosphorylcholine Copolymer',\n",
       "  'INCI_name': 'C4-18 Alkyl Methacrylate/Methacryloyloxyethyl Phosphorylcholine Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d4a1e83-05b5-4180-bebf-4d91cd3a7fd2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1000a48e-650c-6b92-a9dc-a53d51eea570',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294835'),\n",
       "  'Nome_comune': 'C4-24 Alkyl Dimethicone/Divinyldimethicone Crosspolymer',\n",
       "  'INCI_name': 'C4-24 Alkyl Dimethicone/Divinyldimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a6a4914-7ad7-4940-b5b9-76e0ec26876e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294836'),\n",
       "  'Nome_comune': 'C4-5 Isoalkyl Cocoate',\n",
       "  'INCI_name': 'C4-5 Isoalkyl Cocoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e968bc65-fa0a-4ffe-bf9b-1f7848423a5f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294837'),\n",
       "  'Nome_comune': 'C4-6 Olefin/Styrene Copolymer',\n",
       "  'INCI_name': 'C4-6 Olefin/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=82a105ec-2bca-4cab-8d6d-7661e8206e3c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294838'),\n",
       "  'Nome_comune': 'C5-6 Olefin/Styrene Copolymer',\n",
       "  'INCI_name': 'C5-6 Olefin/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d76623a4-fb5a-43b1-bb94-65bb93f17a39',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294839'),\n",
       "  'Nome_comune': 'C6-14 Perfluoroalkylethyl Acrylate/HEMA Copolymer',\n",
       "  'INCI_name': 'C6-14 Perfluoroalkylethyl Acrylate/HEMA Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=602f0ce3-278d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e821365b-edc8-8bc1-b1ed-7554f706933c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):144-161, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d729483a'),\n",
       "  'Nome_comune': 'C7-8 Isoparaffin',\n",
       "  'INCI_name': 'C7-8 Isoalkane (Formerly C7-8 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1358b02e-ecb0-4b00-919c-6733814407a0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d729483b'),\n",
       "  'Nome_comune': 'C8-10 Alkyl Ethyl Phosphate',\n",
       "  'INCI_name': 'C8-10 Alkyl Ethyl Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=49dad11c-9012-4989-bf33-c239b6d03f07',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=587dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):12-32, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d729483c'),\n",
       "  'Nome_comune': 'C8-22 Alkyl Acrylates/Methacrylic Acid Crosspolymer',\n",
       "  'INCI_name': 'C8-22 Alkyl Acrylates/Methacrylic Acid Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=880d8081-76ec-466b-89c7-4d7bad029d59',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d729483d'),\n",
       "  'Nome_comune': 'C8-9 Isoparaffin',\n",
       "  'INCI_name': 'C8-9 Isoalkane (Formerly C8-9 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aea75e64-931d-4c44-b73e-22dd4bda1216',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d729483e'),\n",
       "  'Nome_comune': 'C9-11 Isoparaffin',\n",
       "  'INCI_name': 'C9-11 Isoalkane (Formerly C9-11 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d17a9753-89f1-43a3-a63a-16463d0cbc75',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d729483f'),\n",
       "  'Nome_comune': 'C9-11 Pareth-3',\n",
       "  'INCI_name': 'C9-11 Alketh-3 (Formerly C9-11 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0d261eff-6f00-4c6a-b8f5-9f5c76a4a0b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294840'),\n",
       "  'Nome_comune': 'C9-11 Pareth-4',\n",
       "  'INCI_name': 'C9-11 Alketh-4 (Formerly C9-11 Pareth-4)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66453ec0-265c-4606-92d2-ef03f0089993',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294841'),\n",
       "  'Nome_comune': 'C9-11 Pareth-6',\n",
       "  'INCI_name': 'C9-11 Alketh-6 (Formerly C9-11 Pareth-6)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3121f652-cc2a-42e6-9457-025a896b0239',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294842'),\n",
       "  'Nome_comune': 'C9-11 Pareth-8',\n",
       "  'INCI_name': 'C9-11 Alketh-8 (Formerly C9-11 Pareth-8)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3bd0047a-334c-4a81-ab72-0e77d16c28bc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294843'),\n",
       "  'Nome_comune': 'C9-12 Isoparaffin',\n",
       "  'INCI_name': 'C9-12 Isoalkane (Formerly C9-12 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fcb23855-2774-466c-b03f-656a202a9284',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294844'),\n",
       "  'Nome_comune': 'C9-13 Isoparaffin',\n",
       "  'INCI_name': 'C9-13 Isoalkane (Formerly C9-13 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b513538f-00b5-4170-aaf9-85bc140b6564',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294845'),\n",
       "  'Nome_comune': 'C9-14 Isoparaffin',\n",
       "  'INCI_name': 'C9-14 Isoalkane (Formerly C9-14 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eede2ff2-c13b-493f-9870-b5215f1095ad',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d7294846'),\n",
       "  'Nome_comune': 'C9-15 Alkyl Phosphate',\n",
       "  'INCI_name': 'C9-15 Alkyl Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4be534e2-20de-4140-b92a-f24c025d1fc8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=587dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):12-32, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d7294847'),\n",
       "  'Nome_comune': 'C9-15 Pareth-8',\n",
       "  'INCI_name': 'C9-15 Alketh-8 (Formerly C9-15 Pareth-8)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87c023a3-73b1-4143-8e0b-61a649bcec77',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d7294848'),\n",
       "  'Nome_comune': 'C9-16 Isoparaffin',\n",
       "  'INCI_name': 'C9-16 Isoalkane (Formerly C9-16 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c3ebcdad-6af5-4858-b7f7-2230a80c4ca3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d7294849'),\n",
       "  'Nome_comune': 'Caesalpinia Spinosa Gum',\n",
       "  'INCI_name': 'Caesalpinia Spinosa Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1951a2fe-fd25-4212-bfa5-56aff1cedb88',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484a'),\n",
       "  'Nome_comune': 'Caesalpinia Spinosa Hydroxypropyltrimonium Chloride',\n",
       "  'INCI_name': 'Caesalpinia Spinosa Hydroxypropyltrimonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f3df9f1c-9277-4fdd-b791-584dcbb0c977',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484b'),\n",
       "  'Nome_comune': 'Caffeine',\n",
       "  'INCI_name': 'Caffeine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c82edc7-2115-4ae6-b58a-c78671befe16',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484c'),\n",
       "  'Nome_comune': 'Calcium Acetate',\n",
       "  'INCI_name': 'Calcium Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8e922c77-4e2b-4069-ae1d-89095f90bf1d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b8106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):112-136, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484d'),\n",
       "  'Nome_comune': 'Calcium Alginate',\n",
       "  'INCI_name': 'Calcium Alginate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2fd6b265-914a-4c4f-82b9-a565e5d3e3c4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484e'),\n",
       "  'Nome_comune': 'Calcium Aluminum Borosilicate',\n",
       "  'INCI_name': 'Calcium Aluminum Borosilicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5f69971f-fcef-4669-ba70-00e8e02822fb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9252d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):65-72, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d729484f'),\n",
       "  'Nome_comune': 'Calcium Ascorbate',\n",
       "  'INCI_name': 'Calcium Ascorbate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=564cae71-c216-4b01-a103-e87a6f624d22',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d0ca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 2):51-111, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294850'),\n",
       "  'Nome_comune': 'Calcium Aspartate',\n",
       "  'INCI_name': 'Calcium Aspartate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f0708a7e-6044-475e-87ec-fe3b1a9fc92b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294851'),\n",
       "  'Nome_comune': 'Calcium Behenate',\n",
       "  'INCI_name': 'Calcium Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6710e274-8a17-431c-a558-572d3559a9d3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294852'),\n",
       "  'Nome_comune': 'Calcium Benzoate',\n",
       "  'INCI_name': 'Calcium Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a9620cf-d9f3-495e-9008-3c0b621dbaaf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6b62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):5-30, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294853'),\n",
       "  'Nome_comune': 'Calcium Carbonate',\n",
       "  'INCI_name': 'Calcium Carbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b46f7b21-b2c0-47b2-a4c6-e5c366afadd9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d69e5a23-fad8-81e7-8ce9-48d464c919af',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):80-105, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294854'),\n",
       "  'Nome_comune': 'Calcium Carboxymethyl Cellulose',\n",
       "  'INCI_name': 'Calcium Carboxymethyl Cellulose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=44a1bc08-dde9-4fef-a6c4-f9dce62ab8ca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294855'),\n",
       "  'Nome_comune': 'Calcium Carrageenan',\n",
       "  'INCI_name': 'Calcium Carrageenan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b509b2df-0462-4738-86f3-360f27189fe8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294856'),\n",
       "  'Nome_comune': 'Calcium Caseinate',\n",
       "  'INCI_name': 'Calcium Caseinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=73614427-ba84-457d-99ba-45b7aaa4fb09',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a744d1db-21ea-4172-a676-d17332da9e6e',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):43-56, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294857'),\n",
       "  'Nome_comune': 'Calcium Citrate',\n",
       "  'INCI_name': 'Calcium Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6c081dbb-4204-48fe-928d-458ce74106ea',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2b6dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl.2):16-46, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294858'),\n",
       "  'Nome_comune': 'Calcium Dihydrogen Phosphate',\n",
       "  'INCI_name': 'Calcium Dihydrogen Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fdc85206-67d5-44ea-83af-f8df043f9805',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d7294859'),\n",
       "  'Nome_comune': 'Calcium Disodium EDTA',\n",
       "  'INCI_name': 'Calcium Disodium EDTA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=521524a3-69ed-439e-8111-d8240acf6cf7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f70efd10-f7c9-a0bd-937e-3f0d2d7d6b43',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):32-36, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485a'),\n",
       "  'Nome_comune': 'Calcium Dodecylbenzenesulfonate',\n",
       "  'INCI_name': 'Calcium Dodecylbenzenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=355661b4-10d7-4c92-84fd-0c0dd139dd4f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=80307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 4):288-305, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485b'),\n",
       "  'Nome_comune': 'Calcium Gluconate',\n",
       "  'INCI_name': 'Calcium Gluconate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=88f0f836-e922-455d-82fb-6460857edf5d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):5-38, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485c'),\n",
       "  'Nome_comune': 'Calcium Glycinate',\n",
       "  'INCI_name': 'Calcium Glycinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8f978be8-7df3-495d-89aa-6f5cb90bccdb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485d'),\n",
       "  'Nome_comune': 'Calcium Hydrolyzed Collagen',\n",
       "  'INCI_name': 'Calcium Hydrolyzed Collagen',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=81ee1cee-951a-4ae7-9d28-699fab98e5ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=70af0ca6-3a32-ea93-85bf-c21e81f97048',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):21-42, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485e'),\n",
       "  'Nome_comune': 'Calcium Hydroxide',\n",
       "  'INCI_name': 'Calcium Hydroxide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=501116c7-0418-41c7-a555-3d9aefe0cefe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da248f0f-5cac-3544-be09-3c7448f107e4',\n",
       "  'pdf_date': 'IJT 40(Suppl. 2):16-35, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485f'),\n",
       "  'Nome_comune': 'Calcium Lactate',\n",
       "  'INCI_name': 'Calcium Lactate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=09f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d7294860'),\n",
       "  'Nome_comune': 'Calcium Laurate',\n",
       "  'INCI_name': 'Calcium Laurate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6fd052cf-8767-478c-8671-f161c4feee0a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d7294861'),\n",
       "  'Nome_comune': 'Calcium Lauroyl Taurate',\n",
       "  'INCI_name': 'Calcium Lauroyl Taurate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fd10e90d-d26f-4da4-88f3-16c17e3f63f5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4354b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 15, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294862'),\n",
       "  'Nome_comune': 'Calcium Magnesium Silicate',\n",
       "  'INCI_name': 'Calcium Magnesium Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0743b86e-fdc5-4905-bb72-534d8e9d4f55',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294863'),\n",
       "  'Nome_comune': 'Calcium Myristate',\n",
       "  'INCI_name': 'Calcium Myristate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e26a2cb-8dab-43b6-bd18-894a1e859197',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294864'),\n",
       "  'Nome_comune': 'Calcium Pantothenate',\n",
       "  'INCI_name': 'Calcium Pantothenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1aeb4de0-2329-436f-9d95-01475e48fa1d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b4404ad0-e5dd-d8ed-b8b6-939376f83fc0',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):77-128, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294865'),\n",
       "  'Nome_comune': 'Calcium Paraben',\n",
       "  'INCI_name': 'Calcium Paraben',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5b26e36e-2384-4fc0-b96a-07e547c7487d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl.1):5-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294866'),\n",
       "  'Nome_comune': 'Calcium PCA',\n",
       "  'INCI_name': 'Calcium PCA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d5607f17-de44-4918-9a29-2ab81cdc8e1e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=08efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):5-11, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294867'),\n",
       "  'Nome_comune': 'Calcium Phosphate',\n",
       "  'INCI_name': 'Calcium Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8fcb483c-1407-4e1f-acf4-95b9d2ed87ed',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294868'),\n",
       "  'Nome_comune': 'Calcium Potassium Carbomer',\n",
       "  'INCI_name': 'Calcium Potassium Carbomer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c76bbe3d-81e3-4da7-a758-a69981f2046d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294869'),\n",
       "  'Nome_comune': 'Calcium Potassium Sodium Phosphate',\n",
       "  'INCI_name': 'Calcium Potassium Sodium Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c7610b36-34e7-40e1-afa0-081c4a81def3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d729486a'),\n",
       "  'Nome_comune': 'Calcium Pyrophosphate',\n",
       "  'INCI_name': 'Calcium Pyrophosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=53e2214b-800d-43fa-9ce4-4569f4261e5c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d729486b'),\n",
       "  'Nome_comune': 'Calcium Salicylate',\n",
       "  'INCI_name': 'Calcium Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9860d97b-b539-4de2-a776-5954f12513fc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d729486c'),\n",
       "  'Nome_comune': 'Calcium Silicate',\n",
       "  'INCI_name': 'Calcium Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d21abfa0-6073-44db-a293-7a8d7ae72994',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d729486d'),\n",
       "  'Nome_comune': 'Calcium Sodium Borosilicate',\n",
       "  'INCI_name': 'Calcium Sodium Borosilicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=401878c2-8f42-4e74-93a1-7ae695c8f233',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9252d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):65-72, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d729486e'),\n",
       "  'Nome_comune': 'Calcium Starch Isododecenylsuccinate',\n",
       "  'INCI_name': 'Calcium Starch Isododecenylsuccinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=40909a0d-7d97-417a-9112-833b45d1ea6a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d729486f'),\n",
       "  'Nome_comune': 'Calcium Starch Octenylsuccinate',\n",
       "  'INCI_name': 'Calcium Starch Octenylsuccinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=33b03903-ee41-4569-b91f-5130da7ca8b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294870'),\n",
       "  'Nome_comune': 'Calcium Stearate',\n",
       "  'INCI_name': 'Calcium Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6362ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294871'),\n",
       "  'Nome_comune': 'Calcium Stearoyl Lactylate',\n",
       "  'INCI_name': 'Calcium Stearoyl Lactylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4948b6a1-483e-4e14-9551-60379b75c2d4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=133ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294872'),\n",
       "  'Nome_comune': 'Calcium Thioglycolate',\n",
       "  'INCI_name': 'Calcium Thioglycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32d87819-3b60-4f24-b5ce-cfab308541cc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=17a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 1):68-133, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294873'),\n",
       "  'Nome_comune': 'Calcium Titanium Borosilicate',\n",
       "  'INCI_name': 'Calcium Titanium Borosilicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fc2cb810-b043-47be-aacc-c98795628449',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9252d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):65-72, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294874'),\n",
       "  'Nome_comune': 'Calcium Undecylenate',\n",
       "  'INCI_name': 'Calcium Undecylenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=205ca482-9294-4b1f-bbb8-282ab050b40b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294875'),\n",
       "  'Nome_comune': 'Calcium Xylenesulfonate',\n",
       "  'INCI_name': 'Calcium Xylenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=321fedc0-d2fc-4b12-90a8-9688e07e711d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5ba16b53-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 3):270-283, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294876'),\n",
       "  'Nome_comune': 'Calcium/Sodium PVM/MA Copolymer',\n",
       "  'INCI_name': 'Calcium/Sodium PVM/MA Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3780e2f4-4856-4813-b505-6bfa68d76e7b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8c307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):128-144, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294877'),\n",
       "  'Nome_comune': 'Calendula Officinalis',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=638d21b6-06df-4f10-88b2-8b7351f651c7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b65e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 20(S2):13-20, 2001',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294878'),\n",
       "  'Nome_comune': 'Calendula Officinalis Extract',\n",
       "  'INCI_name': 'Calendula Officinalis Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1e301aee-3dd5-40b4-9c4d-14ef7bbc49c4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294879'),\n",
       "  'Nome_comune': 'Calendula Officinalis Flower',\n",
       "  'INCI_name': 'Calendula Officinalis Flower',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e35926af-e026-4f0c-b1d0-aee318418ea9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d729487a'),\n",
       "  'Nome_comune': 'Calendula Officinalis Flower Extract',\n",
       "  'INCI_name': 'Calendula Officinalis Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4c578393-7b43-45e7-93f7-14d651678c1e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d729487b'),\n",
       "  'Nome_comune': 'Calendula Officinalis Flower Oil',\n",
       "  'INCI_name': 'Calendula Officinalis Flower Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f8a3272f-9818-4b37-8737-ed4718b6a88b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d729487c'),\n",
       "  'Nome_comune': 'Calendula Officinalis Seed Oil',\n",
       "  'INCI_name': 'Calendula Officinalis Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=716b18c4-d192-471b-9f99-cc9038296c06',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d729487d'),\n",
       "  'Nome_comune': 'Calliblepharis Ciliata Extract',\n",
       "  'INCI_name': 'Calliblepharis Ciliata Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=84148bd3-3571-46ab-be01-0aed9ca69861',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d729487e'),\n",
       "  'Nome_comune': 'Camelina Sativa Seed Oil',\n",
       "  'INCI_name': 'Camelina Sativa Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=03e83029-3360-4917-a2bb-f3bf272032fd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d729487f'),\n",
       "  'Nome_comune': 'Camellia Japonica Seed Oil',\n",
       "  'INCI_name': 'Camellia Japonica Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4b5335db-6b10-4276-9cbe-281e0f632b81',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294880'),\n",
       "  'Nome_comune': 'Camellia Kissi Seed Oil',\n",
       "  'INCI_name': 'Camellia Kissi Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b67a6db8-5f17-431a-a5e4-e5a2f783fed5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294881'),\n",
       "  'Nome_comune': 'Camellia Oleifera Seed Oil',\n",
       "  'INCI_name': 'Camellia Oleifera Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=427d5c38-6935-48a1-bc54-099c44ff4bc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294882'),\n",
       "  'Nome_comune': 'Camellia Sinensis Catechins',\n",
       "  'INCI_name': 'Camellia Sinensis Catechins',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5416f977-12c9-40d8-866a-908c7939dc6e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294883'),\n",
       "  'Nome_comune': 'Camellia Sinensis Flower Extract',\n",
       "  'INCI_name': 'Camellia Sinensis Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=86e27c5b-459f-4c8d-9f5a-7aceb456acf5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294884'),\n",
       "  'Nome_comune': 'Camellia Sinensis Flower/Leaf/Stem Juice',\n",
       "  'INCI_name': 'Camellia Sinensis Flower/Leaf/Stem Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=743d5e96-36f1-44df-91f8-52498175732a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294885'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=72748565-b6a1-4921-8f08-27b2dbd57ea2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294886'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf Extract',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ba885956-7690-4d47-8f67-ab567c604d05',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d7294887'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf Oil',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fdf39685-5974-4ec8-8abe-36edc6b1cba6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d7294888'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf Powder',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bc7ee709-a34e-4634-a99b-3550404d6d5f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d7294889'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf Water',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7f2d8e0b-7257-4820-a6f3-08a87ca215c1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488a'),\n",
       "  'Nome_comune': 'Camellia Sinensis Root Extract',\n",
       "  'INCI_name': 'Camellia Sinensis Root Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=07de94a5-87b9-4d31-8635-0533983293c5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488b'),\n",
       "  'Nome_comune': 'Camellia Sinensis Seed Extract',\n",
       "  'INCI_name': 'Camellia Sinensis Seed Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9011736a-1e2b-4af2-a8da-21653f6edd97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488c'),\n",
       "  'Nome_comune': 'Camellia Sinensis Seed Oil',\n",
       "  'INCI_name': 'Camellia Sinensis Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3e0e9f1e-be86-4f2c-97e0-28184e0b18a2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488d'),\n",
       "  'Nome_comune': 'Camellia Sinensis Seed Powder',\n",
       "  'INCI_name': 'Camellia Sinensis Seed Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4eb8fc1e-9408-48fe-825d-0e4e398233fa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488e'),\n",
       "  'Nome_comune': 'Camellia Sinensis Seedcoat Powder',\n",
       "  'INCI_name': 'Camellia Sinensis Seedcoat Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5b613275-f82e-480e-b401-8423f72b583c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488f'),\n",
       "  'Nome_comune': 'Canarium Indicum Seed Oil',\n",
       "  'INCI_name': 'Canarium Indicum Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dbee34ea-955f-42d5-8d5d-80aeaa0c45c4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294890'),\n",
       "  'Nome_comune': 'Candelilla Cera',\n",
       "  'INCI_name': 'Candelilla Cera',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d3345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294891'),\n",
       "  'Nome_comune': 'Candelilla Wax',\n",
       "  'INCI_name': 'Euphorbia Cerifera (Candelilla) Wax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ebf993bf-9da2-4cec-a8de-2e7571b4ac41',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294892'),\n",
       "  'Nome_comune': 'Candelilla/Jojoba/Rice Bran Polyglyceryl-3 Esters',\n",
       "  'INCI_name': 'Candelilla/Jojoba/Rice Bran Polyglyceryl-3 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=70da4706-5484-45f5-bef0-a749d5a5df65',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294893'),\n",
       "  'Nome_comune': 'Canola Oil',\n",
       "  'INCI_name': 'Canola Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e95d26c7-5ba3-4450-9649-df2fdcb245be',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294894'),\n",
       "  'Nome_comune': 'Canola Oil Unsaponifiables',\n",
       "  'INCI_name': 'Canola Oil Unsaponifiables',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=72f6dd40-056b-4b04-874d-b858f49b8892',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294895'),\n",
       "  'Nome_comune': 'Canola Sterols',\n",
       "  'INCI_name': 'Canola Sterols',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3678c6dc-852f-4a05-8e01-17cd2ecb69b6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294896'),\n",
       "  'Nome_comune': 'Canolamidopropyl Betaine',\n",
       "  'INCI_name': 'Canolamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=80b6e75a-9639-44ee-8a8f-16882b591b18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294897'),\n",
       "  'Nome_comune': 'Capramide DEA',\n",
       "  'INCI_name': 'Capramide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87ce5796-826c-4fa2-8bba-07091efe4330',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294898'),\n",
       "  'Nome_comune': 'Capric Acid',\n",
       "  'INCI_name': 'Capric Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b3a1d956-aefb-417e-a287-e2cf0ce9aee6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d7294899'),\n",
       "  'Nome_comune': 'Capric/Lauric/Myristic/Oleic Triglyceride',\n",
       "  'INCI_name': 'Capric/Lauric/Myristic/Oleic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=57c7c76c-7df5-46e8-a90f-8767faadb93e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489a'),\n",
       "  'Nome_comune': 'Caproic Acid',\n",
       "  'INCI_name': 'Caproic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b04b85ef-df2b-4c3a-a599-b9805017168a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489b'),\n",
       "  'Nome_comune': 'Caprooyl Phytosphingosine',\n",
       "  'INCI_name': 'Caprooyl Phytosphingosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7cb05919-237d-4f63-97ad-af6dd8070c1b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489c'),\n",
       "  'Nome_comune': 'Caprooyl Sphingosine',\n",
       "  'INCI_name': 'Caprooyl Sphingosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=61b8da0f-2fa6-47e8-baa5-997dfb2e8fac',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489d'),\n",
       "  'Nome_comune': 'Caproyl Sphingosine',\n",
       "  'INCI_name': 'Caproyl Sphingosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c39093af-3f5a-46ce-b8c5-379f55f84d10',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489e'),\n",
       "  'Nome_comune': 'Capryl Dimethicone',\n",
       "  'INCI_name': 'Capryl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32c9c6f0-c9de-489b-800e-bb4ef38fe64b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489f'),\n",
       "  'Nome_comune': 'Capryl Sultaine',\n",
       "  'INCI_name': 'Capryl Sultaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=86c0bc19-1bd8-46c1-9a7c-384adcf442ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d9cacf74-6299-63fa-b426-0a077ace38f8',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):30-49, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d72948a0'),\n",
       "  'Nome_comune': 'Capryl/Capramidopropyl Betaine',\n",
       "  'INCI_name': 'Capryl/Capramidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad2b94ff-5593-4fb4-ad5d-bf701e382667',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d72948a1'),\n",
       "  'Nome_comune': 'Capryleth-4',\n",
       "  'INCI_name': 'Capryleth-4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e22d320a-a4cb-497b-a68a-e62f4434e4ed',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a2'),\n",
       "  'Nome_comune': 'Capryleth-5',\n",
       "  'INCI_name': 'Capryleth-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=974ed85f-b924-43c7-8335-dd445d6eb98b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a3'),\n",
       "  'Nome_comune': 'Caprylhydroxamic Acid',\n",
       "  'INCI_name': 'Caprylhydroxamic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6f214614-7fdb-4a34-8cb2-cc5ca05f72bd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=883ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 15, 2020',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a4'),\n",
       "  'Nome_comune': 'Caprylic Acid',\n",
       "  'INCI_name': 'Caprylic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bafe1520-9fd0-4a09-ba77-55aeadd19c0a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a5'),\n",
       "  'Nome_comune': 'Caprylic/Capric Glycerides Polyglyceryl-10 Esters',\n",
       "  'INCI_name': 'Caprylic/Capric Glycerides Polyglyceryl-10 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ca08abce-94ee-4257-bafb-7ec8e5e6c4b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a6'),\n",
       "  'Nome_comune': 'Caprylic/Capric Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c9afd5e0-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a7'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Coco Glycerides',\n",
       "  'INCI_name': 'Caprylic/Capric/Coco Glycerides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=134bc2d1-42fc-4c96-bc38-d1fd61351f35',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=79ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 1):5-16, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a8'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Lauric Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Lauric Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1822f53e-1402-465a-a1f1-fe5249893b28',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a9'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Linoleic Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Linoleic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=288047c9-c462-4a1b-ae4e-b51f09d63959',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948aa'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Myristic/Stearic Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Myristic/Stearic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=278ae70e-f657-400a-b785-ba1a0f584c51',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948ab'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Palmitic/Stearic Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Palmitic/Stearic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=107b143e-cc24-4f36-b32b-d2a2c47546a8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948ac'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Stearic Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Stearic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e460132a-8830-4888-b8b6-2fa7baf1521d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948ad'),\n",
       "  'Nome_comune': 'Capryloyl Collagen Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Collagen Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=79120fa9-c738-4b8a-b5e0-2d644a279bc1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948ae'),\n",
       "  'Nome_comune': 'Capryloyl Glycine',\n",
       "  'INCI_name': 'Capryloyl Glycine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c4faaff0-b615-426d-b9e9-090119e9da56',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948af'),\n",
       "  'Nome_comune': 'Capryloyl Gold of Pleasure Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Gold of Pleasure Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8015a3dc-eb43-4f7e-9d0c-a9bc66f6e8d8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b0'),\n",
       "  'Nome_comune': 'Capryloyl Keratin Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Keratin Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a057db1f-458a-4e46-92a2-24d10bd4843d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b1'),\n",
       "  'Nome_comune': 'Capryloyl Pea Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Pea Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3052015b-2685-4e43-83a0-6016e1935b40',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b2'),\n",
       "  'Nome_comune': 'Capryloyl Quinoa Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Quinoa Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=09fa6c65-6bf6-4e28-8c78-95f17fedc996',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b3'),\n",
       "  'Nome_comune': 'Capryloyl Salicylic Acid',\n",
       "  'INCI_name': 'Capryloyl Salicylic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=76d19512-aef9-4ddf-9b02-afb190a01f59',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=995efb2f-f539-86e3-8575-19bea03f915e',\n",
       "  'pdf_date': 'IJT 43(Suppl. 3):92-108, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b4'),\n",
       "  'Nome_comune': 'Capryloyl Salicylic Acid (ester)',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fb0d0ec5-c9be-499d-8cfd-ad253f0aca52',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=49b03823-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 22(Suppl 3):1-108, 2003',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b5'),\n",
       "  'Nome_comune': 'Capryloyl Silk Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Silk Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c4841060-adf3-4daa-835b-ba64fd4e9c87',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b6'),\n",
       "  'Nome_comune': 'Caprylyl Butyrate',\n",
       "  'INCI_name': 'Caprylyl Butyrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e401f39c-9741-4426-b313-31b4efb17a0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b7'),\n",
       "  'Nome_comune': 'Caprylyl Caprylate',\n",
       "  'INCI_name': 'Caprylyl Caprylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fdb4fe0e-ce44-4027-94bb-2ebf7aaa9014',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b8'),\n",
       "  'Nome_comune': 'Caprylyl Eicosenoate',\n",
       "  'INCI_name': 'Caprylyl Eicosenoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9c509e1b-9404-422e-9cae-ceb4e5a52938',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b9'),\n",
       "  'Nome_comune': 'Caprylyl Glucoside',\n",
       "  'INCI_name': 'Caprylyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=507a5f1c-3f8d-424f-8d82-904ce119dc2c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948ba'),\n",
       "  'Nome_comune': 'Caprylyl Glyceryl Ether',\n",
       "  'INCI_name': 'Caprylyl Glyceryl Ether',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=89986e36-f715-43e8-a45e-6e48990848a0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fb6cd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):5-21, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948bb'),\n",
       "  'Nome_comune': 'Caprylyl Glycol',\n",
       "  'INCI_name': 'Caprylyl Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c8271761-5642-4afb-8e5f-2006d13c8f3e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948bc'),\n",
       "  'Nome_comune': 'Caprylyl Glycol/Glycerin/Polyacrylic Acid Copolymer',\n",
       "  'INCI_name': 'Caprylyl Glycol/Glycerin/Polyacrylic Acid Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4b2e3eb0-4977-4c18-a889-9e1a2a014b6e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c79ac89b-d78d-055f-ba88-45f4f5a039b3',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948bd'),\n",
       "  'Nome_comune': 'Caprylyl Methicone',\n",
       "  'INCI_name': 'Caprylyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4f72d70c-6772-4107-9235-2738cf40ce39',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948be'),\n",
       "  'Nome_comune': 'Caprylyl/Capryl Glucoside',\n",
       "  'INCI_name': 'Caprylyl/Capryl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=25971e38-538a-4c16-bf18-6ef6041dd462',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948bf'),\n",
       "  'Nome_comune': 'Capsaicin',\n",
       "  'INCI_name': 'Capsaicin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2f836965-9ff0-4a93-8114-8b39f0aeebd9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c0'),\n",
       "  'Nome_comune': 'Capsicum Annuum Extract',\n",
       "  'INCI_name': 'Capsicum Annuum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a1e059b9-aa39-461c-afb6-884caeb2b966',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c1'),\n",
       "  'Nome_comune': 'Capsicum Annuum Fruit Extract',\n",
       "  'INCI_name': 'Capsicum Annuum Fruit Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=90b58523-5da4-45fc-8240-adac94f0c429',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c2'),\n",
       "  'Nome_comune': 'Capsicum Annuum Resin',\n",
       "  'INCI_name': 'Capsicum Annuum Resin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d1613cfe-d368-44ae-a706-9a0c0f92b2db',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c3'),\n",
       "  'Nome_comune': 'Capsicum Annuum Root Powder',\n",
       "  'INCI_name': 'Capsicum Annuum Fruit Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f91f72a9-cb83-4293-b5ec-61ca74d71f2a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c4'),\n",
       "  'Nome_comune': 'Capsicum Frutescens Fruit',\n",
       "  'INCI_name': 'Capsicum Frutescens Fruit',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b8bf6b22-916a-4ce2-8d3f-e21e1e9ec7b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c5'),\n",
       "  'Nome_comune': 'Capsicum Frutescens Fruit Extract',\n",
       "  'INCI_name': 'Capsicum Frutescens Fruit Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cac1fd0a-1673-4480-9fda-0b2e2fdab690',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c6'),\n",
       "  'Nome_comune': 'Capsicum Frutescens Resin',\n",
       "  'INCI_name': 'Capsicum Frutescens Resin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ed5c698f-7ade-4c50-b2ec-684f891318fe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c7'),\n",
       "  'Nome_comune': 'Captan',\n",
       "  'INCI_name': 'Captan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e4bf9330-4d16-4e47-925f-900904c1aa6a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f698591a-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 8(4):643-680, 1989',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c8'),\n",
       "  'Nome_comune': 'Carapa Guaianensis Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Carapa Guianensis Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=821f24a5-40be-4eee-a8fa-1a6f945ff23e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948c9'),\n",
       "  'Nome_comune': 'Carbomer',\n",
       "  'INCI_name': 'Carbomer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7462ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948ca'),\n",
       "  'Nome_comune': 'Carbomer-910',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=21786afd-1eb8-4af4-b263-fbc9e72e3049',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2c9ec7a4-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 1(2):109-141, 1982',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948cb'),\n",
       "  'Nome_comune': 'Carbomer-934',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=303cb9f8-9c9b-46ae-99f0-a9ab073852d4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2c9ec7a4-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 1(2):109-141, 1982',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948cc'),\n",
       "  'Nome_comune': 'Carbomer-934P',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4424dfe3-4378-4e2f-89fe-c40fea5b0d74',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2c9ec7a4-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 1(2):109-141, 1982',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948cd'),\n",
       "  'Nome_comune': 'Carbomer-941',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e3182b45-eb3b-4101-a62e-86a548f92d7c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2c9ec7a4-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 1(2):109-141, 1982',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948ce'),\n",
       "  'Nome_comune': 'Carbomer-962',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5a805320-a561-4a37-9077-1956ffb29964',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948cf'),\n",
       "  'Nome_comune': 'Carboxymethyl Cellulose Acetate Butyrate',\n",
       "  'INCI_name': 'Carboxymethyl Cellulose Acetate Butyrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8cf81942-5a41-4960-b7ac-d9af5665d8eb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948d0'),\n",
       "  'Nome_comune': 'Carboxymethyl Dextran',\n",
       "  'INCI_name': 'Carboxymethyl Dextran',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=df0a41e1-071a-4844-b94c-2ab880302df5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948d1'),\n",
       "  'Nome_comune': 'Carboxymethyl Hydroxyethylcellulose',\n",
       "  'INCI_name': 'Carboxymethyl Hydroxyethylcellulose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d49cc801-0c6b-4044-a9db-e46471cf3cdc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d2'),\n",
       "  'Nome_comune': 'Carboxymethyl Hydroxypropyl Guar',\n",
       "  'INCI_name': 'Carboxymethyl Hydroxypropyl Guar',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cb91a1da-3b21-4f86-b55c-b0ba87d6e600',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d3'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Fruit',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Fruit',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=485433ad-ab6b-4f0f-ae19-c48b7b426c5c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d4'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Fruit Extract',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Fruit Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3927dc84-42e0-4fb6-a2c6-802bd1fb0531',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d5'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Fruit Juice',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Fruit Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a7a1e6a4-8f81-4228-9335-44c68d99e692',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d6'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Fruit Water',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Fruit Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=284ecc79-76a9-41db-b0db-42844c0e6081',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d7'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Leaf Extract',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=49a35ef1-c9dd-41f4-acd9-f24f3ed9027b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d8'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Seed Oil',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad02c165-4e87-4017-91e4-6cbca77cf5e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d9'),\n",
       "  'Nome_comune': 'Carnauba Wax',\n",
       "  'INCI_name': 'Copernicia Cerifera (Carnauba) Wax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e06f700b-d2af-4d4e-aa5c-33517e03579d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948da'),\n",
       "  'Nome_comune': 'Carnitine',\n",
       "  'INCI_name': 'Carnitine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6fb585ad-1228-4005-9657-e6b7f287161f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948db'),\n",
       "  'Nome_comune': 'Carnitine HCl',\n",
       "  'INCI_name': 'Carnitine HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=267d4d46-d57d-46ff-9313-912c3f40747e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948dc'),\n",
       "  'Nome_comune': 'Carnitine Hydroxycitrate',\n",
       "  'INCI_name': 'Carnitine Hydroxycitrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66084c1e-7861-471d-920c-4ecc23ed91de',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948dd'),\n",
       "  'Nome_comune': 'Carnitine PCA',\n",
       "  'INCI_name': 'Carnitine PCA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a5907d2a-aed0-4726-9d40-5b687d8f01e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948de'),\n",
       "  'Nome_comune': 'Carrageenan',\n",
       "  'INCI_name': 'Carrageenan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=16f38d5d-b7d8-4047-a906-ab3ac39cd885',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948df'),\n",
       "  'Nome_comune': 'Carthamus Tinctorius (Safflower) Seed Oil',\n",
       "  'INCI_name': 'Carthamus Tinctorius (Safflower) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9f75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948e0'),\n",
       "  'Nome_comune': 'Carvacrol',\n",
       "  'INCI_name': 'Carvacrol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=40c4ff5c-042b-42ed-a9f4-28b5e6646e97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=caca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 1):29-127, 2006',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948e1'),\n",
       "  'Nome_comune': 'Carya Illinoensis (Pecan) Seed Oil',\n",
       "  'INCI_name': 'Carya Illinoinensis (Pecan) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=373a7ea9-1d28-4b68-9775-10e1efa1faec',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948e2'),\n",
       "  'Nome_comune': 'Caryocar Brasiliense Fruit Oil',\n",
       "  'INCI_name': 'Caryocar Brasiliense Fruit Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4eb20ae8-45ee-4f81-875a-48104dcfb7fa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948e3'),\n",
       "  'Nome_comune': 'Casein',\n",
       "  'INCI_name': 'Casein',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dc2ffbd9-c374-48bb-a55b-087aff78195b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a744d1db-21ea-4172-a676-d17332da9e6e',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):43-56, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e4'),\n",
       "  'Nome_comune': 'Casein Extract',\n",
       "  'INCI_name': 'Casein Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=37308019-a722-41fb-a9e5-fd56c92fd339',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a744d1db-21ea-4172-a676-d17332da9e6e',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):43-56, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e5'),\n",
       "  'Nome_comune': 'Cassia Angustifolia Seed Polysaccharide',\n",
       "  'INCI_name': 'Cassia Angustifolia Seed Polysaccharide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=95233120-227c-44b0-950b-56fd740aba02',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e6'),\n",
       "  'Nome_comune': 'Cassia Gum',\n",
       "  'INCI_name': 'Cassia Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f9c384cc-d7f3-4da8-b601-44c55a2a3ce1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e7'),\n",
       "  'Nome_comune': 'Cassia Hydroxypropyltrimonium Chloride',\n",
       "  'INCI_name': 'Cassia Hydroxypropyltrimonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8032f0be-5462-4787-859f-f8867834ce6c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e8'),\n",
       "  'Nome_comune': 'Castor Oil Phosphate',\n",
       "  'INCI_name': 'Castor Oil Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=326ce641-32b7-4aca-af12-413fb8e4910e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=587dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):12-32, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e9'),\n",
       "  'Nome_comune': 'Castor Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Castor Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=773a3cd4-0aff-4458-98b6-70822b3d833e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948ea'),\n",
       "  'Nome_comune': 'Cellobiose Octanonanoate',\n",
       "  'INCI_name': 'Cellobiose Octanonanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=852870a4-30c2-4e6b-bb79-2dd0b80ac935',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=11317d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 3):228-269, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948eb'),\n",
       "  'Nome_comune': 'Cellulose',\n",
       "  'INCI_name': 'Cellulose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=90a9216b-9271-4581-93dc-86942c9140cc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948ec'),\n",
       "  'Nome_comune': 'Cellulose Acetate',\n",
       "  'INCI_name': 'Cellulose Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=44fb7025-b848-45d3-9127-8cbb66b29d4a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948ed'),\n",
       "  'Nome_comune': 'Cellulose Acetate Butyrate',\n",
       "  'INCI_name': 'Cellulose Acetate Butyrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f3182232-2543-44d6-bd56-e4d62a1d565f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948ee'),\n",
       "  'Nome_comune': 'Cellulose Acetate Propionate',\n",
       "  'INCI_name': 'Cellulose Acetate Propionate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e3b657f-8eb8-42dd-a045-6c1bc982d404',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948ef'),\n",
       "  'Nome_comune': 'Cellulose Acetate Propionate Carboxylate',\n",
       "  'INCI_name': 'Cellulose Acetate Propionate Carboxylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d84429e4-bc11-4ad2-8c49-ea9a5538fed0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f0'),\n",
       "  'Nome_comune': 'Cellulose Gum',\n",
       "  'INCI_name': 'Cellulose Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b7d5b3b0-8b44-4327-ba5b-99c38f84d1de',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f1'),\n",
       "  'Nome_comune': 'Cellulose Succinate',\n",
       "  'INCI_name': 'Cellulose Succinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=29a7ac5f-f56f-45c9-b16e-47b5091227c5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f2'),\n",
       "  'Nome_comune': 'Centella Asiatica Callus Culture',\n",
       "  'INCI_name': 'Centella Asiatica Callus Culture',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b758ad2c-6cb3-4808-b0e2-a7fbb56e080a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f3'),\n",
       "  'Nome_comune': 'Centella Asiatica Extract',\n",
       "  'INCI_name': 'Centella Asiatica Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eaf36f87-2454-4206-92b5-9289bd3a9bbb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f4'),\n",
       "  'Nome_comune': 'Centella Asiatica Flower/Leaf/Stem Extract',\n",
       "  'INCI_name': 'Centella Asiatica Flower/Leaf/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7f2d057d-f523-49f0-bc1a-8639fee53bd4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f5'),\n",
       "  'Nome_comune': 'Centella Asiatica Leaf Cell Culture Extract',\n",
       "  'INCI_name': 'Centella Asiatica Leaf Cell Culture Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e876c58-73f1-470f-9b5c-25bdffabe204',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f6'),\n",
       "  'Nome_comune': 'Centella Asiatica Leaf Extract',\n",
       "  'INCI_name': 'Centella Asiatica Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67e2a05d-6b51-4797-b899-241004a2e13a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948f7'),\n",
       "  'Nome_comune': 'Centella Asiatica Leaf Water',\n",
       "  'INCI_name': 'Centella Asiatica Leaf Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=918beb40-3cf7-492c-9a22-72cdfde9d1b7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948f8'),\n",
       "  'Nome_comune': 'Centella Asiatica Meristem Cell Culture',\n",
       "  'INCI_name': 'Centella Asiatica Meristem Cell Culture',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a8a88a0c-ce98-4030-ba7a-724fdb271aca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948f9'),\n",
       "  'Nome_comune': 'Centella Asiatica Meristem Cell Culture Extract',\n",
       "  'INCI_name': 'Centella Asiatica Meristem Cell Culture Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2919e744-250b-4031-8c64-84a465b56ba0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fa'),\n",
       "  'Nome_comune': 'Centella Asiatica Root Extract',\n",
       "  'INCI_name': 'Centella Asiatica Root Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1ac1a7b8-b4d3-4fd8-a918-991b2cb16228',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fb'),\n",
       "  'Nome_comune': 'Ceramide 1',\n",
       "  'INCI_name': 'Ceramide 1 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a4d94580-9cfc-4137-87d1-d5709d9d0c10',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fc'),\n",
       "  'Nome_comune': 'Ceramide 1 A',\n",
       "  'INCI_name': 'Ceramide 1 A (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f57cae4f-d5f1-41c4-a7d8-35e77491e1e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fd'),\n",
       "  'Nome_comune': 'Ceramide 2',\n",
       "  'INCI_name': 'Ceramide 2 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=48c7ad50-01f0-4f34-b12e-beae46834db5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fe'),\n",
       "  'Nome_comune': 'Ceramide 3',\n",
       "  'INCI_name': 'Ceramide 3 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=df2127b1-a2f8-4fe2-820f-6bfe52fb4809',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948ff'),\n",
       "  'Nome_comune': 'Ceramide 4',\n",
       "  'INCI_name': 'Ceramide 4 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=504ab79f-df78-4db1-812f-81c16a5b1e0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d7294900'),\n",
       "  'Nome_comune': 'Ceramide 5',\n",
       "  'INCI_name': 'Ceramide 5 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=233a6045-1a8c-4889-9a49-83bd8f778f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294901'),\n",
       "  'Nome_comune': 'Ceramide 6 II',\n",
       "  'INCI_name': 'Ceramide 6 II (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=de56620a-4920-44d5-8b9e-5c1f2842b76d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294902'),\n",
       "  'Nome_comune': 'Ceramide AP',\n",
       "  'INCI_name': 'Ceramide AP',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6b5c2684-b7a9-4a35-9fba-504f5569d9f0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294903'),\n",
       "  'Nome_comune': 'Ceramide AS',\n",
       "  'INCI_name': 'Ceramide AS',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7abf3270-0eee-43ef-b13f-259b1bf895c6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294904'),\n",
       "  'Nome_comune': 'Ceramide EOP',\n",
       "  'INCI_name': 'Ceramide EOP',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b1930767-f845-46f0-a036-5de425ceb8a3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294905'),\n",
       "  'Nome_comune': 'Ceramide EOS',\n",
       "  'INCI_name': 'Ceramide EOS',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5ecf7838-2b60-4bfa-a0be-bfb1bae40964',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294906'),\n",
       "  'Nome_comune': 'Ceramide NG',\n",
       "  'INCI_name': 'Ceramide NG',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32007ea3-0b41-48dd-b672-f8ff0c80c0ee',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294907'),\n",
       "  'Nome_comune': 'Ceramide NP',\n",
       "  'INCI_name': 'Ceramide NP',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=937ab940-cfc4-4b43-8f2c-2e50e5ca3a68',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294908'),\n",
       "  'Nome_comune': 'Ceramide NS',\n",
       "  'INCI_name': 'Ceramide NS',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=be8897b8-58a2-4591-b85d-fd9f07a03734',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294909'),\n",
       "  'Nome_comune': 'Ceramide NS Dilaurate',\n",
       "  'INCI_name': 'Ceramide NS Dilaurate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6886010e-3c2f-44c5-a1ae-7ebe562adceb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490a'),\n",
       "  'Nome_comune': 'Ceramium Kondoi Extract',\n",
       "  'INCI_name': 'Ceramium Kondoi Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6e3c49b7-c07b-41ce-908d-ce6c5228f9b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490b'),\n",
       "  'Nome_comune': 'Ceramium Rubrum Extract',\n",
       "  'INCI_name': 'Ceramium Rubrum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d4ba694-bc48-4569-9dd6-1a232eeb80e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490c'),\n",
       "  'Nome_comune': 'Ceratonia Siliqua (Carob) Gum',\n",
       "  'INCI_name': 'Ceratonia Siliqua (Carob) Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=db761548-69a5-4070-afc2-ea6a7ec9ce92',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490d'),\n",
       "  'Nome_comune': 'Ceresin',\n",
       "  'INCI_name': 'Ceresin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=77345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''}},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490e'),\n",
       "  'Nome_comune': 'Ceteareth-10',\n",
       "  'INCI_name': 'Ceteareth-10',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d516cab-a8bb-4599-8256-c2694cfa8ed5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490f'),\n",
       "  'Nome_comune': 'Ceteareth-100',\n",
       "  'INCI_name': 'Ceteareth-100',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f4251c57-9c28-4a91-8a2f-5b94f8cad60c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d7294910'),\n",
       "  'Nome_comune': 'Ceteareth-11',\n",
       "  'INCI_name': 'Ceteareth-11',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=92001620-9d0a-460f-92e7-19f2adafd2b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d7294911'),\n",
       "  'Nome_comune': 'Ceteareth-12',\n",
       "  'INCI_name': 'Ceteareth-12',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3e66b2b7-b3c8-4aa8-9ec8-875d39f66710',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294912'),\n",
       "  'Nome_comune': 'Ceteareth-13',\n",
       "  'INCI_name': 'Ceteareth-13',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=540d6053-90f5-4ab2-977b-3e65a46b88eb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294913'),\n",
       "  'Nome_comune': 'Ceteareth-14',\n",
       "  'INCI_name': 'Ceteareth-14',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d40006e-cbdc-4e8a-9771-36335dcd7c57',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294914'),\n",
       "  'Nome_comune': 'Ceteareth-15',\n",
       "  'INCI_name': 'Ceteareth-15',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8b37ee9e-8956-4831-a670-5da8c72d3e24',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294915'),\n",
       "  'Nome_comune': 'Ceteareth-16',\n",
       "  'INCI_name': 'Ceteareth-16',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e55b9b5b-b0f2-4395-96c9-2577def23857',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294916'),\n",
       "  'Nome_comune': 'Ceteareth-17',\n",
       "  'INCI_name': 'Ceteareth-17',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=deb5d013-7748-4229-855c-dd05a6fdefc7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294917'),\n",
       "  'Nome_comune': 'Ceteareth-18',\n",
       "  'INCI_name': 'Ceteareth-18',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6dc7e916-dea3-4336-8c73-480fdb6282ba',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294918'),\n",
       "  'Nome_comune': 'Ceteareth-2',\n",
       "  'INCI_name': 'Ceteareth-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7b1f7973-7acc-482b-8f0f-0299c84c17d0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294919'),\n",
       "  'Nome_comune': 'Ceteareth-20',\n",
       "  'INCI_name': 'Ceteareth-20',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a2a8bf6-5dcc-4ffb-a5fb-5a3b3680896b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " {'_id': ObjectId('668ed1c46c1f2275d729491a'),\n",
       "  'Nome_comune': 'Ceteareth-22',\n",
       "  'INCI_name': 'Ceteareth-22',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a97674f2-8854-447e-ab31-52fa87c9109a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''}},\n",
       " ...]"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ingredienti = db.Ingredienti.find({})\n",
    "ingredients = []\n",
    "for el in ingredienti:\n",
    "    ingredients.append(el)\n",
    "\n",
    "ingredients"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "def sorting_func(el):\n",
    "    num = ''\n",
    "    for char in el[0]:\n",
    "        if char.isnumeric():\n",
    "            num = num+char\n",
    "        elif char in [' ','.',',']:\n",
    "            pass\n",
    "        elif char == 'g':\n",
    "            num = int(num)*1000\n",
    "        else:\n",
    "            break\n",
    "             \n",
    "    return int(num)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pymongo.mongo_client import MongoClient\n",
    "from pymongo.server_api import ServerApi\n",
    "import requests as req\n",
    "from tqdm import tqdm\n",
    "\n",
    "\n",
    "uri = \"mongodb+srv://lucagiovagnoli:t7g^Fyi7zpN!Liw@ufs13.dsmvdrx.mongodb.net/?retryWrites=true&w=majority&appName=UFS13\"\n",
    "# Create a new client and connect to the server\n",
    "client = MongoClient(uri, server_api=ServerApi('1'))\n",
    "db = client['INCI']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'_id': ObjectId('668ed1556c1f2275d7294533'),\n",
       "  'Nome_comune': '1,10-Decanediol',\n",
       "  'INCI_name': '1,10-Decanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=940af697-52b5-4a3a-90a6-b9db30ef4a7e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['t Not speci ﬁed Not speci ﬁed No details provided LD 50> 20 g/kg78 1,4-Butanediol Rat, Wistar Imp: DAK12 females 5 g/kg (undiluted liquid) Food and water were available ',\n",
       "   ' accordance with OECD TG 401 (Acute Oral Toxicity)LD50> 5 g/kg for males and females; no mortality; clinical sign',\n",
       "   ' animals. 12,35Various animal studies reported an LD 50 between 1.2 and 2.5 g/kg for 1,4-Butanediol.13,22,34,37,74,82 Findings at n',\n",
       "   ' could not be “retained in contact with the skin ”LD50> 20 mL/kg was reported79 Hexanediol Rabbit, New Zealand(albino)4 males 10 g/kg in a “suitable vehicle ” Rabbit trunk was clipped ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50>20 g/kg in rats for Propanediol, >20 mL/kg in rabbits for 1,5-Pentanediol, >10 g/kg in rabbits for Hexanediol, and >2 g/kg in rabbits ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50> 20 g/kg in rats for Propanediol,78>20 mL/kg in rabbits for'],\n",
       "  'contesti_noael': ['aluating 1 ,4-Butanediol, a NOAEC of 500 mg/L (or NOAEL of 23 mg/kg/day) and a lowest-observed-adverse-effect-concentrati',\n",
       "   'through 15 of gestationMaternal and developmental NOAEL of 100 mg/kg/day; maternal anddevelopmental LOAEL of 300 mg/kg/ da',\n",
       "   'cropsy performedNOAEL of 15 mg/kg/day (males) and NOAEL of 150 mg/kg/day (females); treatment-related deaths of 3 males (1000 mg/kg/day) and 1 male (150 mg/kg/day); the following wereunaffected by treatment: body',\n",
       "   'mg/kg/day on days 6 - 19 ofgestation), a maternal NOAEL of 150 mg/kg/day (reducedactivity, staggering, limb dragging, slow',\n",
       "   'd on gestation day 20; necropsy performedMaternal NOAEL of 150 mg/kg/day; Developmental NOAEL of 1000 mg/kg/ day; maternal',\n",
       "   'nd developmental NOAEL of 100 mg/kg/dayand a LOAEL of 300 mg/kg/day were reported; maternalcentral nervous system int',\n",
       "   're observed (dosing on days 6-15 of gestation). A NOAEL of 100 mg/kg/day and a LOAEL of 300 mg/kg/day 1,4-Buta-nediol were reported for maternal (dosin',\n",
       "   'al toxiceffects were observed (maternal and fetal NOAEL 1000 mg/ kg/day). 12In a mouse study evaluating 1,4-Butanediol at up to 600 mg/kg/day (dosing on days 6 - 15 of gestation), amaternal a',\n",
       "   '00 mg/kg/day); a no-observed-adverse-effect-level(NOAEL) of 200 mg/kg/day was reported. 13The results of testing Hexanediol in rats (up to 1000 mg/kg/day for28 days) 15a n dr a b b i t s( u pt o2 0 0 0m ',\n",
       "   'hrough 15 of gestationMaternal and fetal toxicity NOAEL of 1000 mg/kg/day; no maternal toxiceffects from treatment (fertili',\n",
       "   'onclusion and necropsy performedParental (female) NOAEL of 1000 mg/kg/ day; parental (male) NOAEL of 400 mg/ kg/day; offspring (male/female) NOAELof 1000 mg/kg/day; male parents (1000 mg/kg/day) showed treatment-r',\n",
       "   'nd necropsies performedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal mortalities or clinical signs; mater',\n",
       "   'offspring were examinedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal toxic or embryotoxic effects were ob',\n",
       "   'l toxicity, fetotoxicity, and teratogenic effects NOAEL of 1000 mg/kg/day; intrauterine growth and survival was not affecte',\n",
       "   'ed bytreatment. 13,22A maternal and developmental NOAEL of 1000 mg/kg/day was reported in animal studies on Hex- anediol (r',\n",
       "   'dy weight at 1000 mg/kg dose) and a developmental NOAEL of 1000 mg/kg/day were reported. 17 Genotoxicity Provided below is ',\n",
       "   ' female rats, respectively. In 90- day studies, a NOAEL of 600 mg/kg/day was reported for Methylpropanediol and NOAELs of 1000 mg/kg/day werereported for Propanediol and Hexanediol (in f',\n",
       "   'roductive parameters were changed by treatment. A NOAEL of 1000 mg/kg/day Hexanediol (dosing on days 6-19 of gestation) and'],\n",
       "  'valori_ld50': ['5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '20 g/kg '],\n",
       "  'valori_noael': ['23 mg/kg/day',\n",
       "   '100 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '600 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294534'),\n",
       "  'Nome_comune': '1,2,4-Trihydroxybenzene',\n",
       "  'INCI_name': '1,2,4-Trihydroxybenzene',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d55d919-245e-ee11-be6f-00224824e39e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a1152e70-abec-b78c-b63e-a52bba62a429',\n",
       "  'pdf_date': 'June 04, 2024',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tration.  No further details were provided .  The LD 50 for both sexes was  between 350 and 500 mg/kg bw  for a preparation containing 1% 1,2,4- Trihydroxyb',\n",
       "   ' of 2000 mg/kg bw 1,2,4 - Trihydroxybenzene.  The LD 50 in an acute oral toxicity rat study of 1,2,4- Trihy droxybenzene was between 350 and 500  mg/kg bw for a preparation containing 1% 1,2,4- Trihydroxyb'],\n",
       "  'contesti_noael': ['group.   The no-observed -adverse -effect -level (NOAEL ) was determined  by the  study authors  to be 50 mg/kg bw/d.   However, the SCCP concluded that no NOAEL coul',\n",
       "   'ge study of 1,2,4 -Trihydroxybenzene in rats, the NOAEL were determined to be 50 mg/kg bw/d,  according to the researchers;  this value was d',\n",
       "   'EL:  50 mg/kg bw/d (90- d, gavage, oral, rat)2,3  NOAEL  (extrapolated  from LOAEL  using  an assessment factor of 3):  50 mg/kg bw/d ÷  3 = 16.67 mg/kg bw/d        The value is greater than 100, a  figure g',\n",
       "   'ent factor of 3 for extrapo lation from  LOAEL to NOAEL, and a n SED of 0 .03577 mg/kg bw/d .  The MOS value is greater than 100, a figure ge'],\n",
       "  'valori_ld50': ['500 mg/kg bw  ', '500  mg/kg bw '],\n",
       "  'valori_noael': ['50 mg/kg bw/d',\n",
       "   '50 mg/kg bw/d',\n",
       "   '67 mg/kg bw/d',\n",
       "   '03577 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294535'),\n",
       "  'Nome_comune': '1,2-Butanediol',\n",
       "  'INCI_name': '1,2-Butanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7bf5d549-ac99-4282-a85f-603d8ecb185e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' that death would occur at relatively high doses (LD50 range: 2200 to >20 000 mg/kg). Reportedly, high (unspecified) oral doses of 1,',\n",
       "   'values were reported for 1,2- butanediol: 24-hour LD50 of 66.5 mmol/kg ( *5.99 g/kg) and 144-hour LD50 of 46.5 mmol/kg ( *4.19 mg/kg).32Muscle incoordination was observed in rats at ',\n",
       "   'is was observed at necropsy. In other studies, ip LD 50 values up to 13.7 mL/kg (rats) and 11.2 g/kg (mice) have been reported.1An acute study was per',\n",
       "   'n acute dermal toxicity study involving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg. Prolonged application or repeated applications o',\n",
       "   'lycol (1,2-pentanediol). The following acute oral LD50 values have been reported for pentylene glycol: 1.2700 Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits); and 5200 mg/kg (guinea pigs).30 Steary',\n",
       "   'udy (OECD 423 test procedure) involving rats, the LD50 for caprylyl glycol was >2500 mg/kg.27, 1,2-Butanediol. An acute oral LD50 of 4192 mg/kg was reported for 1,2-butanediol in a study involvi',\n",
       "   'nteral toxicity studies, acute intramuscular (im) LD50 (20 g/kg rats) and acute subcutaneous (sc) LD50 (18.5 g/kg mice) values have been reported.1 Repeated-Dose To',\n",
       "   'l glycol. An LD50 of >5000 mg/kg was reported for rats dosed orally with stearyl gl',\n",
       "   'ated using adult male Sprague-Dawley rats, and an LD50 of >20.0 g/kg body weight was reported.5 Propylene glycol. The 24-hour oral LD50 for PG was 22.8 g/kg body weight in a study involving 5 female Fischer rats. Oral L',\n",
       "   'ailable from Dow Chemical Company, the acute oral LD50 for 1,2-butanediol in rats was 16 g/kg body weight.29Also, high (unspecified) doses caused narcosis ',\n",
       "   'acute dermal toxicity study invol- ving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg.27 Propylene glycol. The dermal LD50 for PG was >11.2 g/kg in mice and was 13 g/kg in rats.1 Intraperitoneal '],\n",
       "  'contesti_noael': ['iod was largely reversible. Both the NOEL and the NOAEL in this study was 100 mg/kg body weight/d.36 Pentylene glycol. Pentylene glycol was adminis',\n",
       "   'ach; analogous structures do not exist in man. An NOAEL of 100 mg/kg/d was reported for rats in a 28-day oral toxicity s',\n",
       "   'females). The no observable adverse effect level (NOAEL) was 200 mg/kg body weight/day in this study.35 According to a summary of data p',\n",
       "   'ministration of 1,2-butanediol to rats yielded an NOAEL of 200 mg/kg/d. Reportedly, in another repeated dose study, the ',\n",
       "   ' mg/kg/d, and a no observed adverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi- city. The NOAEL was based on t',\n",
       "   'this study was calculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/d and a reproductive toxicity uncertainty factor of'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '19 mg/kg',\n",
       "   '2 g/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3700 mg/kg',\n",
       "   '4192 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '8 g/kg body weight ',\n",
       "   '16 g/kg body weight',\n",
       "   '11.2 g/kg '],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg/d',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294536'),\n",
       "  'Nome_comune': '1,2-Hexanediol',\n",
       "  'INCI_name': '1,2-Hexanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=73f09bf1-26dd-4c2b-96f2-59e4285a3b2b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' that death would occur at relatively high doses (LD50 range: 2200 to >20 000 mg/kg). Reportedly, high (unspecified) oral doses of 1,',\n",
       "   'values were reported for 1,2- butanediol: 24-hour LD50 of 66.5 mmol/kg ( *5.99 g/kg) and 144-hour LD50 of 46.5 mmol/kg ( *4.19 mg/kg).32Muscle incoordination was observed in rats at ',\n",
       "   'is was observed at necropsy. In other studies, ip LD 50 values up to 13.7 mL/kg (rats) and 11.2 g/kg (mice) have been reported.1An acute study was per',\n",
       "   'n acute dermal toxicity study involving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg. Prolonged application or repeated applications o',\n",
       "   'lycol (1,2-pentanediol). The following acute oral LD50 values have been reported for pentylene glycol: 1.2700 Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits); and 5200 mg/kg (guinea pigs).30 Steary',\n",
       "   'udy (OECD 423 test procedure) involving rats, the LD50 for caprylyl glycol was >2500 mg/kg.27, 1,2-Butanediol. An acute oral LD50 of 4192 mg/kg was reported for 1,2-butanediol in a study involvi',\n",
       "   'nteral toxicity studies, acute intramuscular (im) LD50 (20 g/kg rats) and acute subcutaneous (sc) LD50 (18.5 g/kg mice) values have been reported.1 Repeated-Dose To',\n",
       "   'l glycol. An LD50 of >5000 mg/kg was reported for rats dosed orally with stearyl gl',\n",
       "   'ated using adult male Sprague-Dawley rats, and an LD50 of >20.0 g/kg body weight was reported.5 Propylene glycol. The 24-hour oral LD50 for PG was 22.8 g/kg body weight in a study involving 5 female Fischer rats. Oral L',\n",
       "   'ailable from Dow Chemical Company, the acute oral LD50 for 1,2-butanediol in rats was 16 g/kg body weight.29Also, high (unspecified) doses caused narcosis ',\n",
       "   'acute dermal toxicity study invol- ving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg.27 Propylene glycol. The dermal LD50 for PG was >11.2 g/kg in mice and was 13 g/kg in rats.1 Intraperitoneal '],\n",
       "  'contesti_noael': ['iod was largely reversible. Both the NOEL and the NOAEL in this study was 100 mg/kg body weight/d.36 Pentylene glycol. Pentylene glycol was adminis',\n",
       "   'ach; analogous structures do not exist in man. An NOAEL of 100 mg/kg/d was reported for rats in a 28-day oral toxicity s',\n",
       "   'females). The no observable adverse effect level (NOAEL) was 200 mg/kg body weight/day in this study.35 According to a summary of data p',\n",
       "   'ministration of 1,2-butanediol to rats yielded an NOAEL of 200 mg/kg/d. Reportedly, in another repeated dose study, the ',\n",
       "   ' mg/kg/d, and a no observed adverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi- city. The NOAEL was based on t',\n",
       "   'this study was calculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/d and a reproductive toxicity uncertainty factor of'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '19 mg/kg',\n",
       "   '2 g/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3700 mg/kg',\n",
       "   '4192 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '8 g/kg body weight ',\n",
       "   '16 g/kg body weight',\n",
       "   '11.2 g/kg '],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg/d',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294537'),\n",
       "  'Nome_comune': '1,4-Butanediol',\n",
       "  'INCI_name': '1,4-Butanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ed04f7c6-4dde-4fe4-8ece-df05e25feecc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/8064',\n",
       "   'valori': ['LD50 Rat oral 1525 mg/kg',\n",
       "    'LD50 Rat oral 1550 mg/kg',\n",
       "    'LD50 Rat oral 1.78 g/kg',\n",
       "    'LD50 Rat (Sprague-Dawley, male) oral about 1350 mg/kg bw /from table/',\n",
       "    'LD50 Rat (Sprague-Dawley, female) oral 1670 mg/kg bw (95%confidence limits: 1420-2040 mg/kg bw) /from table/',\n",
       "    'LD50 Rat (albino, male) ip about 1000 mg/kg bw /from table/',\n",
       "    'LC50 Rat (Wistar) inhalation >5.1 mg/L/4 hr /from table/',\n",
       "    'LC50 Rat (Crl:CD BR, male) inhalation >15 mg/L/4 hr /from table/',\n",
       "    'LD50 Mouse oral 2062 mg/kg',\n",
       "    'LD50 Mouse oral 2.18 g/kg',\n",
       "    'LD50 Mouse ip 1660 mg/kg bw /from table/',\n",
       "    'LD50 Mouse sc 2000 mg/kg bw /from table/',\n",
       "    'LD50 Mouse iv 1000 mg/kg bw /from table/',\n",
       "    'LD50 Rabbit oral 2531 mg/kg bw /from table/',\n",
       "    'LD50 Guinea pig oral 1200 mg/kg bw /from table/'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 585\",\n",
       "    \"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 268\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V7 46\",\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.82 (10/1992).',\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.82 (10/1992).',\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.83 (10/1992).',\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.83 (10/1992).',\n",
       "    'BG Chemie; Toxicological Evaluations Vol.7, No.99: 1,4-Butanediol (110-63-4) p.83 (10/1992).',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 585\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V7 46\",\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html',\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html',\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html',\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html',\n",
       "    'Organization for Economic Cooperation and Development; Screening Information Data Set for 1,4-Butanediol 110-63-4 p.11 (2000). Available from, as of June 29, 2017: https://www.inchem.org/pages/sids.html']},\n",
       "  'contesti_ld50': ['t Not speci ﬁed Not speci ﬁed No details provided LD 50> 20 g/kg78 1,4-Butanediol Rat, Wistar Imp: DAK12 females 5 g/kg (undiluted liquid) Food and water were available ',\n",
       "   ' accordance with OECD TG 401 (Acute Oral Toxicity)LD50> 5 g/kg for males and females; no mortality; clinical sign',\n",
       "   ' animals. 12,35Various animal studies reported an LD 50 between 1.2 and 2.5 g/kg for 1,4-Butanediol.13,22,34,37,74,82 Findings at n',\n",
       "   ' could not be “retained in contact with the skin ”LD50> 20 mL/kg was reported79 Hexanediol Rabbit, New Zealand(albino)4 males 10 g/kg in a “suitable vehicle ” Rabbit trunk was clipped ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50>20 g/kg in rats for Propanediol, >20 mL/kg in rabbits for 1,5-Pentanediol, >10 g/kg in rabbits for Hexanediol, and >2 g/kg in rabbits ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50> 20 g/kg in rats for Propanediol,78>20 mL/kg in rabbits for'],\n",
       "  'contesti_noael': ['aluating 1 ,4-Butanediol, a NOAEC of 500 mg/L (or NOAEL of 23 mg/kg/day) and a lowest-observed-adverse-effect-concentrati',\n",
       "   'through 15 of gestationMaternal and developmental NOAEL of 100 mg/kg/day; maternal anddevelopmental LOAEL of 300 mg/kg/ da',\n",
       "   'cropsy performedNOAEL of 15 mg/kg/day (males) and NOAEL of 150 mg/kg/day (females); treatment-related deaths of 3 males (1000 mg/kg/day) and 1 male (150 mg/kg/day); the following wereunaffected by treatment: body',\n",
       "   'mg/kg/day on days 6 - 19 ofgestation), a maternal NOAEL of 150 mg/kg/day (reducedactivity, staggering, limb dragging, slow',\n",
       "   'd on gestation day 20; necropsy performedMaternal NOAEL of 150 mg/kg/day; Developmental NOAEL of 1000 mg/kg/ day; maternal',\n",
       "   'nd developmental NOAEL of 100 mg/kg/dayand a LOAEL of 300 mg/kg/day were reported; maternalcentral nervous system int',\n",
       "   're observed (dosing on days 6-15 of gestation). A NOAEL of 100 mg/kg/day and a LOAEL of 300 mg/kg/day 1,4-Buta-nediol were reported for maternal (dosin',\n",
       "   'al toxiceffects were observed (maternal and fetal NOAEL 1000 mg/ kg/day). 12In a mouse study evaluating 1,4-Butanediol at up to 600 mg/kg/day (dosing on days 6 - 15 of gestation), amaternal a',\n",
       "   '00 mg/kg/day); a no-observed-adverse-effect-level(NOAEL) of 200 mg/kg/day was reported. 13The results of testing Hexanediol in rats (up to 1000 mg/kg/day for28 days) 15a n dr a b b i t s( u pt o2 0 0 0m ',\n",
       "   'hrough 15 of gestationMaternal and fetal toxicity NOAEL of 1000 mg/kg/day; no maternal toxiceffects from treatment (fertili',\n",
       "   'onclusion and necropsy performedParental (female) NOAEL of 1000 mg/kg/ day; parental (male) NOAEL of 400 mg/ kg/day; offspring (male/female) NOAELof 1000 mg/kg/day; male parents (1000 mg/kg/day) showed treatment-r',\n",
       "   'nd necropsies performedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal mortalities or clinical signs; mater',\n",
       "   'offspring were examinedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal toxic or embryotoxic effects were ob',\n",
       "   'l toxicity, fetotoxicity, and teratogenic effects NOAEL of 1000 mg/kg/day; intrauterine growth and survival was not affecte',\n",
       "   'ed bytreatment. 13,22A maternal and developmental NOAEL of 1000 mg/kg/day was reported in animal studies on Hex- anediol (r',\n",
       "   'dy weight at 1000 mg/kg dose) and a developmental NOAEL of 1000 mg/kg/day were reported. 17 Genotoxicity Provided below is ',\n",
       "   ' female rats, respectively. In 90- day studies, a NOAEL of 600 mg/kg/day was reported for Methylpropanediol and NOAELs of 1000 mg/kg/day werereported for Propanediol and Hexanediol (in f',\n",
       "   'roductive parameters were changed by treatment. A NOAEL of 1000 mg/kg/day Hexanediol (dosing on days 6-19 of gestation) and'],\n",
       "  'valori_ld50': ['5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '20 g/kg '],\n",
       "  'valori_noael': ['23 mg/kg/day',\n",
       "   '100 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '600 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294538'),\n",
       "  'Nome_comune': '1,4-Butanediol/Succinic Acid/Adipic Acid/HDI Copolymer',\n",
       "  'INCI_name': '1,4-Butanediol/Succinic Acid/Adipic Acid/HDI Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=391468f9-9993-47ff-a4ec-163d6b451e65',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ed to be  >2000 ->2500 mg/kg in rats.27  The oral LD 50 for Steareth -100/PEG -136/HDI Copolymer was  report ed to be >10 ,000 mg/kg in rats ; clinical signs included bristled fur, di',\n",
       "   'he anal region due to  feces .24   The acute oral LD 50 was >10 ,000 mg/kg in rats (n=5/sex) for a cosmetic ingredient mixtur',\n",
       "   'sspolymer in leave -on products .  The acute oral LD 50 was >10 ,000 mg/kg in rats for a product  mixture  consisting of Bis-',\n",
       "   'anged from >2000 ->2500 mg/kg in rats .  The oral LD 50 for  Steareth -100/PEG -136/HDI Copolymer was reported to be >10, 000 mg/kg in rats .  The acute inhalation LC 50 of Methoxy P',\n",
       "   '-20 Ether  Rats; not specified  LD 50=>2000 mg/kg  27  Steareth -100/PEG -136/HDI  Copolymer  Rats; 5/sex  LD 50=>10\\u2009000 mg/kg. No mortalities during dosing and the  observatio',\n",
       "   '  mortalities  to rats  (Table 8).15-17  The oral LD 50 of Methoxy PEG -17/Methoxy PEG -11/HDI Isocyanurate Trimer  Crosspolymer was reported to be >2000 mg/kg in  rats.33  The oral LD 50 of PEG -240/HDI Copoly',\n",
       "   'used no clinical signs or mortalities.   The oral LD 50 of Methoxy PEG - 17/Methoxy PEG -11/HDI Isocyanurate Trimer Crosspolymer was reported to be >2000 mg/kg in rats.  The acute oral LD 50  for PEG -240/HDI C',\n",
       "   'nurate  Trimer Crosspolymer  Rats; not specified  LD 50=>2000 mg/kg. OECD TG 423  33  PEG-240/HDI Copolymer Bis - Dec',\n",
       "   'yltetradeceth -20 Ether  Rats; not sp ecified  LD 50=>2500 mg/kg  27  PEG-240/HDI Copolymer Bis - Decyltetra deceth '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2500 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1566c1f2275d7294539'),\n",
       "  'Nome_comune': '1,5-Pentanediol',\n",
       "  'INCI_name': '1,5-Pentanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=14283e30-c75a-47fb-bbb8-4291ecde468f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['t Not speci ﬁed Not speci ﬁed No details provided LD 50> 20 g/kg78 1,4-Butanediol Rat, Wistar Imp: DAK12 females 5 g/kg (undiluted liquid) Food and water were available ',\n",
       "   ' accordance with OECD TG 401 (Acute Oral Toxicity)LD50> 5 g/kg for males and females; no mortality; clinical sign',\n",
       "   ' animals. 12,35Various animal studies reported an LD 50 between 1.2 and 2.5 g/kg for 1,4-Butanediol.13,22,34,37,74,82 Findings at n',\n",
       "   ' could not be “retained in contact with the skin ”LD50> 20 mL/kg was reported79 Hexanediol Rabbit, New Zealand(albino)4 males 10 g/kg in a “suitable vehicle ” Rabbit trunk was clipped ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50>20 g/kg in rats for Propanediol, >20 mL/kg in rabbits for 1,5-Pentanediol, >10 g/kg in rabbits for Hexanediol, and >2 g/kg in rabbits ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50> 20 g/kg in rats for Propanediol,78>20 mL/kg in rabbits for'],\n",
       "  'contesti_noael': ['aluating 1 ,4-Butanediol, a NOAEC of 500 mg/L (or NOAEL of 23 mg/kg/day) and a lowest-observed-adverse-effect-concentrati',\n",
       "   'through 15 of gestationMaternal and developmental NOAEL of 100 mg/kg/day; maternal anddevelopmental LOAEL of 300 mg/kg/ da',\n",
       "   'cropsy performedNOAEL of 15 mg/kg/day (males) and NOAEL of 150 mg/kg/day (females); treatment-related deaths of 3 males (1000 mg/kg/day) and 1 male (150 mg/kg/day); the following wereunaffected by treatment: body',\n",
       "   'mg/kg/day on days 6 - 19 ofgestation), a maternal NOAEL of 150 mg/kg/day (reducedactivity, staggering, limb dragging, slow',\n",
       "   'd on gestation day 20; necropsy performedMaternal NOAEL of 150 mg/kg/day; Developmental NOAEL of 1000 mg/kg/ day; maternal',\n",
       "   'nd developmental NOAEL of 100 mg/kg/dayand a LOAEL of 300 mg/kg/day were reported; maternalcentral nervous system int',\n",
       "   're observed (dosing on days 6-15 of gestation). A NOAEL of 100 mg/kg/day and a LOAEL of 300 mg/kg/day 1,4-Buta-nediol were reported for maternal (dosin',\n",
       "   'al toxiceffects were observed (maternal and fetal NOAEL 1000 mg/ kg/day). 12In a mouse study evaluating 1,4-Butanediol at up to 600 mg/kg/day (dosing on days 6 - 15 of gestation), amaternal a',\n",
       "   '00 mg/kg/day); a no-observed-adverse-effect-level(NOAEL) of 200 mg/kg/day was reported. 13The results of testing Hexanediol in rats (up to 1000 mg/kg/day for28 days) 15a n dr a b b i t s( u pt o2 0 0 0m ',\n",
       "   'hrough 15 of gestationMaternal and fetal toxicity NOAEL of 1000 mg/kg/day; no maternal toxiceffects from treatment (fertili',\n",
       "   'onclusion and necropsy performedParental (female) NOAEL of 1000 mg/kg/ day; parental (male) NOAEL of 400 mg/ kg/day; offspring (male/female) NOAELof 1000 mg/kg/day; male parents (1000 mg/kg/day) showed treatment-r',\n",
       "   'nd necropsies performedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal mortalities or clinical signs; mater',\n",
       "   'offspring were examinedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal toxic or embryotoxic effects were ob',\n",
       "   'l toxicity, fetotoxicity, and teratogenic effects NOAEL of 1000 mg/kg/day; intrauterine growth and survival was not affecte',\n",
       "   'ed bytreatment. 13,22A maternal and developmental NOAEL of 1000 mg/kg/day was reported in animal studies on Hex- anediol (r',\n",
       "   'dy weight at 1000 mg/kg dose) and a developmental NOAEL of 1000 mg/kg/day were reported. 17 Genotoxicity Provided below is ',\n",
       "   ' female rats, respectively. In 90- day studies, a NOAEL of 600 mg/kg/day was reported for Methylpropanediol and NOAELs of 1000 mg/kg/day werereported for Propanediol and Hexanediol (in f',\n",
       "   'roductive parameters were changed by treatment. A NOAEL of 1000 mg/kg/day Hexanediol (dosing on days 6-19 of gestation) and'],\n",
       "  'valori_ld50': ['5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '20 g/kg '],\n",
       "  'valori_noael': ['23 mg/kg/day',\n",
       "   '100 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '600 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d729453a'),\n",
       "  'Nome_comune': '10-Hydroxydecanoic Acid',\n",
       "  'INCI_name': '10-Hydroxydecanoic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0f6c7436-9053-41e4-bd31-7f2ddbfc66ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d729453b'),\n",
       "  'Nome_comune': '10-Hydroxystearic Acid',\n",
       "  'INCI_name': '10-Hydroxystearic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e1a8f9e1-6aac-433d-a048-2c3a1061e97f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d729453c'),\n",
       "  'Nome_comune': '1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate',\n",
       "  'INCI_name': '1-Hydroxyethyl 4,5-Diamino Pyrazole Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e6bed57-49b8-4695-8eb7-44393eaf0252',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ef70343b-cd8c-e060-b172-3e84a17efffc',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):69-79, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['re provided. The no observedadverse effect level (NOAEL) was determined to be 250 mg/kg body weight/d. 19 Reproductive and Developmental Toxicity The p',\n",
       "   'eight of the test material in distilledwater, the NOAEL was determined to be 250 mg/kg bodyweight/d. No effects related to the test material were obs',\n",
       "   'fects of the test material. The maternal toxicity NOAEL was1000 mg/kg body weight/day and the fetotoxicity NOAEL was 300 mg/kg body weight/day in this rat developmental study. 21 Genotoxicity ',\n",
       "   'developmental study in rats, the maternaltoxicity NOAEL was 1000 mg/kg body weight/d and thefetotoxicity NOAEL was 300 mg/kg body weight/d. Ratsreceived 0, 100, 300, or 1000 mg/kg body wei',\n",
       "   ' animals was 300 mg/kg body weight/d andthe fetal NOAEL was 900 mg/kg body weight/d. 20 In a developmental study, mated female Spragu',\n",
       "   'me) and an increase in relativespleen weight. The NOAEL for parental Sprague-Dawley rats was 300 mg/kg body weight/d and the fetal NOAEL was 900 mg/kg body weight/d in an oral reproductive toxicity study of 1-Hydro'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['250 mg/kg body weight/d',\n",
       "   '250 mg/kg bodyweight/d',\n",
       "   '300 mg/kg body weight/day',\n",
       "   '300 mg/kg body weight/d',\n",
       "   '900 mg/kg body weight/d',\n",
       "   '900 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1566c1f2275d729453d'),\n",
       "  'Nome_comune': '1-Naphthol',\n",
       "  'INCI_name': '1-Naphthol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d729453e'),\n",
       "  'Nome_comune': '2,3-Butanediol',\n",
       "  'INCI_name': '2,3-Butanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ebf333ff-4031-4547-a832-4b98c2a3d386',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/262',\n",
       "   'valori': ['LD50 Mouse oral 5462 mg/kg', 'LD50 Mouse oral 9.0 mL/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 585\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V7 47\"]},\n",
       "  'contesti_ld50': ['t Not speci ﬁed Not speci ﬁed No details provided LD 50> 20 g/kg78 1,4-Butanediol Rat, Wistar Imp: DAK12 females 5 g/kg (undiluted liquid) Food and water were available ',\n",
       "   ' accordance with OECD TG 401 (Acute Oral Toxicity)LD50> 5 g/kg for males and females; no mortality; clinical sign',\n",
       "   ' animals. 12,35Various animal studies reported an LD 50 between 1.2 and 2.5 g/kg for 1,4-Butanediol.13,22,34,37,74,82 Findings at n',\n",
       "   ' could not be “retained in contact with the skin ”LD50> 20 mL/kg was reported79 Hexanediol Rabbit, New Zealand(albino)4 males 10 g/kg in a “suitable vehicle ” Rabbit trunk was clipped ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50>20 g/kg in rats for Propanediol, >20 mL/kg in rabbits for 1,5-Pentanediol, >10 g/kg in rabbits for Hexanediol, and >2 g/kg in rabbits ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50> 20 g/kg in rats for Propanediol,78>20 mL/kg in rabbits for'],\n",
       "  'contesti_noael': ['aluating 1 ,4-Butanediol, a NOAEC of 500 mg/L (or NOAEL of 23 mg/kg/day) and a lowest-observed-adverse-effect-concentrati',\n",
       "   'through 15 of gestationMaternal and developmental NOAEL of 100 mg/kg/day; maternal anddevelopmental LOAEL of 300 mg/kg/ da',\n",
       "   'cropsy performedNOAEL of 15 mg/kg/day (males) and NOAEL of 150 mg/kg/day (females); treatment-related deaths of 3 males (1000 mg/kg/day) and 1 male (150 mg/kg/day); the following wereunaffected by treatment: body',\n",
       "   'mg/kg/day on days 6 - 19 ofgestation), a maternal NOAEL of 150 mg/kg/day (reducedactivity, staggering, limb dragging, slow',\n",
       "   'd on gestation day 20; necropsy performedMaternal NOAEL of 150 mg/kg/day; Developmental NOAEL of 1000 mg/kg/ day; maternal',\n",
       "   'nd developmental NOAEL of 100 mg/kg/dayand a LOAEL of 300 mg/kg/day were reported; maternalcentral nervous system int',\n",
       "   're observed (dosing on days 6-15 of gestation). A NOAEL of 100 mg/kg/day and a LOAEL of 300 mg/kg/day 1,4-Buta-nediol were reported for maternal (dosin',\n",
       "   'al toxiceffects were observed (maternal and fetal NOAEL 1000 mg/ kg/day). 12In a mouse study evaluating 1,4-Butanediol at up to 600 mg/kg/day (dosing on days 6 - 15 of gestation), amaternal a',\n",
       "   '00 mg/kg/day); a no-observed-adverse-effect-level(NOAEL) of 200 mg/kg/day was reported. 13The results of testing Hexanediol in rats (up to 1000 mg/kg/day for28 days) 15a n dr a b b i t s( u pt o2 0 0 0m ',\n",
       "   'hrough 15 of gestationMaternal and fetal toxicity NOAEL of 1000 mg/kg/day; no maternal toxiceffects from treatment (fertili',\n",
       "   'onclusion and necropsy performedParental (female) NOAEL of 1000 mg/kg/ day; parental (male) NOAEL of 400 mg/ kg/day; offspring (male/female) NOAELof 1000 mg/kg/day; male parents (1000 mg/kg/day) showed treatment-r',\n",
       "   'nd necropsies performedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal mortalities or clinical signs; mater',\n",
       "   'offspring were examinedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal toxic or embryotoxic effects were ob',\n",
       "   'l toxicity, fetotoxicity, and teratogenic effects NOAEL of 1000 mg/kg/day; intrauterine growth and survival was not affecte',\n",
       "   'ed bytreatment. 13,22A maternal and developmental NOAEL of 1000 mg/kg/day was reported in animal studies on Hex- anediol (r',\n",
       "   'dy weight at 1000 mg/kg dose) and a developmental NOAEL of 1000 mg/kg/day were reported. 17 Genotoxicity Provided below is ',\n",
       "   ' female rats, respectively. In 90- day studies, a NOAEL of 600 mg/kg/day was reported for Methylpropanediol and NOAELs of 1000 mg/kg/day werereported for Propanediol and Hexanediol (in f',\n",
       "   'roductive parameters were changed by treatment. A NOAEL of 1000 mg/kg/day Hexanediol (dosing on days 6-19 of gestation) and'],\n",
       "  'valori_ld50': ['5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '20 g/kg '],\n",
       "  'valori_noael': ['23 mg/kg/day',\n",
       "   '100 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '600 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1576c1f2275d729453f'),\n",
       "  'Nome_comune': '2,3-Naphthalenediol',\n",
       "  'INCI_name': '2,3-Naphthalenediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=03e8b18d-54a7-407c-a9bd-7762b7743d67',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8152792c-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 7(3):353-357, 1988',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294540'),\n",
       "  'Nome_comune': '2,4-Diaminophenol',\n",
       "  'INCI_name': '2,4-Diaminophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=89047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294541'),\n",
       "  'Nome_comune': '2,4-Diaminophenol Dihydrochloride',\n",
       "  'INCI_name': '2,4-Diaminophenol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fb4e11dd-5cfd-4c78-96ff-f0918920fc69',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294542'),\n",
       "  'Nome_comune': '2,4-Diaminophenol HCl',\n",
       "  'INCI_name': '2,4-Diaminophenol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8a047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294543'),\n",
       "  'Nome_comune': '2,4-Diaminophenoxyethanol Dihydrochloride',\n",
       "  'INCI_name': '2,4-Diaminophenoxyethanol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=668d2501-3f7f-4bb7-844c-442e511dae92',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4d65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 11, 2007',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294544'),\n",
       "  'Nome_comune': '2,4-Diaminophenoxyethanol HCl',\n",
       "  'INCI_name': '2,4-Diaminophenoxyethanol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9b2e0890-56f5-42dd-a488-a3780a93027e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4d65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 11, 2007',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294545'),\n",
       "  'Nome_comune': '2,4-Diaminophenoxyethanol Sulfate',\n",
       "  'INCI_name': '2,4-Diaminophenoxyethanol Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0c4e3782-5c83-42a3-8abe-425968594efc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4d65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 11, 2007',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1576c1f2275d7294546'),\n",
       "  'Nome_comune': '2-Amino-3-Hydroxypyridine',\n",
       "  'INCI_name': '2-Amino-3-Hydroxypyridine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=23dc2b3d-2d85-46c5-94ae-c311fcc6c6e2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=657dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 2):91-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d7294547'),\n",
       "  'Nome_comune': '2-Amino-3-Nitrophenol',\n",
       "  'INCI_name': '2-Amino-3-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1b515eb4-7a2d-4ab6-8665-ceb0fadd5348',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d7294548'),\n",
       "  'Nome_comune': '2-Amino-4-Hydroxyethylaminoanisole',\n",
       "  'INCI_name': '2-Amino-4-Hydroxyethylaminoanisole',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=23efee15-ac8c-437f-a56e-8fa646f2e985',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=396dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):25-35, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['nding study in mice found the median lethal dose (LD 50)t ob el e s st h a n8 7 5 mg/kg body weight. The test material was administered once by oral ',\n",
       "   'hed after a range finding study in mice found the LD 50 to be less than 2000 mg/kg body weight. The test material was administered as a 1.25 %to'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5 mg/kg body weight', '2000 mg/kg body weight'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d7294549'),\n",
       "  'Nome_comune': '2-Amino-4-Hydroxyethylaminoanisole Sulfate',\n",
       "  'INCI_name': '2-Amino-4-Hydroxyethylaminoanisole Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=baae8a82-cf0c-4654-8051-d87b2fc08c3a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=396dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):25-35, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['nding study in mice found the median lethal dose (LD 50)t ob el e s st h a n8 7 5 mg/kg body weight. The test material was administered once by oral ',\n",
       "   'hed after a range finding study in mice found the LD 50 to be less than 2000 mg/kg body weight. The test material was administered as a 1.25 %to'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5 mg/kg body weight', '2000 mg/kg body weight'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454a'),\n",
       "  'Nome_comune': '2-Amino-4-Nitrophenol',\n",
       "  'INCI_name': '2-Amino-4-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=52eee821-092a-4a3d-9289-bc8757e609a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454b'),\n",
       "  'Nome_comune': '2-Amino-4-Nitrophenol Sulfate',\n",
       "  'INCI_name': '2-Amino-4-Nitrophenol Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=290b7d53-ab07-4921-bea8-1b0a917e2f7a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454c'),\n",
       "  'Nome_comune': '2-Amino-5-Nitrophenol',\n",
       "  'INCI_name': '2-Amino-5-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9df8e38c-ba50-4d72-a1c3-49d36257fc4c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454d'),\n",
       "  'Nome_comune': '2-Amino-6-Chloro-4-Nitrophenol',\n",
       "  'INCI_name': '2-Amino-6-Chloro-4-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f8f53e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454e'),\n",
       "  'Nome_comune': '2-Amino-6-Chloro-4-Nitrophenol Hydrochloride',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cc4914b4-29c6-4f50-a170-948f1b874969',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1a6dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 16(S1):131-143, 1997',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ive hair dye containing this ingredient. The oral LD 50 of a 20% solution of 2-Amino-6-Chloro-4-Nitrophenol was greater than 2000 mg/kg for rats. In subchronic oral studies, the no-effec'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1586c1f2275d729454f'),\n",
       "  'Nome_comune': '2-Bromo-2-Nitropropane-1,3-Diol',\n",
       "  'INCI_name': '2-Bromo-2-Nitropropane-1,3-Diol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7e75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294550'),\n",
       "  'Nome_comune': '2-Chloro-p-Phenylenediamine',\n",
       "  'INCI_name': '2-Chloro-p-Phenylenediamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=93047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294551'),\n",
       "  'Nome_comune': '2-Chloro-p-Phenylenediamine Sulfate',\n",
       "  'INCI_name': '2-Chloro-p-Phenylenediamine Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=94047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294552'),\n",
       "  'Nome_comune': '2-Ethoxy ethoxy ethyl methacrylate',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c2e8f24f-d285-ec11-8d21-000d3a98a506',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f876505d-1527-c1b5-9039-df537f4c8677',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):61-73, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294553'),\n",
       "  'Nome_comune': '2-Methoxyethanol',\n",
       "  'INCI_name': 'Methoxyethanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3a222a6f-9948-4aa2-88f3-e730210fdc7f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b6624b41-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 18(S2):53-67, 1999',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/8019',\n",
       "   'valori': ['LD50 Rabbit dermal 1280 mg/kg',\n",
       "    'LD50 Rabbit oral 890 mg/kg',\n",
       "    'LD50 Mouse ip 2147 mg/kg',\n",
       "    'LD50 Mouse oral 2560 mg/kg',\n",
       "    'LD50 Rat iv 2140 mg/kg',\n",
       "    'LD50 Rat ip 2500 mg/kg',\n",
       "    'LD50 Rat oral 3400 mg/kg bw',\n",
       "    'LD50 Rat oral 2460 mg/kg',\n",
       "    'LD50 Mouse oral 2.8 g/kg /in oil solution; slightly higher if given in water/',\n",
       "    'LD50 Guinea pig oral 950 mg/kg',\n",
       "    'LCLo Rat inh 6.2 mg/L/4 hr',\n",
       "    'LD50 Rabbit ip 1450 mg/kg bw',\n",
       "    'LD50 Rabbit dermal 2000 mg/kg bw',\n",
       "    'LC50 Mouse inh 4.6 mg/L/7 hr',\n",
       "    'LC50 Mouse inh 1500 ppm/7 hr',\n",
       "    'LC50 Rat inh 1500 ppm/7 hr',\n",
       "    'LC50 Rat inh 4.7 mg/L/7 hr'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    'European Commission, ESIS; IUCLID Dataset, 2-methoxyethanol (109-86-4) p. 39 (2000 CD-ROM edition). Available from as of May 15, 2014 the Database Query page at: https://esis.jrc.ec.europa.eu/.',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V7 88\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    'European Commission, ESIS; IUCLID Dataset, 2-methoxyethanol (109-86-4) p. 44 (2000 CD-ROM edition). Available from as of May 15, 2014 the Database Query page at: https://esis.jrc.ec.europa.eu/.',\n",
       "    'European Commission, ESIS; IUCLID Dataset, 2-methoxyethanol (109-86-4) p. 53 (2000 CD-ROM edition). Available from as of May 15, 2014 the Database Query page at: https://esis.jrc.ec.europa.eu/.',\n",
       "    'European Commission, ESIS; IUCLID Dataset, 2-methoxyethanol (109-86-4) p. 43 (2000 CD-ROM edition). Available from as of May 15, 2014 the Database Query page at: https://esis.jrc.ec.europa.eu/.',\n",
       "    'European Commission, ESIS; IUCLID Dataset, 2-methoxyethanol (109-86-4) p. 47 (2000 CD-ROM edition). Available from as of May 15, 2014 the Database Query page at: https://esis.jrc.ec.europa.eu/.',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 1666\",\n",
       "    'European Commission, ESIS; IUCLID Dataset, 2-methoxyethanol (109-86-4) p. 43 (2000 CD-ROM edition). Available from as of May 15, 2014 the Database Query page at: https://esis.jrc.ec.europa.eu/.']},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ular malformations were observed. The teratogenic NOAEL was 16 mg/kg/day 2-Methoxyethanol. Approximately 36 mg/kg/day caused 50% embryomortality and decreased the surv',\n",
       "   'ted that the no observable adverse effect levels (NOAEL) for maternal and developmental toxicity were 1000 and 2000 mg/kg/day Ethylene Glycol, respectively, when ad- ministere'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['36 mg/kg/day', '2000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294554'),\n",
       "  'Nome_comune': '2-Methyl-5-Hydroxyethylaminophenol',\n",
       "  'INCI_name': '2-Methyl-5-Hydroxyethylaminophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294555'),\n",
       "  'Nome_comune': '2-Methylresorcinol',\n",
       "  'INCI_name': '2-Methylresorcinol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=30a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294556'),\n",
       "  'Nome_comune': '2-Nitro-p-Phenylenediamine',\n",
       "  'INCI_name': '2-Nitro-p-Phenylenediamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1596c1f2275d7294557'),\n",
       "  'Nome_comune': '2-Oleamido-1,3-Octadecanediol',\n",
       "  'INCI_name': '2-Oleamido-1,3-Octadecanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d8aa33db-1156-4826-bffe-b495d07bb710',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d7294558'),\n",
       "  'Nome_comune': '3-Methylamino-4-Nitrophenoxyethanol',\n",
       "  'INCI_name': '3-Methylamino-4-Nitrophenoxyethanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6378aa15-7c0f-4f49-89d2-c2273df5b598',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4f106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 2):41-51, 2008',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d7294559'),\n",
       "  'Nome_comune': '3-Nitro-p-Hydroxyethylaminophenol',\n",
       "  'INCI_name': '3-Nitro-p-Hydroxyethylaminophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5ad921b3-8e2d-49dc-9249-318c36bfb86b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455a'),\n",
       "  'Nome_comune': '4-Amino-2-Hydroxytoluene',\n",
       "  'INCI_name': '4-Amino-2-Hydroxytoluene',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=21a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455b'),\n",
       "  'Nome_comune': '4-Amino-2-Nitrophenol',\n",
       "  'INCI_name': '4-Amino-2-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=62bbeb0a-3e10-49e0-b0e4-0ff55c2f638f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455c'),\n",
       "  'Nome_comune': '4-Amino-3-Nitrophenol',\n",
       "  'INCI_name': '4-Amino-3-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=77d5b990-0a17-40f9-afd3-bb0585e3e1dc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455d'),\n",
       "  'Nome_comune': '4-Amino-m-Cresol',\n",
       "  'INCI_name': '4-Amino-m-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7677eb23-40de-4c20-9975-071b204be829',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7b8f7c68-8baf-7096-93cc-8c18aaf27356',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' rats was 1010 mg/kg bw, and i n male rats, the LD 50 was 870 mg/kg bw.   In Ames tests, 4 -Amino -m-Cresol was not muta',\n",
       "   'the urine within the first 8 h of  dosing.    The LD 50 for 4 -Amino -m-Cresol  (10%)  in the female mice was 908 mg/kg bw.  The LD 50 for the same test material in  female',\n",
       "   'ation not specified) on 2 consecutive days.2  The LD 50 was determined as 1000  mg/kg.  At least 1 mouse in all groups survived until d',\n",
       "   ' no macroscopic organ changes were observed.  The LD 50 for 4 -Amino -m-Cresol in the female mice was 908 mg/kg bw.  The  LD 50 in female rats was 1010 mg/kg bw, and in male rats, the LD 50 was 870 mg/kg bw.   '],\n",
       "  'contesti_noael': ['erved.  The no-observ ed-adverse -effect -level  (NOAEL ) was 60 mg/kg/d .  Repeated -dose toxicity studie s of 4-Amino -m',\n",
       "   ' ) to be 124.4  This calculation is based on  the NOAEL of 60 mg/kg bw/d from a 90 -d oral rat study and a systemic  expos',\n",
       "   'average adult body weight is 60 kg .  By using an NOAEL of  60 mg/kg bw/d derived from a 13- wk oral study ,2 the MOS was c',\n",
       "   'of 0.068%  for 0. 14% 4 -Amino -m- Cresol  and an NOAEL of 60 mg/kg bw/d.  The resulting MOS is approximately 380,000, whi',\n",
       "   'ately 380,000.  This  calculation is based on the NOAEL of 60 mg/kg bw/d from a 13- wk oral rat study and a n SED of 0.000158 mg/kg bw /d.  The  resulting MOS is greater than 10 0, which '],\n",
       "  'valori_ld50': ['870 mg/kg bw',\n",
       "   '908 mg/kg bw',\n",
       "   '1000  mg/kg',\n",
       "   '1010 mg/kg bw'],\n",
       "  'valori_noael': ['60 mg/kg/d',\n",
       "   '60 mg/kg bw/d',\n",
       "   '60 mg/kg bw/d',\n",
       "   '60 mg/kg bw/d',\n",
       "   '000158 mg/kg bw /d']},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455e'),\n",
       "  'Nome_comune': '4-Chloro-2-Aminophenol',\n",
       "  'INCI_name': '4-Chloro-2-Aminophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9957e9f9-7423-ef11-840b-0022482909f5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 23 (Suppl. 2):1-22, 2004',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['as between 1.54 and 2.0 g/kg and for females, the LD 50 was>2.0 g/kg (Henkel KGaA 1994). 5-Amino-6-Chloro- o-Cresol Ma'],\n",
       "  'contesti_noael': ['ed body weight gain in the highest dosegroup. The NOAEL was considered to be 90 mg/kg/day. Nodevelopmental toxicity was associated with tre'],\n",
       "  'valori_ld50': ['0 g/kg'],\n",
       "  'valori_noael': ['90 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d729455f'),\n",
       "  'Nome_comune': '4-Chlororesorcinol',\n",
       "  'INCI_name': '4-Chlororesorcinol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1af63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15a6c1f2275d7294560'),\n",
       "  'Nome_comune': '4-Hydroxybenzoic Acid',\n",
       "  'INCI_name': '4-Hydroxybenzoic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5ce58b93-04c3-4aa7-8a91-912227ba6f32',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl.1):5-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['nts, assuming a no observed adverse effect level (NOAEL) of 1,000 mg/kg/d from an older DART study.2After careful considera',\n",
       "   'al toxicity at that dose. The mater- nal toxicity NOAEL dose was 1,000 mg/kg bw/d. Parabens have been extensively studied to evalua',\n",
       "   'r com- bined paraben use in a single formulation. NOAEL/MOS (adult, multiple paraben) ¼SED¼160 mg/kg/d/100 ¼1.6 mg/kg/d (SED /C2body weight)/ (dermal absorption /C2conve',\n",
       "   'entration tested (10,000 ppm), corresponding to a NOAEL of 1,141.1 +58.9 and 1,087.6 +67.8 mg/kg/d for Methylparaben and Butylparaben, respectively ',\n",
       "   'a, tumor necrosis factor a. 34Scorresponding to a NOAEL of about 1,140 and 1,100 mg/kg/d for Methylparaben and Butylparaben, respectively.',\n",
       "   'nd DART studies, the Panel determined an adequate NOAEL value of 160 mg/kg/d for Butylparaben. An MOS was recalculated accordi',\n",
       "   '90, compared to controls The results suggested an NOAEL of 160 mg/kg bw/d for Butylparaben for male reproduction and develo',\n",
       "   'risk assessment, the Panel determined an adequate NOAEL value of 160 mg/kg/d for Butylparaben in consideration of the new data',\n",
       "   'vative risk assessment was performed. Therein, an NOAEL value of 160 mg/kg/d for Butylparaben was deter- mined to be adequate ',\n",
       "   'tion of all the new data, the Panel determined an NOAEL of 160 mg/kg bw/d for Butylparaben. The Panel determined the differ'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg bw/d',\n",
       "   '6 mg/kg/d',\n",
       "   '8 mg/kg/d',\n",
       "   '100 mg/kg/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg bw/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294561'),\n",
       "  'Nome_comune': '4-Hydroxypropylamino-3-Nitrophenol',\n",
       "  'INCI_name': '4-Hydroxypropylamino-3-Nitrophenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=232d97ca-a20a-4526-a3b4-aef5c9c55fb2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):217-251, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294562'),\n",
       "  'Nome_comune': '4-Methoxy-m-Phenylenediamine',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5fb7939c-df8d-4283-b9e9-45cef73759f3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fe6224f9-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 11(4):381-422, 1992',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294563'),\n",
       "  'Nome_comune': '4-Methoxy-m-Phenylenediamine Sulfate',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c1838f1d-ef27-46d0-9cdc-89a856dd2277',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fe6224f9-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 11(4):381-422, 1992',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294564'),\n",
       "  'Nome_comune': '4-Methoxy-m-Phenylenediamine-HCI',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5a08f95e-036f-4472-bdd9-125a27d6b69c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fe6224f9-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 11(4):381-422, 1992',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294565'),\n",
       "  'Nome_comune': '4-Nitro-m-Phenylenediamine',\n",
       "  'INCI_name': '4-Nitro-m-Phenylenediamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=34f197ac-c3bc-408a-8001-5c84e8983a5b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b177eaf5-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 11(4):489-495, 1992',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294566'),\n",
       "  'Nome_comune': '4-Nitro-o-Phenylenediamine',\n",
       "  'INCI_name': '4-Nitro-o-Phenylenediamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8d75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15b6c1f2275d7294567'),\n",
       "  'Nome_comune': '5-Amino-4-Chloro-o-Cresol',\n",
       "  'INCI_name': '5-Amino-4-Chloro-o-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c672931c-f7bd-ed11-83ff-00224824e39e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=022b1d54-27f0-61b3-84c9-84f8cd262808',\n",
       "  'pdf_date': 'December 05, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['f  1184, 1539, and  2000 mg/kg.2  For males, the  LD 50 was between 1539  and 2000  mg/kg and for females, the LD 50 was >2 000  mg/kg.  Acute toxicity studies of 5-Amino -4-Chloro -o-'],\n",
       "  'contesti_noael': ['ted.  The no-observable -adverse -effect -level  (NOAEL) was 180 mg/kg/d .  Repeated -dose toxicity studies of  5-Amino -4',\n",
       "   ' protective) .4  This calculation is based on the NOAEL of 180  mg/kg bw/d from a  90-d oral rat study and a systemic exposu',\n",
       "   'd a n SED value of 0.83  mg/kg.  By employing the NOAEL of 180 mg/kg bw/d derived from the 90 -d oral rat study, the MOS wa',\n",
       "   'CCP  to be 947.  This calculation was based on an NOAEL of 180 mg/kg bw/d from a 90-d oral rat study and an SED of 0.19  mg'],\n",
       "  'valori_ld50': ['000  mg/kg'],\n",
       "  'valori_noael': ['180 mg/kg/d',\n",
       "   '180  mg/kg bw/d',\n",
       "   '180 mg/kg bw/d',\n",
       "   '180 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d7294568'),\n",
       "  'Nome_comune': '5-Amino-4-Chloro-o-Cresol HCl',\n",
       "  'INCI_name': '5-Amino-4-Chloro-o-Cresol HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=12499228-f7bd-ed11-83ff-00224824e39e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=022b1d54-27f0-61b3-84c9-84f8cd262808',\n",
       "  'pdf_date': 'December 05, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['f  1184, 1539, and  2000 mg/kg.2  For males, the  LD 50 was between 1539  and 2000  mg/kg and for females, the LD 50 was >2 000  mg/kg.  Acute toxicity studies of 5-Amino -4-Chloro -o-'],\n",
       "  'contesti_noael': ['ted.  The no-observable -adverse -effect -level  (NOAEL) was 180 mg/kg/d .  Repeated -dose toxicity studies of  5-Amino -4',\n",
       "   ' protective) .4  This calculation is based on the NOAEL of 180  mg/kg bw/d from a  90-d oral rat study and a systemic exposu',\n",
       "   'd a n SED value of 0.83  mg/kg.  By employing the NOAEL of 180 mg/kg bw/d derived from the 90 -d oral rat study, the MOS wa',\n",
       "   'CCP  to be 947.  This calculation was based on an NOAEL of 180 mg/kg bw/d from a 90-d oral rat study and an SED of 0.19  mg'],\n",
       "  'valori_ld50': ['000  mg/kg'],\n",
       "  'valori_noael': ['180 mg/kg/d',\n",
       "   '180  mg/kg bw/d',\n",
       "   '180 mg/kg bw/d',\n",
       "   '180 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d7294569'),\n",
       "  'Nome_comune': '5-Amino-6-Chloro-o-Cresol',\n",
       "  'INCI_name': '5-Amino-6-Chloro-o-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a73b31bd-e5bd-ed11-83ff-00224824e39e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=26b686af-79a6-00d2-bbb4-f77ce51f0ce0',\n",
       "  'pdf_date': 'June 13, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['inal position, cramps, and uttering of tone.  The LD 50 of the test material was determined to be  1200 mg/kg bw.   Subchronic Toxicity Studies   Oral   In a 13- ',\n",
       "   'µg/cm2.  In an acute oral study in male mice, the LD 50 for 5 -Amino -6-Chloro -o-Cresol was 1200 mg/kg bw.  The NOAEL in a  90-d oral study  of 5-Amino -6-',\n",
       "   'CAL STUDIES   Acute Toxicity Studies   Oral   The LD 50 was 1360 mg/kg in a gavage study of male rats that received  5-Am'],\n",
       "  'contesti_noael': ['body weight gain in the highest dose  group.  The NOAEL was considered to be  90 mg/kg/day.   Additional d evelopment  and reproductive toxi',\n",
       "   'ects persisted through the  recovery period.  The NOAEL was established at 100 mg/kg/d; however, the SCCS noted that this value should b',\n",
       "   'Amino -6-Chloro -o-Cresol was 1200 mg/kg bw.  The NOAEL in a  90-d oral study  of 5-Amino -6-Chloro -o-cresol at 0, 100, 300, or 600 mg/kg/d bw  in rats was 100 mg/kg/d.  Adverse effects  in'],\n",
       "  'valori_ld50': ['1200 mg/kg bw', '1200 mg/kg bw', '1360 mg/kg '],\n",
       "  'valori_noael': ['90 mg/kg/day', '100 mg/kg/d', '600 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456a'),\n",
       "  'Nome_comune': '5-Bromo-5-Nitro-1,3-Dioxane',\n",
       "  'INCI_name': '5-Bromo-5-Nitro-1,3-Dioxane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9a047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456b'),\n",
       "  'Nome_comune': '6-Amino-m-Cresol',\n",
       "  'INCI_name': '6-Amino-m-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=42cc4d10-1777-ed11-81ab-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ed051618-c16f-5387-8646-4ab6e9cd2a5d',\n",
       "  'pdf_date': 'September 12, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['L S TUDIES   Acute Toxicity  Studies   Oral   The LD 50 was calculated to be 1500 mg/kg in an acute study of male CD -1 mice dosed for 2 c'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1500 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456c'),\n",
       "  'Nome_comune': '6-Amino-o-Cresol',\n",
       "  'INCI_name': '6-Amino-o-Cresol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5274c358-1777-ed11-81ab-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9cf3627c-a53e-a518-85e7-cfa3eea92d6c',\n",
       "  'pdf_date': 'September 12, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456d'),\n",
       "  'Nome_comune': '6-Hydroxyindole',\n",
       "  'INCI_name': '6-Hydroxyindole',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0291cd73-e9cc-41c1-9d78-7e4d6709c538',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a97bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 3):24-35, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['g/kg body weight and the oral median lethal dose (LD 50) was greater than 600 mg/kg body weight. In a preliminary range-finding study, 4 of 4 ani'],\n",
       "  'contesti_noael': ['cluded that the no observed adverse effect level (NOAEL) was 100 mg/kg body weight/d.25 Reproductive and Developmental Toxicity In a t',\n",
       "   'dole were observed. This study concluded that the NOAEL for general toxicity was 25 mg/kg body weight/d and the NOEL for carcinogenicity was 100 mg/kg body weight/d.36 Irritation and Sensitization Irritation Dermal',\n",
       "   'of 6-hydroxyindole up to 300 mg/kg/d in rats, the NOAEL was 100 mg/kg body weight/d. Female high-dose rats had a sta tistically signi',\n",
       "   'inogenicity study of 6-hydroxyindole in rats, the NOAEL for general toxicity was 25 mg/kg body weight/d and the NOEL for carcinogenicity was 100 mg/kg body weight/d, the highest dose tested. Decreased body weight g',\n",
       "   'nal NOAEL was 150 mg/kg body weight and the fetal NOAEL was 50 mg/kg body weight in an oral rat teratol- ogy study of 6-hydroxyindole up to 450 mg/kg/d. High dose dams had slightly lower body weight ga'],\n",
       "  'valori_ld50': ['600 mg/kg body weight'],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg body weight/d',\n",
       "   '100 mg/kg body weight/d',\n",
       "   '100 mg/kg body weight/d',\n",
       "   '450 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456e'),\n",
       "  'Nome_comune': 'Acacia Catechu',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=db49395b-e1d5-4f49-8cc4-9f46ff275907',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=20debc46-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 20, 1998',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15c6c1f2275d729456f'),\n",
       "  'Nome_comune': 'Acacia Catechu Gum',\n",
       "  'INCI_name': 'Acacia Catechu Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e80685b6-322c-486e-9e43-3a421fb955b4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294570'),\n",
       "  'Nome_comune': 'Acacia Concinna',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0a1aa0f9-b1b1-4a92-9e24-e4e97ff90a1b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294571'),\n",
       "  'Nome_comune': 'Acacia Concinna Extract',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=80c972a0-577a-4884-8c4d-211f29a098eb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=20debc46-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 20, 1998',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294572'),\n",
       "  'Nome_comune': 'Acacia Concinna Fruit Extract',\n",
       "  'INCI_name': 'Acacia Concinna Fruit Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=63514e63-6517-43ff-8566-457ed951e843',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294573'),\n",
       "  'Nome_comune': 'Acacia Dealbata',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3c1d642e-73a5-4144-baf6-8fe6f6743e57',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294574'),\n",
       "  'Nome_comune': 'Acacia Dealbata Extract',\n",
       "  'INCI_name': 'Acacia Dealbata Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1efa9d3d-2b0e-4305-a472-8f3ed4d9f87b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294575'),\n",
       "  'Nome_comune': 'Acacia Dealbata Leaf Extract',\n",
       "  'INCI_name': 'Acacia Dealbata Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ef6098d9-502e-4234-a969-25687ef8a07b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294576'),\n",
       "  'Nome_comune': 'Acacia Dealbata Leaf Wax',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=339c76f9-49a2-427b-9a12-41c915decd9d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15d6c1f2275d7294577'),\n",
       "  'Nome_comune': 'Acacia Decurrens',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=14ef418b-6d7e-4ae0-b6bb-0e4f84a42fd8',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d7294578'),\n",
       "  'Nome_comune': 'Acacia Decurrens Extract',\n",
       "  'INCI_name': 'Acacia Decurrens Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c86345ca-fd4d-4bac-a042-42176130b5d1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d7294579'),\n",
       "  'Nome_comune': 'Acacia Farnesiana',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dbef23d2-40df-4ee5-bb96-807712244b0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457a'),\n",
       "  'Nome_comune': 'Acacia Farnesiana Extract',\n",
       "  'INCI_name': 'Acacia Farnesiana Flower/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87a4cdfa-20ab-4975-9273-5beca3bc49b7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457b'),\n",
       "  'Nome_comune': 'Acacia Farnesiana Flower Wax',\n",
       "  'INCI_name': 'Acacia Farnesiana Flower Wax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e9cb237d-24be-4eb5-b805-3b645027ac0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457c'),\n",
       "  'Nome_comune': 'Acacia Farnesiana Flower/Stem Extract',\n",
       "  'INCI_name': 'Acacia Farnesiana Flower/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e9fa803-e3f3-4f15-9c77-9033aa06f91d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457d'),\n",
       "  'Nome_comune': 'Acacia Farnesiana Gum',\n",
       "  'INCI_name': 'Acacia Farnesiana Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=80aaf866-3f12-4ccc-981e-073036d2f860',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457e'),\n",
       "  'Nome_comune': 'Acacia Senegal',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e97a71cd-ec24-4e26-b6ae-324e7b597a54',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15e6c1f2275d729457f'),\n",
       "  'Nome_comune': 'Acacia Senegal Extract',\n",
       "  'INCI_name': 'Acacia Senegal Flower/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad4dc545-1d18-45a5-9c67-6972fbdf27a7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294580'),\n",
       "  'Nome_comune': 'Acacia Senegal Flower/Stem Extract',\n",
       "  'INCI_name': 'Acacia Senegal Flower/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a505f2cb-7603-446c-9ff0-95f468979a9f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294581'),\n",
       "  'Nome_comune': 'Acacia Senegal Gum',\n",
       "  'INCI_name': 'Acacia Senegal Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b78d3d8f-c353-ee11-be6f-002248227d1f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294582'),\n",
       "  'Nome_comune': 'Acacia Senegal Gum Extract',\n",
       "  'INCI_name': 'Acacia Senegal Gum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8472ffa1-c353-ee11-be6f-002248227d1f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ffb5313b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 3):75-118, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294583'),\n",
       "  'Nome_comune': 'Acetamide MEA',\n",
       "  'INCI_name': 'Acetamide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a3047ec9-237a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=face160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):73-127, 2011',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294584'),\n",
       "  'Nome_comune': 'Acetic Acid',\n",
       "  'INCI_name': 'Acetic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5cd5b22a-d48b-4e6b-ba06-92c85d2060b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b8106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):112-136, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/176',\n",
       "   'valori': ['LD50 Rat oral 3.53 g/kg',\n",
       "    'LD50 Mouse iv 525 mg/kg',\n",
       "    'LD50 Rabbit dermal 1060 mg/kg',\n",
       "    'LD50 Mouse oral 4960 mg/kg',\n",
       "    'LD50 Rabbit sc 1200 mg/kg',\n",
       "    'LD50 Rabbit oral 1200 mg/kg',\n",
       "    'LD50 Rat oral 3.31 g/kg',\n",
       "    'LC50 Rat inhalation 11.4 mg/L /4 hr',\n",
       "    'LC50 Mouse inhalation 5,620 ppm/1 hr'],\n",
       "   'fonti': [\"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 11\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 16\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 16\",\n",
       "    'WHO Food Additive Series 64: Acetic acid (1967). Available from, as of February 9, 2004: https://www.inchem.org/documents/jecfa/jecmono/40abcj37.htm',\n",
       "    'WHO Food Additive Series 64: Acetic acid (1967). Available from, as of February 9, 2004: https://www.inchem.org/documents/jecfa/jecmono/40abcj37.htm',\n",
       "    'WHO Food Additive Series 64: Acetic acid (1967). Available from, as of February 9, 2004: https://www.inchem.org/documents/jecfa/jecmono/40abcj37.htm',\n",
       "    'WHO Food Additive Series 64: Acetic acid (1967). Available from, as of February 9, 2004: https://www.inchem.org/documents/jecfa/jecmono/40abcj37.htm',\n",
       "    \"EPA/Office of Pollution Prevention and Toxics; High production Volume (HPV) Challenge Program's Robust summaries and Test Plans. Acetic acid and Salts (April 2003). Available from, as of February 9, 2004: https://www.epa.gov/hpv/pubs/hpvrstp.htm\",\n",
       "    \"EPA/Office of Pollution Prevention and Toxics; High production Volume (HPV) Challenge Program's Robust summaries and Test Plans. Acetic acid and Salts (April 2003). Available from, as of February 9, 2004: https://www.epa.gov/hpv/pubs/hpvrstp.htm\"]},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294585'),\n",
       "  'Nome_comune': 'Acetic/Linoleic/Palmitic Triglyceride',\n",
       "  'INCI_name': 'Acetic/Linoleic/Palmitic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b0e7571e-2d72-4a2b-a1c6-0c1428da9486',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294586'),\n",
       "  'Nome_comune': 'Acetyl Arginine',\n",
       "  'INCI_name': 'Acetyl Arginine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7a8d2616-7670-46df-9b4c-5e224499f733',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed15f6c1f2275d7294587'),\n",
       "  'Nome_comune': 'Acetyl Carnitine',\n",
       "  'INCI_name': 'Acetyl Carnitine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e79446ba-83c8-4507-a04a-9d7a8d4075e9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d7294588'),\n",
       "  'Nome_comune': 'Acetyl Carnitine HCl',\n",
       "  'INCI_name': 'Acetyl Carnitine HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a0235c4e-aa25-4257-994b-686bde861d89',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d7294589'),\n",
       "  'Nome_comune': 'Acetyl Cysteine',\n",
       "  'INCI_name': 'Acetyl Cysteine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cadc1ba9-749d-4de4-bd97-cebefe529af3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458a'),\n",
       "  'Nome_comune': 'Acetyl Glucosamine',\n",
       "  'INCI_name': 'Acetyl Glucosamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=046461de-7246-4381-a99c-b6c6d15508bd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a70fc38-f9c8-b5a2-86f7-f3c19ae76f6a',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ier, the acute oral LD 50 for Glucosamine HCl was  reported to be 15,000 mg/kg bw in mice.2    Short -Term Toxicity  Studies   Oral ',\n",
       "   'r, the acute oral LD 50 for Glucosamine HCl was reported to be  15,000 mg/kg bw in mice.   In a 9 -wk study, Glucosamine (0.5%) wa',\n",
       "   '  LD 50 > 8000  mg/kg  26  Glucosamine  Mice (strain unspecified)  NR 15,000  mg/kg ; gavage  LD 50 > 15,000  mg/kg  26  Glucosamine  Sprague -Dawley Rat  NR 8000 mg/k',\n",
       "   'g (method of oral  administration not specified)  LD 50 = 15,000  mg/kg  2    NR = Not reported     Table 6.  Dermal irrita',\n",
       "   'imals  No. /group  Dose /Route of Administration  LD 50/Results  Reference   Glucosamine  Mice (strain unspecified)  NR 5000 mg/kg ; gavage  LD 50 > 5000  mg/kg  26  Glucosamine  CD-1 Mice  NR 8000 mg/kg ; gavage',\n",
       "   'und in Table 5.  The reported median lethal dose (LD 50) values for Glucosamine were higher than the doses tested ( > 15,000 mg/kg in  mice and > 8000 mg/kg in rats and rabbits).26  According to an ECHA doss',\n",
       "   ' administration of Glucosamine HCl . The reported LD 50 values for Glucosamine were higher than the doses tested ( > 15,00 0 mg/kg in mice and > 8000  mg/kg in rats and rabbits).  According to an ECHA dossie',\n",
       "   'g ; gavage  LD 50 > 8000  mg/kg ; no adverse effects reported  26  Glucosamine  Rabbit (strain unspecified)  NR 8000 mg/kg ; gavage  LD 50 > 8000 mg/kg  26  Glucosamine HCl'],\n",
       "  'contesti_noael': ['ere calculated assuming 100% dermal absorption, a NOAEL value of 430 mg/kg/d (obtain ed from a repeated  oral dose toxicity as'],\n",
       "  'valori_ld50': ['000 mg/kg bw ',\n",
       "   '000 mg/kg bw ',\n",
       "   '000  mg/kg  ',\n",
       "   '000  mg/kg  ',\n",
       "   '5000  mg/kg  ',\n",
       "   '8000 mg/kg ',\n",
       "   '8000  mg/kg ',\n",
       "   '8000 mg/kg'],\n",
       "  'valori_noael': ['430 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458b'),\n",
       "  'Nome_comune': 'Acetyl Glutamic Acid',\n",
       "  'INCI_name': 'Acetyl Glutamic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3bfe92a6-deed-4c0a-8a4c-33280d1f0b40',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458c'),\n",
       "  'Nome_comune': 'Acetyl Glutamine',\n",
       "  'INCI_name': 'Acetyl Glutamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=988d1c5e-68bd-4c7c-a76e-e066bb896953',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458d'),\n",
       "  'Nome_comune': 'Acetyl Hexapeptide-8',\n",
       "  'INCI_name': 'Acetyl Hexapeptide-8',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3bb45a94-6b17-4ecd-92dd-d76891fb4e65',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a1f5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ubstance was non -toxic when administered orally (LD 50 > 2500 mg/kg ).   Short-Term, Subchronic , and Chronic  Toxici',\n",
       "   'ubstance was non -toxic when administered orally (LD 50 > 2500 mg/kg ).  Acetyl Hex apeptide -8 Amide was evaluated fo'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2500 mg/kg', '2500 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458e'),\n",
       "  'Nome_comune': 'Acetyl Hexapeptide-8 Amide',\n",
       "  'INCI_name': 'Acetyl Hexapeptide-8 Amide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=11a45db9-41b3-44b0-8db2-084e1f511049',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a1f5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ubstance was non -toxic when administered orally (LD 50 > 2500 mg/kg ).   Short-Term, Subchronic , and Chronic  Toxici',\n",
       "   'ubstance was non -toxic when administered orally (LD 50 > 2500 mg/kg ).  Acetyl Hex apeptide -8 Amide was evaluated fo'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2500 mg/kg', '2500 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d729458f'),\n",
       "  'Nome_comune': 'Acetyl Histidine',\n",
       "  'INCI_name': 'Acetyl Histidine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ee6da64e-5b64-43ba-91b1-e62609a51de9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1606c1f2275d7294590'),\n",
       "  'Nome_comune': 'Acetyl Methionine',\n",
       "  'INCI_name': 'Acetyl Methionine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=534aa127-804f-481e-9863-d3277a006853',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294591'),\n",
       "  'Nome_comune': 'Acetyl Proline',\n",
       "  'INCI_name': 'Acetyl Proline',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=035da07d-ea1d-402a-b2e0-f16258e79ddc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294592'),\n",
       "  'Nome_comune': 'Acetyl Tributyl Citrate',\n",
       "  'INCI_name': 'Acetyl Tributyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=672d8fff-b26b-4577-ab86-27c43d4f5910',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/6505',\n",
       "   'valori': ['LD50 Rat oral 31.4 g/kg',\n",
       "    'LD50 Mouse ip >4 g/kg',\n",
       "    'LD50 Cat oral >50 mL/kg'],\n",
       "   'fonti': ['Sheftel, V.O.; Indirect Food Additives and Polymers. Migration and Toxicology. Lewis Publishers, Boca Raton, FL. 2000., p. 193',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 3512\",\n",
       "    \"EPA/Office of Pollution Prevention and Toxics; High Production Volume (HPV) Challenge Program's Robust Summaries and Test Plans. Acetyltributyl Citrate. Available from, as of May 28, 2015: https://www.epa.gov/hpv/pubs/hpvrstp.htm\"]},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294593'),\n",
       "  'Nome_comune': 'Acetyl Triethyl Citrate',\n",
       "  'INCI_name': 'Acetyl Triethyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aeae8b8b-2e62-4c78-870d-9c3e7984d697',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294594'),\n",
       "  'Nome_comune': 'Acetyl Triethylhexyl Citrate',\n",
       "  'INCI_name': 'Acetyl Triethylhexyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b958b55b-4703-4ba2-acf1-774ca4417ff8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294595'),\n",
       "  'Nome_comune': 'Acetyl Trihexyl Citrate',\n",
       "  'INCI_name': 'Acetyl Trihexyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2af2fdea-7537-4272-a752-635c10f788e8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294596'),\n",
       "  'Nome_comune': 'Acetyl Trioctyl Citrate',\n",
       "  'INCI_name': 'Acetyl Triethylhexyl Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=025cc295-72dd-45a3-9159-451aa7850327',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8a7e1b0e-c0c9-649b-8855-823f80c809c9',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):7-9, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294597'),\n",
       "  'Nome_comune': 'Acetyl Tyrosine',\n",
       "  'INCI_name': 'Acetyl Tyrosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1793fd51-fb71-4d14-8333-1793a70dbb09',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1616c1f2275d7294598'),\n",
       "  'Nome_comune': 'Acetylated Lanolin',\n",
       "  'INCI_name': 'Acetylated Lanolin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ae345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fd11d33d-1cf7-f5c2-b131-d6a2e397b0c4',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['.1  In  a 2-dose (1 or 2 g/kg) study in rats, the LD 50 of Hydroxylated Lanolin was found to be greater than 2.0 g/kg.   Each of the 9 l anolin ingredients has been te',\n",
       "   'cle  Animals/Group  Concentration/Dose  Protocol  LD 50/LC 50/Results  Reference   DERMAL   Lanolin Acid  arachis oil  5 male and 5 female Wistar  rats 2000 mg/kg bw  Acute dermal study performed in accordance  with O',\n",
       "   ' observed in these studies.  In oral studies, the LD 50 for undiluted Hydroxylated Lanolin was > 10 ml/kg  in rats.7  The LD 50 for Lanolin Alcohol was > 5000 mg/kg.11  Subchronic Toxicity Studies   Oral   Lanolin ',\n",
       "   'd in thes e studies.  In  acute oral studies, the LD 50 for undiluted Hydroxylated  Lanolin was > 10 ml/kg in rats.  The LD 50 for Lanolin Alcohol was > 5000 mg/kg.   In separate 90 -d rat studies, the oral  NOAEL'],\n",
       "  'contesti_noael': ['logy.  The no -observable -adverse- effect level (NOAEL) for Lanolin Acid in this study was greater than 1000 mg/kg bw/d. 10  Lanolin Alcohol   In another  90-d oral repe',\n",
       "   'lation of the test material during  dosing.   The NOAEL for Lanolin Alcohol in this study was greater than 1000 mg/kg bw/d.11  DEVELOPMENTAL AND REPRODUCTIVE TOXICITY  STUD',\n",
       "   'ratio or in the fetuses during examination.  The  NOAEL for maternal and developmental toxicity for Lanolin Alcohol in this study was ≥ 1000 mg/kg bw/d.10  Lanolin Alcohol   In an oral developmental to',\n",
       "   'ere were no findings of known malformations.  The NOAEL for  maternal and developmental toxicity for Lanolin Alcohol in this study was > 1000 mg/kg bw/d.11  GENOTOXICITY STUDIES   In vitro genotoxicity ',\n",
       "   'mg/kg.   In separate 90 -d rat studies, the oral  NOAEL was determined to be greater than 1000 mg/kg bw/d for Lanol in Acid and Lanolin Alcohol.  The NOAEL'],\n",
       "  'valori_ld50': ['0 g/kg', '2000 mg/kg bw  ', '5000 mg/kg', '5000 mg/kg'],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1626c1f2275d7294599'),\n",
       "  'Nome_comune': 'Acetylated Lanolin Alcohol',\n",
       "  'INCI_name': 'Acetylated Lanolin Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a5345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fd11d33d-1cf7-f5c2-b131-d6a2e397b0c4',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['.1  In  a 2-dose (1 or 2 g/kg) study in rats, the LD 50 of Hydroxylated Lanolin was found to be greater than 2.0 g/kg.   Each of the 9 l anolin ingredients has been te',\n",
       "   'cle  Animals/Group  Concentration/Dose  Protocol  LD 50/LC 50/Results  Reference   DERMAL   Lanolin Acid  arachis oil  5 male and 5 female Wistar  rats 2000 mg/kg bw  Acute dermal study performed in accordance  with O',\n",
       "   ' observed in these studies.  In oral studies, the LD 50 for undiluted Hydroxylated Lanolin was > 10 ml/kg  in rats.7  The LD 50 for Lanolin Alcohol was > 5000 mg/kg.11  Subchronic Toxicity Studies   Oral   Lanolin ',\n",
       "   'd in thes e studies.  In  acute oral studies, the LD 50 for undiluted Hydroxylated  Lanolin was > 10 ml/kg in rats.  The LD 50 for Lanolin Alcohol was > 5000 mg/kg.   In separate 90 -d rat studies, the oral  NOAEL'],\n",
       "  'contesti_noael': ['logy.  The no -observable -adverse- effect level (NOAEL) for Lanolin Acid in this study was greater than 1000 mg/kg bw/d. 10  Lanolin Alcohol   In another  90-d oral repe',\n",
       "   'lation of the test material during  dosing.   The NOAEL for Lanolin Alcohol in this study was greater than 1000 mg/kg bw/d.11  DEVELOPMENTAL AND REPRODUCTIVE TOXICITY  STUD',\n",
       "   'ratio or in the fetuses during examination.  The  NOAEL for maternal and developmental toxicity for Lanolin Alcohol in this study was ≥ 1000 mg/kg bw/d.10  Lanolin Alcohol   In an oral developmental to',\n",
       "   'ere were no findings of known malformations.  The NOAEL for  maternal and developmental toxicity for Lanolin Alcohol in this study was > 1000 mg/kg bw/d.11  GENOTOXICITY STUDIES   In vitro genotoxicity ',\n",
       "   'mg/kg.   In separate 90 -d rat studies, the oral  NOAEL was determined to be greater than 1000 mg/kg bw/d for Lanol in Acid and Lanolin Alcohol.  The NOAEL'],\n",
       "  'valori_ld50': ['0 g/kg', '2000 mg/kg bw  ', '5000 mg/kg', '5000 mg/kg'],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459a'),\n",
       "  'Nome_comune': 'Achillea Millefolium Extract',\n",
       "  'INCI_name': 'Achillea Millefolium Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e23f50e9-d948-4aa7-9a1a-fce28399835a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=234cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):5-15, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459b'),\n",
       "  'Nome_comune': 'Achillea Millefolium Flower Extract',\n",
       "  'INCI_name': 'Achillea Millefolium Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=44237a51-38bf-4df1-8911-12e57f49429e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=234cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):5-15, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459c'),\n",
       "  'Nome_comune': 'Achillea Millefolium Flower/Leaf/Stem Extract',\n",
       "  'INCI_name': 'Achillea Millefolium Flower/Leaf/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=de965a65-cfb0-4c0c-ba96-cd752c0e8fab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=234cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):5-15, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459d'),\n",
       "  'Nome_comune': 'Acid Orange 3',\n",
       "  'INCI_name': 'Acid Orange 3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4223bcbe-6044-4cec-8bea-457ba4d26c97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4437e464-5a8b-18fb-8bf4-15943e8a7823',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):10-11, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459e'),\n",
       "  'Nome_comune': 'Acid Violet 43',\n",
       "  'INCI_name': 'Acid Violet 43',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b8638a9d-fcb5-4029-98e1-82e6c2908824',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f6b7d52c-2d34-dab9-a522-21c81efb2a28',\n",
       "  'pdf_date': 'IJT 40(Suppl. 2):5-15, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['re observed. The no-observed adverse effect level(NOAEL) was 200 mg/kg bw/d Acid Violet 43 (109 mg dye/kg bw/d), based on the',\n",
       "   'to800 mg/kg bw/d Acid Violet 43 (54.4 %pure), the NOAEL was 200 mg/kg bw/d Acid Violet 43 (109 mg dye/kg bw/d), based onincr',\n",
       "   'ibuted to treat-ment with the test substance. The NOAEL was 800 mg/kg bw/d(435 mg dye/kg bw/d) for teratogenicity and matern',\n",
       "   'ted to treatment with the test substance, and the NOAEL was 800 mg/kg bw/d for teratogenicity and maternal toxicity. In a st',\n",
       "   'ed incidental. According to the research-ers, the NOAEL was 1000 mg/kg bw/d Ext. D&C Violet No. 2(940 mg dye/kg bw/d). Howeve',\n",
       "   's were similar forcontrol and treated groups. The NOAEL for teratogenicity andmaternal toxicity was 1000 mg/kg bw/d (940 mg dye/kg bw/d). Genotoxicity Studies In Vit',\n",
       "   ' mg dye/kgbw/d) on days 6 to 17 of gestation, the NOAEL for teratogenicityand maternal toxicity was 1000 mg/kg bw/d. Acid Violet 43 (54.4 %pure) and Ext. D&C Violet '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg bw/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '800 mg/kg bw/d',\n",
       "   '800 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1626c1f2275d729459f'),\n",
       "  'Nome_comune': 'Acrylamide',\n",
       "  'INCI_name': 'Acrylamide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=428fb52a-b0b2-4e36-8faf-2632aea4c24c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=035b3c2f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 2):21-50, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/6579',\n",
       "   'valori': ['LD50 Mouse ip 170 mg/kg',\n",
       "    'LD50 Rat dermal 1.68 ml/kg',\n",
       "    'LD50 Rat oral 124 mg/kg',\n",
       "    'LD50 Rat skin 400 mg/kg',\n",
       "    'LD50 Rat ip 90 mg/kg',\n",
       "    'LD50 Mouse oral 107 mg/kg',\n",
       "    'LD50 Guinea pig sc 170 mg/kg',\n",
       "    'LD50 Rabbit skin 1680 uL/kg',\n",
       "    'LD50 Rabbit oral 150 mg/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 69\",\n",
       "    'Patricia A et al; J Am Coll Toxicol 1 (2): 115-116 (1990)',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 68\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 69\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 69\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 69\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 69\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 69\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 69\"]},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1626c1f2275d72945a0'),\n",
       "  'Nome_comune': 'Acrylamide/Ammonium Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Ammonium Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3a17189b-3eef-43e4-aba5-6222aab3847c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1626c1f2275d72945a1'),\n",
       "  'Nome_comune': 'Acrylamide/Ethyltrimonium Chloride Acrylate/Ethalkonium Chloride Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Ethyltrimonium Chloride Acrylate/Ethalkonium Chloride Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5a3b92e1-42c0-4ac0-8f89-a9907f3a3c82',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a2'),\n",
       "  'Nome_comune': 'Acrylamide/Sodium Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Sodium Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=93dd8269-eea2-41a4-81ec-c2463fc16bb7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a3'),\n",
       "  'Nome_comune': 'Acrylamide/Sodium Acryloyldimethyltaurate Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Sodium Acryloyldimethyltaurate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4d4730f3-6fb1-4ce9-8b75-e0a5dc2f2ea9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a4'),\n",
       "  'Nome_comune': 'Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer',\n",
       "  'INCI_name': 'Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=84657cc6-7a06-4c45-82bd-b3ea37a0c6a9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a5'),\n",
       "  'Nome_comune': 'Acrylamidopropyltrimonium Chloride/Acrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylamidopropyltrimonium Chloride/Acrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=69286b2f-0555-404d-a3ff-2bb783c3803c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a6'),\n",
       "  'Nome_comune': 'Acrylamidopropyltrimonium Chloride/Acrylates Copolymer',\n",
       "  'INCI_name': 'Acrylamidopropyltrimonium Chloride/Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c9fa268d-a668-4928-b746-2cf43e1bf4e1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a7'),\n",
       "  'Nome_comune': 'Acrylates Copolymer',\n",
       "  'INCI_name': 'Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1212a6cb-8490-4f18-9539-11b8df473486',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a8'),\n",
       "  'Nome_comune': 'Acrylates Crosspolymer',\n",
       "  'INCI_name': 'Acrylates Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=769074f7-d148-4165-9000-2e15a0ca7a5e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945a9'),\n",
       "  'Nome_comune': 'Acrylates Crosspolymer-3',\n",
       "  'INCI_name': 'Acrylates Crosspolymer-3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9650429d-f40e-408a-9d04-a6370c1873b9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1636c1f2275d72945aa'),\n",
       "  'Nome_comune': 'Acrylates Crosspolymer-4',\n",
       "  'INCI_name': 'Acrylates Crosspolymer-4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=46103364-1153-400f-a88e-307ae1b6c604',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945ab'),\n",
       "  'Nome_comune': 'Acrylates Crosspolymer-5',\n",
       "  'INCI_name': 'Acrylates Crosspolymer-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=468c1d43-bd35-43c0-b0f2-50c7e04eab09',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945ac'),\n",
       "  'Nome_comune': 'Acrylates/Acrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylates/Acrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b7c19dab-0272-44ae-a1e7-165991cb0be6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945ad'),\n",
       "  'Nome_comune': 'Acrylates/Ammonium Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Ammonium Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=35d3d850-94b6-4319-924c-e4511fbf581f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945ae'),\n",
       "  'Nome_comune': 'Acrylates/Beheneth-25 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Beheneth-25 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3d97dc2c-110a-4611-8725-1b2b1ccc8831',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945af'),\n",
       "  'Nome_comune': 'Acrylates/Beheneth-25 Methacrylate/Steareth-30 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Beheneth-25 Methacrylate/Steareth-30 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=777434c1-4060-4d07-9206-925a1f7440ae',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945b0'),\n",
       "  'Nome_comune': 'Acrylates/Bis-Hydroxypropyl Dimethicone Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Bis-Hydroxypropyl Dimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a6f725ce-64ac-4171-89e5-6e639eeca3ae',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945b1'),\n",
       "  'Nome_comune': 'Acrylates/C10-30 Alkyl Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/C10-30 Alkyl Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=94871191-15c0-40f5-9a9d-062cee15f759',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945b2'),\n",
       "  'Nome_comune': 'Acrylates/C10-30 Alkyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/C10-30 Alkyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=79a05996-2f38-4133-b9d6-e5d4ed6b2b00',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1646c1f2275d72945b3'),\n",
       "  'Nome_comune': 'Acrylates/C12-13 Alkyl Methacrylates/Methoxyethyl Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/C12-13 Alkyl Methacrylates/Methoxyethyl Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3778cbf4-879f-4a6e-8222-1c6f7d368c51',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b4'),\n",
       "  'Nome_comune': 'Acrylates/C12-22 Alkyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/C12-22 Alkyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d65231e-791f-441a-974b-74ab9eb614dd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b5'),\n",
       "  'Nome_comune': 'Acrylates/C26-28 Olefin Copolymer',\n",
       "  'INCI_name': 'Acrylates/C26-28 Olefin Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9be78183-875d-478c-af15-249e73b3d26e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b6'),\n",
       "  'Nome_comune': 'Acrylates/C5-8 Alkyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/C5-8 Alkyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=635a2b26-8d1c-4d6c-8ced-5a4bf874ae80',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b7'),\n",
       "  'Nome_comune': 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=228bbc84-c88f-481e-91de-8cbc009c3b9a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b8'),\n",
       "  'Nome_comune': 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer-2',\n",
       "  'INCI_name': 'Acrylates/Ceteareth-20 Methacrylate Crosspolymer-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=231453fb-9eac-43dd-a7a6-c86bb78e2c22',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945b9'),\n",
       "  'Nome_comune': 'Acrylates/Ceteth-20 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Ceteth-20 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dcd4c8f7-738e-4813-8a7d-0f66bcd76e4e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945ba'),\n",
       "  'Nome_comune': 'Acrylates/Dimethiconol Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Dimethiconol Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=618d44d3-e129-4b39-bd0d-e4016e2746bb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0c62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):31-50, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['he Dow Corning 2-1845 microemulsion was nontoxic (LD 50> 2 g/kg). An acute dermal toxicity study summary on Dow C',\n",
       "   'ning 60 000CSt, no cosolvent in corn oil (20%w/v; LD 50> 2 g/kg, rats). The latter test substance contains 95 %or',\n",
       "   's. Polymer FD 80 was also classified as nontoxic (LD 50> 2 g/kg) in a dermal toxicity study. Transient ocular irr',\n",
       "   'Dimethiconol stearate was classified as nontoxic (LD 50> 5 g/kg). Dermal. The acute dermal toxicity17of a mixture',\n",
       "   'c in an acute oral toxicity study involving rats (LD 50> 5 g/kg). Following a single dermal application of a mixt'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg', '2 g/kg', '2 g/kg', '5 g/kg', '5 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945bb'),\n",
       "  'Nome_comune': 'Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c1c10569-94d3-483e-ab89-4269249a9cbb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945bc'),\n",
       "  'Nome_comune': 'Acrylates/Ethylhexyl Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Ethylhexyl Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c456442f-61fb-463d-8cf3-2e626b462c6b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1656c1f2275d72945bd'),\n",
       "  'Nome_comune': 'Acrylates/Ethylhexyl Acrylate/Glycidyl Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Ethylhexyl Acrylate/Glycidyl Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87c65ea0-bd23-42ca-9a53-58f945edecc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945be'),\n",
       "  'Nome_comune': 'Acrylates/Ethylhexyl Acrylate/Styrene Copolymer',\n",
       "  'INCI_name': 'Acrylates/Ethylhexyl Acrylate/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ea780806-13d5-46c2-8ae6-748d63cb1168',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' acute oral toxicity study involving rats, and an LD 50 of >  5 ml/kg was reported.  The test protocol was not stated .32    An oral LD 50 of  >  2,000 mg/kg body weight (rats) for Syntran® 5903 was reported in a study ',\n",
       "   'col were  not included.  The estimated acute oral LD 50 was > 5,050 mg/kg (nontoxic).  It was noted that this finding was  ',\n",
       "   'cute dermal toxicity study involving rats, and an LD 50 of  > 5 g/kg was reported.  The test protocol was not stated.32'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight', '050 mg/kg', '5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945bf'),\n",
       "  'Nome_comune': 'Acrylates/Hydroxyesters Acrylates Copolymer',\n",
       "  'INCI_name': 'Acrylates/Hydroxyesters Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=753ee939-0987-44b5-aa7a-9a401ff65f3a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945c0'),\n",
       "  'Nome_comune': 'Acrylates/Hydroxyethyl Acrylate/Lauryl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Hydroxyethyl Acrylate/Lauryl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f404648b-d131-4bcd-88ff-92f346fae829',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945c1'),\n",
       "  'Nome_comune': 'Acrylates/Hydroxyethyl Acrylate/Methoxyethyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Hydroxyethyl Acrylate/Methoxyethyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=be9209d2-9f72-4343-a13f-5a0bec9d7e9d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945c2'),\n",
       "  'Nome_comune': 'Acrylates/Laureth-25 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Laureth-25 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3bca4f0c-de86-41a6-95e2-1fba60cde34a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1666c1f2275d72945c3'),\n",
       "  'Nome_comune': 'Acrylates/Lauryl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Lauryl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b11456c9-f919-4f65-8f75-e77fda6736cb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c4'),\n",
       "  'Nome_comune': 'Acrylates/Lauryl Methacrylate/Tridecyl Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Lauryl Methacrylate/Tridecyl Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e811004b-e2aa-4961-a5d5-6055f9343acd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c5'),\n",
       "  'Nome_comune': 'Acrylates/Methacrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methacrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f284ae0f-172c-4b8b-aee4-f643ec6a11ff',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c6'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-15 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-15 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=be3479ef-f62b-46eb-b535-20f6da215bc4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c7'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-23 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-23 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a09ab80-ec6f-48cb-8418-4a5cdc584e62',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c8'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-23 Methacrylate/Perfluorooctyl Ethyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-23 Methacrylate/Perfluorooctyl Ethyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff9154ac-278d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e821365b-edc8-8bc1-b1ed-7554f706933c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):144-161, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945c9'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-4 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-4 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fefd51d8-1f19-485e-824c-5cdbe609090b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945ca'),\n",
       "  'Nome_comune': 'Acrylates/Methoxy PEG-90 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Methoxy PEG-90 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa561e2a-eadb-4280-8e73-7033e9ae1f39',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945cb'),\n",
       "  'Nome_comune': 'Acrylates/Octylacrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylates/Octylacrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8183845a-d97f-4b01-9729-1435c4321b91',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945cc'),\n",
       "  'Nome_comune': 'Acrylates/Palmeth-25 Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Palmeth-25 Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f8da0eb4-ad2e-4cb7-a266-90d0cadd3a72',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1676c1f2275d72945cd'),\n",
       "  'Nome_comune': 'Acrylates/PEG-4 Dimethacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/PEG-4 Dimethacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d2785572-6601-494a-9d15-863bd60f0a24',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945ce'),\n",
       "  'Nome_comune': 'Acrylates/Perfluorohexylethyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Perfluorohexylethyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b90e5db8-278d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e821365b-edc8-8bc1-b1ed-7554f706933c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):144-161, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945cf'),\n",
       "  'Nome_comune': 'Acrylates/PVP Copolymer',\n",
       "  'INCI_name': 'Acrylates/VP Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bf08a6f5-cdd3-4161-82c5-79415abfaf9b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' clinical  signs were observed.  The acute dermal LD 50 was > 2 g/kg.     Oral   VP Copolymers     VP/VA Copolymer    ',\n",
       "   'yldimethyltaurate/VP Copolymer     The acute oral LD 50  for Ammonium Acryloyldimethyltaurate/VP Copolymer was rep orted to be >2 g/kg in rats.6     VP/Acrylates/Lauryl Methacrylate Cop',\n",
       "   'olymer      An oral LD 50 of > 5 g/kg (rats) has been reported for undiluted VP/Acrylat',\n",
       "   'oss organ changes were observed at necropsy.  The LD 50 was > 5  g/kg.     Shor t-Term Toxicity Studies   Dermal   VP C',\n",
       "   'f 10 New Zealand white rabbits ; the acute dermal LD 50 was > 2 g/kg.  An oral LD 50 of > 5 g/kg  (rats) has been reported for undiluted VP/Acryla',\n",
       "   's organ changes were obse rved  at necropsy.  The LD 50 was > 5 g/kg.       VP/VA C opolymer was administered in the d',\n",
       "   'P and Modified PVP Polymers     PVP      The oral LD 50 of PVP (avg. MW of 40,000) is > 100 g/kg body weight for both rats and guinea pigs .8     Triacontanyl '],\n",
       "  'contesti_noael': ['ded  that the no-observed -adverse -effect level (NOAEL) was  1000 mg/kg/day .     PVP and Modified PVP Polymers       PVP    ',\n",
       "   ' were observed .  The authors concluded  that the NOAEL  was 1000 mg/kg /day.       Inhalation   VP Copolymers     VP/VA Copol',\n",
       "   '  trabeculae of some mesenteric lymph nodes.  The NOAEL was determined to be the target dose of 2500 mg/kg/day (target  dose for highest dose group).36     The ',\n",
       "   'e was  no clear dose -response relationship.  The NOAEL was determined to be the target dose of 2800 mg/kg/day (target dose for  high dose group).  Results rela'],\n",
       "  'valori_ld50': ['2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '100 g/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg/day',\n",
       "   '1000 mg/kg /day',\n",
       "   '2500 mg/kg/day',\n",
       "   '2800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d0'),\n",
       "  'Nome_comune': 'Acrylates/Steareth-20 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Steareth-20 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2834178b-eaf2-448a-92e1-9a20d6245081',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d1'),\n",
       "  'Nome_comune': 'Acrylates/Steareth-20 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Steareth-20 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4f10560c-61b0-4452-8120-abcef93b417d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d2'),\n",
       "  'Nome_comune': 'Acrylates/Steareth-30 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Steareth-30 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6efeb332-81d7-40b0-a934-f3e27f81d00d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d3'),\n",
       "  'Nome_comune': 'Acrylates/Steareth-50 Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Steareth-50 Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0ef65b89-4a8d-4350-b49e-3363a624870b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d4'),\n",
       "  'Nome_comune': 'Acrylates/Stearyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Acrylates/Stearyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d68ddcbc-56ee-4fed-b595-26645f6cb61a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1686c1f2275d72945d5'),\n",
       "  'Nome_comune': 'Acrylates/Stearyl Methacrylate/VP Copolymer',\n",
       "  'INCI_name': 'Acrylates/Stearyl Methacrylate/VP Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f9d53a94-568a-4dd8-9bda-55072521a896',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' clinical  signs were observed.  The acute dermal LD 50 was > 2 g/kg.     Oral   VP Copolymers     VP/VA Copolymer    ',\n",
       "   'yldimethyltaurate/VP Copolymer     The acute oral LD 50  for Ammonium Acryloyldimethyltaurate/VP Copolymer was rep orted to be >2 g/kg in rats.6     VP/Acrylates/Lauryl Methacrylate Cop',\n",
       "   'olymer      An oral LD 50 of > 5 g/kg (rats) has been reported for undiluted VP/Acrylat',\n",
       "   'oss organ changes were observed at necropsy.  The LD 50 was > 5  g/kg.     Shor t-Term Toxicity Studies   Dermal   VP C',\n",
       "   'f 10 New Zealand white rabbits ; the acute dermal LD 50 was > 2 g/kg.  An oral LD 50 of > 5 g/kg  (rats) has been reported for undiluted VP/Acryla',\n",
       "   's organ changes were obse rved  at necropsy.  The LD 50 was > 5 g/kg.       VP/VA C opolymer was administered in the d',\n",
       "   'P and Modified PVP Polymers     PVP      The oral LD 50 of PVP (avg. MW of 40,000) is > 100 g/kg body weight for both rats and guinea pigs .8     Triacontanyl '],\n",
       "  'contesti_noael': ['ded  that the no-observed -adverse -effect level (NOAEL) was  1000 mg/kg/day .     PVP and Modified PVP Polymers       PVP    ',\n",
       "   ' were observed .  The authors concluded  that the NOAEL  was 1000 mg/kg /day.       Inhalation   VP Copolymers     VP/VA Copol',\n",
       "   '  trabeculae of some mesenteric lymph nodes.  The NOAEL was determined to be the target dose of 2500 mg/kg/day (target  dose for highest dose group).36     The ',\n",
       "   'e was  no clear dose -response relationship.  The NOAEL was determined to be the target dose of 2800 mg/kg/day (target dose for  high dose group).  Results rela'],\n",
       "  'valori_ld50': ['2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '100 g/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg/day',\n",
       "   '1000 mg/kg /day',\n",
       "   '2500 mg/kg/day',\n",
       "   '2800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945d6'),\n",
       "  'Nome_comune': 'Acrylates/t-Butylacrylamide Copolymer',\n",
       "  'INCI_name': 'Acrylates/t-Butylacrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5db655bf-766d-4017-a0e0-d35e546b4240',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945d7'),\n",
       "  'Nome_comune': 'Acrylates/VA Copolymer',\n",
       "  'INCI_name': 'Acrylates/VA Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c33a3e01-b9fc-4c17-b497-ad14ba3e8086',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945d8'),\n",
       "  'Nome_comune': 'Acrylates/VA Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/VA Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=25c9e4b8-e443-4186-a6e3-d9b2e20d346a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945d9'),\n",
       "  'Nome_comune': 'Acrylates/Vinyl Isodecanoate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Vinyl Isodecanoate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=610b1f10-7f99-4a4b-9b32-578eb261c6ec',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945da'),\n",
       "  'Nome_comune': 'Acrylates/Vinyl Neodecanoate Crosspolymer',\n",
       "  'INCI_name': 'Acrylates/Vinyl Neodecanoate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e0d2d248-c54b-4818-9378-c1cf655ab55b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945db'),\n",
       "  'Nome_comune': 'Acrylates/VP Copolymer',\n",
       "  'INCI_name': 'Acrylates/VP Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bf63687d-30cb-4454-8a14-ed4fa0a10148',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' clinical  signs were observed.  The acute dermal LD 50 was > 2 g/kg.     Oral   VP Copolymers     VP/VA Copolymer    ',\n",
       "   'yldimethyltaurate/VP Copolymer     The acute oral LD 50  for Ammonium Acryloyldimethyltaurate/VP Copolymer was rep orted to be >2 g/kg in rats.6     VP/Acrylates/Lauryl Methacrylate Cop',\n",
       "   'olymer      An oral LD 50 of > 5 g/kg (rats) has been reported for undiluted VP/Acrylat',\n",
       "   'oss organ changes were observed at necropsy.  The LD 50 was > 5  g/kg.     Shor t-Term Toxicity Studies   Dermal   VP C',\n",
       "   'f 10 New Zealand white rabbits ; the acute dermal LD 50 was > 2 g/kg.  An oral LD 50 of > 5 g/kg  (rats) has been reported for undiluted VP/Acryla',\n",
       "   's organ changes were obse rved  at necropsy.  The LD 50 was > 5 g/kg.       VP/VA C opolymer was administered in the d',\n",
       "   'P and Modified PVP Polymers     PVP      The oral LD 50 of PVP (avg. MW of 40,000) is > 100 g/kg body weight for both rats and guinea pigs .8     Triacontanyl '],\n",
       "  'contesti_noael': ['ded  that the no-observed -adverse -effect level (NOAEL) was  1000 mg/kg/day .     PVP and Modified PVP Polymers       PVP    ',\n",
       "   ' were observed .  The authors concluded  that the NOAEL  was 1000 mg/kg /day.       Inhalation   VP Copolymers     VP/VA Copol',\n",
       "   '  trabeculae of some mesenteric lymph nodes.  The NOAEL was determined to be the target dose of 2500 mg/kg/day (target  dose for highest dose group).36     The ',\n",
       "   'e was  no clear dose -response relationship.  The NOAEL was determined to be the target dose of 2800 mg/kg/day (target dose for  high dose group).  Results rela'],\n",
       "  'valori_ld50': ['2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '100 g/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg/day',\n",
       "   '1000 mg/kg /day',\n",
       "   '2500 mg/kg/day',\n",
       "   '2800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945dc'),\n",
       "  'Nome_comune': 'Acrylic Acid/C12-22 Alkyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylic Acid/C12-22 Alkyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e37feccf-7802-4331-8e05-9b0d04c7bc6b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945dd'),\n",
       "  'Nome_comune': 'Acrylic Acid/Phosphorylcholine Glycol Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Acrylic Acid/Phosphorylcholine Glycol Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6b89e7c7-1a27-4b60-8e46-c4d889c8809e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1000a48e-650c-6b92-a9dc-a53d51eea570',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1696c1f2275d72945de'),\n",
       "  'Nome_comune': 'Acrylic Acid/Stearyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Acrylic Acid/Stearyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3c698227-a57c-4ba4-875b-cd6da696f212',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945df'),\n",
       "  'Nome_comune': 'Acrylic Acid/VP Crosspolymer',\n",
       "  'INCI_name': 'Acrylic Acid/VP Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c32bf61c-e2f6-4b6a-aa74-c6bec87ef6a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' clinical  signs were observed.  The acute dermal LD 50 was > 2 g/kg.     Oral   VP Copolymers     VP/VA Copolymer    ',\n",
       "   'yldimethyltaurate/VP Copolymer     The acute oral LD 50  for Ammonium Acryloyldimethyltaurate/VP Copolymer was rep orted to be >2 g/kg in rats.6     VP/Acrylates/Lauryl Methacrylate Cop',\n",
       "   'olymer      An oral LD 50 of > 5 g/kg (rats) has been reported for undiluted VP/Acrylat',\n",
       "   'oss organ changes were observed at necropsy.  The LD 50 was > 5  g/kg.     Shor t-Term Toxicity Studies   Dermal   VP C',\n",
       "   'f 10 New Zealand white rabbits ; the acute dermal LD 50 was > 2 g/kg.  An oral LD 50 of > 5 g/kg  (rats) has been reported for undiluted VP/Acryla',\n",
       "   's organ changes were obse rved  at necropsy.  The LD 50 was > 5 g/kg.       VP/VA C opolymer was administered in the d',\n",
       "   'P and Modified PVP Polymers     PVP      The oral LD 50 of PVP (avg. MW of 40,000) is > 100 g/kg body weight for both rats and guinea pigs .8     Triacontanyl '],\n",
       "  'contesti_noael': ['ded  that the no-observed -adverse -effect level (NOAEL) was  1000 mg/kg/day .     PVP and Modified PVP Polymers       PVP    ',\n",
       "   ' were observed .  The authors concluded  that the NOAEL  was 1000 mg/kg /day.       Inhalation   VP Copolymers     VP/VA Copol',\n",
       "   '  trabeculae of some mesenteric lymph nodes.  The NOAEL was determined to be the target dose of 2500 mg/kg/day (target  dose for highest dose group).36     The ',\n",
       "   'e was  no clear dose -response relationship.  The NOAEL was determined to be the target dose of 2800 mg/kg/day (target dose for  high dose group).  Results rela'],\n",
       "  'valori_ld50': ['2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '100 g/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg/day',\n",
       "   '1000 mg/kg /day',\n",
       "   '2500 mg/kg/day',\n",
       "   '2800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e0'),\n",
       "  'Nome_comune': 'Acryloyloxypropyl Polysilsesquioxane',\n",
       "  'INCI_name': 'Acryloyloxypropyl Polysilsesquioxane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5e2b40c0-305a-4b5e-9086-fa80ef5e4196',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8b69a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne, a nd Trimethylpentyl Polysilsesquioxane , the LD 50 was  reported  to be > 5000 mg/kg.   In a 28- day dermal toxicity study of a Polyme',\n",
       "   'ghtly  reddened were observed in the fifth rat.   LD 50 = > 5000 mg/kg, Toxicity Category III  (slightly toxic and sligh',\n",
       "   'rance, convulsions, muscle tremors,  and rales.   LD 50 = > 5000 mg/kg , Toxicity Category III 31  Methacryloyloxypropyl  Polysilsesquioxane (5000  mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 50 00 mg/kg, Toxicity Category III 32  Methoxy PEG -10  Polysilsesquioxane (5000 mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   ' and muscle tremors. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 33  Trimethylpentyl  Polysilsesquioxane (5000 mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 34  Trimethylpentyl  Polysilsesquioxane (5000  mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 35          Table 7. Genot'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg',\n",
       "   '5000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e1'),\n",
       "  'Nome_comune': 'Actinidia Chinensis (Kiwi) Seed Oil',\n",
       "  'INCI_name': 'Actinidia Chinensis (Kiwi) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f3d8a5df-7ac0-4db3-aea1-d1c0f1571c84',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e2'),\n",
       "  'Nome_comune': 'Adansonia Digitata Oil',\n",
       "  'INCI_name': 'Adansonia Digitata Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e98f48fd-cfdb-4ac5-ab29-b328dd79e93b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e3'),\n",
       "  'Nome_comune': 'Adansonia Digitata Seed Oil',\n",
       "  'INCI_name': 'Adansonia Digitata Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa29c3ff-13da-4c08-8fd0-3f6d1c06a517',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e4'),\n",
       "  'Nome_comune': 'Adansonia Digitata Seed Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Adansonia Digitata Seed Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c6bd69b4-1790-4a50-aaa3-ac1f819b9d30',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e5'),\n",
       "  'Nome_comune': 'Adansonia Digitata Seed Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Adansonia Digitata Seed Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6f727652-9a25-40d2-a26f-a93952e357d7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e6'),\n",
       "  'Nome_comune': 'Adenosine',\n",
       "  'INCI_name': 'Adenosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=81b9c546-809b-4041-843e-4e9c8fbbecab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cd3b62ad-1279-3043-bf9f-58ee259b08ba',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):50-63, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['(Pa O2). Disodium Adenosine Triphosphate. An oral LD 50 of >2000 mg/kg was reported for both mice and rats treated with D'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e7'),\n",
       "  'Nome_comune': 'Adenosine Phosphate',\n",
       "  'INCI_name': 'Adenosine Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ee88ee88-f2d0-4513-bd4f-e665d8be72a4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cd3b62ad-1279-3043-bf9f-58ee259b08ba',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):50-63, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['(Pa O2). Disodium Adenosine Triphosphate. An oral LD 50 of >2000 mg/kg was reported for both mice and rats treated with D'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16a6c1f2275d72945e8'),\n",
       "  'Nome_comune': 'Adenosine Triphosphate',\n",
       "  'INCI_name': 'Adenosine Triphosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c12e5d09-7c3c-4864-9572-b2ceb0f30a00',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cd3b62ad-1279-3043-bf9f-58ee259b08ba',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):50-63, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['(Pa O2). Disodium Adenosine Triphosphate. An oral LD 50 of >2000 mg/kg was reported for both mice and rats treated with D'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945e9'),\n",
       "  'Nome_comune': 'Adipic Acid',\n",
       "  'INCI_name': 'Adipic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fa017cd8-4eea-4122-b4a4-9e70508dfb0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d8d3785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl 1):5-76, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/196',\n",
       "   'valori': ['Rat: inhalation: no effect level: 126 g/L, 15 x 6 hr (as in source)',\n",
       "    'LD50 Mouse iv 680 mg/kg /From table/',\n",
       "    'LD50 Mouse oral 1900 mg/kg /From table/',\n",
       "    'LD50 Mouse ip 275 mg/kg /From table/',\n",
       "    'LD50 Rat oral >11000 mg/kg /From table/',\n",
       "    'LD50 Rat ip 275 mg/kg /From table/',\n",
       "    'LD50 Rabbit oral >11000 mg/kg /From table/',\n",
       "    'LD50 Mouse intragastric 4.175 g/kg'],\n",
       "   'fonti': ['Verschueren, K. Handbook of Environmental Data of Organic Chemicals. 2nd ed. New York, NY: Van Nostrand Reinhold Co., 1983., p. 165',\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V5 751\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V5 751\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V5 751\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V5 751\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V5 751\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V5 751\",\n",
       "    'Krapotkina MA, et al; Gig Truda Prof Zabolevanija 5: 46-7 (1981)']},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['re no significant toxicological findings, and the NOAEL was 500 mg/kg bw/d. In another 13-week study, groups of 4 male and 4',\n",
       "   'malies were not considered treatment-related. The NOAEL for maternal toxicity was 2000 mg/kg bw/d, and for developmental and reproductive effects it was 800 mg/kg bw/d. Groups of 25 mated female rats were dosed dermal',\n",
       "   'rn live, or their survival, was not affected. The NOAEL was 170 mg/kg bw/d and the LOAEL was 1080 mg/kg bw/d. In another study in which gravid females were fe',\n",
       "   '.) Slight effects were seen in the liver, and the NOAEL was 3333 mg/kg bw. Groups of 13 to 15 male and female rats were fed a diet containing 0, 1600, or 3200 mg/kg bw/d adipic acid for 33 weeks.40Rats were killed at va'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '800 mg/kg bw/d',\n",
       "   '1080 mg/kg bw/d',\n",
       "   '3200 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ea'),\n",
       "  'Nome_comune': 'Adipic Acid Dihydrazide',\n",
       "  'INCI_name': 'Adipic Acid Dihydrazide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=354028a6-8fad-4a26-8c85-4371b6d92c7f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d44621e7-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 13(3):154-156, 1994',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945eb'),\n",
       "  'Nome_comune': 'Adipic Acid/1,4-Butanediol/Terephthalate Copolymer',\n",
       "  'INCI_name': 'Adipic Acid/1,4-Butanediol/Terephthalate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=906bbed6-36ee-4a59-b512-853c01d0825d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9d4cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 3):36-47, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ec'),\n",
       "  'Nome_comune': 'Adipic Acid/CHDM/MA/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       "  'INCI_name': 'Adipic Acid/CHDM/MA/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f50a0ab5-9e83-4c2e-9af3-1b241645ae6f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=59efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):74-92, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['udy with up to 1.0% (667 mg/kg bw/d) in rats, the NOAEL was 0.1% (67 mg/kg bw/d) based on significant changes of clinical chemist',\n",
       "   'up to 1000 mg/kg/d on days 6-20 of gestation, the NOAEL was 100 mg/kg bw/d for developmental toxicity due to decreases in fetal weight and 100 mg/kg bw/d for maternal toxicity due to decreased body weigh',\n",
       "   'cant at any interval and was reversible), and the NOAEL (maternal) was determined to be 140 mg/kg/d Genotoxicity: negative in bacterial gene mutation',\n",
       "   'were dosed via gavage with up to 150 mg/kg/d, the NOAEL for reproductive effects was 55 mg/kg/d (highest dose tested due to parental death at 150 mg/kg/day), but in the parental group, adverse effects (mor',\n",
       "   ' mg/kg bw/d before, during, and after mating, the NOAEL was 800 mg/kg bw/d for reproductive and developmental toxicity and 200 mg/kg bw/d for general toxicity Genotoxicity: not genotoxic,',\n",
       "   'tested (11 g/kg); in feeding studies in rats, the NOAEL was >435 mg/kg bw/d in a 4-week study; with /C2034000 mg/kg bw/d sodi',\n",
       "   'phrosis, pelvic calcification) were observed, the NOAEL was 250 mg/kg/d, and the LOAEL was 800 mg/kg/d Dermal toxicity: No mortality was observed in rab',\n",
       "   'ased fetal weight and postnatal survival) and the NOAEL was 854 mg/kg bw/d, and for reproductive toxicity the LOAEL was grea',\n",
       "   'ted dosing with up to 1000 mg/kg/d by gavage, the NOAEL for males and females were 300 and 1000 mg/kg/d, respectively; in a 90-day gavage study, no adver',\n",
       "   'ter than the highest dose tested and the NOAEL was 1360 mg/kg bw/d Genotoxicity: not genotoxic in vitro in an Ames t',\n",
       "   'um adipate in a protein-deficient diet, the NOAEL was 3333 mg/kg bw in a 19-wk study; 10/14 rats fed a diet containing 3200 mg/kg bw/d died during weeks 0-4 of a 33-week study, body we'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['67 mg/kg bw/d',\n",
       "   '100 mg/kg bw/d',\n",
       "   '140 mg/kg/d',\n",
       "   '150 mg/kg/day',\n",
       "   '200 mg/kg bw/d',\n",
       "   '435 mg/kg bw/d',\n",
       "   '800 mg/kg/d',\n",
       "   '854 mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1360 mg/kg bw/d',\n",
       "   '3200 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ed'),\n",
       "  'Nome_comune': 'Adipic Acid/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       "  'INCI_name': 'Adipic Acid/Neopentyl Glycol/Trimellitic Anhydride Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2010eb80-c416-4969-87b8-448ea41e8cdc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=59efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):74-92, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['udy with up to 1.0% (667 mg/kg bw/d) in rats, the NOAEL was 0.1% (67 mg/kg bw/d) based on significant changes of clinical chemist',\n",
       "   'up to 1000 mg/kg/d on days 6-20 of gestation, the NOAEL was 100 mg/kg bw/d for developmental toxicity due to decreases in fetal weight and 100 mg/kg bw/d for maternal toxicity due to decreased body weigh',\n",
       "   'cant at any interval and was reversible), and the NOAEL (maternal) was determined to be 140 mg/kg/d Genotoxicity: negative in bacterial gene mutation',\n",
       "   'were dosed via gavage with up to 150 mg/kg/d, the NOAEL for reproductive effects was 55 mg/kg/d (highest dose tested due to parental death at 150 mg/kg/day), but in the parental group, adverse effects (mor',\n",
       "   ' mg/kg bw/d before, during, and after mating, the NOAEL was 800 mg/kg bw/d for reproductive and developmental toxicity and 200 mg/kg bw/d for general toxicity Genotoxicity: not genotoxic,',\n",
       "   'tested (11 g/kg); in feeding studies in rats, the NOAEL was >435 mg/kg bw/d in a 4-week study; with /C2034000 mg/kg bw/d sodi',\n",
       "   'phrosis, pelvic calcification) were observed, the NOAEL was 250 mg/kg/d, and the LOAEL was 800 mg/kg/d Dermal toxicity: No mortality was observed in rab',\n",
       "   'ased fetal weight and postnatal survival) and the NOAEL was 854 mg/kg bw/d, and for reproductive toxicity the LOAEL was grea',\n",
       "   'ted dosing with up to 1000 mg/kg/d by gavage, the NOAEL for males and females were 300 and 1000 mg/kg/d, respectively; in a 90-day gavage study, no adver',\n",
       "   'ter than the highest dose tested and the NOAEL was 1360 mg/kg bw/d Genotoxicity: not genotoxic in vitro in an Ames t',\n",
       "   'um adipate in a protein-deficient diet, the NOAEL was 3333 mg/kg bw in a 19-wk study; 10/14 rats fed a diet containing 3200 mg/kg bw/d died during weeks 0-4 of a 33-week study, body we'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['67 mg/kg bw/d',\n",
       "   '100 mg/kg bw/d',\n",
       "   '140 mg/kg/d',\n",
       "   '150 mg/kg/day',\n",
       "   '200 mg/kg bw/d',\n",
       "   '435 mg/kg bw/d',\n",
       "   '800 mg/kg/d',\n",
       "   '854 mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1360 mg/kg bw/d',\n",
       "   '3200 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ee'),\n",
       "  'Nome_comune': 'Agar',\n",
       "  'INCI_name': 'Agar',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d655dd3-23ca-499c-9a9e-482e35cc7a8f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945ef'),\n",
       "  'Nome_comune': 'Agarose',\n",
       "  'INCI_name': 'Agarose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e77d7fc3-7e9b-4074-b378-270642eccd15',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed16b6c1f2275d72945f0'),\n",
       "  'Nome_comune': 'Agarum Cribrosum Extract',\n",
       "  'INCI_name': 'Agarum Cribrosum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=19795793-0662-4a93-a744-0f5aa2af8071',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['her  alterations. Mice were observed for 7 days.  LD 50: Males = 500 mg/kg; females = < 7 50 mg/kg  95  Fucus Vesiculosus Extract  (28.8% polyphenols ',\n",
       "   'd of oral administration was not stated).92   The LD 50 was > 2000 mg/kg when Sprague -Dawley rats were dosed with Ascophyl',\n",
       "   'solution was given to Sprague -Dawley rats.  The  LD 50 was reported to be > 2000 mg/kg when Sprague -Dawley rats were given Ascophyllum N',\n",
       "   ' Extract  Sprague -Dawley  rats NR NR OECD TG 401 LD 50 > 2000 mg/kg  93  Cystoseira Compressa  Extract  (methanol, hexa',\n",
       "   'her  alterations. Mice were observed for 7 days.  LD 50: Males = 1000 mg/kg; females = between 1000  and 2000 mg/kg  95  Fucus Vesiculosus Extract  (18% polyphenols pl',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = between 1000 and 2000  mg/kg  95 Table 27. Acute  oral toxicity studies   Ingred',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = > 2000 mg/kg  95  Lamin aria Digitata Extract (≤  10%), artemisi',\n",
       "   'es were reported for each of the  10 rats tested. LD 50: Males and females = > 5 g/kg  96  Sargassum Fulvellum Extract  (dichloromethane,'],\n",
       "  'contesti_noael': ['g pigs.    In a chronic oral toxicity study, t he NOAEL of a Laminaria Japonica Extract administered to rats by gavage for 6  months was 300 mg/kg/day .  In females, a decrease in AST was observed sta'],\n",
       "  'valori_ld50': ['50 mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000  mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '5 g/kg  '],\n",
       "  'valori_noael': ['300 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f1'),\n",
       "  'Nome_comune': 'Ahnfeltiopsis Concinna Extract',\n",
       "  'INCI_name': 'Ahnfeltiopsis Concinna Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=28149688-a800-488d-be9c-ff9db8ce2cd9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['his study were provided.  The median lethal dose (LD 50) was reported to be > 2000 mg/kg.   Corallina Officinalis Extract   The acute oral',\n",
       "   'thod of oral administration was not  stated.  The LD 50 was reported to be > 2000 mg/kg.   Grateloupia Livida E xtract   The acute oral t',\n",
       "   ' were seen  with any extract or dose level .  The LD 50 values were  expected to be >  2000 mg/kg.   Lithothamnion Calcareum Extract   A Lithothamn',\n",
       "   'lesseria Sanguinea Extract (0.2 –  4% algae), the LD 50 was reported to be > 2000 mg/kg.   The acute oral  toxicity potential of multiple',\n",
       "   'uted dry  Asparagopsis Armata Extract .  The oral LD 50 was reported to be > 5000 mg/kg in an acute toxicity assay using a mixture  contai'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f2'),\n",
       "  'Nome_comune': 'Alanine',\n",
       "  'INCI_name': 'Alanine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8cedbe8d-08c2-4137-9e7a-aa6bacad407f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f3'),\n",
       "  'Nome_comune': 'Alaria Esculenta Extract',\n",
       "  'INCI_name': 'Alaria Esculenta Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fd6dd27b-e907-4df6-b9d9-220d91289fb7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['her  alterations. Mice were observed for 7 days.  LD 50: Males = 500 mg/kg; females = < 7 50 mg/kg  95  Fucus Vesiculosus Extract  (28.8% polyphenols ',\n",
       "   'd of oral administration was not stated).92   The LD 50 was > 2000 mg/kg when Sprague -Dawley rats were dosed with Ascophyl',\n",
       "   'solution was given to Sprague -Dawley rats.  The  LD 50 was reported to be > 2000 mg/kg when Sprague -Dawley rats were given Ascophyllum N',\n",
       "   ' Extract  Sprague -Dawley  rats NR NR OECD TG 401 LD 50 > 2000 mg/kg  93  Cystoseira Compressa  Extract  (methanol, hexa',\n",
       "   'her  alterations. Mice were observed for 7 days.  LD 50: Males = 1000 mg/kg; females = between 1000  and 2000 mg/kg  95  Fucus Vesiculosus Extract  (18% polyphenols pl',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = between 1000 and 2000  mg/kg  95 Table 27. Acute  oral toxicity studies   Ingred',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = > 2000 mg/kg  95  Lamin aria Digitata Extract (≤  10%), artemisi',\n",
       "   'es were reported for each of the  10 rats tested. LD 50: Males and females = > 5 g/kg  96  Sargassum Fulvellum Extract  (dichloromethane,'],\n",
       "  'contesti_noael': ['g pigs.    In a chronic oral toxicity study, t he NOAEL of a Laminaria Japonica Extract administered to rats by gavage for 6  months was 300 mg/kg/day .  In females, a decrease in AST was observed sta'],\n",
       "  'valori_ld50': ['50 mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000  mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '5 g/kg  '],\n",
       "  'valori_noael': ['300 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f4'),\n",
       "  'Nome_comune': 'Alcaligenes Polysaccharides',\n",
       "  'INCI_name': 'Alcaligenes Polysaccharides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4af28630-47d0-4efa-a026-e37bdb0162a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f5'),\n",
       "  'Nome_comune': 'Alcohol Denat.',\n",
       "  'INCI_name': 'Alcohol Denat.',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e809d27-c637-4a87-bdda-85b51475659f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=93ca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):1-43, 2008',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['9.4, 125, and 315 mg/kg. The acute oral toxicity (LD 50) for Denatonium Benzoate was calculated to be 23 mg/kg withconﬁdence limits of 19 to 27 mg/kg. The third acute oral toxicity study with Denaton',\n",
       "   ' determined for each sex. The acute oral toxicity(LD 50) of Denatonium Benzoate in male albino rats was calcu- lated to be 640 mg/kg (conﬁdence limits of 554 to 740 mg/kg).The LD 50v'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['27 mg/kg', '640 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f6'),\n",
       "  'Nome_comune': 'Aldioxa',\n",
       "  'INCI_name': 'Aldioxa',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=651fc2ce-e6aa-484d-8b7e-103be09bebb1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a85227f3-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 12(3):237-242, 1993',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' astringent and skin conditioning agent. The oral LD50 for mice exceeds 23 mg/kg, and  8 g/kg for rats. All of the toxicologic parameters invest'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f7'),\n",
       "  'Nome_comune': 'Aleurites Moluccana Seed Oil',\n",
       "  'INCI_name': 'Aleurites Moluccanus Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a918aa5-cee0-40b6-b780-30fdc41317c3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f8'),\n",
       "  'Nome_comune': 'Aleurites Moluccanus Bakoly Seed Oil',\n",
       "  'INCI_name': 'Aleurites Moluccanus Bakoly Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=84fd3b42-7f30-4167-b235-576d28523dee',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945f9'),\n",
       "  'Nome_comune': 'Algae Exopolysaccharides',\n",
       "  'INCI_name': 'Algae Exopolysaccharides (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=33d3a046-7fa6-476b-ae6c-e9b1389401c6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed16c6c1f2275d72945fa'),\n",
       "  'Nome_comune': 'Algin',\n",
       "  'INCI_name': 'Algin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=88914979-370a-4582-a567-b2b58452d641',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945fb'),\n",
       "  'Nome_comune': 'Alginic Acid',\n",
       "  'INCI_name': 'Alginic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=82be7c0a-ed97-4d94-94c7-ecb28a5367cf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945fc'),\n",
       "  'Nome_comune': 'Allantoin',\n",
       "  'INCI_name': 'Allantoin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d3c2f751-f076-4f84-9d2d-22c14ee18ca2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' Chemicals11reported the oral median lethal dose (LD 50) of allantoin in rats to be more than 5000 mg/kg and considered allantoin to be slightly toxic. Acu'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945fd'),\n",
       "  'Nome_comune': 'Allantoin Ascorbate',\n",
       "  'INCI_name': 'Allantoin Ascorbate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4f51c5ed-4f98-4a25-a938-72959b10488a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' Chemicals11reported the oral median lethal dose (LD 50) of allantoin in rats to be more than 5000 mg/kg and considered allantoin to be slightly toxic. Acu'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945fe'),\n",
       "  'Nome_comune': 'Allantoin Biotin',\n",
       "  'INCI_name': 'Allantoin Biotin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=70c983e4-d5a4-4cdf-af07-427955ad8528',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' Chemicals11reported the oral median lethal dose (LD 50) of allantoin in rats to be more than 5000 mg/kg and considered allantoin to be slightly toxic. Acu'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d72945ff'),\n",
       "  'Nome_comune': 'Allantoin Galacturonic Acid',\n",
       "  'INCI_name': 'Allantoin Galacturonic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4163be75-6c3a-491f-a796-7a9dc6d85b6b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' Chemicals11reported the oral median lethal dose (LD 50) of allantoin in rats to be more than 5000 mg/kg and considered allantoin to be slightly toxic. Acu'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d7294600'),\n",
       "  'Nome_comune': 'Allantoin Glycyrrhetinic Acid',\n",
       "  'INCI_name': 'Allantoin Glycyrrhetinic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d5beaa0-0426-47a4-86df-f666584f386a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' Chemicals11reported the oral median lethal dose (LD 50) of allantoin in rats to be more than 5000 mg/kg and considered allantoin to be slightly toxic. Acu'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d7294601'),\n",
       "  'Nome_comune': 'Allantoin Panthenol',\n",
       "  'INCI_name': 'Allantoin Panthenol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a319a3af-a43b-483a-9904-2e0f6cf8c92d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' Chemicals11reported the oral median lethal dose (LD 50) of allantoin in rats to be more than 5000 mg/kg and considered allantoin to be slightly toxic. Acu'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d7294602'),\n",
       "  'Nome_comune': 'Allantoin Polygalacturonic Acid',\n",
       "  'INCI_name': 'Allantoin Polygalacturonic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e786818f-4e12-46ae-829e-a49912b5d665',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):84-97, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Chemicals11reported the oral median lethal dose (LD 50) of allantoin in rats to be more than 5000 mg/kg and considered allantoin to be slightly toxic. Acu'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16d6c1f2275d7294603'),\n",
       "  'Nome_comune': 'Allyl Methacrylate/Glycol Dimethacryate Crosspolymer',\n",
       "  'INCI_name': 'Allyl Methacrylate/Glycol Dimethacryate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=164b79c8-4ae4-4229-bb42-9a71b3e52fba',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294604'),\n",
       "  'Nome_comune': 'Allyl Methacrylates Crosspolymer',\n",
       "  'INCI_name': 'Allyl Methacrylates Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2c7cc7ce-155f-4d83-9eda-54e4bcd2bab2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294605'),\n",
       "  'Nome_comune': 'Almond Meal',\n",
       "  'INCI_name': 'Prunus Amygdalus Dulcis (Sweet Almond) Seed Meal',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a680b811-592c-408e-ab7a-7159cd0978f3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da627cd7-5592-4942-925d-fd85d7bf38c0',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):93-95, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294606'),\n",
       "  'Nome_comune': 'Almond Oil PEG-6 Esters',\n",
       "  'INCI_name': 'Almond Oil PEG-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=55a82e9b-9152-46b4-8d1c-7c3b0e6c4cc5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294607'),\n",
       "  'Nome_comune': 'Almond Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Almond Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ca3d17ec-0f39-4eaf-8f1d-3f80e35481ac',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294608'),\n",
       "  'Nome_comune': 'Almond Oil Propylene Glycol Esters',\n",
       "  'INCI_name': 'Almond Oil Propylene Glycol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a39c34b-80ea-4e9d-96ed-0fa61c1c8fa9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1c34b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['41  Acute toxicity   Hept anoic acid  IV in mice  LD 50 = 1200 ± 56 mg/kg   42  Undecanoic acid  IV in mice  LD 50 = 140 ± 4.2 mg/kg   42  Dermal irritation – in vitro   Hepta noic acid',\n",
       "   ' Laurate was classified as  practically nontoxic (LD 50 > 34.6 g/kg) when administered orally to rats.   In two skin ',\n",
       "   'zed following ingestion.  In rats, the acute oral LD 50  has been shown to be approximately 25.8 g/kg.  The raw ingredient produced no significant de r',\n",
       "   'ults  in any of the animal tests.  The acute oral LD 50 in rats is e stimated to be greater than 32 g/kg.  The ingredient per se  produced no significant '],\n",
       "  'contesti_noael': [' rats.25  The no observed adverse effects level  (NOAEL ) was concluded  to be 1000   mg/kg/d .  No evidence of adverse effects were foun d in '],\n",
       "  'valori_ld50': ['2 mg/kg   ', '6 g/kg', '8 g/kg', '32 g/kg'],\n",
       "  'valori_noael': ['1000   mg/kg/d']},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d7294609'),\n",
       "  'Nome_comune': 'Almond Oil/Polyglyceryl-10 Esters',\n",
       "  'INCI_name': 'Almond Oil/Polyglyceryl-10 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=846189d1-e02d-435a-855e-fdf41004bf82',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d729460a'),\n",
       "  'Nome_comune': 'Almondamide DEA',\n",
       "  'INCI_name': 'Almondamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b0edbcd4-b6e1-4f0c-ae8e-c055798112f6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne of the animals died, and the lethal dose, 50 %(LD 50) was >2 g/kg. Lauramide DEA. In an acute dermal toxicity study'],\n",
       "  'contesti_noael': ['mental toxicity study in Sprague-Dawley rats, the NOAEL for maternal toxicity and developmental toxicity was 1000 mg/kg/d that was the highest dose tested. No other data o'],\n",
       "  'valori_ld50': ['2 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d729460b'),\n",
       "  'Nome_comune': 'Almondamidopropyl Betaine',\n",
       "  'INCI_name': 'Almondamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4e31d7de-4a7a-408a-82b7-07a85b430ebb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d729460c'),\n",
       "  'Nome_comune': 'Almondamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Almondamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f62991b7-8ba2-4287-b6f9-b903c842fc9b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['n the remaining animals. The oral lethal dose 50 (LD 50) for stearamidopropyl dimethylamine in this study was determined to be greater than 2,000 mg/kg body weight. In another oral toxicity study, 40 %(wt/wt) stea'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16e6c1f2275d729460d'),\n",
       "  'Nome_comune': 'Aloe Andongensis Extract',\n",
       "  'INCI_name': 'Aloe Andongensis Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4b0c2173-2b26-4f7f-8df1-ac0e644879a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d729460e'),\n",
       "  'Nome_comune': 'Aloe Andongensis Leaf Extract',\n",
       "  'INCI_name': 'Aloe Andongensis Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a65f08f3-eee5-4ad9-8b7f-decd4aa569c9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d729460f'),\n",
       "  'Nome_comune': 'Aloe Andongensis Leaf Juice',\n",
       "  'INCI_name': 'Aloe Andongensis Leaf Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1e36623d-4158-4b2a-8990-b882c4a128ff',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294610'),\n",
       "  'Nome_comune': 'Aloe Arborescens Leaf Extract',\n",
       "  'INCI_name': 'Aloe Arborescens Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=549451e0-1646-4a1e-85cb-adb03d121e3b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294611'),\n",
       "  'Nome_comune': 'Aloe Arborescens Leaf Juice',\n",
       "  'INCI_name': 'Aloe Arborescens Leaf Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32aab4c3-228d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294612'),\n",
       "  'Nome_comune': 'Aloe Arborescens Leaf Protoplasts',\n",
       "  'INCI_name': 'Aloe Arborescens Leaf Protoplasts',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f79a30c7-4f4a-451e-8567-1e4049b20dca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294613'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Flower Extract',\n",
       "  'INCI_name': 'Aloe Barbadensis Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c41c0e5f-d1f2-4b02-970a-27aff7081330',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294614'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=78433939-0c86-4ee1-9fa7-9e308d101f80',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed16f6c1f2275d7294615'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf Extract',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa484edd-97bd-4ff0-97dc-952ea3d7cb03',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d7294616'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf Juice',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=571c1793-4928-44d2-a3f7-0101187c0e31',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d7294617'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf Polysaccharides',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf Polysaccharides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e4792fe0-f563-46b8-b071-3e3eff5908c3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d7294618'),\n",
       "  'Nome_comune': 'Aloe Barbadensis Leaf Water',\n",
       "  'INCI_name': 'Aloe Barbadensis Leaf Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=27539795-21e6-46b8-94ef-c615e569d120',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d7294619'),\n",
       "  'Nome_comune': 'Aloe Ferox Leaf Extract',\n",
       "  'INCI_name': 'Aloe Ferox Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2aac596c-44dd-4f35-a0f8-19d1d3a2eba8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461a'),\n",
       "  'Nome_comune': 'Aloe Ferox Leaf Juice',\n",
       "  'INCI_name': 'Aloe Ferox Leaf Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7a12bd9c-c842-4f7d-afb6-1475d42f487b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461b'),\n",
       "  'Nome_comune': 'Aloe Ferox Leaf Juice Extract',\n",
       "  'INCI_name': 'Aloe Ferox Leaf Juice Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=791e34d6-ab5b-4122-be8b-01fac6738c11',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9bca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):1-50, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ng dogs was >50 mg/kg. In intravenous studies the LD 50 using mice was >80 mg/kg, using rats was >15 mg/kg, and using dogs was >10 mg/kg. The 14-day NOEL for the Aloe polysaccharide, ace',\n",
       "   'Species No. of each sex Route Dose (mg/kg) Result LD 50 Mouse 5 IV 20, 40, 80 No effects >80 mg/kg 5 IP 100, 200 No effects >200 mg/kg Rat 5 IV 7.5, 15 No effects >15 mg/kg 5 IP 25, 50 '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 mg/kg', '200 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461c'),\n",
       "  'Nome_comune': 'Alumina',\n",
       "  'INCI_name': 'Alumina',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eb66797c-8a8d-4553-90f9-e19a07311830',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cda7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):16-33, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461d'),\n",
       "  'Nome_comune': 'Alumina Magnesium Metasilicate',\n",
       "  'INCI_name': 'Magnesium Aluminometasilicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f90d327e-15f8-4127-b236-9d5540c2c6fb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1706c1f2275d729461e'),\n",
       "  'Nome_comune': 'Aluminum Calcium Sodium Silicate',\n",
       "  'INCI_name': 'Aluminum Calcium Sodium Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=53910bac-1c13-40fc-8fbb-3dbc9255b184',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d729461f'),\n",
       "  'Nome_comune': 'Aluminum Citrate',\n",
       "  'INCI_name': 'Aluminum Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=efdc68db-1f75-4935-b03d-fa9aed18e105',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2b6dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl.2):16-46, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['xicity Studies. Ingredient AnimalsaNo./group Dose LD 50 Reference Dermal Citric acid Citric acid Rabbits 10 5 g/kg tested >5 g/kg 51 Triethyl citrate Triethyl citrate Rabbits 4 Not'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294620'),\n",
       "  'Nome_comune': 'Aluminum Dilinoleate',\n",
       "  'INCI_name': 'Aluminum Dilinoleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f1ab260b-e668-48df-9c7f-971f9469677b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294621'),\n",
       "  'Nome_comune': 'Aluminum Dimyristate',\n",
       "  'INCI_name': 'Aluminum Dimyristate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=486da2e0-a245-4e48-926f-32b046b5a4a6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['then further metabolized. The median lethal dose (LD 50) of butyl myristate was greater than 8 g/kg in rats. In animal tests, undiluted butyl myristat'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294622'),\n",
       "  'Nome_comune': 'Aluminum Distearate',\n",
       "  'INCI_name': 'Aluminum Distearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7362ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294623'),\n",
       "  'Nome_comune': 'Aluminum Hydroxide',\n",
       "  'INCI_name': 'Aluminum Hydroxide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2fda9be6-efb8-4582-8bbe-01437d95bd0a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cda7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):16-33, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/10176082',\n",
       "   'valori': ['LD50 Rat ip 1100 mg/kg bw', 'LD50 Rat oral >5000 mg/kg bw'],\n",
       "   'fonti': ['Joint FAO/WHO Expert Committee on Food Additives; WHO Food Additives Ser 24: Aluminum (1989). Available from, as of June 4, 2004: https://www.inchem.org/documents/jecfa/jecmono/v024je07.htm',\n",
       "    'European Chemicals Bureau; IUCLID Dataset, Aluminum hydroxide (21645-51-2) (2000 CD-ROM edition). Available from, as of June 15, 2004: https://esis.jrc.ec.europa.eu/']},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294624'),\n",
       "  'Nome_comune': 'Aluminum Iron Calcium Magnesium Germanium Silicates',\n",
       "  'INCI_name': 'Aluminum Iron Calcium Magnesium Germanium Silicates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=21a73c7c-1520-4cd3-90c3-fc6c0aba1c0e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294625'),\n",
       "  'Nome_comune': 'Aluminum Iron Calcium Magnesium Zirconium Silicates',\n",
       "  'INCI_name': 'Aluminum Iron Calcium Magnesium Zirconium Silicates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d197d0cb-8335-4278-a9e6-90368ef7e285',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294626'),\n",
       "  'Nome_comune': 'Aluminum Iron Silicates',\n",
       "  'INCI_name': 'Aluminum Iron Silicates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=30c6ca7a-1730-4f22-b6f3-963d61bf3733',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1716c1f2275d7294627'),\n",
       "  'Nome_comune': 'Aluminum Isostearate',\n",
       "  'INCI_name': 'Aluminum Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=10a85454-0a80-49b7-9533-8dd452b388a4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1726c1f2275d7294628'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Laurates/Palmitates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Laurates/Palmitates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=30d52b81-c8b7-42c1-a6e8-86829888a1bd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1726c1f2275d7294629'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Laurates/Stearates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Laurates/Stearates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f30e4e63-1b3e-4fcc-b003-998a0d32aaa8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462a'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Myristates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Myristates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=077763a8-a91d-4d26-9841-bce5a1331367',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['then further metabolized. The median lethal dose (LD 50) of butyl myristate was greater than 8 g/kg in rats. In animal tests, undiluted butyl myristat'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462b'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Palmitates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Palmitates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=68fefb27-3778-4b9b-b2a2-f2010055512d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462c'),\n",
       "  'Nome_comune': 'Aluminum Isostearates/Stearates',\n",
       "  'INCI_name': 'Aluminum Isostearates/Stearates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ac2e3556-2997-4066-bff6-237e44422e2d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462d'),\n",
       "  'Nome_comune': 'Aluminum Lanolate',\n",
       "  'INCI_name': 'Aluminum Lanolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=df21c2f9-6c94-43ac-bd65-76321b4f0c02',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462e'),\n",
       "  'Nome_comune': 'Aluminum Myristate',\n",
       "  'INCI_name': 'Aluminum Myristate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=00daf653-a257-484f-b18f-9af9dc44d46f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['then further metabolized. The median lethal dose (LD 50) of butyl myristate was greater than 8 g/kg in rats. In animal tests, undiluted butyl myristat'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d729462f'),\n",
       "  'Nome_comune': 'Aluminum Myristates/Palmitates',\n",
       "  'INCI_name': 'Aluminum Myristates/Palmitates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bc1b4575-a43a-4d39-beb9-179aa46bcaa6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['then further metabolized. The median lethal dose (LD 50) of butyl myristate was greater than 8 g/kg in rats. In animal tests, undiluted butyl myristat'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1726c1f2275d7294630'),\n",
       "  'Nome_comune': 'Aluminum Silicate',\n",
       "  'INCI_name': 'Aluminum Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3d7d0f1d-9fec-4e16-a6d8-5d03569dd083',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294631'),\n",
       "  'Nome_comune': 'Aluminum Starch Octenylsuccinate',\n",
       "  'INCI_name': 'Aluminum Starch Octenylsuccinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6ba180f2-2c58-4977-ab89-46ead971c089',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7096b815-7139-efe2-acb9-3bc9074e4412',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):12-13, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294632'),\n",
       "  'Nome_comune': 'Aluminum Stearate',\n",
       "  'INCI_name': 'Aluminum Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5662ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294633'),\n",
       "  'Nome_comune': 'Aluminum Stearates',\n",
       "  'INCI_name': 'Aluminum Stearates',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9d3959d2-6511-49fd-8695-ff3d2bc42013',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294634'),\n",
       "  'Nome_comune': 'Aluminum Tristearate',\n",
       "  'INCI_name': 'Aluminum Tristearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5862ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294635'),\n",
       "  'Nome_comune': 'Amaranthus Hypochondriacus Seed Oil',\n",
       "  'INCI_name': 'Amaranthus Hypochondriacus Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3096551b-15e6-4e72-9ab2-4e00d80c8470',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294636'),\n",
       "  'Nome_comune': 'Amino Bispropyl Dimethicone',\n",
       "  'INCI_name': 'Amino Bispropyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a9f18b97-b08b-4c52-8a3b-0730ee0225ee',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294637'),\n",
       "  'Nome_comune': 'Aminoethyl Propanediol',\n",
       "  'INCI_name': 'Aminoethyl Propanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8889466b-7f21-49da-a7aa-5add6575936e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f74cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):5-18, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['site. 1000 mg/kg caused the formation of lesions. LD 50> 1000 mg/kg47 Rat, strain not provided (5) 500 or 1000 mg/kg as 5% solution by subcutaneous injection500 mg/kg ',\n",
       "   'are described in Table 4.The oral lethal dose 50 (LD 50) for mice was reported to range from 3350 to 5500 mg/kg, and for rats, the LD 50was >3000 mg/kg; in rabbits, the oral LC 50was between 1000 and 2'],\n",
       "  'contesti_noael': ['methamine. The no-observed-adve rse-effect-level (NOAEL) for local toxicity was 100 mg/kg/d and for systemic toxicity was /C211000 mg/kg/d fo',\n",
       "   's, the iv LC 50was reported to be >125 mg/kg. The NOAEL for local toxicity of orally administered trometha- mine was 100 mg/kg/d in a reproduction study. Tromethamine at 1000 and'],\n",
       "  'valori_ld50': ['1000 mg/kg ', '3000 mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg/d', '100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294638'),\n",
       "  'Nome_comune': 'Aminomethyl Propanediol',\n",
       "  'INCI_name': 'Aminomethyl Propanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2965e811-3a18-4aac-82cf-7a1374878b33',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f74cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):5-18, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['site. 1000 mg/kg caused the formation of lesions. LD 50> 1000 mg/kg47 Rat, strain not provided (5) 500 or 1000 mg/kg as 5% solution by subcutaneous injection500 mg/kg ',\n",
       "   'are described in Table 4.The oral lethal dose 50 (LD 50) for mice was reported to range from 3350 to 5500 mg/kg, and for rats, the LD 50was >3000 mg/kg; in rabbits, the oral LC 50was between 1000 and 2'],\n",
       "  'contesti_noael': ['methamine. The no-observed-adve rse-effect-level (NOAEL) for local toxicity was 100 mg/kg/d and for systemic toxicity was /C211000 mg/kg/d fo',\n",
       "   's, the iv LC 50was reported to be >125 mg/kg. The NOAEL for local toxicity of orally administered trometha- mine was 100 mg/kg/d in a reproduction study. Tromethamine at 1000 and'],\n",
       "  'valori_ld50': ['1000 mg/kg ', '3000 mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg/d', '100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1736c1f2275d7294639'),\n",
       "  'Nome_comune': 'Aminomethyl Propanol',\n",
       "  'INCI_name': 'Aminomethyl Propanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c10e0af3-f349-4bd0-a3c2-4103a5031355',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=62ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 2):141-161, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': [' The maternal no observable adverse effect level (NOAEL) was 100 mglkg/d and the NOEL for fetuses was 300 mg/kg/d, Genotoxicity Microbial Assays Aminomethyl propan'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['300 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463a'),\n",
       "  'Nome_comune': 'Aminomethylpropanediol',\n",
       "  'INCI_name': 'Aminomethyl Propanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9d35c8fb-1a9c-4b62-b51e-088bea417fea',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f74cc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):5-18, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['site. 1000 mg/kg caused the formation of lesions. LD 50> 1000 mg/kg47 Rat, strain not provided (5) 500 or 1000 mg/kg as 5% solution by subcutaneous injection500 mg/kg ',\n",
       "   'are described in Table 4.The oral lethal dose 50 (LD 50) for mice was reported to range from 3350 to 5500 mg/kg, and for rats, the LD 50was >3000 mg/kg; in rabbits, the oral LC 50was between 1000 and 2'],\n",
       "  'contesti_noael': ['methamine. The no-observed-adve rse-effect-level (NOAEL) for local toxicity was 100 mg/kg/d and for systemic toxicity was /C211000 mg/kg/d fo',\n",
       "   's, the iv LC 50was reported to be >125 mg/kg. The NOAEL for local toxicity of orally administered trometha- mine was 100 mg/kg/d in a reproduction study. Tromethamine at 1000 and'],\n",
       "  'valori_ld50': ['1000 mg/kg ', '3000 mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg/d', '100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463b'),\n",
       "  'Nome_comune': 'Aminomethylpropanol',\n",
       "  'INCI_name': 'Aminomethyl Propanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b237c496-a701-4eed-807b-86594017017b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=62ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 2):141-161, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': [' The maternal no observable adverse effect level (NOAEL) was 100 mglkg/d and the NOEL for fetuses was 300 mg/kg/d, Genotoxicity Microbial Assays Aminomethyl propan'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['300 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463c'),\n",
       "  'Nome_comune': 'Aminopropyl Dimethicone',\n",
       "  'INCI_name': 'Aminopropyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6532bfa4-8932-42dc-92c3-7b20d6ac40e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463d'),\n",
       "  'Nome_comune': 'Ammonia',\n",
       "  'INCI_name': 'Ammonia',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=099fb3ca-aa61-4668-b117-9b3bfd5a4d5d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e169a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 05, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/222',\n",
       "   'valori': ['LC50 Rabbit inhalation 7,050 mg/cu m/1 hr',\n",
       "    'LC50 Cat inhalation 746 mg/cu m (1064 ppm)/1 hr (Dynamic air flow)',\n",
       "    'LC50 Cat inhalation 7,050 mg/cu m (10,070 ppm)/1 hr  (Static conditions)',\n",
       "    'LC50 Rat inhalation 112 mg/L (16,000 ppm) for 15 min',\n",
       "    'LC50 Rat inhalation 71.9 mg/L (10,270 ppm) for 30 min',\n",
       "    'LC50 Rat inhalation 48.4 mg/L (6,190 ppm) for 60 min',\n",
       "    'LC50 Rat inhalation 7,600 mg/cu m (10,860 ppm)/2 hr',\n",
       "    'LC50 Rat inhalation 5,100 mg/cu m (7,285 ppm)/1 hr',\n",
       "    'LC50 Mouse inhalation 7,105 mg/cu m (10,150 ppm)/10 min',\n",
       "    'LC50 Mouse inhalation 3,360 mg/cu m (4,800 ppm)/1 hr',\n",
       "    'LC50 Mouse inhalation 3,310 mg/cu m (4,800 ppm)/2 hr',\n",
       "    'LD50 Rat oral 350 mg/kg',\n",
       "    'LD50 Mouse inhalation 4,837 ppm/1 hr'],\n",
       "   'fonti': ['Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.101 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.102 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.102 (1981)',\n",
       "    'HHS/ATSDR; Toxicological Profile for Ammonia p.71 (September 2004) TP126. Available from, as of May 24, 2016: https://www.atsdr.cdc.gov/toxprofiles/index.asp',\n",
       "    'HHS/ATSDR; Toxicological Profile for Ammonia p.71 (September 2004) TP126. Available from, as of May 24, 2016: https://www.atsdr.cdc.gov/toxprofiles/index.asp',\n",
       "    'HHS/ATSDR; Toxicological Profile for Ammonia p.71 (September 2004) TP126. Available from, as of May 24, 2016: https://www.atsdr.cdc.gov/toxprofiles/index.asp',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.102 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.102 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.103 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.103 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.103 (1981)',\n",
       "    'Environment Canada; Tech Info for Problem Spills: Ammonia (Draft) p.103 (1981)',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 228\"]},\n",
       "  'contesti_ld50': ['concentration -dependent manner.42  An acute oral LD 50 of 350 mg/kg for Ammonia in rats (groups of 10) has been  repor',\n",
       "   'en reported as 10 -40  µmol/L.      An acute oral LD 50 of 350 mg/kg ha s been reported in a study involving rats dosed',\n",
       "   ' Dosing  followed by 14- day  observation period  LD 50 (calculated) = 350  mg/kg.6,43, 44       Ammonium Hydroxide (1%  or 3%)  Ma'],\n",
       "  'contesti_noael': ['not  statistically significant at the  low dose.  NOAEL for general  toxicity of diammonium  phosphate = 250 mg/kg/day;  LOAEL  for general toxicity of  diammonium phos',\n",
       "   'ignificant when the  2 groups were compared.  The NOAEL for ammonium sulfate was estimated to be 0.6% in both sexes, which is equivalent to 256 and 284 mg/kg/day in males and females, respectively . 6,84  Neopla',\n",
       "   'weeks.67  A no - observed -adverse effect -level (NOAEL) of 250 mg/kg/day for general toxicity and a lowest -observed- adverse effect -level  (LOAEL) of 750 mg/kg/day for general toxicity were reported for diammonium',\n",
       "   'yos were treated in vitro  and then implanted, an NOAEL of 1500 mg/kg/day  (highest dose tested) was reported.6,44   The on',\n",
       "   'yos were treated in vitro  and then implanted, a  NOAEL of 1500 mg/kg/day (highest  dose tested) was re ported.        In t',\n",
       "   'parent effect  on the offspring to day 4 of age.  NOAEL for reproductive and  developmental toxicity  = 1500  mg/kg/day; LOAEL  not  identified .6,44         Inhalation '],\n",
       "  'valori_ld50': ['350 mg/kg ', '350 mg/kg ', '350  mg/kg'],\n",
       "  'valori_noael': ['250 mg/kg/day',\n",
       "   '284 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '1500 mg/kg/day',\n",
       "   '1500 mg/kg/day',\n",
       "   '1500  mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463e'),\n",
       "  'Nome_comune': 'Ammonium Acrylates Copolymer',\n",
       "  'INCI_name': 'Ammonium Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b13084c2-7a82-477b-918d-22df4ed1fdb4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1746c1f2275d729463f'),\n",
       "  'Nome_comune': 'Ammonium Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       "  'INCI_name': 'Ammonium Acrylates/Ethylhexyl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=40845776-2d5d-42d4-8671-e8c428d0cb31',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1746c1f2275d7294640'),\n",
       "  'Nome_comune': 'Ammonium Acrylates/Methylstyrene/Styrene Copolymer',\n",
       "  'INCI_name': 'Ammonium Acrylates/Methylstyrene/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2333ce62-c138-4a5e-b968-0e875bd2afec',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1746c1f2275d7294641'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eeddbd4e-b117-4b6a-9a4e-79f3e8868caa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294642'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Carboxyethyl Acrylate Crosspolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Carboxyethyl Acrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2eea905e-b8c0-4af8-8785-c40dd89f4ce1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294643'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Laureth-7 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Laureth-7 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e3ddf022-cc0f-4036-9b24-0b3f07d98a5b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294644'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Steareth-25 Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Steareth-25 Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ead0cce2-7943-44e6-b34d-f04919f6fecc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294645'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Steareth-8 Methacrylate Copolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Steareth-8 Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6132638d-88b0-44be-963c-c5eb727ea875',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294646'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/Vinyl Formamide Copolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/Vinyl Formamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=af1f700a-a4f9-42d4-b5e0-726bdc5609e2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294647'),\n",
       "  'Nome_comune': 'Ammonium Acryloyldimethyltaurate/VP Copolymer',\n",
       "  'INCI_name': 'Ammonium Acryloyldimethyltaurate/VP Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7f505b4b-124e-4e60-881a-2def10f5d795',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' clinical  signs were observed.  The acute dermal LD 50 was > 2 g/kg.     Oral   VP Copolymers     VP/VA Copolymer    ',\n",
       "   'yldimethyltaurate/VP Copolymer     The acute oral LD 50  for Ammonium Acryloyldimethyltaurate/VP Copolymer was rep orted to be >2 g/kg in rats.6     VP/Acrylates/Lauryl Methacrylate Cop',\n",
       "   'olymer      An oral LD 50 of > 5 g/kg (rats) has been reported for undiluted VP/Acrylat',\n",
       "   'oss organ changes were observed at necropsy.  The LD 50 was > 5  g/kg.     Shor t-Term Toxicity Studies   Dermal   VP C',\n",
       "   'f 10 New Zealand white rabbits ; the acute dermal LD 50 was > 2 g/kg.  An oral LD 50 of > 5 g/kg  (rats) has been reported for undiluted VP/Acryla',\n",
       "   's organ changes were obse rved  at necropsy.  The LD 50 was > 5 g/kg.       VP/VA C opolymer was administered in the d',\n",
       "   'P and Modified PVP Polymers     PVP      The oral LD 50 of PVP (avg. MW of 40,000) is > 100 g/kg body weight for both rats and guinea pigs .8     Triacontanyl '],\n",
       "  'contesti_noael': ['ded  that the no-observed -adverse -effect level (NOAEL) was  1000 mg/kg/day .     PVP and Modified PVP Polymers       PVP    ',\n",
       "   ' were observed .  The authors concluded  that the NOAEL  was 1000 mg/kg /day.       Inhalation   VP Copolymers     VP/VA Copol',\n",
       "   '  trabeculae of some mesenteric lymph nodes.  The NOAEL was determined to be the target dose of 2500 mg/kg/day (target  dose for highest dose group).36     The ',\n",
       "   'e was  no clear dose -response relationship.  The NOAEL was determined to be the target dose of 2800 mg/kg/day (target dose for  high dose group).  Results rela'],\n",
       "  'valori_ld50': ['2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '100 g/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg/day',\n",
       "   '1000 mg/kg /day',\n",
       "   '2500 mg/kg/day',\n",
       "   '2800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294648'),\n",
       "  'Nome_comune': 'Ammonium Alginate',\n",
       "  'INCI_name': 'Ammonium Alginate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c3dc0786-6554-479a-8d82-cea2d105433d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1756c1f2275d7294649'),\n",
       "  'Nome_comune': 'Ammonium Bicarbonate',\n",
       "  'INCI_name': 'Ammonium Bicarbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2e9daa07-8899-4a84-9417-81dc50b74259',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d69e5a23-fad8-81e7-8ce9-48d464c919af',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):80-105, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/14013',\n",
       "   'valori': ['LD50 Mouse iv 245 mg/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 229\"]},\n",
       "  'contesti_ld50': [' had cleared in all animals by day 10. The dermal LD 50 was reported to be >2000 mg/kg body weight. Potassium Carbonate An acute dermal toxicity eva',\n",
       "   'its was >2000 mg/kg body weight. The same results(LD 50> 2000 mg/kg) were reported in acute dermal toxicity studies o',\n",
       "   'rbonate in studies involving rats. The acute oral LD 50 for Calcium Carbonate, and Potassium Bicarbonate was>2000 mg/kg. In an acute inhalation toxicity study on ammonia'],\n",
       "  'contesti_noael': ['e was not teratogenic in rats dosed bygavage. The NOAEL was estimated to be >800 mg/kg bodyweight/d for pregnant rats and their fetuses. The equivale',\n",
       "   'se group, but without intergroup differences. The NOAEL for magnesium chloride hexahydrate was estimated tobe >800 mg/kg body weight/d; the equivalent NOAEL forMagnesium Carbonate was ',\n",
       "   'r adverse effects on body weight development. The NOAEL was 1000 mg/kg body weight/d. Potassium Bicarbonate I na4 - w kt o x i c i t y',\n",
       "   'respectively, in studies involving albino rats. A NOAEL of 1000 mg/kg body weight/day was reported in a study in which male and female ',\n",
       "   'ale rats were dosed similarly for 28 to 29 d. The NOAEL for the reproductive/developmental toxicity of magnesium chloride hexahydrate was 1000 mg/kg bodyweight/d; the equivalent NOAEL for Magnesium Carbonatewas ',\n",
       "   'xperiments, it was determined that the equivalent NOAEL for Magnesium Carbonate was 4128 mg/kg bodyweight/d. Rats fed Calcium Carbonate at 300 mg/kg for3 d h'],\n",
       "  'valori_ld50': ['2000 mg/kg body weight', '2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['800 mg/kg bodyweight/d',\n",
       "   '800 mg/kg body weight/d',\n",
       "   '1000 mg/kg body weight/d',\n",
       "   '1000 mg/kg body weight/day',\n",
       "   '1000 mg/kg bodyweight/d',\n",
       "   '4128 mg/kg bodyweight/d']},\n",
       " {'_id': ObjectId('668ed1756c1f2275d729464a'),\n",
       "  'Nome_comune': 'Ammonium Bisulfite',\n",
       "  'INCI_name': 'Ammonium Bisulfite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e6220e70-be6a-4ffb-b120-dacc4796b15b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=68b03823-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 22(Suppl. 2):63-88, 2003',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464b'),\n",
       "  'Nome_comune': 'Ammonium C12-15 Pareth Sulfate',\n",
       "  'INCI_name': 'Ammonium C12-15 Alketh Sulfate (Formerly Ammonium C12-15 Pareth Sulfate)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9c742790-8415-4c8d-b8d8-ef25fe3a0c38',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1dd4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):151-161, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464c'),\n",
       "  'Nome_comune': 'Ammonium Capryleth Sulfate',\n",
       "  'INCI_name': 'Ammonium Capryleth Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=806eb74c-d6ae-4b06-91e2-57834fedc786',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1dd4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):151-161, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464d'),\n",
       "  'Nome_comune': 'Ammonium Carbonate',\n",
       "  'INCI_name': 'Ammonium Carbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=220acad6-6a4e-4550-8822-80796447e6e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d69e5a23-fad8-81e7-8ce9-48d464c919af',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):80-105, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' had cleared in all animals by day 10. The dermal LD 50 was reported to be >2000 mg/kg body weight. Potassium Carbonate An acute dermal toxicity eva',\n",
       "   'its was >2000 mg/kg body weight. The same results(LD 50> 2000 mg/kg) were reported in acute dermal toxicity studies o',\n",
       "   'rbonate in studies involving rats. The acute oral LD 50 for Calcium Carbonate, and Potassium Bicarbonate was>2000 mg/kg. In an acute inhalation toxicity study on ammonia'],\n",
       "  'contesti_noael': ['e was not teratogenic in rats dosed bygavage. The NOAEL was estimated to be >800 mg/kg bodyweight/d for pregnant rats and their fetuses. The equivale',\n",
       "   'se group, but without intergroup differences. The NOAEL for magnesium chloride hexahydrate was estimated tobe >800 mg/kg body weight/d; the equivalent NOAEL forMagnesium Carbonate was ',\n",
       "   'r adverse effects on body weight development. The NOAEL was 1000 mg/kg body weight/d. Potassium Bicarbonate I na4 - w kt o x i c i t y',\n",
       "   'respectively, in studies involving albino rats. A NOAEL of 1000 mg/kg body weight/day was reported in a study in which male and female ',\n",
       "   'ale rats were dosed similarly for 28 to 29 d. The NOAEL for the reproductive/developmental toxicity of magnesium chloride hexahydrate was 1000 mg/kg bodyweight/d; the equivalent NOAEL for Magnesium Carbonatewas ',\n",
       "   'xperiments, it was determined that the equivalent NOAEL for Magnesium Carbonate was 4128 mg/kg bodyweight/d. Rats fed Calcium Carbonate at 300 mg/kg for3 d h'],\n",
       "  'valori_ld50': ['2000 mg/kg body weight', '2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['800 mg/kg bodyweight/d',\n",
       "   '800 mg/kg body weight/d',\n",
       "   '1000 mg/kg body weight/d',\n",
       "   '1000 mg/kg body weight/day',\n",
       "   '1000 mg/kg bodyweight/d',\n",
       "   '4128 mg/kg bodyweight/d']},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464e'),\n",
       "  'Nome_comune': 'Ammonium Caseinate',\n",
       "  'INCI_name': 'Ammonium Caseinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=abbbdcd6-09f5-4398-85a1-993ae20af4bd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a744d1db-21ea-4172-a676-d17332da9e6e',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):43-56, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d729464f'),\n",
       "  'Nome_comune': 'Ammonium Cocomonoglyceride Sulfate',\n",
       "  'INCI_name': 'Ammonium Cocomonoglyceride Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=25e76f3c-4d41-45cd-ba60-70b547070802',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=79ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 1):5-16, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294650'),\n",
       "  'Nome_comune': 'Ammonium Coco-Sulfate',\n",
       "  'INCI_name': 'Ammonium Coco-Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1312cc3b-7b6c-42e3-9fe7-065a451b1a81',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=12d4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):115-132, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['termined using groups of 5 albino rats.18The oral LD 50 of sodium stearyl sulfate was >3000 mg/kg. No further details were provided. The oral LD 50'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['3000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294651'),\n",
       "  'Nome_comune': 'Ammonium Cocoyl Isethionate',\n",
       "  'INCI_name': 'Ammonium Cocoyl Isethionate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=16ede518-0683-4245-adef-d8fc73aa7c97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cd307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):5-16, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ere were no macroscopic findings at necropsy. The LD 50 value was greater than 5,000 mg/kg body weight.Table 4C. Not Reported in Use. Sodium hydrogenate'],\n",
       "  'contesti_noael': ['s tested in this study and the maternal and fetal NOAEL was considered to be 1,000 mg/kg body weight/day. Genotoxicity Genotoxicity data were available fr',\n",
       "   '0 through 20 of gestation. The maternal and fetal NOAEL were consid- ered to be 1,000 mg/kg body weight/day. Sodium isethionate was not mutagenic in an Ames ',\n",
       "   'cluded that the no observed adverse effect level (NOAEL) for sodium isethionate was 200 mg/kg body weight/day.4 Reproductive and Developmental Effects Sodium I',\n",
       "   ' 1,000 mg/kg body weight/day in bi-distilled, the NOAEL was 200 mg/kg/d. Sodium isethionate was not teratogenic in Wistar'],\n",
       "  'valori_ld50': ['000 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body weight/day',\n",
       "   '000 mg/kg body weight/day',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294652'),\n",
       "  'Nome_comune': 'Ammonium Cocoyl Sarcosinate',\n",
       "  'INCI_name': 'Ammonium Cocoyl Sarcosinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ffbe724f-a5a7-419c-bf98-98cb3abb0c08',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9eca7c04-56ee-1b53-ba7c-854f28363b44',\n",
       "  'pdf_date': 'IJT 40(Suppl. 2):117-133, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ration. Sodium Myristoyl Sarcosinate had a dermal LD 50 of >2000 mg/kg in male and female rats. In acute oral studiesin r'],\n",
       "  'contesti_noael': ['uroyl Sarcosinate on days 5 –10 of gestation. The NOAEL and LOAEL for maternal toxicity were 30 and 100 mg/kg/day. Oleoyl Sarcosine was not mutagenic in an Ames te',\n",
       "   'effects), and no-observable adverse effect level (NOAEL; systemic effects) for male and female animals were 30, 100, and 250 mg/kg/day, respectively. Inhalation Oleoyl Sarcosine. In a ',\n",
       "   ' not observed in the low- or mid-dose groups. The NOAEL(maternal toxicity), LOAEL (maternal toxicity), and NOEL(developmental toxicity) were 30, 100, and ≥250 mg/kg/day Sodium Lauroyl Sarcosinate, respectively. Genotox',\n",
       "   'nate in rats,the NOEL, LOAEL (local effects), and NOAEL (systemic effects) were 30, 100, and 250 mg/kg/day, respectively.Acute inhalation studies were perfo'],\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ['100 mg/kg/day',\n",
       "   '250 mg/kg/day',\n",
       "   '250 mg/kg/day',\n",
       "   '250 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294653'),\n",
       "  'Nome_comune': 'Ammonium Cumenesulfonate',\n",
       "  'INCI_name': 'Ammonium Cumenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e5dba92f-b80c-4b64-bdb2-a1576af9ec86',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5ba16b53-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 3):270-283, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ne sulfonate, Ca 28088-63-3 Dermal rabbit 24 hour LD 50>2000 mg/kg bw USEPA 798.1175 Xylene sulfonate, NH4 26447-10-9 In',\n",
       "   ' 798.1100 Cumenesulfonate, Na 28348-53-0 Oral rat LD 50>7000 mg/kg bw OECD 401 Cumenesulfonate, Na 28348-53-0 Dermal rabbit LD 50>2000 mg/kg bw Not specified Cumenesulfonate, Na 28348-53-0 Inhal',\n",
       "   'oxicity studies for xylene sulfonic acid reported LD 50 values of 2100 to 16 200 mg/kg bw (dermal), 2000 mg/kg bw (oral), and 557 000 to 770 000 mg/m3(inhalation).',\n",
       "   'specified Xylene sulfonate, Na 1300-72-7 Oral rat LD 50>5000-16 200 mg/kg bw Not specified Xylene sulfonate, NH4 26447-10-9 Oral rat LD 50>2100 mg/kg bw Not specified Xylene sulfonate, Ca 28088-63-3 Oral',\n",
       "   'FR1500.40 Xylene sulfonate, Na 1300-72-7 Oral rat LD 50>5000 mg/kg bw Not specified Xylene sulfonate, Na 1300-72-7 Oral rat LD 507200 mg/kg bw Not Specified Xylene sulfonate, Na 1300-72-7 Oral '],\n",
       "  'contesti_noael': ['ges of biological variation for this species. The NOAEL for maternal and fetal toxicity was the highest dose tested, 3000 mg/kg bw/d, which corresponds to 936 mg AI/kg bw/d. Genotoxi'],\n",
       "  'valori_ld50': ['2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2100 mg/kg bw ',\n",
       "   '507200 mg/kg bw '],\n",
       "  'valori_noael': ['3000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1766c1f2275d7294654'),\n",
       "  'Nome_comune': 'Ammonium Dinonyl Sulfosuccinate',\n",
       "  'INCI_name': 'Ammonium Dinonyl Sulfosuccinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cd67ecb6-67f3-49ba-b9b4-653247d99cfa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7ca8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.3):34-46, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [') Toxicity Dermal. The dermal median lethal dose (LD 50)o fu n d i l u t e d diethylhexyl sodium sulfosuccinate in rabbits was >10g/kg.4 Occlusive patches of 10 g/kg of the test materi'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294655'),\n",
       "  'Nome_comune': 'Ammonium Dodecylbenzenesulfonate',\n",
       "  'INCI_name': 'Ammonium Dodecylbenzenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=34d93048-6526-4546-98de-7305ebedcdd1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=80307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 4):288-305, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tated the following. The oral median lethal dose (LD 50) for sodium dodecylben- zenesulfonate (SDDBS) in rats was 1.26 g/kg. No significant toxic effects were observed when '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['26 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294656'),\n",
       "  'Nome_comune': 'Ammonium Glycolate',\n",
       "  'INCI_name': 'Ammonium Glycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=01f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294657'),\n",
       "  'Nome_comune': 'Ammonium Glycyrrhizate',\n",
       "  'INCI_name': 'Ammonium Glycyrrhizate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d71cfddf-d1a0-4487-8496-3dcf6124a9f0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=49a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):79-112, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' 1, 10, 20, and 100 times the median lethal dose (LD 50) of virus, as de- termined in preliminary tests. Mice received doses of 1.25 to 80mg/kg Glycyrrhizic Acid i.p. the day before viral infect',\n",
       "   'Glycyrrhetinic Acid The median acute lethal dose (LD 50) of intraperitoneal (i.p.) injection of Glycyrrhetinic Acid in mice is 308 mg/kg (Infor-matics, Inc. 1972). Finney et al. (1958) f',\n",
       "   ' Potassium Glycyrrhizinate i.p. in mice. The oral LD 50 was 12,400 mg/kg. Short-Term Toxicity Finney et al. (1958) adminis'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['80mg/kg ', '308 mg/kg', '400 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294658'),\n",
       "  'Nome_comune': 'Ammonium Hydrolyzed Collagen',\n",
       "  'INCI_name': 'Ammonium Hydrolyzed Collagen',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=71fdab00-b33e-480a-8d3e-b6f32e297e1e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=70af0ca6-3a32-ea93-85bf-c21e81f97048',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):21-42, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d7294659'),\n",
       "  'Nome_comune': 'Ammonium Hydroxide',\n",
       "  'INCI_name': 'Ammonium Hydroxide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aec980d8-8abe-4a50-93f7-8b30bda27def',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e169a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 05, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['concentration -dependent manner.42  An acute oral LD 50 of 350 mg/kg for Ammonia in rats (groups of 10) has been  repor',\n",
       "   'en reported as 10 -40  µmol/L.      An acute oral LD 50 of 350 mg/kg ha s been reported in a study involving rats dosed',\n",
       "   ' Dosing  followed by 14- day  observation period  LD 50 (calculated) = 350  mg/kg.6,43, 44       Ammonium Hydroxide (1%  or 3%)  Ma'],\n",
       "  'contesti_noael': ['not  statistically significant at the  low dose.  NOAEL for general  toxicity of diammonium  phosphate = 250 mg/kg/day;  LOAEL  for general toxicity of  diammonium phos',\n",
       "   'ignificant when the  2 groups were compared.  The NOAEL for ammonium sulfate was estimated to be 0.6% in both sexes, which is equivalent to 256 and 284 mg/kg/day in males and females, respectively . 6,84  Neopla',\n",
       "   'weeks.67  A no - observed -adverse effect -level (NOAEL) of 250 mg/kg/day for general toxicity and a lowest -observed- adverse effect -level  (LOAEL) of 750 mg/kg/day for general toxicity were reported for diammonium',\n",
       "   'yos were treated in vitro  and then implanted, an NOAEL of 1500 mg/kg/day  (highest dose tested) was reported.6,44   The on',\n",
       "   'yos were treated in vitro  and then implanted, a  NOAEL of 1500 mg/kg/day (highest  dose tested) was re ported.        In t',\n",
       "   'parent effect  on the offspring to day 4 of age.  NOAEL for reproductive and  developmental toxicity  = 1500  mg/kg/day; LOAEL  not  identified .6,44         Inhalation '],\n",
       "  'valori_ld50': ['350 mg/kg ', '350 mg/kg ', '350  mg/kg'],\n",
       "  'valori_noael': ['250 mg/kg/day',\n",
       "   '284 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '1500 mg/kg/day',\n",
       "   '1500 mg/kg/day',\n",
       "   '1500  mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1776c1f2275d729465a'),\n",
       "  'Nome_comune': 'Ammonium Isostearate',\n",
       "  'INCI_name': 'Ammonium Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e9775093-1054-464f-adb4-1340588fdab5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1776c1f2275d729465b'),\n",
       "  'Nome_comune': 'Ammonium Lactate',\n",
       "  'INCI_name': 'Ammonium Lactate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=07f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d729465c'),\n",
       "  'Nome_comune': 'Ammonium Laureth Sulfate',\n",
       "  'INCI_name': 'Ammonium Laureth Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9c345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1dd4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):151-161, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1776c1f2275d729465d'),\n",
       "  'Nome_comune': 'Ammonium Lauroyl Sarcosinate',\n",
       "  'INCI_name': 'Ammonium Lauroyl Sarcosinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b326d09c-9709-40f4-9f91-6aef70ffa3b4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9eca7c04-56ee-1b53-ba7c-854f28363b44',\n",
       "  'pdf_date': 'IJT 40(Suppl. 2):117-133, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ration. Sodium Myristoyl Sarcosinate had a dermal LD 50 of >2000 mg/kg in male and female rats. In acute oral studiesin r'],\n",
       "  'contesti_noael': ['uroyl Sarcosinate on days 5 –10 of gestation. The NOAEL and LOAEL for maternal toxicity were 30 and 100 mg/kg/day. Oleoyl Sarcosine was not mutagenic in an Ames te',\n",
       "   'effects), and no-observable adverse effect level (NOAEL; systemic effects) for male and female animals were 30, 100, and 250 mg/kg/day, respectively. Inhalation Oleoyl Sarcosine. In a ',\n",
       "   ' not observed in the low- or mid-dose groups. The NOAEL(maternal toxicity), LOAEL (maternal toxicity), and NOEL(developmental toxicity) were 30, 100, and ≥250 mg/kg/day Sodium Lauroyl Sarcosinate, respectively. Genotox',\n",
       "   'nate in rats,the NOEL, LOAEL (local effects), and NOAEL (systemic effects) were 30, 100, and 250 mg/kg/day, respectively.Acute inhalation studies were perfo'],\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ['100 mg/kg/day',\n",
       "   '250 mg/kg/day',\n",
       "   '250 mg/kg/day',\n",
       "   '250 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1786c1f2275d729465e'),\n",
       "  'Nome_comune': 'Ammonium Lauryl Sulfate',\n",
       "  'INCI_name': 'Ammonium Lauryl Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['e Panel calculated the MOS of DBP by dividing the NOAEL of 331 mg/kg/day (from a feeding study) by the ex-pected exposure of 9.13 μg/kg/day, yielding an MOS of 36,254. If the more conservat',\n",
       "   'l noted thatthe no observed adverse effect level (NOAEL) of DBP in a gav-age study was 50 mg/kg/day (Mylchreest et al. 2000). However,a feeding study',\n",
       "   'ive NOAEL of 50 mg/kg/day (from a gav-age study) is used, the MOS is 5476. ',\n",
       "   ' reported a NOAEL of 331 mg/kg/day (Ema et al.1998). Overall, the Panel felt that fe'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['13 μg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '331 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1786c1f2275d729465f'),\n",
       "  'Nome_comune': 'Ammonium Myreth Sulfate',\n",
       "  'INCI_name': 'Ammonium Myreth Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d1c5648a-256b-4c90-aa2e-322a5c69afe6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1dd4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):151-161, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294660'),\n",
       "  'Nome_comune': 'Ammonium Myristyl Sulfate',\n",
       "  'INCI_name': 'Ammonium Myristyl Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=07ae8b83-aea3-4a54-a1a7-87ce930ab3ab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=12d4785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 2):115-132, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['termined using groups of 5 albino rats.18The oral LD 50 of sodium stearyl sulfate was >3000 mg/kg. No further details were provided. The oral LD 50'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['3000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294661'),\n",
       "  'Nome_comune': 'Ammonium Oleate',\n",
       "  'INCI_name': 'Ammonium Oleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e44dba44-980e-4b29-b074-8a0e24d141ff',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294662'),\n",
       "  'Nome_comune': 'Ammonium Persulfate',\n",
       "  'INCI_name': 'Ammonium Persulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a7152517-a7b9-4a0c-aaa6-1eb598c9e334',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b2769572-1904-d977-9587-1be4a26422ba',\n",
       "  'pdf_date': 'IJT 41(Suppl. 3):5-21, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ats, Ammonium Persulfate was considered non-toxic(LD 50> 2000 mg/kg body weight). In an acute dermal toxicity study involving male rabbits, an LD 50> 10 000 mg/kg body weight was reported. An acute oral LD 50of 742 mg/kg body'],\n",
       "  'contesti_noael': ['hest dose. The no- observed adverse effect level (NOAEL) was determined to be 41.1 mg/kg bw/d. Potassium persulfate. Potassium Persulfate was t',\n",
       "   'w/d,no signi ﬁcant pathology was observed and the NOAEL was determined to be 41.1 mg/kg bw/d. No signi ﬁcant pathology was observed and the NO',\n",
       "   'eriod. No signi ﬁcant pathology was observed. The NOAEL was estimated to be 131.5 mg/kg bw/d. Inhalation Ammonium Persulfate. In a study invol',\n",
       "   'm Sodium Persulfate) of rats for 13 wk. LOAEL and NOAEL values of 200 and 91 mg/kg bw/d, respectively,were determined. The frequency of g',\n",
       "   ' for male and female fertilityperformance and the NOAEL for F 1viability and development were reported to be ≥250 mg/kg/d. Genotoxicity In Vitro Ammonium persulfate. Resul',\n",
       "   'her sex or in F 1pups at any treatment level. The NOAEL for male and female fertility performance and the NOAEL for F 1viability and development were ≥250 mg/kg/d. Sodium Persulfate was non-genotoxic in the in vi'],\n",
       "  'valori_ld50': ['000 mg/kg body weight '],\n",
       "  'valori_noael': ['1 mg/kg bw/d',\n",
       "   '1 mg/kg bw/d',\n",
       "   '5 mg/kg bw/d',\n",
       "   '91 mg/kg bw/d',\n",
       "   '250 mg/kg/d',\n",
       "   '250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294663'),\n",
       "  'Nome_comune': 'Ammonium Phosphate',\n",
       "  'INCI_name': 'Ammonium Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a117e391-6d24-494c-af87-c95bb19ad73b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['40 mg/kg.3 Ammonium Salts Ammonium Phosphate Rats LD 50>1000 mg/kg.48 Ammonium Phosphate Rats LD 50¼3250 mg/kg.88 Am',\n",
       "   '0 mg/kg.48 Disodium Pyrophosphate Rats LD 50>1000 mg/kg.48 Disodium Pyrophosphate Rats LD 50¼1690 mg/kg.8',\n",
       "   '/kg.48 Potassium Salts Dipotassium Phosphate Rats LD 50>500 mg/kg.48 Dipotassium Phosphate Rats LD 50>1000 mg/kg.48 Dipotassium Phosphate(liquid) Rats LD 50¼4810 ',\n",
       "   'mg/kg.48 Tetrapotassium Pyrophosphate Rats (male) LD 50>1000 mg/kg.48 Tetrapotassium Pyrophosphate Rats LD 50¼2980 m',\n",
       "   ' (5 males and 5 females) LD 50>2000 mg/kg.87 Calcium Phosphate Rats LD 50>1000 mg/kg.48 Calcium Phosphate Rats LD 50¼2170 mg/kg.48 Cal',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>1260 mg/kg.68 Phosphoric Acid Rabbits LD 50¼2740 mg/kg.48,66',\n",
       "   ' Rats LD 50¼5750 mg/kg.48 Ammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50>1000 mg/kg.48 Diammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50¼6500 mg/kg.48 ',\n",
       "   'Rats LD 50¼8390 mg/kg.48,66 Sodium Phosphate Mice LD 50>3700 mg/kg.48,8 Sodium Phosphate Guinea pigs LD 50>2000 mg/kg.48,89 Sodium Trimetaphosphate Rats LD 50¼10600 mg',\n",
       "   'ups of 5) No clinical signs or necropsy findings. LD 50>2000 mg/ kg.30,91 Tetrasodium Pyrophosphate Mice LD 50¼1300 mg/kg.8 Trisodium Phosphate Rats LD 50>2000 mg/kg.48,92 Trisodium Phosphate Rats LD 50¼4100 mg/kg.4',\n",
       "   't stated)Rabbits LD 50>2000 mg/kg.48Johnson et al 63S Table 6. Acute Dermal Toxicit',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>3160 mg/kg.68 Phosphoric Acid 85% solution Rabbits LD 50>2000 mg/kg.48 Ammonium Salts Ammonium Phosphate Rats LD 50>5',\n",
       "   'ts No clinical signs or necropsy findings. LD 50 >2000 mg/kg.31 Tetrasodium Pyrophosphate Rabbits LD 50>2000 mg/kg.48 Tetrasodium Pyrophosphate Rabbits LD 50>7940 m',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>10000 mg/kg.48 Calcium Salts Calcium Dihydrogen Phosphate 2000 mg/kg Rabbits (5 males and 5 females) Severe erythema an',\n",
       "   'd mild edema. LD 50> 2000 mg/kg.86 Calcium Phosphate Rabbits LD 50>300 mg/kg.98 Calcium Phosphate Rabbits LD 50>2000 mg/kg.48 Calcium Pyrophosphate Rabbits LD 50>7940 mg/kg',\n",
       "   'Stauffland albino rabbits (5 males and 5 females) LD 50>2000 mg/kg.67 Dicalcium Phosphate Rabbits LD 50>7940 mg/kg.48 Tricalcium Phosphate Rabbits LD 50>2000 mg/kg.48 Magnesium Salts Magnesium Phosphate Solution (',\n",
       "   's involving rabbits, an LD 50of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   'ute dermal toxicity studies involving rabbits, an LD 50 of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   's LD 50¼3600 mg/kg.48 Disodium Pyrophosphate Rats LD 50>4000 mg/kg.48,89 Disodium Pyrophosphate Mice LD 50¼3350 mg/k',\n",
       "   '/kg.48,95 Pentapotassium Triphosphate Rats (male) LD 50>1000 mg/kg.48 Potassium Phosphate Rats (male) LD 50>4640 mg/kg.48 Potassium Phosphate Rats LD 50¼7100 mg/kg.48 P',\n",
       "   '0¼4150 mg/kg.48 Trisodium Phosphate Rats (female) LD 50<5000 mg/kg.48 Trisodium Phosphate 20% solution Rats LD 50¼65',\n",
       "   'phosphate Solution (concentration not stated)Rats LD 50<5000 mg/kg.48 Tetrapotassium Pyrophosphate Mice LD 50¼1000 m',\n",
       "   'LD 50¼3986 mg/kg.48 Calcium Phosphate Rats (male) LD 50>5000 mg/kg.48 Calcium Phosphate Mice LD 50¼4600 mg/kg.8 Dica',\n",
       "   'male) LD 50>10000 mg/kg.67 Dicalcium Phosphate Mice LD 50/C251700 mg/kg.17 Tricalcium Phosphate Rats LD 50>5000 mg/kg.48 Tricalcium Phosphate Sprague-Dawley rats (fema',\n",
       "   'LD 50>300 mg/kg.48 Dipotassium Phosphate(liquid) Rabbits LD 50>5000 mg/kg.48 Dipotassium Phosphate Rabbits LD 50>5000 mg/kg',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>4640 mg/kg.48 Tetrapotassium Pyrophosphate (liquid)Rabbits LD 50>5000 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>794',\n",
       "   'ed for calcium salts of phosphoric acid. Reported LD 50 values ranging from >2000 mg/kg to >7940 mg/kg were reported for magnesium salts of phosphoric ac',\n",
       "   'm >7940 mg/kg to >10000 mg/kg for rabbits. Dermal LD 50 values ranging from >300 mg/kg to >7940 mg/kg (rabbits) were reported for sodium salts of Phosp',\n",
       "   'lcium Phosphate 6 Sprague-Dawley rats (female) LD 50/C212000 mg/kg.67 Dicalcium Phosphate Rats LD 50¼7100 mg/kg.48 Dicalcium Phosphate Rats LD 50>7940 mg/kg.48 Dicalcium Phosphate 10 Sprague-Dawley rats (fe',\n",
       "   '000 mg/kg.88 Ammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.88 Diammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rabbits LD 50>10000 mg/kg',\n",
       "   '.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.97 Sodium Salts Disodium Phosphate Rabbits LD 50>7940 mg/kg.48 Disodium Pyrophosphate Rabbits LD 50>300 mg/kg',\n",
       "   '.98 Disodium Pyrophosphate Rabbits LD 50>7940 mg/kg.48 Pentasodium Triphosphate Rabbits LD 50¼4640 mg',\n",
       "   '/kg.48 Pentasodium Triphosphate Rabbits LD 50>7940 mg/kg.48 Sodium Phosphate Rabbits LD 50>7940 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateR',\n",
       "   'abbits LD 50>7940 mg/kg.48 Tetrasodium Pyrophosphate 20 Sprague-Dawley ra',\n",
       "   'g/kg.48 Trisodium Phosphate Rabbits LD 50>300 mg/kg.98 Trisodium Phosphate Rabbits LD 50>7940 mg/kg.48 Potassium Salts Dipotassium Phosphate Rabbits ',\n",
       "   '.48 Pentapotassium Triphosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>7940 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>200',\n",
       "   'concentration not stated)Rabbits LD 50>2000 mg/kg.48 Magnesium Phosphate Rabbits LD 50>4640 mg/kg.48 Trimagnesium Phosphate Rabbits LD 50>7940 mg/kg.4864S International Journal of Toxicology 40(Supp',\n",
       "   'sphoric acid involving rats or mice, the reported LD 50 ranged from 2170 mg/kg (Calcium Phosphate [rats]) to > 10000 mg/kg (Calcium Pyrophosphate [rats]). The reportedLD 50',\n",
       "   'Sodium Polyphosphate/Sodium HexametaphosphateRats LD 50>10000 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateM',\n",
       "   'ed water)Female Sprague-Dawley rats (groups of 3) LD 50>2000 mg/kg.86,87 Calcium Dihydrogen Phosphate Female Sprague-Dawley rats (groups of 5) LD 50>10000 mg/kg.86,87 Calcium Dihydrogen Phosphate Albino rabbits',\n",
       "   'le, groups of 3) LD 50>2000 mg/kg.55 Calcium Pyrophosphate Rats LD 50>10000 mg/kg.48 Magnesium Salts Magnesium Phosphate Rats LD 50',\n",
       "   '>1000 mg/kg.48 Magnesium Phosphate Rats LD 50>4640 mg/kg.48 Magnesium Phosphate Rats LD 50>5000 mg/kg.48 Trimagnesium Phosphate Rats LD 50>10000 mg/kg.48 Magnesium Phosphate Solution (concentration no',\n",
       "   'd guinea pigs in acute oral toxicity studies, and LD 50 values ranged from 1300 mg/kg (Tetrasodium Pyrophosphate[mice]) to 10600 mg/kg (Sodium Trimetaphosphate [rats]). Forpotassium sa',\n",
       "   'Diammonium Phosphate Rats LD 50>25100 mg/kg.48 Sodium Salts Disodium Phosphate Rats LD 50¼595'],\n",
       "  'contesti_noael': ['daily for 150 days. In studies involving dogs, an NOAEL of 100 mg/kg/d was reportedfor the following sodium salts, each ',\n",
       "   's for 52 weeks yielded an NOEL of 338 mg/kg/d. An NOAEL of 105 mg/kg/d was reported in astudy in which sheep received doses of Phosphoric Acid up to 211 mg/kg/d for 70 days. An NOAEL of 250 mg/kg/d was reported',\n",
       "   ') No reproductive or developmental toxic effects. NOAEL ¼1000 mg/kg/d.17 Potassium Phosphate Doses (in water) up to 320 mg/kg/d on gestation d 6-15 20 to 22 CD-1 mice No treatme',\n",
       "   'e or developmental effects at doses administered. NOAEL ¼1500 mg/kg/d.88,100 Sodium Salts Disodium PyrophosphateDoses (in water) up to 335 mg/kg/d on gestation d 6-15 19 to 22 CD-1 mice No treatme',\n",
       "   '13/sex/dose) 2 females of 500 mg/kg/d group died. NOAEL ¼250 mg/kg/d.65,68 Phosphoric Acid Up to 0.75% in diet (338 mg/kg/d*) for >52 wk Rats NOEL ¼338 mg/kg/d*.48,89 Phosph',\n",
       "   'l inflammation (not dose-dependent) at all doses. NOAEL ¼250 mg/kg/d.88,100 Diammonium Phosphate Increasing oral doses (in drinking water) of 300 to 700 mg/kg/d for 5 to 16 mo10 Rabbits (females) Average weight',\n",
       "   ' Trimetaphosphate 0 and 100 mg/kg/d for 30 d Dogs NOAEL ¼100 mg/kg/d.90 Tetrasodium Pyrophosphate 250, 500, or 1000 mg/kg/d by gavage for 90 d (5 d/week) (OECD Guideline 408',\n",
       "   'group, but no morphological findings in the liver.NOAEL ¼1000 mg/kg/d. 86,120 Dicalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d for 28 d by gastric intubation Sprague-Dawley rat',\n",
       "   's (10/sex/dose) No gross or microscopic eff ects. NOAEL >1000 mg/kg/d.67 Tricalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d by gavage. Males dosed from 2 wk before mating to',\n",
       "   ' on mating, gestation, or external malformations. NOAEL of 1000 mg/kg/d (parents and pups).86,120 (continued)72S Internat',\n",
       "   'females of 1000 mg/kg/d group. NOEL ¼250 mg/kg/d; NOAEL ¼500 mg/kg/d. 31 Tetrasodium Pyrophosphate 0%, 1.1%, 1.8%, 3%, or 5% in diet (0, 495, 810, 1350 mg/kg/d*) for 39 wkRats LOEL ¼495 mg/kg/d*.48,103 Trisodi',\n",
       "   'ic Acid 0, 35, 105, or 211 mg/kg/d for 70 d Sheep NOAEL ¼105 mg/kg/d.99 Ammonium Salts Diammonium Phosphate Oral doses (by gavage) of 0, 250, 750, or 1500 mg/kg/d (7 d/wk) for 35 dRats (groups of 10 [5 males and ',\n",
       "   ' diet (0, 23, 225, 2250 mg/kg/d*) for 104 wk Rats NOAEL ¼225 mg/kg/d*.90 Sodium Polyphosphate/Sodium Hexametaphosphate0%, 0.93%, or 3.5% in diet (0, 419, 1575 mg/kg/d*) for 21 wk Rats NOAEL ¼1575 mg/kg/d*.48,107 Sodi',\n",
       "   'ipotassium Phosphate 0.87% or 5.1% for 21 wk Rats NOAEL ¼2295 mg/kg/d*.48,107 Dipotassium Phosphate 5% in diet (2250 mg/kg/d*) in medium-term bioassay Male Wistar rats Renal ',\n",
       "   '.75 %in the diet daily for >52 weeks. The highest NOAEL (2623 mg/kg/d) was reported in a study in which rats were fed D'],\n",
       "  'valori_ld50': ['1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1260 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3160 mg/kg ',\n",
       "   '3160 mg/kg ',\n",
       "   '4000 mg/kg',\n",
       "   '4640 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '7940 mg/kg ',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10600 mg/kg',\n",
       "   '25100 mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg/d',\n",
       "   '211 mg/kg/d',\n",
       "   '320 mg/kg/d',\n",
       "   '335 mg/kg/d',\n",
       "   '338 mg/kg/d',\n",
       "   '700 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1350 mg/kg/d',\n",
       "   '1500 mg/kg/d',\n",
       "   '1575 mg/kg/d',\n",
       "   '2250 mg/kg/d',\n",
       "   '2623 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294664'),\n",
       "  'Nome_comune': 'Ammonium Phosphatidyl Rapeseedate',\n",
       "  'INCI_name': 'Ammonium Phosphatidyl Rapeseedate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c177c35-9a47-48c4-9e71-fc7f882a0727',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1aefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 2):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1786c1f2275d7294665'),\n",
       "  'Nome_comune': 'Ammonium Polyacrylate',\n",
       "  'INCI_name': 'Ammonium Polyacrylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=164d667f-a52e-458b-bfb9-a85742ff4328',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1796c1f2275d7294666'),\n",
       "  'Nome_comune': 'Ammonium Polyacryloyldimethyl Taurate',\n",
       "  'INCI_name': 'Ammonium Polyacryloyldimethyl Taurate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=362bf41d-8ea3-43a4-bcd5-b8d99df63614',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e02abb3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 11, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Rats (strain and n not specified) ;  OECD TG 402  LD 50 >5000 mg/ kg (>1200 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'Rats (strain and n not specified) ;  OECD TG 425  LD 50 >5000 mg/ kg (>1200 mg/kg polymer)  12  Acryla mide /Sodium  Acryloyldimethy',\n",
       "   'rain and n not specified);  method not specified  LD 50 >2000 mg/kg  (>1200 mg/kg)  11  OECD TG  = Organization for Economic Co -op',\n",
       "   'abnormal  behavior). Necropsy was unremarkable.   LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'rain and n not specified);  method not specified  LD 50 >5000 mg/kg  (>1250 to >1350 mg/kg  Acryla mide /Sodium Acr yloyldimethyltaurate/Acryl',\n",
       "   'er  HanRcc:WIST (SPF) Rats  (n=3 );  OECD T G 423 LD 50 >2000 mg/kg; 5 h after treatment, 3 rats showed  slight ruffl',\n",
       "   'dimethyltaurate/VP  Copolymer  Rats; OECD TG 401  LD 50 >2000 mg/kg  6  Hydroxyethyl Acrylate/Sodium  Acryloyldimethyl ',\n",
       "   'e shadow (leave -on products).   The acute dermal LD 50 for Acrylamide/Sodium Acryloyldimethyltaurate/Acrylic Acid Copolymer was reported to be >5000 mg/kg in rats .  The acute dermal LD 50 for a product co'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1200 mg/kg  ',\n",
       "   '1200 mg/kg ',\n",
       "   '1200 mg/kg',\n",
       "   '1350 mg/kg  ',\n",
       "   '1350 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg  ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d7294667'),\n",
       "  'Nome_comune': 'Ammonium Silver Zeolite',\n",
       "  'INCI_name': 'Ammonium Silver Zeolite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=effd64f1-8565-49db-946e-44604310bebc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5b047156-d323-2325-85e7-c654069ebcbd',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ed here are described  in Table 5. 3  The dermal  LD 50 for  Zeolite ( various synthetic subtypes and natural - smellerite) was > 16,000 mg/kg bw in studies with rabbits.  Mild erythema  that reso',\n",
       "   'emaining zeolite ingredient .    The acute dermal LD 50 for Zeolite ( various synt hetic subtypes and natural - smellerite ) was > 16,000 mg/kg bw in  studies with rabbits.  Mild erythema that reso',\n",
       "   ' of synthetic Zeolite orally had an oral  LD 50 > 32,000 mg/kg bw.  An extremely low order of toxicity was observed in rats that received up to 32,000 mg/kg bw  Zeolite (synthetic bonded with bentonite).   Other',\n",
       "   'ity observed.  One synthetic Zeolite  had an oral LD 50 > 16,520  mg/kg bw in rats, while rats that received various subtypes',\n",
       "   'arious  synthetic subtypes of Zeolite had an oral LD 50 > 31,600 mg/kg in rat studies.  An oral study of Zeolite (natural',\n",
       "   'ite ( natural ; sme llerite ) in rats reported an LD 50 > 16,000 mg/kg bw.  An oral study of Zeolite (synthetic) in dogs  reported an LD 50 > 1000 mg/kg bw: emesis occurred within 5 min of dosing.     In i',\n",
       "   '; smellerite) in rats reported an LD 50 > 16,000 mg/kg bw.  An oral study of  Zeolite (synthetic) in dogs reported an LD 50 > 1000 mg/kg bw: emesis occurred within 5 min of dosing.    In ac',\n",
       "   ' No./Group  Vehicle  Concentration/Dose/Protocol  LD 50/LC 50/Results   DERMAL   Zeolite ( synthetic ) Female New Zealand  White rabbits  10 Not reported  2000 mg/kg bw; skin abraded in 5 animals and all  patches were ',\n",
       "   'l signs of toxicity for 14 d;  necropsy performed LD 50 > 5000 mg/kg bw/d; no deaths observed; slight signs of rough  fur',\n",
       "   ' subtypes of synthetic Zeolite orally had an oral LD 50 > 32,000 mg/kg  bw.  An extremely low order of toxicity was observed in rats that received up to 32,000 mg/kg bw Zeolite (synthetic bonded  with bentonite ).  Othe'],\n",
       "  'contesti_noael': ['e study of Zeolite (synthetic)  in male rats, the NOAEL was > 1250.8 mg/kg bw/d.  The  NOAEL for rep roductive effects was > 50 m',\n",
       "   've study of Zeolite (synthetic) in male rats, the NOAEL was >  1250.8 mg/kg bw/d.  The NOAEL for reproductive effects was > 50 mg/',\n",
       "   'day 200; gross pathology and necropsy  performed  NOAEL = 0.125% (75.14 mg/kg bw/d); no effects were observed in  body weight gains,',\n",
       "   'erformed in a similar manner as described  above  NOAEL for both maternal and fetal toxicity > 1600 mg/kg  bw/day; no maternal toxic effects observed; no embryotox',\n",
       "   'performed in a similar manner as described above  NOAEL for both maternal and fetal toxicity > 1600 mg/kg  bw/day; no maternal toxic effects observed; no embryotox',\n",
       "   'during the week; necropsy performed at study end  NOAEL > 5000 mg/kg bw/d; no deaths or clinical signs of toxicity  observe'],\n",
       "  'valori_ld50': ['000 mg/kg bw ',\n",
       "   '000 mg/kg bw ',\n",
       "   '000 mg/kg bw  ',\n",
       "   '520  mg/kg bw ',\n",
       "   '600 mg/kg ',\n",
       "   '1000 mg/kg bw',\n",
       "   '1000 mg/kg bw',\n",
       "   '2000 mg/kg bw',\n",
       "   '5000 mg/kg bw',\n",
       "   '32,000 mg/kg bw '],\n",
       "  'valori_noael': ['8 mg/kg bw/d',\n",
       "   '8 mg/kg bw/d',\n",
       "   '14 mg/kg bw/d',\n",
       "   '1600 mg/kg  bw/day',\n",
       "   '1600 mg/kg  bw/day',\n",
       "   '5000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1796c1f2275d7294668'),\n",
       "  'Nome_comune': 'Ammonium Silver Zinc Aluminum Silicate',\n",
       "  'INCI_name': 'Ammonium Silver Zinc Aluminum Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6bb630fc-6e91-4703-b007-66771137aaab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d7294669'),\n",
       "  'Nome_comune': 'Ammonium Stearate',\n",
       "  'INCI_name': 'Ammonium Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d62ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466a'),\n",
       "  'Nome_comune': 'Ammonium Styrene/Acrylates Copolymer',\n",
       "  'INCI_name': 'Ammonium Styrene/Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c4e73f01-1d3e-4baf-abec-de9b1b7090b5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466b'),\n",
       "  'Nome_comune': 'Ammonium Styrene/Acrylates/Ethylhexyl Acrylate/Lauryl Acrylate Copolymer',\n",
       "  'INCI_name': 'Ammonium Styrene/Acrylates/Ethylhexyl Acrylate/Lauryl Acrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7887ab12-df19-45a2-b922-cbb9e981e8f1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466c'),\n",
       "  'Nome_comune': 'Ammonium Sulfite',\n",
       "  'INCI_name': 'Ammonium Sulfite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=97ba360d-91e3-465d-8ecd-6cc2e5fed437',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2ae51402-cfde-abc3-94fe-6b634e1851cc',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):110-114, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466d'),\n",
       "  'Nome_comune': 'Ammonium Tallate',\n",
       "  'INCI_name': 'Ammonium Tallate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c186f777-4039-4db3-84d5-71d4b80e175d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ce62e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):252-258, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1796c1f2275d729466e'),\n",
       "  'Nome_comune': 'Ammonium Thioglycolate',\n",
       "  'INCI_name': 'Ammonium Thioglycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3a6a7264-45ee-4d41-9438-42dbbf53b04a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=17a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 1):68-133, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['queous solution)10 Sprague-Dawley rats Intubation LD 50> 50 mg/kg Thioesters Association, 2006 (personal communicati',\n",
       "   'active benzalkonium chloride. The least toxicity (LD 50> 365 mg/kg, 12 animals) was noted in the group treated with ',\n",
       "   'Thioglycolate)10 albino rats (208-260 g)Oral dose LD 50> 1 g/kg Consumer Product Testing Com- pany, Inc,1851982b P',\n",
       "   'Thioglycolate)10 albino rats (216-286 g)Oral dose LD 50> 1 g/kg Consumer Product Testing Com- pany, Inc,1901982a E',\n",
       "   'colate)10 Wistar albino rats (200-300 g)Oral dose LD 50< 5 g/kg Consumer Product Testing Com- pany, Inc,1911982c G'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['50 mg/kg ', '365 mg/kg', '1 g/kg ', '1 g/kg ', '5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d729466f'),\n",
       "  'Nome_comune': 'Ammonium VA/Acrylates Copolymer',\n",
       "  'INCI_name': 'Ammonium VA/Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b1c3c012-3c3c-4b0b-bde8-15954ac48db8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294670'),\n",
       "  'Nome_comune': 'Ammonium Xylenesulfonate',\n",
       "  'INCI_name': 'Ammonium Xylenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8fb06fb6-7680-4c19-bcf5-42ec6214fea3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5ba16b53-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 3):270-283, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ne sulfonate, Ca 28088-63-3 Dermal rabbit 24 hour LD 50>2000 mg/kg bw USEPA 798.1175 Xylene sulfonate, NH4 26447-10-9 In',\n",
       "   ' 798.1100 Cumenesulfonate, Na 28348-53-0 Oral rat LD 50>7000 mg/kg bw OECD 401 Cumenesulfonate, Na 28348-53-0 Dermal rabbit LD 50>2000 mg/kg bw Not specified Cumenesulfonate, Na 28348-53-0 Inhal',\n",
       "   'oxicity studies for xylene sulfonic acid reported LD 50 values of 2100 to 16 200 mg/kg bw (dermal), 2000 mg/kg bw (oral), and 557 000 to 770 000 mg/m3(inhalation).',\n",
       "   'specified Xylene sulfonate, Na 1300-72-7 Oral rat LD 50>5000-16 200 mg/kg bw Not specified Xylene sulfonate, NH4 26447-10-9 Oral rat LD 50>2100 mg/kg bw Not specified Xylene sulfonate, Ca 28088-63-3 Oral',\n",
       "   'FR1500.40 Xylene sulfonate, Na 1300-72-7 Oral rat LD 50>5000 mg/kg bw Not specified Xylene sulfonate, Na 1300-72-7 Oral rat LD 507200 mg/kg bw Not Specified Xylene sulfonate, Na 1300-72-7 Oral '],\n",
       "  'contesti_noael': ['ges of biological variation for this species. The NOAEL for maternal and fetal toxicity was the highest dose tested, 3000 mg/kg bw/d, which corresponds to 936 mg AI/kg bw/d. Genotoxi'],\n",
       "  'valori_ld50': ['2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2100 mg/kg bw ',\n",
       "   '507200 mg/kg bw '],\n",
       "  'valori_noael': ['3000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294671'),\n",
       "  'Nome_comune': 'Amodimethicone',\n",
       "  'INCI_name': 'Amodimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=066bca27-d54a-48e4-85be-01e0111d5030',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294672'),\n",
       "  'Nome_comune': 'Amodimethicone Hydroxystearate',\n",
       "  'INCI_name': 'Amodimethicone Hydroxystearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=74a67b3b-3072-4ee0-9132-5f63709117e9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294673'),\n",
       "  'Nome_comune': 'AMP-Acrylates Copolymer',\n",
       "  'INCI_name': 'AMP-Acrylates Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=80f47db3-98be-4c72-ae19-0a789e4e2456',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294674'),\n",
       "  'Nome_comune': 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide Copolymer',\n",
       "  'INCI_name': 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c7e4b0d1-81fb-4131-8bf9-6067e8c37f88',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294675'),\n",
       "  'Nome_comune': 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide/Hydroxyethylacrylate Copolymer',\n",
       "  'INCI_name': 'AMP-Acrylates/C1-18 Alkyl Acrylate/C1-8 Alkyl Acrylamide/Hydroxyethylacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=64344123-668c-4428-b166-0985b50b6a58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294676'),\n",
       "  'Nome_comune': 'Amyl Acetate',\n",
       "  'INCI_name': 'Amyl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6bbf9814-d016-4269-b924-758a6e3b0c5e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=71fc240e-c88f-8e1a-8234-b421f7bb29ca',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):14-16, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17a6c1f2275d7294677'),\n",
       "  'Nome_comune': 'Amyl Benzoate',\n",
       "  'INCI_name': 'Amyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a45475d-aff1-4e35-8f59-908b2974bf23',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rted to be 2.69 g/kg. Dodecyl alcohol has an oral LD 50 of 12 800 mg/kg for rats. Tridecyl alcohol has an oral LD 50of17 200 mg/kg for rats. Tetradecyl alcohol has an oral LD 50 33 ',\n",
       "   ' reported to be 5600 mg/kg in rabbits. The dermal LD 50 of hexadecyl alcohol for rabbits was reported to be >2.6 g/kg. Aerosolized amyl alcohol at near saturation caus'],\n",
       "  'contesti_noael': ['(15, 40, or 120 mL/m3; purity 99.9 %).87 The oral NOAEL for noncancer systemic toxicity end points were 200 and 50 mg/kg/d in mice and rats, respectively, exposed chronical',\n",
       "   ' decreased food consumption and body weights. The NOAEL was 125 mg/kg/d for male and female F344 rats and B6C3Fl mice tre',\n",
       "   ' maternal weight gain. Maternal and developmental NOAEL was found to be 130 mg/kg/d in Wistar rats (n ¼10) orally exposed to ethylhex',\n",
       "   'ose females at birth and on day 4 postpartum. The NOAEL was 1000 mg/kg/d. In Ames tests, methyl benzoate, ethyl benzoate, '],\n",
       "  'valori_ld50': ['200 mg/kg ', '6 g/kg'],\n",
       "  'valori_noael': ['50 mg/kg/d',\n",
       "   '125 mg/kg/d',\n",
       "   '130 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d7294678'),\n",
       "  'Nome_comune': 'Amyl Cinnamal',\n",
       "  'INCI_name': 'Amyl Cinnamal',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e5623c28-baaa-4b68-b3c6-8dc39b01c2cf',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'pdf_name': None,\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d7294679'),\n",
       "  'Nome_comune': 'Amyl Salicylate',\n",
       "  'INCI_name': 'Amyl Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=65374d82-1435-4047-96bb-1a1d708b462c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['.  No clinical signs were observed .  The dermal  LD 50 in rabbits exceeded 5.0 g/kg .    Hexyl Salicylate     Ten rabbits received a ',\n",
       "   ' clinical signs were observed .  The acute dermal LD 50 in rabbits exceeded 5.0 g/kg based  on 0/10 deaths at that dose.       Methyl S',\n",
       "   '-dosing. 7  It was concluded that t he acute oral LD 50  exceeded 5.0 g/kg , based on one animal death at that dose  on day ',\n",
       "   'was observed at  24 h. It was concluded that  the LD 50 exceeded 5.0 g/kg, based on one animal death at that dose on day 4 ',\n",
       "   '4  rats dosed 5 days per week for 15 weeks.1  The LD 50 during 15 weeks of dosing was estimated to be 366.5 mg/kg; a dose - related decrease in hindlimb grip stren',\n",
       "   'queous Sodium Salicylate for 4 weeks, the 28- day LD 50 was 646.5 mg/kg.  Liver and kidney necrosis was  observed in dogs that received 300 mg/kg of 10% aqueous Sodium Salicylate for 2 weeks .  A ',\n",
       "   'any  pathological abnormality.   The acute dermal LD 50 was considered to be > 2 g/kg.      Oral     The following acute oral toxicity ',\n",
       "   'tudies involving rats:    Butyloctyl Salicylate ( LD 50 > 5 g/kg),  Ethylhexyl Salicylate (  LD 50 > 2 g/kg),  Isodecyl Salicylate (no toxicity at levels as ',\n",
       "   'gum Arabic) was administered to 10 Wistar rats.4  LD 50  values in the range of 0.5 to 2 g/kg were reported.      Sodium Salicylate    The acute',\n",
       "   'with 0.5 mL  water) to the skin.  An acute dermal LD 50 of > 2 g/kg was reported for Sodium  Salicylate in a study inv',\n",
       "   'nd no clinical signs were  observed .  The dermal LD 50 in rabbits exceeded 5 g/kg.     Salicylic Acid          In a study involving',\n",
       "   'te, and Methyl Salicylate involving rabbits,  the LD 50 was > 5 g/kg for each salicylate.   No signs of systemic toxici',\n",
       "   'olving rats.  An a cute oral LD 50 of > 5 g/kg for Ethylhexyl Salicylate and Hexyl Salicylate in ',\n",
       "   ' studies on Methyl Salicylate involving mice, the LD 50 was  calculated to be 1.39 g/kg (95% CI of 1.25 to 1.54 g/kg) and a dose of 0.5 g/kg was selected as the maximum tolerated dose.    LD ',\n",
       "   'y data for the sexes  combined projected an acute LD 50 of 1.44 g/kg/day .    Salicylic Acid      In groups of rats do',\n",
       "   '/kg. Most animal  deaths occurred  on day 1.  The LD 50 was calculated to be 1.39 g/kg (95% CI  1.25 - 1.54 g/kg) .    Methyl S alicylate was evaluated as a part ',\n",
       "   ' high as 4.83 g/kg),  Methyl Salicylate (LD 50 between 0.887 g/kg and 1.25 g/kg),  Salicylic Acid ( LD 50 ranging from 0.891 g/kg  to 1.58 g/kg),  Sodium Salicyla te (LD 50 between 0.9 g/kg and',\n",
       "   ' 1.7 g/kg) ; and Tridecyl Salicylate (LD 50 > 1.98 g/kg).1  Values  for acute oral toxicity in other spec'],\n",
       "  'contesti_noael': ['size, the no -observed - adverse- effect -level ( NOAEL ) for developmental toxicity was determined to be 25 mg/kg/day.     Methyl Salicylate    Methyl Salicylate was d',\n",
       "   'n the gestation index, and lower litter size, the NOAEL for developmenta l toxicity was  determined to be 25 mg/kg/day.  On  postnatal day 1, 89% of the pups from dams ',\n",
       "   ', “b ased on the  available  data, and using the  NOAEL values of 50 mg/kg body weight/day identified in subchronic and chronic toxicity  st',\n",
       "   'MOS for systemic exposure is mentioned.  Based on NOAEL values of 50 mg/kg body weight/day in subchronic and chronic toxicity studies, a MOS',\n",
       "   '63  In a risk assessment conducted by  SCCNFP , a NOAEL of 75 mg/kg/day, derived from several rat oral teratogenicity  st',\n",
       "   '/kg/day  MOS (Butyloctyl Salicylate , lipstick) = NOAEL ( from rat oral teratogenicity stu dies; see above)  / SED   = 75 mg/kg/day  /0.1705 mg/kg/day   = 220       Oral   Salicylic Acid      An expos'],\n",
       "  'valori_ld50': ['0 g/kg',\n",
       "   '0 g/kg ',\n",
       "   '0 g/kg',\n",
       "   '0 g/kg',\n",
       "   '5 mg/kg',\n",
       "   '300 mg/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '44 g/kg',\n",
       "   '54 g/kg',\n",
       "   '58 g/kg',\n",
       "   '98 g/kg'],\n",
       "  'valori_noael': ['25 mg/kg/day',\n",
       "   '25 mg/kg/day',\n",
       "   '50 mg/kg body weight/day',\n",
       "   '50 mg/kg body weight/day',\n",
       "   '75 mg/kg/day',\n",
       "   '1705 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467a'),\n",
       "  'Nome_comune': 'Amylcinnamyl Alcohol',\n",
       "  'INCI_name': 'Amylcinnamyl Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=41dbb5e1-bc07-413c-aebd-1b9c58352d4a',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467b'),\n",
       "  'Nome_comune': 'Amylodextrin',\n",
       "  'INCI_name': 'Amylodextrin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aea4d1f6-626f-4c7e-87de-4fd7ef49414f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467c'),\n",
       "  'Nome_comune': 'Amylopectin',\n",
       "  'INCI_name': 'Amylopectin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e2a97d84-d244-4ec4-a1f5-99cb0b43ad54',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467d'),\n",
       "  'Nome_comune': 'Amylose',\n",
       "  'INCI_name': 'Amylose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66e9c906-bee6-4a31-a10b-b9ddff229f58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467e'),\n",
       "  'Nome_comune': 'Anacardium Occidentale (Cashew) Seed Oil',\n",
       "  'INCI_name': 'Anacardium Occidentale (Cashew) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f2f604d1-e9a6-47a1-8a71-1c30127dc38f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d729467f'),\n",
       "  'Nome_comune': 'Anhydrogalactose',\n",
       "  'INCI_name': 'Anhydrogalactose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=14a4533c-f918-4aea-b428-9f8ec2ebff50',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bbf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['oss pathological changes were observed , and  the LD 50 was  > 2 g/kg.   In an acute oral toxicity study on Arabinose, the LD 50 was calculated to be 12.1  g/kg in male rats and 11 .6 g/kg in female  rats (numbe',\n",
       "   'oss pathological changes were observed , and the  LD 50 was > 2 g/kg.   The acute oral toxicity of the dried extract o',\n",
       "   'not stated) in accordance with OECD TG 401.15  An LD 50 of  > 2 g/kg was reported.   Short -Term and Chronic Toxicity S',\n",
       "   'city study involving rats (number not stated), an LD 50 of > 2 g/kg was reported for a trade name  mixture co ntain in',\n",
       "   'oss pathological changes were observed.   An oral LD 50 of > 2  g/kg was also reported for the same trade name mixture ',\n",
       "   ' other tissues was not performed.   An acute oral LD 50 of  > 2 g/kg  was reported  for undiluted Saccharide Isomerate (',\n",
       "   's, or gross  pathological changes observed .  The LD 50 > 2 g/kg.  3  ORAL   Anhydroxylitol (25%  to 35% ) Rats No',\n",
       "   ' gross  pathological changes were observed .  The LD 50 > 2 g/kg    3    Arabinose  Rats (male and  female; strain not',\n",
       "   'nvolving groups of 8 male Wistar rats, calculated LD 50 values  (2 different methods used) of 15.8 g/kg and 16.3 g/kg were reported.  Bleeding in the mucous layers of t',\n",
       "   'es or gross pathological changes were observed.   LD 50 values of 12 .1 g/kg  and 11.6  g/kg were reported for male and female rats  (number no',\n",
       "   'age translation of Japanese publication abstract  LD 50 (calculated )  = 12.1 g/kg (male s) and 11.6 g/kg (female s) 40  Psicose  (50%)  Male Wistar  rats ',\n",
       "   ' and 8 rats (20 g/kg dose group).  The calculated LD 50 values were 16.3 g/kg (using the  Behrens -Karber method) and 15.8 g/kg (using the Litchfield -Wilcoxon method).  In anot',\n",
       "   'ine i n rats of 17 g/kg or 20 g/kg  dose group.   LD 50  = 16.3 g/kg (Behrens -Karber method) and 15.8 g/kg (Litchfield - Wilcoxon method)  41  Psicose  Beag'],\n",
       "  'contesti_noael': ['se of multiple products) of 8.550 mg/kg/d and the NOAEL of 1000 mg/kg/d for xylitol (from 2 -yr dietary  studies).  An Mo',\n",
       "   'ntra - and inter -species differences.  Using the NOAEL  of 1000 mg/kg/d, an MoE of 117 was estimated for cosmetic product'],\n",
       "  'valori_ld50': ['1  g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '2  g/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg    ',\n",
       "   '3 g/kg ',\n",
       "   '6  g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d', '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17b6c1f2275d7294680'),\n",
       "  'Nome_comune': 'Anhydroglucitol',\n",
       "  'INCI_name': 'Anhydroglucitol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=43e1184a-d0a9-4da4-8f1c-3f2ec7754ab6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bbf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['oss pathological changes were observed , and  the LD 50 was  > 2 g/kg.   In an acute oral toxicity study on Arabinose, the LD 50 was calculated to be 12.1  g/kg in male rats and 11 .6 g/kg in female  rats (numbe',\n",
       "   'oss pathological changes were observed , and the  LD 50 was > 2 g/kg.   The acute oral toxicity of the dried extract o',\n",
       "   'not stated) in accordance with OECD TG 401.15  An LD 50 of  > 2 g/kg was reported.   Short -Term and Chronic Toxicity S',\n",
       "   'city study involving rats (number not stated), an LD 50 of > 2 g/kg was reported for a trade name  mixture co ntain in',\n",
       "   'oss pathological changes were observed.   An oral LD 50 of > 2  g/kg was also reported for the same trade name mixture ',\n",
       "   ' other tissues was not performed.   An acute oral LD 50 of  > 2 g/kg  was reported  for undiluted Saccharide Isomerate (',\n",
       "   's, or gross  pathological changes observed .  The LD 50 > 2 g/kg.  3  ORAL   Anhydroxylitol (25%  to 35% ) Rats No',\n",
       "   ' gross  pathological changes were observed .  The LD 50 > 2 g/kg    3    Arabinose  Rats (male and  female; strain not',\n",
       "   'nvolving groups of 8 male Wistar rats, calculated LD 50 values  (2 different methods used) of 15.8 g/kg and 16.3 g/kg were reported.  Bleeding in the mucous layers of t',\n",
       "   'es or gross pathological changes were observed.   LD 50 values of 12 .1 g/kg  and 11.6  g/kg were reported for male and female rats  (number no',\n",
       "   'age translation of Japanese publication abstract  LD 50 (calculated )  = 12.1 g/kg (male s) and 11.6 g/kg (female s) 40  Psicose  (50%)  Male Wistar  rats ',\n",
       "   ' and 8 rats (20 g/kg dose group).  The calculated LD 50 values were 16.3 g/kg (using the  Behrens -Karber method) and 15.8 g/kg (using the Litchfield -Wilcoxon method).  In anot',\n",
       "   'ine i n rats of 17 g/kg or 20 g/kg  dose group.   LD 50  = 16.3 g/kg (Behrens -Karber method) and 15.8 g/kg (Litchfield - Wilcoxon method)  41  Psicose  Beag'],\n",
       "  'contesti_noael': ['se of multiple products) of 8.550 mg/kg/d and the NOAEL of 1000 mg/kg/d for xylitol (from 2 -yr dietary  studies).  An Mo',\n",
       "   'ntra - and inter -species differences.  Using the NOAEL  of 1000 mg/kg/d, an MoE of 117 was estimated for cosmetic product'],\n",
       "  'valori_ld50': ['1  g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '2  g/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg    ',\n",
       "   '3 g/kg ',\n",
       "   '6  g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d', '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294681'),\n",
       "  'Nome_comune': 'Anhydroxylitol',\n",
       "  'INCI_name': 'Anhydroxylitol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=51353f8c-c133-4916-b7f1-d8a34e0fdf8b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bbf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['oss pathological changes were observed , and  the LD 50 was  > 2 g/kg.   In an acute oral toxicity study on Arabinose, the LD 50 was calculated to be 12.1  g/kg in male rats and 11 .6 g/kg in female  rats (numbe',\n",
       "   'oss pathological changes were observed , and the  LD 50 was > 2 g/kg.   The acute oral toxicity of the dried extract o',\n",
       "   'not stated) in accordance with OECD TG 401.15  An LD 50 of  > 2 g/kg was reported.   Short -Term and Chronic Toxicity S',\n",
       "   'city study involving rats (number not stated), an LD 50 of > 2 g/kg was reported for a trade name  mixture co ntain in',\n",
       "   'oss pathological changes were observed.   An oral LD 50 of > 2  g/kg was also reported for the same trade name mixture ',\n",
       "   ' other tissues was not performed.   An acute oral LD 50 of  > 2 g/kg  was reported  for undiluted Saccharide Isomerate (',\n",
       "   's, or gross  pathological changes observed .  The LD 50 > 2 g/kg.  3  ORAL   Anhydroxylitol (25%  to 35% ) Rats No',\n",
       "   ' gross  pathological changes were observed .  The LD 50 > 2 g/kg    3    Arabinose  Rats (male and  female; strain not',\n",
       "   'nvolving groups of 8 male Wistar rats, calculated LD 50 values  (2 different methods used) of 15.8 g/kg and 16.3 g/kg were reported.  Bleeding in the mucous layers of t',\n",
       "   'es or gross pathological changes were observed.   LD 50 values of 12 .1 g/kg  and 11.6  g/kg were reported for male and female rats  (number no',\n",
       "   'age translation of Japanese publication abstract  LD 50 (calculated )  = 12.1 g/kg (male s) and 11.6 g/kg (female s) 40  Psicose  (50%)  Male Wistar  rats ',\n",
       "   ' and 8 rats (20 g/kg dose group).  The calculated LD 50 values were 16.3 g/kg (using the  Behrens -Karber method) and 15.8 g/kg (using the Litchfield -Wilcoxon method).  In anot',\n",
       "   'ine i n rats of 17 g/kg or 20 g/kg  dose group.   LD 50  = 16.3 g/kg (Behrens -Karber method) and 15.8 g/kg (Litchfield - Wilcoxon method)  41  Psicose  Beag'],\n",
       "  'contesti_noael': ['se of multiple products) of 8.550 mg/kg/d and the NOAEL of 1000 mg/kg/d for xylitol (from 2 -yr dietary  studies).  An Mo',\n",
       "   'ntra - and inter -species differences.  Using the NOAEL  of 1000 mg/kg/d, an MoE of 117 was estimated for cosmetic product'],\n",
       "  'valori_ld50': ['1  g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '2  g/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg    ',\n",
       "   '3 g/kg ',\n",
       "   '6  g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d', '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294682'),\n",
       "  'Nome_comune': 'Anthemis Nobilis Flower Extract',\n",
       "  'INCI_name': 'Anthemis Nobilis Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6dd207a7-6a90-40fb-9fb1-8ebab76cd5fc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6da8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):57-66, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294683'),\n",
       "  'Nome_comune': 'Anthemis Nobilis Flower Oil',\n",
       "  'INCI_name': 'Anthemis Nobilis Flower Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c9109158-8c09-4b25-a090-ed74c1d8b914',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6da8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):57-66, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294684'),\n",
       "  'Nome_comune': 'Anthemis Nobilis Flower Powder',\n",
       "  'INCI_name': 'Anthemis Nobilis Flower Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=31313ec7-35c1-4ac0-8203-6f917082c7c0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6da8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):57-66, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294685'),\n",
       "  'Nome_comune': 'Anthemis Nobilis Flower Water',\n",
       "  'INCI_name': 'Anthemis Nobilis Flower Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=188da513-3deb-4a0c-8b92-1337fa58e115',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6da8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):57-66, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294686'),\n",
       "  'Nome_comune': 'Aphanothece Sacrum Polysaccharide',\n",
       "  'INCI_name': 'Aphanothece Sacrum Exopolysaccharides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2dc61d4f-0fa9-4aef-a868-c457fece7516',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294687'),\n",
       "  'Nome_comune': 'Apricot Kernel Amino Acids',\n",
       "  'INCI_name': 'Apricot Kernel Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6b290c07-d2fa-4944-b4b9-0a726a6db918',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=de4bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):5-12, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294688'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil PEG-40 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil PEG-40 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=563b1f58-1e31-42d7-b7dd-7be8f752ed28',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d7294689'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil PEG-6 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil PEG-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b00988cb-e7ab-48ae-bd3d-29d5399c11a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17c6c1f2275d729468a'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a4f90314-9785-42fe-954e-32d6d5429820',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468b'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-10 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-10 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3727359b-05b0-42a9-a65d-5ab340609929',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468c'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-3 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-3 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=894d09b2-609d-4bf6-be75-2854cf40051d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468d'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-4 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-4 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=02e676eb-d425-48a6-b3e0-743cb00cfffb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468e'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-5 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-5 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bd157cec-4ec2-48f2-833c-467b3e5cc68c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d729468f'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5061fb85-4984-4f93-b6b7-7cfe7f6ea3ee',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294690'),\n",
       "  'Nome_comune': 'Apricot Kernel Oil Propylene Glycol Esters',\n",
       "  'INCI_name': 'Apricot Kernel Oil Propylene Glycol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6810192b-07cc-42d7-9e0b-872ce29318ab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1c34b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['41  Acute toxicity   Hept anoic acid  IV in mice  LD 50 = 1200 ± 56 mg/kg   42  Undecanoic acid  IV in mice  LD 50 = 140 ± 4.2 mg/kg   42  Dermal irritation – in vitro   Hepta noic acid',\n",
       "   ' Laurate was classified as  practically nontoxic (LD 50 > 34.6 g/kg) when administered orally to rats.   In two skin ',\n",
       "   'zed following ingestion.  In rats, the acute oral LD 50  has been shown to be approximately 25.8 g/kg.  The raw ingredient produced no significant de r',\n",
       "   'ults  in any of the animal tests.  The acute oral LD 50 in rats is e stimated to be greater than 32 g/kg.  The ingredient per se  produced no significant '],\n",
       "  'contesti_noael': [' rats.25  The no observed adverse effects level  (NOAEL ) was concluded  to be 1000   mg/kg/d .  No evidence of adverse effects were foun d in '],\n",
       "  'valori_ld50': ['2 mg/kg   ', '6 g/kg', '8 g/kg', '32 g/kg'],\n",
       "  'valori_noael': ['1000   mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294691'),\n",
       "  'Nome_comune': 'Apricotamide DEA',\n",
       "  'INCI_name': 'Apricotamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d0468d8f-15d3-42bf-8c1e-fdacc52a3c98',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne of the animals died, and the lethal dose, 50 %(LD 50) was >2 g/kg. Lauramide DEA. In an acute dermal toxicity study'],\n",
       "  'contesti_noael': ['mental toxicity study in Sprague-Dawley rats, the NOAEL for maternal toxicity and developmental toxicity was 1000 mg/kg/d that was the highest dose tested. No other data o'],\n",
       "  'valori_ld50': ['2 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294692'),\n",
       "  'Nome_comune': 'Apricotamidopropyl Betaine',\n",
       "  'INCI_name': 'Apricotamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=42a1d736-32de-464c-9d4f-7069b79e3a83',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294693'),\n",
       "  'Nome_comune': 'Arabinose',\n",
       "  'INCI_name': 'Arabinose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c702ea32-1e29-4d2c-9486-59e6dfa3ed17',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bbf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['oss pathological changes were observed , and  the LD 50 was  > 2 g/kg.   In an acute oral toxicity study on Arabinose, the LD 50 was calculated to be 12.1  g/kg in male rats and 11 .6 g/kg in female  rats (numbe',\n",
       "   'oss pathological changes were observed , and the  LD 50 was > 2 g/kg.   The acute oral toxicity of the dried extract o',\n",
       "   'not stated) in accordance with OECD TG 401.15  An LD 50 of  > 2 g/kg was reported.   Short -Term and Chronic Toxicity S',\n",
       "   'city study involving rats (number not stated), an LD 50 of > 2 g/kg was reported for a trade name  mixture co ntain in',\n",
       "   'oss pathological changes were observed.   An oral LD 50 of > 2  g/kg was also reported for the same trade name mixture ',\n",
       "   ' other tissues was not performed.   An acute oral LD 50 of  > 2 g/kg  was reported  for undiluted Saccharide Isomerate (',\n",
       "   's, or gross  pathological changes observed .  The LD 50 > 2 g/kg.  3  ORAL   Anhydroxylitol (25%  to 35% ) Rats No',\n",
       "   ' gross  pathological changes were observed .  The LD 50 > 2 g/kg    3    Arabinose  Rats (male and  female; strain not',\n",
       "   'nvolving groups of 8 male Wistar rats, calculated LD 50 values  (2 different methods used) of 15.8 g/kg and 16.3 g/kg were reported.  Bleeding in the mucous layers of t',\n",
       "   'es or gross pathological changes were observed.   LD 50 values of 12 .1 g/kg  and 11.6  g/kg were reported for male and female rats  (number no',\n",
       "   'age translation of Japanese publication abstract  LD 50 (calculated )  = 12.1 g/kg (male s) and 11.6 g/kg (female s) 40  Psicose  (50%)  Male Wistar  rats ',\n",
       "   ' and 8 rats (20 g/kg dose group).  The calculated LD 50 values were 16.3 g/kg (using the  Behrens -Karber method) and 15.8 g/kg (using the Litchfield -Wilcoxon method).  In anot',\n",
       "   'ine i n rats of 17 g/kg or 20 g/kg  dose group.   LD 50  = 16.3 g/kg (Behrens -Karber method) and 15.8 g/kg (Litchfield - Wilcoxon method)  41  Psicose  Beag'],\n",
       "  'contesti_noael': ['se of multiple products) of 8.550 mg/kg/d and the NOAEL of 1000 mg/kg/d for xylitol (from 2 -yr dietary  studies).  An Mo',\n",
       "   'ntra - and inter -species differences.  Using the NOAEL  of 1000 mg/kg/d, an MoE of 117 was estimated for cosmetic product'],\n",
       "  'valori_ld50': ['1  g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '2  g/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg    ',\n",
       "   '3 g/kg ',\n",
       "   '6  g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d', '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17d6c1f2275d7294694'),\n",
       "  'Nome_comune': 'Arabinoxylan',\n",
       "  'INCI_name': 'Arabinoxylan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=54053140-e6ed-4a67-b3e4-77bff34582a2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294695'),\n",
       "  'Nome_comune': 'Arachideth-20',\n",
       "  'INCI_name': 'Arachideth-20',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9453669d-8003-47fd-b8cb-251f90ef9415',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294696'),\n",
       "  'Nome_comune': 'Arachidic Acid',\n",
       "  'INCI_name': 'Arachidic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=02a22b02-14f1-42f4-bcac-315198c45490',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294697'),\n",
       "  'Nome_comune': 'Arachidonic Acid',\n",
       "  'INCI_name': 'Arachidonic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d151fe53-1c3a-4e7d-a14c-52ffe4979be8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6a9219ed-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 12(5):507-559, 1993',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294698'),\n",
       "  'Nome_comune': 'Arachidyl Behenate',\n",
       "  'INCI_name': 'Arachidyl Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5207cf12-607c-43ae-88b8-8ecf2d743617',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d7294699'),\n",
       "  'Nome_comune': 'Arachidyl Erucate',\n",
       "  'INCI_name': 'Arachidyl Erucate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=95609c74-2529-4a14-846d-fc885df836b0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d729469a'),\n",
       "  'Nome_comune': 'Arachidyl Glucoside',\n",
       "  'INCI_name': 'Arachidyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=751aba8f-ea4e-4a5a-a2a9-da2cf4b83d23',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['fe as used Myristyl alcoholAnimal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg Inhalation: 3%, 1 h, ataxia and moderate nasal irr',\n",
       "   ' glucoside using rabbits, the median lethal dose (LD 50) was greater than the 2 g/kg dose administered. In oral studies with the same t',\n",
       "   'erides and phospholipids66 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD 50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   'sorbed from the GI tract68 Animal toxicology Oral LD 50: >8 g/kg; 3 mos dermal study: formulations w/8%, some derm',\n",
       "   ' as used Isostearyl alcoholAnimal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg66 Dermal ',\n",
       "   'afe as used Octyl dodecanolAnimal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD50: >3 g/kg68 (continued)24S Internatio',\n",
       "   ' and 2.7% in the urine65 Animal toxicology Dermal LD 50(rabbits), 4.2 g/kg; oral LD 50(rats), 0.79-4.36 g/kg Short-term oral: 6.9% n-butyl alcohol and 25% sucr'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '36 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d729469b'),\n",
       "  'Nome_comune': 'Arachidyl Glycol',\n",
       "  'INCI_name': 'Arachidyl Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=feb64da1-cd4d-4c98-9a74-b976bb4d8d2f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' that death would occur at relatively high doses (LD50 range: 2200 to >20 000 mg/kg). Reportedly, high (unspecified) oral doses of 1,',\n",
       "   'values were reported for 1,2- butanediol: 24-hour LD50 of 66.5 mmol/kg ( *5.99 g/kg) and 144-hour LD50 of 46.5 mmol/kg ( *4.19 mg/kg).32Muscle incoordination was observed in rats at ',\n",
       "   'is was observed at necropsy. In other studies, ip LD 50 values up to 13.7 mL/kg (rats) and 11.2 g/kg (mice) have been reported.1An acute study was per',\n",
       "   'n acute dermal toxicity study involving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg. Prolonged application or repeated applications o',\n",
       "   'lycol (1,2-pentanediol). The following acute oral LD50 values have been reported for pentylene glycol: 1.2700 Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits); and 5200 mg/kg (guinea pigs).30 Steary',\n",
       "   'udy (OECD 423 test procedure) involving rats, the LD50 for caprylyl glycol was >2500 mg/kg.27, 1,2-Butanediol. An acute oral LD50 of 4192 mg/kg was reported for 1,2-butanediol in a study involvi',\n",
       "   'nteral toxicity studies, acute intramuscular (im) LD50 (20 g/kg rats) and acute subcutaneous (sc) LD50 (18.5 g/kg mice) values have been reported.1 Repeated-Dose To',\n",
       "   'l glycol. An LD50 of >5000 mg/kg was reported for rats dosed orally with stearyl gl',\n",
       "   'ated using adult male Sprague-Dawley rats, and an LD50 of >20.0 g/kg body weight was reported.5 Propylene glycol. The 24-hour oral LD50 for PG was 22.8 g/kg body weight in a study involving 5 female Fischer rats. Oral L',\n",
       "   'ailable from Dow Chemical Company, the acute oral LD50 for 1,2-butanediol in rats was 16 g/kg body weight.29Also, high (unspecified) doses caused narcosis ',\n",
       "   'acute dermal toxicity study invol- ving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg.27 Propylene glycol. The dermal LD50 for PG was >11.2 g/kg in mice and was 13 g/kg in rats.1 Intraperitoneal '],\n",
       "  'contesti_noael': ['iod was largely reversible. Both the NOEL and the NOAEL in this study was 100 mg/kg body weight/d.36 Pentylene glycol. Pentylene glycol was adminis',\n",
       "   'ach; analogous structures do not exist in man. An NOAEL of 100 mg/kg/d was reported for rats in a 28-day oral toxicity s',\n",
       "   'females). The no observable adverse effect level (NOAEL) was 200 mg/kg body weight/day in this study.35 According to a summary of data p',\n",
       "   'ministration of 1,2-butanediol to rats yielded an NOAEL of 200 mg/kg/d. Reportedly, in another repeated dose study, the ',\n",
       "   ' mg/kg/d, and a no observed adverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi- city. The NOAEL was based on t',\n",
       "   'this study was calculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/d and a reproductive toxicity uncertainty factor of'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '19 mg/kg',\n",
       "   '2 g/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3700 mg/kg',\n",
       "   '4192 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '8 g/kg body weight ',\n",
       "   '16 g/kg body weight',\n",
       "   '11.2 g/kg '],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg/d',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d729469c'),\n",
       "  'Nome_comune': 'Arachidyl Propionate',\n",
       "  'INCI_name': 'Arachidyl Propionate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4aa76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed17e6c1f2275d729469d'),\n",
       "  'Nome_comune': 'Arachis Hypogaea (Peanut) Flour',\n",
       "  'INCI_name': 'Arachis Hypogaea (Peanut) Flour',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e61aac83-1195-4b2a-bc74-c600306d9402',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=072b261d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 20(S2):65-77, 2001',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d729469e'),\n",
       "  'Nome_comune': 'Arachis Hypogaea (Peanut) Oil',\n",
       "  'INCI_name': 'Arachis Hypogaea (Peanut) Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=36de9be4-3ada-489e-bd6c-bec25a11a67d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d729469f'),\n",
       "  'Nome_comune': 'Arctium Lappa Seed Oil',\n",
       "  'INCI_name': 'Arctium Lappa Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eead38f3-8e3b-4e8a-bc1b-ba36d66199a5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a0'),\n",
       "  'Nome_comune': 'Argan Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Argan Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87e51260-213e-4f48-8938-57998e8e79b1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a1'),\n",
       "  'Nome_comune': 'Argan Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Argan Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8b5e5faf-ea89-4d71-86ae-39f392ace14b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a2'),\n",
       "  'Nome_comune': 'Argania Spinosa Kernel Oil',\n",
       "  'INCI_name': 'Argania Spinosa Kernel Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=93cfd974-764d-402e-a47d-9da840cc3586',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a3'),\n",
       "  'Nome_comune': 'Arginine',\n",
       "  'INCI_name': 'Arginine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2954191f-3508-4152-b8c1-3e3f95395f28',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a4'),\n",
       "  'Nome_comune': 'Arginine HCl',\n",
       "  'INCI_name': 'Arginine HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2f1d5b8f-ae6a-4cb0-a9d0-2dde5b1185b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a5'),\n",
       "  'Nome_comune': 'Arnica Montana',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7c4dc5a7-bf0d-42e0-8ada-f550ebe47a02',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d75e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 20(S2):1-11, 2001',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a6'),\n",
       "  'Nome_comune': 'Arnica Montana Flower Extract',\n",
       "  'INCI_name': 'Arnica Montana Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4d519c23-caaf-4bac-8a6f-2f7e891da178',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d75e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 20(S2):1-11, 2001',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed17f6c1f2275d72946a7'),\n",
       "  'Nome_comune': 'Ascophyllum Nodosum',\n",
       "  'INCI_name': 'Ascophyllum Nodosum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9d04ea69-f6c8-4ea0-930f-67b32f98587d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['her  alterations. Mice were observed for 7 days.  LD 50: Males = 500 mg/kg; females = < 7 50 mg/kg  95  Fucus Vesiculosus Extract  (28.8% polyphenols ',\n",
       "   'd of oral administration was not stated).92   The LD 50 was > 2000 mg/kg when Sprague -Dawley rats were dosed with Ascophyl',\n",
       "   'solution was given to Sprague -Dawley rats.  The  LD 50 was reported to be > 2000 mg/kg when Sprague -Dawley rats were given Ascophyllum N',\n",
       "   ' Extract  Sprague -Dawley  rats NR NR OECD TG 401 LD 50 > 2000 mg/kg  93  Cystoseira Compressa  Extract  (methanol, hexa',\n",
       "   'her  alterations. Mice were observed for 7 days.  LD 50: Males = 1000 mg/kg; females = between 1000  and 2000 mg/kg  95  Fucus Vesiculosus Extract  (18% polyphenols pl',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = between 1000 and 2000  mg/kg  95 Table 27. Acute  oral toxicity studies   Ingred',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = > 2000 mg/kg  95  Lamin aria Digitata Extract (≤  10%), artemisi',\n",
       "   'es were reported for each of the  10 rats tested. LD 50: Males and females = > 5 g/kg  96  Sargassum Fulvellum Extract  (dichloromethane,'],\n",
       "  'contesti_noael': ['g pigs.    In a chronic oral toxicity study, t he NOAEL of a Laminaria Japonica Extract administered to rats by gavage for 6  months was 300 mg/kg/day .  In females, a decrease in AST was observed sta'],\n",
       "  'valori_ld50': ['50 mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000  mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '5 g/kg  '],\n",
       "  'valori_noael': ['300 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946a8'),\n",
       "  'Nome_comune': 'Ascophyllum Nodosum Extract',\n",
       "  'INCI_name': 'Ascophyllum Nodosum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f96de745-7ed3-454a-a91b-248d2005553b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['her  alterations. Mice were observed for 7 days.  LD 50: Males = 500 mg/kg; females = < 7 50 mg/kg  95  Fucus Vesiculosus Extract  (28.8% polyphenols ',\n",
       "   'd of oral administration was not stated).92   The LD 50 was > 2000 mg/kg when Sprague -Dawley rats were dosed with Ascophyl',\n",
       "   'solution was given to Sprague -Dawley rats.  The  LD 50 was reported to be > 2000 mg/kg when Sprague -Dawley rats were given Ascophyllum N',\n",
       "   ' Extract  Sprague -Dawley  rats NR NR OECD TG 401 LD 50 > 2000 mg/kg  93  Cystoseira Compressa  Extract  (methanol, hexa',\n",
       "   'her  alterations. Mice were observed for 7 days.  LD 50: Males = 1000 mg/kg; females = between 1000  and 2000 mg/kg  95  Fucus Vesiculosus Extract  (18% polyphenols pl',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = between 1000 and 2000  mg/kg  95 Table 27. Acute  oral toxicity studies   Ingred',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = > 2000 mg/kg  95  Lamin aria Digitata Extract (≤  10%), artemisi',\n",
       "   'es were reported for each of the  10 rats tested. LD 50: Males and females = > 5 g/kg  96  Sargassum Fulvellum Extract  (dichloromethane,'],\n",
       "  'contesti_noael': ['g pigs.    In a chronic oral toxicity study, t he NOAEL of a Laminaria Japonica Extract administered to rats by gavage for 6  months was 300 mg/kg/day .  In females, a decrease in AST was observed sta'],\n",
       "  'valori_ld50': ['50 mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000  mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '5 g/kg  '],\n",
       "  'valori_noael': ['300 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946a9'),\n",
       "  'Nome_comune': 'Ascophyllum Nodosum Powder',\n",
       "  'INCI_name': 'Ascophyllum Nodosum Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=486fe4d1-3f1c-49ee-80c0-603e1fc59bd1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 17, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['her  alterations. Mice were observed for 7 days.  LD 50: Males = 500 mg/kg; females = < 7 50 mg/kg  95  Fucus Vesiculosus Extract  (28.8% polyphenols ',\n",
       "   'd of oral administration was not stated).92   The LD 50 was > 2000 mg/kg when Sprague -Dawley rats were dosed with Ascophyl',\n",
       "   'solution was given to Sprague -Dawley rats.  The  LD 50 was reported to be > 2000 mg/kg when Sprague -Dawley rats were given Ascophyllum N',\n",
       "   ' Extract  Sprague -Dawley  rats NR NR OECD TG 401 LD 50 > 2000 mg/kg  93  Cystoseira Compressa  Extract  (methanol, hexa',\n",
       "   'her  alterations. Mice were observed for 7 days.  LD 50: Males = 1000 mg/kg; females = between 1000  and 2000 mg/kg  95  Fucus Vesiculosus Extract  (18% polyphenols pl',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = between 1000 and 2000  mg/kg  95 Table 27. Acute  oral toxicity studies   Ingred',\n",
       "   'her  alterations. Rats were observed for 7 days.  LD 50: Males and females = > 2000 mg/kg  95  Lamin aria Digitata Extract (≤  10%), artemisi',\n",
       "   'es were reported for each of the  10 rats tested. LD 50: Males and females = > 5 g/kg  96  Sargassum Fulvellum Extract  (dichloromethane,'],\n",
       "  'contesti_noael': ['g pigs.    In a chronic oral toxicity study, t he NOAEL of a Laminaria Japonica Extract administered to rats by gavage for 6  months was 300 mg/kg/day .  In females, a decrease in AST was observed sta'],\n",
       "  'valori_ld50': ['50 mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000  mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '5 g/kg  '],\n",
       "  'valori_noael': ['300 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946aa'),\n",
       "  'Nome_comune': 'Ascorbyl Dipalmitate',\n",
       "  'INCI_name': 'Ascorbyl Dipalmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ae6a4b9f-d7a2-4a8d-8fdc-055074276753',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['byl Palmitate was determined to be 2500 mg/kg. An LD 50 of 2000 mg/kg was reported for Ascorbyl Palmitate (33.3%suspensi'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946ab'),\n",
       "  'Nome_comune': 'Ascorbyl Glucoside',\n",
       "  'INCI_name': 'Ascorbyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=49d62643-0ced-49c2-9a59-b61acbc4a694',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5bf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 15, 2020',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ded that  Ascorbyl Glucoside was of low toxicity (LD 50 > 2000 mg/kg) when administered dermally.   Oral   The acute o',\n",
       "   'uded that Ascorbyl Glucoside was of low toxicity (LD 50 > 2000 mg/kg) when administered  orally.   Short -Term  Toxici',\n",
       "   'ated) was evaluated using 10 Wistar rats, and an  LD 50 of > 2000 mg/kg was reported.  None of the animals died, and there',\n",
       "   'ns of systemic toxicity or effect on  organs.  An LD 50 of > 2000 mg/kg was also reported in a study in which 3 groups of '],\n",
       "  'contesti_noael': [' for 28 d, no adverse effects were reported.  The NOAEL was 1000 mg/kg/d.   In the Ames test, Ascorbyl Glucosi de (doses u'],\n",
       "  'valori_ld50': ['2000 mg/kg', '2000 mg/kg', '2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946ac'),\n",
       "  'Nome_comune': 'Ascorbyl Isostearate',\n",
       "  'INCI_name': 'Ascorbyl Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=da860c5c-e0b0-4edd-8b78-eb91c6900fb2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['byl Palmitate was determined to be 2500 mg/kg. An LD 50 of 2000 mg/kg was reported for Ascorbyl Palmitate (33.3%suspensi'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946ad'),\n",
       "  'Nome_comune': 'Ascorbyl Linoleate',\n",
       "  'INCI_name': 'Ascorbyl Linoleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8f2a3261-2e5a-43a9-b287-9cd15458d2a7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['byl Palmitate was determined to be 2500 mg/kg. An LD 50 of 2000 mg/kg was reported for Ascorbyl Palmitate (33.3%suspensi'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946ae'),\n",
       "  'Nome_comune': 'Ascorbyl Palmitate',\n",
       "  'INCI_name': 'Ascorbyl Palmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ac3df6b9-c2e4-4744-a905-5faba9de397e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/54680660',\n",
       "   'valori': ['LD50 Guinea pig dermal >3 g/kg',\n",
       "    'LD50 Mouse oral >2 g/kg /33% suspension/',\n",
       "    'LD50 Rat oral >5 g/kg  /33% suspension/'],\n",
       "   'fonti': ['Cosmetic Ingredient Review; Final Report of the Cosmetic Ingredient Review Expert Panel; Final Report on the Safety Assessment of Ascorbyl Palmitate, Ascorbyl Dipalmitate, Ascorbyl Stearate, Erythorbic Acid, and Sodium Erythorbate; Scientific Regulatory Reference CD-ROM (2006). Cosmetic, Toiletry, and Fragrance Association, Washington D.C.',\n",
       "    'Cosmetic Ingredient Review; Final Report of the Cosmetic Ingredient Review Expert Panel; Final Report on the Safety Assessment of Ascorbyl Palmitate, Ascorbyl Dipalmitate, Ascorbyl Stearate, Erythorbic Acid, and Sodium Erythorbate; Scientific Regulatory Reference CD-ROM (2006). Cosmetic, Toiletry, and Fragrance Association, Washington D.C.',\n",
       "    'Cosmetic Ingredient Review; Final Report of the Cosmetic Ingredient Review Expert Panel; Final Report on the Safety Assessment of Ascorbyl Palmitate, Ascorbyl Dipalmitate, Ascorbyl Stearate, Erythorbic Acid, and Sodium Erythorbate; Scientific Regulatory Reference CD-ROM (2006). Cosmetic, Toiletry, and Fragrance Association, Washington D.C.']},\n",
       "  'contesti_ld50': ['byl Palmitate was determined to be 2500 mg/kg. An LD 50 of 2000 mg/kg was reported for Ascorbyl Palmitate (33.3%suspensi'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1806c1f2275d72946af'),\n",
       "  'Nome_comune': 'Ascorbyl Stearate',\n",
       "  'INCI_name': 'Ascorbyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ee22b3fd-1ff1-45e9-8f18-629378fe18fe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['byl Palmitate was determined to be 2500 mg/kg. An LD 50 of 2000 mg/kg was reported for Ascorbyl Palmitate (33.3%suspensi'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b0'),\n",
       "  'Nome_comune': 'Ascorbyl Tetraisopalmitate',\n",
       "  'INCI_name': 'Ascorbyl Tetraisopalmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=01b8e72e-5c2b-4cce-984a-6937c7c38a8d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=55dd0cb4-0c4c-5834-93b4-d57172fc4433',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):57-75, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['byl Palmitate was determined to be 2500 mg/kg. An LD 50 of 2000 mg/kg was reported for Ascorbyl Palmitate (33.3%suspensi'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b1'),\n",
       "  'Nome_comune': 'Ascorbyl Tocopheryl Acetate',\n",
       "  'INCI_name': 'Ascorbyl Tocopheryl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=693416fe-7b49-461e-830b-0856185a85fb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=297dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.2):61-94, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b2'),\n",
       "  'Nome_comune': 'Ascorbyl Tocopheryl Maleate',\n",
       "  'INCI_name': 'Ascorbyl Tocopheryl Maleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4eea394b-2a12-45a0-b7db-610d89ad8b97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=297dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.2):61-94, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b3'),\n",
       "  'Nome_comune': 'Asparagine',\n",
       "  'INCI_name': 'Asparagine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7f64cd4a-c0e9-4230-9d38-b1258cb62df8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b4'),\n",
       "  'Nome_comune': 'Asparagopsis Armata Extract',\n",
       "  'INCI_name': 'Asparagopsis Armata Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66421cde-4edd-4c80-816d-41829901a281',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['his study were provided.  The median lethal dose (LD 50) was reported to be > 2000 mg/kg.   Corallina Officinalis Extract   The acute oral',\n",
       "   'thod of oral administration was not  stated.  The LD 50 was reported to be > 2000 mg/kg.   Grateloupia Livida E xtract   The acute oral t',\n",
       "   ' were seen  with any extract or dose level .  The LD 50 values were  expected to be >  2000 mg/kg.   Lithothamnion Calcareum Extract   A Lithothamn',\n",
       "   'lesseria Sanguinea Extract (0.2 –  4% algae), the LD 50 was reported to be > 2000 mg/kg.   The acute oral  toxicity potential of multiple',\n",
       "   'uted dry  Asparagopsis Armata Extract .  The oral LD 50 was reported to be > 5000 mg/kg in an acute toxicity assay using a mixture  contai'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b5'),\n",
       "  'Nome_comune': 'Aspartic Acid',\n",
       "  'INCI_name': 'Aspartic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4e99552f-6984-4d4f-8db1-1fe14156d2d7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b6'),\n",
       "  'Nome_comune': 'Astragalus Gummifer Gum',\n",
       "  'INCI_name': 'Astragalus Gummifer Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8875d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b7'),\n",
       "  'Nome_comune': 'Astrocaryum Murumuru Seed Butter',\n",
       "  'INCI_name': 'Astrocaryum Murumuru Seed Butter',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aec9b952-44f1-43bf-af01-792478851e7f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1816c1f2275d72946b8'),\n",
       "  'Nome_comune': 'Astrocaryum Vulgare Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Astrocaryum Vulgare Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=af655c65-a339-4497-b8ed-ff1eca3ddbef',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946b9'),\n",
       "  'Nome_comune': 'Atelocollagen',\n",
       "  'INCI_name': 'Atelocollagen',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1c51be99-7372-41a2-9500-4e58f858e35f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=70af0ca6-3a32-ea93-85bf-c21e81f97048',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):21-42, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946ba'),\n",
       "  'Nome_comune': 'Attapulgite',\n",
       "  'INCI_name': 'Attapulgite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0edc8dd2-ec14-4122-a9e8-63acb51a3bb8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d5fd5bfa-685d-6aab-94d5-67acbc8713fb',\n",
       "  'pdf_date': 'March 07, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['age.1  None  of the animals died ; the acute oral LD 50 was > 5.0 g/kg bw .  Kaolin   In an acute oral study, 120 rats were',\n",
       "   'r c linical signs of toxicity were observed.  The LD 50  was greater than 2000 mg/kg.  No further details were provided.   Oral   Clay',\n",
       "   'was not considered to be treatment- related.  The LD 50 was greater than 2000 mg/kg bw.  No further de tails were  provided.  Hectorite ',\n",
       "   'lite, 19% Kaolin, and 6% Montmorillonite ) had an LD 50  greater than 2000 mg/kg.   The same product was tested in an acute inhala'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 g/kg bw', '2000 mg/kg', '2000 mg/kg bw', '2000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946bb'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Bran',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Bran',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c69cc8c-8f05-4574-b5a0-f40e253c38d4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946bc'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Bran Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Bran Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=05b9cb1c-ddbe-4a71-840e-8898d1935ddd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946bd'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Flower/Leaf/Stem Juice',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Flower/Leaf/Stem Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a6cd2173-2fde-43ed-b987-7ade193c0231',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946be'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f17fb106-f944-46c1-94be-b0d3f658b4da',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946bf'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Flour',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Flour',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=feceda54-050a-4dea-9983-7971d3de5c58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946c0'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Meal',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Meal',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dcb14cb9-a5db-448b-865e-3488e1b3f69c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1826c1f2275d72946c1'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Oil',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=99ae19e0-36a6-4174-ae4f-031c92dd2ee4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c2'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Kernel Protein',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Kernel Protein',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=320c61ba-a162-434a-ab34-a205f91add30',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c3'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Leaf Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d5349e4-b386-44f9-b3a6-7a2ed34504e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c4'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Leaf/Stalk Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Leaf/Stalk Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e6d27777-d7b5-4ed9-9c70-d7f0bd7c9f5d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c5'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Leaf/Stem Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Leaf/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ac89b733-abfe-49ae-80fa-8a8edd77b220',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c6'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Meal Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Meal Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d87ab2a3-161f-489d-89b0-99b3f36b47cc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c7'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Meristem Cell Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Meristem Cell Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=77b0b331-7801-4208-bdbb-4b18751455e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c8'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Peptide',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Peptide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=50f05bf0-41f2-4cd3-b52b-8bb69c9c38b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946c9'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Protein Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Protein Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=18f95a50-1453-464a-915c-c46f44e4fc76',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946ca'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Seed Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Seed Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8501a96b-8af8-456a-86f8-329e2c2b8c4c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1836c1f2275d72946cb'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Seed Water',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Seed Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67367937-85f4-4523-a765-c1f346faf5bb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946cc'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Sprout Oil',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Sprout Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bd484d97-d2b4-404b-815a-6a9dd0957dc0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946cd'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Starch',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Starch',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e059b355-7866-42d0-8a0a-f79f44c3abb2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946ce'),\n",
       "  'Nome_comune': 'Avena Sativa (Oat) Straw Extract',\n",
       "  'INCI_name': 'Avena Sativa (Oat) Straw Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dcab5344-af35-4ac2-ab66-b9bdb5a74e82',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=947dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):23-47, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946cf'),\n",
       "  'Nome_comune': 'Avocadamide DEA',\n",
       "  'INCI_name': 'Avocadamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2988ca8b-dace-442b-9fd9-a224337cd471',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne of the animals died, and the lethal dose, 50 %(LD 50) was >2 g/kg. Lauramide DEA. In an acute dermal toxicity study'],\n",
       "  'contesti_noael': ['mental toxicity study in Sprague-Dawley rats, the NOAEL for maternal toxicity and developmental toxicity was 1000 mg/kg/d that was the highest dose tested. No other data o'],\n",
       "  'valori_ld50': ['2 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d0'),\n",
       "  'Nome_comune': 'Avocadamidopropyl Betaine',\n",
       "  'INCI_name': 'Avocadamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c1de33c-9ec0-4dda-a19f-abe4a3c640a0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d1'),\n",
       "  'Nome_comune': 'Avocadamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Avocadamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=57a0d67a-47d1-4f1c-87d0-c04927e32db4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['n the remaining animals. The oral lethal dose 50 (LD 50) for stearamidopropyl dimethylamine in this study was determined to be greater than 2,000 mg/kg body weight. In another oral toxicity study, 40 %(wt/wt) stea'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d2'),\n",
       "  'Nome_comune': 'Avocado Oil',\n",
       "  'INCI_name': 'Persea Gratissima (Avocado) Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f3916e5b-2390-4e99-bdd2-7e29463be5c1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d3'),\n",
       "  'Nome_comune': 'Avocado Oil PEG-11 Esters',\n",
       "  'INCI_name': 'Avocado Oil PEG-11 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aca83640-557b-4add-ae95-72c22fb16fe3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1846c1f2275d72946d4'),\n",
       "  'Nome_comune': 'Avocado Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Avocado Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b8f27a03-0463-4d33-baad-0fea9086f57b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d5'),\n",
       "  'Nome_comune': 'Avocado Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Avocado Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2cb59cef-e3c7-4f55-80e3-2bdf377811b4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d6'),\n",
       "  'Nome_comune': 'Avocado Oil Propylene Glycol Esters',\n",
       "  'INCI_name': 'Avocado Oil Propylene Glycol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e94d4495-6eb3-4cf6-9a00-3a4412fb8bae',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1c34b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['41  Acute toxicity   Hept anoic acid  IV in mice  LD 50 = 1200 ± 56 mg/kg   42  Undecanoic acid  IV in mice  LD 50 = 140 ± 4.2 mg/kg   42  Dermal irritation – in vitro   Hepta noic acid',\n",
       "   ' Laurate was classified as  practically nontoxic (LD 50 > 34.6 g/kg) when administered orally to rats.   In two skin ',\n",
       "   'zed following ingestion.  In rats, the acute oral LD 50  has been shown to be approximately 25.8 g/kg.  The raw ingredient produced no significant de r',\n",
       "   'ults  in any of the animal tests.  The acute oral LD 50 in rats is e stimated to be greater than 32 g/kg.  The ingredient per se  produced no significant '],\n",
       "  'contesti_noael': [' rats.25  The no observed adverse effects level  (NOAEL ) was concluded  to be 1000   mg/kg/d .  No evidence of adverse effects were foun d in '],\n",
       "  'valori_ld50': ['2 mg/kg   ', '6 g/kg', '8 g/kg', '32 g/kg'],\n",
       "  'valori_noael': ['1000   mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d7'),\n",
       "  'Nome_comune': 'Azelaic Acid',\n",
       "  'INCI_name': 'Azelaic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a8e9bfd6-d1f0-4a99-a5c0-344f5baa4863',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d8d3785f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl 1):5-76, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['re no significant toxicological findings, and the NOAEL was 500 mg/kg bw/d. In another 13-week study, groups of 4 male and 4',\n",
       "   'malies were not considered treatment-related. The NOAEL for maternal toxicity was 2000 mg/kg bw/d, and for developmental and reproductive effects it was 800 mg/kg bw/d. Groups of 25 mated female rats were dosed dermal',\n",
       "   'rn live, or their survival, was not affected. The NOAEL was 170 mg/kg bw/d and the LOAEL was 1080 mg/kg bw/d. In another study in which gravid females were fe',\n",
       "   '.) Slight effects were seen in the liver, and the NOAEL was 3333 mg/kg bw. Groups of 13 to 15 male and female rats were fed a diet containing 0, 1600, or 3200 mg/kg bw/d adipic acid for 33 weeks.40Rats were killed at va'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '800 mg/kg bw/d',\n",
       "   '1080 mg/kg bw/d',\n",
       "   '3200 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d8'),\n",
       "  'Nome_comune': 'Azelamide MEA',\n",
       "  'INCI_name': 'Azelamide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9c6a068a-68ec-4923-bd59-4a970498f008',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=61a5d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):18-34, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['EA.2 Cocamide MEA. The dermal median lethal dose (LD 50)o f cocamide MEA was evaluated by applying 2 g/kg to the abraded and intact skin of rabbit under occlusive '],\n",
       "  'contesti_noael': ['e observed. The no observed adverse effect level (NOAEL) was >750 mg/kg bw/d. Reproductive and Developmental Toxicity Data on ',\n",
       "   'eeks) were not toxic. In a 14-day oral study, the NOAEL of cocamide MEA in rats was >750 mg/kg/d, the highest dose tested. No data on the reproduc'],\n",
       "  'valori_ld50': ['2 g/kg to the '],\n",
       "  'valori_noael': ['750 mg/kg bw/d', '750 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946d9'),\n",
       "  'Nome_comune': 'Azulene',\n",
       "  'INCI_name': 'Azulene',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=791185e2-2fed-4235-ad0a-9c6e6218652a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=62cf160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 18(S3):27-32, 1999',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' 4 g/kg and 3 g/kg, respectively. The intravenous LD50 in the mouse was 56 mg/kg. The subcutaneous LDsos in the rat and mouse were, respectively, 520 mg/kg and 145 mg/kg. The intraperi- toneal LDsos were 18'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['520 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946da'),\n",
       "  'Nome_comune': 'Babassu Acid',\n",
       "  'INCI_name': 'Babassu Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a4560db7-55c7-474d-b0fc-8454dd6db1a8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946db'),\n",
       "  'Nome_comune': 'Babassu Oil Polyglyceryl-4 Esters',\n",
       "  'INCI_name': 'Babassu Oil Polyglyceryl-4 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7bd0653b-8d64-4113-87e0-fddb4c667023',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946dc'),\n",
       "  'Nome_comune': 'Babassu Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Babassu Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b1fe1511-c3d6-4e1c-aa2c-0ffc58416769',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946dd'),\n",
       "  'Nome_comune': 'Babassuamide DEA',\n",
       "  'INCI_name': 'Babassuamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e754766f-b70c-4148-9663-716ba2522677',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne of the animals died, and the lethal dose, 50 %(LD 50) was >2 g/kg. Lauramide DEA. In an acute dermal toxicity study'],\n",
       "  'contesti_noael': ['mental toxicity study in Sprague-Dawley rats, the NOAEL for maternal toxicity and developmental toxicity was 1000 mg/kg/d that was the highest dose tested. No other data o'],\n",
       "  'valori_ld50': ['2 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1856c1f2275d72946de'),\n",
       "  'Nome_comune': 'Babassuamide MEA',\n",
       "  'INCI_name': 'Babassuamide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8688d7a2-4584-4b08-8f3a-6209b95306d2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=61a5d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):18-34, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['EA.2 Cocamide MEA. The dermal median lethal dose (LD 50)o f cocamide MEA was evaluated by applying 2 g/kg to the abraded and intact skin of rabbit under occlusive '],\n",
       "  'contesti_noael': ['e observed. The no observed adverse effect level (NOAEL) was >750 mg/kg bw/d. Reproductive and Developmental Toxicity Data on ',\n",
       "   'eeks) were not toxic. In a 14-day oral study, the NOAEL of cocamide MEA in rats was >750 mg/kg/d, the highest dose tested. No data on the reproduc'],\n",
       "  'valori_ld50': ['2 g/kg to the '],\n",
       "  'valori_noael': ['750 mg/kg bw/d', '750 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946df'),\n",
       "  'Nome_comune': 'Babassuamidopropyl Betaine',\n",
       "  'INCI_name': 'Babassuamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dfdfc59e-48d9-4819-9072-a1dfa74e71ed',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e0'),\n",
       "  'Nome_comune': 'Babassuamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Babassuamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a4ad126e-73f2-4ce5-893e-51750796dd7d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['n the remaining animals. The oral lethal dose 50 (LD 50) for stearamidopropyl dimethylamine in this study was determined to be greater than 2,000 mg/kg body weight. In another oral toxicity study, 40 %(wt/wt) stea'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e1'),\n",
       "  'Nome_comune': 'Barium Sulfate',\n",
       "  'INCI_name': 'Barium Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=56a131dc-9e59-404a-a128-6c2a40bb2ece',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9c7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl3):5-11, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e2'),\n",
       "  'Nome_comune': 'Basic Blue 7',\n",
       "  'INCI_name': 'Basic Blue 7',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f098479e-5e32-ef11-8409-6045bdda3581',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=74c358f7-d495-3ba0-9f14-9032a7cc5b2a',\n",
       "  'pdf_date': 'June 24, 2024',\n",
       "  'pdf_name': 'Notice to Proceed without the Preparation of a Scientific Literature Review',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e3'),\n",
       "  'Nome_comune': 'Basic Blue 99',\n",
       "  'INCI_name': 'Basic Blue 99',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e3814c36-1977-ed11-81ab-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a0a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 2):51-63, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e4'),\n",
       "  'Nome_comune': 'Basic Brown 17',\n",
       "  'INCI_name': 'Basic Brown 17',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e56d1ea7-98db-4957-b68f-35c92ac66153',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7bf5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['oss pathological examination .   The acute dermal LD 50 of Basic Brown 17 was greater than 2 000 mg/kg bw.   Oral   In an acute oral toxicity study, CF1 mi',\n",
       "   'at in the 16 ,000 mg/kg  bw dose group died.  The LD 50 in this study was determined to be between 8000  and 16 ,000 mg/kg bw.   Subchronic Toxicity  Studies   Oral   In a 90-',\n",
       "   'ueous isopropanol was tested.   The acute derm al LD 50 of Basic Brown 17 in rats was greater than 2 000 mg/kg bw.   The acute oral LD 50 of Basic Brown  17 in mic',\n",
       "   'ties in any of the  test animals . The acute oral LD 50 of Basic Brown 17 was greater than 2000 mg/kg bw in rats .   In another acute oral study, the toxic',\n",
       "   'vation period,  no mortalities were recorded. The LD 50 was reported to be greater than 5000 mg/kg bw in mic e.  The acute oral toxicity  of Basic Brown'],\n",
       "  'contesti_noael': [' 1000. This calculation was  based on an adjusted NOAEL of 23 mg/kg bw/d and a SED of 0.023 mg/kg bw.   The Panel determin',\n",
       "   ' 1000.3  This calculation is based on an adjusted NOAEL of 23 mg/kg bw/d (46 mg/kg bw/d with a  bioavailability of 50%) from a 90 -d oral',\n",
       "   'in body w eight gains was not dose -related.  The NOAEL for Basic Brown 17  (77.4% pure)  was 46  mg/kg/d in a  90-d oral toxicity study in rats.  Adverse ',\n",
       "   'd 450 mg/kg  bw/d, but not at 50 mg/kg bw /d. The NOAEL of th is study was determined to be 150 mg/kg bw/d, and the no-observed - effect-level ( NOE L) was ',\n",
       "   ' than controls .  In a 15- wk study in  rats, the NOAEL of Basic Brown 1 7 (68% as chloride) was determined to be 150 mg/kg bw/d and the NOEL was determined  to be 50 mg/kg bw/d ',\n",
       "   'material,  the NOAEL s were 93 mg/kg bw/d and >  186 mg/kg  bw/d , respectively .3  In another oral teratogenicity',\n",
       "   'ity study of Basic Brown 17 (77.4%), the maternal NOAEL was 120 mg/kg/d and the fetal  NOAEL was > 240 mg/kg/d,  which was corrected to 93 mg/kg/d and >  186 mg/kg bw/d when account ing for the purity of the  test mate',\n",
       "   'e  fetuses.  For the test material, the  maternal NOAEL was considered to be 120 mg/kg bw/d and the fetal NOAEL was > 240  mg/kg bw/d; when taking into account the purity of the test '],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '5000 mg/kg bw '],\n",
       "  'valori_noael': ['23 mg/kg bw/d',\n",
       "   '46 mg/kg bw/d',\n",
       "   '46  mg/kg/d',\n",
       "   '150 mg/kg bw/d',\n",
       "   '150 mg/kg bw/d',\n",
       "   '186 mg/kg  bw/d',\n",
       "   '186 mg/kg bw/d',\n",
       "   '240  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e5'),\n",
       "  'Nome_comune': 'Basic Red 76',\n",
       "  'INCI_name': 'Basic Red 76',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=53e70981-bdc4-4c57-94cb-389672a6c6c9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7471582e-79fe-c5cc-890b-29d2a97bccd7',\n",
       "  'pdf_date': 'IJT 43(Suppl. 3):109-119, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['rved in offspring. The maternal and developmental NOAEL was determined to be 60 mg/kg bw/d. Another study was performed using Sprague-Dawley',\n",
       "   'ed lowered body and organweights. The established NOAEL in a 90-day study in- volving Wistar rats dosed via gavage was 60 mg/kg/d (test material, 80.5% Basic Red 76). No signs of ',\n",
       "   'substance was used. The maternal anddevelopmental NOAEL was determined to be 60 mg/kg bw/d. In a different study, no adverse effects were re',\n",
       "   'animals. The no-observable- adverse-effect-level (NOAEL) was reported to be <200 mg/kg bw/d. Subchronic Toxicity Studies Oral. Groups of 10 f'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['60 mg/kg bw/d',\n",
       "   '60 mg/kg/d',\n",
       "   '60 mg/kg bw/d',\n",
       "   '200 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e6'),\n",
       "  'Nome_comune': 'Basic Violet 1',\n",
       "  'INCI_name': 'Basic Violet 1',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a94906dc-175b-4585-a183-52b1b363c911',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a362e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):193-204, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1866c1f2275d72946e7'),\n",
       "  'Nome_comune': 'Basic Violet 3',\n",
       "  'INCI_name': 'Basic Violet 3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=477522d7-0959-4545-9265-236adccbb20a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a362e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):193-204, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946e8'),\n",
       "  'Nome_comune': 'Basic Violet 4',\n",
       "  'INCI_name': 'Basic Violet 4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f5a81bb4-1161-4069-830e-cc7ae6d73fbe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a362e6c2-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 3):193-204, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946e9'),\n",
       "  'Nome_comune': 'Basic Yellow 57',\n",
       "  'INCI_name': 'Basic Yellow 57',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1367622e-ee2f-428c-9e49-3da8c2092f78',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=815a45dd-8f24-6350-abc7-68b23eadcd69',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ibed in Table 2.  In a dermal stud y in rats, the LD 50 for Basic  Yellow 57 was greater than 2000 mg/kg bw.2  The LD 50 for Basic Yellow 57 in an oral study',\n",
       "   'was tested.   In acute dermal stu dy in rats, the LD 50 for Basic Yellow 57 was greater than 2000 mg/kg bw.  The LD 50 for Basic Yellow  57 in an acute oral',\n",
       "   ' 57   Animals  No./Group  Vehicle  Dose/Protocol  LD 50/Results  Reference   DERMAL   Sprague -Dawley rats  5 male and 5  female/dose  group  None  2000 mg/kg  (purity not reported)  in  accordance with OECD ',\n",
       "   ' while in studies using Sprague -Dawley rats, the LD 50 was greater than 2000 mg/kg bw.2-4  A study that tested Basic Yellow 57  at doses  up to 4000 mg/kg bw in CFY rats found the LD 50 to be between 1000 - 2',\n",
       "   ' while in studies using Sprague -Dawley rats, the LD 50 was greater than  2000 mg/kg bw.   A study that test ed Basic Yellow 57 at doses  up to 4000 mg/kg bw in CFY rats found the LD 50 for Basic  Yellow 57  '],\n",
       "  'contesti_noael': ['erved.  The no -observed -adverse -effect -level (NOAEL) was 20 mg/kg bw/d.   DEVELOPMENTAL AND REP RODUCTI VE TOXICITY  STU',\n",
       "   'ts tested with 0 or 20 mg/kg Basic Yellow 57; the NOAEL was 20 mg/kg  bw/d.   In an oral teratogenicity study of Basic Yello',\n",
       "   'EL  (/3; adjustment factor for the average LOAEL: NOAEL ratio  CIR Staff) of 26 mg/kg  bw/d ( 100 mg/kg bw, corrected to 79 mg/kg bw for 79% ',\n",
       "   'AEL (/3; adjustment factor for the average LOAEL: NOAEL ratio ) of 26 mg/kg bw/d from a 90 -d  oral rat study and a SED of 0.076 m',\n",
       "   ' corrected for dye content) and the developmental NOAEL  was determined to be 300 mg/kg bw/day (237 mg/kg bw/d corrected  for dye content).4  GENOTOXICITY STUDI',\n",
       "   'rnal NOEL was 100 mg/kg/d and the developmental   NOAEL was 300 mg/kg/d, which was cor rected to 237  mg/kg/d for dye content of the  test material.  Enlarged '],\n",
       "  'valori_ld50': ['2000 mg/kg bw',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg',\n",
       "   '4000 mg/kg bw ',\n",
       "   '4000 mg/kg bw '],\n",
       "  'valori_noael': ['20 mg/kg bw/d',\n",
       "   '20 mg/kg  bw/d',\n",
       "   '26 mg/kg  bw/d',\n",
       "   '26 mg/kg bw/d',\n",
       "   '237 mg/kg bw/d',\n",
       "   '237  mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ea'),\n",
       "  'Nome_comune': 'Basic Yellow 87',\n",
       "  'INCI_name': 'Basic Yellow 87',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5283cca5-3f0c-ed11-82e5-000d3a9cc019',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=110d3b0e-b035-a1ac-a0ea-fe3ae3a7201a',\n",
       "  'pdf_date': 'March 07, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['s, when tested  at up to 2000 mg/kg bw . 2,3  The LD 50 was estimated to be 1000 mg/kg bw  in another  study where Basic Yellow 87 (purity no',\n",
       "   'w in males when tested at up to 2000 mg/kg.   The LD 50 was estimated to be 1000 mg/kg bw in  another  study where Basic Yellow 87 (purity n',\n",
       "   ' reported )  via single gavage dose (limit test)  LD 50 between 500 and 1000 mg/kg in females and > 1500 mg/kg  in males : all males survived the 500 and 1000 mg/kg doses and 1  male survived the 1500 mg/kg dose, no',\n",
       "   'al toxicity study in accordance with OECD TG 4 20 LD 50 estimated as 1000 mg/kg; 2/5 males in the 1000 mg/kg   died, no females died ; prior to death,  clinical sign',\n",
       "   'Table 3.  In an acute  dermal stud y in rats, the LD 50 for  Basic Yellow 87 (87.7% pure) was greater than 2000 mg/kg bw.3  In oral studies using rats, the LD 50 in a lim',\n",
       "   'sure .     In an acute  dermal study in rats, the LD 50 for Basic Yellow 87 (87.7% pure) was greater than 2000 mg/kg bw.  In oral  studies using rats, the LD 50 in a lim',\n",
       "   'w 87  Animals  No./Group  Vehicle  Dose/Protocol  LD 50/Results  Reference   DERMAL   Crl:CD (SD)IGS BR rats  5 male s and 5 female s none 2000 mg/kg  (87.7% pure ) in accordance with OECD  TG 402; t'],\n",
       "  'contesti_noael': ['ted.  The no -observable -adverse -effect -level (NOAEL) for this study was 174 mg/kg bw/d and the  NOEL was ~ 39 mg/kg bw/d.  In a 13- wk dietary study, the NOAEL was 10 mg/',\n",
       "   'lobulin ratios at the  highest doses tested.  The NOAEL for this study was 174 mg/kg bw/d and the NOEL was ~ 39 mg/kg bw/d.  In a 13 -wk dietary  study, the NOAEL was 10 mg',\n",
       "   ' with OECD  TG 407; controls received normal diet NOAEL = 174 mg/kg bw/d and NOEL = ~ 39 mg/kg bw/d; yellow  discoloration of feces noted in all high',\n",
       "   ') at mid and high doses.   The maternal and fetal NOAEL for Basic Yellow 87  (> 92% pure) was determined to be 60 mg/kg bw/d in a teratogenic  study in mated female rats.  Th',\n",
       "   'D  TG 408; control animals received normal   diet NOAEL = 10 mg/kg  bw/d , corresponding to a dose of 6.76 mg/kg  bw/d of the cation; no adverse effects observed in oph',\n",
       "   '  184.4  This calculation is based on an adjusted NOAEL  (10% bioavailability  due to the low oral bioavailability  as shown in an  ADME study) of 0.676  mg/kg bw/d from a 13-wk oral rat study  (as cation)  and a s',\n",
       "   'e  184. This calculation was based on an adjusted NOAEL  of 0.676 mg/kg bw/d from a 13-wk oral rat study and a SED of 0.0037  '],\n",
       "  'valori_ld50': ['1000 mg/kg bw  ',\n",
       "   '1000 mg/kg bw ',\n",
       "   '1000 mg/kg ',\n",
       "   '1000 mg/kg   died',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg'],\n",
       "  'valori_noael': ['39 mg/kg bw/d',\n",
       "   '39 mg/kg bw/d',\n",
       "   '39 mg/kg bw/d',\n",
       "   '60 mg/kg bw/d',\n",
       "   '76 mg/kg  bw/d',\n",
       "   '676  mg/kg bw/d',\n",
       "   '676 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946eb'),\n",
       "  'Nome_comune': 'Bassia Butyracea Seed Butter',\n",
       "  'INCI_name': 'Bassia Butyracea Seed Butter',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1414f2c0-d378-46fb-b769-be6bf8a24aab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ec'),\n",
       "  'Nome_comune': 'Bassia Latifolia Seed Butter',\n",
       "  'INCI_name': 'Bassia Latifolia Seed Butter',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bb58dbb6-5b9d-4ecb-95ef-09287a2a4052',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ed'),\n",
       "  'Nome_comune': 'Batyl Alcohol',\n",
       "  'INCI_name': 'Batyl Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b30fdae8-64b8-4e8a-92d2-bfa0c4fa10e8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fb6cd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):5-21, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['he OECD TG 401 test method.25,27An lethal dosage (LD50) of >2000 mg/kg (low toxicity, no deaths) was reported, and clini',\n",
       "   'dy. None of the animals died, and an acute dermal LD50 of >2000 mg/kg (nontoxic) was reported. Necropsy findings were d'],\n",
       "  'contesti_noael': ['3-week study, it was not possible to establish an NOAEL because increased liver weight was observed at all doses. The study authors considered 50 mg/kg/d to be an NOAEL, because this dose was associated ',\n",
       "   'ed treatment related. Based on these results, the NOAEL was considered to be 800 mg/kg/d, and this was the highest dose tested in the 1-ge',\n",
       "   'ose groups. The 100 mg/kg dose was defined as the NOAEL. Ethylhexylglycerin administered orally to rats, at doses up to 800 mg/kg/d, in a 13-week study did not result in any treatme',\n",
       "   'negative. None of the dosed animals died, and the NOAEL for developmental toxi- city was considered to be 800 mg/kg/d. In the 1-generation developmental toxicity study'],\n",
       "  'valori_ld50': ['2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg/d', '800 mg/kg/d', '800 mg/kg/d', '800 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ee'),\n",
       "  'Nome_comune': 'Batyl Isostearate',\n",
       "  'INCI_name': 'Batyl Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e013a87-5ef6-43b7-8686-d7a1f1ee1dd9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946ef'),\n",
       "  'Nome_comune': 'Batyl Stearate',\n",
       "  'INCI_name': 'Batyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1d001494-8799-45e4-a1ba-d55096ba167e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1876c1f2275d72946f0'),\n",
       "  'Nome_comune': 'Beeswax',\n",
       "  'INCI_name': 'Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cb345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['e Panel calculated the MOS of DBP by dividing the NOAEL of 331 mg/kg/day (from a feeding study) by the ex-pected exposure of 9.13 μg/kg/day, yielding an MOS of 36,254. If the more conservat',\n",
       "   'l noted thatthe no observed adverse effect level (NOAEL) of DBP in a gav-age study was 50 mg/kg/day (Mylchreest et al. 2000). However,a feeding study',\n",
       "   'ive NOAEL of 50 mg/kg/day (from a gav-age study) is used, the MOS is 5476. ',\n",
       "   ' reported a NOAEL of 331 mg/kg/day (Ema et al.1998). Overall, the Panel felt that fe'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['13 μg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '331 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f1'),\n",
       "  'Nome_comune': 'Beeswax Acid',\n",
       "  'INCI_name': 'Beeswax Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4748b92a-0a84-4282-b92e-00cc914f6f64',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f2'),\n",
       "  'Nome_comune': 'Behenamide DEA',\n",
       "  'INCI_name': 'Behenamide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff164f93-423c-487e-9f8c-e5369089b665',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ne of the animals died, and the lethal dose, 50 %(LD 50) was >2 g/kg. Lauramide DEA. In an acute dermal toxicity study'],\n",
       "  'contesti_noael': ['mental toxicity study in Sprague-Dawley rats, the NOAEL for maternal toxicity and developmental toxicity was 1000 mg/kg/d that was the highest dose tested. No other data o'],\n",
       "  'valori_ld50': ['2 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f3'),\n",
       "  'Nome_comune': 'Behenamide MEA',\n",
       "  'INCI_name': 'Behenamide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff06816d-e69e-427b-90dd-fcc1a253a983',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=61a5d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):18-34, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['EA.2 Cocamide MEA. The dermal median lethal dose (LD 50)o f cocamide MEA was evaluated by applying 2 g/kg to the abraded and intact skin of rabbit under occlusive '],\n",
       "  'contesti_noael': ['e observed. The no observed adverse effect level (NOAEL) was >750 mg/kg bw/d. Reproductive and Developmental Toxicity Data on ',\n",
       "   'eeks) were not toxic. In a 14-day oral study, the NOAEL of cocamide MEA in rats was >750 mg/kg/d, the highest dose tested. No data on the reproduc'],\n",
       "  'valori_ld50': ['2 g/kg to the '],\n",
       "  'valori_noael': ['750 mg/kg bw/d', '750 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f4'),\n",
       "  'Nome_comune': 'Behenamidopropyl Betaine',\n",
       "  'INCI_name': 'Behenamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0705da6d-0d53-4085-8744-fdb045fcf49c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f5'),\n",
       "  'Nome_comune': 'Behenamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Behenamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1a964f74-9934-4ab4-b026-dce544166be5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['n the remaining animals. The oral lethal dose 50 (LD 50) for stearamidopropyl dimethylamine in this study was determined to be greater than 2,000 mg/kg body weight. In another oral toxicity study, 40 %(wt/wt) stea'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f6'),\n",
       "  'Nome_comune': 'Beheneth-10',\n",
       "  'INCI_name': 'Beheneth-10',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1c341831-09d0-4692-9a7c-6a3f89ab0c70',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f7'),\n",
       "  'Nome_comune': 'Beheneth-15',\n",
       "  'INCI_name': 'Beheneth-15',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=25a4cc23-77cd-4b89-b721-f26d4b89d390',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f8'),\n",
       "  'Nome_comune': 'Beheneth-2',\n",
       "  'INCI_name': 'Beheneth-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d760191-a831-4cc5-9626-de37b3a0ad63',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946f9'),\n",
       "  'Nome_comune': 'Beheneth-20',\n",
       "  'INCI_name': 'Beheneth-20',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f6a07233-142f-4f24-acaf-00a0fe0da8f8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1886c1f2275d72946fa'),\n",
       "  'Nome_comune': 'Beheneth-25',\n",
       "  'INCI_name': 'Beheneth-25',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=29078760-5b52-4f01-ae04-7785d81a1edc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946fb'),\n",
       "  'Nome_comune': 'Beheneth-30',\n",
       "  'INCI_name': 'Beheneth-30',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5e4bc8fd-74c4-468f-9068-c5ded224addd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946fc'),\n",
       "  'Nome_comune': 'Beheneth-5',\n",
       "  'INCI_name': 'Beheneth-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cac3fa48-5dc2-4fe1-93c7-449a25cd7bf8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946fd'),\n",
       "  'Nome_comune': 'Behenic Acid',\n",
       "  'INCI_name': 'Behenic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2547608c-8aaa-47ff-83b5-88ccef6a1752',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946fe'),\n",
       "  'Nome_comune': 'Behenoxy Dimethicone',\n",
       "  'INCI_name': 'Behenoxy Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=496e51ca-82ec-479b-8c65-48411855fa11',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1896c1f2275d72946ff'),\n",
       "  'Nome_comune': 'Behenoxy PEG-10 Dimethicone',\n",
       "  'INCI_name': 'Behenoxy PEG-10 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0d88eee9-1e57-4b57-a655-7d673710bf80',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1896c1f2275d7294700'),\n",
       "  'Nome_comune': 'Behentrimonium Chloride',\n",
       "  'INCI_name': 'Behentrimonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=216c134e-0a87-4f37-88ec-95b0de229bcb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d7294701'),\n",
       "  'Nome_comune': 'Behentrimonium Methosulfate',\n",
       "  'INCI_name': 'Behentrimonium Methosulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a0c8783a-823f-41de-82af-e139dff85561',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d7294702'),\n",
       "  'Nome_comune': 'Behenyl Alcohol',\n",
       "  'INCI_name': 'Behenyl Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=45a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1896c1f2275d7294703'),\n",
       "  'Nome_comune': 'Behenyl Beeswax',\n",
       "  'INCI_name': 'Behenyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9be19c0f-6a42-4212-a1d0-8dcabec9339c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294704'),\n",
       "  'Nome_comune': 'Behenyl Behenate',\n",
       "  'INCI_name': 'Behenyl Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c5918593-a880-4ccc-910f-9ea9bde5f8a7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294705'),\n",
       "  'Nome_comune': 'Behenyl Benzoate',\n",
       "  'INCI_name': 'Behenyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5504a672-33f8-42de-ba76-e9839c11c4b8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rted to be 2.69 g/kg. Dodecyl alcohol has an oral LD 50 of 12 800 mg/kg for rats. Tridecyl alcohol has an oral LD 50of17 200 mg/kg for rats. Tetradecyl alcohol has an oral LD 50 33 ',\n",
       "   ' reported to be 5600 mg/kg in rabbits. The dermal LD 50 of hexadecyl alcohol for rabbits was reported to be >2.6 g/kg. Aerosolized amyl alcohol at near saturation caus'],\n",
       "  'contesti_noael': ['(15, 40, or 120 mL/m3; purity 99.9 %).87 The oral NOAEL for noncancer systemic toxicity end points were 200 and 50 mg/kg/d in mice and rats, respectively, exposed chronical',\n",
       "   ' decreased food consumption and body weights. The NOAEL was 125 mg/kg/d for male and female F344 rats and B6C3Fl mice tre',\n",
       "   ' maternal weight gain. Maternal and developmental NOAEL was found to be 130 mg/kg/d in Wistar rats (n ¼10) orally exposed to ethylhex',\n",
       "   'ose females at birth and on day 4 postpartum. The NOAEL was 1000 mg/kg/d. In Ames tests, methyl benzoate, ethyl benzoate, '],\n",
       "  'valori_ld50': ['200 mg/kg ', '6 g/kg'],\n",
       "  'valori_noael': ['50 mg/kg/d',\n",
       "   '125 mg/kg/d',\n",
       "   '130 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294706'),\n",
       "  'Nome_comune': 'Behenyl Betaine',\n",
       "  'INCI_name': 'Behenyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff71e9e5-c717-4bf1-bb80-2c055a34e00f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4ca8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):28-46, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['xicity studies are presented in Table 4. The oral LD 50 values of betaine, cetyl betaine, lauryl betaine, and C12 to C14alkyldimethyl betaines were 11.1 g/kg, 1.62 g/kg, 0.071 g/kg, and 3 mL/kg, respectively',\n",
       "   ' and 1.3 g/kg for lauryl betaine. The intravenous LD 50 of betaine in mice has been reported to be 0.83 g/kg bw. The LD50values were 0.15 g/kg for cetyl betaine and 0.053 g/kg for lauryl betain'],\n",
       "  'contesti_noael': ['methyl betaines study determined the reproductive NOAEL to be 300 mg/kg/d when the test material was tested up to 1,000 mg/kg/d.4,28,29 Carcinogenicity Repeated dose toxicity re',\n",
       "   'methyl betaines study determined the reproductive NOAEL to be 300 mg/kg/d when the test material was tested up to 1,000 mg/kg/d. Betaine was not carcinogenic when tested up to 5',\n",
       "   '0 mg/kg/d due to decreased bw gain and a maternal NOAEL could not be established. The developmental LOAEL was 40 mg/kg/d and the developmental NOAEL was 20 mg/kg/d. In oral reproductive and developmental toxicity ',\n",
       "   '0 mg/kg/d due to decreased bw gain and a maternal NOAEL could not be established. The developmental LOAEL was 40 mg/kg/d and the developmental NOAEL was 20 mg/kg/d. In oral reproductive and developmental toxicity ',\n",
       "   'pmental LOAEL was 250 mg/kg and the developmental NOAEL was 150 mg/kg. In an oral C12 to C14 alkyldimethyl betaines study, the repro- ductive NOEL was 150 mg/kg bw/d and the reproductive LOAEL was 300 mg/kg bw/d due',\n",
       "   'pmental LOAEL was 250 mg/kg and the developmental NOAEL was 150 mg/kg. In an oral C12 to C14 alkyldimethyl betaines study, the reproductive NOEL was 150 mg/kg bw/d and the reproductive LOAEL was 300 mg/kg bw/d due',\n",
       "   'dverse effects on reproduction were observed. The NOAEL of the test substance for reproduction was 300 mg/kg/d4 Cetyl betaine; 0, 10, 20, 40, 100, or 200 mg/kg/d in 5% isopropanol in dosages of 2 mL/kgDermal dev'],\n",
       "  'valori_ld50': ['1 g/kg', '15 g/kg '],\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg/d',\n",
       "   '20 mg/kg/d',\n",
       "   '20 mg/kg/d',\n",
       "   '150 mg/kg bw/d',\n",
       "   '150 mg/kg bw/d',\n",
       "   '200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294707'),\n",
       "  'Nome_comune': 'Behenyl Dimethicone/Bis-Vinyldimethicone Crosspolymer',\n",
       "  'INCI_name': 'Behenyl Dimethicone/Bis-Vinyldimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ba4b8829-1156-4e40-9b26-340ce007ecea',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294708'),\n",
       "  'Nome_comune': 'Behenyl Erucate',\n",
       "  'INCI_name': 'Behenyl Erucate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2643c269-9ba5-4921-bdea-049a56132f23',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d7294709'),\n",
       "  'Nome_comune': 'Behenyl Isostearate',\n",
       "  'INCI_name': 'Behenyl Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fe83e9a6-60bd-4502-b67e-8cf908d1a44b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d729470a'),\n",
       "  'Nome_comune': 'Behenyl Methacrylate/Perfluorooctylethyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Behenyl Methacrylate/Perfluorooctylethyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1b51d9d0-278d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e821365b-edc8-8bc1-b1ed-7554f706933c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):144-161, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d729470b'),\n",
       "  'Nome_comune': 'Behenyl Methacrylate/t-Butyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Behenyl Methacrylate/t-Butyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4eb74c83-9c65-4423-80d6-e1d58a239f89',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed18a6c1f2275d729470c'),\n",
       "  'Nome_comune': 'Behenyl Olivate',\n",
       "  'INCI_name': 'Behenyl Olivate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9320d319-ee15-47a9-b97b-74a80b72118b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d729470d'),\n",
       "  'Nome_comune': 'Behenyl/Isostearyl Beeswax',\n",
       "  'INCI_name': 'Behenyl/Isostearyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0821fbdc-26cd-435b-b22c-3375b38a59a9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d729470e'),\n",
       "  'Nome_comune': 'Bentonite',\n",
       "  'INCI_name': 'Bentonite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d6779b56-71f5-4b94-83aa-56fbe58b339a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d5fd5bfa-685d-6aab-94d5-67acbc8713fb',\n",
       "  'pdf_date': 'March 07, 2023',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/BENTONITE',\n",
       "   'valori': ['LD50 Rat intravenous 35 mg/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 351\"]},\n",
       "  'contesti_ld50': ['age.1  None  of the animals died ; the acute oral LD 50 was > 5.0 g/kg bw .  Kaolin   In an acute oral study, 120 rats were',\n",
       "   'r c linical signs of toxicity were observed.  The LD 50  was greater than 2000 mg/kg.  No further details were provided.   Oral   Clay',\n",
       "   'was not considered to be treatment- related.  The LD 50 was greater than 2000 mg/kg bw.  No further de tails were  provided.  Hectorite ',\n",
       "   'lite, 19% Kaolin, and 6% Montmorillonite ) had an LD 50  greater than 2000 mg/kg.   The same product was tested in an acute inhala'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 g/kg bw', '2000 mg/kg', '2000 mg/kg bw', '2000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d729470f'),\n",
       "  'Nome_comune': 'Benzaldehyde',\n",
       "  'INCI_name': 'Benzaldehyde',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=74924e88-ce11-ee11-8f6c-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2da63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 1):11-27, 2006',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/240',\n",
       "   'valori': ['LD50 Rabbit dermal >1250 mg/kg',\n",
       "    'LD50 Guinea pig oral 1000 mg/kg',\n",
       "    'LD50 Rat oral 1300 mg/kg',\n",
       "    'LD50 Rat oral 1430 mg/kg bw',\n",
       "    'LD50 Mouse oral 28 mg/kg',\n",
       "    'LD50 Mouse ip 9 mg/kg',\n",
       "    'LD50 Mouse ip 1020 mg/kg',\n",
       "    'LD50 Rabbit subcutaneous 5000 mg/kg',\n",
       "    'LC50 Rat inhalation 1.0-5 mg/L/4 hr'],\n",
       "   'fonti': ['DHHS/NTP; Toxicology and Carcinogenesis Studies of Benzaldehyde in F344/N Rats and B6C3F1 Mice (Gavage Studies) p.15 (1988) Technical Rpt Series No. 332 NIH Pub No. 88-2588',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 353\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 353\",\n",
       "    'European Chemicals Agency (ECHA); Registered Substances, Benzaldehyde (CAS Number: 100-52-7) (EC Number: 202-860-4) (Last updated: December 29, 2015). Available from, as of April 25, 2016: https://echa.europa.eu/',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 353\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 353\",\n",
       "    'DHHS/NTP; Toxicology and Carcinogenesis Studies of Benzaldehyde in F344/N Rats and B6C3F1 Mice (Gavage Studies) p.14 (1988) Technical Rpt Series No. 332 NIH Pub No. 88-2588',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 353\",\n",
       "    'European Chemicals Agency (ECHA); Registered Substances, Benzaldehyde (CAS Number: 100-52-7) (EC Number: 202-860-4) (Last updated: December 29, 2015). Available from, as of April 25, 2016: https://echa.europa.eu/']},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294710'),\n",
       "  'Nome_comune': 'Benzalkonium Chloride',\n",
       "  'INCI_name': 'Benzalkonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=43a76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294711'),\n",
       "  'Nome_comune': 'Benzalkonium Montmorillonite',\n",
       "  'INCI_name': 'Benzalkonium Montmorillonite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bdfd412a-e572-434f-a2b8-7d32aec50bad',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e553b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 01, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['   Single dose (acute) toxicity -oral: Acute oral LD 50 for rats dosed with benzalkonium  chloride ranged from 342 to 525 mg/kg.   Single dose (acute) toxicity -dermal:  Of 96 m',\n",
       "   'Non-Human   STEARALKONIUM BENTONITE    The dermal LD 50 of stearalkonium bentonite was > 2000 mg/kg (in deionized water) in Sprague -Dawley rats  (n=',\n",
       "   'ntonite  was a lotion, not a powder .  The dermal LD 50 of stearalkonium bentonite was > 2000 mg/kg in rats.     The oral LD 50 of stearalkonium bento',\n",
       "   'cate.   Single -dose (acute) toxicity -oral: oral LD 50 of hectorite, >5 g/kg in rats; calcium silicate,  3400 mg/kg in rats; magnesium aluminum silicate, > 50000 mg/k',\n",
       "   '-dose (acute) toxicity -dermal:  The acute dermal LD 50 was >3.5 g/kg for rabbits  exposed to 4% magnesium aluminum sili',\n",
       "   '– Non-Human   STEARALKONIUM BENTONITE    The oral LD 50 of stearalkonium bentonite was >5000 mg/kg (in corn oil) in albino Wistar rats  (n=5/sex) .2',\n",
       "   'MMONIUM MONTMORILLONITE CLAY    The reported oral LD 50 for benzyl -dimethyl -hydrog enated tallow ammonium montmorillonite clay was >5000  mg/kg in Sprague -Dawley rats  (n not specified) .10    ',\n",
       "   'nite was > 5000 mg/kg in rats.   The oral LD 50 for benzyl -dimethyl - hydrogenated tallow ammonium montmorillonite clay was >5000 mg/kg i n rats.    The reported inhalation LC 50 for benzy',\n",
       "   't little or no systemic toxic effects.   The oral LD 50 of quaternium -18 bentonite was 8 g/kg in rats.    Single dose (acute) toxicity -inhalati',\n",
       "   ' at  28%.     Single dose (acute) toxicity -oral :LD 50 dihydrogenated tallow benzylmonium hectorite,  5.0 g/kg for rats; quaternium -18, >10 g/kg.   Single dose (acute) toxicity -inhalation :  LC',\n",
       "   '.    Single dose (acute) toxicity -oral: The oral LD 50 of stearalkonium chloride in rats ranged  from 0.5 -1.25 g/kg.   Repeated dose toxicity -oral: In mice, an LD 5'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['525 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '3400 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg ',\n",
       "   '5000 mg/kg i ',\n",
       "   '8 g/kg ',\n",
       "   '10 g/kg',\n",
       "   '25 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294712'),\n",
       "  'Nome_comune': 'Benzalkonium Sepiolite',\n",
       "  'INCI_name': 'Benzalkonium Sepiolite',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=318cfc57-5bd0-4f12-a7d8-c0009c33c9f7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e553b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 01, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['   Single dose (acute) toxicity -oral: Acute oral LD 50 for rats dosed with benzalkonium  chloride ranged from 342 to 525 mg/kg.   Single dose (acute) toxicity -dermal:  Of 96 m',\n",
       "   'Non-Human   STEARALKONIUM BENTONITE    The dermal LD 50 of stearalkonium bentonite was > 2000 mg/kg (in deionized water) in Sprague -Dawley rats  (n=',\n",
       "   'ntonite  was a lotion, not a powder .  The dermal LD 50 of stearalkonium bentonite was > 2000 mg/kg in rats.     The oral LD 50 of stearalkonium bento',\n",
       "   'cate.   Single -dose (acute) toxicity -oral: oral LD 50 of hectorite, >5 g/kg in rats; calcium silicate,  3400 mg/kg in rats; magnesium aluminum silicate, > 50000 mg/k',\n",
       "   '-dose (acute) toxicity -dermal:  The acute dermal LD 50 was >3.5 g/kg for rabbits  exposed to 4% magnesium aluminum sili',\n",
       "   '– Non-Human   STEARALKONIUM BENTONITE    The oral LD 50 of stearalkonium bentonite was >5000 mg/kg (in corn oil) in albino Wistar rats  (n=5/sex) .2',\n",
       "   'MMONIUM MONTMORILLONITE CLAY    The reported oral LD 50 for benzyl -dimethyl -hydrog enated tallow ammonium montmorillonite clay was >5000  mg/kg in Sprague -Dawley rats  (n not specified) .10    ',\n",
       "   'nite was > 5000 mg/kg in rats.   The oral LD 50 for benzyl -dimethyl - hydrogenated tallow ammonium montmorillonite clay was >5000 mg/kg i n rats.    The reported inhalation LC 50 for benzy',\n",
       "   't little or no systemic toxic effects.   The oral LD 50 of quaternium -18 bentonite was 8 g/kg in rats.    Single dose (acute) toxicity -inhalati',\n",
       "   ' at  28%.     Single dose (acute) toxicity -oral :LD 50 dihydrogenated tallow benzylmonium hectorite,  5.0 g/kg for rats; quaternium -18, >10 g/kg.   Single dose (acute) toxicity -inhalation :  LC',\n",
       "   '.    Single dose (acute) toxicity -oral: The oral LD 50 of stearalkonium chloride in rats ranged  from 0.5 -1.25 g/kg.   Repeated dose toxicity -oral: In mice, an LD 5'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['525 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '3400 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg ',\n",
       "   '5000 mg/kg i ',\n",
       "   '8 g/kg ',\n",
       "   '10 g/kg',\n",
       "   '25 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294713'),\n",
       "  'Nome_comune': 'Benzethonium Chloride',\n",
       "  'INCI_name': 'Benzethonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9d75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18b6c1f2275d7294714'),\n",
       "  'Nome_comune': 'Benzoic Acid',\n",
       "  'INCI_name': 'Benzoic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ebfc799c-8d0b-4433-b55c-2879d70aa3bb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6b62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):5-30, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/243',\n",
       "   'valori': ['LD50 Cat oral 2000 mg/kg',\n",
       "    'LD50 Dog oral 2000 mg/kg',\n",
       "    'LD50 Mouse intraperitoneal 1460 mg/kg',\n",
       "    'LD50 Mouse oral 1940 mg/kg',\n",
       "    'LD50 Rat oral 1700 mg/kg',\n",
       "    'LC50 Rat inhalation >0.026 mg/L/1 hr',\n",
       "    'LD50 Rabbit dermal > 5000 mg/kg bw'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    'European Chemicals Bureau; IUCLID Dataset, Benzoic acid (65-85-0) (2000 CD-ROM edition). Available from, as of March 22, 2005: https://esis.jrc.ec.europa.eu/',\n",
       "    'European Chemicals Bureau; IUCLID Dataset, Benzoic acid (65-85-0) (2000 CD-ROM edition). Available from, as of March 22, 2005: https://esis.jrc.ec.europa.eu/']},\n",
       "  'contesti_ld50': ['ts (number not stated), and a median lethal dose (LD 50) of 4,000 mg/kg body weight was reported.4Study details were not included. In '],\n",
       "  'contesti_noael': ['udies yielded a no-observed-adverse-effect level (NOAEL) of 800 mg/kg/ day for benzoic acid and >1,000 mg/kg/day for the salts.3At higher doses, increased mortali',\n",
       "   'sodium benzoate in the diet (/C212,800 mg/kg/day; NOAEL ¼1,400 mg/kg/day). Tes- ticular atrophy was observed in rabbits th',\n",
       "   'ts in a 4-generation reproductive toxicity study (NOAEL > 750 mg/kg).3Groups of rats (20 rats/sex/group) received benzoic acid doses of 375 or 750 mg/kg/day in the diet continuously. Animals of the third ge',\n",
       "   'ed strain dosed with benzyl alcohol by gavage, an NOAEL of 550 mg/kg (only dose) body weight for developmental toxicity was reported. An LOAEL of 750 mg/kg/day (only dose) for developmental toxicity wasreporte',\n",
       "   'y (reduced food intake and decreased body weight; NOAEL ¼ 1,400 mg/kg/day). All developmental effects were observed at doses/C212,800 mg/kg/day. On days 6 through 10, 15, or 18 of gestation, do'],\n",
       "  'valori_ld50': ['000 mg/kg body weight '],\n",
       "  'valori_noael': ['000 mg/kg/day',\n",
       "   '400 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294715'),\n",
       "  'Nome_comune': 'Benzophenone-1',\n",
       "  'INCI_name': 'Benzophenone-1',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=64345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294716'),\n",
       "  'Nome_comune': 'Benzophenone-10',\n",
       "  'INCI_name': 'Benzophenone-10',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=63c0f69c-f9f8-4676-98bc-481735687bbd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294717'),\n",
       "  'Nome_comune': 'Benzophenone-11',\n",
       "  'INCI_name': 'Benzophenone-11',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=58345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294718'),\n",
       "  'Nome_comune': 'Benzophenone-12',\n",
       "  'INCI_name': 'Benzophenone-12',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e57b6190-fc11-4f7b-beb2-6f6fb20ef37e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d7294719'),\n",
       "  'Nome_comune': 'Benzophenone-2',\n",
       "  'INCI_name': 'Benzophenone-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5b345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d729471a'),\n",
       "  'Nome_comune': 'Benzophenone-3',\n",
       "  'INCI_name': 'Benzophenone-3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d729471b'),\n",
       "  'Nome_comune': 'Benzophenone-4',\n",
       "  'INCI_name': 'Benzophenone-4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=62345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18c6c1f2275d729471c'),\n",
       "  'Nome_comune': 'Benzophenone-5',\n",
       "  'INCI_name': 'Benzophenone-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=63345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d729471d'),\n",
       "  'Nome_comune': 'Benzophenone-6',\n",
       "  'INCI_name': 'Benzophenone-6',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5e345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d729471e'),\n",
       "  'Nome_comune': 'Benzophenone-8',\n",
       "  'INCI_name': 'Benzophenone-8',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d729471f'),\n",
       "  'Nome_comune': 'Benzophenone-9',\n",
       "  'INCI_name': 'Benzophenone-9',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=60345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b13b17-ff25-954d-937e-c6fe6e6a6a4b',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['e -12 was evaluated using 5 albino rabbits.5  The LD 50 was > 10,000 mg/kg.     Oral   Benzophenones -1, -2, -3, -4, -6, -8,',\n",
       "   'sing 10 male rats of the CF Nelson strain.5  The  LD 50 was > 10,000 mg/kg.   Short -Term Toxicity  Studies   Repeated dose ',\n",
       "   '-12 involving rabbits, the LD 50 was > 10,000 mg/kg.   After oral dosing  (method not stated) , Benzo',\n",
       "   'osing of rats with Benzophenone -8 resulted in an LD 50 of > 2000 mg/kg.  An LD 50 of > 10,000 mg/kg was reported  for rats dosed orally (in water) wit',\n",
       "   'nd no clinical  signs or adverse findings.    The LD 50 > 10,000 mg/kg.      5  ORAL   Benzophenone -1 Rats  Number and ',\n",
       "   'No clinical signs and no  findings at necropsy.   LD 50  > 10,000  mg/kg  5          Table  7. Repeated dose toxicity studie',\n",
       "   ').69  The authors concluded that the acute dermal LD 50 of the sunscreen  formulation was greater than 2000 mg/kg in male and female rats.   The same sunscreen form',\n",
       "   'uated  using 10 female Wistar albino rats.69  The LD 50 for the sunscreen formulation was > 2000 mg/kg.   The acute oral toxicity of  Benzop henone -8 w',\n",
       "   'emale Wistar rats  of the CLR:( WI) strain.8  The LD 50 was > 2000 mg/kg.    Benzophenone -12 (20% suspension) was evaluat',\n",
       "   'tion containing 0.6% to 0.9% Benzophenone -3, and LD 50  of > 2000 mg/kg was reported.  In a similar study on Benzophenone ',\n",
       "   'alities  at necropsy or microscopic  examination. LD 50 > 2000  mg/kg .  69  Benzophenone -3  New Zealand  rabbits  6 m',\n",
       "   'e pharmacological effects, or  abnormal behavior. LD 50 >  2000 mg/kg . 69  Benzophenone -8 Female Wistar  rats of the ',\n",
       "   'ects. N o  evidence of macroscopic  changes.  The LD 50 > 2000  mg/kg.  8      Benzophenone -12 Male rats of  the CF Ne',\n",
       "   'iod.  Clinical signs (ataxia) were  observed.  An LD 50 of 3530 mg/kg was reported.   The acute oral toxicity of Benzoph',\n",
       "   ' 0.9%) was > 2000  mg/kg.  An acute oral (gavage) LD 50 of 3530 mg/kg for Benzophenone -4 was reported in a study involv',\n",
       "   ' using rats (number and strain not stated).6  The LD 50 was  8600 mg/kg.  The acute oral toxicity of a sunscreen formulat',\n",
       "   'none -1 was classified as practically non -toxic (LD 50 = 8600 mg/kg) in  rats.  The acute oral (gavage) LD 50 (rats) ',\n",
       "   'train not stated  Not stated  Details not stated  LD 50 = 8600 mg/kg .   Practically non -toxic.  6  Benzophenone -3 F'],\n",
       "  'contesti_noael': ['  substance was admi nistered orally for 3 d.  An NOAEL of 10 0 mg/kg/d  was reported.  The developmental toxicity  of  B',\n",
       "   'r and strain not stated).  After 3 d of dosing, a NOAEL of 10 0 mg/kg/d  was reported.   The oral dosing of groups  of 5 ',\n",
       "   'nistered doses  not stated  Oral dosing for 3 d.  NOAEL of 10 0 mg/kg/d . Any reproductive effects observed  not  specifi',\n",
       "   ' gavage)  on days 6 through 19 post -coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  In a study involving groups of 26  Wistar rats ',\n",
       "   'day over 6 h.24  The MOS  values are based on an  NOAEL of 200 mg/kg/da y from a rat oral t eratogenicity  study.9  The a',\n",
       "   'nscreen):    18 g/d   Typical human bw:   60 kg   NOAEL ( oral terato genicity -rat):  200 mg/kg/d     Systemic exposure dose (SED)  = 18.103 mg/d x',\n",
       "   'oducts):  17.79 g/d   Typical human bw:   60 kg   NOAEL (terato genicity -rat):  200 mg/kg bw/d   Systemic exposure dose (SED)  = (17.79.10 3 mg/',\n",
       "   ' mg/kg/d  on days 6 through 19  post-coitum.  The NOAEL for Benzophenone -3 was 200 mg/kg /d.  Groups of 25 pregnant Sprague -Dawley rats were',\n",
       "   't possess any selective  teratogenic properties.  NOAEL of 200 mg/kg/d.  9     Table  8. Developmental and reproductive ',\n",
       "   'male rats (number  and strai n not stated).6  The NOAEL was 236 mg/kg bw/d.   In a 13-wk oral toxicity study, B6C3F 1 mice (',\n",
       "   'involving rats (number and strain not stated),  a NOAEL of 236 mg/kg /d  was reported  for Benzophenone -1.  In a 13 -wk ',\n",
       "   'n  Details relating to test protocol not  stated  NOAEL of 236 mg/kg /d.  Regarding  organ toxicity endpoint, critical  e',\n",
       "   's) for specific post -weaning  examinations.  A n NOAEL of 1000 mg/kg/d  for general, systemic toxicity was determined.  ',\n",
       "   'e expected day of parturition ( GD 6 to 19 ). The NOAEL for maternal and prenatal  developmental toxicity was 1000 mg/kg/d.   Benzophenone -12 (in 0.5% carboxymethylcellulo',\n",
       "   'k mating period, and up to 30 d of lactation, a n NOAEL of 1000  mg/kg bw/d for general systemic toxicity was determined.   B',\n",
       "   'letal,  or visceral malformations not observed.   NOAEL (for maternal and  prenatal developmental toxicity ) of 1000 mg/kg/d.    5     Table  8. Developmental and reproductiv',\n",
       "   'r a total of appro ximately  63 d of dosing.  The NOAEL  (systemic toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d  for male and female rats .  Groups of 6  male ra',\n",
       "   'or a total of approximately 63 d of  dosing.  The NOAEL (reproductive toxicity) for Benzophenone -4 in this study was established at 1250 mg/kg/d.   The developmental toxicity of Benzophenone -12',\n",
       "   ') at doses of 750, 1000,  and 1250 mg/kg/d .  The NOAEL (reproductive toxicity) for Benzophenone -4  was 1250 mg/kg/d . Benzophenone -12 (in 0.5% carboxymethylcellulos',\n",
       "   'y mortalities observed were due to gavage error.  NOAEL (systemic toxicity) established at 1250 mg/kg /d for male and  female rats.     7    Benzophenone ',\n",
       "   '50 mg/kg dose groups revealed no  abnormaliti es. NOAEL (reproductive toxicity) of 1250 mg/kg/d . 7    Benzophenone -12 Groups of 50  Wistar rats'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '000  mg/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '3530 mg/kg ',\n",
       "   '3530 mg/kg ',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg',\n",
       "   '8600 mg/kg'],\n",
       "  'valori_noael': ['0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '0 mg/kg/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/da',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg bw/d',\n",
       "   '200 mg/kg /d',\n",
       "   '200 mg/kg/d',\n",
       "   '236 mg/kg bw/d',\n",
       "   '236 mg/kg /d',\n",
       "   '236 mg/kg /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg/d',\n",
       "   '1250 mg/kg /d',\n",
       "   '1250 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d7294720'),\n",
       "  'Nome_comune': 'Benzoxiquine',\n",
       "  'INCI_name': 'Benzoxiquine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=36c3974b-1ecf-46bf-bbb8-300b7216eaa3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d5a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 16(S1):117-122, 1997',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d7294721'),\n",
       "  'Nome_comune': 'Benzyl Alcohol',\n",
       "  'INCI_name': 'Benzyl Alcohol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=540c836b-b763-4f2f-9cd1-3daabf54abff',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6b62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):5-30, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/244',\n",
       "   'valori': ['LD50 Mouse sc 950 mg/kg bw',\n",
       "    'LD50 Rat sc 1700 mg/kg bw',\n",
       "    'LD50 Guinea pig ip > 400-800 mg/kg bw',\n",
       "    'LD50 Rat ip > 400-800 mg/kg bw',\n",
       "    'LD50 Rat oral 1230-3120 mg/kg bw',\n",
       "    'LD50 Mouse iv < 0.5 mL/kg /94% benzyl alcohol/',\n",
       "    'LC100 Rat inhalation 200-300 ppm/8 hr',\n",
       "    'LC50 Rat inhalation > 4.178 mg/L/4hr',\n",
       "    'LD50 Mouse oral 1580 mg/kg',\n",
       "    'LD50 Rabbit oral 1940 mg/kg',\n",
       "    'LD50 Rabbit dermal 2000 mg/kg',\n",
       "    'LD50 Guinea pig dermal <5 mL/kg',\n",
       "    'LC50 Rat inhalation 1000 ppm/8 hr',\n",
       "    'LD50 Rat iv 53 mg/kg bw',\n",
       "    'LD50 Rat iv 314 mg/kg bw',\n",
       "    'LD50 Mouse iv 324 mg/kg',\n",
       "    'LD50 Mouse oral 1360 mg/kg',\n",
       "    'LD50 Rat iv 53 mg/kg',\n",
       "    'LD50 Mouse CD-1, Male ip 1000mg/kg bw after 4 hours',\n",
       "    'LD50 Rat ip 400 mg/kg'],\n",
       "   'fonti': ['OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.259 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    'OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.258 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    'OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.258 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    'OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.258 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    'European Medicines Agency (EMEA), The European Agency for the Evaluation of Medicinal Products, Veterinary Medicines Evaluation Unit, Committee for Veterinary Medicinal Products; Benzyl Alcohol, Summary Report (1997). Available from, as of July 8, 2008: https://www.emea.europa.eu/pdfs/vet/mrls/Benzylalcohol.pdf',\n",
       "    'PMID:5542834',\n",
       "    'Verschueren, K. Handbook of Environmental Data of Organic Chemicals. 2nd ed. New York, NY: Van Nostrand Reinhold Co., 1983., p. 284',\n",
       "    'OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.14 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V6 498\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V6 498\",\n",
       "    'OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.13 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V6 498\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V6 498\",\n",
       "    'OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.259 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    'OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.259 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 399\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 399\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 399\",\n",
       "    'OECD; SIDS Initial Assessment Report for SIAM 13. Report on Benzoates: Benzoic acid, Sodium benzoate, Potassium benzoate, Benzyl alcohol (CAS No: 65-85-0, 532-32-1, 582-25-2, 100-51-6) p.258 UNEP Publications (November 2001). Available from, as of November 18, 2014: https://www.inchem.org/pages/sids.html',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 399\"]},\n",
       "  'contesti_ld50': ['ts (number not stated), and a median lethal dose (LD 50) of 4,000 mg/kg body weight was reported.4Study details were not included. In '],\n",
       "  'contesti_noael': ['udies yielded a no-observed-adverse-effect level (NOAEL) of 800 mg/kg/ day for benzoic acid and >1,000 mg/kg/day for the salts.3At higher doses, increased mortali',\n",
       "   'sodium benzoate in the diet (/C212,800 mg/kg/day; NOAEL ¼1,400 mg/kg/day). Tes- ticular atrophy was observed in rabbits th',\n",
       "   'ts in a 4-generation reproductive toxicity study (NOAEL > 750 mg/kg).3Groups of rats (20 rats/sex/group) received benzoic acid doses of 375 or 750 mg/kg/day in the diet continuously. Animals of the third ge',\n",
       "   'ed strain dosed with benzyl alcohol by gavage, an NOAEL of 550 mg/kg (only dose) body weight for developmental toxicity was reported. An LOAEL of 750 mg/kg/day (only dose) for developmental toxicity wasreporte',\n",
       "   'y (reduced food intake and decreased body weight; NOAEL ¼ 1,400 mg/kg/day). All developmental effects were observed at doses/C212,800 mg/kg/day. On days 6 through 10, 15, or 18 of gestation, do'],\n",
       "  'valori_ld50': ['000 mg/kg body weight '],\n",
       "  'valori_noael': ['000 mg/kg/day',\n",
       "   '400 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d7294722'),\n",
       "  'Nome_comune': 'Benzyl Benzoate',\n",
       "  'INCI_name': 'Benzyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6c3ea246-7c07-4fbc-8484-eb7ce6009164',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6b62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):5-30, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/2345',\n",
       "   'valori': ['LD50 Rat oral 1700 mg/kg',\n",
       "    'LD50 Rat dermal 4 g/kg',\n",
       "    'LD50 Mouse oral 1400 mg/kg',\n",
       "    'LD50 Cat oral 2240 mg/kg',\n",
       "    'LD50 Rabbit oral 1680 mg/kg',\n",
       "    'LD50 Rabbit dermal 4000 mg/kg',\n",
       "    'LD50 Guinea pig oral 1000 mg/kg',\n",
       "    'LD50 Rabbit oral 1.8 g/kg',\n",
       "    'LD50 Rat (male) oral 3650 mg/kg',\n",
       "    'LD50 Rat (female) oral 2804 mg/kg',\n",
       "    'LD50 Rat dermal >5000 mg/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 379\",\n",
       "    \"O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 199\",\n",
       "    'USEPA/Office of Prevention, Pesticides and Toxic Substances; Reregistration Eligibility Decision Document - Benzyl Benzoate (Benzoic Acid case 4013) p.5, EPA-HQ-OPP-2007-0470-0002 (June 2007). Available from, as of December 19, 2018: https://iaspub.epa.gov/apex/pesticides/f?p=chemicalsearch:1',\n",
       "    'USEPA/Office of Prevention, Pesticides and Toxic Substances; Reregistration Eligibility Decision Document - Benzyl Benzoate (Benzoic Acid case 4013) p.5, EPA-HQ-OPP-2007-0470-0002 (June 2007). Available from, as of December 19, 2018: https://iaspub.epa.gov/apex/pesticides/f?p=chemicalsearch:1',\n",
       "    'USEPA/Office of Prevention, Pesticides and Toxic Substances; Reregistration Eligibility Decision Document - Benzyl Benzoate (Benzoic Acid case 4013) p.5, EPA-HQ-OPP-2007-0470-0002 (June 2007). Available from, as of December 19, 2018: https://iaspub.epa.gov/apex/pesticides/f?p=chemicalsearch:1']},\n",
       "  'contesti_ld50': ['ts (number not stated), and a median lethal dose (LD 50) of 4,000 mg/kg body weight was reported.4Study details were not included. In '],\n",
       "  'contesti_noael': ['udies yielded a no-observed-adverse-effect level (NOAEL) of 800 mg/kg/ day for benzoic acid and >1,000 mg/kg/day for the salts.3At higher doses, increased mortali',\n",
       "   'sodium benzoate in the diet (/C212,800 mg/kg/day; NOAEL ¼1,400 mg/kg/day). Tes- ticular atrophy was observed in rabbits th',\n",
       "   'ts in a 4-generation reproductive toxicity study (NOAEL > 750 mg/kg).3Groups of rats (20 rats/sex/group) received benzoic acid doses of 375 or 750 mg/kg/day in the diet continuously. Animals of the third ge',\n",
       "   'ed strain dosed with benzyl alcohol by gavage, an NOAEL of 550 mg/kg (only dose) body weight for developmental toxicity was reported. An LOAEL of 750 mg/kg/day (only dose) for developmental toxicity wasreporte',\n",
       "   'y (reduced food intake and decreased body weight; NOAEL ¼ 1,400 mg/kg/day). All developmental effects were observed at doses/C212,800 mg/kg/day. On days 6 through 10, 15, or 18 of gestation, do'],\n",
       "  'valori_ld50': ['000 mg/kg body weight '],\n",
       "  'valori_noael': ['000 mg/kg/day',\n",
       "   '400 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed18d6c1f2275d7294723'),\n",
       "  'Nome_comune': 'Benzyl Salicylate',\n",
       "  'INCI_name': 'Benzyl Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a6440801-5670-4209-bb1c-73eca2fff644',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=543ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['l treated at the 20 g/kg level.  The acute dermal LD 50 of  Benzyl Salicylate  was calculated to be 14.15 g/kg .     Oral   Three groups of 6 rats were dosed by',\n",
       "   '  reported low toxicity levels. The acute dermal  LD 50 of Benzyl Salicylate  was calculated to be 14.15 g/kg in rabbits .  The LD 50 for Benzyl Salicylate  was',\n",
       "   'e a lbino rabbits.4  As a part of an acute dermal LD 50 study, irritation was not  observed with neat Benzyl Salicylate  at 5, 10,  or 20 g/kg when applied to a clipped area and held in contact',\n",
       "   'hree Albino rabbits. As a part of an acute dermal LD 50 study, irritation was not observed with neat Benzyl  Salicylate  at 5, 10,  or 20 g/kg when applied to a clipped area and held in contact',\n",
       "   ' 1.25, 2.5, or 5.0 g/kg Benzyl Salicylate .5  The LD 50 was reported  to be 2. 23 g/kg.   Rats were observed for a 7-day period.   At 1.25 g/kg, no deaths (0/6) were observed; 4/6 deaths were  '],\n",
       "  'contesti_noael': ['t .  The no-observable -adverse -effect - level ( NOAEL ) in this oral repeated dose toxicity study was 360 mg/kg bw/day.  There were no adverse systemic effects on  rats',\n",
       "   ' adverse systemic effects w ere observed, and the NOAEL was 360 mg/kg  bw/day.     Following a short -term screening assessment'],\n",
       "  'valori_ld50': ['15 g/kg', '15 g/kg ', '20 g/kg ', '20 g/kg ', '25 g/kg'],\n",
       "  'valori_noael': ['360 mg/kg bw/day', '360 mg/kg  bw/day']},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294724'),\n",
       "  'Nome_comune': 'Benzylparaben',\n",
       "  'INCI_name': 'Benzylparaben',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2147d914-2c1d-473b-8178-37d49c53e31c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl.1):5-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['nts, assuming a no observed adverse effect level (NOAEL) of 1,000 mg/kg/d from an older DART study.2After careful considera',\n",
       "   'al toxicity at that dose. The mater- nal toxicity NOAEL dose was 1,000 mg/kg bw/d. Parabens have been extensively studied to evalua',\n",
       "   'r com- bined paraben use in a single formulation. NOAEL/MOS (adult, multiple paraben) ¼SED¼160 mg/kg/d/100 ¼1.6 mg/kg/d (SED /C2body weight)/ (dermal absorption /C2conve',\n",
       "   'entration tested (10,000 ppm), corresponding to a NOAEL of 1,141.1 +58.9 and 1,087.6 +67.8 mg/kg/d for Methylparaben and Butylparaben, respectively ',\n",
       "   'a, tumor necrosis factor a. 34Scorresponding to a NOAEL of about 1,140 and 1,100 mg/kg/d for Methylparaben and Butylparaben, respectively.',\n",
       "   'nd DART studies, the Panel determined an adequate NOAEL value of 160 mg/kg/d for Butylparaben. An MOS was recalculated accordi',\n",
       "   '90, compared to controls The results suggested an NOAEL of 160 mg/kg bw/d for Butylparaben for male reproduction and develo',\n",
       "   'risk assessment, the Panel determined an adequate NOAEL value of 160 mg/kg/d for Butylparaben in consideration of the new data',\n",
       "   'vative risk assessment was performed. Therein, an NOAEL value of 160 mg/kg/d for Butylparaben was deter- mined to be adequate ',\n",
       "   'tion of all the new data, the Panel determined an NOAEL of 160 mg/kg bw/d for Butylparaben. The Panel determined the differ'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg bw/d',\n",
       "   '6 mg/kg/d',\n",
       "   '8 mg/kg/d',\n",
       "   '100 mg/kg/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg bw/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294725'),\n",
       "  'Nome_comune': 'Bertholletia Excelsa Seed Oil',\n",
       "  'INCI_name': 'Bertholletia Excelsa Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=23a70782-ecab-4d49-a64f-4c22cbd27974',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294726'),\n",
       "  'Nome_comune': 'Bertholletia Excelsa Seed Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Bertholletia Excelsa Seed Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3b887d26-3e85-4ffe-9a82-55efecb418c8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294727'),\n",
       "  'Nome_comune': 'Bertholletia Excelsa Seed Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Bertholletia Excelsa Seed Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4e745e26-70e0-4030-bbe4-e4cb290fcf03',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294728'),\n",
       "  'Nome_comune': 'Beta-Alanine Diacetic Acid',\n",
       "  'INCI_name': 'Beta-Alanine Diacetic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2ee4fb99-4aad-47a0-8ff9-52c30ad099a9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=58aabee3-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['accordance with OECD TG 401;  obser ved for 14 d  LD 50 > 560 mg/kg bw; no  mortalities; no clinical signs of toxicity  ',\n",
       "   'accordance  with OECD TG  402; observed for  14 d LD 50 > 2000 mg/kg bw; no  mortalities; flat and/or hunched posture, pi',\n",
       "   'Sprague- Dawley rats  Gavage; observed  for 14 d  LD 50 > 2000 mg/kg bw; no  mortalities; no clinical signs of toxicity; '],\n",
       "  'contesti_noael': ['termined to be  30 mg/kg bw/d ; the developmental NOAEL was determined  to be at  least 300  mg/kg bw /d. 3   GENOTOXICITY  STUDIES    Genotoxicity studie',\n",
       "   ' with and without a zinc supplement, the maternal NOAEL was 30 mg/kg bw/ d and the developmental NOAEL was  at least 300 mg/kg  bw/d .   Tetrasodium Glutamate Diacetate (70.7%) was n'],\n",
       "  'valori_ld50': ['560 mg/kg bw', '2000 mg/kg bw', '2000 mg/kg bw'],\n",
       "  'valori_noael': ['300  mg/kg bw /d', '300 mg/kg  bw/d']},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d7294729'),\n",
       "  'Nome_comune': 'Beta-Glucan',\n",
       "  'INCI_name': 'Beta-Glucan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cc4dcba5-7a50-4f37-8fe8-7a28a0e9a21a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d729472a'),\n",
       "  'Nome_comune': 'Beta-Glucan Hydroxypropyltrimonium Chloride',\n",
       "  'INCI_name': 'Beta-Glucan Hydroxypropyltrimonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=88f3bb35-78f7-4fff-a61a-9b12c06bdda4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d729472b'),\n",
       "  'Nome_comune': 'Beta-Glucan Palmitate',\n",
       "  'INCI_name': 'Beta-Glucan Palmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d27ee8b9-0a2d-4bf8-9dc6-a1ed7cb23876',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18e6c1f2275d729472c'),\n",
       "  'Nome_comune': 'Betaine',\n",
       "  'INCI_name': 'Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=42545615-7197-407c-91eb-4c7d708a7e52',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4ca8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl.1):28-46, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['xicity studies are presented in Table 4. The oral LD 50 values of betaine, cetyl betaine, lauryl betaine, and C12 to C14alkyldimethyl betaines were 11.1 g/kg, 1.62 g/kg, 0.071 g/kg, and 3 mL/kg, respectively',\n",
       "   ' and 1.3 g/kg for lauryl betaine. The intravenous LD 50 of betaine in mice has been reported to be 0.83 g/kg bw. The LD50values were 0.15 g/kg for cetyl betaine and 0.053 g/kg for lauryl betain'],\n",
       "  'contesti_noael': ['methyl betaines study determined the reproductive NOAEL to be 300 mg/kg/d when the test material was tested up to 1,000 mg/kg/d.4,28,29 Carcinogenicity Repeated dose toxicity re',\n",
       "   'methyl betaines study determined the reproductive NOAEL to be 300 mg/kg/d when the test material was tested up to 1,000 mg/kg/d. Betaine was not carcinogenic when tested up to 5',\n",
       "   '0 mg/kg/d due to decreased bw gain and a maternal NOAEL could not be established. The developmental LOAEL was 40 mg/kg/d and the developmental NOAEL was 20 mg/kg/d. In oral reproductive and developmental toxicity ',\n",
       "   '0 mg/kg/d due to decreased bw gain and a maternal NOAEL could not be established. The developmental LOAEL was 40 mg/kg/d and the developmental NOAEL was 20 mg/kg/d. In oral reproductive and developmental toxicity ',\n",
       "   'pmental LOAEL was 250 mg/kg and the developmental NOAEL was 150 mg/kg. In an oral C12 to C14 alkyldimethyl betaines study, the repro- ductive NOEL was 150 mg/kg bw/d and the reproductive LOAEL was 300 mg/kg bw/d due',\n",
       "   'pmental LOAEL was 250 mg/kg and the developmental NOAEL was 150 mg/kg. In an oral C12 to C14 alkyldimethyl betaines study, the reproductive NOEL was 150 mg/kg bw/d and the reproductive LOAEL was 300 mg/kg bw/d due',\n",
       "   'dverse effects on reproduction were observed. The NOAEL of the test substance for reproduction was 300 mg/kg/d4 Cetyl betaine; 0, 10, 20, 40, 100, or 200 mg/kg/d in 5% isopropanol in dosages of 2 mL/kgDermal dev'],\n",
       "  'valori_ld50': ['1 g/kg', '15 g/kg '],\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg/d',\n",
       "   '20 mg/kg/d',\n",
       "   '20 mg/kg/d',\n",
       "   '150 mg/kg bw/d',\n",
       "   '150 mg/kg bw/d',\n",
       "   '200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d729472d'),\n",
       "  'Nome_comune': 'Betaphycus Gelatinum Extract',\n",
       "  'INCI_name': 'Betaphycus Gelatinum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c960d60-745d-4d92-91c1-b0027f316a7c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['his study were provided.  The median lethal dose (LD 50) was reported to be > 2000 mg/kg.   Corallina Officinalis Extract   The acute oral',\n",
       "   'thod of oral administration was not  stated.  The LD 50 was reported to be > 2000 mg/kg.   Grateloupia Livida E xtract   The acute oral t',\n",
       "   ' were seen  with any extract or dose level .  The LD 50 values were  expected to be >  2000 mg/kg.   Lithothamnion Calcareum Extract   A Lithothamn',\n",
       "   'lesseria Sanguinea Extract (0.2 –  4% algae), the LD 50 was reported to be > 2000 mg/kg.   The acute oral  toxicity potential of multiple',\n",
       "   'uted dry  Asparagopsis Armata Extract .  The oral LD 50 was reported to be > 5000 mg/kg in an acute toxicity assay using a mixture  contai'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d729472e'),\n",
       "  'Nome_comune': 'Beta-Sitosterol',\n",
       "  'INCI_name': 'Beta-Sitosterol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=27563589-1a34-41bc-a8df-b6cd45affc83',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['on  toxicity .    Dermal - Non-Human   The dermal LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg.59  A wood -derived mixture  (a stanol compositio',\n",
       "   ' cytotoxic  to mouse macrophages  in vitro .  The LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg .  There were no maternal or teratogenic  effects'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d729472f'),\n",
       "  'Nome_comune': 'Beta-Sitosteryl Acetate',\n",
       "  'INCI_name': 'Beta-Sitosteryl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2eaf8d90-b950-4850-a439-87e05f0b5bb5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['on  toxicity .    Dermal - Non-Human   The dermal LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg.59  A wood -derived mixture  (a stanol compositio',\n",
       "   ' cytotoxic  to mouse macrophages  in vitro .  The LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg .  There were no maternal or teratogenic  effects'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294730'),\n",
       "  'Nome_comune': 'BHA',\n",
       "  'INCI_name': 'BHA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a575d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=138d48dd-b490-c938-8d57-f81ad33db764',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['A was also > 5000 mg/kg in rats.   The acute oral LD 50 of BHA, administered in dimethyl sulfoxide ( DMSO ) to mice, was 1670 mg/kg; the acute oral LD 50  of BHA, administered in ol',\n",
       "   'idelines outlined in 16 CFR 1500.40.2  The dermal LD 50 was determined to be > 2000  mg/kg.   Oral   The acute oral LD 50 values of BHA admi',\n",
       "   'g and 1320 mg/kg,  respectively.2  The acute oral LD 50 values for BHA in 2 additional studies using mice were 1250 and 2000 mg/kg.  The acute  oral LD 50 values for male rats were',\n",
       "   ', the acute oral LD 50 for BHA administered in olive oil was determined to be 2000 mg/kg.  Non -fasted rats  received a single oral dose o',\n",
       "   'yl alcohol) and 2950 mg/kg (BHA); the  acute oral LD 50 values for BHA  in rats were determined to be 2200 mg/kg and 2900 mg/kg  in 2 separate studies .  For male  and female rats',\n",
       "   'SO  or in olive oil; the corresponding acute oral LD 50 values were 2910 mg/kg and 2960 mg/kg, respectively.   Short -Term Toxicity  Studies   ',\n",
       "   'f BHA in corn oil; the acute oral LD 50 was 4100 mg/kg.  Fasted rats were administered a single  oral do',\n",
       "   'se of BHA in water; the acute oral LD 50 was > 5000 mg/kg.   Cosmetic products containing BHA have also bee',\n",
       "   ', to female albino rats  (n=5) .  The  acute oral LD 50 for both products was > 5000  mg/kg.  The acute oral LD 50 of an eye makeup preparati'],\n",
       "  'contesti_noael': [' based on a no -observed -adverse -effect -level (NOAEL) of 100 mg/kg bw/d BHA for growth retardation,  increased mortality ',\n",
       "   ' 110, 220, or 420 mg/kg/d BHA, in  the diet; t he NOAEL for maternal toxicity was determined to be 420 mg/kg/d for.15  For offspring toxicity, a  NOAEL of 220  mg/kg/d BHA and a LOAEL of 420 mg/kg/d BHA was establishe',\n",
       "   'dosed with up to 420 mg/kg/d BHA in the diet, the NOAEL for maternal  toxicity was determined to be 420 mg/kg/d.  Based on reduced weight of progeny during lacta',\n",
       "   'n and lactation, and up to 90 d for most  pups.   NOAEL for maternal toxicity: 420 mg/kg/d   Based on reduced weight of proge ny during  lac',\n",
       "   'e) and increasing peri-weaning mortality (13%), a NOAEL of 220  mg/kg/d BHA and a LOAEL of 420 mg/kg/d  BHA in the diets of dams and offspring was  esta'],\n",
       "  'valori_ld50': ['1670 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2900 mg/kg  ',\n",
       "   '2960 mg/kg',\n",
       "   '4100 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg bw/d',\n",
       "   '220  mg/kg/d',\n",
       "   '420 mg/kg/d',\n",
       "   '420 mg/kg/d',\n",
       "   '420 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294731'),\n",
       "  'Nome_comune': 'BHT',\n",
       "  'INCI_name': 'BHT',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4fa9543a-9c8e-41ab-bfa5-de2f56d0e39c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=36412d37-a9e4-79a3-a2b0-5348e659547c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):17-19, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294732'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-1',\n",
       "  'INCI_name': 'Biosaccharide Gum-1',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=657b0252-d1ab-477a-ad0b-8f608effdd1b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294733'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-2',\n",
       "  'INCI_name': 'Biosaccharide Gum-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=180ee849-45dd-4c88-9ec5-2e2aa2dcc40f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294734'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-3',\n",
       "  'INCI_name': 'Biosaccharide Gum-3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e40f50ef-4208-40cd-8c43-3d1e66edfd2f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294735'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-4',\n",
       "  'INCI_name': 'Biosaccharide Gum-4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=db1dbfa8-c813-4830-a4c9-722143ee00c4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed18f6c1f2275d7294736'),\n",
       "  'Nome_comune': 'Biosaccharide Gum-5',\n",
       "  'INCI_name': 'Biosaccharide Gum-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0c0f3b68-48cc-4cdd-b680-63ff5e7d4d6c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d7294737'),\n",
       "  'Nome_comune': 'Biotin',\n",
       "  'INCI_name': 'Biotin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d4b4afe-da75-45e0-a56f-929bec060220',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=41404048-93dc-df74-aa5c-61ce594a4873',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):20-21, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/171548',\n",
       "   'valori': ['LD50 Rat oral >1.45 mmol/kg', 'LD50 Mouse oral >10 g/kg'],\n",
       "   'fonti': ['PMID:11800048', 'PMID:11800048']},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d7294738'),\n",
       "  'Nome_comune': 'Bis(Glyceryl Dimethacylate) Pyromellitate',\n",
       "  'INCI_name': 'Bis-(Glyceryl Dimethacrylate) Pyromellitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dcfc94eb-527d-ec11-8d21-0022482f7740',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f876505d-1527-c1b5-9039-df537f4c8677',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):61-73, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d7294739'),\n",
       "  'Nome_comune': 'Bis(Tripeptide-1) Copper Acetate',\n",
       "  'INCI_name': 'Bis(Tripeptide-1) Copper Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b1385f95-f5c8-49c3-8558-534d9fd4c7d5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5a97bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 37(Suppl3):90-102, 2018',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ecropsy. This mixture was classified as nontoxic (LD 50>2,000 mg/kg). Repeated Dose Toxicity Palmitoyl Tripeptide-1 (',\n",
       "   'ning 100 ppm Palmitoyl Tripeptide-1 was nontoxic (LD 50>2,000 mg/kg) in an acute oral toxicity study involving rats. '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg', '000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473a'),\n",
       "  'Nome_comune': 'Bisabolol',\n",
       "  'INCI_name': 'Bisabolol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=19f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473b'),\n",
       "  'Nome_comune': 'Bis-C16-20 Isoalkoxy TMHDI/PEG-90 Copolymer',\n",
       "  'INCI_name': 'Bis-C16-20 Isoalkoxy TMHDI/PEG-90 Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e95e7bb9-9548-434f-8be2-69124c4ae996',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ed to be  >2000 ->2500 mg/kg in rats.27  The oral LD 50 for Steareth -100/PEG -136/HDI Copolymer was  report ed to be >10 ,000 mg/kg in rats ; clinical signs included bristled fur, di',\n",
       "   'he anal region due to  feces .24   The acute oral LD 50 was >10 ,000 mg/kg in rats (n=5/sex) for a cosmetic ingredient mixtur',\n",
       "   'sspolymer in leave -on products .  The acute oral LD 50 was >10 ,000 mg/kg in rats for a product  mixture  consisting of Bis-',\n",
       "   'anged from >2000 ->2500 mg/kg in rats .  The oral LD 50 for  Steareth -100/PEG -136/HDI Copolymer was reported to be >10, 000 mg/kg in rats .  The acute inhalation LC 50 of Methoxy P',\n",
       "   '-20 Ether  Rats; not specified  LD 50=>2000 mg/kg  27  Steareth -100/PEG -136/HDI  Copolymer  Rats; 5/sex  LD 50=>10\\u2009000 mg/kg. No mortalities during dosing and the  observatio',\n",
       "   '  mortalities  to rats  (Table 8).15-17  The oral LD 50 of Methoxy PEG -17/Methoxy PEG -11/HDI Isocyanurate Trimer  Crosspolymer was reported to be >2000 mg/kg in  rats.33  The oral LD 50 of PEG -240/HDI Copoly',\n",
       "   'used no clinical signs or mortalities.   The oral LD 50 of Methoxy PEG - 17/Methoxy PEG -11/HDI Isocyanurate Trimer Crosspolymer was reported to be >2000 mg/kg in rats.  The acute oral LD 50  for PEG -240/HDI C',\n",
       "   'nurate  Trimer Crosspolymer  Rats; not specified  LD 50=>2000 mg/kg. OECD TG 423  33  PEG-240/HDI Copolymer Bis - Dec',\n",
       "   'yltetradeceth -20 Ether  Rats; not sp ecified  LD 50=>2500 mg/kg  27  PEG-240/HDI Copolymer Bis - Decyltetra deceth '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2500 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473c'),\n",
       "  'Nome_comune': 'Bis-Cetyl/PEG-8 Cetyl PEG-8 Dimethicone',\n",
       "  'INCI_name': 'Bis-Cetyl/PEG-8 Cetyl PEG-8 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e6000b64-c4a7-4343-8ec2-e6f419ef3bd2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473d'),\n",
       "  'Nome_comune': 'Bis-Diglyceryl Polyacyladipate-1',\n",
       "  'INCI_name': 'Bis-Diglyceryl Polyacyladipate-1',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a20cb463-815c-424d-8df8-544acce86dbe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bfa4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):56-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ty or dermal irritation were observed. The dermal LD 50 of bis-diglyceryl polyacyladipate-1 is >2 g/kg bw. Oral Bis-Diglyceryl Polyacyladipate-2. Groups of'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg bw'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473e'),\n",
       "  'Nome_comune': 'Bis-Diglyceryl Polyacyladipate-2',\n",
       "  'INCI_name': 'Bis-Diglyceryl Polyacyladipate-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=08c02115-ea0f-496d-9bb8-c9a8dfd08c22',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bfa4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):56-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ty or dermal irritation were observed. The dermal LD 50 of bis-diglyceryl polyacyladipate-1 is >2 g/kg bw. Oral Bis-Diglyceryl Polyacyladipate-2. Groups of'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg bw'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1906c1f2275d729473f'),\n",
       "  'Nome_comune': 'Bis-Hydroxyethoxypropyl Dimethicone',\n",
       "  'INCI_name': 'Bis-Hydroxyethoxypropyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=17923d9c-f68e-4cfc-ba63-ec3891659a60',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294740'),\n",
       "  'Nome_comune': 'Bis-Hydroxyethyl Acrylate Poly(1,4-Butanediol)-9/TMHDI Copolymer',\n",
       "  'INCI_name': 'Bis-Hydroxyethyl Acrylate Poly(1,4-Butanediol)-9/TMHDI Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a68fc55-8758-4be0-ad53-7f90afa70ecb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ed to be  >2000 ->2500 mg/kg in rats.27  The oral LD 50 for Steareth -100/PEG -136/HDI Copolymer was  report ed to be >10 ,000 mg/kg in rats ; clinical signs included bristled fur, di',\n",
       "   'he anal region due to  feces .24   The acute oral LD 50 was >10 ,000 mg/kg in rats (n=5/sex) for a cosmetic ingredient mixtur',\n",
       "   'sspolymer in leave -on products .  The acute oral LD 50 was >10 ,000 mg/kg in rats for a product  mixture  consisting of Bis-',\n",
       "   'anged from >2000 ->2500 mg/kg in rats .  The oral LD 50 for  Steareth -100/PEG -136/HDI Copolymer was reported to be >10, 000 mg/kg in rats .  The acute inhalation LC 50 of Methoxy P',\n",
       "   '-20 Ether  Rats; not specified  LD 50=>2000 mg/kg  27  Steareth -100/PEG -136/HDI  Copolymer  Rats; 5/sex  LD 50=>10\\u2009000 mg/kg. No mortalities during dosing and the  observatio',\n",
       "   '  mortalities  to rats  (Table 8).15-17  The oral LD 50 of Methoxy PEG -17/Methoxy PEG -11/HDI Isocyanurate Trimer  Crosspolymer was reported to be >2000 mg/kg in  rats.33  The oral LD 50 of PEG -240/HDI Copoly',\n",
       "   'used no clinical signs or mortalities.   The oral LD 50 of Methoxy PEG - 17/Methoxy PEG -11/HDI Isocyanurate Trimer Crosspolymer was reported to be >2000 mg/kg in rats.  The acute oral LD 50  for PEG -240/HDI C',\n",
       "   'nurate  Trimer Crosspolymer  Rats; not specified  LD 50=>2000 mg/kg. OECD TG 423  33  PEG-240/HDI Copolymer Bis - Dec',\n",
       "   'yltetradeceth -20 Ether  Rats; not sp ecified  LD 50=>2500 mg/kg  27  PEG-240/HDI Copolymer Bis - Decyltetra deceth '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2500 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294741'),\n",
       "  'Nome_comune': 'Bis-Isobutyl PEG/PPG-10/7/Dimethicone Copolymer',\n",
       "  'INCI_name': 'Bis-Isobutyl PEG/PPG-10/7/Dimethicone Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=98413d82-8b08-4a5f-8701-31b2076c03cd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294742'),\n",
       "  'Nome_comune': 'Bis-Isobutyl PEG-13/Dimethicone Copolymer',\n",
       "  'INCI_name': 'Bis-Isobutyl PEG-13/Dimethicone Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=99c68c58-b222-4562-88ec-cb0bac1185e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294743'),\n",
       "  'Nome_comune': 'Bis-Isobutyl PEG-24/PPG-7/Dimethicone Copolymer',\n",
       "  'INCI_name': 'Bis-Isobutyl PEG-24/PPG-7/Dimethicone Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2c904292-c7b1-4fbe-ad1f-f67174b5188d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294744'),\n",
       "  'Nome_comune': 'Bis-Isostearyl 1,4-Butanediol/HDI/Hydrogenated Dimer Dilinoleyl Alcohol Copolymer',\n",
       "  'INCI_name': 'Bis-Isostearyl 1,4-Butanediol/HDI/Hydrogenated Dimer Dilinoleyl Alcohol Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a3a72385-bda2-4a23-bf5f-19e36758e76d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ed to be  >2000 ->2500 mg/kg in rats.27  The oral LD 50 for Steareth -100/PEG -136/HDI Copolymer was  report ed to be >10 ,000 mg/kg in rats ; clinical signs included bristled fur, di',\n",
       "   'he anal region due to  feces .24   The acute oral LD 50 was >10 ,000 mg/kg in rats (n=5/sex) for a cosmetic ingredient mixtur',\n",
       "   'sspolymer in leave -on products .  The acute oral LD 50 was >10 ,000 mg/kg in rats for a product  mixture  consisting of Bis-',\n",
       "   'anged from >2000 ->2500 mg/kg in rats .  The oral LD 50 for  Steareth -100/PEG -136/HDI Copolymer was reported to be >10, 000 mg/kg in rats .  The acute inhalation LC 50 of Methoxy P',\n",
       "   '-20 Ether  Rats; not specified  LD 50=>2000 mg/kg  27  Steareth -100/PEG -136/HDI  Copolymer  Rats; 5/sex  LD 50=>10\\u2009000 mg/kg. No mortalities during dosing and the  observatio',\n",
       "   '  mortalities  to rats  (Table 8).15-17  The oral LD 50 of Methoxy PEG -17/Methoxy PEG -11/HDI Isocyanurate Trimer  Crosspolymer was reported to be >2000 mg/kg in  rats.33  The oral LD 50 of PEG -240/HDI Copoly',\n",
       "   'used no clinical signs or mortalities.   The oral LD 50 of Methoxy PEG - 17/Methoxy PEG -11/HDI Isocyanurate Trimer Crosspolymer was reported to be >2000 mg/kg in rats.  The acute oral LD 50  for PEG -240/HDI C',\n",
       "   'nurate  Trimer Crosspolymer  Rats; not specified  LD 50=>2000 mg/kg. OECD TG 423  33  PEG-240/HDI Copolymer Bis - Dec',\n",
       "   'yltetradeceth -20 Ether  Rats; not sp ecified  LD 50=>2500 mg/kg  27  PEG-240/HDI Copolymer Bis - Decyltetra deceth '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2500 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294745'),\n",
       "  'Nome_comune': 'Bis-Lauryl Cocaminopropylamine/HDI/PEG-100 Copolymer',\n",
       "  'INCI_name': 'Bis-Lauryl Cocaminopropylamine/HDI/PEG-100 Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6fc5d2b4-b689-40d9-a587-55aad3a88cae',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ed to be  >2000 ->2500 mg/kg in rats.27  The oral LD 50 for Steareth -100/PEG -136/HDI Copolymer was  report ed to be >10 ,000 mg/kg in rats ; clinical signs included bristled fur, di',\n",
       "   'he anal region due to  feces .24   The acute oral LD 50 was >10 ,000 mg/kg in rats (n=5/sex) for a cosmetic ingredient mixtur',\n",
       "   'sspolymer in leave -on products .  The acute oral LD 50 was >10 ,000 mg/kg in rats for a product  mixture  consisting of Bis-',\n",
       "   'anged from >2000 ->2500 mg/kg in rats .  The oral LD 50 for  Steareth -100/PEG -136/HDI Copolymer was reported to be >10, 000 mg/kg in rats .  The acute inhalation LC 50 of Methoxy P',\n",
       "   '-20 Ether  Rats; not specified  LD 50=>2000 mg/kg  27  Steareth -100/PEG -136/HDI  Copolymer  Rats; 5/sex  LD 50=>10\\u2009000 mg/kg. No mortalities during dosing and the  observatio',\n",
       "   '  mortalities  to rats  (Table 8).15-17  The oral LD 50 of Methoxy PEG -17/Methoxy PEG -11/HDI Isocyanurate Trimer  Crosspolymer was reported to be >2000 mg/kg in  rats.33  The oral LD 50 of PEG -240/HDI Copoly',\n",
       "   'used no clinical signs or mortalities.   The oral LD 50 of Methoxy PEG - 17/Methoxy PEG -11/HDI Isocyanurate Trimer Crosspolymer was reported to be >2000 mg/kg in rats.  The acute oral LD 50  for PEG -240/HDI C',\n",
       "   'nurate  Trimer Crosspolymer  Rats; not specified  LD 50=>2000 mg/kg. OECD TG 423  33  PEG-240/HDI Copolymer Bis - Dec',\n",
       "   'yltetradeceth -20 Ether  Rats; not sp ecified  LD 50=>2500 mg/kg  27  PEG-240/HDI Copolymer Bis - Decyltetra deceth '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2500 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294746'),\n",
       "  'Nome_comune': 'Bis-Methoxy PEG-10 Dimethyl MEA/HDI/Bis-PEG-10 Dimethicone Copolymer',\n",
       "  'INCI_name': 'Bis-Methoxy PEG-10 Dimethyl MEA/HDI/Bis-PEG-10 Dimethicone Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=172354ac-328e-46c0-b2ac-1ab8f3d27a9c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7154b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ed to be  >2000 ->2500 mg/kg in rats.27  The oral LD 50 for Steareth -100/PEG -136/HDI Copolymer was  report ed to be >10 ,000 mg/kg in rats ; clinical signs included bristled fur, di',\n",
       "   'he anal region due to  feces .24   The acute oral LD 50 was >10 ,000 mg/kg in rats (n=5/sex) for a cosmetic ingredient mixtur',\n",
       "   'sspolymer in leave -on products .  The acute oral LD 50 was >10 ,000 mg/kg in rats for a product  mixture  consisting of Bis-',\n",
       "   'anged from >2000 ->2500 mg/kg in rats .  The oral LD 50 for  Steareth -100/PEG -136/HDI Copolymer was reported to be >10, 000 mg/kg in rats .  The acute inhalation LC 50 of Methoxy P',\n",
       "   '-20 Ether  Rats; not specified  LD 50=>2000 mg/kg  27  Steareth -100/PEG -136/HDI  Copolymer  Rats; 5/sex  LD 50=>10\\u2009000 mg/kg. No mortalities during dosing and the  observatio',\n",
       "   '  mortalities  to rats  (Table 8).15-17  The oral LD 50 of Methoxy PEG -17/Methoxy PEG -11/HDI Isocyanurate Trimer  Crosspolymer was reported to be >2000 mg/kg in  rats.33  The oral LD 50 of PEG -240/HDI Copoly',\n",
       "   'used no clinical signs or mortalities.   The oral LD 50 of Methoxy PEG - 17/Methoxy PEG -11/HDI Isocyanurate Trimer Crosspolymer was reported to be >2000 mg/kg in rats.  The acute oral LD 50  for PEG -240/HDI C',\n",
       "   'nurate  Trimer Crosspolymer  Rats; not specified  LD 50=>2000 mg/kg. OECD TG 423  33  PEG-240/HDI Copolymer Bis - Dec',\n",
       "   'yltetradeceth -20 Ether  Rats; not sp ecified  LD 50=>2500 mg/kg  27  PEG-240/HDI Copolymer Bis - Decyltetra deceth '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg ',\n",
       "   '000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2500 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294747'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-14/14 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-14/14 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=755a460a-97a0-480c-a6c2-f8b3d77cc46f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294748'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-15/5 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-15/5 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bbe2a5c1-9d11-41d3-b2f2-531b1c04d338',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1916c1f2275d7294749'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-16/16 PEG/PPG-16/16 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-16/16 PEG/PPG-16/16 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa1f3f0b-f4c9-473a-a4e4-4c02257c59f6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474a'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-18/6 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-18/6 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad2617a0-0494-4525-b1b4-6a3bb672df86',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474b'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-20/20 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-20/20 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=60da67c0-cff8-4990-8cae-0f1640391e92',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474c'),\n",
       "  'Nome_comune': 'Bis-PEG/PPG-20/5 PEG/PPG-20/5 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG/PPG-20/5 PEG/PPG-20/5 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=24807d9d-3a95-4538-9a03-c8e0d3c31970',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474d'),\n",
       "  'Nome_comune': 'Bis-PEG-1 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-1 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c54769b5-7a80-4b1a-b05e-87c2b1dc133f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474e'),\n",
       "  'Nome_comune': 'Bis-PEG-10 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-10 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d15205ce-ffb7-4aa1-bd62-63165812bb4b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d729474f'),\n",
       "  'Nome_comune': 'Bis-PEG-12 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-12 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c4153969-7b25-4977-9aa2-75123500a3e2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d7294750'),\n",
       "  'Nome_comune': 'Bis-PEG-12 Dimethicone Beeswax',\n",
       "  'INCI_name': 'Bis-PEG-12 Dimethicone Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d8bd5d1a-5008-4ba8-aa6d-84ae3fa49f58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d7294751'),\n",
       "  'Nome_comune': 'Bis-PEG-12 Dimethicone Candelillate',\n",
       "  'INCI_name': 'Bis-PEG-12 Dimethicone Candelillate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87e0f306-79f6-4d5c-a8aa-aaf417e83700',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d7294752'),\n",
       "  'Nome_comune': 'Bis-PEG-15 Methyl Ether Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-15 Methyl Ether Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d8d910a-79af-4301-b718-7063345f8c71',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1926c1f2275d7294753'),\n",
       "  'Nome_comune': 'Bis-PEG-20 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-20 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=807c2b18-b445-45d6-bdcd-61431404c136',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294754'),\n",
       "  'Nome_comune': 'Bis-PEG-4 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-4 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0fa1babe-9af3-4684-a8de-9690466f3e51',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294755'),\n",
       "  'Nome_comune': 'Bis-PEG-8 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-8 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1a72739f-0720-4726-85cc-2a48253ddb02',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294756'),\n",
       "  'Nome_comune': 'Bis-PEG-8 PEG-8 Dimethicone',\n",
       "  'INCI_name': 'Bis-PEG-8 PEG-8 Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=46f5a58d-3a12-449b-8965-2fbb237f7775',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294757'),\n",
       "  'Nome_comune': 'Bis-Phenylisopropyl Phenylisopropyl Dimethicone/Vinyl Dimethicone Crosspolymer',\n",
       "  'INCI_name': 'Bis-Phenylisopropyl Phenylisopropyl Dimethicone/Vinyl Dimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=60f67896-09e8-41ac-97a3-18464083c29d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294758'),\n",
       "  'Nome_comune': 'Bis-Propylheptyl Carbonate',\n",
       "  'INCI_name': 'Dipropylheptyl Carbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cc863345-1ed2-46eb-92b7-6482853ad3e7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5084a7bf-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 06, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ne of the animals died during the study. The oral LD 50 of  Propylheptyl C aprylate was >2 mg/kg bw.     Inhalation        Dimethyl Carbonate      Th',\n",
       "   'stance -related  gross pathological changes.  The LD 50 was  determined to be > 2 g/kg body weight.     Dimethyl Carbonate      The acute d ermal to',\n",
       "   ' signs of toxicity were reported, and  the dermal LD 50    of Propylheptyl  Caprylate was >2 g/kg b ody weight .      Oral     Dicaprylyl Carbonate      The acu',\n",
       "   'ot reveal any abnormal macroscopic findings.  The LD 50 was determined to be > 2 g/kg body weight.      Dimethyl Carbonate      The acute oral toxi',\n",
       "   'its (number and strain not stated), an acute oral LD 50 of 3.2 g/kg was reported for Dipropyl  Carbonate (> 95%).29  S',\n",
       "   ' In acute dermal toxicity stu dies, the following LD 50 values have been reported for Dialkyl Carbonates: > 5 g/kg  (Dicaprylyl Carbonate, rats), > 2 g/kg (Diethylhexyl Carbonate, rats), > 5  g/kg or 2.5 ',\n",
       "   ' g/ kg (Dipropyl Carbonate, rats).     The dermal LD 50 in rats of Propylheptyl C aprylate was >2 g/kg body weight.      The following LD 50 values have been report',\n",
       "   'lving mice (number and strain  not stated).29  An LD 50 of 0.3 g/kg was reported.  Study details were not provided.   ',\n",
       "   'other acute oral toxicity studies, the acute oral LD 50  of Dimethyl Carbonate in rats and mice (number of animals and strains not stated) ranges from 6.4 g/kg to 12.8 g/kg.  The  exposure -related signs reported ',\n",
       "   'evidence of organ abnormalities at necropsy.  The LD 50 was determined to be >5 g/kg.      Diethylhexyl Carbonate      Groups of 10  W',\n",
       "   'ered to be treatment -related.  The acute  dermal LD 50 was reported to be  > 2 g/kg body weight for Dimethyl Carbonate .    An acute dermal LD 50 of  > 2.5 g/kg was reported for Dimethyl Carbonate in a study inv',\n",
       "   'tudy details were not provided.  An acute dermal  LD 50 of 2.5 g/kg was reported for Dimethyl Carbonate in a st udy in',\n",
       "   'uated using 4 rabbits.  One  animal died, and the LD 50 was > 5 g/kg.28  There was no evidence of erythema or edema.  ',\n",
       "   'vidence of organ abnormalities at necropsy.   The LD 50 was  determined to be > 5 g/kg.      Diethylhexyl Carbonate     Twelve  Wistar r',\n",
       "   'gs were within normal limits in all animals.  The LD 50 was determined to be > 5 g/kg body weight in this study.      In an acute oral toxicity stud',\n",
       "   'involving rats (number and strain not stated), an LD 50 of 13.8 g/kg was report ed for  Dimethyl Carbonate.  20,27  Stu',\n",
       "   'ther acute  oral toxicity studies, the acute oral LD 50 value for Dimethyl Carbonate in rats and mice is between 6.4 g/kg and 12.8 g/kg.     The oral LD 50 in rats was >2 g/kg for Propy',\n",
       "   ' (number and strain not stated), a n acute dermal LD 50 of 0.98 g/kg was reported for  Dipropyl Carbonate (> 95%).6,29 '],\n",
       "  'contesti_noael': ['mg/kg/day, and  nonexistent at 130 mg/kg/day, the NOAEL for this endpoint was determined to be 130 mg/kg/day.  Because dose -dependent  signs of embryotoxicit',\n",
       "   'toxicity at doses of 650 and 1300  mg/kg/day, the NOAEL was determined to be 130 mg/kg/day 2 -ethylhexanol for this endpoint.  The NOAEL for',\n",
       "   'toxicity at doses  of 650 and 1300 mg/kg/day, the NOAEL was determined to be 130 mg/kg/day for this endpoint.  The NOAEL for teratogenicity ',\n",
       "   'thylhexanol.  A no observed adverse effect level (NOAEL) was  estimated to be approximately 250 mg/kg/day based on study results.         Dimethyl Carbonat',\n",
       "   'ice, and a NOEL of 125 mg/kg/day was reported.  A NOAEL was  not derived, but was estimated at 250 mg/kg/day.        In a 13 -week toxicity study , Dimethyl C'],\n",
       "  'valori_ld50': ['2 mg/kg bw',\n",
       "   '2 g/kg body weight',\n",
       "   '2 g/kg b ody weight',\n",
       "   '2 g/kg body weight',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg body weight',\n",
       "   '3 g/kg ',\n",
       "   '4 g/kg to ',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg body weight ',\n",
       "   '8 g/kg ',\n",
       "   '8 g/kg',\n",
       "   '98 g/kg '],\n",
       "  'valori_noael': ['130 mg/kg/day',\n",
       "   '130 mg/kg/day',\n",
       "   '130 mg/kg/day',\n",
       "   '250 mg/kg/day',\n",
       "   '250 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1936c1f2275d7294759'),\n",
       "  'Nome_comune': 'Bis-Stearoxy Dimethicone',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c894bdb-a142-4d38-8222-8a2543971027',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1936c1f2275d729475a'),\n",
       "  'Nome_comune': 'Bis-Stearoxydimethylsilane',\n",
       "  'INCI_name': 'Bis-Stearoxydimethylsilane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=89d15e74-92a1-429b-a6ad-1dd909b93bc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3412a8b9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 06, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ion and hemorrhages of the urinary bladder.   The LD 50 was 12 ,200 mg/kg  for male rats , 11,500 mg/kg  for female rats , and 11,800 mg/kg for the combined s exes.  Triethoxycapryl ylsilane',\n",
       "   'nremarkable.  F or  Triethoxycaprylylsilane , the LD 50 was 12 ,200 mg/kg for  male rats , 11,500 mg/kg for female rats , and 11,800 mg/kg for the  combined s exes.  In another assay, t he ',\n",
       "   'lane   The reported oral LD 50 for Trimethoxycaprylylsilane  in Wistar rats (n=10/sex) was >3500 mg/kg for both males and  females .4  After a dos age of',\n",
       "   ' that survived until  the end of the  study.  The LD 50 was >5110 mg/kg  for male and female rats.     Trimethoxycaprylylsi',\n",
       "   'LD 50 value was > 5110 mg/kg for male and female rats.   The reported oral LD 5',\n",
       "   'idneys , and urinary bladder).   The acute dermal LD 50 in male  rabbits was 6730 mg/kg and i n female rabbits > 8000 mg/kg .    Trimethoxycaprylylsilane    When Trimethoxyc',\n",
       "   'e skin in an  in vitro  assay.   The acute dermal LD 50 of Triethoxycapryly lsilane was 6730 mg/kg in male rabbits  and > 8000 mg/kg  in female  rabbits.   When Trimethoxycaprylylsilan'],\n",
       "  'contesti_noael': ['city and reproductive groups at 1000 mg/kg/d, the NOAEL for systemic toxicity was 300 mg/kg/d.5  Fischer 344 rats (n=5/sex, 10/sex in high-dose',\n",
       "   ' with confidence if 1000 mg/kg /d  represents the NOAEL.  Therefore, the reprod uctive toxicity NOAEL wa s considered to be > 300 mg/kg/d.   To evaluate the develop mental toxicity of Tri',\n",
       "   'e with confidence if  1000 mg/kg/d represents the NOAEL.  Therefore, the y considered the  developmental toxicity  NOAEL to be  >300 mg/kg/d.5    GENOTOXICITY  STUDIES   In Vitro    In vitro',\n",
       "   'tive/developmental toxic ity screening test , the NOAEL for systemic toxicity was 300  mg/kg/d  Triethoxycaprylylsilane  when administered fo r ',\n",
       "   '.   The reproductive  and developmental toxicity  NOAEL s were  >300 mg/kg/d  for orally administered  Triethoxycaprylylsilane',\n",
       "   ' to have a  no-observed -adverse -effect level   (NOAEL ) of 1000 mg/kg/d (approximately 750 mg/kg/d B is-Stearoxydimethylsilane) in SPF -bred Wistar ',\n",
       "   'lane at approximately 75% was reported  to have a NOAEL of 1000 mg/kg/d (approximately 750 mg/kg/d B is-Stearoxydimethylsilane) in rats.   In a repe',\n",
       "   'atment related clinical pathology findings.   The NOAEL was >10,000 ppm (the highest dose tested), corresponding to  dosages of approximately 592.2 and 639.6 mg/kg /d for male and female rats, respectively , when Tri'],\n",
       "  'valori_ld50': ['800 mg/kg ',\n",
       "   '800 mg/kg ',\n",
       "   '3500 mg/kg ',\n",
       "   '5110 mg/kg  ',\n",
       "   '5110 mg/kg ',\n",
       "   '8000 mg/kg',\n",
       "   '8000 mg/kg  '],\n",
       "  'valori_noael': ['300 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '300  mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '750 mg/kg/d',\n",
       "   '750 mg/kg/d',\n",
       "   '639.6 mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1936c1f2275d729475b'),\n",
       "  'Nome_comune': 'Bis-Stearoxyethyl Dimethicone',\n",
       "  'INCI_name': 'Bis-Stearoxyethyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0b339c34-8a19-42cd-b2b1-2cf805383f43',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=67e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['an   BIS-PEG/PPG -14/14 DIMETHICONE    The dermal LD 50 of bis -PEG/PPG -14/14 dimethicone , under occlusion , in Wistar rats (n=10) was >2000 mg/kg.    The time of exposure was not provided.   No m',\n",
       "   's dermally administered  to rabbits.   The dermal LD 50 of bis -PEG/P PG-14/14  dimethicone rats was >2000 mg/kg.   In an acute inhalation  study of PEG -12 dimet',\n",
       "   'BIS-PEG -15 METHYL ETHY L DIMETHICONE    The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was > 4640 mg/kg for rats.   No further information was  provided.1',\n",
       "   'hicone did not penetrate pig ear s kin.  The oral LD 50 of bis -PEG -15 methyl ethyl dimethicone was >4640 mg/kg for rats.   The oral LD 50 of cetyl   PEG/PPG -10/',\n",
       "   'EG -12 DIMETHICONE    The estimated acute der mal LD 50 was > 5 g/kg PEG -12 dimethicone in male albino rabbits (n=5).3',\n",
       "   '8    CETYL PEG /PPG -10/1 DIMETHICONE    The oral LD 50 of cetyl PEG /PPG -10/1 dimethicone was > 5000 mg/kg for Wistar rats (n=5).16  The rats were  observed ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of lauryl PEG -9 polydimethylsiloxyethyl dimethicone was reported to be 5000 mg/kg for rats.29   There were no adverse effects observ',\n",
       "   '9 POLYDIMETHYLSILOXYETHYL DIMETHICONE    The oral LD 50 of PEG -9 polydimethylsiloxyethyl dimethicone in rats was reported to be >5000 mg/kg.8  No  mortalities or clinical signs were observe',\n",
       "   '1 dimethicone was > 5000 mg/kg in rats.  The oral LD 50 of laury l PEG -9 polydimethylsiloxyethyl dimethicone   was reported to be 5000 mg/kg in rats.  The oral LD 50 of PEG -9 polydimethylsil',\n",
       "   ' mg/kg PEG/PP G-25/25 dimethicone .    The dermal LD 50 was > 5000 mg/kg PEG -12 dimethicone for rabbits .  There were no o'],\n",
       "  'contesti_noael': ['ONE   The oral no observed adverse effect level  (NOAEL ) of PEG -12 dimethicone was 1000  mg/kg /d for Sprague-Dawley  rats (n=5/sex) when administe'],\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '4640 mg/kg ',\n",
       "   '4640 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ['1000  mg/kg /d']},\n",
       " {'_id': ObjectId('668ed1936c1f2275d729475c'),\n",
       "  'Nome_comune': 'Bis-Vinyldimethicone Crosspolymer',\n",
       "  'INCI_name': 'Bis-Vinyldimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad8441ce-9d43-48e0-8b0b-a1391380524a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1936c1f2275d729475d'),\n",
       "  'Nome_comune': 'Bis-Vinyldimethicone/Bis-Isobutyl PPG-20 Crosspolymer',\n",
       "  'INCI_name': 'Bis-Vinyldimethicone/Bis-Isobutyl PPG-20 Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3f385cf6-9766-4a24-8536-7976c883f9b0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1946c1f2275d729475e'),\n",
       "  'Nome_comune': 'Bis-Vinyldimethicone/PEG-10 Dimethicone Crosspolymer',\n",
       "  'INCI_name': 'Bis-Vinyldimethicone/PEG-10 Dimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=019428e6-faea-4716-859f-6bfcb4757597',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1946c1f2275d729475f'),\n",
       "  'Nome_comune': 'Bis-Vinyldimethicone/PPG-20 Crosspolymer',\n",
       "  'INCI_name': 'Bis-Vinyldimethicone/PPG-20 Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b3bfe02e-2c95-4b8f-b465-f5b4dfcbd2e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294760'),\n",
       "  'Nome_comune': 'Borage Seed Oil PEG-8 Esters',\n",
       "  'INCI_name': 'Borage Seed Oil PEG-8 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e7d12c03-a794-429a-a342-93ab5cecf33a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a54bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl 4):13-39, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294761'),\n",
       "  'Nome_comune': 'Borage Seed Oil Polyglyceryl-4 Esters',\n",
       "  'INCI_name': 'Borage Seed Oil Polyglyceryl-4 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b205fac8-d24a-40ee-9fff-ffea8ec661ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294762'),\n",
       "  'Nome_comune': 'Borage Seed Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Borage Seed Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6ce8da2b-3b37-4d21-8a06-a87dccb1cd06',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294763'),\n",
       "  'Nome_comune': 'Borago Officinalis Seed Oil',\n",
       "  'INCI_name': 'Borago Officinalis Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2d992197-eca4-48dd-bf7b-f279a1ce7555',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294764'),\n",
       "  'Nome_comune': 'Boric Acid',\n",
       "  'INCI_name': 'Boric Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a875d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/7628',\n",
       "   'valori': ['LD50 Mouse iv 1780 mg/kg bw',\n",
       "    'LD50 Mouse sc 2070 mg/kg bw',\n",
       "    'LC50 Rat inhalation >0.16 mg/L 4hr',\n",
       "    'LD50 Rat oral 3000-4000 mg/kg bw',\n",
       "    'LD50 Rat oral 2660 mg/kg',\n",
       "    'LD50 Rat sc 1400 mg/kg',\n",
       "    'LD50 Rat iv 1330 mg/kg',\n",
       "    'LD50 Mouse oral 3450 mg/kg',\n",
       "    'LD50 Mouse sc 1740 mg/kg',\n",
       "    'LD50 Mouse iv 1240 mg/kg',\n",
       "    'LD50 Dog oral 2000 mg/kg',\n",
       "    'LD50 Rabbit dermal >2000 mg/kg bw',\n",
       "    'LC50 Rat inhalation >2 mg/cu m/4 hr',\n",
       "    'LD50 Guinea pig sc 1200 mg/kg bw',\n",
       "    'LD50 Chicken (1 day old) oral 2.95 g/kg'],\n",
       "   'fonti': ['European Chemicals Bureau; IUCLID Dataset for Boric Acid (10043-35-3), p.26 (2000 CD-ROM edition). Available from, as of October 3, 2011: https://esis.jrc.ec.europa.eu/',\n",
       "    'European Chemicals Bureau; IUCLID Dataset for Boric Acid (10043-35-3), p.26 (2000 CD-ROM edition). Available from, as of October 3, 2011: https://esis.jrc.ec.europa.eu/',\n",
       "    'European Chemicals Bureau; IUCLID Dataset for Boric Acid (10043-35-3), p.26 (2000 CD-ROM edition). Available from, as of October 3, 2011: https://esis.jrc.ec.europa.eu/',\n",
       "    'European Chemicals Bureau; IUCLID Dataset for Boric Acid (10043-35-3), p.26 (2000 CD-ROM edition). Available from, as of October 3, 2011: https://esis.jrc.ec.europa.eu/',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 536\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 536\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 536\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 536\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 536\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 536\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V3 p.532\",\n",
       "    'Krieger, R. (ed.). Handbook of Pesticide Toxicology. Volume 2, 2nd ed. 2001. Academic Press, San Diego, California., p. 1430',\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V3 p.533\",\n",
       "    'European Chemicals Bureau; IUCLID Dataset, Boric acid (10043-35-3) (2000 CD-ROM edition). Available from, as of May 18, 2005: https://esis.jrc.ec.europa.eu/',\n",
       "    'PMID:1786007']},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294765'),\n",
       "  'Nome_comune': 'Boron Nitride',\n",
       "  'INCI_name': 'Boron Nitride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c302851a-c2d1-4622-b320-5ff2743a71fa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1897bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.3):53-60, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1946c1f2275d7294766'),\n",
       "  'Nome_comune': 'Botryocladia Occidentalis Extract',\n",
       "  'INCI_name': 'Botryocladia Occidentalis Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4ddc8dd4-9719-4ac4-b41b-611460684f5c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['his study were provided.  The median lethal dose (LD 50) was reported to be > 2000 mg/kg.   Corallina Officinalis Extract   The acute oral',\n",
       "   'thod of oral administration was not  stated.  The LD 50 was reported to be > 2000 mg/kg.   Grateloupia Livida E xtract   The acute oral t',\n",
       "   ' were seen  with any extract or dose level .  The LD 50 values were  expected to be >  2000 mg/kg.   Lithothamnion Calcareum Extract   A Lithothamn',\n",
       "   'lesseria Sanguinea Extract (0.2 –  4% algae), the LD 50 was reported to be > 2000 mg/kg.   The acute oral  toxicity potential of multiple',\n",
       "   'uted dry  Asparagopsis Armata Extract .  The oral LD 50 was reported to be > 5000 mg/kg in an acute toxicity assay using a mixture  contai'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d7294767'),\n",
       "  'Nome_comune': 'Brassica Campestris (Rapeseed) Oil Unsaponifiables',\n",
       "  'INCI_name': 'Brassica Campestris (Rapeseed) Oil Unsaponifiables',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e4241f2-0deb-4f84-840c-2c30f1d6d709',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d7294768'),\n",
       "  'Nome_comune': 'Brassica Campestris (Rapeseed) Seed Oil',\n",
       "  'INCI_name': 'Brassica Campestris (Rapeseed) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67818909-a7c2-400f-94ab-5be2869cb44d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d7294769'),\n",
       "  'Nome_comune': 'Brassica Campestris (Rapeseed) Sterols',\n",
       "  'INCI_name': 'Brassica Campestris (Rapeseed) Sterols',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d383a0f-6c51-4fe5-9767-6f78e75c4d01',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['on  toxicity .    Dermal - Non-Human   The dermal LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg.59  A wood -derived mixture  (a stanol compositio',\n",
       "   ' cytotoxic  to mouse macrophages  in vitro .  The LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg .  There were no maternal or teratogenic  effects'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476a'),\n",
       "  'Nome_comune': 'Brassica Napus Seed Oil',\n",
       "  'INCI_name': 'Brassica Napus Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5d9371a5-15e0-4a8d-89d6-c2b898a95548',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476b'),\n",
       "  'Nome_comune': 'Brassica Oleracea Acephala Seed Oil',\n",
       "  'INCI_name': 'Brassica Oleracea Acephala Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6533a822-40e3-4935-b063-c0d906e17d04',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476c'),\n",
       "  'Nome_comune': 'Brassica Oleracea Italica (Broccoli) Seed Oil',\n",
       "  'INCI_name': 'Brassica Oleracea Italica (Broccoli) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bc624334-9796-4f20-96c2-0586742c5c36',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476d'),\n",
       "  'Nome_comune': 'Brassicamidopropyl Dimethylamine',\n",
       "  'INCI_name': 'Brassicamidopropyl Dimethylamine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=671f9078-5b83-461f-85ec-39540a4b073f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da9dc889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):39-69, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['n the remaining animals. The oral lethal dose 50 (LD 50) for stearamidopropyl dimethylamine in this study was determined to be greater than 2,000 mg/kg body weight. In another oral toxicity study, 40 %(wt/wt) stea'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476e'),\n",
       "  'Nome_comune': 'Brucine',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b388ce93-b53d-4e60-aeb6-a79f563f20ab',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/442021',\n",
       "   'valori': ['LD50 Rabbit oral 4 mg/kg',\n",
       "    'LD50 Rat ip 91 mg/kg',\n",
       "    'LD50 Mouse sc 60 mg/kg'],\n",
       "   'fonti': ['Sax, N.I. Dangerous Properties of Industrial Materials. 6th ed. New York, NY: Van Nostrand Reinhold, 1984., p. 542',\n",
       "    \"Lewis, R.J. Sax's Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 533\",\n",
       "    \"Lewis, R.J. Sax's Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 533\"]},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1956c1f2275d729476f'),\n",
       "  'Nome_comune': 'Brucine Sulfate',\n",
       "  'INCI_name': 'Brucine Sulfate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8900a5e9-172e-45ac-ac71-80934b91c95f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=93ca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):1-43, 2008',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['9.4, 125, and 315 mg/kg. The acute oral toxicity (LD 50) for Denatonium Benzoate was calculated to be 23 mg/kg withconﬁdence limits of 19 to 27 mg/kg. The third acute oral toxicity study with Denaton',\n",
       "   ' determined for each sex. The acute oral toxicity(LD 50) of Denatonium Benzoate in male albino rats was calcu- lated to be 640 mg/kg (conﬁdence limits of 554 to 740 mg/kg).The LD 50v'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['27 mg/kg', '640 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294770'),\n",
       "  'Nome_comune': 'Butane',\n",
       "  'INCI_name': 'Butane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e1800789-ca53-ee11-be6f-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7457789c-652d-5ebc-9488-c792baa1ba9a',\n",
       "  'pdf_date': 'September 12, 2023',\n",
       "  'pdf_name': 'Re-evaluation - Report not opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294771'),\n",
       "  'Nome_comune': 'Butene/Propylene Copolymer',\n",
       "  'INCI_name': 'Butene/Propylene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=db6fc93a-fd98-4e8b-881b-501cc9285f33',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=32efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Supp. 2):59-90, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['xicity study in rats (no further details provided)LD50>2,000 mg/kg, no mortalities observed6 Polybutene analog di-n-',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, 1 animal had partial thickening of the forestoma',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, no mortalities observed6 Polybutene analog tetra',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, no mortalities observed6 Polyisobutene (100%), M',\n",
       "   'patches for 24 hours (no further details provided)LD50>2,000 mg/kg; no mortalities or overt signs of toxicity were o',\n",
       "   'bbits/ sex); material applied to clippedEstimated LD 50>3,000 mg/kg; skin reactions observed at 24 hours post-patch r'],\n",
       "  'contesti_noael': ['gue-Dawley rats received test material via gavage.NOAEL ¼1,000 mg/kg/d; toxicity of the test material was examined in F ',\n",
       "   'ss necropsy or histopathological examination. The NOAEL for reproductive and development toxicity in this rat study is 1,000 mg/kg/d. Genotoxicity In Vitro Ethylene/Octene Copolymer.',\n",
       "   'rl:CD (SD) IGS BR strain rats (10 rats/sex/group).NOAEL ¼1,000 mg/kg/d; during the dosing period, one rat in the control group and one rat in the 250 mg/kg/d dose group died but deaths were not treatment-rel',\n",
       "   'er. In a 4-week oral repeated dose rat study, the NOAEL for Hydrogenated Polydecene was 6,245 mg/kg/d in males and 6,771 mg/kg/d in females. Gross necropsy, histo- pathology, and',\n",
       "   'ats (5 sex/dose)No observed adverse effect level (NOAEL) ¼6,245 mg/kg/d in males and 6,771 mg/kg/d in females; no clinical signs of toxicity or mort',\n",
       "   'er. In a 4-week oral repeated dose rat study, the NOAEL for Hydrogenated Polydecene was 6,245 mg/kg/d in males and 6,771 mg/kg/d in females. Gross necropsy, histopathol- ogy, and'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg'],\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg/d',\n",
       "   '250 mg/kg/d',\n",
       "   '771 mg/kg/d',\n",
       "   '771 mg/kg/d',\n",
       "   '771 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294772'),\n",
       "  'Nome_comune': 'Buteth-3',\n",
       "  'INCI_name': 'Buteth-3',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b6dad73d-3207-4387-9954-843e2ef4d506',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=071ce85a-0f95-02b1-9531-587773c294f2',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):5-43, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['00, 4200, or 5600 mg/kgLD 50combined –4000 mg/ kg LD50 males –4400 mg/kg LD50 females –3700 mg/kg9 1-(2-butoxy-1- methyleth'],\n",
       "  'contesti_noael': ['day LOAEL/local skin irritation –100 mg/kg bw/day NOAEL/systemic toxicity – 1000 mg/kg bw/day -Dermal irritation in the mid and high dose group'],\n",
       "  'valori_ld50': ['4400 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294773'),\n",
       "  'Nome_comune': 'Butoxyethanol',\n",
       "  'INCI_name': 'Butoxyethanol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d4345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['e Panel calculated the MOS of DBP by dividing the NOAEL of 331 mg/kg/day (from a feeding study) by the ex-pected exposure of 9.13 μg/kg/day, yielding an MOS of 36,254. If the more conservat',\n",
       "   'l noted thatthe no observed adverse effect level (NOAEL) of DBP in a gav-age study was 50 mg/kg/day (Mylchreest et al. 2000). However,a feeding study',\n",
       "   'ive NOAEL of 50 mg/kg/day (from a gav-age study) is used, the MOS is 5476. ',\n",
       "   ' reported a NOAEL of 331 mg/kg/day (Ema et al.1998). Overall, the Panel felt that fe'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['13 μg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '331 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294774'),\n",
       "  'Nome_comune': 'Butoxyethyl Acetate',\n",
       "  'INCI_name': 'Butoxyethyl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f8618e54-3623-4dda-bb5c-dd1ebbb6c20c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b8106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):112-136, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294775'),\n",
       "  'Nome_comune': 'Butyl Acetate',\n",
       "  'INCI_name': 'Butyl Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4ca76795-3a7a-ec11-8d21-0022482fd227',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e4ce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 27(Suppl. 1):77-142, 2008',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294776'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Cyclohexyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Cyclohexyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=934b8064-aed5-4892-8255-408a9770da18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294777'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Ethylhexyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Ethylhexyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=528b71a9-7cf5-4f76-8ee3-e06e8978a321',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1966c1f2275d7294778'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Glycol Dimethacrylate Crosspolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Glycol Dimethacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c3d6f6fc-9ded-4c21-8266-5a0623d82002',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1976c1f2275d7294779'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Hydroxyethyl Methacrylate Copolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Hydroxyethyl Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=233a1269-10f9-4540-9156-1ab8df1cb5f1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477a'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Isopropylacrylamide/PEG-18 Dimethacrylate Crosspolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Isopropylacrylamide/PEG-18 Dimethacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=872e9050-2c25-4f6d-9151-494f16151fc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8e1e8683-376a-7ecd-ac1b-aeb96bc6506b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' below can be found in Table 6.  The acute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylate s/Octylacrylamide  ',\n",
       "   'and secondary food additives.   The a cute dermal LD 50 was reported to be greater than 2000 mg/kg in rabbits dosed with Acrylates/Octylacrylamide  C'],\n",
       "  'contesti_noael': [' study.  The no -observed -adverse -effect level (NOAEL) was determined to be  1000 mg/kg bw/d.   Subchronic Toxicity Studies   Inhalation   Acr',\n",
       "   'bserved for any of the evaluated parameters.  The NOAEL for maternal and fetal toxicity was determined to be greater than 1000 mg/kg bw/d.   GENOT OXICITY   In Vitro   Acry lamide/Ammoniu',\n",
       "   'in water  in doses of up to 1000 mg/kg bw/d.  The NOAEL was determined to  be 1000 mg/kg bw/d.  The potential subchronic inhalation toxicity of',\n",
       "   's  evaluated in pregnant female Wistar rats.  The NOAEL for maternal and fetal toxicity was determined to be  greater than  1000  mg/kg bw/d.   Ames assays were performed on several test sub'],\n",
       "  'valori_ld50': ['2000 mg/kg ', '2000 mg/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000  mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477b'),\n",
       "  'Nome_comune': 'Butyl Acrylate/Styrene Copolymer',\n",
       "  'INCI_name': 'Butyl Acrylate/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cfe822d6-5390-4039-95b5-48309f6f5e22',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' acute oral toxicity study involving rats, and an LD 50 of >  5 ml/kg was reported.  The test protocol was not stated .32    An oral LD 50 of  >  2,000 mg/kg body weight (rats) for Syntran® 5903 was reported in a study ',\n",
       "   'col were  not included.  The estimated acute oral LD 50 was > 5,050 mg/kg (nontoxic).  It was noted that this finding was  ',\n",
       "   'cute dermal toxicity study involving rats, and an LD 50 of  > 5 g/kg was reported.  The test protocol was not stated.32'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight', '050 mg/kg', '5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477c'),\n",
       "  'Nome_comune': 'Butyl Avocadate',\n",
       "  'INCI_name': 'Butyl Avocadate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a7e7fb3b-ac89-45d9-99bf-c8c4eebd1138',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477d'),\n",
       "  'Nome_comune': 'Butyl Babassuate',\n",
       "  'INCI_name': 'Butyl Babassuate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a4ff9fc-f58e-4d12-b69b-8c94ec5c7a6f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477e'),\n",
       "  'Nome_comune': 'Butyl Benzoate',\n",
       "  'INCI_name': 'Butyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fd8ecd5c-bd9e-4902-ad11-86b183ae748b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rted to be 2.69 g/kg. Dodecyl alcohol has an oral LD 50 of 12 800 mg/kg for rats. Tridecyl alcohol has an oral LD 50of17 200 mg/kg for rats. Tetradecyl alcohol has an oral LD 50 33 ',\n",
       "   ' reported to be 5600 mg/kg in rabbits. The dermal LD 50 of hexadecyl alcohol for rabbits was reported to be >2.6 g/kg. Aerosolized amyl alcohol at near saturation caus'],\n",
       "  'contesti_noael': ['(15, 40, or 120 mL/m3; purity 99.9 %).87 The oral NOAEL for noncancer systemic toxicity end points were 200 and 50 mg/kg/d in mice and rats, respectively, exposed chronical',\n",
       "   ' decreased food consumption and body weights. The NOAEL was 125 mg/kg/d for male and female F344 rats and B6C3Fl mice tre',\n",
       "   ' maternal weight gain. Maternal and developmental NOAEL was found to be 130 mg/kg/d in Wistar rats (n ¼10) orally exposed to ethylhex',\n",
       "   'ose females at birth and on day 4 postpartum. The NOAEL was 1000 mg/kg/d. In Ames tests, methyl benzoate, ethyl benzoate, '],\n",
       "  'valori_ld50': ['200 mg/kg ', '6 g/kg'],\n",
       "  'valori_noael': ['50 mg/kg/d',\n",
       "   '125 mg/kg/d',\n",
       "   '130 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1976c1f2275d729477f'),\n",
       "  'Nome_comune': 'Butyl Benzyl Phthalate',\n",
       "  'INCI_name': 'Butyl Benzyl Phthalate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=18f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1976c1f2275d7294780'),\n",
       "  'Nome_comune': 'Butyl Ester of PVM/MA Copolymer',\n",
       "  'INCI_name': 'Butyl Ester of PVM/MA Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e39b8379-1d54-4861-87b5-017be2d10ab6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8c307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):128-144, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294781'),\n",
       "  'Nome_comune': 'Butyl Ethyl Propanediol',\n",
       "  'INCI_name': 'Butyl Ethyl Propanediol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=566006f4-4686-4e74-a8c8-6478b0de51ab',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=94742a1a-c561-614f-9f89-14ce58abfc0b',\n",
       "  'pdf_date': 'IJT 43(Suppl. 2):70-131, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['t Not speci ﬁed Not speci ﬁed No details provided LD 50> 20 g/kg78 1,4-Butanediol Rat, Wistar Imp: DAK12 females 5 g/kg (undiluted liquid) Food and water were available ',\n",
       "   ' accordance with OECD TG 401 (Acute Oral Toxicity)LD50> 5 g/kg for males and females; no mortality; clinical sign',\n",
       "   ' animals. 12,35Various animal studies reported an LD 50 between 1.2 and 2.5 g/kg for 1,4-Butanediol.13,22,34,37,74,82 Findings at n',\n",
       "   ' could not be “retained in contact with the skin ”LD50> 20 mL/kg was reported79 Hexanediol Rabbit, New Zealand(albino)4 males 10 g/kg in a “suitable vehicle ” Rabbit trunk was clipped ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50>20 g/kg in rats for Propanediol, >20 mL/kg in rabbits for 1,5-Pentanediol, >10 g/kg in rabbits for Hexanediol, and >2 g/kg in rabbits ',\n",
       "   'ing the toxicity of the alkane diols indicated an LD 50> 20 g/kg in rats for Propanediol,78>20 mL/kg in rabbits for'],\n",
       "  'contesti_noael': ['aluating 1 ,4-Butanediol, a NOAEC of 500 mg/L (or NOAEL of 23 mg/kg/day) and a lowest-observed-adverse-effect-concentrati',\n",
       "   'through 15 of gestationMaternal and developmental NOAEL of 100 mg/kg/day; maternal anddevelopmental LOAEL of 300 mg/kg/ da',\n",
       "   'cropsy performedNOAEL of 15 mg/kg/day (males) and NOAEL of 150 mg/kg/day (females); treatment-related deaths of 3 males (1000 mg/kg/day) and 1 male (150 mg/kg/day); the following wereunaffected by treatment: body',\n",
       "   'mg/kg/day on days 6 - 19 ofgestation), a maternal NOAEL of 150 mg/kg/day (reducedactivity, staggering, limb dragging, slow',\n",
       "   'd on gestation day 20; necropsy performedMaternal NOAEL of 150 mg/kg/day; Developmental NOAEL of 1000 mg/kg/ day; maternal',\n",
       "   'nd developmental NOAEL of 100 mg/kg/dayand a LOAEL of 300 mg/kg/day were reported; maternalcentral nervous system int',\n",
       "   're observed (dosing on days 6-15 of gestation). A NOAEL of 100 mg/kg/day and a LOAEL of 300 mg/kg/day 1,4-Buta-nediol were reported for maternal (dosin',\n",
       "   'al toxiceffects were observed (maternal and fetal NOAEL 1000 mg/ kg/day). 12In a mouse study evaluating 1,4-Butanediol at up to 600 mg/kg/day (dosing on days 6 - 15 of gestation), amaternal a',\n",
       "   '00 mg/kg/day); a no-observed-adverse-effect-level(NOAEL) of 200 mg/kg/day was reported. 13The results of testing Hexanediol in rats (up to 1000 mg/kg/day for28 days) 15a n dr a b b i t s( u pt o2 0 0 0m ',\n",
       "   'hrough 15 of gestationMaternal and fetal toxicity NOAEL of 1000 mg/kg/day; no maternal toxiceffects from treatment (fertili',\n",
       "   'onclusion and necropsy performedParental (female) NOAEL of 1000 mg/kg/ day; parental (male) NOAEL of 400 mg/ kg/day; offspring (male/female) NOAELof 1000 mg/kg/day; male parents (1000 mg/kg/day) showed treatment-r',\n",
       "   'nd necropsies performedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal mortalities or clinical signs; mater',\n",
       "   'offspring were examinedMaternal and developmental NOAEL of 1000 mg/kg/day; no maternal toxic or embryotoxic effects were ob',\n",
       "   'l toxicity, fetotoxicity, and teratogenic effects NOAEL of 1000 mg/kg/day; intrauterine growth and survival was not affecte',\n",
       "   'ed bytreatment. 13,22A maternal and developmental NOAEL of 1000 mg/kg/day was reported in animal studies on Hex- anediol (r',\n",
       "   'dy weight at 1000 mg/kg dose) and a developmental NOAEL of 1000 mg/kg/day were reported. 17 Genotoxicity Provided below is ',\n",
       "   ' female rats, respectively. In 90- day studies, a NOAEL of 600 mg/kg/day was reported for Methylpropanediol and NOAELs of 1000 mg/kg/day werereported for Propanediol and Hexanediol (in f',\n",
       "   'roductive parameters were changed by treatment. A NOAEL of 1000 mg/kg/day Hexanediol (dosing on days 6-19 of gestation) and'],\n",
       "  'valori_ld50': ['5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '10 g/kg ',\n",
       "   '20 g/kg '],\n",
       "  'valori_noael': ['23 mg/kg/day',\n",
       "   '100 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '150 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '300 mg/kg/day',\n",
       "   '600 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day',\n",
       "   '1000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294782'),\n",
       "  'Nome_comune': 'Butyl Glucoside',\n",
       "  'INCI_name': 'Butyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2ff04713-2f57-4aea-bb6f-4e022b3affda',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['fe as used Myristyl alcoholAnimal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg Inhalation: 3%, 1 h, ataxia and moderate nasal irr',\n",
       "   ' glucoside using rabbits, the median lethal dose (LD 50) was greater than the 2 g/kg dose administered. In oral studies with the same t',\n",
       "   'erides and phospholipids66 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD 50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   'sorbed from the GI tract68 Animal toxicology Oral LD 50: >8 g/kg; 3 mos dermal study: formulations w/8%, some derm',\n",
       "   ' as used Isostearyl alcoholAnimal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg66 Dermal ',\n",
       "   'afe as used Octyl dodecanolAnimal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD50: >3 g/kg68 (continued)24S Internatio',\n",
       "   ' and 2.7% in the urine65 Animal toxicology Dermal LD 50(rabbits), 4.2 g/kg; oral LD 50(rats), 0.79-4.36 g/kg Short-term oral: 6.9% n-butyl alcohol and 25% sucr'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '36 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294783'),\n",
       "  'Nome_comune': 'Butyl Glycolate',\n",
       "  'INCI_name': 'Butyl Glycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=06f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294784'),\n",
       "  'Nome_comune': 'Butyl Isostearate',\n",
       "  'INCI_name': 'Butyl Isostearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=31d61bee-9fd0-4d8c-8ebf-2f7c578a7ecd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294785'),\n",
       "  'Nome_comune': 'Butyl Lactate',\n",
       "  'INCI_name': 'Butyl Lactate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0cf63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294786'),\n",
       "  'Nome_comune': 'Butyl Methacrylate',\n",
       "  'INCI_name': 'Butyl Methacrylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d33b9cfe-527d-ec11-8d21-0022482f7740',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f876505d-1527-c1b5-9039-df537f4c8677',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):61-73, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294787'),\n",
       "  'Nome_comune': 'Butyl Methacrylate/Acryoyloxy PG Methacrylate Copolymer',\n",
       "  'INCI_name': 'Butyl Methacrylate/Acryloyloxy PG Methacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b93d99e9-e7ce-42d1-8ccb-bd8699ee997f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294788'),\n",
       "  'Nome_comune': 'Butyl Myristate',\n",
       "  'INCI_name': 'Butyl Myristate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=811f3917-3182-4925-a279-57945bf66ab5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1986c1f2275d7294789'),\n",
       "  'Nome_comune': 'Butyl Oleate',\n",
       "  'INCI_name': 'Butyl Oleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8e0fb056-0632-4eb4-b786-e1c73a7d31a6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478a'),\n",
       "  'Nome_comune': 'Butyl Stearate',\n",
       "  'INCI_name': 'Butyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dd345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478b'),\n",
       "  'Nome_comune': 'Butyl Thioglycolate',\n",
       "  'INCI_name': 'Butyl Thioglycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87452885-9341-4f70-89a3-243082bcf719',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=17a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 1):68-133, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['queous solution)10 Sprague-Dawley rats Intubation LD 50> 50 mg/kg Thioesters Association, 2006 (personal communicati',\n",
       "   'active benzalkonium chloride. The least toxicity (LD 50> 365 mg/kg, 12 animals) was noted in the group treated with ',\n",
       "   'Thioglycolate)10 albino rats (208-260 g)Oral dose LD 50> 1 g/kg Consumer Product Testing Com- pany, Inc,1851982b P',\n",
       "   'Thioglycolate)10 albino rats (216-286 g)Oral dose LD 50> 1 g/kg Consumer Product Testing Com- pany, Inc,1901982a E',\n",
       "   'colate)10 Wistar albino rats (200-300 g)Oral dose LD 50< 5 g/kg Consumer Product Testing Com- pany, Inc,1911982c G'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['50 mg/kg ', '365 mg/kg', '1 g/kg ', '1 g/kg ', '5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478c'),\n",
       "  'Nome_comune': 'Butylated Hydroxyanisole',\n",
       "  'INCI_name': 'BHA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=565284ed-377d-4d33-aca7-eb205b0f8997',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=138d48dd-b490-c938-8d57-f81ad33db764',\n",
       "  'pdf_date': 'March 29, 2024',\n",
       "  'pdf_name': 'Tentative Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['A was also > 5000 mg/kg in rats.   The acute oral LD 50 of BHA, administered in dimethyl sulfoxide ( DMSO ) to mice, was 1670 mg/kg; the acute oral LD 50  of BHA, administered in ol',\n",
       "   'idelines outlined in 16 CFR 1500.40.2  The dermal LD 50 was determined to be > 2000  mg/kg.   Oral   The acute oral LD 50 values of BHA admi',\n",
       "   'g and 1320 mg/kg,  respectively.2  The acute oral LD 50 values for BHA in 2 additional studies using mice were 1250 and 2000 mg/kg.  The acute  oral LD 50 values for male rats were',\n",
       "   ', the acute oral LD 50 for BHA administered in olive oil was determined to be 2000 mg/kg.  Non -fasted rats  received a single oral dose o',\n",
       "   'yl alcohol) and 2950 mg/kg (BHA); the  acute oral LD 50 values for BHA  in rats were determined to be 2200 mg/kg and 2900 mg/kg  in 2 separate studies .  For male  and female rats',\n",
       "   'SO  or in olive oil; the corresponding acute oral LD 50 values were 2910 mg/kg and 2960 mg/kg, respectively.   Short -Term Toxicity  Studies   ',\n",
       "   'f BHA in corn oil; the acute oral LD 50 was 4100 mg/kg.  Fasted rats were administered a single  oral do',\n",
       "   'se of BHA in water; the acute oral LD 50 was > 5000 mg/kg.   Cosmetic products containing BHA have also bee',\n",
       "   ', to female albino rats  (n=5) .  The  acute oral LD 50 for both products was > 5000  mg/kg.  The acute oral LD 50 of an eye makeup preparati'],\n",
       "  'contesti_noael': [' based on a no -observed -adverse -effect -level (NOAEL) of 100 mg/kg bw/d BHA for growth retardation,  increased mortality ',\n",
       "   ' 110, 220, or 420 mg/kg/d BHA, in  the diet; t he NOAEL for maternal toxicity was determined to be 420 mg/kg/d for.15  For offspring toxicity, a  NOAEL of 220  mg/kg/d BHA and a LOAEL of 420 mg/kg/d BHA was establishe',\n",
       "   'dosed with up to 420 mg/kg/d BHA in the diet, the NOAEL for maternal  toxicity was determined to be 420 mg/kg/d.  Based on reduced weight of progeny during lacta',\n",
       "   'n and lactation, and up to 90 d for most  pups.   NOAEL for maternal toxicity: 420 mg/kg/d   Based on reduced weight of proge ny during  lac',\n",
       "   'e) and increasing peri-weaning mortality (13%), a NOAEL of 220  mg/kg/d BHA and a LOAEL of 420 mg/kg/d  BHA in the diets of dams and offspring was  esta'],\n",
       "  'valori_ld50': ['1670 mg/kg',\n",
       "   '2000  mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2900 mg/kg  ',\n",
       "   '2960 mg/kg',\n",
       "   '4100 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg bw/d',\n",
       "   '220  mg/kg/d',\n",
       "   '420 mg/kg/d',\n",
       "   '420 mg/kg/d',\n",
       "   '420 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478d'),\n",
       "  'Nome_comune': 'Butylated PVP',\n",
       "  'INCI_name': 'Butylated PVP',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8180c981-91e4-40d6-86fa-656dbfdfa710',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d7a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' clinical  signs were observed.  The acute dermal LD 50 was > 2 g/kg.     Oral   VP Copolymers     VP/VA Copolymer    ',\n",
       "   'yldimethyltaurate/VP Copolymer     The acute oral LD 50  for Ammonium Acryloyldimethyltaurate/VP Copolymer was rep orted to be >2 g/kg in rats.6     VP/Acrylates/Lauryl Methacrylate Cop',\n",
       "   'olymer      An oral LD 50 of > 5 g/kg (rats) has been reported for undiluted VP/Acrylat',\n",
       "   'oss organ changes were observed at necropsy.  The LD 50 was > 5  g/kg.     Shor t-Term Toxicity Studies   Dermal   VP C',\n",
       "   'f 10 New Zealand white rabbits ; the acute dermal LD 50 was > 2 g/kg.  An oral LD 50 of > 5 g/kg  (rats) has been reported for undiluted VP/Acryla',\n",
       "   's organ changes were obse rved  at necropsy.  The LD 50 was > 5 g/kg.       VP/VA C opolymer was administered in the d',\n",
       "   'P and Modified PVP Polymers     PVP      The oral LD 50 of PVP (avg. MW of 40,000) is > 100 g/kg body weight for both rats and guinea pigs .8     Triacontanyl '],\n",
       "  'contesti_noael': ['ded  that the no-observed -adverse -effect level (NOAEL) was  1000 mg/kg/day .     PVP and Modified PVP Polymers       PVP    ',\n",
       "   ' were observed .  The authors concluded  that the NOAEL  was 1000 mg/kg /day.       Inhalation   VP Copolymers     VP/VA Copol',\n",
       "   '  trabeculae of some mesenteric lymph nodes.  The NOAEL was determined to be the target dose of 2500 mg/kg/day (target  dose for highest dose group).36     The ',\n",
       "   'e was  no clear dose -response relationship.  The NOAEL was determined to be the target dose of 2800 mg/kg/day (target dose for  high dose group).  Results rela'],\n",
       "  'valori_ld50': ['2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '100 g/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg/day',\n",
       "   '1000 mg/kg /day',\n",
       "   '2500 mg/kg/day',\n",
       "   '2800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478e'),\n",
       "  'Nome_comune': 'Butyldimethicone Methacrylate/Methyl Methacrylate Crosspolymer',\n",
       "  'INCI_name': 'Butyldimethicone Methacrylate/Methyl Methacrylate Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bbe950e5-d42a-4861-9327-3ce4ab80cc60',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1996c1f2275d729478f'),\n",
       "  'Nome_comune': 'Butylene Glycol',\n",
       "  'INCI_name': 'Butylene Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8f75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=adce160b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 2) :1-89,2006,',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1996c1f2275d7294790'),\n",
       "  'Nome_comune': 'Butylene Glycol Cocoate',\n",
       "  'INCI_name': 'Butylene Glycol Cocoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0c86f0ad-9bc5-4e03-b936-6398508d8b71',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=79ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 1):5-16, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1996c1f2275d7294791'),\n",
       "  'Nome_comune': 'Butylene Glycol Dicaprylate/Dicaprate',\n",
       "  'INCI_name': 'Butylene Glycol Dicaprylate/Dicaprate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d2474879-6e6c-4da6-a2e6-d9856d35fbc5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8759a9c5-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 12, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['o  clinical signs.  Two guinea pigs lost weight.  LD 50 > 20 mL/kg.  7,18,34  Trimethyl Pentanyl   Diisobutyrate  Guinea pigs (not  specified)  5 mg/kg. Slightly irritating.  18  Trimethyl Pentanyl  Di',\n",
       "   ' to the end of the 14 -day  observation period.   LD 50 > 2000 mL/kg (>  1880 mg/kg)  9  Neopentyl Glycol  Diheptanoate  Male and fem',\n",
       "   ' were not indicative of any abnormalities  and an LD 50 of > 2000 mg/kg was  reported.     Acute dermal toxicity studies a',\n",
       "   're summarized in Table 9.  The dermal  LD 50 of Trimethyl Pentanyl Diisobutyrate was  reported to be  > 20 mL/kg in guinea pigs and >  2000 mg/kg in  rabbits.7,18,34  Clinical signs were: instance',\n",
       "   'opsy did not reveal any abnormal findings  and an LD 50 of  > 2000 mg/kg body weight was reported.     Glycol Distearate   Glycol Diste',\n",
       "   'ty studies are summarized in  Table 9.   The oral LD 50 of Trimethyl Pentanyl Diisobutyrate was  reported to be  > 2000 mg/kg in rats.7,18,34  Clinical signs included  moderate',\n",
       "   'e was reported to be >  5000 mg/kg.5,37  The oral LD 50 of Neopentyl Glycol Dicaprate  was reported to  be > 2000 mg/kg in rats.17  The oral LD 50 of Neopentyl Glycol Die',\n",
       "   ' radioactivity was detected in CO 2.  The dermal  LD 50 of Trimethyl Pentanyl Diisobutyrate was  reported to be  > 20 mL/kg in guinea pigs and >  2000 mg/kg in  rabbits.  Clinical signs were:  diarrhea, few ',\n",
       "   'ate was not toxic to rabbits at  100%.   The oral LD 50 for Trimethyl Pentanyl Diisobutyrate was  reported to be  > 2000 mg/kg in rats.  Clinical signs included  moderate weakne',\n",
       "   ' Rats were observed for 14  days after dosing.    LD 50 = 2000 mg/kg   None of the rats died in the 3 low -dose  groups. ',\n",
       "   ' areas in the pancreas of 1 male and 2 females.   LD 50 > 2000 mg/kg.  7,34  Glycol Distearate  New Zealand White  rab',\n",
       "   '). Single dose at 2000 mg/kg neat after fasting.  LD 50 > 2000 mg/kg.   No mortalities or clinical signs of toxicity w',\n",
       "   ' by gavage.   OECD TG 401 (Acute Oral Toxicity)   LD 50 > 2000 mg/kg   No mortalities or clinical signs of toxicity were ',\n",
       "   'red up to 6400 mg/kg by  gavage.7,18,34  The oral LD 50 of Diethylpentanediol Dineopentanoate was estimat ed to be ≥ 2500 mg/kg in rats.16,36  The oral LD 50  of Glycol Distearat',\n",
       "   ' nistered up to 6400 mg/kg by  gavage.   The oral LD 50 of Diethylpentanediol Dineopentanoate was reported to be ≥ 2500 mg/kg in rats.   The oral LD 50 for Glycol  Distearate i',\n",
       "   'e (not  specified)  Not Specified  Not Specified  LD 50 = 6.3 g/kg; somnolence, exci tement,  and muscle weakness no',\n",
       "   'd)  73  Rabbit (not Not Specified  Not Specified  LD 50 = 6.3 g/kg; somnolence, excitement, 73 Table 4. Available t ',\n",
       "   'on. The rabbits were  then observed for 14 days.  LD 50 = 3160 mg/kg   Two rabbits died within 48 h of exposure in  the 3160 mg/kg group.  Death was  preceded by marked depression, ',\n",
       "   ' 401  (Acute Oral Toxicity); necropsy  performed  LD 50 > 5 g/kg; no mortality; gross necropsy  revealed no abnorm',\n",
       "   's after dosing, which resolved Day 10.   The oral LD 50 for mice was  reported to be  > 5000 mg/kg.  In  another study in rats, there were no mortal',\n",
       "   's after dosing, which resolved Day 10.   The oral LD 50 of Glycol Distearate was   reported to be  > 5000 mg/kg in mice.  The oral LD 50 of Neopentyl Glycol Dieth',\n",
       "   'nd no abnormalities were observed at  necropsy.   LD 50 was estimated to be > 2500 mg/kg  16,36  Glycol Distearate    Sprague -Dawley rats  (n = 5/sex)  5000 mg/kg (2.5% in CMC) by oral gavage in two 2.2  - 2.3 mL',\n",
       "   's.  No mortalities or clinical signs of toxicity. LD 50 > 5000  mg/kg.  5  Glycol Distearate  Rats (not specified)  OEC',\n",
       "   'D TG 401 (Acute Oral Toxicity)   LD 50 > 2000 mg/kg  37  Glycol Distearate  Female Swiss mice ( n  = 5) Single dose at 5000 mg/kg by gavage. LD 50 > 5000 mg/kg .  No mortalities or cl',\n",
       "   'g (not  specified)  Not Specified  Not Specified  LD 50 = 4.6 g/kg; somnolence, excitement,  and muscle weakness not',\n",
       "   'd on Days 0 and 1. Necropsies  were unremarkable. LD 50 > 2000 mg/kg.  7,34  Trimethyl Pentanyl  Diisobutyrate  Mice ( n = 2) 400, 800, 1600, 3200 or 6400  mg/kg by gavage and observed for 2 weeks. 1 mouse  died wit',\n",
       "   'vage; animals  observed for 14 days post -dosing  LD 50 = 10 g/kg for males and females; 1  death in 24 h (6.81 g/kg dose), 3 deaths in  24 h (10 g/kg dose), no deaths at two lower  doses; reduced weig',\n",
       "   '  observed for 14 days post -dosing  An estimated LD 50 of 5.89 g/kg  ± 1.96  standard deviations was reported, LD 50 '],\n",
       "  'contesti_noael': ['sobutyrate  in feed for up to 99 days.   The oral NOAEL  for Trimethyl Pentanyl Diisobutyrate was reported to be  30 mg/kg /day  for males  (44 days)  and 150 mg/kg/d ay for females  (40 to 53 days) .  All rats survi',\n",
       "   'LOEL was  reported to be  750 mg/ kg/day  and the NOAEL was reported to be 150 mg/kg/day  for  Trimethyl Pentanyl Diisobutyrate  administe',\n",
       "   '(Repeated Dose  28-Day Oral Toxicity in Rodents)  NOAEL  = 30 mg/kg/day   Immediately after dosing the 100 or 300  mg/kg/day groups, rats were observed to  sneeze and produce',\n",
       "   ' body  weight gain s and/or body weight loss, the NOAEL for maternal toxic ity wa s reported  to be 343 mg/kg/d ay.   There were no test  substance -related exte',\n",
       "   'EL ) was reported to be  750  mg/kg/day, and  the NOAEL was  reported to be  150 mg/kg/day.  The NOAEL in fe male rats was  reported to be  750 mg/kg/day.   In three feeding experiments conducted concurr',\n",
       "   'emonstrate any treatment -related effec ts.  The  NOAEL for embryo /fetal toxicity was  reported to be  750 mg/kg /day.  In a study conducted in accordance with OECD TG',\n",
       "   'red in feed for  90 day s; the NOAEL in female rats was  reported to be  750  mg/kg/day.   The NOAEL in both male and female rats  was re',\n",
       "   ' fetal abnormalities were found at necropsy.  The NOAEL for maternal toxicity was  reported to be  > 900 mg/kg /day.  The  teratogenicity NOAEL was  reported to be  '],\n",
       "  'valori_ld50': ['5 mg/kg',\n",
       "   '1880 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg   ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg   ',\n",
       "   '2500 mg/kg ',\n",
       "   '2500 mg/kg ',\n",
       "   '3 g/kg',\n",
       "   '3 g/kg',\n",
       "   '3160 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg',\n",
       "   '5000 mg/kg by ',\n",
       "   '6 g/kg',\n",
       "   '6400  mg/kg by ',\n",
       "   '10 g/kg ',\n",
       "   '89 g/kg'],\n",
       "  'valori_noael': ['150 mg/kg/d',\n",
       "   '150 mg/kg/day',\n",
       "   '300  mg/kg/day',\n",
       "   '343 mg/kg/d',\n",
       "   '750 mg/kg/day',\n",
       "   '750 mg/kg /day',\n",
       "   '750  mg/kg/day',\n",
       "   '900 mg/kg /day']},\n",
       " {'_id': ObjectId('668ed1996c1f2275d7294792'),\n",
       "  'Nome_comune': 'Butylene Glycol Diisononanoate',\n",
       "  'INCI_name': 'Butylene Glycol Diisononanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=02c8475b-0146-4646-8615-5965537ebde9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8759a9c5-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 12, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['o  clinical signs.  Two guinea pigs lost weight.  LD 50 > 20 mL/kg.  7,18,34  Trimethyl Pentanyl   Diisobutyrate  Guinea pigs (not  specified)  5 mg/kg. Slightly irritating.  18  Trimethyl Pentanyl  Di',\n",
       "   ' to the end of the 14 -day  observation period.   LD 50 > 2000 mL/kg (>  1880 mg/kg)  9  Neopentyl Glycol  Diheptanoate  Male and fem',\n",
       "   ' were not indicative of any abnormalities  and an LD 50 of > 2000 mg/kg was  reported.     Acute dermal toxicity studies a',\n",
       "   're summarized in Table 9.  The dermal  LD 50 of Trimethyl Pentanyl Diisobutyrate was  reported to be  > 20 mL/kg in guinea pigs and >  2000 mg/kg in  rabbits.7,18,34  Clinical signs were: instance',\n",
       "   'opsy did not reveal any abnormal findings  and an LD 50 of  > 2000 mg/kg body weight was reported.     Glycol Distearate   Glycol Diste',\n",
       "   'ty studies are summarized in  Table 9.   The oral LD 50 of Trimethyl Pentanyl Diisobutyrate was  reported to be  > 2000 mg/kg in rats.7,18,34  Clinical signs included  moderate',\n",
       "   'e was reported to be >  5000 mg/kg.5,37  The oral LD 50 of Neopentyl Glycol Dicaprate  was reported to  be > 2000 mg/kg in rats.17  The oral LD 50 of Neopentyl Glycol Die',\n",
       "   ' radioactivity was detected in CO 2.  The dermal  LD 50 of Trimethyl Pentanyl Diisobutyrate was  reported to be  > 20 mL/kg in guinea pigs and >  2000 mg/kg in  rabbits.  Clinical signs were:  diarrhea, few ',\n",
       "   'ate was not toxic to rabbits at  100%.   The oral LD 50 for Trimethyl Pentanyl Diisobutyrate was  reported to be  > 2000 mg/kg in rats.  Clinical signs included  moderate weakne',\n",
       "   ' Rats were observed for 14  days after dosing.    LD 50 = 2000 mg/kg   None of the rats died in the 3 low -dose  groups. ',\n",
       "   ' areas in the pancreas of 1 male and 2 females.   LD 50 > 2000 mg/kg.  7,34  Glycol Distearate  New Zealand White  rab',\n",
       "   '). Single dose at 2000 mg/kg neat after fasting.  LD 50 > 2000 mg/kg.   No mortalities or clinical signs of toxicity w',\n",
       "   ' by gavage.   OECD TG 401 (Acute Oral Toxicity)   LD 50 > 2000 mg/kg   No mortalities or clinical signs of toxicity were ',\n",
       "   'red up to 6400 mg/kg by  gavage.7,18,34  The oral LD 50 of Diethylpentanediol Dineopentanoate was estimat ed to be ≥ 2500 mg/kg in rats.16,36  The oral LD 50  of Glycol Distearat',\n",
       "   ' nistered up to 6400 mg/kg by  gavage.   The oral LD 50 of Diethylpentanediol Dineopentanoate was reported to be ≥ 2500 mg/kg in rats.   The oral LD 50 for Glycol  Distearate i',\n",
       "   'e (not  specified)  Not Specified  Not Specified  LD 50 = 6.3 g/kg; somnolence, exci tement,  and muscle weakness no',\n",
       "   'd)  73  Rabbit (not Not Specified  Not Specified  LD 50 = 6.3 g/kg; somnolence, excitement, 73 Table 4. Available t ',\n",
       "   'on. The rabbits were  then observed for 14 days.  LD 50 = 3160 mg/kg   Two rabbits died within 48 h of exposure in  the 3160 mg/kg group.  Death was  preceded by marked depression, ',\n",
       "   ' 401  (Acute Oral Toxicity); necropsy  performed  LD 50 > 5 g/kg; no mortality; gross necropsy  revealed no abnorm',\n",
       "   's after dosing, which resolved Day 10.   The oral LD 50 for mice was  reported to be  > 5000 mg/kg.  In  another study in rats, there were no mortal',\n",
       "   's after dosing, which resolved Day 10.   The oral LD 50 of Glycol Distearate was   reported to be  > 5000 mg/kg in mice.  The oral LD 50 of Neopentyl Glycol Dieth',\n",
       "   'nd no abnormalities were observed at  necropsy.   LD 50 was estimated to be > 2500 mg/kg  16,36  Glycol Distearate    Sprague -Dawley rats  (n = 5/sex)  5000 mg/kg (2.5% in CMC) by oral gavage in two 2.2  - 2.3 mL',\n",
       "   's.  No mortalities or clinical signs of toxicity. LD 50 > 5000  mg/kg.  5  Glycol Distearate  Rats (not specified)  OEC',\n",
       "   'D TG 401 (Acute Oral Toxicity)   LD 50 > 2000 mg/kg  37  Glycol Distearate  Female Swiss mice ( n  = 5) Single dose at 5000 mg/kg by gavage. LD 50 > 5000 mg/kg .  No mortalities or cl',\n",
       "   'g (not  specified)  Not Specified  Not Specified  LD 50 = 4.6 g/kg; somnolence, excitement,  and muscle weakness not',\n",
       "   'd on Days 0 and 1. Necropsies  were unremarkable. LD 50 > 2000 mg/kg.  7,34  Trimethyl Pentanyl  Diisobutyrate  Mice ( n = 2) 400, 800, 1600, 3200 or 6400  mg/kg by gavage and observed for 2 weeks. 1 mouse  died wit',\n",
       "   'vage; animals  observed for 14 days post -dosing  LD 50 = 10 g/kg for males and females; 1  death in 24 h (6.81 g/kg dose), 3 deaths in  24 h (10 g/kg dose), no deaths at two lower  doses; reduced weig',\n",
       "   '  observed for 14 days post -dosing  An estimated LD 50 of 5.89 g/kg  ± 1.96  standard deviations was reported, LD 50 '],\n",
       "  'contesti_noael': ['sobutyrate  in feed for up to 99 days.   The oral NOAEL  for Trimethyl Pentanyl Diisobutyrate was reported to be  30 mg/kg /day  for males  (44 days)  and 150 mg/kg/d ay for females  (40 to 53 days) .  All rats survi',\n",
       "   'LOEL was  reported to be  750 mg/ kg/day  and the NOAEL was reported to be 150 mg/kg/day  for  Trimethyl Pentanyl Diisobutyrate  administe',\n",
       "   '(Repeated Dose  28-Day Oral Toxicity in Rodents)  NOAEL  = 30 mg/kg/day   Immediately after dosing the 100 or 300  mg/kg/day groups, rats were observed to  sneeze and produce',\n",
       "   ' body  weight gain s and/or body weight loss, the NOAEL for maternal toxic ity wa s reported  to be 343 mg/kg/d ay.   There were no test  substance -related exte',\n",
       "   'EL ) was reported to be  750  mg/kg/day, and  the NOAEL was  reported to be  150 mg/kg/day.  The NOAEL in fe male rats was  reported to be  750 mg/kg/day.   In three feeding experiments conducted concurr',\n",
       "   'emonstrate any treatment -related effec ts.  The  NOAEL for embryo /fetal toxicity was  reported to be  750 mg/kg /day.  In a study conducted in accordance with OECD TG',\n",
       "   'red in feed for  90 day s; the NOAEL in female rats was  reported to be  750  mg/kg/day.   The NOAEL in both male and female rats  was re',\n",
       "   ' fetal abnormalities were found at necropsy.  The NOAEL for maternal toxicity was  reported to be  > 900 mg/kg /day.  The  teratogenicity NOAEL was  reported to be  '],\n",
       "  'valori_ld50': ['5 mg/kg',\n",
       "   '1880 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg   ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg   ',\n",
       "   '2500 mg/kg ',\n",
       "   '2500 mg/kg ',\n",
       "   '3 g/kg',\n",
       "   '3 g/kg',\n",
       "   '3160 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg',\n",
       "   '5000 mg/kg by ',\n",
       "   '6 g/kg',\n",
       "   '6400  mg/kg by ',\n",
       "   '10 g/kg ',\n",
       "   '89 g/kg'],\n",
       "  'valori_noael': ['150 mg/kg/d',\n",
       "   '150 mg/kg/day',\n",
       "   '300  mg/kg/day',\n",
       "   '343 mg/kg/d',\n",
       "   '750 mg/kg/day',\n",
       "   '750 mg/kg /day',\n",
       "   '750  mg/kg/day',\n",
       "   '900 mg/kg /day']},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294793'),\n",
       "  'Nome_comune': 'Butylene/Ethylene Copolymer',\n",
       "  'INCI_name': 'Butylene/Ethylene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=45c674ca-153b-4287-a339-3236540b5ba5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=32efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Supp. 2):59-90, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['xicity study in rats (no further details provided)LD50>2,000 mg/kg, no mortalities observed6 Polybutene analog di-n-',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, 1 animal had partial thickening of the forestoma',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, no mortalities observed6 Polybutene analog tetra',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, no mortalities observed6 Polyisobutene (100%), M',\n",
       "   'patches for 24 hours (no further details provided)LD50>2,000 mg/kg; no mortalities or overt signs of toxicity were o',\n",
       "   'bbits/ sex); material applied to clippedEstimated LD 50>3,000 mg/kg; skin reactions observed at 24 hours post-patch r'],\n",
       "  'contesti_noael': ['gue-Dawley rats received test material via gavage.NOAEL ¼1,000 mg/kg/d; toxicity of the test material was examined in F ',\n",
       "   'ss necropsy or histopathological examination. The NOAEL for reproductive and development toxicity in this rat study is 1,000 mg/kg/d. Genotoxicity In Vitro Ethylene/Octene Copolymer.',\n",
       "   'rl:CD (SD) IGS BR strain rats (10 rats/sex/group).NOAEL ¼1,000 mg/kg/d; during the dosing period, one rat in the control group and one rat in the 250 mg/kg/d dose group died but deaths were not treatment-rel',\n",
       "   'er. In a 4-week oral repeated dose rat study, the NOAEL for Hydrogenated Polydecene was 6,245 mg/kg/d in males and 6,771 mg/kg/d in females. Gross necropsy, histo- pathology, and',\n",
       "   'ats (5 sex/dose)No observed adverse effect level (NOAEL) ¼6,245 mg/kg/d in males and 6,771 mg/kg/d in females; no clinical signs of toxicity or mort',\n",
       "   'er. In a 4-week oral repeated dose rat study, the NOAEL for Hydrogenated Polydecene was 6,245 mg/kg/d in males and 6,771 mg/kg/d in females. Gross necropsy, histopathol- ogy, and'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg'],\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg/d',\n",
       "   '250 mg/kg/d',\n",
       "   '771 mg/kg/d',\n",
       "   '771 mg/kg/d',\n",
       "   '771 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294794'),\n",
       "  'Nome_comune': 'Butylene/Ethylene/Propylene Copolymer',\n",
       "  'INCI_name': 'Butylene/Ethylene/Propylene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=58226157-aba4-42c3-8dd9-906605446ca7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=32efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Supp. 2):59-90, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['xicity study in rats (no further details provided)LD50>2,000 mg/kg, no mortalities observed6 Polybutene analog di-n-',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, 1 animal had partial thickening of the forestoma',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, no mortalities observed6 Polybutene analog tetra',\n",
       "   'xicity study in rats (no further details provided)LD50>10,000 mg/kg, no mortalities observed6 Polyisobutene (100%), M',\n",
       "   'patches for 24 hours (no further details provided)LD50>2,000 mg/kg; no mortalities or overt signs of toxicity were o',\n",
       "   'bbits/ sex); material applied to clippedEstimated LD 50>3,000 mg/kg; skin reactions observed at 24 hours post-patch r'],\n",
       "  'contesti_noael': ['gue-Dawley rats received test material via gavage.NOAEL ¼1,000 mg/kg/d; toxicity of the test material was examined in F ',\n",
       "   'ss necropsy or histopathological examination. The NOAEL for reproductive and development toxicity in this rat study is 1,000 mg/kg/d. Genotoxicity In Vitro Ethylene/Octene Copolymer.',\n",
       "   'rl:CD (SD) IGS BR strain rats (10 rats/sex/group).NOAEL ¼1,000 mg/kg/d; during the dosing period, one rat in the control group and one rat in the 250 mg/kg/d dose group died but deaths were not treatment-rel',\n",
       "   'er. In a 4-week oral repeated dose rat study, the NOAEL for Hydrogenated Polydecene was 6,245 mg/kg/d in males and 6,771 mg/kg/d in females. Gross necropsy, histo- pathology, and',\n",
       "   'ats (5 sex/dose)No observed adverse effect level (NOAEL) ¼6,245 mg/kg/d in males and 6,771 mg/kg/d in females; no clinical signs of toxicity or mort',\n",
       "   'er. In a 4-week oral repeated dose rat study, the NOAEL for Hydrogenated Polydecene was 6,245 mg/kg/d in males and 6,771 mg/kg/d in females. Gross necropsy, histopathol- ogy, and'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg'],\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg/d',\n",
       "   '250 mg/kg/d',\n",
       "   '771 mg/kg/d',\n",
       "   '771 mg/kg/d',\n",
       "   '771 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294795'),\n",
       "  'Nome_comune': 'Butylene/Ethylene/Styrene Copolymer',\n",
       "  'INCI_name': 'Butylene/Ethylene/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4151c43e-a36d-4c90-917e-4165b00908db',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' acute oral toxicity study involving rats, and an LD 50 of >  5 ml/kg was reported.  The test protocol was not stated .32    An oral LD 50 of  >  2,000 mg/kg body weight (rats) for Syntran® 5903 was reported in a study ',\n",
       "   'col were  not included.  The estimated acute oral LD 50 was > 5,050 mg/kg (nontoxic).  It was noted that this finding was  ',\n",
       "   'cute dermal toxicity study involving rats, and an LD 50 of  > 5 g/kg was reported.  The test protocol was not stated.32'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight', '050 mg/kg', '5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294796'),\n",
       "  'Nome_comune': 'Butyloctyl Beeswax',\n",
       "  'INCI_name': 'Butyloctyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8f7174f2-fe8c-4db6-b800-cb8780a4675a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294797'),\n",
       "  'Nome_comune': 'Butyloctyl Behenate',\n",
       "  'INCI_name': 'Butyloctyl Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0161d7c2-d6bc-498a-8184-69ad62ab2fd8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294798'),\n",
       "  'Nome_comune': 'Butyloctyl Benzoate',\n",
       "  'INCI_name': 'Butyloctyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1211a4b2-273e-46ab-90cf-42ea2c469a48',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rted to be 2.69 g/kg. Dodecyl alcohol has an oral LD 50 of 12 800 mg/kg for rats. Tridecyl alcohol has an oral LD 50of17 200 mg/kg for rats. Tetradecyl alcohol has an oral LD 50 33 ',\n",
       "   ' reported to be 5600 mg/kg in rabbits. The dermal LD 50 of hexadecyl alcohol for rabbits was reported to be >2.6 g/kg. Aerosolized amyl alcohol at near saturation caus'],\n",
       "  'contesti_noael': ['(15, 40, or 120 mL/m3; purity 99.9 %).87 The oral NOAEL for noncancer systemic toxicity end points were 200 and 50 mg/kg/d in mice and rats, respectively, exposed chronical',\n",
       "   ' decreased food consumption and body weights. The NOAEL was 125 mg/kg/d for male and female F344 rats and B6C3Fl mice tre',\n",
       "   ' maternal weight gain. Maternal and developmental NOAEL was found to be 130 mg/kg/d in Wistar rats (n ¼10) orally exposed to ethylhex',\n",
       "   'ose females at birth and on day 4 postpartum. The NOAEL was 1000 mg/kg/d. In Ames tests, methyl benzoate, ethyl benzoate, '],\n",
       "  'valori_ld50': ['200 mg/kg ', '6 g/kg'],\n",
       "  'valori_noael': ['50 mg/kg/d',\n",
       "   '125 mg/kg/d',\n",
       "   '130 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d7294799'),\n",
       "  'Nome_comune': 'Butyloctyl Candelillate',\n",
       "  'INCI_name': 'Butyloctyl Candelillate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bdac2550-3bd0-48ce-9730-380e7b2574d9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d729479a'),\n",
       "  'Nome_comune': 'Butyloctyl Cetearate',\n",
       "  'INCI_name': 'Butyloctyl Cetearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67e208d5-efd0-44da-9627-966d438cae9c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19a6c1f2275d729479b'),\n",
       "  'Nome_comune': 'Butyloctyl Oleate',\n",
       "  'INCI_name': 'Butyloctyl Oleate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e11cab95-65d2-433a-b672-771be2eaaee9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d729479c'),\n",
       "  'Nome_comune': 'Butyloctyl Palmitate',\n",
       "  'INCI_name': 'Butyloctyl Palmitate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3b195713-675c-409a-8178-3fc9ad3e7406',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d729479d'),\n",
       "  'Nome_comune': 'Butyloctyl Salicylate',\n",
       "  'INCI_name': 'Butyloctyl Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=51e405f7-eccf-454d-9e5a-53a352397bdf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['.  No clinical signs were observed .  The dermal  LD 50 in rabbits exceeded 5.0 g/kg .    Hexyl Salicylate     Ten rabbits received a ',\n",
       "   ' clinical signs were observed .  The acute dermal LD 50 in rabbits exceeded 5.0 g/kg based  on 0/10 deaths at that dose.       Methyl S',\n",
       "   '-dosing. 7  It was concluded that t he acute oral LD 50  exceeded 5.0 g/kg , based on one animal death at that dose  on day ',\n",
       "   'was observed at  24 h. It was concluded that  the LD 50 exceeded 5.0 g/kg, based on one animal death at that dose on day 4 ',\n",
       "   '4  rats dosed 5 days per week for 15 weeks.1  The LD 50 during 15 weeks of dosing was estimated to be 366.5 mg/kg; a dose - related decrease in hindlimb grip stren',\n",
       "   'queous Sodium Salicylate for 4 weeks, the 28- day LD 50 was 646.5 mg/kg.  Liver and kidney necrosis was  observed in dogs that received 300 mg/kg of 10% aqueous Sodium Salicylate for 2 weeks .  A ',\n",
       "   'any  pathological abnormality.   The acute dermal LD 50 was considered to be > 2 g/kg.      Oral     The following acute oral toxicity ',\n",
       "   'tudies involving rats:    Butyloctyl Salicylate ( LD 50 > 5 g/kg),  Ethylhexyl Salicylate (  LD 50 > 2 g/kg),  Isodecyl Salicylate (no toxicity at levels as ',\n",
       "   'gum Arabic) was administered to 10 Wistar rats.4  LD 50  values in the range of 0.5 to 2 g/kg were reported.      Sodium Salicylate    The acute',\n",
       "   'with 0.5 mL  water) to the skin.  An acute dermal LD 50 of > 2 g/kg was reported for Sodium  Salicylate in a study inv',\n",
       "   'nd no clinical signs were  observed .  The dermal LD 50 in rabbits exceeded 5 g/kg.     Salicylic Acid          In a study involving',\n",
       "   'te, and Methyl Salicylate involving rabbits,  the LD 50 was > 5 g/kg for each salicylate.   No signs of systemic toxici',\n",
       "   'olving rats.  An a cute oral LD 50 of > 5 g/kg for Ethylhexyl Salicylate and Hexyl Salicylate in ',\n",
       "   ' studies on Methyl Salicylate involving mice, the LD 50 was  calculated to be 1.39 g/kg (95% CI of 1.25 to 1.54 g/kg) and a dose of 0.5 g/kg was selected as the maximum tolerated dose.    LD ',\n",
       "   'y data for the sexes  combined projected an acute LD 50 of 1.44 g/kg/day .    Salicylic Acid      In groups of rats do',\n",
       "   '/kg. Most animal  deaths occurred  on day 1.  The LD 50 was calculated to be 1.39 g/kg (95% CI  1.25 - 1.54 g/kg) .    Methyl S alicylate was evaluated as a part ',\n",
       "   ' high as 4.83 g/kg),  Methyl Salicylate (LD 50 between 0.887 g/kg and 1.25 g/kg),  Salicylic Acid ( LD 50 ranging from 0.891 g/kg  to 1.58 g/kg),  Sodium Salicyla te (LD 50 between 0.9 g/kg and',\n",
       "   ' 1.7 g/kg) ; and Tridecyl Salicylate (LD 50 > 1.98 g/kg).1  Values  for acute oral toxicity in other spec'],\n",
       "  'contesti_noael': ['size, the no -observed - adverse- effect -level ( NOAEL ) for developmental toxicity was determined to be 25 mg/kg/day.     Methyl Salicylate    Methyl Salicylate was d',\n",
       "   'n the gestation index, and lower litter size, the NOAEL for developmenta l toxicity was  determined to be 25 mg/kg/day.  On  postnatal day 1, 89% of the pups from dams ',\n",
       "   ', “b ased on the  available  data, and using the  NOAEL values of 50 mg/kg body weight/day identified in subchronic and chronic toxicity  st',\n",
       "   'MOS for systemic exposure is mentioned.  Based on NOAEL values of 50 mg/kg body weight/day in subchronic and chronic toxicity studies, a MOS',\n",
       "   '63  In a risk assessment conducted by  SCCNFP , a NOAEL of 75 mg/kg/day, derived from several rat oral teratogenicity  st',\n",
       "   '/kg/day  MOS (Butyloctyl Salicylate , lipstick) = NOAEL ( from rat oral teratogenicity stu dies; see above)  / SED   = 75 mg/kg/day  /0.1705 mg/kg/day   = 220       Oral   Salicylic Acid      An expos'],\n",
       "  'valori_ld50': ['0 g/kg',\n",
       "   '0 g/kg ',\n",
       "   '0 g/kg',\n",
       "   '0 g/kg',\n",
       "   '5 mg/kg',\n",
       "   '300 mg/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '44 g/kg',\n",
       "   '54 g/kg',\n",
       "   '58 g/kg',\n",
       "   '98 g/kg'],\n",
       "  'valori_noael': ['25 mg/kg/day',\n",
       "   '25 mg/kg/day',\n",
       "   '50 mg/kg body weight/day',\n",
       "   '50 mg/kg body weight/day',\n",
       "   '75 mg/kg/day',\n",
       "   '1705 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d729479e'),\n",
       "  'Nome_comune': 'Butylparaben',\n",
       "  'INCI_name': 'Butylparaben',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bf95c8fe-94b2-428c-a243-127a9e275dca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl.1):5-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/7184',\n",
       "   'valori': ['LD50 Mouse (dd-strain) oral 13200 mg/kg',\n",
       "    'LD50 Mouse oral 5.0 g/kg',\n",
       "    'LD50 Mouse ip 230 mg/kg'],\n",
       "   'fonti': ['Cosmetic Ingredient Review; Final Amended Report on the Safety Assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in Cosmetic Products p 35. Int J Toxicol 27 Suppl 4: 1-82 (2008). Available from, as of November 21, 2016: https://online.personalcarecouncil.org/ctfa-static/online/lists/cir-pdfs/PR427.pdf',\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. v6 672\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 637\"]},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['nts, assuming a no observed adverse effect level (NOAEL) of 1,000 mg/kg/d from an older DART study.2After careful considera',\n",
       "   'al toxicity at that dose. The mater- nal toxicity NOAEL dose was 1,000 mg/kg bw/d. Parabens have been extensively studied to evalua',\n",
       "   'r com- bined paraben use in a single formulation. NOAEL/MOS (adult, multiple paraben) ¼SED¼160 mg/kg/d/100 ¼1.6 mg/kg/d (SED /C2body weight)/ (dermal absorption /C2conve',\n",
       "   'entration tested (10,000 ppm), corresponding to a NOAEL of 1,141.1 +58.9 and 1,087.6 +67.8 mg/kg/d for Methylparaben and Butylparaben, respectively ',\n",
       "   'a, tumor necrosis factor a. 34Scorresponding to a NOAEL of about 1,140 and 1,100 mg/kg/d for Methylparaben and Butylparaben, respectively.',\n",
       "   'nd DART studies, the Panel determined an adequate NOAEL value of 160 mg/kg/d for Butylparaben. An MOS was recalculated accordi',\n",
       "   '90, compared to controls The results suggested an NOAEL of 160 mg/kg bw/d for Butylparaben for male reproduction and develo',\n",
       "   'risk assessment, the Panel determined an adequate NOAEL value of 160 mg/kg/d for Butylparaben in consideration of the new data',\n",
       "   'vative risk assessment was performed. Therein, an NOAEL value of 160 mg/kg/d for Butylparaben was deter- mined to be adequate ',\n",
       "   'tion of all the new data, the Panel determined an NOAEL of 160 mg/kg bw/d for Butylparaben. The Panel determined the differ'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg bw/d',\n",
       "   '6 mg/kg/d',\n",
       "   '8 mg/kg/d',\n",
       "   '100 mg/kg/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg bw/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d729479f'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Butter',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Butter',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cbfd9ceb-3162-43bd-b07e-29cdb4479deb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a0'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Butter Extract',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Butter Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=06d3d739-d734-45eb-b960-ab8c7a662580',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a1'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Butter Unsaponifiables',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Butter Unsaponifiables',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c79fcac9-63f9-4b74-bff3-2ba5fcb85f6f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a2'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Nut Extract',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Nut Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b371c7f5-5fe1-4b68-af3b-97a9c2705caf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a3'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Nut Shell Powder',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Nut Shell Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ece5a6d0-3ebb-485a-baf9-391938d67df7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19b6c1f2275d72947a4'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Oil',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3400cc9e-f3ac-4c35-8de6-5b607a67c9d7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a5'),\n",
       "  'Nome_comune': 'Butyrospermum Parkii (Shea) Seedcake Extract',\n",
       "  'INCI_name': 'Butyrospermum Parkii (Shea) Seedcake Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=096d0449-9e18-481a-a7a3-e9192bdff35d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=119162d0-bdd5-4f59-a27f-b8347d6473e3',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):82-95, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a6'),\n",
       "  'Nome_comune': 'C10-11 Isoparaffin',\n",
       "  'INCI_name': 'C10-11 Isoalkane (Formerly C10-11 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=036f40a8-d75b-4435-9493-9643026d6862',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a7'),\n",
       "  'Nome_comune': 'C10-12 Isoparaffin',\n",
       "  'INCI_name': 'C10-12 Isoalkane (Formerly C10-12 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2b8254ae-d629-462b-bf97-b9a4cd9262d6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a8'),\n",
       "  'Nome_comune': 'C10-13 Isoparaffin',\n",
       "  'INCI_name': 'C10-13 Isoalkane (Formerly C10-13 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=79eea325-2c88-4ccb-818f-f528ab5063e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947a9'),\n",
       "  'Nome_comune': 'C10-16 Alkyl Glucoside',\n",
       "  'INCI_name': 'C10-16 Alkyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ba099352-eb0d-4588-ab16-2d978247e56e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['fe as used Myristyl alcoholAnimal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg Inhalation: 3%, 1 h, ataxia and moderate nasal irr',\n",
       "   ' glucoside using rabbits, the median lethal dose (LD 50) was greater than the 2 g/kg dose administered. In oral studies with the same t',\n",
       "   'erides and phospholipids66 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD 50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   'sorbed from the GI tract68 Animal toxicology Oral LD 50: >8 g/kg; 3 mos dermal study: formulations w/8%, some derm',\n",
       "   ' as used Isostearyl alcoholAnimal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg66 Dermal ',\n",
       "   'afe as used Octyl dodecanolAnimal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD50: >3 g/kg68 (continued)24S Internatio',\n",
       "   ' and 2.7% in the urine65 Animal toxicology Dermal LD 50(rabbits), 4.2 g/kg; oral LD 50(rats), 0.79-4.36 g/kg Short-term oral: 6.9% n-butyl alcohol and 25% sucr'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '36 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947aa'),\n",
       "  'Nome_comune': 'C10-16 Pareth-1',\n",
       "  'INCI_name': 'C10-16 Alketh-1 (Formerly C10-16 Pareth-1)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e145bb52-5323-4f3b-a03d-8f9a6742c381',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947ab'),\n",
       "  'Nome_comune': 'C10-16 Pareth-2',\n",
       "  'INCI_name': 'C10-16 Alketh-2 (Formerly C10-16 Pareth-2)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=917fed05-94a0-4782-b161-774c688cf1f3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947ac'),\n",
       "  'Nome_comune': 'C10-18 Triglycerides',\n",
       "  'INCI_name': 'C10-18 Triglycerides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=84a85e95-e6f6-4181-b7fe-283b241d021f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed19c6c1f2275d72947ad'),\n",
       "  'Nome_comune': 'C10-40 Isoalkyl Acid',\n",
       "  'INCI_name': 'C10-40 Isoalkyl Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e62a513-fdc8-47d8-a8ef-661d2baef6d9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947ae'),\n",
       "  'Nome_comune': 'C10-40 Isoalkyl Acid Octyldodecanol Esters',\n",
       "  'INCI_name': 'C10-40 Isoalkyl Acid Octyldodecanol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dfa5ca17-d21e-43a5-90a7-4bd7424e6ef2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947af'),\n",
       "  'Nome_comune': 'C10-40 Isoalkyl Acid Phytosterol Esters',\n",
       "  'INCI_name': 'C10-40 Isoalkyl Acid Phytosterol Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f96cefc1-5f8c-451f-a245-4346c31589bf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['on  toxicity .    Dermal - Non-Human   The dermal LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg.59  A wood -derived mixture  (a stanol compositio',\n",
       "   ' cytotoxic  to mouse macrophages  in vitro .  The LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg .  There were no maternal or teratogenic  effects'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b0'),\n",
       "  'Nome_comune': 'C10-40 Isoalkyl Acid Triglyceride',\n",
       "  'INCI_name': 'C10-40 Isoalkyl Acid Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6e59b8df-f271-4a0b-b9ba-2784b8286b4c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b1'),\n",
       "  'Nome_comune': 'C11-12 Isoparaffin',\n",
       "  'INCI_name': 'C11-12 Isoalkane (Formerly C11-12 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3d977ec4-fda8-4db4-9fe7-569d72437816',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b2'),\n",
       "  'Nome_comune': 'C11-13 Isoparaffin',\n",
       "  'INCI_name': 'C11-13 Isoalkane (Formerly C11-13 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=79cee1ec-48f1-42e2-b7d9-f35c2af2201a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b3'),\n",
       "  'Nome_comune': 'C11-13 Pareth-10',\n",
       "  'INCI_name': 'C11-13 Alketh-10 (Formerly C11-13 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=001cc67a-424c-467b-89f4-9312df1f70b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b4'),\n",
       "  'Nome_comune': 'C11-13 Pareth-6',\n",
       "  'INCI_name': 'C11-13 Alketh-6 (Formerly C11-13 Pareth-6)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=973bde9a-0033-4c2f-aa1b-6246e1f42f41',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b5'),\n",
       "  'Nome_comune': 'C11-13 Pareth-9',\n",
       "  'INCI_name': 'C11-13 Alketh-9 (Formerly C11-13 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff5fe46f-8ffd-469d-8248-1c3d493a7d90',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19d6c1f2275d72947b6'),\n",
       "  'Nome_comune': 'C11-14 Isoparaffin',\n",
       "  'INCI_name': 'C11-14 Isoalkane (Formerly C11-14 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bec0069d-1e3f-45e9-a2a4-1abc3ede1e7e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947b7'),\n",
       "  'Nome_comune': 'C11-15 Pareth-12',\n",
       "  'INCI_name': 'C11-15 Alketh-12 (Formerly C11-15 Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bca281de-5688-4b5b-b1d3-eb33c933d8d3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947b8'),\n",
       "  'Nome_comune': 'C11-15 Pareth-15',\n",
       "  'INCI_name': 'C11-15 Alketh-15 (Formerly C11-15 Pareth-15)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6c564534-6cd3-46a6-a6b2-fbbe2e06e825',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947b9'),\n",
       "  'Nome_comune': 'C11-15 Pareth-20',\n",
       "  'INCI_name': 'C11-15 Alketh-20 (Formerly C11-15 Pareth-20)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f801f709-52aa-43a2-8cb0-5ef439574dd1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947ba'),\n",
       "  'Nome_comune': 'C11-15 Pareth-3',\n",
       "  'INCI_name': 'C11-15 Alketh-3 (Formerly C11-15 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5fb2b1d7-2553-4244-b330-b6d6e4d895a2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947bb'),\n",
       "  'Nome_comune': 'C11-15 Pareth-30',\n",
       "  'INCI_name': 'C11-15 Alketh-30 (Formerly C11-15 Pareth-30)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=acfca8ec-87df-4d6e-8a8d-3fc64e0acb05',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947bc'),\n",
       "  'Nome_comune': 'C11-15 Pareth-40',\n",
       "  'INCI_name': 'C11-15 Alketh-40 (Formerly C11-15 Pareth-40)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3c5e4dcc-6e95-4b26-b261-4dfdfa0a8188',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947bd'),\n",
       "  'Nome_comune': 'C11-15 Pareth-5',\n",
       "  'INCI_name': 'C11-15 Alketh-5 (Formerly C11-15 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=14066adc-546b-4616-8f94-0e6786886ead',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947be'),\n",
       "  'Nome_comune': 'C11-15 Pareth-7',\n",
       "  'INCI_name': 'C11-15 Alketh-7 (Formerly C11-15 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e6768857-27cc-42b7-b1c9-d862588b1156',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947bf'),\n",
       "  'Nome_comune': 'C11-15 Pareth-9',\n",
       "  'INCI_name': 'C11-15 Alketh-9 (Formerly C11-15 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7094c8b1-2e08-4261-9e9f-414adf165b45',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19e6c1f2275d72947c0'),\n",
       "  'Nome_comune': 'C11-15 Sec-Pareth-12',\n",
       "  'INCI_name': 'C11-15 Sec-Alketh-12 (Formerly C11-15 Sec-Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e20d9ef9-6761-4a22-bd93-bdbfc456d5e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c1'),\n",
       "  'Nome_comune': 'C11-21 Pareth-10',\n",
       "  'INCI_name': 'C11-21 Alketh-10 (Formerly C11-21 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=90ffea43-f013-45bb-82e7-ed18ad15c331',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c2'),\n",
       "  'Nome_comune': 'C11-21 Pareth-3',\n",
       "  'INCI_name': 'C11-21 Alketh-3 (Formerly C11-21 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7c0f0941-d8b3-40a5-ba9b-62bff5719fc8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c3'),\n",
       "  'Nome_comune': 'C12-13 Alkyl Ethylhexanoate',\n",
       "  'INCI_name': 'C12-13 Alkyl Ethylhexanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b14283fd-b180-4cfd-b365-8d4209f3575a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9897bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.3):61-73, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c4'),\n",
       "  'Nome_comune': 'C12-13 Pareth-1',\n",
       "  'INCI_name': 'C12-13 Alketh-1 (Formerly C12-13 Pareth-1)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=197af9b4-3b20-4158-a272-713a49bf3403',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c5'),\n",
       "  'Nome_comune': 'C12-13 Pareth-10',\n",
       "  'INCI_name': 'C12-13 Alketh-10 (Formerly C12-13 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d267f919-1fc1-477a-a430-eebf6ccf80de',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c6'),\n",
       "  'Nome_comune': 'C12-13 Pareth-15',\n",
       "  'INCI_name': 'C12-13 Alketh-15 (Formerly C12-13 Pareth-15)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1e9d89da-edec-48ba-b434-ea5ff0adb8bb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c7'),\n",
       "  'Nome_comune': 'C12-13 Pareth-2',\n",
       "  'INCI_name': 'C12-13 Alketh-2 (Formerly C12-13 Pareth-2)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8ed4d216-a147-425c-a631-f68098e019f4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c8'),\n",
       "  'Nome_comune': 'C12-13 Pareth-23',\n",
       "  'INCI_name': 'C12-13 Alketh-23 (Formerly C12-13 Pareth-23)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bc8b6ffb-0c88-4e2e-8daa-fe5a0041f54d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947c9'),\n",
       "  'Nome_comune': 'C12-13 Pareth-3',\n",
       "  'INCI_name': 'C12-13 Alketh-3 (Formerly C12-13 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=78b3a87d-2e72-4541-9569-88fedaa42331',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed19f6c1f2275d72947ca'),\n",
       "  'Nome_comune': 'C12-13 Pareth-4',\n",
       "  'INCI_name': 'C12-13 Alketh-4 (Formerly C12-13 Pareth-4)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cb5b63f2-955d-41d3-b976-f6d077ccc253',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947cb'),\n",
       "  'Nome_comune': 'C12-13 Pareth-5',\n",
       "  'INCI_name': 'C12-13 Alketh-5 (Formerly C12-13 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fef34f6b-b76e-4911-904f-66867dedf937',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947cc'),\n",
       "  'Nome_comune': 'C12-13 Pareth-6',\n",
       "  'INCI_name': 'C12-13 Alketh-6 (Formerly C12-13 Pareth-6)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6bfbdf56-d635-4213-8b9c-2dc810919a78',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947cd'),\n",
       "  'Nome_comune': 'C12-13 Pareth-7',\n",
       "  'INCI_name': 'C12-13 Alketh-7 (Formerly C12-13 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c423a901-7ea5-405f-9f40-5e96b5c745b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947ce'),\n",
       "  'Nome_comune': 'C12-13 Pareth-9',\n",
       "  'INCI_name': 'C12-13 Alketh-9 (Formerly C12-13 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fb185a25-e39d-45ab-84d9-32d0c743cf3d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947cf'),\n",
       "  'Nome_comune': 'C12-14 Isoparaffin',\n",
       "  'INCI_name': 'C12-14 Isoalkane (Formerly C12-14 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=53860a81-369e-479d-aae9-14cda1099758',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947d0'),\n",
       "  'Nome_comune': 'C12-14 Pareth-11',\n",
       "  'INCI_name': 'C12-14 Alketh-11 (Formerly C12-14 Pareth-11)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8a645dff-c940-47ed-b3f7-7896897200a3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947d1'),\n",
       "  'Nome_comune': 'C12-14 Pareth-12',\n",
       "  'INCI_name': 'C12-14 Alketh-12 (Formerly C12-14 Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d6e9de3f-76eb-44ef-b952-839bb6f8201a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947d2'),\n",
       "  'Nome_comune': 'C12-14 Pareth-3',\n",
       "  'INCI_name': 'C12-14 Alketh-3 (Formerly C12-14 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1d9a3b62-419b-45e2-abc7-f77942389fa8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a06c1f2275d72947d3'),\n",
       "  'Nome_comune': 'C12-14 Pareth-5',\n",
       "  'INCI_name': 'C12-14 Alketh-5 (Formerly C12-14 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d5c45459-97c4-4145-8da8-2b164de9acca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d4'),\n",
       "  'Nome_comune': 'C12-14 Pareth-7',\n",
       "  'INCI_name': 'C12-14 Alketh-7 (Formerly C12-14 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2d0a2026-e4b4-4f76-9549-9672d639d1f5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d5'),\n",
       "  'Nome_comune': 'C12-14 Pareth-9',\n",
       "  'INCI_name': 'C12-14 Alketh-9 (Formerly C12-14 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=94093418-2d63-4e20-ac5e-b788abc1c0de',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d6'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-12',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-12 (Formerly C12-14 Sec-Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9a32ec12-14b9-4c82-b404-1f8dffc67e8d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d7'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-15',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-15 (Formerly C12-14 Sec-Pareth-15)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f50003c9-adc4-4740-8172-6594a735a5cb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d8'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-20',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-20 (Formerly C12-14 Sec-Pareth-20)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fa793c7b-31e5-40ca-a71b-89e7cd69f18b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947d9'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-3',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-3 (Formerly C12-14 Sec-Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=617c1136-baed-4d31-bbd3-094c26e0d2ca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947da'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-30',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-30 (Formerly C12-14 Sec-Pareth-30)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c7707b54-74c2-4f0b-bbfa-b92204da84ed',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947db'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-40',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-40 (Formerly C12-14 Sec-Pareth-40)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1ac4376a-1fd4-4fe1-b235-687864584d33',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947dc'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-5',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-5 (Formerly C12-14 Sec-Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c960d82-4cb5-4314-8b08-92576e9ae529',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a16c1f2275d72947dd'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-50',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-50 (Formerly C12-14 Sec-Pareth-50)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a0beae96-d3c3-4771-8d44-3a7957a79177',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947de'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-7',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-7 (Formerly C12-14 Sec-Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4e1dc8c9-9829-4b75-9953-1acaa2149144',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947df'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-8',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-8 (Formerly C12-14 Sec-Pareth-8)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=af9dbfc8-b3c5-4e56-9066-b2d1cc0b90ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e0'),\n",
       "  'Nome_comune': 'C12-14 Sec-Pareth-9',\n",
       "  'INCI_name': 'C12-14 Sec-Alketh-9 (Formerly C12-14 Sec-Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a68dce9-a21c-459a-a2fd-2b31d5458402',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e1'),\n",
       "  'Nome_comune': 'C12-15 Alkyl Benzoate',\n",
       "  'INCI_name': 'C12-15 Alkyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ef996fe2-294a-4622-8c61-baa6a8ca360e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['rted to be 2.69 g/kg. Dodecyl alcohol has an oral LD 50 of 12 800 mg/kg for rats. Tridecyl alcohol has an oral LD 50of17 200 mg/kg for rats. Tetradecyl alcohol has an oral LD 50 33 ',\n",
       "   ' reported to be 5600 mg/kg in rabbits. The dermal LD 50 of hexadecyl alcohol for rabbits was reported to be >2.6 g/kg. Aerosolized amyl alcohol at near saturation caus'],\n",
       "  'contesti_noael': ['(15, 40, or 120 mL/m3; purity 99.9 %).87 The oral NOAEL for noncancer systemic toxicity end points were 200 and 50 mg/kg/d in mice and rats, respectively, exposed chronical',\n",
       "   ' decreased food consumption and body weights. The NOAEL was 125 mg/kg/d for male and female F344 rats and B6C3Fl mice tre',\n",
       "   ' maternal weight gain. Maternal and developmental NOAEL was found to be 130 mg/kg/d in Wistar rats (n ¼10) orally exposed to ethylhex',\n",
       "   'ose females at birth and on day 4 postpartum. The NOAEL was 1000 mg/kg/d. In Ames tests, methyl benzoate, ethyl benzoate, '],\n",
       "  'valori_ld50': ['200 mg/kg ', '6 g/kg'],\n",
       "  'valori_noael': ['50 mg/kg/d',\n",
       "   '125 mg/kg/d',\n",
       "   '130 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e2'),\n",
       "  'Nome_comune': 'C12-15 Alkyl Ethylhexanoate',\n",
       "  'INCI_name': 'C12-15 Alkyl Ethylhexanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ec23291f-3031-4514-8474-1803bbfbf5d5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9897bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.3):61-73, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e3'),\n",
       "  'Nome_comune': 'C12-15 Alkyl Salicylate',\n",
       "  'INCI_name': 'C12-15 Alkyl Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=73069494-dfe0-46ea-b6d8-08ce2dab4596',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['.  No clinical signs were observed .  The dermal  LD 50 in rabbits exceeded 5.0 g/kg .    Hexyl Salicylate     Ten rabbits received a ',\n",
       "   ' clinical signs were observed .  The acute dermal LD 50 in rabbits exceeded 5.0 g/kg based  on 0/10 deaths at that dose.       Methyl S',\n",
       "   '-dosing. 7  It was concluded that t he acute oral LD 50  exceeded 5.0 g/kg , based on one animal death at that dose  on day ',\n",
       "   'was observed at  24 h. It was concluded that  the LD 50 exceeded 5.0 g/kg, based on one animal death at that dose on day 4 ',\n",
       "   '4  rats dosed 5 days per week for 15 weeks.1  The LD 50 during 15 weeks of dosing was estimated to be 366.5 mg/kg; a dose - related decrease in hindlimb grip stren',\n",
       "   'queous Sodium Salicylate for 4 weeks, the 28- day LD 50 was 646.5 mg/kg.  Liver and kidney necrosis was  observed in dogs that received 300 mg/kg of 10% aqueous Sodium Salicylate for 2 weeks .  A ',\n",
       "   'any  pathological abnormality.   The acute dermal LD 50 was considered to be > 2 g/kg.      Oral     The following acute oral toxicity ',\n",
       "   'tudies involving rats:    Butyloctyl Salicylate ( LD 50 > 5 g/kg),  Ethylhexyl Salicylate (  LD 50 > 2 g/kg),  Isodecyl Salicylate (no toxicity at levels as ',\n",
       "   'gum Arabic) was administered to 10 Wistar rats.4  LD 50  values in the range of 0.5 to 2 g/kg were reported.      Sodium Salicylate    The acute',\n",
       "   'with 0.5 mL  water) to the skin.  An acute dermal LD 50 of > 2 g/kg was reported for Sodium  Salicylate in a study inv',\n",
       "   'nd no clinical signs were  observed .  The dermal LD 50 in rabbits exceeded 5 g/kg.     Salicylic Acid          In a study involving',\n",
       "   'te, and Methyl Salicylate involving rabbits,  the LD 50 was > 5 g/kg for each salicylate.   No signs of systemic toxici',\n",
       "   'olving rats.  An a cute oral LD 50 of > 5 g/kg for Ethylhexyl Salicylate and Hexyl Salicylate in ',\n",
       "   ' studies on Methyl Salicylate involving mice, the LD 50 was  calculated to be 1.39 g/kg (95% CI of 1.25 to 1.54 g/kg) and a dose of 0.5 g/kg was selected as the maximum tolerated dose.    LD ',\n",
       "   'y data for the sexes  combined projected an acute LD 50 of 1.44 g/kg/day .    Salicylic Acid      In groups of rats do',\n",
       "   '/kg. Most animal  deaths occurred  on day 1.  The LD 50 was calculated to be 1.39 g/kg (95% CI  1.25 - 1.54 g/kg) .    Methyl S alicylate was evaluated as a part ',\n",
       "   ' high as 4.83 g/kg),  Methyl Salicylate (LD 50 between 0.887 g/kg and 1.25 g/kg),  Salicylic Acid ( LD 50 ranging from 0.891 g/kg  to 1.58 g/kg),  Sodium Salicyla te (LD 50 between 0.9 g/kg and',\n",
       "   ' 1.7 g/kg) ; and Tridecyl Salicylate (LD 50 > 1.98 g/kg).1  Values  for acute oral toxicity in other spec'],\n",
       "  'contesti_noael': ['size, the no -observed - adverse- effect -level ( NOAEL ) for developmental toxicity was determined to be 25 mg/kg/day.     Methyl Salicylate    Methyl Salicylate was d',\n",
       "   'n the gestation index, and lower litter size, the NOAEL for developmenta l toxicity was  determined to be 25 mg/kg/day.  On  postnatal day 1, 89% of the pups from dams ',\n",
       "   ', “b ased on the  available  data, and using the  NOAEL values of 50 mg/kg body weight/day identified in subchronic and chronic toxicity  st',\n",
       "   'MOS for systemic exposure is mentioned.  Based on NOAEL values of 50 mg/kg body weight/day in subchronic and chronic toxicity studies, a MOS',\n",
       "   '63  In a risk assessment conducted by  SCCNFP , a NOAEL of 75 mg/kg/day, derived from several rat oral teratogenicity  st',\n",
       "   '/kg/day  MOS (Butyloctyl Salicylate , lipstick) = NOAEL ( from rat oral teratogenicity stu dies; see above)  / SED   = 75 mg/kg/day  /0.1705 mg/kg/day   = 220       Oral   Salicylic Acid      An expos'],\n",
       "  'valori_ld50': ['0 g/kg',\n",
       "   '0 g/kg ',\n",
       "   '0 g/kg',\n",
       "   '0 g/kg',\n",
       "   '5 mg/kg',\n",
       "   '300 mg/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '44 g/kg',\n",
       "   '54 g/kg',\n",
       "   '58 g/kg',\n",
       "   '98 g/kg'],\n",
       "  'valori_noael': ['25 mg/kg/day',\n",
       "   '25 mg/kg/day',\n",
       "   '50 mg/kg body weight/day',\n",
       "   '50 mg/kg body weight/day',\n",
       "   '75 mg/kg/day',\n",
       "   '1705 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e4'),\n",
       "  'Nome_comune': 'C12-15 Pareth-10',\n",
       "  'INCI_name': 'C12-15 Alketh-10 (Formerly C12-15 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8191ac85-df8d-4d24-ae7b-6eaf4565e2ad',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e5'),\n",
       "  'Nome_comune': 'C12-15 Pareth-11',\n",
       "  'INCI_name': 'C12-15 Alketh-11 (Formerly C12-15 Pareth-11)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=26c5c958-4195-4973-83b5-996e2b0af4ac',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a26c1f2275d72947e6'),\n",
       "  'Nome_comune': 'C12-15 Pareth-12',\n",
       "  'INCI_name': 'C12-15 Alketh-12 (Formerly C12-15 Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3347d339-e848-49e0-b627-7fc83c097e55',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947e7'),\n",
       "  'Nome_comune': 'C12-15 Pareth-2',\n",
       "  'INCI_name': 'C12-15 Alketh-2 (Formerly C12-15 Pareth-2)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3187c1e8-e31f-47a5-9574-5cd57f8fd28e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947e8'),\n",
       "  'Nome_comune': 'C12-15 Pareth-3',\n",
       "  'INCI_name': 'C12-15 Alketh-3 (Formerly C12-15 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8afe7629-85e2-4b23-b51c-6fc946a1d25b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947e9'),\n",
       "  'Nome_comune': 'C12-15 Pareth-4',\n",
       "  'INCI_name': 'C12-15 Alketh-4 (Formerly C12-15 Pareth-4)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=23650a51-85ef-4ba1-b3bd-2bd9328a610b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ea'),\n",
       "  'Nome_comune': 'C12-15 Pareth-5',\n",
       "  'INCI_name': 'C12-15 Alketh-5 (Formerly C12-15 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cb65b33e-51da-489f-ad85-3713f5031e41',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947eb'),\n",
       "  'Nome_comune': 'C12-15 Pareth-7',\n",
       "  'INCI_name': 'C12-15 Alketh-7 (Formerly C12-15 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6166763a-2949-4ce9-80d9-4d1dd70250d8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ec'),\n",
       "  'Nome_comune': 'C12-15 Pareth-9',\n",
       "  'INCI_name': 'C12-15 Alketh-9 (Formerly C12-15 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eaffb005-0c5f-4492-88d4-b44cad04d82b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ed'),\n",
       "  'Nome_comune': 'C12-16 Pareth-5',\n",
       "  'INCI_name': 'C12-16 Alketh-5 (Formerly C12-16 Pareth-5)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1684b1a2-0fa3-44f9-89db-b906d19af242',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ee'),\n",
       "  'Nome_comune': 'C12-16 Pareth-7',\n",
       "  'INCI_name': 'C12-16 Alketh-7 (Formerly C12-16 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aebd5859-787a-417e-823f-a69de9be323c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947ef'),\n",
       "  'Nome_comune': 'C12-16 Pareth-9',\n",
       "  'INCI_name': 'C12-16 Alketh-9 (Formerly C12-16 Pareth-9)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=550b21b2-5116-4f19-b18e-fc0de1f97fd4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a36c1f2275d72947f0'),\n",
       "  'Nome_comune': 'C12-18 Acid Triglyceride',\n",
       "  'INCI_name': 'C12-18 Acid Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7941147c-c487-4cb0-baaa-316a2dc64f5a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f1'),\n",
       "  'Nome_comune': 'C12-18 Alkyl Glucoside',\n",
       "  'INCI_name': 'C12-18 Alkyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1b51bc76-4ee3-43f3-a172-68cbe61108b9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['fe as used Myristyl alcoholAnimal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg Inhalation: 3%, 1 h, ataxia and moderate nasal irr',\n",
       "   ' glucoside using rabbits, the median lethal dose (LD 50) was greater than the 2 g/kg dose administered. In oral studies with the same t',\n",
       "   'erides and phospholipids66 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD 50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   'sorbed from the GI tract68 Animal toxicology Oral LD 50: >8 g/kg; 3 mos dermal study: formulations w/8%, some derm',\n",
       "   ' as used Isostearyl alcoholAnimal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg66 Dermal ',\n",
       "   'afe as used Octyl dodecanolAnimal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD50: >3 g/kg68 (continued)24S Internatio',\n",
       "   ' and 2.7% in the urine65 Animal toxicology Dermal LD 50(rabbits), 4.2 g/kg; oral LD 50(rats), 0.79-4.36 g/kg Short-term oral: 6.9% n-butyl alcohol and 25% sucr'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '36 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f2'),\n",
       "  'Nome_comune': 'C12-20 Alkyl Glucoside',\n",
       "  'INCI_name': 'C12-20 Alkyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a9988a63-b0ed-4d6b-9f29-0a0f4a8237b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['fe as used Myristyl alcoholAnimal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg Inhalation: 3%, 1 h, ataxia and moderate nasal irr',\n",
       "   ' glucoside using rabbits, the median lethal dose (LD 50) was greater than the 2 g/kg dose administered. In oral studies with the same t',\n",
       "   'erides and phospholipids66 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD 50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   'sorbed from the GI tract68 Animal toxicology Oral LD 50: >8 g/kg; 3 mos dermal study: formulations w/8%, some derm',\n",
       "   ' as used Isostearyl alcoholAnimal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg66 Dermal ',\n",
       "   'afe as used Octyl dodecanolAnimal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD50: >3 g/kg68 (continued)24S Internatio',\n",
       "   ' and 2.7% in the urine65 Animal toxicology Dermal LD 50(rabbits), 4.2 g/kg; oral LD 50(rats), 0.79-4.36 g/kg Short-term oral: 6.9% n-butyl alcohol and 25% sucr'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '36 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f3'),\n",
       "  'Nome_comune': 'C12-20 Isoparaffin',\n",
       "  'INCI_name': 'C12-20 Isoalkane (Formerly C12-20 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ff4341ed-580b-4929-896f-5c8577432b34',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f4'),\n",
       "  'Nome_comune': 'C12-22 Alkyl Acrylate/Hydroxyethylacrylate Copolymer',\n",
       "  'INCI_name': 'C12-22 Alkyl Acrylate/Hydroxyethylacrylate Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a253bb75-9198-403e-b214-f3e92eaaf866',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f5'),\n",
       "  'Nome_comune': 'C13-14 Isoparaffin',\n",
       "  'INCI_name': 'C13-14 Isoalkane (Formerly C13-14 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7ebf05a3-727a-447d-b0bc-aecb3d1aadaa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f6'),\n",
       "  'Nome_comune': 'C13-15 Pareth-21',\n",
       "  'INCI_name': 'C13-15 Alketh-21 (Formerly C13-15 Pareth-21)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9b6a73e4-0ff3-49aa-afde-bc167a51b0fd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f7'),\n",
       "  'Nome_comune': 'C13-16 Isoparaffin',\n",
       "  'INCI_name': 'C13-16 Isoalkane (Formerly C13-16 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5fb995fd-d3ff-44e2-93c5-46e0974d867c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f8'),\n",
       "  'Nome_comune': 'C14-15 Dialkyl Carbonate',\n",
       "  'INCI_name': 'C14-15 Dialkyl Carbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a554974b-251d-4f43-9f1c-82ab5b53d8d1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5084a7bf-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 06, 2016',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne of the animals died during the study. The oral LD 50 of  Propylheptyl C aprylate was >2 mg/kg bw.     Inhalation        Dimethyl Carbonate      Th',\n",
       "   'stance -related  gross pathological changes.  The LD 50 was  determined to be > 2 g/kg body weight.     Dimethyl Carbonate      The acute d ermal to',\n",
       "   ' signs of toxicity were reported, and  the dermal LD 50    of Propylheptyl  Caprylate was >2 g/kg b ody weight .      Oral     Dicaprylyl Carbonate      The acu',\n",
       "   'ot reveal any abnormal macroscopic findings.  The LD 50 was determined to be > 2 g/kg body weight.      Dimethyl Carbonate      The acute oral toxi',\n",
       "   'its (number and strain not stated), an acute oral LD 50 of 3.2 g/kg was reported for Dipropyl  Carbonate (> 95%).29  S',\n",
       "   ' In acute dermal toxicity stu dies, the following LD 50 values have been reported for Dialkyl Carbonates: > 5 g/kg  (Dicaprylyl Carbonate, rats), > 2 g/kg (Diethylhexyl Carbonate, rats), > 5  g/kg or 2.5 ',\n",
       "   ' g/ kg (Dipropyl Carbonate, rats).     The dermal LD 50 in rats of Propylheptyl C aprylate was >2 g/kg body weight.      The following LD 50 values have been report',\n",
       "   'lving mice (number and strain  not stated).29  An LD 50 of 0.3 g/kg was reported.  Study details were not provided.   ',\n",
       "   'other acute oral toxicity studies, the acute oral LD 50  of Dimethyl Carbonate in rats and mice (number of animals and strains not stated) ranges from 6.4 g/kg to 12.8 g/kg.  The  exposure -related signs reported ',\n",
       "   'evidence of organ abnormalities at necropsy.  The LD 50 was determined to be >5 g/kg.      Diethylhexyl Carbonate      Groups of 10  W',\n",
       "   'ered to be treatment -related.  The acute  dermal LD 50 was reported to be  > 2 g/kg body weight for Dimethyl Carbonate .    An acute dermal LD 50 of  > 2.5 g/kg was reported for Dimethyl Carbonate in a study inv',\n",
       "   'tudy details were not provided.  An acute dermal  LD 50 of 2.5 g/kg was reported for Dimethyl Carbonate in a st udy in',\n",
       "   'uated using 4 rabbits.  One  animal died, and the LD 50 was > 5 g/kg.28  There was no evidence of erythema or edema.  ',\n",
       "   'vidence of organ abnormalities at necropsy.   The LD 50 was  determined to be > 5 g/kg.      Diethylhexyl Carbonate     Twelve  Wistar r',\n",
       "   'gs were within normal limits in all animals.  The LD 50 was determined to be > 5 g/kg body weight in this study.      In an acute oral toxicity stud',\n",
       "   'involving rats (number and strain not stated), an LD 50 of 13.8 g/kg was report ed for  Dimethyl Carbonate.  20,27  Stu',\n",
       "   'ther acute  oral toxicity studies, the acute oral LD 50 value for Dimethyl Carbonate in rats and mice is between 6.4 g/kg and 12.8 g/kg.     The oral LD 50 in rats was >2 g/kg for Propy',\n",
       "   ' (number and strain not stated), a n acute dermal LD 50 of 0.98 g/kg was reported for  Dipropyl Carbonate (> 95%).6,29 '],\n",
       "  'contesti_noael': ['mg/kg/day, and  nonexistent at 130 mg/kg/day, the NOAEL for this endpoint was determined to be 130 mg/kg/day.  Because dose -dependent  signs of embryotoxicit',\n",
       "   'toxicity at doses of 650 and 1300  mg/kg/day, the NOAEL was determined to be 130 mg/kg/day 2 -ethylhexanol for this endpoint.  The NOAEL for',\n",
       "   'toxicity at doses  of 650 and 1300 mg/kg/day, the NOAEL was determined to be 130 mg/kg/day for this endpoint.  The NOAEL for teratogenicity ',\n",
       "   'thylhexanol.  A no observed adverse effect level (NOAEL) was  estimated to be approximately 250 mg/kg/day based on study results.         Dimethyl Carbonat',\n",
       "   'ice, and a NOEL of 125 mg/kg/day was reported.  A NOAEL was  not derived, but was estimated at 250 mg/kg/day.        In a 13 -week toxicity study , Dimethyl C'],\n",
       "  'valori_ld50': ['2 mg/kg bw',\n",
       "   '2 g/kg body weight',\n",
       "   '2 g/kg b ody weight',\n",
       "   '2 g/kg body weight',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg body weight',\n",
       "   '3 g/kg ',\n",
       "   '4 g/kg to ',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg body weight ',\n",
       "   '8 g/kg ',\n",
       "   '8 g/kg',\n",
       "   '98 g/kg '],\n",
       "  'valori_noael': ['130 mg/kg/day',\n",
       "   '130 mg/kg/day',\n",
       "   '130 mg/kg/day',\n",
       "   '250 mg/kg/day',\n",
       "   '250 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1a46c1f2275d72947f9'),\n",
       "  'Nome_comune': 'C14-15 Pareth-11',\n",
       "  'INCI_name': 'C14-15 Alketh-11 (Formerly C14-15 Pareth-11)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1fd38acd-4718-4509-8d59-e48badb6cae3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fa'),\n",
       "  'Nome_comune': 'C14-15 Pareth-12',\n",
       "  'INCI_name': 'C14-15 Alketh-12 (Formerly C14-15 Pareth-12)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a4a6f70-cd48-42e3-9008-031dbb3a0849',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fb'),\n",
       "  'Nome_comune': 'C14-15 Pareth-13',\n",
       "  'INCI_name': 'C14-15 Alketh-13 (Formerly C14-15 Pareth-13)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b9a6aa4b-2209-419d-80cb-34ad27c9fe5c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fc'),\n",
       "  'Nome_comune': 'C14-15 Pareth-4',\n",
       "  'INCI_name': 'C14-15 Alketh-4 (Formerly C14-15 Pareth-4)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=20eaca63-cf82-43a1-8c28-315051d2f8a9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fd'),\n",
       "  'Nome_comune': 'C14-15 Pareth-7',\n",
       "  'INCI_name': 'C14-15 Alketh-7 (Formerly C14-15 Pareth-7)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b052dcce-8f02-4225-8750-80380249c9a2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947fe'),\n",
       "  'Nome_comune': 'C14-15 Pareth-8',\n",
       "  'INCI_name': 'C14-15 Alketh-8 (Formerly C14-15 Pareth-8)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c896f605-b883-4530-94ff-7587ad4d365b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d72947ff'),\n",
       "  'Nome_comune': 'C14-18 Alkyl Ethylhexanoate',\n",
       "  'INCI_name': 'C14-18 Alkyl Ethylhexanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1f835e6c-30b5-4a38-8427-826f358702eb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9897bb95-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.3):61-73, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d7294800'),\n",
       "  'Nome_comune': 'C14-18 Glycol',\n",
       "  'INCI_name': 'C14-18 Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a5b6da3f-67ac-4b97-837b-d93ec5dcb679',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' that death would occur at relatively high doses (LD50 range: 2200 to >20 000 mg/kg). Reportedly, high (unspecified) oral doses of 1,',\n",
       "   'values were reported for 1,2- butanediol: 24-hour LD50 of 66.5 mmol/kg ( *5.99 g/kg) and 144-hour LD50 of 46.5 mmol/kg ( *4.19 mg/kg).32Muscle incoordination was observed in rats at ',\n",
       "   'is was observed at necropsy. In other studies, ip LD 50 values up to 13.7 mL/kg (rats) and 11.2 g/kg (mice) have been reported.1An acute study was per',\n",
       "   'n acute dermal toxicity study involving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg. Prolonged application or repeated applications o',\n",
       "   'lycol (1,2-pentanediol). The following acute oral LD50 values have been reported for pentylene glycol: 1.2700 Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits); and 5200 mg/kg (guinea pigs).30 Steary',\n",
       "   'udy (OECD 423 test procedure) involving rats, the LD50 for caprylyl glycol was >2500 mg/kg.27, 1,2-Butanediol. An acute oral LD50 of 4192 mg/kg was reported for 1,2-butanediol in a study involvi',\n",
       "   'nteral toxicity studies, acute intramuscular (im) LD50 (20 g/kg rats) and acute subcutaneous (sc) LD50 (18.5 g/kg mice) values have been reported.1 Repeated-Dose To',\n",
       "   'l glycol. An LD50 of >5000 mg/kg was reported for rats dosed orally with stearyl gl',\n",
       "   'ated using adult male Sprague-Dawley rats, and an LD50 of >20.0 g/kg body weight was reported.5 Propylene glycol. The 24-hour oral LD50 for PG was 22.8 g/kg body weight in a study involving 5 female Fischer rats. Oral L',\n",
       "   'ailable from Dow Chemical Company, the acute oral LD50 for 1,2-butanediol in rats was 16 g/kg body weight.29Also, high (unspecified) doses caused narcosis ',\n",
       "   'acute dermal toxicity study invol- ving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg.27 Propylene glycol. The dermal LD50 for PG was >11.2 g/kg in mice and was 13 g/kg in rats.1 Intraperitoneal '],\n",
       "  'contesti_noael': ['iod was largely reversible. Both the NOEL and the NOAEL in this study was 100 mg/kg body weight/d.36 Pentylene glycol. Pentylene glycol was adminis',\n",
       "   'ach; analogous structures do not exist in man. An NOAEL of 100 mg/kg/d was reported for rats in a 28-day oral toxicity s',\n",
       "   'females). The no observable adverse effect level (NOAEL) was 200 mg/kg body weight/day in this study.35 According to a summary of data p',\n",
       "   'ministration of 1,2-butanediol to rats yielded an NOAEL of 200 mg/kg/d. Reportedly, in another repeated dose study, the ',\n",
       "   ' mg/kg/d, and a no observed adverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi- city. The NOAEL was based on t',\n",
       "   'this study was calculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/d and a reproductive toxicity uncertainty factor of'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '19 mg/kg',\n",
       "   '2 g/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3700 mg/kg',\n",
       "   '4192 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '8 g/kg body weight ',\n",
       "   '16 g/kg body weight',\n",
       "   '11.2 g/kg '],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg/d',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d7294801'),\n",
       "  'Nome_comune': 'C14-28 Alkyl Acid',\n",
       "  'INCI_name': 'C14-28 Alkyl Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9a1ee188-71ba-4293-8074-bc338d5e4ea3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d7294802'),\n",
       "  'Nome_comune': 'C14-28 Isoalkyl Acid',\n",
       "  'INCI_name': 'C14-28 Isoalkyl Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a76f24fa-175a-41fe-8d45-d977d18176e1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1a56c1f2275d7294803'),\n",
       "  'Nome_comune': 'C14-30 Alkyl Beeswax',\n",
       "  'INCI_name': 'C14-30 Alkyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=424c9e29-a663-4a71-9e4f-c5e02f1edff6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294804'),\n",
       "  'Nome_comune': 'C15-18 Glycol',\n",
       "  'INCI_name': 'C15-18 Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c2d9b2c4-bd01-4539-b218-04404dd706bc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' that death would occur at relatively high doses (LD50 range: 2200 to >20 000 mg/kg). Reportedly, high (unspecified) oral doses of 1,',\n",
       "   'values were reported for 1,2- butanediol: 24-hour LD50 of 66.5 mmol/kg ( *5.99 g/kg) and 144-hour LD50 of 46.5 mmol/kg ( *4.19 mg/kg).32Muscle incoordination was observed in rats at ',\n",
       "   'is was observed at necropsy. In other studies, ip LD 50 values up to 13.7 mL/kg (rats) and 11.2 g/kg (mice) have been reported.1An acute study was per',\n",
       "   'n acute dermal toxicity study involving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg. Prolonged application or repeated applications o',\n",
       "   'lycol (1,2-pentanediol). The following acute oral LD50 values have been reported for pentylene glycol: 1.2700 Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits); and 5200 mg/kg (guinea pigs).30 Steary',\n",
       "   'udy (OECD 423 test procedure) involving rats, the LD50 for caprylyl glycol was >2500 mg/kg.27, 1,2-Butanediol. An acute oral LD50 of 4192 mg/kg was reported for 1,2-butanediol in a study involvi',\n",
       "   'nteral toxicity studies, acute intramuscular (im) LD50 (20 g/kg rats) and acute subcutaneous (sc) LD50 (18.5 g/kg mice) values have been reported.1 Repeated-Dose To',\n",
       "   'l glycol. An LD50 of >5000 mg/kg was reported for rats dosed orally with stearyl gl',\n",
       "   'ated using adult male Sprague-Dawley rats, and an LD50 of >20.0 g/kg body weight was reported.5 Propylene glycol. The 24-hour oral LD50 for PG was 22.8 g/kg body weight in a study involving 5 female Fischer rats. Oral L',\n",
       "   'ailable from Dow Chemical Company, the acute oral LD50 for 1,2-butanediol in rats was 16 g/kg body weight.29Also, high (unspecified) doses caused narcosis ',\n",
       "   'acute dermal toxicity study invol- ving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg.27 Propylene glycol. The dermal LD50 for PG was >11.2 g/kg in mice and was 13 g/kg in rats.1 Intraperitoneal '],\n",
       "  'contesti_noael': ['iod was largely reversible. Both the NOEL and the NOAEL in this study was 100 mg/kg body weight/d.36 Pentylene glycol. Pentylene glycol was adminis',\n",
       "   'ach; analogous structures do not exist in man. An NOAEL of 100 mg/kg/d was reported for rats in a 28-day oral toxicity s',\n",
       "   'females). The no observable adverse effect level (NOAEL) was 200 mg/kg body weight/day in this study.35 According to a summary of data p',\n",
       "   'ministration of 1,2-butanediol to rats yielded an NOAEL of 200 mg/kg/d. Reportedly, in another repeated dose study, the ',\n",
       "   ' mg/kg/d, and a no observed adverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi- city. The NOAEL was based on t',\n",
       "   'this study was calculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/d and a reproductive toxicity uncertainty factor of'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '19 mg/kg',\n",
       "   '2 g/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3700 mg/kg',\n",
       "   '4192 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '8 g/kg body weight ',\n",
       "   '16 g/kg body weight',\n",
       "   '11.2 g/kg '],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg/d',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294805'),\n",
       "  'Nome_comune': 'C15-35 Isoparaffin/Isoalkylcycloalkanes',\n",
       "  'INCI_name': 'C15-35 Isoparaffin/Isoalkylcycloalkanes',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=068cafc4-72ae-408b-99a1-90c578402de1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294806'),\n",
       "  'Nome_comune': 'C16-17 Alkyl Benzoate',\n",
       "  'INCI_name': 'C16-17 Alkyl Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f2de6d4a-0373-420a-9404-5f90a75882ca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl.3):342-372, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['rted to be 2.69 g/kg. Dodecyl alcohol has an oral LD 50 of 12 800 mg/kg for rats. Tridecyl alcohol has an oral LD 50of17 200 mg/kg for rats. Tetradecyl alcohol has an oral LD 50 33 ',\n",
       "   ' reported to be 5600 mg/kg in rabbits. The dermal LD 50 of hexadecyl alcohol for rabbits was reported to be >2.6 g/kg. Aerosolized amyl alcohol at near saturation caus'],\n",
       "  'contesti_noael': ['(15, 40, or 120 mL/m3; purity 99.9 %).87 The oral NOAEL for noncancer systemic toxicity end points were 200 and 50 mg/kg/d in mice and rats, respectively, exposed chronical',\n",
       "   ' decreased food consumption and body weights. The NOAEL was 125 mg/kg/d for male and female F344 rats and B6C3Fl mice tre',\n",
       "   ' maternal weight gain. Maternal and developmental NOAEL was found to be 130 mg/kg/d in Wistar rats (n ¼10) orally exposed to ethylhex',\n",
       "   'ose females at birth and on day 4 postpartum. The NOAEL was 1000 mg/kg/d. In Ames tests, methyl benzoate, ethyl benzoate, '],\n",
       "  'valori_ld50': ['200 mg/kg ', '6 g/kg'],\n",
       "  'valori_noael': ['50 mg/kg/d',\n",
       "   '125 mg/kg/d',\n",
       "   '130 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294807'),\n",
       "  'Nome_comune': 'C16-22 Acid Amide MEA',\n",
       "  'INCI_name': 'C16-22 Acid Amide MEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d09b980-5ade-4658-a79b-0cef556fbb08',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=61a5d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):18-34, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['EA.2 Cocamide MEA. The dermal median lethal dose (LD 50)o f cocamide MEA was evaluated by applying 2 g/kg to the abraded and intact skin of rabbit under occlusive '],\n",
       "  'contesti_noael': ['e observed. The no observed adverse effect level (NOAEL) was >750 mg/kg bw/d. Reproductive and Developmental Toxicity Data on ',\n",
       "   'eeks) were not toxic. In a 14-day oral study, the NOAEL of cocamide MEA in rats was >750 mg/kg/d, the highest dose tested. No data on the reproduc'],\n",
       "  'valori_ld50': ['2 g/kg to the '],\n",
       "  'valori_noael': ['750 mg/kg bw/d', '750 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294808'),\n",
       "  'Nome_comune': 'C16-36 Alkyl Stearate',\n",
       "  'INCI_name': 'C16-36 Alkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bf1e7166-1a70-4918-8f1b-bfe27bd2ac7f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d7294809'),\n",
       "  'Nome_comune': 'C18-22 Hydroxyalkyl Hydroxypropyl Guar',\n",
       "  'INCI_name': 'C18-22 Hydroxyalkyl Hydroxypropyl Guar',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=30f24379-f467-446b-8ea9-4d3c68622720',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['dy weight) over a 24-hour period.54The acute oral LD50 was >10 000 mg/kg body weight. Repeated Dose Toxicity—Oral Studies Cyamopsis te',\n",
       "   'ngredients: guar hydroxypropyltrimonium chloride (LD50 ¼12.5 g/kg), hydroxypropyl guar hydroxypropyltrimonium chloride (LD50 ¼12.0 g/kg), carboxymethyl guar (LD50 ¼17.8 g/kg), hydro- ly',\n",
       "   'here were no macroscopic findings at necropsy. An LD50 of >2000 mg/kg was reported. Gum guar, oxidized 2-hydro xypropyl ',\n",
       "   ' fecal staining; and irritability. The acute oral LD50 was 17.8 g/kg (95 %confidence limits of 13.1-22.5 g/kg). Hydrolyzed guar. An acute oral toxicity study o',\n",
       "   '0 mg/kg body weight at a 2-hour interval. An oral LD50 value of >5000 mg/kg body weight was reported. In a similar test, 10 male and 10 fe',\n",
       "   'ce and rats). None of the ani- mals died, and the LD50 was >6000 mg/kg in both the species. Ceratonia siliqua gum. The ac',\n",
       "   'ity; and generally poor condition. The acute oral LD50 was 12.0 g/kg (95 %confidence limits of 9.2-14.8 g/kg). Carboxymethyl guar. The acute oral toxicity of ',\n",
       "   '/kg), which yielded 90 %mortality. The acute oral LD50 was 15 g/kg (95 %confidence limits of 13-17 g/kg). Hydroxypropyl guar hydroxypropyltrimonium chlor',\n",
       "   ' piloerection. The acute oral median lethal dose (LD50) was 12.5 g/kg (95 %confidence limits of 10.22-14.78 g/kg). The acute oral toxicity of a guar hydroxypropyl',\n",
       "   'zed guar (LD50 > 6 g/kg), cassia gum (LD50 > 5 g/kg), and C siliqua gum (LD50 ¼5 g/kg). The LD50s for C siliqua gum in other species include 13.1 g/kg (mice), 9.1 g/kg (rabbits), and 10.3 g/kg (hamste'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight',\n",
       "   '0 g/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg body weight ',\n",
       "   '6000 mg/kg ',\n",
       "   '8 g/kg',\n",
       "   '17 g/kg',\n",
       "   '78 g/kg',\n",
       "   '13.1 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d729480a'),\n",
       "  'Nome_comune': 'C18-30 Glycol',\n",
       "  'INCI_name': 'C18-30 Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2080910f-f91a-47d8-b916-fed43ade2a70',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' that death would occur at relatively high doses (LD50 range: 2200 to >20 000 mg/kg). Reportedly, high (unspecified) oral doses of 1,',\n",
       "   'values were reported for 1,2- butanediol: 24-hour LD50 of 66.5 mmol/kg ( *5.99 g/kg) and 144-hour LD50 of 46.5 mmol/kg ( *4.19 mg/kg).32Muscle incoordination was observed in rats at ',\n",
       "   'is was observed at necropsy. In other studies, ip LD 50 values up to 13.7 mL/kg (rats) and 11.2 g/kg (mice) have been reported.1An acute study was per',\n",
       "   'n acute dermal toxicity study involving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg. Prolonged application or repeated applications o',\n",
       "   'lycol (1,2-pentanediol). The following acute oral LD50 values have been reported for pentylene glycol: 1.2700 Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits); and 5200 mg/kg (guinea pigs).30 Steary',\n",
       "   'udy (OECD 423 test procedure) involving rats, the LD50 for caprylyl glycol was >2500 mg/kg.27, 1,2-Butanediol. An acute oral LD50 of 4192 mg/kg was reported for 1,2-butanediol in a study involvi',\n",
       "   'nteral toxicity studies, acute intramuscular (im) LD50 (20 g/kg rats) and acute subcutaneous (sc) LD50 (18.5 g/kg mice) values have been reported.1 Repeated-Dose To',\n",
       "   'l glycol. An LD50 of >5000 mg/kg was reported for rats dosed orally with stearyl gl',\n",
       "   'ated using adult male Sprague-Dawley rats, and an LD50 of >20.0 g/kg body weight was reported.5 Propylene glycol. The 24-hour oral LD50 for PG was 22.8 g/kg body weight in a study involving 5 female Fischer rats. Oral L',\n",
       "   'ailable from Dow Chemical Company, the acute oral LD50 for 1,2-butanediol in rats was 16 g/kg body weight.29Also, high (unspecified) doses caused narcosis ',\n",
       "   'acute dermal toxicity study invol- ving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg.27 Propylene glycol. The dermal LD50 for PG was >11.2 g/kg in mice and was 13 g/kg in rats.1 Intraperitoneal '],\n",
       "  'contesti_noael': ['iod was largely reversible. Both the NOEL and the NOAEL in this study was 100 mg/kg body weight/d.36 Pentylene glycol. Pentylene glycol was adminis',\n",
       "   'ach; analogous structures do not exist in man. An NOAEL of 100 mg/kg/d was reported for rats in a 28-day oral toxicity s',\n",
       "   'females). The no observable adverse effect level (NOAEL) was 200 mg/kg body weight/day in this study.35 According to a summary of data p',\n",
       "   'ministration of 1,2-butanediol to rats yielded an NOAEL of 200 mg/kg/d. Reportedly, in another repeated dose study, the ',\n",
       "   ' mg/kg/d, and a no observed adverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi- city. The NOAEL was based on t',\n",
       "   'this study was calculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/d and a reproductive toxicity uncertainty factor of'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '19 mg/kg',\n",
       "   '2 g/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3700 mg/kg',\n",
       "   '4192 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '8 g/kg body weight ',\n",
       "   '16 g/kg body weight',\n",
       "   '11.2 g/kg '],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg/d',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d729480b'),\n",
       "  'Nome_comune': 'C18-36 Acid Triglyceride',\n",
       "  'INCI_name': 'C18-36 Acid Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fc0bb560-ee0b-475a-89a6-88e283e1d8d9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1a66c1f2275d729480c'),\n",
       "  'Nome_comune': 'C18-38 Alkyl Beeswax',\n",
       "  'INCI_name': 'C18-38 Alkyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=08133edf-77a7-4937-8a8f-007ee4a636a6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d729480d'),\n",
       "  'Nome_comune': 'C18-38 Alkyl C24-54 Acid Ester',\n",
       "  'INCI_name': 'C18-38 Alkyl C24-54 Acid Ester',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ab3872bd-e462-43bb-88b0-b2b7a0228a5e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d729480e'),\n",
       "  'Nome_comune': 'C18-70 Isoparaffin',\n",
       "  'INCI_name': 'C18-70 Isoalkane (Formerly C18-70 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b60c6156-be48-45b7-a1b7-4c0ad78ca974',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d729480f'),\n",
       "  'Nome_comune': 'C20-22 Alkyl Glucoside',\n",
       "  'INCI_name': 'C20-22 Alkyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=71b50f56-441b-41d3-b913-ba3d8cbcd934',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['fe as used Myristyl alcoholAnimal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg Inhalation: 3%, 1 h, ataxia and moderate nasal irr',\n",
       "   ' glucoside using rabbits, the median lethal dose (LD 50) was greater than the 2 g/kg dose administered. In oral studies with the same t',\n",
       "   'erides and phospholipids66 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD 50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   'sorbed from the GI tract68 Animal toxicology Oral LD 50: >8 g/kg; 3 mos dermal study: formulations w/8%, some derm',\n",
       "   ' as used Isostearyl alcoholAnimal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg66 Dermal ',\n",
       "   'afe as used Octyl dodecanolAnimal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD50: >3 g/kg68 (continued)24S Internatio',\n",
       "   ' and 2.7% in the urine65 Animal toxicology Dermal LD 50(rabbits), 4.2 g/kg; oral LD 50(rats), 0.79-4.36 g/kg Short-term oral: 6.9% n-butyl alcohol and 25% sucr'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '36 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294810'),\n",
       "  'Nome_comune': 'C20-22 Alkyl Phosphate',\n",
       "  'INCI_name': 'C20-22 Alkyl Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=370c32b6-ed35-49f2-9fc3-72b51ad9ab1a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=587dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):12-32, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Animals/Group VehicleConcentration/Dose/ Protocol LD50/LC50 Results Reference DERMAL C20-22 alkyl phosphate 5 Sprague-Dawley rats/sexParaffin oil 2 g/kg bw (10 ml/kg bw) applied using a 24-hour semi-occlus'],\n",
       "  'contesti_noael': ['bw/d (active ingredient [a.i.]), and the NOEL and NOAEL for mater- nal toxicity were 36.1 and 361 mg/kg bw/d (a.i.), respectively(Table 7).22For C20-22 alkyl ',\n",
       "   'osphate had a no-observable adverse effect level (NOAEL) of 600 mg/kg bw/d for both males and females, and oral administr a ',\n",
       "   'w / df o rf e m a l e s .22 Oleyl phosphate had a NOAEL of 1000 mg/kg bw/d for male and female rats in a 28-day gavage study',\n",
       "   'ing and fertility) and neonatal toxicity, and the NOAEL for parental toxicity, were 1000 mg/kg bw/d in rats.20 Oleyl phosphate also was not a reprodu',\n",
       "   'e study with sodium lauryl phosphate in rats, the NOAEL for parental male and female animals and the NOEL for the F 1generation were 1000 mg/kg bw/d.19 Genotoxicity In vitro genotoxicity assays have',\n",
       "   ' 14-day studies, potassium lauryl phosphate had a NOAEL of 600 mg/kg bw/d for both males and females, and oral admin- istration of up to 1000 mg/kg bw/d sodium lauryl phosphate for 14 days did not resul',\n",
       "   'ing and fertility) and neonatal toxicity, and the NOAEL for parental toxicity, were 1000 mg/kg bw/d in rats. Oleyl phosphate also was not a reproduct',\n",
       "   'e study in rats with sodium lauryl phosphate, the NOAEL for parental male and female animals and the NOEL for the F 1generation was 1000 mg/kg bw/d.28S International Journal of Toxicology 38(Supple',\n",
       "   'erved in females fed 505 and 1564 mg/kg bw/d, the NOAEL was 1564 mg/kg bw/d for females. Oleyl phosphate had a NOAEL of 1000 '],\n",
       "  'valori_ld50': ['2 g/kg bw'],\n",
       "  'valori_noael': ['361 mg/kg bw/d',\n",
       "   '600 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1564 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294811'),\n",
       "  'Nome_comune': 'C20-22 Pareth-30',\n",
       "  'INCI_name': 'C20-22 Alketh-30 (Formerly C20-22 Pareth-30)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=21a89a70-f813-4384-b9e8-666592ea08ac',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294812'),\n",
       "  'Nome_comune': 'C20-24 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C20-24 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b5c0fb06-06aa-4c0f-9197-f6fa9d325783',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294813'),\n",
       "  'Nome_comune': 'C20-24 Alkyl Methicone',\n",
       "  'INCI_name': 'C20-24 Alkyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f9b17635-7ebd-40e9-868d-63ba25114da7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294814'),\n",
       "  'Nome_comune': 'C20-30 Glycol',\n",
       "  'INCI_name': 'C20-30 Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=180d8d02-099a-4d76-9588-07e1aa2bc74b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' that death would occur at relatively high doses (LD50 range: 2200 to >20 000 mg/kg). Reportedly, high (unspecified) oral doses of 1,',\n",
       "   'values were reported for 1,2- butanediol: 24-hour LD50 of 66.5 mmol/kg ( *5.99 g/kg) and 144-hour LD50 of 46.5 mmol/kg ( *4.19 mg/kg).32Muscle incoordination was observed in rats at ',\n",
       "   'is was observed at necropsy. In other studies, ip LD 50 values up to 13.7 mL/kg (rats) and 11.2 g/kg (mice) have been reported.1An acute study was per',\n",
       "   'n acute dermal toxicity study involving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg. Prolonged application or repeated applications o',\n",
       "   'lycol (1,2-pentanediol). The following acute oral LD50 values have been reported for pentylene glycol: 1.2700 Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits); and 5200 mg/kg (guinea pigs).30 Steary',\n",
       "   'udy (OECD 423 test procedure) involving rats, the LD50 for caprylyl glycol was >2500 mg/kg.27, 1,2-Butanediol. An acute oral LD50 of 4192 mg/kg was reported for 1,2-butanediol in a study involvi',\n",
       "   'nteral toxicity studies, acute intramuscular (im) LD50 (20 g/kg rats) and acute subcutaneous (sc) LD50 (18.5 g/kg mice) values have been reported.1 Repeated-Dose To',\n",
       "   'l glycol. An LD50 of >5000 mg/kg was reported for rats dosed orally with stearyl gl',\n",
       "   'ated using adult male Sprague-Dawley rats, and an LD50 of >20.0 g/kg body weight was reported.5 Propylene glycol. The 24-hour oral LD50 for PG was 22.8 g/kg body weight in a study involving 5 female Fischer rats. Oral L',\n",
       "   'ailable from Dow Chemical Company, the acute oral LD50 for 1,2-butanediol in rats was 16 g/kg body weight.29Also, high (unspecified) doses caused narcosis ',\n",
       "   'acute dermal toxicity study invol- ving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg.27 Propylene glycol. The dermal LD50 for PG was >11.2 g/kg in mice and was 13 g/kg in rats.1 Intraperitoneal '],\n",
       "  'contesti_noael': ['iod was largely reversible. Both the NOEL and the NOAEL in this study was 100 mg/kg body weight/d.36 Pentylene glycol. Pentylene glycol was adminis',\n",
       "   'ach; analogous structures do not exist in man. An NOAEL of 100 mg/kg/d was reported for rats in a 28-day oral toxicity s',\n",
       "   'females). The no observable adverse effect level (NOAEL) was 200 mg/kg body weight/day in this study.35 According to a summary of data p',\n",
       "   'ministration of 1,2-butanediol to rats yielded an NOAEL of 200 mg/kg/d. Reportedly, in another repeated dose study, the ',\n",
       "   ' mg/kg/d, and a no observed adverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi- city. The NOAEL was based on t',\n",
       "   'this study was calculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/d and a reproductive toxicity uncertainty factor of'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '19 mg/kg',\n",
       "   '2 g/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3700 mg/kg',\n",
       "   '4192 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '8 g/kg body weight ',\n",
       "   '16 g/kg body weight',\n",
       "   '11.2 g/kg '],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg/d',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294815'),\n",
       "  'Nome_comune': 'C20-40 Alkyl Behenate',\n",
       "  'INCI_name': 'C20-40 Alkyl Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=45d295f5-8c99-401e-8843-8a1ea207c306',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a76c1f2275d7294816'),\n",
       "  'Nome_comune': 'C20-40 Alkyl Stearate',\n",
       "  'INCI_name': 'C20-40 Alkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4dbd2a3b-c9d5-440d-a537-74cbdfe13670',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d7294817'),\n",
       "  'Nome_comune': 'C20-40 Isoparaffin',\n",
       "  'INCI_name': 'C20-40 Isoalkane (Formerly C20-40 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2636d1bd-2a6a-4c5f-9865-f598d44ee034',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d7294818'),\n",
       "  'Nome_comune': 'C20-40 Pareth-10',\n",
       "  'INCI_name': 'C20-40 Alketh-10 (Formerly C20-40 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aa8ef3e2-c14d-4fe2-9ce3-96cda4575f60',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d7294819'),\n",
       "  'Nome_comune': 'C20-40 Pareth-24',\n",
       "  'INCI_name': 'C20-40 Alketh-24 (Formerly C20-40 Pareth-24)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d52fd315-a3f1-4674-b48e-1ca0075eb4e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481a'),\n",
       "  'Nome_comune': 'C20-40 Pareth-3',\n",
       "  'INCI_name': 'C20-40 Alketh-3 (Formerly C20-40 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=55502f15-64d7-4b14-b62b-cd59293d650c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481b'),\n",
       "  'Nome_comune': 'C20-40 Pareth-40',\n",
       "  'INCI_name': 'C20-40 Alketh-40 (Formerly C20-40 Pareth-40)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=81a9e9bb-526b-40be-92f3-c7c6fdf205b9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481c'),\n",
       "  'Nome_comune': 'C20-40 Pareth-95',\n",
       "  'INCI_name': 'C20-40 Alketh-95 (Formerly C20-40 Pareth-95)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=05cdbe06-19ad-4cde-b32d-88f84c9ed39b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481d'),\n",
       "  'Nome_comune': 'C22-24 Pareth-33',\n",
       "  'INCI_name': 'C22-24 Alketh-33 (Formerly C22-24 Pareth-33)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fb2c7dfc-b619-40b9-9a80-d5172324c90c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481e'),\n",
       "  'Nome_comune': 'C24-28 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C24-28 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=93e16fab-c4e9-4f2d-bed5-dffd70af4672',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d729481f'),\n",
       "  'Nome_comune': 'C24-28 Alkyl Methicone',\n",
       "  'INCI_name': 'C24-28 Alkyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=448c367c-a0a2-4952-b9f7-720bc54b315e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a86c1f2275d7294820'),\n",
       "  'Nome_comune': 'C26-28 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C26-28 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a374646b-557a-44d9-842c-6d3aaf04398f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294821'),\n",
       "  'Nome_comune': 'C26-28 Alkyl Methicone',\n",
       "  'INCI_name': 'C26-28 Alkyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=397cfa71-18dd-44b2-b943-acc0f928fe4b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294822'),\n",
       "  'Nome_comune': 'C26-28 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       "  'INCI_name': 'C26-28 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cce4c69e-c7a7-40bc-b22c-062196c59cc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8b69a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne, a nd Trimethylpentyl Polysilsesquioxane , the LD 50 was  reported  to be > 5000 mg/kg.   In a 28- day dermal toxicity study of a Polyme',\n",
       "   'ghtly  reddened were observed in the fifth rat.   LD 50 = > 5000 mg/kg, Toxicity Category III  (slightly toxic and sligh',\n",
       "   'rance, convulsions, muscle tremors,  and rales.   LD 50 = > 5000 mg/kg , Toxicity Category III 31  Methacryloyloxypropyl  Polysilsesquioxane (5000  mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 50 00 mg/kg, Toxicity Category III 32  Methoxy PEG -10  Polysilsesquioxane (5000 mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   ' and muscle tremors. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 33  Trimethylpentyl  Polysilsesquioxane (5000 mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 34  Trimethylpentyl  Polysilsesquioxane (5000  mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 35          Table 7. Genot'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg',\n",
       "   '5000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294823'),\n",
       "  'Nome_comune': 'C30-45 Alkyl Cetearyl Dimethicone Crosspolymer',\n",
       "  'INCI_name': 'C30-45 Alkyl Cetearyl Dimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=97601953-51f6-436e-8f66-4c81c94faa75',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294824'),\n",
       "  'Nome_comune': 'C30-45 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C30-45 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8bf02639-c969-4840-99d4-548481bff40c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294825'),\n",
       "  'Nome_comune': 'C30-45 Alkyl Dimethicone/Polycyclohexene Oxide Crosspolymer',\n",
       "  'INCI_name': 'C30-45 Alkyl Dimethicone/Polycyclohexene Oxide Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=96cee631-a921-45f4-8487-ca1b4588fdb3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294826'),\n",
       "  'Nome_comune': 'C30-45 Alkyl Methicone',\n",
       "  'INCI_name': 'C30-45 Alkyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b2e535ec-2627-4000-b53b-39cdb03907da',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294827'),\n",
       "  'Nome_comune': 'C30-45 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       "  'INCI_name': 'C30-45 Alkyldimethylsilyl Polypropylsilsesquioxane',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5c864c38-c4b6-4435-81cd-0efa0b6683a4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8b69a6cb-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2017',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne, a nd Trimethylpentyl Polysilsesquioxane , the LD 50 was  reported  to be > 5000 mg/kg.   In a 28- day dermal toxicity study of a Polyme',\n",
       "   'ghtly  reddened were observed in the fifth rat.   LD 50 = > 5000 mg/kg, Toxicity Category III  (slightly toxic and sligh',\n",
       "   'rance, convulsions, muscle tremors,  and rales.   LD 50 = > 5000 mg/kg , Toxicity Category III 31  Methacryloyloxypropyl  Polysilsesquioxane (5000  mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 50 00 mg/kg, Toxicity Category III 32  Methoxy PEG -10  Polysilsesquioxane (5000 mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   ' and muscle tremors. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 33  Trimethylpentyl  Polysilsesquioxane (5000 mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 34  Trimethylpentyl  Polysilsesquioxane (5000  mg/kg)  Female Sprague  Dawley albino rats (3)  Single ',\n",
       "   'rats gained  weight. Necropsy was unremarkable.   LD 50 = > 5000 mg/kg, Toxicity Category III 35          Table 7. Genot'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000  mg/kg',\n",
       "   '5000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294828'),\n",
       "  'Nome_comune': 'C30-50 Alkyl Beeswax',\n",
       "  'INCI_name': 'C30-50 Alkyl Beeswax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=16884307-3911-4093-a938-732467475c9d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1a96c1f2275d7294829'),\n",
       "  'Nome_comune': 'C30-50 Alkyl Stearate',\n",
       "  'INCI_name': 'C30-50 Alkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8bc82851-635b-474b-af2e-0d1d2c16fd77',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482a'),\n",
       "  'Nome_comune': 'C30-50 Pareth-10',\n",
       "  'INCI_name': 'C30-50 Alketh-10 (Formerly C30-50 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b9a75c31-c11c-4834-9142-cbbe64312362',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482b'),\n",
       "  'Nome_comune': 'C30-50 Pareth-3',\n",
       "  'INCI_name': 'C30-50 Alketh-3 (Formerly C30-50 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=04494971-6092-43ed-9c73-048f0b8308af',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482c'),\n",
       "  'Nome_comune': 'C30-50 Pareth-40',\n",
       "  'INCI_name': 'C30-50 Alketh-40 (Formerly C30-50 Pareth-40)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9755b85f-55ce-4062-8d3e-7b1cd92a6a2c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482d'),\n",
       "  'Nome_comune': 'C30-60 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C30-60 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3f24e15d-fe42-47d9-8006-e2790d5d0a58',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482e'),\n",
       "  'Nome_comune': 'C32 Alkyl Dimethicone',\n",
       "  'INCI_name': 'C32 Alkyl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8b78c505-1383-42cd-893b-9b8f6f1c93f3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d729482f'),\n",
       "  'Nome_comune': 'C32-36 Isoalkyl Acid',\n",
       "  'INCI_name': 'C32-36 Isoalkyl Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d0ba4df-64cc-4ea2-8b7b-0409467b0396',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d7294830'),\n",
       "  'Nome_comune': 'C32-36 Isoalkyl Stearate',\n",
       "  'INCI_name': 'C32-36 Isoalkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ef64e407-c848-443c-b967-0266c0e2e8ec',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d7294831'),\n",
       "  'Nome_comune': 'C40-60 Alkyl Stearate',\n",
       "  'INCI_name': 'C40-60 Alkyl Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=195fac04-916b-47b6-bc27-fddb8f37dba1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d7294832'),\n",
       "  'Nome_comune': 'C40-60 Pareth-10',\n",
       "  'INCI_name': 'C40-60 Alketh-10 (Formerly C40-60 Pareth-10)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=466245ce-bec0-4ed9-9b5f-45c7ce983965',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1aa6c1f2275d7294833'),\n",
       "  'Nome_comune': 'C40-60 Pareth-3',\n",
       "  'INCI_name': 'C40-60 Alketh-3 (Formerly C40-60 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d5fc0847-aedd-4dc0-8206-34e60c44df6c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294834'),\n",
       "  'Nome_comune': 'C4-18 Alkyl Methacrylate/Methacryloyloxyethyl Phosphorylcholine Copolymer',\n",
       "  'INCI_name': 'C4-18 Alkyl Methacrylate/Methacryloyloxyethyl Phosphorylcholine Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7d4a1e83-05b5-4180-bebf-4d91cd3a7fd2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=1000a48e-650c-6b92-a9dc-a53d51eea570',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294835'),\n",
       "  'Nome_comune': 'C4-24 Alkyl Dimethicone/Divinyldimethicone Crosspolymer',\n",
       "  'INCI_name': 'C4-24 Alkyl Dimethicone/Divinyldimethicone Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a6a4914-7ad7-4940-b5b9-76e0ec26876e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2f9ec889-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl. 2):65-115, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' is reported to have a dermal median lethal dose (LD 50) of >2000 mg/kg in rabbits (n ¼5/sex).5There were no deaths or cli'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294836'),\n",
       "  'Nome_comune': 'C4-5 Isoalkyl Cocoate',\n",
       "  'INCI_name': 'C4-5 Isoalkyl Cocoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e968bc65-fa0a-4ffe-bf9b-1f7848423a5f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294837'),\n",
       "  'Nome_comune': 'C4-6 Olefin/Styrene Copolymer',\n",
       "  'INCI_name': 'C4-6 Olefin/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=82a105ec-2bca-4cab-8d6d-7661e8206e3c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' acute oral toxicity study involving rats, and an LD 50 of >  5 ml/kg was reported.  The test protocol was not stated .32    An oral LD 50 of  >  2,000 mg/kg body weight (rats) for Syntran® 5903 was reported in a study ',\n",
       "   'col were  not included.  The estimated acute oral LD 50 was > 5,050 mg/kg (nontoxic).  It was noted that this finding was  ',\n",
       "   'cute dermal toxicity study involving rats, and an LD 50 of  > 5 g/kg was reported.  The test protocol was not stated.32'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight', '050 mg/kg', '5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294838'),\n",
       "  'Nome_comune': 'C5-6 Olefin/Styrene Copolymer',\n",
       "  'INCI_name': 'C5-6 Olefin/Styrene Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d76623a4-fb5a-43b1-bb94-65bb93f17a39',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9e33b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 09, 2014',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' acute oral toxicity study involving rats, and an LD 50 of >  5 ml/kg was reported.  The test protocol was not stated .32    An oral LD 50 of  >  2,000 mg/kg body weight (rats) for Syntran® 5903 was reported in a study ',\n",
       "   'col were  not included.  The estimated acute oral LD 50 was > 5,050 mg/kg (nontoxic).  It was noted that this finding was  ',\n",
       "   'cute dermal toxicity study involving rats, and an LD 50 of  > 5 g/kg was reported.  The test protocol was not stated.32'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight', '050 mg/kg', '5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d7294839'),\n",
       "  'Nome_comune': 'C6-14 Perfluoroalkylethyl Acrylate/HEMA Copolymer',\n",
       "  'INCI_name': 'C6-14 Perfluoroalkylethyl Acrylate/HEMA Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=602f0ce3-278d-ed11-81ad-000d3a983f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e821365b-edc8-8bc1-b1ed-7554f706933c',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):144-161, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d729483a'),\n",
       "  'Nome_comune': 'C7-8 Isoparaffin',\n",
       "  'INCI_name': 'C7-8 Isoalkane (Formerly C7-8 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1358b02e-ecb0-4b00-919c-6733814407a0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d729483b'),\n",
       "  'Nome_comune': 'C8-10 Alkyl Ethyl Phosphate',\n",
       "  'INCI_name': 'C8-10 Alkyl Ethyl Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=49dad11c-9012-4989-bf33-c239b6d03f07',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=587dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):12-32, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Animals/Group VehicleConcentration/Dose/ Protocol LD50/LC50 Results Reference DERMAL C20-22 alkyl phosphate 5 Sprague-Dawley rats/sexParaffin oil 2 g/kg bw (10 ml/kg bw) applied using a 24-hour semi-occlus'],\n",
       "  'contesti_noael': ['bw/d (active ingredient [a.i.]), and the NOEL and NOAEL for mater- nal toxicity were 36.1 and 361 mg/kg bw/d (a.i.), respectively(Table 7).22For C20-22 alkyl ',\n",
       "   'osphate had a no-observable adverse effect level (NOAEL) of 600 mg/kg bw/d for both males and females, and oral administr a ',\n",
       "   'w / df o rf e m a l e s .22 Oleyl phosphate had a NOAEL of 1000 mg/kg bw/d for male and female rats in a 28-day gavage study',\n",
       "   'ing and fertility) and neonatal toxicity, and the NOAEL for parental toxicity, were 1000 mg/kg bw/d in rats.20 Oleyl phosphate also was not a reprodu',\n",
       "   'e study with sodium lauryl phosphate in rats, the NOAEL for parental male and female animals and the NOEL for the F 1generation were 1000 mg/kg bw/d.19 Genotoxicity In vitro genotoxicity assays have',\n",
       "   ' 14-day studies, potassium lauryl phosphate had a NOAEL of 600 mg/kg bw/d for both males and females, and oral admin- istration of up to 1000 mg/kg bw/d sodium lauryl phosphate for 14 days did not resul',\n",
       "   'ing and fertility) and neonatal toxicity, and the NOAEL for parental toxicity, were 1000 mg/kg bw/d in rats. Oleyl phosphate also was not a reproduct',\n",
       "   'e study in rats with sodium lauryl phosphate, the NOAEL for parental male and female animals and the NOEL for the F 1generation was 1000 mg/kg bw/d.28S International Journal of Toxicology 38(Supple',\n",
       "   'erved in females fed 505 and 1564 mg/kg bw/d, the NOAEL was 1564 mg/kg bw/d for females. Oleyl phosphate had a NOAEL of 1000 '],\n",
       "  'valori_ld50': ['2 g/kg bw'],\n",
       "  'valori_noael': ['361 mg/kg bw/d',\n",
       "   '600 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1564 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1ab6c1f2275d729483c'),\n",
       "  'Nome_comune': 'C8-22 Alkyl Acrylates/Methacrylic Acid Crosspolymer',\n",
       "  'INCI_name': 'C8-22 Alkyl Acrylates/Methacrylic Acid Crosspolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=880d8081-76ec-466b-89c7-4d7bad029d59',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d729483d'),\n",
       "  'Nome_comune': 'C8-9 Isoparaffin',\n",
       "  'INCI_name': 'C8-9 Isoalkane (Formerly C8-9 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=aea75e64-931d-4c44-b73e-22dd4bda1216',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d729483e'),\n",
       "  'Nome_comune': 'C9-11 Isoparaffin',\n",
       "  'INCI_name': 'C9-11 Isoalkane (Formerly C9-11 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d17a9753-89f1-43a3-a63a-16463d0cbc75',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d729483f'),\n",
       "  'Nome_comune': 'C9-11 Pareth-3',\n",
       "  'INCI_name': 'C9-11 Alketh-3 (Formerly C9-11 Pareth-3)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0d261eff-6f00-4c6a-b8f5-9f5c76a4a0b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294840'),\n",
       "  'Nome_comune': 'C9-11 Pareth-4',\n",
       "  'INCI_name': 'C9-11 Alketh-4 (Formerly C9-11 Pareth-4)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66453ec0-265c-4606-92d2-ef03f0089993',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294841'),\n",
       "  'Nome_comune': 'C9-11 Pareth-6',\n",
       "  'INCI_name': 'C9-11 Alketh-6 (Formerly C9-11 Pareth-6)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3121f652-cc2a-42e6-9457-025a896b0239',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294842'),\n",
       "  'Nome_comune': 'C9-11 Pareth-8',\n",
       "  'INCI_name': 'C9-11 Alketh-8 (Formerly C9-11 Pareth-8)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3bd0047a-334c-4a81-ab72-0e77d16c28bc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294843'),\n",
       "  'Nome_comune': 'C9-12 Isoparaffin',\n",
       "  'INCI_name': 'C9-12 Isoalkane (Formerly C9-12 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fcb23855-2774-466c-b03f-656a202a9284',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294844'),\n",
       "  'Nome_comune': 'C9-13 Isoparaffin',\n",
       "  'INCI_name': 'C9-13 Isoalkane (Formerly C9-13 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b513538f-00b5-4170-aaf9-85bc140b6564',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ac6c1f2275d7294845'),\n",
       "  'Nome_comune': 'C9-14 Isoparaffin',\n",
       "  'INCI_name': 'C9-14 Isoalkane (Formerly C9-14 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eede2ff2-c13b-493f-9870-b5215f1095ad',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d7294846'),\n",
       "  'Nome_comune': 'C9-15 Alkyl Phosphate',\n",
       "  'INCI_name': 'C9-15 Alkyl Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4be534e2-20de-4140-b92a-f24c025d1fc8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=587dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):12-32, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Animals/Group VehicleConcentration/Dose/ Protocol LD50/LC50 Results Reference DERMAL C20-22 alkyl phosphate 5 Sprague-Dawley rats/sexParaffin oil 2 g/kg bw (10 ml/kg bw) applied using a 24-hour semi-occlus'],\n",
       "  'contesti_noael': ['bw/d (active ingredient [a.i.]), and the NOEL and NOAEL for mater- nal toxicity were 36.1 and 361 mg/kg bw/d (a.i.), respectively(Table 7).22For C20-22 alkyl ',\n",
       "   'osphate had a no-observable adverse effect level (NOAEL) of 600 mg/kg bw/d for both males and females, and oral administr a ',\n",
       "   'w / df o rf e m a l e s .22 Oleyl phosphate had a NOAEL of 1000 mg/kg bw/d for male and female rats in a 28-day gavage study',\n",
       "   'ing and fertility) and neonatal toxicity, and the NOAEL for parental toxicity, were 1000 mg/kg bw/d in rats.20 Oleyl phosphate also was not a reprodu',\n",
       "   'e study with sodium lauryl phosphate in rats, the NOAEL for parental male and female animals and the NOEL for the F 1generation were 1000 mg/kg bw/d.19 Genotoxicity In vitro genotoxicity assays have',\n",
       "   ' 14-day studies, potassium lauryl phosphate had a NOAEL of 600 mg/kg bw/d for both males and females, and oral admin- istration of up to 1000 mg/kg bw/d sodium lauryl phosphate for 14 days did not resul',\n",
       "   'ing and fertility) and neonatal toxicity, and the NOAEL for parental toxicity, were 1000 mg/kg bw/d in rats. Oleyl phosphate also was not a reproduct',\n",
       "   'e study in rats with sodium lauryl phosphate, the NOAEL for parental male and female animals and the NOEL for the F 1generation was 1000 mg/kg bw/d.28S International Journal of Toxicology 38(Supple',\n",
       "   'erved in females fed 505 and 1564 mg/kg bw/d, the NOAEL was 1564 mg/kg bw/d for females. Oleyl phosphate had a NOAEL of 1000 '],\n",
       "  'valori_ld50': ['2 g/kg bw'],\n",
       "  'valori_noael': ['361 mg/kg bw/d',\n",
       "   '600 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1564 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d7294847'),\n",
       "  'Nome_comune': 'C9-15 Pareth-8',\n",
       "  'INCI_name': 'C9-15 Alketh-8 (Formerly C9-15 Pareth-8)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87c023a3-73b1-4143-8e0b-61a649bcec77',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d7294848'),\n",
       "  'Nome_comune': 'C9-16 Isoparaffin',\n",
       "  'INCI_name': 'C9-16 Isoalkane (Formerly C9-16 Isoparaffin)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c3ebcdad-6af5-4858-b7f7-2230a80c4ca3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ee0fa771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):269-295, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Oral. Isododecane had an oral median lethal dose (LD 50)o f >2 g/kg in mice and other isoparaffin mixtures had oral LD 50 values >10 g/kg in rats as summarized in Table 8.276S Internationa',\n",
       "   'g/kg103 Isododecane (10% in olive oil) C12 5 mice LD 50> 2 g/kg79 Isohexadecane C16 90 rats (males and females) LD 50> 46.4 mL/kg (>3.57 g/kg)104 Isooctane C8 Rats LD 50> 5 g/kg8 Isooctane C8'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['10 g/kg ', '57 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d7294849'),\n",
       "  'Nome_comune': 'Caesalpinia Spinosa Gum',\n",
       "  'INCI_name': 'Caesalpinia Spinosa Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1951a2fe-fd25-4212-bfa5-56aff1cedb88',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['dy weight) over a 24-hour period.54The acute oral LD50 was >10 000 mg/kg body weight. Repeated Dose Toxicity—Oral Studies Cyamopsis te',\n",
       "   'ngredients: guar hydroxypropyltrimonium chloride (LD50 ¼12.5 g/kg), hydroxypropyl guar hydroxypropyltrimonium chloride (LD50 ¼12.0 g/kg), carboxymethyl guar (LD50 ¼17.8 g/kg), hydro- ly',\n",
       "   'here were no macroscopic findings at necropsy. An LD50 of >2000 mg/kg was reported. Gum guar, oxidized 2-hydro xypropyl ',\n",
       "   ' fecal staining; and irritability. The acute oral LD50 was 17.8 g/kg (95 %confidence limits of 13.1-22.5 g/kg). Hydrolyzed guar. An acute oral toxicity study o',\n",
       "   '0 mg/kg body weight at a 2-hour interval. An oral LD50 value of >5000 mg/kg body weight was reported. In a similar test, 10 male and 10 fe',\n",
       "   'ce and rats). None of the ani- mals died, and the LD50 was >6000 mg/kg in both the species. Ceratonia siliqua gum. The ac',\n",
       "   'ity; and generally poor condition. The acute oral LD50 was 12.0 g/kg (95 %confidence limits of 9.2-14.8 g/kg). Carboxymethyl guar. The acute oral toxicity of ',\n",
       "   '/kg), which yielded 90 %mortality. The acute oral LD50 was 15 g/kg (95 %confidence limits of 13-17 g/kg). Hydroxypropyl guar hydroxypropyltrimonium chlor',\n",
       "   ' piloerection. The acute oral median lethal dose (LD50) was 12.5 g/kg (95 %confidence limits of 10.22-14.78 g/kg). The acute oral toxicity of a guar hydroxypropyl',\n",
       "   'zed guar (LD50 > 6 g/kg), cassia gum (LD50 > 5 g/kg), and C siliqua gum (LD50 ¼5 g/kg). The LD50s for C siliqua gum in other species include 13.1 g/kg (mice), 9.1 g/kg (rabbits), and 10.3 g/kg (hamste'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight',\n",
       "   '0 g/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg body weight ',\n",
       "   '6000 mg/kg ',\n",
       "   '8 g/kg',\n",
       "   '17 g/kg',\n",
       "   '78 g/kg',\n",
       "   '13.1 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484a'),\n",
       "  'Nome_comune': 'Caesalpinia Spinosa Hydroxypropyltrimonium Chloride',\n",
       "  'INCI_name': 'Caesalpinia Spinosa Hydroxypropyltrimonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f3df9f1c-9277-4fdd-b791-584dcbb0c977',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['dy weight) over a 24-hour period.54The acute oral LD50 was >10 000 mg/kg body weight. Repeated Dose Toxicity—Oral Studies Cyamopsis te',\n",
       "   'ngredients: guar hydroxypropyltrimonium chloride (LD50 ¼12.5 g/kg), hydroxypropyl guar hydroxypropyltrimonium chloride (LD50 ¼12.0 g/kg), carboxymethyl guar (LD50 ¼17.8 g/kg), hydro- ly',\n",
       "   'here were no macroscopic findings at necropsy. An LD50 of >2000 mg/kg was reported. Gum guar, oxidized 2-hydro xypropyl ',\n",
       "   ' fecal staining; and irritability. The acute oral LD50 was 17.8 g/kg (95 %confidence limits of 13.1-22.5 g/kg). Hydrolyzed guar. An acute oral toxicity study o',\n",
       "   '0 mg/kg body weight at a 2-hour interval. An oral LD50 value of >5000 mg/kg body weight was reported. In a similar test, 10 male and 10 fe',\n",
       "   'ce and rats). None of the ani- mals died, and the LD50 was >6000 mg/kg in both the species. Ceratonia siliqua gum. The ac',\n",
       "   'ity; and generally poor condition. The acute oral LD50 was 12.0 g/kg (95 %confidence limits of 9.2-14.8 g/kg). Carboxymethyl guar. The acute oral toxicity of ',\n",
       "   '/kg), which yielded 90 %mortality. The acute oral LD50 was 15 g/kg (95 %confidence limits of 13-17 g/kg). Hydroxypropyl guar hydroxypropyltrimonium chlor',\n",
       "   ' piloerection. The acute oral median lethal dose (LD50) was 12.5 g/kg (95 %confidence limits of 10.22-14.78 g/kg). The acute oral toxicity of a guar hydroxypropyl',\n",
       "   'zed guar (LD50 > 6 g/kg), cassia gum (LD50 > 5 g/kg), and C siliqua gum (LD50 ¼5 g/kg). The LD50s for C siliqua gum in other species include 13.1 g/kg (mice), 9.1 g/kg (rabbits), and 10.3 g/kg (hamste'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight',\n",
       "   '0 g/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg body weight ',\n",
       "   '6000 mg/kg ',\n",
       "   '8 g/kg',\n",
       "   '17 g/kg',\n",
       "   '78 g/kg',\n",
       "   '13.1 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484b'),\n",
       "  'Nome_comune': 'Caffeine',\n",
       "  'INCI_name': 'Caffeine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8c82edc7-2115-4ae6-b58a-c78671befe16',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/2519',\n",
       "   'valori': ['LD50 Rat ip 260 mg/kg',\n",
       "    'LD50 Rat oral 192 mg/kg',\n",
       "    'LD50 Rat rectal 300 mg/kg',\n",
       "    'LD50 Rat iv 105 mg/kg',\n",
       "    'LD50 Rat sc 170 mg/kg',\n",
       "    'LD50 Mouse oral 127 mg/kg',\n",
       "    'LD50 Mouse ip 168 mg/kg',\n",
       "    'LD50 Mouse iv 62 mg/kg',\n",
       "    'LD50 Mouse sc 270 mg/kg',\n",
       "    'LD50 Dog oral 140 mg/kg',\n",
       "    'LD50 Rabbit oral 224 mg/kg',\n",
       "    'LD50 Guinea pig oral 230 mg/kg',\n",
       "    'LD50 Hamster oral 230 mg/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 666\",\n",
       "    'IUCLID Data Sheets for Caffeine (CAS 58-08-2); Available from, as of January 9, 2014: https://esis.jrc.ec.europa.eu/doc/IUCLID/data_sheets/58082.pdf',\n",
       "    'IUCLID Data Sheets for Caffeine (CAS 58-08-2); Available from, as of January 9, 2014: https://esis.jrc.ec.europa.eu/doc/IUCLID/data_sheets/58082.pdf',\n",
       "    'IUCLID Data Sheets for Caffeine (CAS 58-08-2); Available from, as of January 9, 2014: https://esis.jrc.ec.europa.eu/doc/IUCLID/data_sheets/58082.pdf']},\n",
       "  'contesti_ld50': [' No./Group  Vehicle  Concentration/Dose/Protocol  LD 50/Results  Reference   Caffeine  Rat 5 corn oil  90, 130, 200, 300, 450, 670, 1000, 1500  mg/kg  483 mg/kg bw  5  Caffeine  Rat 10 gum Arabic  NR 700 mg/kg bw; m',\n",
       "   '  semi -occlusive patch f or 24 h  to rats .  The LD 50 was >  2000 mg/kg bw for both test substances .5,6   Numerous acute ora',\n",
       "   'ts reported low toxicity.  The reported   dermal  LD 50 for Caffeine and Theophylline were >  2000 mg/kg bw when test substances were appl ied via a semi -occ'],\n",
       "  'contesti_noael': ['o difference between treated and  control rats.   NOAEL male: 151 mg/kg bw/d   NOAEL female: 174 .2 mg/kg bw/d  5  Theobromine  male Sprague -Dawley  rats (# of',\n",
       "   'r irregular microscopic findings were observed.   NOAEL male: 167 .4 mg/kg bw/d   NOAEL female: 179 .4 mg/kg bw/d  5  Caffeine  male Sprague -Dawley  rats (# of ra',\n",
       "   'er, t he no-observable - adverse effect -levels ( NOAEL s) were 167  and 179 mg/kg bw/day in male and female mice, respectively, and 151 and 174 mg/kg bw/day in male and female rats, respectively; the highes',\n",
       "   ' were dosed with Caffeine in drinking water, t he NOAEL s were 167 and  179 mg/kg bw/day in male and female mice, respectively, and 151 and 174 mg/kg bw/day in male and female rats,  respectively; the highe'],\n",
       "  'valori_ld50': ['483 mg/kg bw  ', '2000 mg/kg bw ', '2000 mg/kg bw '],\n",
       "  'valori_noael': ['2 mg/kg bw/d',\n",
       "   '4 mg/kg bw/d',\n",
       "   '174 mg/kg bw/day',\n",
       "   '174 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484c'),\n",
       "  'Nome_comune': 'Calcium Acetate',\n",
       "  'INCI_name': 'Calcium Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8e922c77-4e2b-4069-ae1d-89095f90bf1d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b8106c4d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):112-136, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/6116',\n",
       "   'valori': ['LD50 Mouse ip 75 mg/kg', 'LD50 Mouse iv 52 mg/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sax's Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 626\",\n",
       "    \"Lewis, R.J. Sax's Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 626\"]},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484d'),\n",
       "  'Nome_comune': 'Calcium Alginate',\n",
       "  'INCI_name': 'Calcium Alginate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2fd6b265-914a-4c4f-82b9-a565e5d3e3c4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1ad6c1f2275d729484e'),\n",
       "  'Nome_comune': 'Calcium Aluminum Borosilicate',\n",
       "  'INCI_name': 'Calcium Aluminum Borosilicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5f69971f-fcef-4669-ba70-00e8e02822fb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9252d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):65-72, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d729484f'),\n",
       "  'Nome_comune': 'Calcium Ascorbate',\n",
       "  'INCI_name': 'Calcium Ascorbate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=564cae71-c216-4b01-a103-e87a6f624d22',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d0ca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 2):51-111, 2005',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['000 mg/kg bw. The following oral Sodium Ascorbate LD50 values were estimated; mice >5000 mg/kg bw, rats>5000 mg/kg bw, and guinea pigs >5000 mg/kg bw. The following acute parenteral LD 50s of Ascorbi',\n",
       "   ' 5.5, and 7 g/kg bw Ascorbic Acid. The acute oral LD 50 for mice dosed with Ascorbic Acid was 5.2 ±0.19 g/kg bw. With higher doses, stupor, prostration, and deat'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5000 mg/kg bw', '19 g/kg bw'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294850'),\n",
       "  'Nome_comune': 'Calcium Aspartate',\n",
       "  'INCI_name': 'Calcium Aspartate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f0708a7e-6044-475e-87ec-fe3b1a9fc92b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294851'),\n",
       "  'Nome_comune': 'Calcium Behenate',\n",
       "  'INCI_name': 'Calcium Behenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6710e274-8a17-431c-a558-572d3559a9d3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294852'),\n",
       "  'Nome_comune': 'Calcium Benzoate',\n",
       "  'INCI_name': 'Calcium Benzoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2a9620cf-d9f3-495e-9008-3c0b621dbaaf',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6b62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):5-30, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ts (number not stated), and a median lethal dose (LD 50) of 4,000 mg/kg body weight was reported.4Study details were not included. In '],\n",
       "  'contesti_noael': ['udies yielded a no-observed-adverse-effect level (NOAEL) of 800 mg/kg/ day for benzoic acid and >1,000 mg/kg/day for the salts.3At higher doses, increased mortali',\n",
       "   'sodium benzoate in the diet (/C212,800 mg/kg/day; NOAEL ¼1,400 mg/kg/day). Tes- ticular atrophy was observed in rabbits th',\n",
       "   'ts in a 4-generation reproductive toxicity study (NOAEL > 750 mg/kg).3Groups of rats (20 rats/sex/group) received benzoic acid doses of 375 or 750 mg/kg/day in the diet continuously. Animals of the third ge',\n",
       "   'ed strain dosed with benzyl alcohol by gavage, an NOAEL of 550 mg/kg (only dose) body weight for developmental toxicity was reported. An LOAEL of 750 mg/kg/day (only dose) for developmental toxicity wasreporte',\n",
       "   'y (reduced food intake and decreased body weight; NOAEL ¼ 1,400 mg/kg/day). All developmental effects were observed at doses/C212,800 mg/kg/day. On days 6 through 10, 15, or 18 of gestation, do'],\n",
       "  'valori_ld50': ['000 mg/kg body weight '],\n",
       "  'valori_noael': ['000 mg/kg/day',\n",
       "   '400 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '750 mg/kg/day',\n",
       "   '800 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294853'),\n",
       "  'Nome_comune': 'Calcium Carbonate',\n",
       "  'INCI_name': 'Calcium Carbonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b46f7b21-b2c0-47b2-a4c6-e5c366afadd9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d69e5a23-fad8-81e7-8ce9-48d464c919af',\n",
       "  'pdf_date': 'IJT 41(Suppl. 1):80-105, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/10112',\n",
       "   'valori': ['LD50 Mouse oral 6450 mg/kg bw', 'LD50 Rat oral 6450 mg/kg'],\n",
       "   'fonti': ['European Chemicals Bureau; IUCLID Dataset, Calcium carbonate (471-34-1) (2000 CD-ROM  edition). Available from, as of July 14, 2006: https://esis.jrc.ec.europa.eu/',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 677\"]},\n",
       "  'contesti_ld50': [' had cleared in all animals by day 10. The dermal LD 50 was reported to be >2000 mg/kg body weight. Potassium Carbonate An acute dermal toxicity eva',\n",
       "   'its was >2000 mg/kg body weight. The same results(LD 50> 2000 mg/kg) were reported in acute dermal toxicity studies o',\n",
       "   'rbonate in studies involving rats. The acute oral LD 50 for Calcium Carbonate, and Potassium Bicarbonate was>2000 mg/kg. In an acute inhalation toxicity study on ammonia'],\n",
       "  'contesti_noael': ['e was not teratogenic in rats dosed bygavage. The NOAEL was estimated to be >800 mg/kg bodyweight/d for pregnant rats and their fetuses. The equivale',\n",
       "   'se group, but without intergroup differences. The NOAEL for magnesium chloride hexahydrate was estimated tobe >800 mg/kg body weight/d; the equivalent NOAEL forMagnesium Carbonate was ',\n",
       "   'r adverse effects on body weight development. The NOAEL was 1000 mg/kg body weight/d. Potassium Bicarbonate I na4 - w kt o x i c i t y',\n",
       "   'respectively, in studies involving albino rats. A NOAEL of 1000 mg/kg body weight/day was reported in a study in which male and female ',\n",
       "   'ale rats were dosed similarly for 28 to 29 d. The NOAEL for the reproductive/developmental toxicity of magnesium chloride hexahydrate was 1000 mg/kg bodyweight/d; the equivalent NOAEL for Magnesium Carbonatewas ',\n",
       "   'xperiments, it was determined that the equivalent NOAEL for Magnesium Carbonate was 4128 mg/kg bodyweight/d. Rats fed Calcium Carbonate at 300 mg/kg for3 d h'],\n",
       "  'valori_ld50': ['2000 mg/kg body weight', '2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['800 mg/kg bodyweight/d',\n",
       "   '800 mg/kg body weight/d',\n",
       "   '1000 mg/kg body weight/d',\n",
       "   '1000 mg/kg body weight/day',\n",
       "   '1000 mg/kg bodyweight/d',\n",
       "   '4128 mg/kg bodyweight/d']},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294854'),\n",
       "  'Nome_comune': 'Calcium Carboxymethyl Cellulose',\n",
       "  'INCI_name': 'Calcium Carboxymethyl Cellulose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=44a1bc08-dde9-4fef-a6c4-f9dce62ab8ca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294855'),\n",
       "  'Nome_comune': 'Calcium Carrageenan',\n",
       "  'INCI_name': 'Calcium Carrageenan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b509b2df-0462-4738-86f3-360f27189fe8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294856'),\n",
       "  'Nome_comune': 'Calcium Caseinate',\n",
       "  'INCI_name': 'Calcium Caseinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=73614427-ba84-457d-99ba-45b7aaa4fb09',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a744d1db-21ea-4172-a676-d17332da9e6e',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):43-56, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294857'),\n",
       "  'Nome_comune': 'Calcium Citrate',\n",
       "  'INCI_name': 'Calcium Citrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6c081dbb-4204-48fe-928d-458ce74106ea',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2b6dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 33(Suppl.2):16-46, 2014',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['xicity Studies. Ingredient AnimalsaNo./group Dose LD 50 Reference Dermal Citric acid Citric acid Rabbits 10 5 g/kg tested >5 g/kg 51 Triethyl citrate Triethyl citrate Rabbits 4 Not'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ae6c1f2275d7294858'),\n",
       "  'Nome_comune': 'Calcium Dihydrogen Phosphate',\n",
       "  'INCI_name': 'Calcium Dihydrogen Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fdc85206-67d5-44ea-83af-f8df043f9805',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['40 mg/kg.3 Ammonium Salts Ammonium Phosphate Rats LD 50>1000 mg/kg.48 Ammonium Phosphate Rats LD 50¼3250 mg/kg.88 Am',\n",
       "   '0 mg/kg.48 Disodium Pyrophosphate Rats LD 50>1000 mg/kg.48 Disodium Pyrophosphate Rats LD 50¼1690 mg/kg.8',\n",
       "   '/kg.48 Potassium Salts Dipotassium Phosphate Rats LD 50>500 mg/kg.48 Dipotassium Phosphate Rats LD 50>1000 mg/kg.48 Dipotassium Phosphate(liquid) Rats LD 50¼4810 ',\n",
       "   'mg/kg.48 Tetrapotassium Pyrophosphate Rats (male) LD 50>1000 mg/kg.48 Tetrapotassium Pyrophosphate Rats LD 50¼2980 m',\n",
       "   ' (5 males and 5 females) LD 50>2000 mg/kg.87 Calcium Phosphate Rats LD 50>1000 mg/kg.48 Calcium Phosphate Rats LD 50¼2170 mg/kg.48 Cal',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>1260 mg/kg.68 Phosphoric Acid Rabbits LD 50¼2740 mg/kg.48,66',\n",
       "   ' Rats LD 50¼5750 mg/kg.48 Ammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50>1000 mg/kg.48 Diammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50¼6500 mg/kg.48 ',\n",
       "   'Rats LD 50¼8390 mg/kg.48,66 Sodium Phosphate Mice LD 50>3700 mg/kg.48,8 Sodium Phosphate Guinea pigs LD 50>2000 mg/kg.48,89 Sodium Trimetaphosphate Rats LD 50¼10600 mg',\n",
       "   'ups of 5) No clinical signs or necropsy findings. LD 50>2000 mg/ kg.30,91 Tetrasodium Pyrophosphate Mice LD 50¼1300 mg/kg.8 Trisodium Phosphate Rats LD 50>2000 mg/kg.48,92 Trisodium Phosphate Rats LD 50¼4100 mg/kg.4',\n",
       "   't stated)Rabbits LD 50>2000 mg/kg.48Johnson et al 63S Table 6. Acute Dermal Toxicit',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>3160 mg/kg.68 Phosphoric Acid 85% solution Rabbits LD 50>2000 mg/kg.48 Ammonium Salts Ammonium Phosphate Rats LD 50>5',\n",
       "   'ts No clinical signs or necropsy findings. LD 50 >2000 mg/kg.31 Tetrasodium Pyrophosphate Rabbits LD 50>2000 mg/kg.48 Tetrasodium Pyrophosphate Rabbits LD 50>7940 m',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>10000 mg/kg.48 Calcium Salts Calcium Dihydrogen Phosphate 2000 mg/kg Rabbits (5 males and 5 females) Severe erythema an',\n",
       "   'd mild edema. LD 50> 2000 mg/kg.86 Calcium Phosphate Rabbits LD 50>300 mg/kg.98 Calcium Phosphate Rabbits LD 50>2000 mg/kg.48 Calcium Pyrophosphate Rabbits LD 50>7940 mg/kg',\n",
       "   'Stauffland albino rabbits (5 males and 5 females) LD 50>2000 mg/kg.67 Dicalcium Phosphate Rabbits LD 50>7940 mg/kg.48 Tricalcium Phosphate Rabbits LD 50>2000 mg/kg.48 Magnesium Salts Magnesium Phosphate Solution (',\n",
       "   's involving rabbits, an LD 50of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   'ute dermal toxicity studies involving rabbits, an LD 50 of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   's LD 50¼3600 mg/kg.48 Disodium Pyrophosphate Rats LD 50>4000 mg/kg.48,89 Disodium Pyrophosphate Mice LD 50¼3350 mg/k',\n",
       "   '/kg.48,95 Pentapotassium Triphosphate Rats (male) LD 50>1000 mg/kg.48 Potassium Phosphate Rats (male) LD 50>4640 mg/kg.48 Potassium Phosphate Rats LD 50¼7100 mg/kg.48 P',\n",
       "   '0¼4150 mg/kg.48 Trisodium Phosphate Rats (female) LD 50<5000 mg/kg.48 Trisodium Phosphate 20% solution Rats LD 50¼65',\n",
       "   'phosphate Solution (concentration not stated)Rats LD 50<5000 mg/kg.48 Tetrapotassium Pyrophosphate Mice LD 50¼1000 m',\n",
       "   'LD 50¼3986 mg/kg.48 Calcium Phosphate Rats (male) LD 50>5000 mg/kg.48 Calcium Phosphate Mice LD 50¼4600 mg/kg.8 Dica',\n",
       "   'male) LD 50>10000 mg/kg.67 Dicalcium Phosphate Mice LD 50/C251700 mg/kg.17 Tricalcium Phosphate Rats LD 50>5000 mg/kg.48 Tricalcium Phosphate Sprague-Dawley rats (fema',\n",
       "   'LD 50>300 mg/kg.48 Dipotassium Phosphate(liquid) Rabbits LD 50>5000 mg/kg.48 Dipotassium Phosphate Rabbits LD 50>5000 mg/kg',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>4640 mg/kg.48 Tetrapotassium Pyrophosphate (liquid)Rabbits LD 50>5000 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>794',\n",
       "   'ed for calcium salts of phosphoric acid. Reported LD 50 values ranging from >2000 mg/kg to >7940 mg/kg were reported for magnesium salts of phosphoric ac',\n",
       "   'm >7940 mg/kg to >10000 mg/kg for rabbits. Dermal LD 50 values ranging from >300 mg/kg to >7940 mg/kg (rabbits) were reported for sodium salts of Phosp',\n",
       "   'lcium Phosphate 6 Sprague-Dawley rats (female) LD 50/C212000 mg/kg.67 Dicalcium Phosphate Rats LD 50¼7100 mg/kg.48 Dicalcium Phosphate Rats LD 50>7940 mg/kg.48 Dicalcium Phosphate 10 Sprague-Dawley rats (fe',\n",
       "   '000 mg/kg.88 Ammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.88 Diammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rabbits LD 50>10000 mg/kg',\n",
       "   '.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.97 Sodium Salts Disodium Phosphate Rabbits LD 50>7940 mg/kg.48 Disodium Pyrophosphate Rabbits LD 50>300 mg/kg',\n",
       "   '.98 Disodium Pyrophosphate Rabbits LD 50>7940 mg/kg.48 Pentasodium Triphosphate Rabbits LD 50¼4640 mg',\n",
       "   '/kg.48 Pentasodium Triphosphate Rabbits LD 50>7940 mg/kg.48 Sodium Phosphate Rabbits LD 50>7940 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateR',\n",
       "   'abbits LD 50>7940 mg/kg.48 Tetrasodium Pyrophosphate 20 Sprague-Dawley ra',\n",
       "   'g/kg.48 Trisodium Phosphate Rabbits LD 50>300 mg/kg.98 Trisodium Phosphate Rabbits LD 50>7940 mg/kg.48 Potassium Salts Dipotassium Phosphate Rabbits ',\n",
       "   '.48 Pentapotassium Triphosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>7940 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>200',\n",
       "   'concentration not stated)Rabbits LD 50>2000 mg/kg.48 Magnesium Phosphate Rabbits LD 50>4640 mg/kg.48 Trimagnesium Phosphate Rabbits LD 50>7940 mg/kg.4864S International Journal of Toxicology 40(Supp',\n",
       "   'sphoric acid involving rats or mice, the reported LD 50 ranged from 2170 mg/kg (Calcium Phosphate [rats]) to > 10000 mg/kg (Calcium Pyrophosphate [rats]). The reportedLD 50',\n",
       "   'Sodium Polyphosphate/Sodium HexametaphosphateRats LD 50>10000 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateM',\n",
       "   'ed water)Female Sprague-Dawley rats (groups of 3) LD 50>2000 mg/kg.86,87 Calcium Dihydrogen Phosphate Female Sprague-Dawley rats (groups of 5) LD 50>10000 mg/kg.86,87 Calcium Dihydrogen Phosphate Albino rabbits',\n",
       "   'le, groups of 3) LD 50>2000 mg/kg.55 Calcium Pyrophosphate Rats LD 50>10000 mg/kg.48 Magnesium Salts Magnesium Phosphate Rats LD 50',\n",
       "   '>1000 mg/kg.48 Magnesium Phosphate Rats LD 50>4640 mg/kg.48 Magnesium Phosphate Rats LD 50>5000 mg/kg.48 Trimagnesium Phosphate Rats LD 50>10000 mg/kg.48 Magnesium Phosphate Solution (concentration no',\n",
       "   'd guinea pigs in acute oral toxicity studies, and LD 50 values ranged from 1300 mg/kg (Tetrasodium Pyrophosphate[mice]) to 10600 mg/kg (Sodium Trimetaphosphate [rats]). Forpotassium sa',\n",
       "   'Diammonium Phosphate Rats LD 50>25100 mg/kg.48 Sodium Salts Disodium Phosphate Rats LD 50¼595'],\n",
       "  'contesti_noael': ['daily for 150 days. In studies involving dogs, an NOAEL of 100 mg/kg/d was reportedfor the following sodium salts, each ',\n",
       "   's for 52 weeks yielded an NOEL of 338 mg/kg/d. An NOAEL of 105 mg/kg/d was reported in astudy in which sheep received doses of Phosphoric Acid up to 211 mg/kg/d for 70 days. An NOAEL of 250 mg/kg/d was reported',\n",
       "   ') No reproductive or developmental toxic effects. NOAEL ¼1000 mg/kg/d.17 Potassium Phosphate Doses (in water) up to 320 mg/kg/d on gestation d 6-15 20 to 22 CD-1 mice No treatme',\n",
       "   'e or developmental effects at doses administered. NOAEL ¼1500 mg/kg/d.88,100 Sodium Salts Disodium PyrophosphateDoses (in water) up to 335 mg/kg/d on gestation d 6-15 19 to 22 CD-1 mice No treatme',\n",
       "   '13/sex/dose) 2 females of 500 mg/kg/d group died. NOAEL ¼250 mg/kg/d.65,68 Phosphoric Acid Up to 0.75% in diet (338 mg/kg/d*) for >52 wk Rats NOEL ¼338 mg/kg/d*.48,89 Phosph',\n",
       "   'l inflammation (not dose-dependent) at all doses. NOAEL ¼250 mg/kg/d.88,100 Diammonium Phosphate Increasing oral doses (in drinking water) of 300 to 700 mg/kg/d for 5 to 16 mo10 Rabbits (females) Average weight',\n",
       "   ' Trimetaphosphate 0 and 100 mg/kg/d for 30 d Dogs NOAEL ¼100 mg/kg/d.90 Tetrasodium Pyrophosphate 250, 500, or 1000 mg/kg/d by gavage for 90 d (5 d/week) (OECD Guideline 408',\n",
       "   'group, but no morphological findings in the liver.NOAEL ¼1000 mg/kg/d. 86,120 Dicalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d for 28 d by gastric intubation Sprague-Dawley rat',\n",
       "   's (10/sex/dose) No gross or microscopic eff ects. NOAEL >1000 mg/kg/d.67 Tricalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d by gavage. Males dosed from 2 wk before mating to',\n",
       "   ' on mating, gestation, or external malformations. NOAEL of 1000 mg/kg/d (parents and pups).86,120 (continued)72S Internat',\n",
       "   'females of 1000 mg/kg/d group. NOEL ¼250 mg/kg/d; NOAEL ¼500 mg/kg/d. 31 Tetrasodium Pyrophosphate 0%, 1.1%, 1.8%, 3%, or 5% in diet (0, 495, 810, 1350 mg/kg/d*) for 39 wkRats LOEL ¼495 mg/kg/d*.48,103 Trisodi',\n",
       "   'ic Acid 0, 35, 105, or 211 mg/kg/d for 70 d Sheep NOAEL ¼105 mg/kg/d.99 Ammonium Salts Diammonium Phosphate Oral doses (by gavage) of 0, 250, 750, or 1500 mg/kg/d (7 d/wk) for 35 dRats (groups of 10 [5 males and ',\n",
       "   ' diet (0, 23, 225, 2250 mg/kg/d*) for 104 wk Rats NOAEL ¼225 mg/kg/d*.90 Sodium Polyphosphate/Sodium Hexametaphosphate0%, 0.93%, or 3.5% in diet (0, 419, 1575 mg/kg/d*) for 21 wk Rats NOAEL ¼1575 mg/kg/d*.48,107 Sodi',\n",
       "   'ipotassium Phosphate 0.87% or 5.1% for 21 wk Rats NOAEL ¼2295 mg/kg/d*.48,107 Dipotassium Phosphate 5% in diet (2250 mg/kg/d*) in medium-term bioassay Male Wistar rats Renal ',\n",
       "   '.75 %in the diet daily for >52 weeks. The highest NOAEL (2623 mg/kg/d) was reported in a study in which rats were fed D'],\n",
       "  'valori_ld50': ['1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1260 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3160 mg/kg ',\n",
       "   '3160 mg/kg ',\n",
       "   '4000 mg/kg',\n",
       "   '4640 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '7940 mg/kg ',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10600 mg/kg',\n",
       "   '25100 mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg/d',\n",
       "   '211 mg/kg/d',\n",
       "   '320 mg/kg/d',\n",
       "   '335 mg/kg/d',\n",
       "   '338 mg/kg/d',\n",
       "   '700 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1350 mg/kg/d',\n",
       "   '1500 mg/kg/d',\n",
       "   '1575 mg/kg/d',\n",
       "   '2250 mg/kg/d',\n",
       "   '2623 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d7294859'),\n",
       "  'Nome_comune': 'Calcium Disodium EDTA',\n",
       "  'INCI_name': 'Calcium Disodium EDTA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=521524a3-69ed-439e-8111-d8240acf6cf7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f70efd10-f7c9-a0bd-937e-3f0d2d7d6b43',\n",
       "  'pdf_date': 'IJT 42(Suppl. 3):32-36, 2023',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485a'),\n",
       "  'Nome_comune': 'Calcium Dodecylbenzenesulfonate',\n",
       "  'INCI_name': 'Calcium Dodecylbenzenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=355661b4-10d7-4c92-84fd-0c0dd139dd4f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=80307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 4):288-305, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tated the following. The oral median lethal dose (LD 50) for sodium dodecylben- zenesulfonate (SDDBS) in rats was 1.26 g/kg. No significant toxic effects were observed when '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['26 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485b'),\n",
       "  'Nome_comune': 'Calcium Gluconate',\n",
       "  'INCI_name': 'Calcium Gluconate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=88f0f836-e922-455d-82fb-6460857edf5d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.1):5-38, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/9290',\n",
       "   'valori': ['LD50 Rat oral >5,000 mg/kg bw'],\n",
       "   'fonti': ['European Chemicals Bureau; IUCLID Dataset, Calcium gluconate (299-28-5) (2000 CD-ROM  edition). Available from, as of July 14, 2006: https://esis.jrc.ec.europa.eu/']},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485c'),\n",
       "  'Nome_comune': 'Calcium Glycinate',\n",
       "  'INCI_name': 'Calcium Glycinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8f978be8-7df3-495d-89aa-6f5cb90bccdb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5352d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 4):41-64, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485d'),\n",
       "  'Nome_comune': 'Calcium Hydrolyzed Collagen',\n",
       "  'INCI_name': 'Calcium Hydrolyzed Collagen',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=81ee1cee-951a-4ae7-9d28-699fab98e5ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=70af0ca6-3a32-ea93-85bf-c21e81f97048',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):21-42, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485e'),\n",
       "  'Nome_comune': 'Calcium Hydroxide',\n",
       "  'INCI_name': 'Calcium Hydroxide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=501116c7-0418-41c7-a555-3d9aefe0cefe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=da248f0f-5cac-3544-be09-3c7448f107e4',\n",
       "  'pdf_date': 'IJT 40(Suppl. 2):16-35, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/6093208',\n",
       "   'valori': ['LD50 rat oral 500 - 2000  mg/kg bw',\n",
       "    'LD50 mouse oral 7300  mg/kg bw',\n",
       "    'LD50 rat oral 7,340 mg/kg',\n",
       "    'LD50 Rat oral 7.3 (4.8 - 11.1) g/kg.'],\n",
       "   'fonti': ['European Chemicals Bureau; IUCLID Dataset, Calcium Hydroxide (1306-62-0). Available from, as of February 7, 2014: https://esis.jrc.ec.europa.eu/doc/IUCLID/data_sheets/1305620.pdf',\n",
       "    'European Chemicals Bureau; IUCLID Dataset, Calcium Hydroxide (1306-62-0). Available from, as of February 7, 2014: https://esis.jrc.ec.europa.eu/doc/IUCLID/data_sheets/1305620.pdf',\n",
       "    'Sax, N.I. Dangerous Properties of Industrial Materials. 6th ed. New York, NY: Van Nostrand Reinhold, 1984., p. 621',\n",
       "    'National Institute for Working Life/Scientific Basis for Swedish Occupational Standards XX; Consensus report for Calcium Hydroxide (1305-62-0). Available from, as of February 10, 2014: https://www.inchem.org/documents/kemi/kemi/ah1999_26.pdf']},\n",
       "  'contesti_ld50': ['ernational Journal of Toxicology 40(Supplement 2) LD 50>7300 mg/kg bodyweight in rats and mice and Magnesium Hydroxide had an LD 50>2000 mg/kg body- weight in rats. An LD 50of 1230 mg/kg bodyweight',\n",
       "   'ge (10 mL/kg dose volume) in 3 female Wistar rats LD 50>2000 mg/kg bodyweight9 Magnesium Hydroxide Details not provid',\n",
       "   'n oral toxicity studies, Calcium Hydroxide had an LD 50 >7300 mg/kg bodyweight in rats and mice and Magnesium Hydroxide had an LD 50>2000 mg/kg bodyweight in rats. An LD50of 1230 mg/kg bodyweight was obser',\n",
       "   'rmal toxicity stud- ies, Calcium Hydroxide had an LD 50>2.5 g/kg bodyweightTable 4. Frequency and Concentration of '],\n",
       "  'contesti_noael': ['e) and >750mg/L (2-h exposure), respectively. The NOAEL for parental and offspring effects following oral exposure to Magnesium Hydroxide (pH ¼10) was 1000 mg/kg bw/d. No treatment-related effects were observed on cl'],\n",
       "  'valori_ld50': ['2000 mg/kg body',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg bodyweight ',\n",
       "   '5 g/kg '],\n",
       "  'valori_noael': ['1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d729485f'),\n",
       "  'Nome_comune': 'Calcium Lactate',\n",
       "  'INCI_name': 'Calcium Lactate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=09f63e9d-9778-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=73d818db-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl2):14-58, 2017',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d7294860'),\n",
       "  'Nome_comune': 'Calcium Laurate',\n",
       "  'INCI_name': 'Calcium Laurate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6fd052cf-8767-478c-8671-f161c4feee0a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1af6c1f2275d7294861'),\n",
       "  'Nome_comune': 'Calcium Lauroyl Taurate',\n",
       "  'INCI_name': 'Calcium Lauroyl Taurate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fd10e90d-d26f-4da4-88f3-16c17e3f63f5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4354b0ad-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 15, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['for 3 weeks afte r the last  administration.  The LD 50 was >6.5 mg/kg/d for N -ammonium thioglycolate alone; 1 rabbit d',\n",
       "   'ied after 12 doses.  The LD 50  was reduced to 3.44 ±0.14 mg/kg/d when sodium methyl cocoyl taurate was included ',\n",
       "   ' administered  under semi -occlusion  in a paste  LD 50>2000 mg/kg  18  Sodium Methyl  Cocoyl Taurate  Rats Not specified  OECD TG 402 LD 50 >20 mg/kg; No signs of toxicity  observed in the 14 -day ob',\n",
       "   'ompared to N -ammonium thioglycolate  alone.  The LD 50 of N-ammonium thioglycolate   decreased from >6.5 mg/kg/d to 3.44 mg/kg/d when combined with 3.0- 4.0 mg/mL s odium methy',\n",
       "   ' squatting posture,  and coat bristling.  An oral LD 50 of 6.63 g/kg was reported for sodium methyl cocoyl taurate in mice.   The NOAEL was ≥1000 mg/kg/d for both sodium methyl cocoyl taurate and sodiu',\n",
       "   'le Dose ( Acute ) Toxicity    The reported dermal LD 50 value s for sodium methyl cocoyl taurate were >20 and  >2000 mg/kg and values were  ≥2000 mg/kg for sodium methyl oleoyl taurate  in rats  (Table ',\n",
       "   'l cocoyl taurate .  The reported  acute dermal LD 50 for sodium methyl cocoyl taurate was >2000 mg/kg and values were >2000 mg/kg  for sodium methyl oleoyl taurate  in rats.  The re',\n",
       "   'Sprague - Dawley rats  Not specified  OECD TG 401 LD 50>2000 mg/kg  18  Sodium Methyl  Cocoyl Taurate  Wistar rats  (n',\n",
       "   '=5/sex)  Not specified  OECD TG 401 LD 50>2000 mg/kg. No mortalities or signs  of toxicity were  obser',\n",
       "   '6).12,13,17,18,44  The reported oral LD 50 for sodium methyltaurate  was ≥4670 mg/kg in  rats and values  for sodium methyl cocoyl taur',\n",
       "   'ported oral LD 50 for sodium methyltaur ate was ≥4670 mg/kg in  rats and  values for sodium methyl cocoyl taur',\n",
       "   ' 4000, 4500,  4750, 5000, 6300 mg/kg  OECD TG 401 LD 50≥4670 mg/kg in water (the highest  dose tested). Necropsies sh',\n",
       "   ', squatting posture, and coat bristling.  An oral LD 50 of 6.63 g/kg was reported for sodium methyl  cocoyl taurate  in',\n",
       "   ' The mice were  observed for 72 h after  dosing.  LD 50=6.63 g/kg  45  OECD TG - Organization for Economic Cooperatio'],\n",
       "  'contesti_noael': ['uman   The no-observed -adverse- effects -level  (NOAEL ) was reported to  be ≥1000 mg/kg/d for both sodium methyl cocoyl  taurate and sodium',\n",
       "   'necropsy .  The authors determined that the  oral NOAEL for reproduction/developmental toxicity was > 1000  mg/kg/d for both males and females.     GENOTOXICITY   In',\n",
       "   'd for sodium methyl cocoyl taurate in mice.   The NOAEL was ≥1000 mg/kg/d for both sodium methyl cocoyl taurate and sodium ',\n",
       "   'ses .  In a reproduction/developmental assay, the NOAEL for reproduction/developmental toxicity was ≥1000 mg/kg/d for  both mal e and female rats when sodium methy',\n",
       "   'Repeated Dose 28 - Day Oral Toxicity in Rodents)  NOAEL≥1000 mg/kg/d (actual dose  received) . No clinical signs with ',\n",
       "   ')  62.5, 250, or  1000 mg/kg  Gavage for 14 days  NOAEL≥1000 mg/kg/d (actual dose  received). No clinical signs with  '],\n",
       "  'valori_ld50': ['5 mg/kg',\n",
       "   '14 mg/kg',\n",
       "   '20 mg/kg',\n",
       "   '44 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000 mg/kg  ',\n",
       "   '2000 mg/kg',\n",
       "   '4670 mg/kg ',\n",
       "   '4670 mg/kg ',\n",
       "   '4670 mg/kg ',\n",
       "   '63 g/kg ',\n",
       "   '63 g/kg  '],\n",
       "  'valori_noael': ['1000 mg/kg/d',\n",
       "   '1000  mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294862'),\n",
       "  'Nome_comune': 'Calcium Magnesium Silicate',\n",
       "  'INCI_name': 'Calcium Magnesium Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0743b86e-fdc5-4905-bb72-534d8e9d4f55',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294863'),\n",
       "  'Nome_comune': 'Calcium Myristate',\n",
       "  'INCI_name': 'Calcium Myristate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e26a2cb-8dab-43b6-bd18-894a1e859197',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6aee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl. 3):162-186, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['then further metabolized. The median lethal dose (LD 50) of butyl myristate was greater than 8 g/kg in rats. In animal tests, undiluted butyl myristat'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294864'),\n",
       "  'Nome_comune': 'Calcium Pantothenate',\n",
       "  'INCI_name': 'Calcium Pantothenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1aeb4de0-2329-436f-9d95-01475e48fa1d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b4404ad0-e5dd-d8ed-b8b6-939376f83fc0',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):77-128, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['nremarkable, and no skin reactions were observed; LD 50> 3 mL/kg/d was reported. Rats were der- mally exposed to a single semi-occl usive application of 2 g/kg (no vehicle) DL-Panthenyl Ethyl Ether for 24 h us',\n",
       "   'nic Acid. In acute dermal exposure experiments an LD 50> 3 mL/kg D-Panthenol and an LD 50> 2 g/kg DL-Panthenyl Ethyl Ether in rats were reported. In',\n",
       "   'xperiments in ratsadministered single dosages, an LD 50> 10 g/kg D-Panthenol, an LD 50> 2 g/kg DL-Panthenyl Ethyl Ether, and an LD 50> 10 mL/kg P',\n",
       "   'ral dosages, resulted inan LD 50of 10 g/kg and an LD 50> 10 g/kg for mice and rats, respectively. An acute inhalati'],\n",
       "  'contesti_noael': ['red to Group 2; in Group 4 diarrhea was reported; NOAEL of 1% and LOAEL of 3% were reported; study researchersspeculated that 10 mg/kg/day of CalciumPantothenate would be a “tolerable uppe',\n",
       "   'y exposed to Panthenol in a 13-wk study . Oral. A NOAEL of 200 mg/kg/d was reported for rats dosed daily in drinking wat',\n",
       "   'iet for 9 wk) as compared to the control group. A NOAEL of 200 mg/kg/d for DL-Panthenol was reported in dosed daily in d',\n",
       "   ' in a chronic study. A maternal and developmental NOAEL ≥1000 mg/kg/d for DL-Panthenyl Ethyl Ether was reported in rats',\n",
       "   '414; controls were usedMaternal and developmental NOAEL ≥1000 mg/kg/day was reported 6 D-Calcium PantothenateRat n = 20 50 or 200 mg/day ( ∼500 or 2000 mg/kg/day)Adult animals dosed daily in diet; weaned offspri'],\n",
       "  'valori_ld50': ['2 g/kg', '2 g/kg ', '2 g/kg ', '10 g/kg '],\n",
       "  'valori_noael': ['10 mg/kg/day',\n",
       "   '200 mg/kg/d',\n",
       "   '200 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '2000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294865'),\n",
       "  'Nome_comune': 'Calcium Paraben',\n",
       "  'INCI_name': 'Calcium Paraben',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5b26e36e-2384-4fc0-b96a-07e547c7487d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=beefb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl.1):5-97, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['nts, assuming a no observed adverse effect level (NOAEL) of 1,000 mg/kg/d from an older DART study.2After careful considera',\n",
       "   'al toxicity at that dose. The mater- nal toxicity NOAEL dose was 1,000 mg/kg bw/d. Parabens have been extensively studied to evalua',\n",
       "   'r com- bined paraben use in a single formulation. NOAEL/MOS (adult, multiple paraben) ¼SED¼160 mg/kg/d/100 ¼1.6 mg/kg/d (SED /C2body weight)/ (dermal absorption /C2conve',\n",
       "   'entration tested (10,000 ppm), corresponding to a NOAEL of 1,141.1 +58.9 and 1,087.6 +67.8 mg/kg/d for Methylparaben and Butylparaben, respectively ',\n",
       "   'a, tumor necrosis factor a. 34Scorresponding to a NOAEL of about 1,140 and 1,100 mg/kg/d for Methylparaben and Butylparaben, respectively.',\n",
       "   'nd DART studies, the Panel determined an adequate NOAEL value of 160 mg/kg/d for Butylparaben. An MOS was recalculated accordi',\n",
       "   '90, compared to controls The results suggested an NOAEL of 160 mg/kg bw/d for Butylparaben for male reproduction and develo',\n",
       "   'risk assessment, the Panel determined an adequate NOAEL value of 160 mg/kg/d for Butylparaben in consideration of the new data',\n",
       "   'vative risk assessment was performed. Therein, an NOAEL value of 160 mg/kg/d for Butylparaben was deter- mined to be adequate ',\n",
       "   'tion of all the new data, the Panel determined an NOAEL of 160 mg/kg bw/d for Butylparaben. The Panel determined the differ'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['000 mg/kg/d',\n",
       "   '000 mg/kg bw/d',\n",
       "   '6 mg/kg/d',\n",
       "   '8 mg/kg/d',\n",
       "   '100 mg/kg/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg bw/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg/d',\n",
       "   '160 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294866'),\n",
       "  'Nome_comune': 'Calcium PCA',\n",
       "  'INCI_name': 'Calcium PCA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d5607f17-de44-4918-9a29-2ab81cdc8e1e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=08efb9a7-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):5-11, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['observed. The no observable adverse effect level (NOAEL) for maternal and reproductive toxicity was listed as 1000 mg/kg body weight/day. Ocular Irritation No ocular irritation was obser',\n",
       "   'eproductive and developmental toxicity study, the NOAEL was 1000 mg/kg body weight/day, the highest dose tested. Sodium PCA ( L-form) wa'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['1000 mg/kg body weight/day',\n",
       "   '1000 mg/kg body weight/day']},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294867'),\n",
       "  'Nome_comune': 'Calcium Phosphate',\n",
       "  'INCI_name': 'Calcium Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8fcb483c-1407-4e1f-acf4-95b9d2ed87ed',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['40 mg/kg.3 Ammonium Salts Ammonium Phosphate Rats LD 50>1000 mg/kg.48 Ammonium Phosphate Rats LD 50¼3250 mg/kg.88 Am',\n",
       "   '0 mg/kg.48 Disodium Pyrophosphate Rats LD 50>1000 mg/kg.48 Disodium Pyrophosphate Rats LD 50¼1690 mg/kg.8',\n",
       "   '/kg.48 Potassium Salts Dipotassium Phosphate Rats LD 50>500 mg/kg.48 Dipotassium Phosphate Rats LD 50>1000 mg/kg.48 Dipotassium Phosphate(liquid) Rats LD 50¼4810 ',\n",
       "   'mg/kg.48 Tetrapotassium Pyrophosphate Rats (male) LD 50>1000 mg/kg.48 Tetrapotassium Pyrophosphate Rats LD 50¼2980 m',\n",
       "   ' (5 males and 5 females) LD 50>2000 mg/kg.87 Calcium Phosphate Rats LD 50>1000 mg/kg.48 Calcium Phosphate Rats LD 50¼2170 mg/kg.48 Cal',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>1260 mg/kg.68 Phosphoric Acid Rabbits LD 50¼2740 mg/kg.48,66',\n",
       "   ' Rats LD 50¼5750 mg/kg.48 Ammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50>1000 mg/kg.48 Diammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50¼6500 mg/kg.48 ',\n",
       "   'Rats LD 50¼8390 mg/kg.48,66 Sodium Phosphate Mice LD 50>3700 mg/kg.48,8 Sodium Phosphate Guinea pigs LD 50>2000 mg/kg.48,89 Sodium Trimetaphosphate Rats LD 50¼10600 mg',\n",
       "   'ups of 5) No clinical signs or necropsy findings. LD 50>2000 mg/ kg.30,91 Tetrasodium Pyrophosphate Mice LD 50¼1300 mg/kg.8 Trisodium Phosphate Rats LD 50>2000 mg/kg.48,92 Trisodium Phosphate Rats LD 50¼4100 mg/kg.4',\n",
       "   't stated)Rabbits LD 50>2000 mg/kg.48Johnson et al 63S Table 6. Acute Dermal Toxicit',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>3160 mg/kg.68 Phosphoric Acid 85% solution Rabbits LD 50>2000 mg/kg.48 Ammonium Salts Ammonium Phosphate Rats LD 50>5',\n",
       "   'ts No clinical signs or necropsy findings. LD 50 >2000 mg/kg.31 Tetrasodium Pyrophosphate Rabbits LD 50>2000 mg/kg.48 Tetrasodium Pyrophosphate Rabbits LD 50>7940 m',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>10000 mg/kg.48 Calcium Salts Calcium Dihydrogen Phosphate 2000 mg/kg Rabbits (5 males and 5 females) Severe erythema an',\n",
       "   'd mild edema. LD 50> 2000 mg/kg.86 Calcium Phosphate Rabbits LD 50>300 mg/kg.98 Calcium Phosphate Rabbits LD 50>2000 mg/kg.48 Calcium Pyrophosphate Rabbits LD 50>7940 mg/kg',\n",
       "   'Stauffland albino rabbits (5 males and 5 females) LD 50>2000 mg/kg.67 Dicalcium Phosphate Rabbits LD 50>7940 mg/kg.48 Tricalcium Phosphate Rabbits LD 50>2000 mg/kg.48 Magnesium Salts Magnesium Phosphate Solution (',\n",
       "   's involving rabbits, an LD 50of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   'ute dermal toxicity studies involving rabbits, an LD 50 of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   's LD 50¼3600 mg/kg.48 Disodium Pyrophosphate Rats LD 50>4000 mg/kg.48,89 Disodium Pyrophosphate Mice LD 50¼3350 mg/k',\n",
       "   '/kg.48,95 Pentapotassium Triphosphate Rats (male) LD 50>1000 mg/kg.48 Potassium Phosphate Rats (male) LD 50>4640 mg/kg.48 Potassium Phosphate Rats LD 50¼7100 mg/kg.48 P',\n",
       "   '0¼4150 mg/kg.48 Trisodium Phosphate Rats (female) LD 50<5000 mg/kg.48 Trisodium Phosphate 20% solution Rats LD 50¼65',\n",
       "   'phosphate Solution (concentration not stated)Rats LD 50<5000 mg/kg.48 Tetrapotassium Pyrophosphate Mice LD 50¼1000 m',\n",
       "   'LD 50¼3986 mg/kg.48 Calcium Phosphate Rats (male) LD 50>5000 mg/kg.48 Calcium Phosphate Mice LD 50¼4600 mg/kg.8 Dica',\n",
       "   'male) LD 50>10000 mg/kg.67 Dicalcium Phosphate Mice LD 50/C251700 mg/kg.17 Tricalcium Phosphate Rats LD 50>5000 mg/kg.48 Tricalcium Phosphate Sprague-Dawley rats (fema',\n",
       "   'LD 50>300 mg/kg.48 Dipotassium Phosphate(liquid) Rabbits LD 50>5000 mg/kg.48 Dipotassium Phosphate Rabbits LD 50>5000 mg/kg',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>4640 mg/kg.48 Tetrapotassium Pyrophosphate (liquid)Rabbits LD 50>5000 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>794',\n",
       "   'ed for calcium salts of phosphoric acid. Reported LD 50 values ranging from >2000 mg/kg to >7940 mg/kg were reported for magnesium salts of phosphoric ac',\n",
       "   'm >7940 mg/kg to >10000 mg/kg for rabbits. Dermal LD 50 values ranging from >300 mg/kg to >7940 mg/kg (rabbits) were reported for sodium salts of Phosp',\n",
       "   'lcium Phosphate 6 Sprague-Dawley rats (female) LD 50/C212000 mg/kg.67 Dicalcium Phosphate Rats LD 50¼7100 mg/kg.48 Dicalcium Phosphate Rats LD 50>7940 mg/kg.48 Dicalcium Phosphate 10 Sprague-Dawley rats (fe',\n",
       "   '000 mg/kg.88 Ammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.88 Diammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rabbits LD 50>10000 mg/kg',\n",
       "   '.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.97 Sodium Salts Disodium Phosphate Rabbits LD 50>7940 mg/kg.48 Disodium Pyrophosphate Rabbits LD 50>300 mg/kg',\n",
       "   '.98 Disodium Pyrophosphate Rabbits LD 50>7940 mg/kg.48 Pentasodium Triphosphate Rabbits LD 50¼4640 mg',\n",
       "   '/kg.48 Pentasodium Triphosphate Rabbits LD 50>7940 mg/kg.48 Sodium Phosphate Rabbits LD 50>7940 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateR',\n",
       "   'abbits LD 50>7940 mg/kg.48 Tetrasodium Pyrophosphate 20 Sprague-Dawley ra',\n",
       "   'g/kg.48 Trisodium Phosphate Rabbits LD 50>300 mg/kg.98 Trisodium Phosphate Rabbits LD 50>7940 mg/kg.48 Potassium Salts Dipotassium Phosphate Rabbits ',\n",
       "   '.48 Pentapotassium Triphosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>7940 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>200',\n",
       "   'concentration not stated)Rabbits LD 50>2000 mg/kg.48 Magnesium Phosphate Rabbits LD 50>4640 mg/kg.48 Trimagnesium Phosphate Rabbits LD 50>7940 mg/kg.4864S International Journal of Toxicology 40(Supp',\n",
       "   'sphoric acid involving rats or mice, the reported LD 50 ranged from 2170 mg/kg (Calcium Phosphate [rats]) to > 10000 mg/kg (Calcium Pyrophosphate [rats]). The reportedLD 50',\n",
       "   'Sodium Polyphosphate/Sodium HexametaphosphateRats LD 50>10000 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateM',\n",
       "   'ed water)Female Sprague-Dawley rats (groups of 3) LD 50>2000 mg/kg.86,87 Calcium Dihydrogen Phosphate Female Sprague-Dawley rats (groups of 5) LD 50>10000 mg/kg.86,87 Calcium Dihydrogen Phosphate Albino rabbits',\n",
       "   'le, groups of 3) LD 50>2000 mg/kg.55 Calcium Pyrophosphate Rats LD 50>10000 mg/kg.48 Magnesium Salts Magnesium Phosphate Rats LD 50',\n",
       "   '>1000 mg/kg.48 Magnesium Phosphate Rats LD 50>4640 mg/kg.48 Magnesium Phosphate Rats LD 50>5000 mg/kg.48 Trimagnesium Phosphate Rats LD 50>10000 mg/kg.48 Magnesium Phosphate Solution (concentration no',\n",
       "   'd guinea pigs in acute oral toxicity studies, and LD 50 values ranged from 1300 mg/kg (Tetrasodium Pyrophosphate[mice]) to 10600 mg/kg (Sodium Trimetaphosphate [rats]). Forpotassium sa',\n",
       "   'Diammonium Phosphate Rats LD 50>25100 mg/kg.48 Sodium Salts Disodium Phosphate Rats LD 50¼595'],\n",
       "  'contesti_noael': ['daily for 150 days. In studies involving dogs, an NOAEL of 100 mg/kg/d was reportedfor the following sodium salts, each ',\n",
       "   's for 52 weeks yielded an NOEL of 338 mg/kg/d. An NOAEL of 105 mg/kg/d was reported in astudy in which sheep received doses of Phosphoric Acid up to 211 mg/kg/d for 70 days. An NOAEL of 250 mg/kg/d was reported',\n",
       "   ') No reproductive or developmental toxic effects. NOAEL ¼1000 mg/kg/d.17 Potassium Phosphate Doses (in water) up to 320 mg/kg/d on gestation d 6-15 20 to 22 CD-1 mice No treatme',\n",
       "   'e or developmental effects at doses administered. NOAEL ¼1500 mg/kg/d.88,100 Sodium Salts Disodium PyrophosphateDoses (in water) up to 335 mg/kg/d on gestation d 6-15 19 to 22 CD-1 mice No treatme',\n",
       "   '13/sex/dose) 2 females of 500 mg/kg/d group died. NOAEL ¼250 mg/kg/d.65,68 Phosphoric Acid Up to 0.75% in diet (338 mg/kg/d*) for >52 wk Rats NOEL ¼338 mg/kg/d*.48,89 Phosph',\n",
       "   'l inflammation (not dose-dependent) at all doses. NOAEL ¼250 mg/kg/d.88,100 Diammonium Phosphate Increasing oral doses (in drinking water) of 300 to 700 mg/kg/d for 5 to 16 mo10 Rabbits (females) Average weight',\n",
       "   ' Trimetaphosphate 0 and 100 mg/kg/d for 30 d Dogs NOAEL ¼100 mg/kg/d.90 Tetrasodium Pyrophosphate 250, 500, or 1000 mg/kg/d by gavage for 90 d (5 d/week) (OECD Guideline 408',\n",
       "   'group, but no morphological findings in the liver.NOAEL ¼1000 mg/kg/d. 86,120 Dicalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d for 28 d by gastric intubation Sprague-Dawley rat',\n",
       "   's (10/sex/dose) No gross or microscopic eff ects. NOAEL >1000 mg/kg/d.67 Tricalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d by gavage. Males dosed from 2 wk before mating to',\n",
       "   ' on mating, gestation, or external malformations. NOAEL of 1000 mg/kg/d (parents and pups).86,120 (continued)72S Internat',\n",
       "   'females of 1000 mg/kg/d group. NOEL ¼250 mg/kg/d; NOAEL ¼500 mg/kg/d. 31 Tetrasodium Pyrophosphate 0%, 1.1%, 1.8%, 3%, or 5% in diet (0, 495, 810, 1350 mg/kg/d*) for 39 wkRats LOEL ¼495 mg/kg/d*.48,103 Trisodi',\n",
       "   'ic Acid 0, 35, 105, or 211 mg/kg/d for 70 d Sheep NOAEL ¼105 mg/kg/d.99 Ammonium Salts Diammonium Phosphate Oral doses (by gavage) of 0, 250, 750, or 1500 mg/kg/d (7 d/wk) for 35 dRats (groups of 10 [5 males and ',\n",
       "   ' diet (0, 23, 225, 2250 mg/kg/d*) for 104 wk Rats NOAEL ¼225 mg/kg/d*.90 Sodium Polyphosphate/Sodium Hexametaphosphate0%, 0.93%, or 3.5% in diet (0, 419, 1575 mg/kg/d*) for 21 wk Rats NOAEL ¼1575 mg/kg/d*.48,107 Sodi',\n",
       "   'ipotassium Phosphate 0.87% or 5.1% for 21 wk Rats NOAEL ¼2295 mg/kg/d*.48,107 Dipotassium Phosphate 5% in diet (2250 mg/kg/d*) in medium-term bioassay Male Wistar rats Renal ',\n",
       "   '.75 %in the diet daily for >52 weeks. The highest NOAEL (2623 mg/kg/d) was reported in a study in which rats were fed D'],\n",
       "  'valori_ld50': ['1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1260 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3160 mg/kg ',\n",
       "   '3160 mg/kg ',\n",
       "   '4000 mg/kg',\n",
       "   '4640 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '7940 mg/kg ',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10600 mg/kg',\n",
       "   '25100 mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg/d',\n",
       "   '211 mg/kg/d',\n",
       "   '320 mg/kg/d',\n",
       "   '335 mg/kg/d',\n",
       "   '338 mg/kg/d',\n",
       "   '700 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1350 mg/kg/d',\n",
       "   '1500 mg/kg/d',\n",
       "   '1575 mg/kg/d',\n",
       "   '2250 mg/kg/d',\n",
       "   '2623 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294868'),\n",
       "  'Nome_comune': 'Calcium Potassium Carbomer',\n",
       "  'INCI_name': 'Calcium Potassium Carbomer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c76bbe3d-81e3-4da7-a758-a69981f2046d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d7294869'),\n",
       "  'Nome_comune': 'Calcium Potassium Sodium Phosphate',\n",
       "  'INCI_name': 'Calcium Potassium Sodium Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c7610b36-34e7-40e1-afa0-081c4a81def3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['40 mg/kg.3 Ammonium Salts Ammonium Phosphate Rats LD 50>1000 mg/kg.48 Ammonium Phosphate Rats LD 50¼3250 mg/kg.88 Am',\n",
       "   '0 mg/kg.48 Disodium Pyrophosphate Rats LD 50>1000 mg/kg.48 Disodium Pyrophosphate Rats LD 50¼1690 mg/kg.8',\n",
       "   '/kg.48 Potassium Salts Dipotassium Phosphate Rats LD 50>500 mg/kg.48 Dipotassium Phosphate Rats LD 50>1000 mg/kg.48 Dipotassium Phosphate(liquid) Rats LD 50¼4810 ',\n",
       "   'mg/kg.48 Tetrapotassium Pyrophosphate Rats (male) LD 50>1000 mg/kg.48 Tetrapotassium Pyrophosphate Rats LD 50¼2980 m',\n",
       "   ' (5 males and 5 females) LD 50>2000 mg/kg.87 Calcium Phosphate Rats LD 50>1000 mg/kg.48 Calcium Phosphate Rats LD 50¼2170 mg/kg.48 Cal',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>1260 mg/kg.68 Phosphoric Acid Rabbits LD 50¼2740 mg/kg.48,66',\n",
       "   ' Rats LD 50¼5750 mg/kg.48 Ammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50>1000 mg/kg.48 Diammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50¼6500 mg/kg.48 ',\n",
       "   'Rats LD 50¼8390 mg/kg.48,66 Sodium Phosphate Mice LD 50>3700 mg/kg.48,8 Sodium Phosphate Guinea pigs LD 50>2000 mg/kg.48,89 Sodium Trimetaphosphate Rats LD 50¼10600 mg',\n",
       "   'ups of 5) No clinical signs or necropsy findings. LD 50>2000 mg/ kg.30,91 Tetrasodium Pyrophosphate Mice LD 50¼1300 mg/kg.8 Trisodium Phosphate Rats LD 50>2000 mg/kg.48,92 Trisodium Phosphate Rats LD 50¼4100 mg/kg.4',\n",
       "   't stated)Rabbits LD 50>2000 mg/kg.48Johnson et al 63S Table 6. Acute Dermal Toxicit',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>3160 mg/kg.68 Phosphoric Acid 85% solution Rabbits LD 50>2000 mg/kg.48 Ammonium Salts Ammonium Phosphate Rats LD 50>5',\n",
       "   'ts No clinical signs or necropsy findings. LD 50 >2000 mg/kg.31 Tetrasodium Pyrophosphate Rabbits LD 50>2000 mg/kg.48 Tetrasodium Pyrophosphate Rabbits LD 50>7940 m',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>10000 mg/kg.48 Calcium Salts Calcium Dihydrogen Phosphate 2000 mg/kg Rabbits (5 males and 5 females) Severe erythema an',\n",
       "   'd mild edema. LD 50> 2000 mg/kg.86 Calcium Phosphate Rabbits LD 50>300 mg/kg.98 Calcium Phosphate Rabbits LD 50>2000 mg/kg.48 Calcium Pyrophosphate Rabbits LD 50>7940 mg/kg',\n",
       "   'Stauffland albino rabbits (5 males and 5 females) LD 50>2000 mg/kg.67 Dicalcium Phosphate Rabbits LD 50>7940 mg/kg.48 Tricalcium Phosphate Rabbits LD 50>2000 mg/kg.48 Magnesium Salts Magnesium Phosphate Solution (',\n",
       "   's involving rabbits, an LD 50of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   'ute dermal toxicity studies involving rabbits, an LD 50 of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   's LD 50¼3600 mg/kg.48 Disodium Pyrophosphate Rats LD 50>4000 mg/kg.48,89 Disodium Pyrophosphate Mice LD 50¼3350 mg/k',\n",
       "   '/kg.48,95 Pentapotassium Triphosphate Rats (male) LD 50>1000 mg/kg.48 Potassium Phosphate Rats (male) LD 50>4640 mg/kg.48 Potassium Phosphate Rats LD 50¼7100 mg/kg.48 P',\n",
       "   '0¼4150 mg/kg.48 Trisodium Phosphate Rats (female) LD 50<5000 mg/kg.48 Trisodium Phosphate 20% solution Rats LD 50¼65',\n",
       "   'phosphate Solution (concentration not stated)Rats LD 50<5000 mg/kg.48 Tetrapotassium Pyrophosphate Mice LD 50¼1000 m',\n",
       "   'LD 50¼3986 mg/kg.48 Calcium Phosphate Rats (male) LD 50>5000 mg/kg.48 Calcium Phosphate Mice LD 50¼4600 mg/kg.8 Dica',\n",
       "   'male) LD 50>10000 mg/kg.67 Dicalcium Phosphate Mice LD 50/C251700 mg/kg.17 Tricalcium Phosphate Rats LD 50>5000 mg/kg.48 Tricalcium Phosphate Sprague-Dawley rats (fema',\n",
       "   'LD 50>300 mg/kg.48 Dipotassium Phosphate(liquid) Rabbits LD 50>5000 mg/kg.48 Dipotassium Phosphate Rabbits LD 50>5000 mg/kg',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>4640 mg/kg.48 Tetrapotassium Pyrophosphate (liquid)Rabbits LD 50>5000 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>794',\n",
       "   'ed for calcium salts of phosphoric acid. Reported LD 50 values ranging from >2000 mg/kg to >7940 mg/kg were reported for magnesium salts of phosphoric ac',\n",
       "   'm >7940 mg/kg to >10000 mg/kg for rabbits. Dermal LD 50 values ranging from >300 mg/kg to >7940 mg/kg (rabbits) were reported for sodium salts of Phosp',\n",
       "   'lcium Phosphate 6 Sprague-Dawley rats (female) LD 50/C212000 mg/kg.67 Dicalcium Phosphate Rats LD 50¼7100 mg/kg.48 Dicalcium Phosphate Rats LD 50>7940 mg/kg.48 Dicalcium Phosphate 10 Sprague-Dawley rats (fe',\n",
       "   '000 mg/kg.88 Ammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.88 Diammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rabbits LD 50>10000 mg/kg',\n",
       "   '.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.97 Sodium Salts Disodium Phosphate Rabbits LD 50>7940 mg/kg.48 Disodium Pyrophosphate Rabbits LD 50>300 mg/kg',\n",
       "   '.98 Disodium Pyrophosphate Rabbits LD 50>7940 mg/kg.48 Pentasodium Triphosphate Rabbits LD 50¼4640 mg',\n",
       "   '/kg.48 Pentasodium Triphosphate Rabbits LD 50>7940 mg/kg.48 Sodium Phosphate Rabbits LD 50>7940 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateR',\n",
       "   'abbits LD 50>7940 mg/kg.48 Tetrasodium Pyrophosphate 20 Sprague-Dawley ra',\n",
       "   'g/kg.48 Trisodium Phosphate Rabbits LD 50>300 mg/kg.98 Trisodium Phosphate Rabbits LD 50>7940 mg/kg.48 Potassium Salts Dipotassium Phosphate Rabbits ',\n",
       "   '.48 Pentapotassium Triphosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>7940 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>200',\n",
       "   'concentration not stated)Rabbits LD 50>2000 mg/kg.48 Magnesium Phosphate Rabbits LD 50>4640 mg/kg.48 Trimagnesium Phosphate Rabbits LD 50>7940 mg/kg.4864S International Journal of Toxicology 40(Supp',\n",
       "   'sphoric acid involving rats or mice, the reported LD 50 ranged from 2170 mg/kg (Calcium Phosphate [rats]) to > 10000 mg/kg (Calcium Pyrophosphate [rats]). The reportedLD 50',\n",
       "   'Sodium Polyphosphate/Sodium HexametaphosphateRats LD 50>10000 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateM',\n",
       "   'ed water)Female Sprague-Dawley rats (groups of 3) LD 50>2000 mg/kg.86,87 Calcium Dihydrogen Phosphate Female Sprague-Dawley rats (groups of 5) LD 50>10000 mg/kg.86,87 Calcium Dihydrogen Phosphate Albino rabbits',\n",
       "   'le, groups of 3) LD 50>2000 mg/kg.55 Calcium Pyrophosphate Rats LD 50>10000 mg/kg.48 Magnesium Salts Magnesium Phosphate Rats LD 50',\n",
       "   '>1000 mg/kg.48 Magnesium Phosphate Rats LD 50>4640 mg/kg.48 Magnesium Phosphate Rats LD 50>5000 mg/kg.48 Trimagnesium Phosphate Rats LD 50>10000 mg/kg.48 Magnesium Phosphate Solution (concentration no',\n",
       "   'd guinea pigs in acute oral toxicity studies, and LD 50 values ranged from 1300 mg/kg (Tetrasodium Pyrophosphate[mice]) to 10600 mg/kg (Sodium Trimetaphosphate [rats]). Forpotassium sa',\n",
       "   'Diammonium Phosphate Rats LD 50>25100 mg/kg.48 Sodium Salts Disodium Phosphate Rats LD 50¼595'],\n",
       "  'contesti_noael': ['daily for 150 days. In studies involving dogs, an NOAEL of 100 mg/kg/d was reportedfor the following sodium salts, each ',\n",
       "   's for 52 weeks yielded an NOEL of 338 mg/kg/d. An NOAEL of 105 mg/kg/d was reported in astudy in which sheep received doses of Phosphoric Acid up to 211 mg/kg/d for 70 days. An NOAEL of 250 mg/kg/d was reported',\n",
       "   ') No reproductive or developmental toxic effects. NOAEL ¼1000 mg/kg/d.17 Potassium Phosphate Doses (in water) up to 320 mg/kg/d on gestation d 6-15 20 to 22 CD-1 mice No treatme',\n",
       "   'e or developmental effects at doses administered. NOAEL ¼1500 mg/kg/d.88,100 Sodium Salts Disodium PyrophosphateDoses (in water) up to 335 mg/kg/d on gestation d 6-15 19 to 22 CD-1 mice No treatme',\n",
       "   '13/sex/dose) 2 females of 500 mg/kg/d group died. NOAEL ¼250 mg/kg/d.65,68 Phosphoric Acid Up to 0.75% in diet (338 mg/kg/d*) for >52 wk Rats NOEL ¼338 mg/kg/d*.48,89 Phosph',\n",
       "   'l inflammation (not dose-dependent) at all doses. NOAEL ¼250 mg/kg/d.88,100 Diammonium Phosphate Increasing oral doses (in drinking water) of 300 to 700 mg/kg/d for 5 to 16 mo10 Rabbits (females) Average weight',\n",
       "   ' Trimetaphosphate 0 and 100 mg/kg/d for 30 d Dogs NOAEL ¼100 mg/kg/d.90 Tetrasodium Pyrophosphate 250, 500, or 1000 mg/kg/d by gavage for 90 d (5 d/week) (OECD Guideline 408',\n",
       "   'group, but no morphological findings in the liver.NOAEL ¼1000 mg/kg/d. 86,120 Dicalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d for 28 d by gastric intubation Sprague-Dawley rat',\n",
       "   's (10/sex/dose) No gross or microscopic eff ects. NOAEL >1000 mg/kg/d.67 Tricalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d by gavage. Males dosed from 2 wk before mating to',\n",
       "   ' on mating, gestation, or external malformations. NOAEL of 1000 mg/kg/d (parents and pups).86,120 (continued)72S Internat',\n",
       "   'females of 1000 mg/kg/d group. NOEL ¼250 mg/kg/d; NOAEL ¼500 mg/kg/d. 31 Tetrasodium Pyrophosphate 0%, 1.1%, 1.8%, 3%, or 5% in diet (0, 495, 810, 1350 mg/kg/d*) for 39 wkRats LOEL ¼495 mg/kg/d*.48,103 Trisodi',\n",
       "   'ic Acid 0, 35, 105, or 211 mg/kg/d for 70 d Sheep NOAEL ¼105 mg/kg/d.99 Ammonium Salts Diammonium Phosphate Oral doses (by gavage) of 0, 250, 750, or 1500 mg/kg/d (7 d/wk) for 35 dRats (groups of 10 [5 males and ',\n",
       "   ' diet (0, 23, 225, 2250 mg/kg/d*) for 104 wk Rats NOAEL ¼225 mg/kg/d*.90 Sodium Polyphosphate/Sodium Hexametaphosphate0%, 0.93%, or 3.5% in diet (0, 419, 1575 mg/kg/d*) for 21 wk Rats NOAEL ¼1575 mg/kg/d*.48,107 Sodi',\n",
       "   'ipotassium Phosphate 0.87% or 5.1% for 21 wk Rats NOAEL ¼2295 mg/kg/d*.48,107 Dipotassium Phosphate 5% in diet (2250 mg/kg/d*) in medium-term bioassay Male Wistar rats Renal ',\n",
       "   '.75 %in the diet daily for >52 weeks. The highest NOAEL (2623 mg/kg/d) was reported in a study in which rats were fed D'],\n",
       "  'valori_ld50': ['1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1260 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3160 mg/kg ',\n",
       "   '3160 mg/kg ',\n",
       "   '4000 mg/kg',\n",
       "   '4640 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '7940 mg/kg ',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10600 mg/kg',\n",
       "   '25100 mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg/d',\n",
       "   '211 mg/kg/d',\n",
       "   '320 mg/kg/d',\n",
       "   '335 mg/kg/d',\n",
       "   '338 mg/kg/d',\n",
       "   '700 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1350 mg/kg/d',\n",
       "   '1500 mg/kg/d',\n",
       "   '1575 mg/kg/d',\n",
       "   '2250 mg/kg/d',\n",
       "   '2623 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d729486a'),\n",
       "  'Nome_comune': 'Calcium Pyrophosphate',\n",
       "  'INCI_name': 'Calcium Pyrophosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=53e2214b-800d-43fa-9ce4-4569f4261e5c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c4604e94-fd18-a76a-b85c-469b1779bbc9',\n",
       "  'pdf_date': 'IJT 40(Suppl. 1):34-85, 2021',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['40 mg/kg.3 Ammonium Salts Ammonium Phosphate Rats LD 50>1000 mg/kg.48 Ammonium Phosphate Rats LD 50¼3250 mg/kg.88 Am',\n",
       "   '0 mg/kg.48 Disodium Pyrophosphate Rats LD 50>1000 mg/kg.48 Disodium Pyrophosphate Rats LD 50¼1690 mg/kg.8',\n",
       "   '/kg.48 Potassium Salts Dipotassium Phosphate Rats LD 50>500 mg/kg.48 Dipotassium Phosphate Rats LD 50>1000 mg/kg.48 Dipotassium Phosphate(liquid) Rats LD 50¼4810 ',\n",
       "   'mg/kg.48 Tetrapotassium Pyrophosphate Rats (male) LD 50>1000 mg/kg.48 Tetrapotassium Pyrophosphate Rats LD 50¼2980 m',\n",
       "   ' (5 males and 5 females) LD 50>2000 mg/kg.87 Calcium Phosphate Rats LD 50>1000 mg/kg.48 Calcium Phosphate Rats LD 50¼2170 mg/kg.48 Cal',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>1260 mg/kg.68 Phosphoric Acid Rabbits LD 50¼2740 mg/kg.48,66',\n",
       "   ' Rats LD 50¼5750 mg/kg.48 Ammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50>1000 mg/kg.48 Diammonium Phosphate Rats LD 50>2000 mg/kg.88 Diammonium Phosphate Rats LD 50¼6500 mg/kg.48 ',\n",
       "   'Rats LD 50¼8390 mg/kg.48,66 Sodium Phosphate Mice LD 50>3700 mg/kg.48,8 Sodium Phosphate Guinea pigs LD 50>2000 mg/kg.48,89 Sodium Trimetaphosphate Rats LD 50¼10600 mg',\n",
       "   'ups of 5) No clinical signs or necropsy findings. LD 50>2000 mg/ kg.30,91 Tetrasodium Pyrophosphate Mice LD 50¼1300 mg/kg.8 Trisodium Phosphate Rats LD 50>2000 mg/kg.48,92 Trisodium Phosphate Rats LD 50¼4100 mg/kg.4',\n",
       "   't stated)Rabbits LD 50>2000 mg/kg.48Johnson et al 63S Table 6. Acute Dermal Toxicit',\n",
       "   'ite rabbits (males and females; groups of up to 2)LD50>3160 mg/kg.68 Phosphoric Acid 85% solution Rabbits LD 50>2000 mg/kg.48 Ammonium Salts Ammonium Phosphate Rats LD 50>5',\n",
       "   'ts No clinical signs or necropsy findings. LD 50 >2000 mg/kg.31 Tetrasodium Pyrophosphate Rabbits LD 50>2000 mg/kg.48 Tetrasodium Pyrophosphate Rabbits LD 50>7940 m',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>10000 mg/kg.48 Calcium Salts Calcium Dihydrogen Phosphate 2000 mg/kg Rabbits (5 males and 5 females) Severe erythema an',\n",
       "   'd mild edema. LD 50> 2000 mg/kg.86 Calcium Phosphate Rabbits LD 50>300 mg/kg.98 Calcium Phosphate Rabbits LD 50>2000 mg/kg.48 Calcium Pyrophosphate Rabbits LD 50>7940 mg/kg',\n",
       "   'Stauffland albino rabbits (5 males and 5 females) LD 50>2000 mg/kg.67 Dicalcium Phosphate Rabbits LD 50>7940 mg/kg.48 Tricalcium Phosphate Rabbits LD 50>2000 mg/kg.48 Magnesium Salts Magnesium Phosphate Solution (',\n",
       "   's involving rabbits, an LD 50of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   'ute dermal toxicity studies involving rabbits, an LD 50 of 2740 mg/kg and an LD 50>3160 mg/kg were reported for Phosphoric Acid. For ammonium sa',\n",
       "   's LD 50¼3600 mg/kg.48 Disodium Pyrophosphate Rats LD 50>4000 mg/kg.48,89 Disodium Pyrophosphate Mice LD 50¼3350 mg/k',\n",
       "   '/kg.48,95 Pentapotassium Triphosphate Rats (male) LD 50>1000 mg/kg.48 Potassium Phosphate Rats (male) LD 50>4640 mg/kg.48 Potassium Phosphate Rats LD 50¼7100 mg/kg.48 P',\n",
       "   '0¼4150 mg/kg.48 Trisodium Phosphate Rats (female) LD 50<5000 mg/kg.48 Trisodium Phosphate 20% solution Rats LD 50¼65',\n",
       "   'phosphate Solution (concentration not stated)Rats LD 50<5000 mg/kg.48 Tetrapotassium Pyrophosphate Mice LD 50¼1000 m',\n",
       "   'LD 50¼3986 mg/kg.48 Calcium Phosphate Rats (male) LD 50>5000 mg/kg.48 Calcium Phosphate Mice LD 50¼4600 mg/kg.8 Dica',\n",
       "   'male) LD 50>10000 mg/kg.67 Dicalcium Phosphate Mice LD 50/C251700 mg/kg.17 Tricalcium Phosphate Rats LD 50>5000 mg/kg.48 Tricalcium Phosphate Sprague-Dawley rats (fema',\n",
       "   'LD 50>300 mg/kg.48 Dipotassium Phosphate(liquid) Rabbits LD 50>5000 mg/kg.48 Dipotassium Phosphate Rabbits LD 50>5000 mg/kg',\n",
       "   '0 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>4640 mg/kg.48 Tetrapotassium Pyrophosphate (liquid)Rabbits LD 50>5000 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>794',\n",
       "   'ed for calcium salts of phosphoric acid. Reported LD 50 values ranging from >2000 mg/kg to >7940 mg/kg were reported for magnesium salts of phosphoric ac',\n",
       "   'm >7940 mg/kg to >10000 mg/kg for rabbits. Dermal LD 50 values ranging from >300 mg/kg to >7940 mg/kg (rabbits) were reported for sodium salts of Phosp',\n",
       "   'lcium Phosphate 6 Sprague-Dawley rats (female) LD 50/C212000 mg/kg.67 Dicalcium Phosphate Rats LD 50¼7100 mg/kg.48 Dicalcium Phosphate Rats LD 50>7940 mg/kg.48 Dicalcium Phosphate 10 Sprague-Dawley rats (fe',\n",
       "   '000 mg/kg.88 Ammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.88 Diammonium Phosphate Rabbits LD 50>7940 mg/kg.48 Diammonium Phosphate Rabbits LD 50>10000 mg/kg',\n",
       "   '.48 Diammonium Phosphate Rats LD 50>5000 mg/kg.97 Sodium Salts Disodium Phosphate Rabbits LD 50>7940 mg/kg.48 Disodium Pyrophosphate Rabbits LD 50>300 mg/kg',\n",
       "   '.98 Disodium Pyrophosphate Rabbits LD 50>7940 mg/kg.48 Pentasodium Triphosphate Rabbits LD 50¼4640 mg',\n",
       "   '/kg.48 Pentasodium Triphosphate Rabbits LD 50>7940 mg/kg.48 Sodium Phosphate Rabbits LD 50>7940 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateR',\n",
       "   'abbits LD 50>7940 mg/kg.48 Tetrasodium Pyrophosphate 20 Sprague-Dawley ra',\n",
       "   'g/kg.48 Trisodium Phosphate Rabbits LD 50>300 mg/kg.98 Trisodium Phosphate Rabbits LD 50>7940 mg/kg.48 Potassium Salts Dipotassium Phosphate Rabbits ',\n",
       "   '.48 Pentapotassium Triphosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>4640 mg/kg.48 Potassium Phosphate Rabbits LD 50>7940 mg/kg.48 Tetrapotassium Pyrophosphate Rabbits LD 50>200',\n",
       "   'concentration not stated)Rabbits LD 50>2000 mg/kg.48 Magnesium Phosphate Rabbits LD 50>4640 mg/kg.48 Trimagnesium Phosphate Rabbits LD 50>7940 mg/kg.4864S International Journal of Toxicology 40(Supp',\n",
       "   'sphoric acid involving rats or mice, the reported LD 50 ranged from 2170 mg/kg (Calcium Phosphate [rats]) to > 10000 mg/kg (Calcium Pyrophosphate [rats]). The reportedLD 50',\n",
       "   'Sodium Polyphosphate/Sodium HexametaphosphateRats LD 50>10000 mg/kg.48 Sodium Polyphosphate/Sodium HexametaphosphateM',\n",
       "   'ed water)Female Sprague-Dawley rats (groups of 3) LD 50>2000 mg/kg.86,87 Calcium Dihydrogen Phosphate Female Sprague-Dawley rats (groups of 5) LD 50>10000 mg/kg.86,87 Calcium Dihydrogen Phosphate Albino rabbits',\n",
       "   'le, groups of 3) LD 50>2000 mg/kg.55 Calcium Pyrophosphate Rats LD 50>10000 mg/kg.48 Magnesium Salts Magnesium Phosphate Rats LD 50',\n",
       "   '>1000 mg/kg.48 Magnesium Phosphate Rats LD 50>4640 mg/kg.48 Magnesium Phosphate Rats LD 50>5000 mg/kg.48 Trimagnesium Phosphate Rats LD 50>10000 mg/kg.48 Magnesium Phosphate Solution (concentration no',\n",
       "   'd guinea pigs in acute oral toxicity studies, and LD 50 values ranged from 1300 mg/kg (Tetrasodium Pyrophosphate[mice]) to 10600 mg/kg (Sodium Trimetaphosphate [rats]). Forpotassium sa',\n",
       "   'Diammonium Phosphate Rats LD 50>25100 mg/kg.48 Sodium Salts Disodium Phosphate Rats LD 50¼595'],\n",
       "  'contesti_noael': ['daily for 150 days. In studies involving dogs, an NOAEL of 100 mg/kg/d was reportedfor the following sodium salts, each ',\n",
       "   's for 52 weeks yielded an NOEL of 338 mg/kg/d. An NOAEL of 105 mg/kg/d was reported in astudy in which sheep received doses of Phosphoric Acid up to 211 mg/kg/d for 70 days. An NOAEL of 250 mg/kg/d was reported',\n",
       "   ') No reproductive or developmental toxic effects. NOAEL ¼1000 mg/kg/d.17 Potassium Phosphate Doses (in water) up to 320 mg/kg/d on gestation d 6-15 20 to 22 CD-1 mice No treatme',\n",
       "   'e or developmental effects at doses administered. NOAEL ¼1500 mg/kg/d.88,100 Sodium Salts Disodium PyrophosphateDoses (in water) up to 335 mg/kg/d on gestation d 6-15 19 to 22 CD-1 mice No treatme',\n",
       "   '13/sex/dose) 2 females of 500 mg/kg/d group died. NOAEL ¼250 mg/kg/d.65,68 Phosphoric Acid Up to 0.75% in diet (338 mg/kg/d*) for >52 wk Rats NOEL ¼338 mg/kg/d*.48,89 Phosph',\n",
       "   'l inflammation (not dose-dependent) at all doses. NOAEL ¼250 mg/kg/d.88,100 Diammonium Phosphate Increasing oral doses (in drinking water) of 300 to 700 mg/kg/d for 5 to 16 mo10 Rabbits (females) Average weight',\n",
       "   ' Trimetaphosphate 0 and 100 mg/kg/d for 30 d Dogs NOAEL ¼100 mg/kg/d.90 Tetrasodium Pyrophosphate 250, 500, or 1000 mg/kg/d by gavage for 90 d (5 d/week) (OECD Guideline 408',\n",
       "   'group, but no morphological findings in the liver.NOAEL ¼1000 mg/kg/d. 86,120 Dicalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d for 28 d by gastric intubation Sprague-Dawley rat',\n",
       "   's (10/sex/dose) No gross or microscopic eff ects. NOAEL >1000 mg/kg/d.67 Tricalcium Phosphate Doses of 0, 250, 500, or 1000 mg/kg/d by gavage. Males dosed from 2 wk before mating to',\n",
       "   ' on mating, gestation, or external malformations. NOAEL of 1000 mg/kg/d (parents and pups).86,120 (continued)72S Internat',\n",
       "   'females of 1000 mg/kg/d group. NOEL ¼250 mg/kg/d; NOAEL ¼500 mg/kg/d. 31 Tetrasodium Pyrophosphate 0%, 1.1%, 1.8%, 3%, or 5% in diet (0, 495, 810, 1350 mg/kg/d*) for 39 wkRats LOEL ¼495 mg/kg/d*.48,103 Trisodi',\n",
       "   'ic Acid 0, 35, 105, or 211 mg/kg/d for 70 d Sheep NOAEL ¼105 mg/kg/d.99 Ammonium Salts Diammonium Phosphate Oral doses (by gavage) of 0, 250, 750, or 1500 mg/kg/d (7 d/wk) for 35 dRats (groups of 10 [5 males and ',\n",
       "   ' diet (0, 23, 225, 2250 mg/kg/d*) for 104 wk Rats NOAEL ¼225 mg/kg/d*.90 Sodium Polyphosphate/Sodium Hexametaphosphate0%, 0.93%, or 3.5% in diet (0, 419, 1575 mg/kg/d*) for 21 wk Rats NOAEL ¼1575 mg/kg/d*.48,107 Sodi',\n",
       "   'ipotassium Phosphate 0.87% or 5.1% for 21 wk Rats NOAEL ¼2295 mg/kg/d*.48,107 Dipotassium Phosphate 5% in diet (2250 mg/kg/d*) in medium-term bioassay Male Wistar rats Renal ',\n",
       "   '.75 %in the diet daily for >52 weeks. The highest NOAEL (2623 mg/kg/d) was reported in a study in which rats were fed D'],\n",
       "  'valori_ld50': ['1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1000 mg/kg',\n",
       "   '1260 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3160 mg/kg ',\n",
       "   '3160 mg/kg ',\n",
       "   '4000 mg/kg',\n",
       "   '4640 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '7940 mg/kg ',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '7940 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10000 mg/kg',\n",
       "   '10600 mg/kg',\n",
       "   '25100 mg/kg'],\n",
       "  'valori_noael': ['100 mg/kg/d',\n",
       "   '211 mg/kg/d',\n",
       "   '320 mg/kg/d',\n",
       "   '335 mg/kg/d',\n",
       "   '338 mg/kg/d',\n",
       "   '700 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1350 mg/kg/d',\n",
       "   '1500 mg/kg/d',\n",
       "   '1575 mg/kg/d',\n",
       "   '2250 mg/kg/d',\n",
       "   '2623 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b06c1f2275d729486b'),\n",
       "  'Nome_comune': 'Calcium Salicylate',\n",
       "  'INCI_name': 'Calcium Salicylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9860d97b-b539-4de2-a776-5954f12513fc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=81b5b3d7-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['.  No clinical signs were observed .  The dermal  LD 50 in rabbits exceeded 5.0 g/kg .    Hexyl Salicylate     Ten rabbits received a ',\n",
       "   ' clinical signs were observed .  The acute dermal LD 50 in rabbits exceeded 5.0 g/kg based  on 0/10 deaths at that dose.       Methyl S',\n",
       "   '-dosing. 7  It was concluded that t he acute oral LD 50  exceeded 5.0 g/kg , based on one animal death at that dose  on day ',\n",
       "   'was observed at  24 h. It was concluded that  the LD 50 exceeded 5.0 g/kg, based on one animal death at that dose on day 4 ',\n",
       "   '4  rats dosed 5 days per week for 15 weeks.1  The LD 50 during 15 weeks of dosing was estimated to be 366.5 mg/kg; a dose - related decrease in hindlimb grip stren',\n",
       "   'queous Sodium Salicylate for 4 weeks, the 28- day LD 50 was 646.5 mg/kg.  Liver and kidney necrosis was  observed in dogs that received 300 mg/kg of 10% aqueous Sodium Salicylate for 2 weeks .  A ',\n",
       "   'any  pathological abnormality.   The acute dermal LD 50 was considered to be > 2 g/kg.      Oral     The following acute oral toxicity ',\n",
       "   'tudies involving rats:    Butyloctyl Salicylate ( LD 50 > 5 g/kg),  Ethylhexyl Salicylate (  LD 50 > 2 g/kg),  Isodecyl Salicylate (no toxicity at levels as ',\n",
       "   'gum Arabic) was administered to 10 Wistar rats.4  LD 50  values in the range of 0.5 to 2 g/kg were reported.      Sodium Salicylate    The acute',\n",
       "   'with 0.5 mL  water) to the skin.  An acute dermal LD 50 of > 2 g/kg was reported for Sodium  Salicylate in a study inv',\n",
       "   'nd no clinical signs were  observed .  The dermal LD 50 in rabbits exceeded 5 g/kg.     Salicylic Acid          In a study involving',\n",
       "   'te, and Methyl Salicylate involving rabbits,  the LD 50 was > 5 g/kg for each salicylate.   No signs of systemic toxici',\n",
       "   'olving rats.  An a cute oral LD 50 of > 5 g/kg for Ethylhexyl Salicylate and Hexyl Salicylate in ',\n",
       "   ' studies on Methyl Salicylate involving mice, the LD 50 was  calculated to be 1.39 g/kg (95% CI of 1.25 to 1.54 g/kg) and a dose of 0.5 g/kg was selected as the maximum tolerated dose.    LD ',\n",
       "   'y data for the sexes  combined projected an acute LD 50 of 1.44 g/kg/day .    Salicylic Acid      In groups of rats do',\n",
       "   '/kg. Most animal  deaths occurred  on day 1.  The LD 50 was calculated to be 1.39 g/kg (95% CI  1.25 - 1.54 g/kg) .    Methyl S alicylate was evaluated as a part ',\n",
       "   ' high as 4.83 g/kg),  Methyl Salicylate (LD 50 between 0.887 g/kg and 1.25 g/kg),  Salicylic Acid ( LD 50 ranging from 0.891 g/kg  to 1.58 g/kg),  Sodium Salicyla te (LD 50 between 0.9 g/kg and',\n",
       "   ' 1.7 g/kg) ; and Tridecyl Salicylate (LD 50 > 1.98 g/kg).1  Values  for acute oral toxicity in other spec'],\n",
       "  'contesti_noael': ['size, the no -observed - adverse- effect -level ( NOAEL ) for developmental toxicity was determined to be 25 mg/kg/day.     Methyl Salicylate    Methyl Salicylate was d',\n",
       "   'n the gestation index, and lower litter size, the NOAEL for developmenta l toxicity was  determined to be 25 mg/kg/day.  On  postnatal day 1, 89% of the pups from dams ',\n",
       "   ', “b ased on the  available  data, and using the  NOAEL values of 50 mg/kg body weight/day identified in subchronic and chronic toxicity  st',\n",
       "   'MOS for systemic exposure is mentioned.  Based on NOAEL values of 50 mg/kg body weight/day in subchronic and chronic toxicity studies, a MOS',\n",
       "   '63  In a risk assessment conducted by  SCCNFP , a NOAEL of 75 mg/kg/day, derived from several rat oral teratogenicity  st',\n",
       "   '/kg/day  MOS (Butyloctyl Salicylate , lipstick) = NOAEL ( from rat oral teratogenicity stu dies; see above)  / SED   = 75 mg/kg/day  /0.1705 mg/kg/day   = 220       Oral   Salicylic Acid      An expos'],\n",
       "  'valori_ld50': ['0 g/kg',\n",
       "   '0 g/kg ',\n",
       "   '0 g/kg',\n",
       "   '0 g/kg',\n",
       "   '5 mg/kg',\n",
       "   '300 mg/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5 g/kg ',\n",
       "   '44 g/kg',\n",
       "   '54 g/kg',\n",
       "   '58 g/kg',\n",
       "   '98 g/kg'],\n",
       "  'valori_noael': ['25 mg/kg/day',\n",
       "   '25 mg/kg/day',\n",
       "   '50 mg/kg body weight/day',\n",
       "   '50 mg/kg body weight/day',\n",
       "   '75 mg/kg/day',\n",
       "   '1705 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d729486c'),\n",
       "  'Nome_comune': 'Calcium Silicate',\n",
       "  'INCI_name': 'Calcium Silicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d21abfa0-6073-44db-a293-7a8d7ae72994',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6234e9fc-e987-17b6-abb8-09e6fef3b64a',\n",
       "  'pdf_date': 'December 07, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/14941',\n",
       "   'valori': ['LD50 Rat male oral > 5,000 mg/kg'],\n",
       "   'fonti': ['Elmore AR; Cosmetic Ingredient Review Expert Panel; J Am Coll Toxicol 22 (Suppl. 1): 37-102 (2003)']},\n",
       "  'contesti_ld50': [' .1 The following are acute  oral LD 50 determinations: Calcium Silicate, 3400 mg/kg in rats; Magnesium Aluminum Silicate, 50,000 mg/kg in mice; and  Zirconium Silicate, > 200,000  mg/kg',\n",
       "   'O 2/Na 2O and the concentration.2  The acute oral LD 50 of Sodium Metasilicate ranged from 847 mg/kg in male rat s to 1349.3  mg/kg in female rats, and from 770 mg/kg in female mice ',\n",
       "   'ium Silicate (30% solution in water) had a dermal LD 50 > 5 g/kg in rats.  In oral rat studies, the LD 50s were > 2 g/kg  for Aluminum Silicate (concentration not reported)',\n",
       "   'um Silicate (30% solution in water) had a  dermal LD 50 > 5000 mg/kg in rats.9  In oral rat studies, the LD 50s were > 2000 mg/kg for Aluminum Silicate (concentration not  reported',\n",
       "   'centration/Vehicle  Dose/Study Protocol  Results  LD 50 or LC 50 Reference   Dermal   30% Potassium Silicate solution in water ;  molar ratio = 2.47  5000 mg/kg bw applied for 24 h to 5  male and 5 female Sprague -',\n",
       "   '000 mg/kg in rats ,  respectively.9,13,14 An oral LD 50 for Sodium Silicate in male mice was 6600 mg/kg.11 Orally administered Aluminum Calcium  Sodium S',\n",
       "   'g/kg and > 5  g/kg in rats, respectively. An oral LD 50 for Sodium Silicate in mice was 6.60 g/kg. Or ally administered Aluminum Calcium  Sodium Si',\n",
       "   'm3, respectively.    Silicates   The acute dermal LD 50 was > 3500 g/kg for rabbits exposed to Magnesium Aluminum Silicate'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg ',\n",
       "   '3  mg/kg ',\n",
       "   '2 g/kg  ',\n",
       "   '2000 mg/kg ',\n",
       "   '5000 mg/kg bw ',\n",
       "   '6600 mg/kg',\n",
       "   '60 g/kg',\n",
       "   '3500 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d729486d'),\n",
       "  'Nome_comune': 'Calcium Sodium Borosilicate',\n",
       "  'INCI_name': 'Calcium Sodium Borosilicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=401878c2-8f42-4e74-93a1-7ae695c8f233',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9252d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):65-72, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d729486e'),\n",
       "  'Nome_comune': 'Calcium Starch Isododecenylsuccinate',\n",
       "  'INCI_name': 'Calcium Starch Isododecenylsuccinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=40909a0d-7d97-417a-9112-833b45d1ea6a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d729486f'),\n",
       "  'Nome_comune': 'Calcium Starch Octenylsuccinate',\n",
       "  'INCI_name': 'Calcium Starch Octenylsuccinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=33b03903-ee41-4569-b91f-5130da7ca8b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294870'),\n",
       "  'Nome_comune': 'Calcium Stearate',\n",
       "  'INCI_name': 'Calcium Stearate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6362ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294871'),\n",
       "  'Nome_comune': 'Calcium Stearoyl Lactylate',\n",
       "  'INCI_name': 'Calcium Stearoyl Lactylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4948b6a1-483e-4e14-9551-60379b75c2d4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=133ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'June 07, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['was followed by a  14-day observation period.  An LD 50 of > 6 .1 g/kg was reported.     Sodium Lauroyl Lactylate    In  ',\n",
       "   'nvolving male rats  (strain not stated) , an oral LD 50 of 25 g/kg body weight  was  reported for Calcium Stearoyl Lactylate.2  De',\n",
       "   ' involving male rats (strain not stated), an oral LD 50 of 25 g/kg body weight  was  reported for Sodium S tearoyl Lactylate.2  De',\n",
       "   'ral toxicity studies involving male rats, an oral LD 50 of 25 g/kg body weight was reported for Sodium  Stearoyl Lactylate and fo',\n",
       "   ' dosed orally with Sodium Lauroyl  Lactylate, the LD 50 was 6 .81 g/kg.2  The test protocol was not stated.    The acute',\n",
       "   'earoyl Lactylate.  The following other acute oral LD 50 values have b een reported: > 6 .1  g/kg (Sodium Isostearoyl Lactylate, in rats), 6 .81 g/kg (Sodium Lauroyl Lactylate, in male rats), and 4 .',\n",
       "   ' Additional  details were not included.  The oral LD 50 was estimated to be 4.88 g/kg.     Sodium Stearoyl Lactylate   In an acute oral'],\n",
       "  'contesti_noael': ['based on the n o-observed -adverse -effect-level (NOAEL) of 2200  mg/kg body weight /day Sodium Stearoyl Lactylate  that was derived from ',\n",
       "   'aroyl  Lactylate at concentrations up to 5%.  The NOAEL s for Sodium Stearoyl Lactylate w ere 2214 mg/kg/day for males and 2641  mg/kg/day for females , which were the highest doses tested',\n",
       "   'chemistry, and  urinalysis findings were normal.  NOAEL = 2214 mg/kg/day (males) and 2641 mg/kg/day  (females).15    Table 6. Skin Irritation and Sen'],\n",
       "  'valori_ld50': ['1 g/kg ',\n",
       "   '25 g/kg body weight  ',\n",
       "   '25 g/kg body weight  ',\n",
       "   '25 g/kg body weight ',\n",
       "   '81 g/kg',\n",
       "   '81 g/kg',\n",
       "   '88 g/kg'],\n",
       "  'valori_noael': ['2200  mg/kg body weight /day',\n",
       "   '2641  mg/kg/day',\n",
       "   '2641 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294872'),\n",
       "  'Nome_comune': 'Calcium Thioglycolate',\n",
       "  'INCI_name': 'Calcium Thioglycolate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32d87819-3b60-4f24-b5ce-cfab308541cc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=17a63435-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 28(Suppl. 1):68-133, 2009',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['queous solution)10 Sprague-Dawley rats Intubation LD 50> 50 mg/kg Thioesters Association, 2006 (personal communicati',\n",
       "   'active benzalkonium chloride. The least toxicity (LD 50> 365 mg/kg, 12 animals) was noted in the group treated with ',\n",
       "   'Thioglycolate)10 albino rats (208-260 g)Oral dose LD 50> 1 g/kg Consumer Product Testing Com- pany, Inc,1851982b P',\n",
       "   'Thioglycolate)10 albino rats (216-286 g)Oral dose LD 50> 1 g/kg Consumer Product Testing Com- pany, Inc,1901982a E',\n",
       "   'colate)10 Wistar albino rats (200-300 g)Oral dose LD 50< 5 g/kg Consumer Product Testing Com- pany, Inc,1911982c G'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['50 mg/kg ', '365 mg/kg', '1 g/kg ', '1 g/kg ', '5 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294873'),\n",
       "  'Nome_comune': 'Calcium Titanium Borosilicate',\n",
       "  'INCI_name': 'Calcium Titanium Borosilicate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fc2cb810-b043-47be-aacc-c98795628449',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9252d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):65-72, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b16c1f2275d7294874'),\n",
       "  'Nome_comune': 'Calcium Undecylenate',\n",
       "  'INCI_name': 'Calcium Undecylenate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=205ca482-9294-4b1f-bbb8-282ab050b40b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294875'),\n",
       "  'Nome_comune': 'Calcium Xylenesulfonate',\n",
       "  'INCI_name': 'Calcium Xylenesulfonate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=321fedc0-d2fc-4b12-90a8-9688e07e711d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=5ba16b53-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 3):270-283, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ne sulfonate, Ca 28088-63-3 Dermal rabbit 24 hour LD 50>2000 mg/kg bw USEPA 798.1175 Xylene sulfonate, NH4 26447-10-9 In',\n",
       "   ' 798.1100 Cumenesulfonate, Na 28348-53-0 Oral rat LD 50>7000 mg/kg bw OECD 401 Cumenesulfonate, Na 28348-53-0 Dermal rabbit LD 50>2000 mg/kg bw Not specified Cumenesulfonate, Na 28348-53-0 Inhal',\n",
       "   'oxicity studies for xylene sulfonic acid reported LD 50 values of 2100 to 16 200 mg/kg bw (dermal), 2000 mg/kg bw (oral), and 557 000 to 770 000 mg/m3(inhalation).',\n",
       "   'specified Xylene sulfonate, Na 1300-72-7 Oral rat LD 50>5000-16 200 mg/kg bw Not specified Xylene sulfonate, NH4 26447-10-9 Oral rat LD 50>2100 mg/kg bw Not specified Xylene sulfonate, Ca 28088-63-3 Oral',\n",
       "   'FR1500.40 Xylene sulfonate, Na 1300-72-7 Oral rat LD 50>5000 mg/kg bw Not specified Xylene sulfonate, Na 1300-72-7 Oral rat LD 507200 mg/kg bw Not Specified Xylene sulfonate, Na 1300-72-7 Oral '],\n",
       "  'contesti_noael': ['ges of biological variation for this species. The NOAEL for maternal and fetal toxicity was the highest dose tested, 3000 mg/kg bw/d, which corresponds to 936 mg AI/kg bw/d. Genotoxi'],\n",
       "  'valori_ld50': ['2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2100 mg/kg bw ',\n",
       "   '507200 mg/kg bw '],\n",
       "  'valori_noael': ['3000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294876'),\n",
       "  'Nome_comune': 'Calcium/Sodium PVM/MA Copolymer',\n",
       "  'INCI_name': 'Calcium/Sodium PVM/MA Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3780e2f4-4856-4813-b505-6bfa68d76e7b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=8c307d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 2):128-144, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294877'),\n",
       "  'Nome_comune': 'Calendula Officinalis',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=638d21b6-06df-4f10-88b2-8b7351f651c7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b65e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 20(S2):13-20, 2001',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294878'),\n",
       "  'Nome_comune': 'Calendula Officinalis Extract',\n",
       "  'INCI_name': 'Calendula Officinalis Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1e301aee-3dd5-40b4-9c4d-14ef7bbc49c4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['icity According to CTFA,34the median lethal dose (LD 50)o f C officinalis flower extract for rats was greater than 4.64 g/kg. Chemisches Laboratorium Dr Kurt Richter GmbH16 r',\n",
       "   'immunostimulating properties in another. The oral LD 50 forC officinalis extract was greater than 4650 mg/kg in rats. The oral LD 50was greater than 5000 g/kg for a hydroalcohol extract of C officinalis L in r'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['64 g/kg', '5000 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d7294879'),\n",
       "  'Nome_comune': 'Calendula Officinalis Flower',\n",
       "  'INCI_name': 'Calendula Officinalis Flower',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e35926af-e026-4f0c-b1d0-aee318418ea9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['icity According to CTFA,34the median lethal dose (LD 50)o f C officinalis flower extract for rats was greater than 4.64 g/kg. Chemisches Laboratorium Dr Kurt Richter GmbH16 r',\n",
       "   'immunostimulating properties in another. The oral LD 50 forC officinalis extract was greater than 4650 mg/kg in rats. The oral LD 50was greater than 5000 g/kg for a hydroalcohol extract of C officinalis L in r'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['64 g/kg', '5000 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d729487a'),\n",
       "  'Nome_comune': 'Calendula Officinalis Flower Extract',\n",
       "  'INCI_name': 'Calendula Officinalis Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4c578393-7b43-45e7-93f7-14d651678c1e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['icity According to CTFA,34the median lethal dose (LD 50)o f C officinalis flower extract for rats was greater than 4.64 g/kg. Chemisches Laboratorium Dr Kurt Richter GmbH16 r',\n",
       "   'immunostimulating properties in another. The oral LD 50 forC officinalis extract was greater than 4650 mg/kg in rats. The oral LD 50was greater than 5000 g/kg for a hydroalcohol extract of C officinalis L in r'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['64 g/kg', '5000 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d729487b'),\n",
       "  'Nome_comune': 'Calendula Officinalis Flower Oil',\n",
       "  'INCI_name': 'Calendula Officinalis Flower Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f8a3272f-9818-4b37-8737-ed4718b6a88b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['icity According to CTFA,34the median lethal dose (LD 50)o f C officinalis flower extract for rats was greater than 4.64 g/kg. Chemisches Laboratorium Dr Kurt Richter GmbH16 r',\n",
       "   'immunostimulating properties in another. The oral LD 50 forC officinalis extract was greater than 4650 mg/kg in rats. The oral LD 50was greater than 5000 g/kg for a hydroalcohol extract of C officinalis L in r'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['64 g/kg', '5000 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d729487c'),\n",
       "  'Nome_comune': 'Calendula Officinalis Seed Oil',\n",
       "  'INCI_name': 'Calendula Officinalis Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=716b18c4-d192-471b-9f99-cc9038296c06',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a9ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 29(Suppl 4):221-243, 2010',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['icity According to CTFA,34the median lethal dose (LD 50)o f C officinalis flower extract for rats was greater than 4.64 g/kg. Chemisches Laboratorium Dr Kurt Richter GmbH16 r',\n",
       "   'immunostimulating properties in another. The oral LD 50 forC officinalis extract was greater than 4650 mg/kg in rats. The oral LD 50was greater than 5000 g/kg for a hydroalcohol extract of C officinalis L in r'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['64 g/kg', '5000 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b26c1f2275d729487d'),\n",
       "  'Nome_comune': 'Calliblepharis Ciliata Extract',\n",
       "  'INCI_name': 'Calliblepharis Ciliata Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=84148bd3-3571-46ab-be01-0aed9ca69861',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['his study were provided.  The median lethal dose (LD 50) was reported to be > 2000 mg/kg.   Corallina Officinalis Extract   The acute oral',\n",
       "   'thod of oral administration was not  stated.  The LD 50 was reported to be > 2000 mg/kg.   Grateloupia Livida E xtract   The acute oral t',\n",
       "   ' were seen  with any extract or dose level .  The LD 50 values were  expected to be >  2000 mg/kg.   Lithothamnion Calcareum Extract   A Lithothamn',\n",
       "   'lesseria Sanguinea Extract (0.2 –  4% algae), the LD 50 was reported to be > 2000 mg/kg.   The acute oral  toxicity potential of multiple',\n",
       "   'uted dry  Asparagopsis Armata Extract .  The oral LD 50 was reported to be > 5000 mg/kg in an acute toxicity assay using a mixture  contai'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d729487e'),\n",
       "  'Nome_comune': 'Camelina Sativa Seed Oil',\n",
       "  'INCI_name': 'Camelina Sativa Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=03e83029-3360-4917-a2bb-f3bf272032fd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d729487f'),\n",
       "  'Nome_comune': 'Camellia Japonica Seed Oil',\n",
       "  'INCI_name': 'Camellia Japonica Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4b5335db-6b10-4276-9cbe-281e0f632b81',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294880'),\n",
       "  'Nome_comune': 'Camellia Kissi Seed Oil',\n",
       "  'INCI_name': 'Camellia Kissi Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b67a6db8-5f17-431a-a5e4-e5a2f783fed5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294881'),\n",
       "  'Nome_comune': 'Camellia Oleifera Seed Oil',\n",
       "  'INCI_name': 'Camellia Oleifera Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=427d5c38-6935-48a1-bc54-099c44ff4bc3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294882'),\n",
       "  'Nome_comune': 'Camellia Sinensis Catechins',\n",
       "  'INCI_name': 'Camellia Sinensis Catechins',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5416f977-12c9-40d8-866a-908c7939dc6e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294883'),\n",
       "  'Nome_comune': 'Camellia Sinensis Flower Extract',\n",
       "  'INCI_name': 'Camellia Sinensis Flower Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=86e27c5b-459f-4c8d-9f5a-7aceb456acf5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294884'),\n",
       "  'Nome_comune': 'Camellia Sinensis Flower/Leaf/Stem Juice',\n",
       "  'INCI_name': 'Camellia Sinensis Flower/Leaf/Stem Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=743d5e96-36f1-44df-91f8-52498175732a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294885'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=72748565-b6a1-4921-8f08-27b2dbd57ea2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b36c1f2275d7294886'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf Extract',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ba885956-7690-4d47-8f67-ab567c604d05',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d7294887'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf Oil',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fdf39685-5974-4ec8-8abe-36edc6b1cba6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d7294888'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf Powder',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bc7ee709-a34e-4634-a99b-3550404d6d5f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d7294889'),\n",
       "  'Nome_comune': 'Camellia Sinensis Leaf Water',\n",
       "  'INCI_name': 'Camellia Sinensis Leaf Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7f2d8e0b-7257-4820-a6f3-08a87ca215c1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488a'),\n",
       "  'Nome_comune': 'Camellia Sinensis Root Extract',\n",
       "  'INCI_name': 'Camellia Sinensis Root Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=07de94a5-87b9-4d31-8635-0533983293c5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488b'),\n",
       "  'Nome_comune': 'Camellia Sinensis Seed Extract',\n",
       "  'INCI_name': 'Camellia Sinensis Seed Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9011736a-1e2b-4af2-a8da-21653f6edd97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488c'),\n",
       "  'Nome_comune': 'Camellia Sinensis Seed Oil',\n",
       "  'INCI_name': 'Camellia Sinensis Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3e0e9f1e-be86-4f2c-97e0-28184e0b18a2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488d'),\n",
       "  'Nome_comune': 'Camellia Sinensis Seed Powder',\n",
       "  'INCI_name': 'Camellia Sinensis Seed Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4eb8fc1e-9408-48fe-825d-0e4e398233fa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488e'),\n",
       "  'Nome_comune': 'Camellia Sinensis Seedcoat Powder',\n",
       "  'INCI_name': 'Camellia Sinensis Seedcoat Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5b613275-f82e-480e-b401-8423f72b583c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c6a8b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl. 3):48-70, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['ogical examination revealed no abnormalities. The NOAEL was 200 mg/kg/d EGCG. Catechins were not genotoxic in multiple in'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['200 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b46c1f2275d729488f'),\n",
       "  'Nome_comune': 'Canarium Indicum Seed Oil',\n",
       "  'INCI_name': 'Canarium Indicum Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dbee34ea-955f-42d5-8d5d-80aeaa0c45c4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294890'),\n",
       "  'Nome_comune': 'Candelilla Cera',\n",
       "  'INCI_name': 'Candelilla Cera',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d3345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['e Panel calculated the MOS of DBP by dividing the NOAEL of 331 mg/kg/day (from a feeding study) by the ex-pected exposure of 9.13 μg/kg/day, yielding an MOS of 36,254. If the more conservat',\n",
       "   'l noted thatthe no observed adverse effect level (NOAEL) of DBP in a gav-age study was 50 mg/kg/day (Mylchreest et al. 2000). However,a feeding study',\n",
       "   'ive NOAEL of 50 mg/kg/day (from a gav-age study) is used, the MOS is 5476. ',\n",
       "   ' reported a NOAEL of 331 mg/kg/day (Ema et al.1998). Overall, the Panel felt that fe'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['13 μg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '331 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294891'),\n",
       "  'Nome_comune': 'Candelilla Wax',\n",
       "  'INCI_name': 'Euphorbia Cerifera (Candelilla) Wax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ebf993bf-9da2-4cec-a8de-2e7571b4ac41',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['e Panel calculated the MOS of DBP by dividing the NOAEL of 331 mg/kg/day (from a feeding study) by the ex-pected exposure of 9.13 μg/kg/day, yielding an MOS of 36,254. If the more conservat',\n",
       "   'l noted thatthe no observed adverse effect level (NOAEL) of DBP in a gav-age study was 50 mg/kg/day (Mylchreest et al. 2000). However,a feeding study',\n",
       "   'ive NOAEL of 50 mg/kg/day (from a gav-age study) is used, the MOS is 5476. ',\n",
       "   ' reported a NOAEL of 331 mg/kg/day (Ema et al.1998). Overall, the Panel felt that fe'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['13 μg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '331 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294892'),\n",
       "  'Nome_comune': 'Candelilla/Jojoba/Rice Bran Polyglyceryl-3 Esters',\n",
       "  'INCI_name': 'Candelilla/Jojoba/Rice Bran Polyglyceryl-3 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=70da4706-5484-45f5-bef0-a749d5a5df65',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294893'),\n",
       "  'Nome_comune': 'Canola Oil',\n",
       "  'INCI_name': 'Canola Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e95d26c7-5ba3-4450-9649-df2fdcb245be',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294894'),\n",
       "  'Nome_comune': 'Canola Oil Unsaponifiables',\n",
       "  'INCI_name': 'Canola Oil Unsaponifiables',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=72f6dd40-056b-4b04-874d-b858f49b8892',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294895'),\n",
       "  'Nome_comune': 'Canola Sterols',\n",
       "  'INCI_name': 'Canola Sterols',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3678c6dc-852f-4a05-8e01-17cd2ecb69b6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=56e8bd9b-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 09, 2013',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['on  toxicity .    Dermal - Non-Human   The dermal LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg.59  A wood -derived mixture  (a stanol compositio',\n",
       "   ' cytotoxic  to mouse macrophages  in vitro .  The LD 50 of two mixtures of phytosterol esters was reported to be > 2000 mg/kg .  There were no maternal or teratogenic  effects'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294896'),\n",
       "  'Nome_comune': 'Canolamidopropyl Betaine',\n",
       "  'INCI_name': 'Canolamidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=80b6e75a-9639-44ee-8a8f-16882b591b18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294897'),\n",
       "  'Nome_comune': 'Capramide DEA',\n",
       "  'INCI_name': 'Capramide DEA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=87ce5796-826c-4fa2-8bba-07091efe4330',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=526dd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 1):36-58, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ne of the animals died, and the lethal dose, 50 %(LD 50) was >2 g/kg. Lauramide DEA. In an acute dermal toxicity study'],\n",
       "  'contesti_noael': ['mental toxicity study in Sprague-Dawley rats, the NOAEL for maternal toxicity and developmental toxicity was 1000 mg/kg/d that was the highest dose tested. No other data o'],\n",
       "  'valori_ld50': ['2 g/kg'],\n",
       "  'valori_noael': ['1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b56c1f2275d7294898'),\n",
       "  'Nome_comune': 'Capric Acid',\n",
       "  'INCI_name': 'Capric Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b3a1d956-aefb-417e-a287-e2cf0ce9aee6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d7294899'),\n",
       "  'Nome_comune': 'Capric/Lauric/Myristic/Oleic Triglyceride',\n",
       "  'INCI_name': 'Capric/Lauric/Myristic/Oleic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=57c7c76c-7df5-46e8-a90f-8767faadb93e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489a'),\n",
       "  'Nome_comune': 'Caproic Acid',\n",
       "  'INCI_name': 'Caproic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b04b85ef-df2b-4c3a-a599-b9805017168a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489b'),\n",
       "  'Nome_comune': 'Caprooyl Phytosphingosine',\n",
       "  'INCI_name': 'Caprooyl Phytosphingosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7cb05919-237d-4f63-97ad-af6dd8070c1b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489c'),\n",
       "  'Nome_comune': 'Caprooyl Sphingosine',\n",
       "  'INCI_name': 'Caprooyl Sphingosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=61b8da0f-2fa6-47e8-baa5-997dfb2e8fac',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489d'),\n",
       "  'Nome_comune': 'Caproyl Sphingosine',\n",
       "  'INCI_name': 'Caproyl Sphingosine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c39093af-3f5a-46ce-b8c5-379f55f84d10',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489e'),\n",
       "  'Nome_comune': 'Capryl Dimethicone',\n",
       "  'INCI_name': 'Capryl Dimethicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32c9c6f0-c9de-489b-800e-bb4ef38fe64b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d729489f'),\n",
       "  'Nome_comune': 'Capryl Sultaine',\n",
       "  'INCI_name': 'Capryl Sultaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=86c0bc19-1bd8-46c1-9a7c-384adcf442ce',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=d9cacf74-6299-63fa-b426-0a077ace38f8',\n",
       "  'pdf_date': 'IJT 43(Suppl. 1):30-49, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['cluded that the no-observed-adverse-effect-level (NOAEL) for 36.2% Cocamidopropyl Hydroxysultaine was 100 mg/kg/day based on microscopic ﬁndings in the forestomach, '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['100 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d72948a0'),\n",
       "  'Nome_comune': 'Capryl/Capramidopropyl Betaine',\n",
       "  'INCI_name': 'Capryl/Capramidopropyl Betaine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad2b94ff-5593-4fb4-ad5d-bf701e382667',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=bcee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 1):77-111, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b66c1f2275d72948a1'),\n",
       "  'Nome_comune': 'Capryleth-4',\n",
       "  'INCI_name': 'Capryleth-4',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e22d320a-a4cb-497b-a68a-e62f4434e4ed',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a2'),\n",
       "  'Nome_comune': 'Capryleth-5',\n",
       "  'INCI_name': 'Capryleth-5',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=974ed85f-b924-43c7-8335-dd445d6eb98b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a3'),\n",
       "  'Nome_comune': 'Caprylhydroxamic Acid',\n",
       "  'INCI_name': 'Caprylhydroxamic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6f214614-7fdb-4a34-8cb2-cc5ca05f72bd',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=883ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 15, 2020',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' LD 50 in rats is >  10,700 mg/kg.21  (Further d etails were not available.)    Sub',\n",
       "   'UDIES   Acute Toxicity  Studies   Oral   The oral LD 50 of Caprylhydroxamic Acid is repor ted to be > 8820 mg/kg  in rats .2  Another source reported that the oral ',\n",
       "   'the urine and the feces, respectively .  The oral LD 50 of Caprylhydroxamic Acid is reported to be > 8820 mg/kg in rats .  In a 13 -wk study in which groups of  2'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['700 mg/kg', '8820 mg/kg  ', '8820 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a4'),\n",
       "  'Nome_comune': 'Caprylic Acid',\n",
       "  'INCI_name': 'Caprylic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=bafe1520-9fd0-4a09-ba77-55aeadd19c0a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=3a3ac6dd-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'April 09, 2019',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater than  2000  mg/kg/bw.23,28,30,32  The LD 50 values in oral studies ',\n",
       "   'Stearate, Stearic Acid, and Undecylenic Acid, the LD 50 values were greater  than 2000 mg/kg/bw . The  LD 50 values in oral studies of numerou'],\n",
       "  'contesti_noael': ['ral gavage studies with Sodium  Undecylenate, the NOAEL was <  50 mg/kg bw/day with adverse effects including dose -dependent  c',\n",
       "   'oral gavage studies with Sodium Undecylenate, the NOAEL  was < 50 mg/kg bw/day with adverse effects including dose -dependent cl',\n",
       "   'h OECD TG 407; animals  were treated for 14 days  NOAEL < 50 mg/kg bw/day;   treatment -related mortality  observed in high',\n",
       "   'tes washed  with  distilled water after exposure  NOAEL > 1000 mg/kg bw/day  in paternal animals for systemic  effects ; NOAEL = 100 mg/kg  bw/day for local effects;  treatment -related  increased',\n",
       "   'h OECD TG 408; animals  were treated for 90 days  NOAEL = 60 mg/kg bw/day;  LOAEL = 180 mg/kg bw/day;  clinical signs of toxicity  included ptyalism, ',\n",
       "   'dance with  OECD TG  421 (male rats were Maternal NOAEL  = 200 mg/kg  bw/day and fetal NOAEL > 2000 23 Table 13. DART studies ',\n",
       "   'egnancy, and lactation  until day 4 post -partum  NOAEL = 150 mg/kg bw/day for  parental toxicity; NOEL = 450 mg/kg bw/day for rep roductive  performance; 2 males died on d',\n",
       "   'aterial from day 6 to day of  gestation  Maternal NOAEL = 150 mg/kg  bw/day and maternal LOAEL =  450 mg/kg bw/day; fetal NOAEL  = 450 mg/kg bw/day; high dose  group treatment was terminated  due t',\n",
       "   'le 12.  The no -observable -adverse effect level (NOAEL)  in a dermal study of Lithium Stearate in rats  was  >  1000 mg/kg bw/day for systemic effects, but the NOAEL for local eff',\n",
       "   't ingredients were above the  doses tested.   The NOAEL in a dermal study of Lithium Stearate in rats was >  1000 mg/kg bw/day for systemic effects, but the  NOAEL for local ef',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related advers e  effects observe',\n",
       "   'y g avage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  slight to moderate breathing difficulties in se',\n",
       "   'ay gavage study in  accordance with OECD TG   407 NOAEL > 1000 mg/kg bw/day;  no treatment -related effects were  obser ved, ',\n",
       "   ' 14  days prior to mating to day 3  of lactation  NOAEL > 1000 mg/kg bw/day;  no treatment -related adverse  effects observed',\n",
       "   'for 14 days prior  to mating to gestation day 19  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse  reproductive eff',\n",
       "   ' 14 days  prior to mating to day 3 of  lactation  NOAEL > 1000 mg/kg bw/day; no  treatment -related adverse effects  observed',\n",
       "   'r 14 days prior to mating to day  3 of lactation  NOAEL = 1000 mg/kg bw/day for  parental animals and for offspring; no treat',\n",
       "   'al on gestation days 6  to 15  Maternal and fetal NOAEL > 1000  mg/kg bw/day; no treatment- related adverse effects observed i',\n",
       "   'rial on gestation days 6  to15 Maternal and fetal NOAEL > 1500  mg/kg bw/day; no treatment - related adverse effects observed ',\n",
       "   'ects was 100 mg/kg bw/day.28  The NOAEL s for  Behenic Acid  (up to 1000 mg/kg bw/day) , Calcium Stearate (up to 2000 mg/kg bw/day) , and Capric Acid  (up to 1000 mg/kg  bw/day)  w',\n",
       "   'low - and  mid-dose groups  28 day gavage study   NOAEL  > 2000 mg/kg bw/day;  no unscheduled deaths; no  significant toxicolo',\n",
       "   'ed with a  proprietary blend with  safflower oil  NOAEL was 5% for the  proprietary blend (equivalent to   2433 mg/kg/day for male a nd  2728 mg/kg/day for female rats );  no clinical signs of toxicity'],\n",
       "  'valori_ld50': ['2000  mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '50 mg/kg bw/day',\n",
       "   '100 mg/kg  bw/day',\n",
       "   '180 mg/kg bw/day',\n",
       "   '200 mg/kg  bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '450 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000 mg/kg bw/day',\n",
       "   '1000  mg/kg bw/day',\n",
       "   '1500  mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2000 mg/kg bw/day',\n",
       "   '2728 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a5'),\n",
       "  'Nome_comune': 'Caprylic/Capric Glycerides Polyglyceryl-10 Esters',\n",
       "  'INCI_name': 'Caprylic/Capric Glycerides Polyglyceryl-10 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ca08abce-94ee-4257-bafb-7ec8e5e6c4b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a6'),\n",
       "  'Nome_comune': 'Caprylic/Capric Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c9afd5e0-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a7'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Coco Glycerides',\n",
       "  'INCI_name': 'Caprylic/Capric/Coco Glycerides',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=134bc2d1-42fc-4c96-bc38-d1fd61351f35',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=79ee6359-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 1):5-16, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a8'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Lauric Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Lauric Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1822f53e-1402-465a-a1f1-fe5249893b28',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948a9'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Linoleic Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Linoleic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=288047c9-c462-4a1b-ae4e-b51f09d63959',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948aa'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Myristic/Stearic Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Myristic/Stearic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=278ae70e-f657-400a-b785-ba1a0f584c51',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b76c1f2275d72948ab'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Palmitic/Stearic Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Palmitic/Stearic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=107b143e-cc24-4f36-b32b-d2a2c47546a8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948ac'),\n",
       "  'Nome_comune': 'Caprylic/Capric/Stearic Triglyceride',\n",
       "  'INCI_name': 'Caprylic/Capric/Stearic Triglyceride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e460132a-8830-4888-b8b6-2fa7baf1521d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=01c28e01-d54c-3cfe-9864-b6d71355ec26',\n",
       "  'pdf_date': 'IJT 41(Suppl.3):22-68, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ls No./Group VehicleConcentration/Dose/ Procedure LD 50/observations Reference DERMAL Triheptanoin rats 5/sex none 24 h semi-occlusive patch with 2 g/kg>2 g/kg31 Tristearin rats 5/sex corn oil 24 h semi',\n",
       "   ' for both Triheptanoin31and Tristearin.32The oral LD 50 was > 2 g/kg for Triisostearin in mice and rats,33> 2 g/kg Triolein in mice,34> 5 g/kg Triheptanoin in mice, and > 48 g/kg Triethylhexano'],\n",
       "  'contesti_noael': ['d. 38In rats, a no-observed-adverse-effect-level (NOAEL) of 10 mg/kg bw/d was reported in a 30 d studywith Caprylic/Capric Triglyceride, 39and a NOAEL of 3500 mg/kg/d was reported with MLCT.28In a human study, no adv',\n",
       "   'ted with Caprylic/Capric Triglyceride. In rats, a NOAEL of 10mg/kg bw/d was reported in a 30 d study with Caprylic/CapricTriglyceride, and a NOAEL of 3500 mg/kg/d was reportedwith mixture of triglycerides with al',\n",
       "   'ontrol) (equiv to 3.5 g/kg/day)6-wk dietary study NOAEL = 3.5 g/kg/day no adverse effects were observed feed consumption'],\n",
       "  'valori_ld50': ['2 g/kg', '5 g/kg '],\n",
       "  'valori_noael': ['3500 mg/kg/d', '3500 mg/kg/d', '5 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948ad'),\n",
       "  'Nome_comune': 'Capryloyl Collagen Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Collagen Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=79120fa9-c738-4b8a-b5e0-2d644a279bc1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948ae'),\n",
       "  'Nome_comune': 'Capryloyl Glycine',\n",
       "  'INCI_name': 'Capryloyl Glycine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c4faaff0-b615-426d-b9e9-090119e9da56',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948af'),\n",
       "  'Nome_comune': 'Capryloyl Gold of Pleasure Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Gold of Pleasure Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8015a3dc-eb43-4f7e-9d0c-a9bc66f6e8d8',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b0'),\n",
       "  'Nome_comune': 'Capryloyl Keratin Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Keratin Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a057db1f-458a-4e46-92a2-24d10bd4843d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b1'),\n",
       "  'Nome_comune': 'Capryloyl Pea Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Pea Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3052015b-2685-4e43-83a0-6016e1935b40',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b2'),\n",
       "  'Nome_comune': 'Capryloyl Quinoa Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Quinoa Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=09fa6c65-6bf6-4e28-8c78-95f17fedc996',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b3'),\n",
       "  'Nome_comune': 'Capryloyl Salicylic Acid',\n",
       "  'INCI_name': 'Capryloyl Salicylic Acid',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=76d19512-aef9-4ddf-9b02-afb190a01f59',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=995efb2f-f539-86e3-8575-19bea03f915e',\n",
       "  'pdf_date': 'IJT 43(Suppl. 3):92-108, 2024',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' killed at theend of the study. The combined oral LD 50(males + females) for the test material was 3354 mg/kg (95% con ﬁdence limit between 2834 and 3970 mg/kg). Results relating to acute oral to xicity are in',\n",
       "   'se administered was 4217 mg/kg. The combined oral LD 50(males + females) was 3354 mg/kg (95% con ﬁdence limit between 2834 and 3970 mg/kg). Abnormalities observed at necropsy of animals(2'],\n",
       "  'contesti_noael': ['ummary of this study from adifferent source, “The NOAEL for developmental toxicity was established as 40 mg/kg/day, based on an increase in theincidence of fetuses ',\n",
       "   'with 100 mg/kg/day on gestation days 6 to 15. The NOAEL for developmental toxicity was established as 40 mg/kg/day, based on an increase in the incidence of fetuses'],\n",
       "  'valori_ld50': ['3970 mg/kg', '3970 mg/kg'],\n",
       "  'valori_noael': ['40 mg/kg/day', '40 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1b86c1f2275d72948b4'),\n",
       "  'Nome_comune': 'Capryloyl Salicylic Acid (ester)',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fb0d0ec5-c9be-499d-8cfd-ad253f0aca52',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=49b03823-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 22(Suppl 3):1-108, 2003',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['groups of 8 to 10 male Fischer 344 rats, the oral LD 50 of Sodium Salicylate was 1126 mg/kg (Pryor et al. 1983). The oral LD 50of Sodium Sali'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['1126 mg/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b5'),\n",
       "  'Nome_comune': 'Capryloyl Silk Amino Acids',\n",
       "  'INCI_name': 'Capryloyl Silk Amino Acids',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c4841060-adf3-4daa-835b-ba64fd4e9c87',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f8a7b89b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.1):17-56, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['rmal penetration of several drugs. The acute oral LD 50 and acute dermal LD 50of salts of myristic acid were >8 g/kg and >16 mL/kg, respectively, in rats. Acute dermal'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['8 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b6'),\n",
       "  'Nome_comune': 'Caprylyl Butyrate',\n",
       "  'INCI_name': 'Caprylyl Butyrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e401f39c-9741-4426-b313-31b4efb17a0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b7'),\n",
       "  'Nome_comune': 'Caprylyl Caprylate',\n",
       "  'INCI_name': 'Caprylyl Caprylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=fdb4fe0e-ce44-4027-94bb-2ebf7aaa9014',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b8'),\n",
       "  'Nome_comune': 'Caprylyl Eicosenoate',\n",
       "  'INCI_name': 'Caprylyl Eicosenoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9c509e1b-9404-422e-9cae-ceb4e5a52938',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b34bc38f-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.2):5-69, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' animals died, and the dermal median lethal dose (LD 50) of butyl oleate in rabbits was >5 g/kg bw. Additional details were not provided. Propylhept'],\n",
       "  'contesti_noael': ['ose and male and female high-dose animals and the NOAEL was 100 mg/kg/d – Not a reproductive toxicant in a study in which'],\n",
       "  'valori_ld50': ['5 g/kg bw'],\n",
       "  'valori_noael': ['100 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948b9'),\n",
       "  'Nome_comune': 'Caprylyl Glucoside',\n",
       "  'INCI_name': 'Caprylyl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=507a5f1c-3f8d-424f-8d82-904ce119dc2c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['fe as used Myristyl alcoholAnimal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg Inhalation: 3%, 1 h, ataxia and moderate nasal irr',\n",
       "   ' glucoside using rabbits, the median lethal dose (LD 50) was greater than the 2 g/kg dose administered. In oral studies with the same t',\n",
       "   'erides and phospholipids66 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD 50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   'sorbed from the GI tract68 Animal toxicology Oral LD 50: >8 g/kg; 3 mos dermal study: formulations w/8%, some derm',\n",
       "   ' as used Isostearyl alcoholAnimal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg66 Dermal ',\n",
       "   'afe as used Octyl dodecanolAnimal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD50: >3 g/kg68 (continued)24S Internatio',\n",
       "   ' and 2.7% in the urine65 Animal toxicology Dermal LD 50(rabbits), 4.2 g/kg; oral LD 50(rats), 0.79-4.36 g/kg Short-term oral: 6.9% n-butyl alcohol and 25% sucr'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '36 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948ba'),\n",
       "  'Nome_comune': 'Caprylyl Glyceryl Ether',\n",
       "  'INCI_name': 'Caprylyl Glyceryl Ether',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=89986e36-f715-43e8-a45e-6e48990848a0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=fb6cd177-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):5-21, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['he OECD TG 401 test method.25,27An lethal dosage (LD50) of >2000 mg/kg (low toxicity, no deaths) was reported, and clini',\n",
       "   'dy. None of the animals died, and an acute dermal LD50 of >2000 mg/kg (nontoxic) was reported. Necropsy findings were d'],\n",
       "  'contesti_noael': ['3-week study, it was not possible to establish an NOAEL because increased liver weight was observed at all doses. The study authors considered 50 mg/kg/d to be an NOAEL, because this dose was associated ',\n",
       "   'ed treatment related. Based on these results, the NOAEL was considered to be 800 mg/kg/d, and this was the highest dose tested in the 1-ge',\n",
       "   'ose groups. The 100 mg/kg dose was defined as the NOAEL. Ethylhexylglycerin administered orally to rats, at doses up to 800 mg/kg/d, in a 13-week study did not result in any treatme',\n",
       "   'negative. None of the dosed animals died, and the NOAEL for developmental toxi- city was considered to be 800 mg/kg/d. In the 1-generation developmental toxicity study'],\n",
       "  'valori_ld50': ['2000 mg/kg', '2000 mg/kg'],\n",
       "  'valori_noael': ['50 mg/kg/d', '800 mg/kg/d', '800 mg/kg/d', '800 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948bb'),\n",
       "  'Nome_comune': 'Caprylyl Glycol',\n",
       "  'INCI_name': 'Caprylyl Glycol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=c8271761-5642-4afb-8e5f-2006d13c8f3e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9862ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):147-168, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': [' that death would occur at relatively high doses (LD50 range: 2200 to >20 000 mg/kg). Reportedly, high (unspecified) oral doses of 1,',\n",
       "   'values were reported for 1,2- butanediol: 24-hour LD50 of 66.5 mmol/kg ( *5.99 g/kg) and 144-hour LD50 of 46.5 mmol/kg ( *4.19 mg/kg).32Muscle incoordination was observed in rats at ',\n",
       "   'is was observed at necropsy. In other studies, ip LD 50 values up to 13.7 mL/kg (rats) and 11.2 g/kg (mice) have been reported.1An acute study was per',\n",
       "   'n acute dermal toxicity study involving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg. Prolonged application or repeated applications o',\n",
       "   'lycol (1,2-pentanediol). The following acute oral LD50 values have been reported for pentylene glycol: 1.2700 Eþ04 mg/kg (rats); 7400 mg/kg (mice); 3700 mg/kg (rabbits); and 5200 mg/kg (guinea pigs).30 Steary',\n",
       "   'udy (OECD 423 test procedure) involving rats, the LD50 for caprylyl glycol was >2500 mg/kg.27, 1,2-Butanediol. An acute oral LD50 of 4192 mg/kg was reported for 1,2-butanediol in a study involvi',\n",
       "   'nteral toxicity studies, acute intramuscular (im) LD50 (20 g/kg rats) and acute subcutaneous (sc) LD50 (18.5 g/kg mice) values have been reported.1 Repeated-Dose To',\n",
       "   'l glycol. An LD50 of >5000 mg/kg was reported for rats dosed orally with stearyl gl',\n",
       "   'ated using adult male Sprague-Dawley rats, and an LD50 of >20.0 g/kg body weight was reported.5 Propylene glycol. The 24-hour oral LD50 for PG was 22.8 g/kg body weight in a study involving 5 female Fischer rats. Oral L',\n",
       "   'ailable from Dow Chemical Company, the acute oral LD50 for 1,2-butanediol in rats was 16 g/kg body weight.29Also, high (unspecified) doses caused narcosis ',\n",
       "   'acute dermal toxicity study invol- ving rats, the LD50 for decylene glycol (SymClariol) was >2000 mg/kg.27 Propylene glycol. The dermal LD50 for PG was >11.2 g/kg in mice and was 13 g/kg in rats.1 Intraperitoneal '],\n",
       "  'contesti_noael': ['iod was largely reversible. Both the NOEL and the NOAEL in this study was 100 mg/kg body weight/d.36 Pentylene glycol. Pentylene glycol was adminis',\n",
       "   'ach; analogous structures do not exist in man. An NOAEL of 100 mg/kg/d was reported for rats in a 28-day oral toxicity s',\n",
       "   'females). The no observable adverse effect level (NOAEL) was 200 mg/kg body weight/day in this study.35 According to a summary of data p',\n",
       "   'ministration of 1,2-butanediol to rats yielded an NOAEL of 200 mg/kg/d. Reportedly, in another repeated dose study, the ',\n",
       "   ' mg/kg/d, and a no observed adverse effect level (NOAEL) of 300 mg/kg/d for systemic toxi- city. The NOAEL was based on t',\n",
       "   'this study was calculated as 10 mg/kg/d, using an NOAEL of 1000 mg/kg/d and a reproductive toxicity uncertainty factor of'],\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '19 mg/kg',\n",
       "   '2 g/kg',\n",
       "   '2000 mg/kg',\n",
       "   '3700 mg/kg',\n",
       "   '4192 mg/kg ',\n",
       "   '5 g/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '8 g/kg body weight ',\n",
       "   '16 g/kg body weight',\n",
       "   '11.2 g/kg '],\n",
       "  'valori_noael': ['100 mg/kg body weight/d',\n",
       "   '100 mg/kg/d',\n",
       "   '200 mg/kg body weight/day',\n",
       "   '200 mg/kg/d',\n",
       "   '300 mg/kg/d',\n",
       "   '1000 mg/kg/d']},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948bc'),\n",
       "  'Nome_comune': 'Caprylyl Glycol/Glycerin/Polyacrylic Acid Copolymer',\n",
       "  'INCI_name': 'Caprylyl Glycol/Glycerin/Polyacrylic Acid Copolymer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4b2e3eb0-4977-4c18-a889-9e1a2a014b6e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c79ac89b-d78d-055f-ba88-45f4f5a039b3',\n",
       "  'pdf_date': 'June 17, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['d for 14 d; no mortality was reported.  The  oral LD 50 of Glyceryl Acrylate/Acrylic Acid Copolymer was > 5 g/kg in rats.   Short -Term, Subchronic, and Chronic  T',\n",
       "   'st article was  administered by gavage.  The oral LD 50 was > 5 g/kg.   The mutagenic potential of Glyceryl Acrylate/A'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['5 g/kg ', '5 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948bd'),\n",
       "  'Nome_comune': 'Caprylyl Methicone',\n",
       "  'INCI_name': 'Caprylyl Methicone',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4f72d70c-6772-4107-9235-2738cf40ce39',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7c88046f-950e-56b3-8f3d-05a1d904658b',\n",
       "  'pdf_date': 'March 08, 2022',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['  Under the conditions of this study, the acut e  LD 50 of Dimethicone in adult male and female rabbits was considered to be > 2 000 mg/kg bw.   Oral   Dimethicone, Methicone, and Vinyl  Dime',\n",
       "   ' necropsy lesions were  observed.  The acute oral LD 50 of Dimethicone in male and female rats was determined as > 2 000 mg/kg bw.   Inhalation   Two dogs, 7 guinea pigs, and 7 ra',\n",
       "   're observed in either study  and the acute dermal LD 50 for each ingredient was determined to  be > 2 000 mg/kg bw  in rats and rabbits , respectively .  A single, 20',\n",
       "   'IES  Acute Toxicity Studies   Dermal   The dermal LD 50 for Dimethicone was >  2000 mg/kg in rats and rabbits.1  The dermal LD 50 for Methic',\n",
       "   ' [ 40 CFR § 798.1100] Test Guideline (TG) .4  The LD 50 in rats was reported to be > 2000  mg/kg bw.4  No further details were provided.   Caprylyl M',\n",
       "   'thological changes were observed.  The acute oral LD 50 of Caprylyl Methicone was determined as > 2000 mg/kg bw in female rats.   Dimethicone   Five male and 5 fe',\n",
       "   'as water -soluble metabolites.   The acute dermal LD 50 of C30- 45 Alkyl Dimethicone was determined to be >  2000 mg/kg bw in rats.  In two separat e  acute dermal studies, ',\n",
       "   'of systemic toxicity were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw.  Five male  and female Sprague -Dawley  rats wer',\n",
       "   'oss necropsy lesions were observed, and the acute LD 50 was determined to be > 2000 mg/kg bw in rats.  Caprylyl  Methicone was administered in ',\n",
       "   's of systemic toxicity were observed.  The dermal LD 50 of Caprylyl Methicone  was determined to be > 2000 mg/kg bw in rats.   Dimethicone   A single, 2008 mg/kg bw dermal application of Dimethicone ( 332.5 kg/m ⋅s)',\n",
       "   'ticeable abnormalities were observed.  The dermal LD 50 in this study was determined to be > 2008 mg/kg bw.   Undiluted Dimethicone ( 54,150 kg/m ⋅s) was ap',\n",
       "   '; under these study conditions  the  acute dermal LD 50 was determined to be >  2008 mg/kg bw.  Three groups of 10 New Zealand white rabbits we'],\n",
       "  'contesti_noael': ['not significantly different from controls.    The NOAEL was determined to be 1000 mg/kg bw/d and the no -observed -effect -level (NOEL) was deemed to b e 500 mg/kg bw/d.   Dimethicone   In a 28- d oral toxicity  study,',\n",
       "   'kg group were  statistically significant, and the NOAEL was determined to be 1000 mg/kg bw/d, while the NOEL was determined to be 500  mg/kg bw/d.   In a 28 -d oral toxicity study, Dimethicone wa',\n",
       "   'ce.  The no -observ able- adverse -effect -level (NOAEL) for dermal application of  Dimethicone in rabbits in this study was therefore considered to be 1000 mg/kg/d.   Oral   Mongrel dogs were fed with up to 3.0 g/',\n",
       "   'nt   or toxicologically irrelevant.  The reported NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Four  groups of 10 male and 10 female Sprague ',\n",
       "   ', or external malformations  were observed .  The NOAEL for Caprylyl Methicone maternal toxicity and  developmental effects was determined to be > 1000 mg/kg bw /d.  GENOTOXICITY STUDIES   Dimethicone tested negat',\n",
       "   'events related  to the exposure occurred, and the NOAEL for dermal application in rabbits was determined to be 1000 mg/kg/d.    Three female Wistar rats were administered a ',\n",
       "   'e all considered toxicologically irrelevant.  The NOAEL of Caprylyl Methicone was determined to be > 1000 mg/kg  bw/d.  In another 28 -d oral toxicity study of Capryly',\n",
       "   ' fetal  outcomes were not adversely affected; the NOAEL for Caprylyl Methicone was determined to be > 1000 mg/kg bw/d.   Bacterial rev erse mutation assay s were perfo'],\n",
       "  'valori_ld50': ['000 mg/kg bw',\n",
       "   '000 mg/kg bw',\n",
       "   '000 mg/kg bw  ',\n",
       "   '2000 mg/kg ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2008 mg/kg bw ',\n",
       "   '2008 mg/kg bw',\n",
       "   '2008 mg/kg bw'],\n",
       "  'valori_noael': ['500 mg/kg bw/d',\n",
       "   '500  mg/kg bw/d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw /d',\n",
       "   '1000 mg/kg/d',\n",
       "   '1000 mg/kg  bw/d',\n",
       "   '1000 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1b96c1f2275d72948be'),\n",
       "  'Nome_comune': 'Caprylyl/Capryl Glucoside',\n",
       "  'INCI_name': 'Caprylyl/Capryl Glucoside',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=25971e38-538a-4c16-bf18-6ef6041dd462',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=9810a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 32(Suppl. 3):22-48, 2013',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['fe as used Myristyl alcoholAnimal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg Inhalation: 3%, 1 h, ataxia and moderate nasal irr',\n",
       "   ' glucoside using rabbits, the median lethal dose (LD 50) was greater than the 2 g/kg dose administered. In oral studies with the same t',\n",
       "   'erides and phospholipids66 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD 50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   'sorbed from the GI tract68 Animal toxicology Oral LD 50: >8 g/kg; 3 mos dermal study: formulations w/8%, some derm',\n",
       "   ' as used Isostearyl alcoholAnimal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg66 Dermal ',\n",
       "   'afe as used Octyl dodecanolAnimal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD50: >3 g/kg68 (continued)24S Internatio',\n",
       "   ' and 2.7% in the urine65 Animal toxicology Dermal LD 50(rabbits), 4.2 g/kg; oral LD 50(rats), 0.79-4.36 g/kg Short-term oral: 6.9% n-butyl alcohol and 25% sucr'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg ',\n",
       "   '6 g/kg',\n",
       "   '8 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '36 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948bf'),\n",
       "  'Nome_comune': 'Capsaicin',\n",
       "  'INCI_name': 'Capsaicin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2f836965-9ff0-4a93-8114-8b39f0aeebd9',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/1548943',\n",
       "   'valori': ['LD50 Mouse oral >2500 mg/kg',\n",
       "    'LD50 Rat ip 9500 ug/kg',\n",
       "    'LD50 Mouse oral 47200 ug/kg',\n",
       "    'LD50 Mouse ip 6500 ug/kg',\n",
       "    'LD50 Mouse sc 9000 ug/kg',\n",
       "    'LD50 Mouse iv 400 ug/kg',\n",
       "    'LD50 Mouse im 7800 ug/kg',\n",
       "    'LD50 Mouse intratracheal 1600 ug/kg',\n",
       "    'LD50 Guinea pig ip 1100 ug/kg',\n",
       "    'LD50 Rat (male) oral 161.2 mg/kg',\n",
       "    'LD50 Rat (female) oral 148.1 mg/kg',\n",
       "    'LD50 Mouse (male) oral 118.8 mg/kg',\n",
       "    'LD50 Mouse (female) oral 97.4 mg/kg'],\n",
       "   'fonti': ['Crop Protection Handbook Volume 100, Meister Media Worldwide, Willoughby, OH 2014, p. 156',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 690\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 690\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 690\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 690\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 690\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 690\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 690\",\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 690\",\n",
       "    'PMID:8887888',\n",
       "    'PMID:8887888',\n",
       "    'PMID:8887888',\n",
       "    'PMID:8887888']},\n",
       "  'contesti_ld50': ['FT strain (35 to 30 g) with Capsaicin in DMSO. An LD 50(computed statistically us- ing probit analysis) of 8.0 mg/kg body weight was reported. Acute Subcutaneous Toxicity Glinsuko',\n",
       "   'study, Kim and Park (1981) reported an acute i.v. LD 50 of 0.4 mg/kg (conﬁdence limits =0.37 to 0.43 mg/kg) for mice. Biggs and Goel (1985) reported that si',\n",
       "   'ublethal dose inprotocol,corresponding to 1/15 of LD 50)Micronucleus test Animals dosed with 1.46 mg/kg had a statisticallysigniﬁcant increase in thenumbe'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 mg/kg body weight ', '43 mg/kg', '46 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c0'),\n",
       "  'Nome_comune': 'Capsicum Annuum Extract',\n",
       "  'INCI_name': 'Capsicum Annuum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a1e059b9-aa39-461c-afb6-884caeb2b966',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['FT strain (35 to 30 g) with Capsaicin in DMSO. An LD 50(computed statistically us- ing probit analysis) of 8.0 mg/kg body weight was reported. Acute Subcutaneous Toxicity Glinsuko',\n",
       "   'study, Kim and Park (1981) reported an acute i.v. LD 50 of 0.4 mg/kg (conﬁdence limits =0.37 to 0.43 mg/kg) for mice. Biggs and Goel (1985) reported that si',\n",
       "   'ublethal dose inprotocol,corresponding to 1/15 of LD 50)Micronucleus test Animals dosed with 1.46 mg/kg had a statisticallysigniﬁcant increase in thenumbe'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 mg/kg body weight ', '43 mg/kg', '46 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c1'),\n",
       "  'Nome_comune': 'Capsicum Annuum Fruit Extract',\n",
       "  'INCI_name': 'Capsicum Annuum Fruit Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=90b58523-5da4-45fc-8240-adac94f0c429',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['FT strain (35 to 30 g) with Capsaicin in DMSO. An LD 50(computed statistically us- ing probit analysis) of 8.0 mg/kg body weight was reported. Acute Subcutaneous Toxicity Glinsuko',\n",
       "   'study, Kim and Park (1981) reported an acute i.v. LD 50 of 0.4 mg/kg (conﬁdence limits =0.37 to 0.43 mg/kg) for mice. Biggs and Goel (1985) reported that si',\n",
       "   'ublethal dose inprotocol,corresponding to 1/15 of LD 50)Micronucleus test Animals dosed with 1.46 mg/kg had a statisticallysigniﬁcant increase in thenumbe'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 mg/kg body weight ', '43 mg/kg', '46 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c2'),\n",
       "  'Nome_comune': 'Capsicum Annuum Resin',\n",
       "  'INCI_name': 'Capsicum Annuum Resin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d1613cfe-d368-44ae-a706-9a0c0f92b2db',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['FT strain (35 to 30 g) with Capsaicin in DMSO. An LD 50(computed statistically us- ing probit analysis) of 8.0 mg/kg body weight was reported. Acute Subcutaneous Toxicity Glinsuko',\n",
       "   'study, Kim and Park (1981) reported an acute i.v. LD 50 of 0.4 mg/kg (conﬁdence limits =0.37 to 0.43 mg/kg) for mice. Biggs and Goel (1985) reported that si',\n",
       "   'ublethal dose inprotocol,corresponding to 1/15 of LD 50)Micronucleus test Animals dosed with 1.46 mg/kg had a statisticallysigniﬁcant increase in thenumbe'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 mg/kg body weight ', '43 mg/kg', '46 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c3'),\n",
       "  'Nome_comune': 'Capsicum Annuum Root Powder',\n",
       "  'INCI_name': 'Capsicum Annuum Fruit Powder',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f91f72a9-cb83-4293-b5ec-61ca74d71f2a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['FT strain (35 to 30 g) with Capsaicin in DMSO. An LD 50(computed statistically us- ing probit analysis) of 8.0 mg/kg body weight was reported. Acute Subcutaneous Toxicity Glinsuko',\n",
       "   'study, Kim and Park (1981) reported an acute i.v. LD 50 of 0.4 mg/kg (conﬁdence limits =0.37 to 0.43 mg/kg) for mice. Biggs and Goel (1985) reported that si',\n",
       "   'ublethal dose inprotocol,corresponding to 1/15 of LD 50)Micronucleus test Animals dosed with 1.46 mg/kg had a statisticallysigniﬁcant increase in thenumbe'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 mg/kg body weight ', '43 mg/kg', '46 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c4'),\n",
       "  'Nome_comune': 'Capsicum Frutescens Fruit',\n",
       "  'INCI_name': 'Capsicum Frutescens Fruit',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b8bf6b22-916a-4ce2-8d3f-e21e1e9ec7b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['FT strain (35 to 30 g) with Capsaicin in DMSO. An LD 50(computed statistically us- ing probit analysis) of 8.0 mg/kg body weight was reported. Acute Subcutaneous Toxicity Glinsuko',\n",
       "   'study, Kim and Park (1981) reported an acute i.v. LD 50 of 0.4 mg/kg (conﬁdence limits =0.37 to 0.43 mg/kg) for mice. Biggs and Goel (1985) reported that si',\n",
       "   'ublethal dose inprotocol,corresponding to 1/15 of LD 50)Micronucleus test Animals dosed with 1.46 mg/kg had a statisticallysigniﬁcant increase in thenumbe'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 mg/kg body weight ', '43 mg/kg', '46 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c5'),\n",
       "  'Nome_comune': 'Capsicum Frutescens Fruit Extract',\n",
       "  'INCI_name': 'Capsicum Frutescens Fruit Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cac1fd0a-1673-4480-9fda-0b2e2fdab690',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['FT strain (35 to 30 g) with Capsaicin in DMSO. An LD 50(computed statistically us- ing probit analysis) of 8.0 mg/kg body weight was reported. Acute Subcutaneous Toxicity Glinsuko',\n",
       "   'study, Kim and Park (1981) reported an acute i.v. LD 50 of 0.4 mg/kg (conﬁdence limits =0.37 to 0.43 mg/kg) for mice. Biggs and Goel (1985) reported that si',\n",
       "   'ublethal dose inprotocol,corresponding to 1/15 of LD 50)Micronucleus test Animals dosed with 1.46 mg/kg had a statisticallysigniﬁcant increase in thenumbe'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 mg/kg body weight ', '43 mg/kg', '46 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c6'),\n",
       "  'Nome_comune': 'Capsicum Frutescens Resin',\n",
       "  'INCI_name': 'Capsicum Frutescens Resin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ed5c698f-7ade-4c50-b2ec-684f891318fe',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=555e3329-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 26(Suppl. 1):3-106, 2007',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['FT strain (35 to 30 g) with Capsaicin in DMSO. An LD 50(computed statistically us- ing probit analysis) of 8.0 mg/kg body weight was reported. Acute Subcutaneous Toxicity Glinsuko',\n",
       "   'study, Kim and Park (1981) reported an acute i.v. LD 50 of 0.4 mg/kg (conﬁdence limits =0.37 to 0.43 mg/kg) for mice. Biggs and Goel (1985) reported that si',\n",
       "   'ublethal dose inprotocol,corresponding to 1/15 of LD 50)Micronucleus test Animals dosed with 1.46 mg/kg had a statisticallysigniﬁcant increase in thenumbe'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 mg/kg body weight ', '43 mg/kg', '46 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c7'),\n",
       "  'Nome_comune': 'Captan',\n",
       "  'INCI_name': 'Captan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e4bf9330-4d16-4e47-925f-900904c1aa6a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=f698591a-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 8(4):643-680, 1989',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': 'https://pubchem.ncbi.nlm.nih.gov/compound/8606',\n",
       "   'valori': ['LD50 Rat oral 9000 mg/kg',\n",
       "    'LD50 Rabbit dermal >4500 mg/kg',\n",
       "    'LD50 Swiss- Webster mouse oral about 7500 mg/kg',\n",
       "    'LD50 Swiss-Webster mouse ip 500 mg/kg',\n",
       "    'LC50 Swiss-Webster mouse (male) inhalation 4.5 mg/L/2 hr',\n",
       "    'LC50 Swiss-Webster mouse (female) inhalation 5 mg/L/2 hr',\n",
       "    'LC50 Mouse inhalation 4 mg/L/4 hr',\n",
       "    'LC50 Mouse inhalation 5000 mg/cu m/2 hr',\n",
       "    'LD50 Rat oral 12,500 mg/kg',\n",
       "    'LD50 Rabbit dermal >9000 mg/kg',\n",
       "    'LC50 Rat inhalation >5.7 mg/L/2 hr',\n",
       "    'LD50 Mouse (male) ip 518 mg/kg',\n",
       "    'LD50 Mouse (female) ip 462 mg/kg',\n",
       "    'LD50 Mouse (male) oral 7840 mg/kg',\n",
       "    'LD50 Mouse (female) oral 7000 mg/kg'],\n",
       "   'fonti': [\"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 691\",\n",
       "    'Tomlin, C.D.S. (ed.). The Pesticide Manual - World Compendium. 10th ed. Surrey, UK: The British Crop Protection Council, 1994., p. 146',\n",
       "    'IARC. Monographs on the Evaluation of the Carcinogenic Risk  of Chemicals to Humans. Geneva: World Health Organization,  International Agency for Research on Cancer, 1972-PRESENT.  (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V30 304 (1983)',\n",
       "    'IARC. Monographs on the Evaluation of the Carcinogenic Risk  of Chemicals to Humans. Geneva: World Health Organization,  International Agency for Research on Cancer, 1972-PRESENT.  (Multivolume work). Available at: https://monographs.iarc.fr/ENG/Classification/index.php, p. V30 304 (1983)',\n",
       "    'American Conference of Governmental Industrial Hygienists. Documentation of the TLVs and BEIs with Other World Wide Occupational Exposure Values. 7th Ed. CD-ROM Cincinnati, OH 45240-1634 2013., p. 2',\n",
       "    'American Conference of Governmental Industrial Hygienists. Documentation of the TLVs and BEIs with Other World Wide Occupational Exposure Values. 7th Ed. CD-ROM Cincinnati, OH 45240-1634 2013., p. 2',\n",
       "    'Tomlin, C.D.S. (ed.). The Pesticide Manual - World Compendium. 10th ed. Surrey, UK: The British Crop Protection Council, 1994., p. 146',\n",
       "    \"Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 691\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V4 1166\",\n",
       "    \"Bingham, E.; Cohrssen, B.; Powell, C.H.; Patty's Toxicology Volumes 1-9 5th ed. John Wiley & Sons. New York, N.Y. (2001)., p. V4 1116\",\n",
       "    'American Conference of Governmental Industrial Hygienists. Documentation of the TLVs and BEIs with Other World Wide Occupational Exposure Values. 7th Ed. CD-ROM Cincinnati, OH 45240-1634 2013., p. 2',\n",
       "    'American Conference of Governmental Industrial Hygienists. Documentation of the TLVs and BEIs with Other World Wide Occupational Exposure Values. 7th Ed. CD-ROM Cincinnati, OH 45240-1634 2013., p. 1',\n",
       "    'American Conference of Governmental Industrial Hygienists. Documentation of the TLVs and BEIs with Other World Wide Occupational Exposure Values. 7th Ed. CD-ROM Cincinnati, OH 45240-1634 2013., p. 1',\n",
       "    'American Conference of Governmental Industrial Hygienists. Documentation of the TLVs and BEIs with Other World Wide Occupational Exposure Values. 7th Ed. CD-ROM Cincinnati, OH 45240-1634 2013., p. 1',\n",
       "    'American Conference of Governmental Industrial Hygienists. Documentation of the TLVs and BEIs with Other World Wide Occupational Exposure Values. 7th Ed. CD-ROM Cincinnati, OH 45240-1634 2013., p. 1']},\n",
       "  'contesti_ld50': [' of Captan than were the nonpregnant females. The LD50  (i.p.) for the W’ rstar rat was approximately 25 mg/kg body weight. In the rats  that died, a bloody discharge from ',\n",
       "   'ethal to zebrafish  larvae.  lntraperitoneal  The LD50 for an i.p. dose of Captan was approximately 500 mg/kg body  weight in mice.  body weight.c2) (36) For rats, the LD50 ',\n",
       "   'all  respects except for casein content, the oral LD50 of Captan was 12.6 f 2.1  g/kg, which is approximately equal to that of the rats',\n",
       "   'IEW  ANIMAL TOXICOLOGY  Acute Toxicity  Oral  The LD50 for Captan administered to young, male albino rats fed a diet of  laboratory chow was 12.5 & 3.5 g/kg. c3’) Death usually occurred between 2  and 4 day',\n",
       "   'than that for rats fed normal protein  diets, the LD50 being 0.48 + 0.11 g/kg. Of the test rats on the low-protein  diet, 25% d',\n",
       "   'ingested.  Subchronic Toxicity  Oral  The 100 day LD50 in rats administered Captan daily by gavage was  0.92 & 0.23 g/kg/day. (37) The oral IOO-day LD50 was about 7.3% of'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['25 mg/kg body weight',\n",
       "   '500 mg/kg body  weight ',\n",
       "   '1  g/kg',\n",
       "   '5 g/kg',\n",
       "   '11 g/kg',\n",
       "   '23 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1ba6c1f2275d72948c8'),\n",
       "  'Nome_comune': 'Carapa Guaianensis Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Carapa Guianensis Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=821f24a5-40be-4eee-a8fa-1a6f945ff23e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948c9'),\n",
       "  'Nome_comune': 'Carbomer',\n",
       "  'INCI_name': 'Carbomer',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7462ddda-da7a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c3a1aad1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'December 04, 2018',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' Acrylates Copolymer in rats, and in rabbits , an LD 50 of > 2 g/kg was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   ' .8  For Polyacrylate -1  Crosspolymer , the oral LD 50 in rats was >  2 g/kg.12  In an acute inhalation study in rats, a 4 -h ',\n",
       "   'Acrylates Copolymer in rats , and in rabbits , an LD 50 of > 2 g/kg  was reported for VA/Butyl Maleate/Iso bornyl Acryl',\n",
       "   'ol .  For Polyacrylate -1 Crosspolymer , the oral LD 50 in rats was >  2 g/kg.  In an acute inhalation study  of Acrylates  Cop',\n",
       "   'arbomer  in albino rats was 1.71 mg/l. The dermal LD 50 of rats exposed to Carbomer was > 3  g/kg.     The acute toxicity studies summarized here a',\n",
       "   ' dermal and oral administration to rats; the oral LD 50 was >  5 g/kg.  The oral LD 50 for rats of an ammonium salt of ',\n",
       "   'ied .  The dermal LD 50 for rabbits  and the oral LD 50 for rats of Vinyl Acetate/Maleate/ Acrylate   Copolymer solution was >  5 g/kg.  For rats, the oral LD 50 values  of Polyacrylic',\n",
       "   'ssessment of Acrylates Copolymers1  The following LD 50 values were reported for Acryla tes Copolymer: > 16 g/kg (dermal, rabbits), > 16 ml/kg (dermal),  >9 g/kg  (dermal), 9 g/kg (dermal, rats), >  5.2 mg/ l (r',\n",
       "   '> 2.0 g/kg and > 5.0 g/kg, respectively) and oral LD 50 values  in rats  for Acrylates/C10 -30 Alkyl Acrylate Cross polymer  (>10 g/kg) , Acrylate s/ Vinyl Isodecanoate Crosspolymer  ('],\n",
       "  'contesti_noael': ['orted.   The no -observed - adverse effect level (NOAEL) was 2000 mg/kg bw/day.   In a 28 -day study, groups of 3 male a nd 3 fe',\n",
       "   ' days .  There were no not able findings, and the NOAEL was  2000 mg/kg bw/day .  In a 28 -day dietary study in which rats we re'],\n",
       "  'valori_ld50': ['2 g/kg ',\n",
       "   '2 g/kg',\n",
       "   '2 g/kg  ',\n",
       "   '2 g/kg',\n",
       "   '3  g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '9 g/kg',\n",
       "   '10 g/kg'],\n",
       "  'valori_noael': ['2000 mg/kg bw/day', '2000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948ca'),\n",
       "  'Nome_comune': 'Carbomer-910',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=21786afd-1eb8-4af4-b263-fbc9e72e3049',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2c9ec7a4-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 1(2):109-141, 1982',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  served. Under these test conditions, the dermal LD50 was determined to be  > 3.0 g/kg.‘73’  Carbomer-934: A skin moisturizer containing',\n",
       "   'omer-910 in albino rats was 1.71 mg/l. The dermal LD50 of  rats exposed to Carbomer-910 was > 3.0 g/kg. No mortalities occurred in rabbits  injected int',\n",
       "   'hs or toxic signs were reported. The acute dermal LD50  and MLD of the skin moisturizer formulation were considered to be > 10 g/kg.‘78)  Acute toxicity: intravenous administration '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 g/kg', '0 g/kg', '10 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948cb'),\n",
       "  'Nome_comune': 'Carbomer-934',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=303cb9f8-9c9b-46ae-99f0-a9ab073852d4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2c9ec7a4-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 1(2):109-141, 1982',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['  served. Under these test conditions, the dermal LD50 was determined to be  > 3.0 g/kg.‘73’  Carbomer-934: A skin moisturizer containing',\n",
       "   'omer-910 in albino rats was 1.71 mg/l. The dermal LD50 of  rats exposed to Carbomer-910 was > 3.0 g/kg. No mortalities occurred in rabbits  injected int',\n",
       "   'hs or toxic signs were reported. The acute dermal LD50  and MLD of the skin moisturizer formulation were considered to be > 10 g/kg.‘78)  Acute toxicity: intravenous administration '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 g/kg', '0 g/kg', '10 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948cc'),\n",
       "  'Nome_comune': 'Carbomer-934P',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4424dfe3-4378-4e2f-89fe-c40fea5b0d74',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2c9ec7a4-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 1(2):109-141, 1982',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['  served. Under these test conditions, the dermal LD50 was determined to be  > 3.0 g/kg.‘73’  Carbomer-934: A skin moisturizer containing',\n",
       "   'omer-910 in albino rats was 1.71 mg/l. The dermal LD50 of  rats exposed to Carbomer-910 was > 3.0 g/kg. No mortalities occurred in rabbits  injected int',\n",
       "   'hs or toxic signs were reported. The acute dermal LD50  and MLD of the skin moisturizer formulation were considered to be > 10 g/kg.‘78)  Acute toxicity: intravenous administration '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 g/kg', '0 g/kg', '10 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948cd'),\n",
       "  'Nome_comune': 'Carbomer-941',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e3182b45-eb3b-4101-a62e-86a548f92d7c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2c9ec7a4-8d74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'JACT 1(2):109-141, 1982',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['  served. Under these test conditions, the dermal LD50 was determined to be  > 3.0 g/kg.‘73’  Carbomer-934: A skin moisturizer containing',\n",
       "   'omer-910 in albino rats was 1.71 mg/l. The dermal LD50 of  rats exposed to Carbomer-910 was > 3.0 g/kg. No mortalities occurred in rabbits  injected int',\n",
       "   'hs or toxic signs were reported. The acute dermal LD50  and MLD of the skin moisturizer formulation were considered to be > 10 g/kg.‘78)  Acute toxicity: intravenous administration '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 g/kg', '0 g/kg', '10 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948ce'),\n",
       "  'Nome_comune': 'Carbomer-962',\n",
       "  'INCI_name': '',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5a805320-a561-4a37-9077-1956ffb29964',\n",
       "  'pdf_link': None,\n",
       "  'pdf_date': None,\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948cf'),\n",
       "  'Nome_comune': 'Carboxymethyl Cellulose Acetate Butyrate',\n",
       "  'INCI_name': 'Carboxymethyl Cellulose Acetate Butyrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8cf81942-5a41-4960-b7ac-d9af5665d8eb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948d0'),\n",
       "  'Nome_comune': 'Carboxymethyl Dextran',\n",
       "  'INCI_name': 'Carboxymethyl Dextran',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=df0a41e1-071a-4844-b94c-2ab880302df5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c052d083-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 35(Suppl.1):5-49, 2016',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bb6c1f2275d72948d1'),\n",
       "  'Nome_comune': 'Carboxymethyl Hydroxyethylcellulose',\n",
       "  'INCI_name': 'Carboxymethyl Hydroxyethylcellulose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d49cc801-0c6b-4044-a9db-e46471cf3cdc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d2'),\n",
       "  'Nome_comune': 'Carboxymethyl Hydroxypropyl Guar',\n",
       "  'INCI_name': 'Carboxymethyl Hydroxypropyl Guar',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=cb91a1da-3b21-4f86-b55c-b0ba87d6e600',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['dy weight) over a 24-hour period.54The acute oral LD50 was >10 000 mg/kg body weight. Repeated Dose Toxicity—Oral Studies Cyamopsis te',\n",
       "   'ngredients: guar hydroxypropyltrimonium chloride (LD50 ¼12.5 g/kg), hydroxypropyl guar hydroxypropyltrimonium chloride (LD50 ¼12.0 g/kg), carboxymethyl guar (LD50 ¼17.8 g/kg), hydro- ly',\n",
       "   'here were no macroscopic findings at necropsy. An LD50 of >2000 mg/kg was reported. Gum guar, oxidized 2-hydro xypropyl ',\n",
       "   ' fecal staining; and irritability. The acute oral LD50 was 17.8 g/kg (95 %confidence limits of 13.1-22.5 g/kg). Hydrolyzed guar. An acute oral toxicity study o',\n",
       "   '0 mg/kg body weight at a 2-hour interval. An oral LD50 value of >5000 mg/kg body weight was reported. In a similar test, 10 male and 10 fe',\n",
       "   'ce and rats). None of the ani- mals died, and the LD50 was >6000 mg/kg in both the species. Ceratonia siliqua gum. The ac',\n",
       "   'ity; and generally poor condition. The acute oral LD50 was 12.0 g/kg (95 %confidence limits of 9.2-14.8 g/kg). Carboxymethyl guar. The acute oral toxicity of ',\n",
       "   '/kg), which yielded 90 %mortality. The acute oral LD50 was 15 g/kg (95 %confidence limits of 13-17 g/kg). Hydroxypropyl guar hydroxypropyltrimonium chlor',\n",
       "   ' piloerection. The acute oral median lethal dose (LD50) was 12.5 g/kg (95 %confidence limits of 10.22-14.78 g/kg). The acute oral toxicity of a guar hydroxypropyl',\n",
       "   'zed guar (LD50 > 6 g/kg), cassia gum (LD50 > 5 g/kg), and C siliqua gum (LD50 ¼5 g/kg). The LD50s for C siliqua gum in other species include 13.1 g/kg (mice), 9.1 g/kg (rabbits), and 10.3 g/kg (hamste'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight',\n",
       "   '0 g/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg body weight ',\n",
       "   '6000 mg/kg ',\n",
       "   '8 g/kg',\n",
       "   '17 g/kg',\n",
       "   '78 g/kg',\n",
       "   '13.1 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d3'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Fruit',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Fruit',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=485433ad-ab6b-4f0f-ae19-c48b7b426c5c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Carica papaya leaf extract via gavage.42  An oral LD 50 of greater than  2000 mg/kg bw was determined in a study  involving rats given up to 2000 mg/kg bw of an aqueous Carica papaya  leaf extract.43  No m',\n",
       "   ' Carica papaya  leaf extract via gavage.  An oral LD 50 of greater than  2000 mg/kg bw Carica papaya  leaf extract (highest dose  tested)',\n",
       "   ' were free of gross pathological  changes.   The  LD 50 was greater than 2000  mg/kg bw.  43  Carica  papaya  leaf extract   (methanolic)',\n",
       "   'p spray suntan products at up to 0.01%.   An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving W',\n",
       "   'ated .  Control  group received 1.0 ml of saline  LD 50 = 2520 mg/kg ; no significant changes  in liver, renal, and he',\n",
       "   'marized below are presente d in Table 5.  An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving Wi star rats given up to 3200 mg/kg  of an  aqueous unripe Carica papaya  fruit extract'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2520 mg/kg ',\n",
       "   '2520 mg/kg',\n",
       "   '3200 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d4'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Fruit Extract',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Fruit Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3927dc84-42e0-4fb6-a2c6-802bd1fb0531',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Carica papaya leaf extract via gavage.42  An oral LD 50 of greater than  2000 mg/kg bw was determined in a study  involving rats given up to 2000 mg/kg bw of an aqueous Carica papaya  leaf extract.43  No m',\n",
       "   ' Carica papaya  leaf extract via gavage.  An oral LD 50 of greater than  2000 mg/kg bw Carica papaya  leaf extract (highest dose  tested)',\n",
       "   ' were free of gross pathological  changes.   The  LD 50 was greater than 2000  mg/kg bw.  43  Carica  papaya  leaf extract   (methanolic)',\n",
       "   'p spray suntan products at up to 0.01%.   An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving W',\n",
       "   'ated .  Control  group received 1.0 ml of saline  LD 50 = 2520 mg/kg ; no significant changes  in liver, renal, and he',\n",
       "   'marized below are presente d in Table 5.  An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving Wi star rats given up to 3200 mg/kg  of an  aqueous unripe Carica papaya  fruit extract'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2520 mg/kg ',\n",
       "   '2520 mg/kg',\n",
       "   '3200 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d5'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Fruit Juice',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Fruit Juice',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a7a1e6a4-8f81-4228-9335-44c68d99e692',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Carica papaya leaf extract via gavage.42  An oral LD 50 of greater than  2000 mg/kg bw was determined in a study  involving rats given up to 2000 mg/kg bw of an aqueous Carica papaya  leaf extract.43  No m',\n",
       "   ' Carica papaya  leaf extract via gavage.  An oral LD 50 of greater than  2000 mg/kg bw Carica papaya  leaf extract (highest dose  tested)',\n",
       "   ' were free of gross pathological  changes.   The  LD 50 was greater than 2000  mg/kg bw.  43  Carica  papaya  leaf extract   (methanolic)',\n",
       "   'p spray suntan products at up to 0.01%.   An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving W',\n",
       "   'ated .  Control  group received 1.0 ml of saline  LD 50 = 2520 mg/kg ; no significant changes  in liver, renal, and he',\n",
       "   'marized below are presente d in Table 5.  An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving Wi star rats given up to 3200 mg/kg  of an  aqueous unripe Carica papaya  fruit extract'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2520 mg/kg ',\n",
       "   '2520 mg/kg',\n",
       "   '3200 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d6'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Fruit Water',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Fruit Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=284ecc79-76a9-41db-b0db-42844c0e6081',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Carica papaya leaf extract via gavage.42  An oral LD 50 of greater than  2000 mg/kg bw was determined in a study  involving rats given up to 2000 mg/kg bw of an aqueous Carica papaya  leaf extract.43  No m',\n",
       "   ' Carica papaya  leaf extract via gavage.  An oral LD 50 of greater than  2000 mg/kg bw Carica papaya  leaf extract (highest dose  tested)',\n",
       "   ' were free of gross pathological  changes.   The  LD 50 was greater than 2000  mg/kg bw.  43  Carica  papaya  leaf extract   (methanolic)',\n",
       "   'p spray suntan products at up to 0.01%.   An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving W',\n",
       "   'ated .  Control  group received 1.0 ml of saline  LD 50 = 2520 mg/kg ; no significant changes  in liver, renal, and he',\n",
       "   'marized below are presente d in Table 5.  An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving Wi star rats given up to 3200 mg/kg  of an  aqueous unripe Carica papaya  fruit extract'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2520 mg/kg ',\n",
       "   '2520 mg/kg',\n",
       "   '3200 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d7'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Leaf Extract',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=49a35ef1-c9dd-41f4-acd9-f24f3ed9027b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=6ef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 12, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['Carica papaya leaf extract via gavage.42  An oral LD 50 of greater than  2000 mg/kg bw was determined in a study  involving rats given up to 2000 mg/kg bw of an aqueous Carica papaya  leaf extract.43  No m',\n",
       "   ' Carica papaya  leaf extract via gavage.  An oral LD 50 of greater than  2000 mg/kg bw Carica papaya  leaf extract (highest dose  tested)',\n",
       "   ' were free of gross pathological  changes.   The  LD 50 was greater than 2000  mg/kg bw.  43  Carica  papaya  leaf extract   (methanolic)',\n",
       "   'p spray suntan products at up to 0.01%.   An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving W',\n",
       "   'ated .  Control  group received 1.0 ml of saline  LD 50 = 2520 mg/kg ; no significant changes  in liver, renal, and he',\n",
       "   'marized below are presente d in Table 5.  An oral LD 50 of 2520 mg/kg was determined in acute toxicity study involving Wi star rats given up to 3200 mg/kg  of an  aqueous unripe Carica papaya  fruit extract'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg bw ',\n",
       "   '2000 mg/kg bw ',\n",
       "   '2000  mg/kg bw',\n",
       "   '2520 mg/kg ',\n",
       "   '2520 mg/kg',\n",
       "   '3200 mg/kg  '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d8'),\n",
       "  'Nome_comune': 'Carica Papaya (Papaya) Seed Oil',\n",
       "  'INCI_name': 'Carica Papaya (Papaya) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=ad02c165-4e87-4017-91e4-6cbca77cf5e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948d9'),\n",
       "  'Nome_comune': 'Carnauba Wax',\n",
       "  'INCI_name': 'Copernicia Cerifera (Carnauba) Wax',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e06f700b-d2af-4d4e-aa5c-33517e03579d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['e Panel calculated the MOS of DBP by dividing the NOAEL of 331 mg/kg/day (from a feeding study) by the ex-pected exposure of 9.13 μg/kg/day, yielding an MOS of 36,254. If the more conservat',\n",
       "   'l noted thatthe no observed adverse effect level (NOAEL) of DBP in a gav-age study was 50 mg/kg/day (Mylchreest et al. 2000). However,a feeding study',\n",
       "   'ive NOAEL of 50 mg/kg/day (from a gav-age study) is used, the MOS is 5476. ',\n",
       "   ' reported a NOAEL of 331 mg/kg/day (Ema et al.1998). Overall, the Panel felt that fe'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['13 μg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '331 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1bc6c1f2275d72948da'),\n",
       "  'Nome_comune': 'Carnitine',\n",
       "  'INCI_name': 'Carnitine',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6fb585ad-1228-4005-9657-e6b7f287161f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948db'),\n",
       "  'Nome_comune': 'Carnitine HCl',\n",
       "  'INCI_name': 'Carnitine HCl',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=267d4d46-d57d-46ff-9313-912c3f40747e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948dc'),\n",
       "  'Nome_comune': 'Carnitine Hydroxycitrate',\n",
       "  'INCI_name': 'Carnitine Hydroxycitrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=66084c1e-7861-471d-920c-4ecc23ed91de',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948dd'),\n",
       "  'Nome_comune': 'Carnitine PCA',\n",
       "  'INCI_name': 'Carnitine PCA',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a5907d2a-aed0-4726-9d40-5b687d8f01e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=4462ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 3):296-341, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948de'),\n",
       "  'Nome_comune': 'Carrageenan',\n",
       "  'INCI_name': 'Carrageenan',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=16f38d5d-b7d8-4047-a906-ab3ac39cd885',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948df'),\n",
       "  'Nome_comune': 'Carthamus Tinctorius (Safflower) Seed Oil',\n",
       "  'INCI_name': 'Carthamus Tinctorius (Safflower) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9f75d9ea-c67a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948e0'),\n",
       "  'Nome_comune': 'Carvacrol',\n",
       "  'INCI_name': 'Carvacrol',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=40c4ff5c-042b-42ed-a9f4-28b5e6646e97',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=caca1f11-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 25(Suppl. 1):29-127, 2006',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['d 3 of 10 rats dosed with 0.5 g/kg died. The oral LD 50 was determined to be >0.5 g/kg but <5.0 g/kg. No other details were available (RIFM 1976a as c',\n",
       "   ' to give a volume of 0.1 ml/10 g body weight. The LD 50 ofo-Cresol was 350 mg/kg body weight (Sternitzke et al. 1992). p-Cresol. Deichmann and',\n",
       "   ' dying within 30 min. The calculated subcutaneous LD 50 of PCMC for mice was 360 mg/kg. Three groups of 10 albino rats per group (sex no',\n",
       "   'd LD 50was for Thymol (243 mg/kg) and the highest LD 50 was for Thymol (800 mg/kg). In mice exposed intraperitoneally,the lowest re',\n",
       "   'male/5 female) were used in the study. The Thymol LD 50 in rats was 980 mg/kg (with 95% conﬁdence limits of 817 to1180 mg/kg). ',\n",
       "   ' mg/kg in rats (Deichmann and Witherup 1944). The LD 50 ofp-Cresol (10% in oil) was reported as 1430 mg/kg and 1460 mg/kg in rats (WHO 1995). p-Cresol (20% aqueous emulsion',\n",
       "   'esol. Uzhdavini et al. (1974) calculated the oral LD 50 ofm-Cresol (in oil) to be 823 and 2010 mg/kg for mice and rats, respectively. The WHO (1995) re'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['0 g/kg',\n",
       "   '350 mg/kg body weight',\n",
       "   '360 mg/kg',\n",
       "   '800 mg/kg',\n",
       "   '980 mg/kg',\n",
       "   '1460 mg/kg ',\n",
       "   '2010 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948e1'),\n",
       "  'Nome_comune': 'Carya Illinoensis (Pecan) Seed Oil',\n",
       "  'INCI_name': 'Carya Illinoinensis (Pecan) Seed Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=373a7ea9-1d28-4b68-9775-10e1efa1faec',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948e2'),\n",
       "  'Nome_comune': 'Caryocar Brasiliense Fruit Oil',\n",
       "  'INCI_name': 'Caryocar Brasiliense Fruit Oil',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=4eb20ae8-45ee-4f81-875a-48104dcfb7fa',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=ad62ac6b-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 36(Suppl.3):51-129, 2017',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bd6c1f2275d72948e3'),\n",
       "  'Nome_comune': 'Casein',\n",
       "  'INCI_name': 'Casein',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=dc2ffbd9-c374-48bb-a55b-087aff78195b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a744d1db-21ea-4172-a676-d17332da9e6e',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):43-56, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e4'),\n",
       "  'Nome_comune': 'Casein Extract',\n",
       "  'INCI_name': 'Casein Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=37308019-a722-41fb-a9e5-fd56c92fd339',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=a744d1db-21ea-4172-a676-d17332da9e6e',\n",
       "  'pdf_date': 'IJT 41(Suppl. 2):43-56, 2022',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e5'),\n",
       "  'Nome_comune': 'Cassia Angustifolia Seed Polysaccharide',\n",
       "  'INCI_name': 'Cassia Angustifolia Seed Polysaccharide',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=95233120-227c-44b0-950b-56fd740aba02',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0334b6a1-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 22, 2015',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['tate, or 2,000 mg/kg stearoyl inulin.  Acute oral LD 50 values of  > 2,800 mg/kg body weight (mice) and  >  5,000 mg/kg body weigh t (rats) have been reported for glucomannan.     In',\n",
       "   'ed, dextrin myristate, and  dextrin palmitate, an LD 50 of  > 2,000 mg/kg (rats) was reported.  The same results were repor',\n",
       "   'le and female rats (number and strain not stated. LD 50 > 5,000 mg/kg body weight.151     Sterculia Urens Gum:  Vehicle: corn oil. ',\n",
       "   ' 5 fasted male Sprague -Dawley rats.   LD 50 > 10,000 mg/kg body weight. Transient depression, but no  other  toxic effec',\n",
       "   'observation period.  No abnormal systemic signs.  LD 50 > 5,000 mg/kg body weight.63,64,154     Corn Starch Modified:  Vehicle: dis',\n",
       "   'y observation period.  Alopecia  in one animal.   LD 50  > 2,000 mg/kg body weight.66   Dextrin Myristate: Rats (number and strain not stated). LD 50 > 2,000 mg/kg body weight .67   Dextrin Palmitate: Rats (number and strain ',\n",
       "   'not stated).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified:   30% aqueous sol',\n",
       "   ' signs. Body weight changes at necropsy  normal.  LD 50  > 5,000 mg/kg body weight.70,155     Stearoyl Inulin: Rats (number and stra',\n",
       "   'in not stated).   Protocol not stated. LD 50  > 2,000 mg/kg body weight.71,72   Dermal   Branched  - Unmodified   Glucoma',\n",
       "   'ber and strain not stated).  Protocol not stated. LD 50  > 2,000 mg/kg body weight.151   Branched  - Modified   Carboxymethyl Inulin',\n",
       "   'servation period. Nine of 10  rabbits survived.   LD 50 > 2,000 mg/kg body weight.66    Dextrin Myristate:   Rats (number and strai',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.67   Dextrin Palmitate:   Rats (number and strain',\n",
       "   'usive dressing technique (details not included).  LD 50 > 2,000 mg/kg body weight.68,69   Potato Starch Modified: 10 rats (strain n',\n",
       "   ' ot specified). OECD 402 test guideline.  LD 50  > 2,000 mg/kg body weight.155    Potato Starch Modified:  18.5% solids aque',\n",
       "   'rritation may have been due to mechanical trauma. LD 50 > 2,000 mg/kg body weight.70    Intravenous   Linear Polysaccharides and Th',\n",
       "   'e and female mice (number and strain not stated). LD 50  > 2,800 mg/kg body weight.  No abnormalities with respect to the following:'],\n",
       "  'contesti_noael': ['served at gross examinat ion of treated animals.  NOAEL ≥ 2,000 mg/kg body  weight/day.155    Potato Starch Modified:   10% solids aqueo',\n",
       "   'ormal in detailed  histopathological evaluation.  NOAEL = 50,000 ppm (mean calculated test material consumption of 3394 ± 706 mg/kg/day in males  and 3867 ± 647  mg/kg/day in females).1',\n",
       "   'ccurrences, possibly attributable to basal diet.  NOAEL = 5% in diet; NOAELs for males and females estimated  at 3044  and 3309 mg/kg/day, respectively.164  Ghatti Gum:  5% Ghatti gum. Gr',\n",
       "   'eated and control groups  similar for each  sex.  NOAEL = 5% in diet;  NOAELs  at 3670 and 3825 mg/kg/d ay for different control diets.164   Glucomannan:',\n",
       "   'little, if any, toxicological  significance.  The NOAEL for wheat bran extract in rats was 4.4 g/kg/day, the highest dose administered; there were  no re',\n",
       "   'arkable findings in control rats fed  basal diet. NOAEL =  4. 4 g/kg/day.163  Ghatti Gum: Ghatti gum concentrations of 0, '],\n",
       "  'valori_ld50': ['000 mg/kg body weigh t',\n",
       "   '000 mg/kg',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '000 mg/kg body weight',\n",
       "   '800 mg/kg body weight'],\n",
       "  'valori_noael': ['000 mg/kg body  weight/day',\n",
       "   '706 mg/kg/day',\n",
       "   '3309 mg/kg/day',\n",
       "   '3825 mg/kg/d',\n",
       "   '4 g/kg/day',\n",
       "   '4 g/kg/day']},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e6'),\n",
       "  'Nome_comune': 'Cassia Gum',\n",
       "  'INCI_name': 'Cassia Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f9c384cc-d7f3-4da8-b601-44c55a2a3ce1',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['dy weight) over a 24-hour period.54The acute oral LD50 was >10 000 mg/kg body weight. Repeated Dose Toxicity—Oral Studies Cyamopsis te',\n",
       "   'ngredients: guar hydroxypropyltrimonium chloride (LD50 ¼12.5 g/kg), hydroxypropyl guar hydroxypropyltrimonium chloride (LD50 ¼12.0 g/kg), carboxymethyl guar (LD50 ¼17.8 g/kg), hydro- ly',\n",
       "   'here were no macroscopic findings at necropsy. An LD50 of >2000 mg/kg was reported. Gum guar, oxidized 2-hydro xypropyl ',\n",
       "   ' fecal staining; and irritability. The acute oral LD50 was 17.8 g/kg (95 %confidence limits of 13.1-22.5 g/kg). Hydrolyzed guar. An acute oral toxicity study o',\n",
       "   '0 mg/kg body weight at a 2-hour interval. An oral LD50 value of >5000 mg/kg body weight was reported. In a similar test, 10 male and 10 fe',\n",
       "   'ce and rats). None of the ani- mals died, and the LD50 was >6000 mg/kg in both the species. Ceratonia siliqua gum. The ac',\n",
       "   'ity; and generally poor condition. The acute oral LD50 was 12.0 g/kg (95 %confidence limits of 9.2-14.8 g/kg). Carboxymethyl guar. The acute oral toxicity of ',\n",
       "   '/kg), which yielded 90 %mortality. The acute oral LD50 was 15 g/kg (95 %confidence limits of 13-17 g/kg). Hydroxypropyl guar hydroxypropyltrimonium chlor',\n",
       "   ' piloerection. The acute oral median lethal dose (LD50) was 12.5 g/kg (95 %confidence limits of 10.22-14.78 g/kg). The acute oral toxicity of a guar hydroxypropyl',\n",
       "   'zed guar (LD50 > 6 g/kg), cassia gum (LD50 > 5 g/kg), and C siliqua gum (LD50 ¼5 g/kg). The LD50s for C siliqua gum in other species include 13.1 g/kg (mice), 9.1 g/kg (rabbits), and 10.3 g/kg (hamste'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight',\n",
       "   '0 g/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg body weight ',\n",
       "   '6000 mg/kg ',\n",
       "   '8 g/kg',\n",
       "   '17 g/kg',\n",
       "   '78 g/kg',\n",
       "   '13.1 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e7'),\n",
       "  'Nome_comune': 'Cassia Hydroxypropyltrimonium Chloride',\n",
       "  'INCI_name': 'Cassia Hydroxypropyltrimonium Chloride',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8032f0be-5462-4787-859f-f8867834ce6c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['dy weight) over a 24-hour period.54The acute oral LD50 was >10 000 mg/kg body weight. Repeated Dose Toxicity—Oral Studies Cyamopsis te',\n",
       "   'ngredients: guar hydroxypropyltrimonium chloride (LD50 ¼12.5 g/kg), hydroxypropyl guar hydroxypropyltrimonium chloride (LD50 ¼12.0 g/kg), carboxymethyl guar (LD50 ¼17.8 g/kg), hydro- ly',\n",
       "   'here were no macroscopic findings at necropsy. An LD50 of >2000 mg/kg was reported. Gum guar, oxidized 2-hydro xypropyl ',\n",
       "   ' fecal staining; and irritability. The acute oral LD50 was 17.8 g/kg (95 %confidence limits of 13.1-22.5 g/kg). Hydrolyzed guar. An acute oral toxicity study o',\n",
       "   '0 mg/kg body weight at a 2-hour interval. An oral LD50 value of >5000 mg/kg body weight was reported. In a similar test, 10 male and 10 fe',\n",
       "   'ce and rats). None of the ani- mals died, and the LD50 was >6000 mg/kg in both the species. Ceratonia siliqua gum. The ac',\n",
       "   'ity; and generally poor condition. The acute oral LD50 was 12.0 g/kg (95 %confidence limits of 9.2-14.8 g/kg). Carboxymethyl guar. The acute oral toxicity of ',\n",
       "   '/kg), which yielded 90 %mortality. The acute oral LD50 was 15 g/kg (95 %confidence limits of 13-17 g/kg). Hydroxypropyl guar hydroxypropyltrimonium chlor',\n",
       "   ' piloerection. The acute oral median lethal dose (LD50) was 12.5 g/kg (95 %confidence limits of 10.22-14.78 g/kg). The acute oral toxicity of a guar hydroxypropyl',\n",
       "   'zed guar (LD50 > 6 g/kg), cassia gum (LD50 > 5 g/kg), and C siliqua gum (LD50 ¼5 g/kg). The LD50s for C siliqua gum in other species include 13.1 g/kg (mice), 9.1 g/kg (rabbits), and 10.3 g/kg (hamste'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight',\n",
       "   '0 g/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg body weight ',\n",
       "   '6000 mg/kg ',\n",
       "   '8 g/kg',\n",
       "   '17 g/kg',\n",
       "   '78 g/kg',\n",
       "   '13.1 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e8'),\n",
       "  'Nome_comune': 'Castor Oil Phosphate',\n",
       "  'INCI_name': 'Castor Oil Phosphate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=326ce641-32b7-4aca-af12-413fb8e4910e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=587dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 38(Suppl.2):12-32, 2019',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['Animals/Group VehicleConcentration/Dose/ Protocol LD50/LC50 Results Reference DERMAL C20-22 alkyl phosphate 5 Sprague-Dawley rats/sexParaffin oil 2 g/kg bw (10 ml/kg bw) applied using a 24-hour semi-occlus'],\n",
       "  'contesti_noael': ['bw/d (active ingredient [a.i.]), and the NOEL and NOAEL for mater- nal toxicity were 36.1 and 361 mg/kg bw/d (a.i.), respectively(Table 7).22For C20-22 alkyl ',\n",
       "   'osphate had a no-observable adverse effect level (NOAEL) of 600 mg/kg bw/d for both males and females, and oral administr a ',\n",
       "   'w / df o rf e m a l e s .22 Oleyl phosphate had a NOAEL of 1000 mg/kg bw/d for male and female rats in a 28-day gavage study',\n",
       "   'ing and fertility) and neonatal toxicity, and the NOAEL for parental toxicity, were 1000 mg/kg bw/d in rats.20 Oleyl phosphate also was not a reprodu',\n",
       "   'e study with sodium lauryl phosphate in rats, the NOAEL for parental male and female animals and the NOEL for the F 1generation were 1000 mg/kg bw/d.19 Genotoxicity In vitro genotoxicity assays have',\n",
       "   ' 14-day studies, potassium lauryl phosphate had a NOAEL of 600 mg/kg bw/d for both males and females, and oral admin- istration of up to 1000 mg/kg bw/d sodium lauryl phosphate for 14 days did not resul',\n",
       "   'ing and fertility) and neonatal toxicity, and the NOAEL for parental toxicity, were 1000 mg/kg bw/d in rats. Oleyl phosphate also was not a reproduct',\n",
       "   'e study in rats with sodium lauryl phosphate, the NOAEL for parental male and female animals and the NOEL for the F 1generation was 1000 mg/kg bw/d.28S International Journal of Toxicology 38(Supple',\n",
       "   'erved in females fed 505 and 1564 mg/kg bw/d, the NOAEL was 1564 mg/kg bw/d for females. Oleyl phosphate had a NOAEL of 1000 '],\n",
       "  'valori_ld50': ['2 g/kg bw'],\n",
       "  'valori_noael': ['361 mg/kg bw/d',\n",
       "   '600 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1000 mg/kg bw/d',\n",
       "   '1564 mg/kg bw/d']},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948e9'),\n",
       "  'Nome_comune': 'Castor Oil Polyglyceryl-6 Esters',\n",
       "  'INCI_name': 'Castor Oil Polyglyceryl-6 Esters',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=773a3cd4-0aff-4458-98b6-70822b3d833e',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=c320f257-28ea-905f-bdcb-1a82026562d3',\n",
       "  'pdf_date': 'IJT 42(Suppl. 2):5-101, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': [' was reported in acute oral studies. In rats, the LD50> 2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'speci ﬁed OECD 423 (acute oral toxicity by gavage)LD50> 2 g/kg bw48 tetraisostearoyl polyglyceryl-3 dimer dilinol',\n",
       "   ' was reported in acute oral studies. In rats, the LD 50>2 g/kg for Polyglyceryl-3 Caprate, Polyglyceryl-3 Capryla',\n",
       "   'ales arachis oil BP 2 g/kg bw by gavage (2 groups)LD50> 2.5 g/kg bw (estimated)45 Polyglyceryl Multi-Esters Polyglyce'],\n",
       "  'contesti_noael': ['gni ﬁcance. The no observed adverse effect level (NOAEL) was 845 mg/kg/day in males and 922 mg/kg/day in females, corre-sponding to the highest dietary',\n",
       "   'some additional organs were weighed. The NOEL and NOAEL for systemic effects were ≥300 mg/kg bw/ day and ≥1000 mg/kg bw/day 1,2,3-propanetriol, homopol- ymer, diisooctadecan'],\n",
       "  'valori_ld50': ['2 g/kg ', '2 g/kg ', '2 g/kg ', '5 g/kg bw'],\n",
       "  'valori_noael': ['922 mg/kg/day', '1000 mg/kg bw/day']},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948ea'),\n",
       "  'Nome_comune': 'Cellobiose Octanonanoate',\n",
       "  'INCI_name': 'Cellobiose Octanonanoate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=852870a4-30c2-4e6b-bb79-2dd0b80ac935',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=11317d65-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 30(Suppl. 3):228-269, 2011',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['LD50 for isotridecyl alco- hol62in rats is 17 000 mg/kg.246S International Journal of Toxicology 30(Suppl',\n",
       "   ' were not provided. Ethyl pelargonate. Acute oral LD50 values of >43 000 mg/kg and 24 190 mg/kg have been reported for rats and guinea pigs, respe',\n",
       "   'of pelargonic acid using 10 mice was studied.66An LD50 of 224 +6 mg/kg was reported. Similarly, an LD50 of 224 mg/kg was reported for mice dosed iv with undiluted pela',\n",
       "   '500, 0.200, 0.794, and 3.16 g/kg. An acute dermal LD50 of 3.2 g/kg was reported. Signs of percutaneous toxicity were ',\n",
       "   'opsy did not reveal any abnormal findings, and an LD50 of >2000 mg/kg body weight was reported. Cetearyl isononanoate. A c c o r d i',\n",
       "   'opsy did not reveal any abnormal findings, and an LD50 of >2000 mg/kg body weight was reported. PEG-5 isononanoate. The acute oral t',\n",
       "   ' controls) at necropsy. It was concluded that the LD50 for nonanoic acid in males and females was >2000 mg/kg. Cetearyl nonanoate. The acute dermal toxicity of',\n",
       "   ' were not indicative of any abnormalities, and an LD50 of >2000 mg/kg body weight was reported.Ethyl pelargonate. The acute dermal L',\n",
       "   ' were not indicative of any abnormalities, and an LD50 of >2000 mg/kg was reported. Acute Intravenous Toxicity The acute',\n",
       "   'necropsy did not reveal any abnormal findings. An LD50 of >2500 mg/kg body weight was reported. Neopentyl glycol. The Organisation f',\n",
       "   'on and Development (OECD)32reported an acute oral LD50 of 3200 mg/kg (rats) for neopentyl glycol; others have reported',\n",
       "   ' the acute oral LD50 for neopentyl glycol62in rats is 3259 mg/kg. Acute Dermal Toxicity Pelargonic acid. In a stud',\n",
       "   'psy was per- formed on animals that survived. The LD50 was >5 g/kg. Isononyl alcohol. The acute oral toxicity of iso',\n",
       "   'y involving rabbits,50the acute dermal LD50 was greater than 5 g/kg (number of animals not stated). Results relating ',\n",
       "   'nce of macroscopic abnormalities at necropsy. The LD50 was >5000 mg/kg, and nonanoic acid was considered nontoxic. Cetea',\n",
       "   ' n gt oam a n u f a c t u r e r ,59an LD50 of >5000 mg/kg was reported for cetearyl isononanoate in a study ',\n",
       "   'yl isononanoate. According to a manufacturer,60an LD50 of >5000 mg/kg was reported for isononyl isononanoate in a study ',\n",
       "   'te-to-severe skin irritation, and an acute dermal LD50 of 9000 mg/kg was reported in this study. An acute dermal LD50 of 5000 mg/kg (rabbits) for undiluted pelargonic acid also has ',\n",
       "   'asted, male SD rats was evaluated.52An acute oral LD50 of 2.98 g/kg was reported. Isotridecyl alcohol. The acute oral '],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg',\n",
       "   '190 mg/kg ',\n",
       "   '224 mg/kg ',\n",
       "   '2 g/kg ',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg ',\n",
       "   '2500 mg/kg body weight ',\n",
       "   '3200 mg/kg',\n",
       "   '3259 mg/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg ',\n",
       "   '5000 mg/kg',\n",
       "   '98 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948eb'),\n",
       "  'Nome_comune': 'Cellulose',\n",
       "  'INCI_name': 'Cellulose',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=90a9216b-9271-4581-93dc-86942c9140cc',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948ec'),\n",
       "  'Nome_comune': 'Cellulose Acetate',\n",
       "  'INCI_name': 'Cellulose Acetate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=44fb7025-b848-45d3-9127-8cbb66b29d4a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1be6c1f2275d72948ed'),\n",
       "  'Nome_comune': 'Cellulose Acetate Butyrate',\n",
       "  'INCI_name': 'Cellulose Acetate Butyrate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f3182232-2543-44d6-bd56-e4d62a1d565f',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948ee'),\n",
       "  'Nome_comune': 'Cellulose Acetate Propionate',\n",
       "  'INCI_name': 'Cellulose Acetate Propionate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=0e3b657f-8eb8-42dd-a045-6c1bc982d404',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948ef'),\n",
       "  'Nome_comune': 'Cellulose Acetate Propionate Carboxylate',\n",
       "  'INCI_name': 'Cellulose Acetate Propionate Carboxylate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=d84429e4-bc11-4ad2-8c49-ea9a5538fed0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f0'),\n",
       "  'Nome_comune': 'Cellulose Gum',\n",
       "  'INCI_name': 'Cellulose Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b7d5b3b0-8b44-4327-ba5b-99c38f84d1de',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f1'),\n",
       "  'Nome_comune': 'Cellulose Succinate',\n",
       "  'INCI_name': 'Cellulose Succinate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=29a7ac5f-f56f-45c9-b16e-47b5091227c5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=2e65c18f-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'March 24, 2009',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['his study, the no-observed- adverse-effect level (NOAEL), for female rats were in excess of 4515 g/kg/day; the NOAEL) for male rats was 903 mg/kg/day. DeMerlis et al. (2005) reported on a subchronic ',\n",
       "   ' the authors reported that the maternal and fetal NOAEL was in excess of 4515 mg/kg/day (Palmieri et al. 2000). Cappon et al. (2003) eval',\n",
       "   'pendent test article-related adverse effects. The NOAEL was 5000 mg/kg/day, the highest dose tested. Hydroxypropylcellulose '],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['903 mg/kg/day', '4515 mg/kg/day', '5000 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f2'),\n",
       "  'Nome_comune': 'Centella Asiatica Callus Culture',\n",
       "  'INCI_name': 'Centella Asiatica Callus Culture',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b758ad2c-6cb3-4808-b0e2-a7fbb56e080a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f3'),\n",
       "  'Nome_comune': 'Centella Asiatica Extract',\n",
       "  'INCI_name': 'Centella Asiatica Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=eaf36f87-2454-4206-92b5-9289bd3a9bbb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f4'),\n",
       "  'Nome_comune': 'Centella Asiatica Flower/Leaf/Stem Extract',\n",
       "  'INCI_name': 'Centella Asiatica Flower/Leaf/Stem Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7f2d057d-f523-49f0-bc1a-8639fee53bd4',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f5'),\n",
       "  'Nome_comune': 'Centella Asiatica Leaf Cell Culture Extract',\n",
       "  'INCI_name': 'Centella Asiatica Leaf Cell Culture Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=9e876c58-73f1-470f-9b5c-25bdffabe204',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1bf6c1f2275d72948f6'),\n",
       "  'Nome_comune': 'Centella Asiatica Leaf Extract',\n",
       "  'INCI_name': 'Centella Asiatica Leaf Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=67e2a05d-6b51-4797-b899-241004a2e13a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948f7'),\n",
       "  'Nome_comune': 'Centella Asiatica Leaf Water',\n",
       "  'INCI_name': 'Centella Asiatica Leaf Water',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=918beb40-3cf7-492c-9a22-72cdfde9d1b7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948f8'),\n",
       "  'Nome_comune': 'Centella Asiatica Meristem Cell Culture',\n",
       "  'INCI_name': 'Centella Asiatica Meristem Cell Culture',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a8a88a0c-ce98-4030-ba7a-724fdb271aca',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948f9'),\n",
       "  'Nome_comune': 'Centella Asiatica Meristem Cell Culture Extract',\n",
       "  'INCI_name': 'Centella Asiatica Meristem Cell Culture Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=2919e744-250b-4031-8c64-84a465b56ba0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fa'),\n",
       "  'Nome_comune': 'Centella Asiatica Root Extract',\n",
       "  'INCI_name': 'Centella Asiatica Root Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=1ac1a7b8-b4d3-4fd8-a918-991b2cb16228',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=b1bbde69-df02-dd55-89b0-c21d18770d61',\n",
       "  'pdf_date': 'IJT 42(Suppl. 1):5-22, 2023',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fb'),\n",
       "  'Nome_comune': 'Ceramide 1',\n",
       "  'INCI_name': 'Ceramide 1 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a4d94580-9cfc-4137-87d1-d5709d9d0c10',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fc'),\n",
       "  'Nome_comune': 'Ceramide 1 A',\n",
       "  'INCI_name': 'Ceramide 1 A (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f57cae4f-d5f1-41c4-a7d8-35e77491e1e0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fd'),\n",
       "  'Nome_comune': 'Ceramide 2',\n",
       "  'INCI_name': 'Ceramide 2 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=48c7ad50-01f0-4f34-b12e-beae46834db5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948fe'),\n",
       "  'Nome_comune': 'Ceramide 3',\n",
       "  'INCI_name': 'Ceramide 3 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=df2127b1-a2f8-4fe2-820f-6bfe52fb4809',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d72948ff'),\n",
       "  'Nome_comune': 'Ceramide 4',\n",
       "  'INCI_name': 'Ceramide 4 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=504ab79f-df78-4db1-812f-81c16a5b1e0c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c06c1f2275d7294900'),\n",
       "  'Nome_comune': 'Ceramide 5',\n",
       "  'INCI_name': 'Ceramide 5 (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=233a6045-1a8c-4889-9a49-83bd8f778f18',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294901'),\n",
       "  'Nome_comune': 'Ceramide 6 II',\n",
       "  'INCI_name': 'Ceramide 6 II (Retired)',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=de56620a-4920-44d5-8b9e-5c1f2842b76d',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294902'),\n",
       "  'Nome_comune': 'Ceramide AP',\n",
       "  'INCI_name': 'Ceramide AP',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6b5c2684-b7a9-4a35-9fba-504f5569d9f0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294903'),\n",
       "  'Nome_comune': 'Ceramide AS',\n",
       "  'INCI_name': 'Ceramide AS',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7abf3270-0eee-43ef-b13f-259b1bf895c6',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294904'),\n",
       "  'Nome_comune': 'Ceramide EOP',\n",
       "  'INCI_name': 'Ceramide EOP',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=b1930767-f845-46f0-a036-5de425ceb8a3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294905'),\n",
       "  'Nome_comune': 'Ceramide EOS',\n",
       "  'INCI_name': 'Ceramide EOS',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=5ecf7838-2b60-4bfa-a0be-bfb1bae40964',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294906'),\n",
       "  'Nome_comune': 'Ceramide NG',\n",
       "  'INCI_name': 'Ceramide NG',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=32007ea3-0b41-48dd-b672-f8ff0c80c0ee',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294907'),\n",
       "  'Nome_comune': 'Ceramide NP',\n",
       "  'INCI_name': 'Ceramide NP',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=937ab940-cfc4-4b43-8f2c-2e50e5ca3a68',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294908'),\n",
       "  'Nome_comune': 'Ceramide NS',\n",
       "  'INCI_name': 'Ceramide NS',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=be8897b8-58a2-4591-b85d-fd9f07a03734',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c16c1f2275d7294909'),\n",
       "  'Nome_comune': 'Ceramide NS Dilaurate',\n",
       "  'INCI_name': 'Ceramide NS Dilaurate',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6886010e-3c2f-44c5-a1ae-7ebe562adceb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=7a7dbaa1-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 39(Suppl. 3):5-25, 2020',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': ['ized in Table 5.23-31The median lethal oral dose (LD 50) was greater than 2000 mg/kg in rat studies of Ceramide 2, Ceramide AP, Hydroxy',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>20% (2000 mg/kg) for both sexes; no mortalities; nonsignificant d',\n",
       "   '4 hours5 male and 5 female Wistar ratsOral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed27 Ceramide NP 2000 mg/kg body weight in propylene glycol; dose volume 10 mL/kg body wei',\n",
       "   'ght2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   ' weight2 male and 2 female Wistar ratsOral gavage LD 50>2000 mg/kg; uncoordinated movement 2 and 4 hours posttreatme',\n",
       "   'male and 5 female Sprague- Dawley ratsOral gavage LD 50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   'tar ratsDermal patch (no further details provided)LD50>2000 mg/kg; body weight gain not affected by treatment; no m',\n",
       "   's provided)Rats (no further details provided)Oral LD 50>2000 mg/kg; no signs of toxicity observed31 Ceramide NP 5000 mg/kg (no further details provided)5 male and 5 female ',\n",
       "   'rats (strain not reported)Oral gavage LD 50>5000 mg/kg; ataxia noted after each dosing; no other adverse effects observed23 Ceramide NP 5000 mg/kg body weight in propylene glycol given as 2 dosages of 2500 mg/'],\n",
       "  'contesti_noael': ['ed the maternal no observed adverse effect level (NOAEL) to be 1000 mg/kg body weight/d, and the NOEL for mating and fertility to be 1000 mg/kg body weight/d.34 Genotoxicity In vitro genotoxicity st udies ar',\n",
       "   's or systemic effects were observed, The maternal NOAEL and mating and fertility NOEL were both 1000 mg/kg body weight/d, respectively, in a rat repro- duction and develo'],\n",
       "  'valori_ld50': ['2000 mg/kg ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg body weight ',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg',\n",
       "   '5000 mg/kg body weight '],\n",
       "  'valori_noael': ['1000 mg/kg body weight/d', '1000 mg/kg body weight/d']},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490a'),\n",
       "  'Nome_comune': 'Ceramium Kondoi Extract',\n",
       "  'INCI_name': 'Ceramium Kondoi Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6e3c49b7-c07b-41ce-908d-ce6c5228f9b3',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['his study were provided.  The median lethal dose (LD 50) was reported to be > 2000 mg/kg.   Corallina Officinalis Extract   The acute oral',\n",
       "   'thod of oral administration was not  stated.  The LD 50 was reported to be > 2000 mg/kg.   Grateloupia Livida E xtract   The acute oral t',\n",
       "   ' were seen  with any extract or dose level .  The LD 50 values were  expected to be >  2000 mg/kg.   Lithothamnion Calcareum Extract   A Lithothamn',\n",
       "   'lesseria Sanguinea Extract (0.2 –  4% algae), the LD 50 was reported to be > 2000 mg/kg.   The acute oral  toxicity potential of multiple',\n",
       "   'uted dry  Asparagopsis Armata Extract .  The oral LD 50 was reported to be > 5000 mg/kg in an acute toxicity assay using a mixture  contai'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490b'),\n",
       "  'Nome_comune': 'Ceramium Rubrum Extract',\n",
       "  'INCI_name': 'Ceramium Rubrum Extract',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d4ba694-bc48-4569-9dd6-1a232eeb80e5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=cef5b6e9-8c74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'September 14, 2021',\n",
       "  'pdf_name': 'Final Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['his study were provided.  The median lethal dose (LD 50) was reported to be > 2000 mg/kg.   Corallina Officinalis Extract   The acute oral',\n",
       "   'thod of oral administration was not  stated.  The LD 50 was reported to be > 2000 mg/kg.   Grateloupia Livida E xtract   The acute oral t',\n",
       "   ' were seen  with any extract or dose level .  The LD 50 values were  expected to be >  2000 mg/kg.   Lithothamnion Calcareum Extract   A Lithothamn',\n",
       "   'lesseria Sanguinea Extract (0.2 –  4% algae), the LD 50 was reported to be > 2000 mg/kg.   The acute oral  toxicity potential of multiple',\n",
       "   'uted dry  Asparagopsis Armata Extract .  The oral LD 50 was reported to be > 5000 mg/kg in an acute toxicity assay using a mixture  contai'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '2000 mg/kg',\n",
       "   '5000 mg/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490c'),\n",
       "  'Nome_comune': 'Ceratonia Siliqua (Carob) Gum',\n",
       "  'INCI_name': 'Ceratonia Siliqua (Carob) Gum',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=db761548-69a5-4070-afc2-ea6a7ec9ce92',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=e6a4d57d-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 34(Suppl.1):35-65, 2015',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['dy weight) over a 24-hour period.54The acute oral LD50 was >10 000 mg/kg body weight. Repeated Dose Toxicity—Oral Studies Cyamopsis te',\n",
       "   'ngredients: guar hydroxypropyltrimonium chloride (LD50 ¼12.5 g/kg), hydroxypropyl guar hydroxypropyltrimonium chloride (LD50 ¼12.0 g/kg), carboxymethyl guar (LD50 ¼17.8 g/kg), hydro- ly',\n",
       "   'here were no macroscopic findings at necropsy. An LD50 of >2000 mg/kg was reported. Gum guar, oxidized 2-hydro xypropyl ',\n",
       "   ' fecal staining; and irritability. The acute oral LD50 was 17.8 g/kg (95 %confidence limits of 13.1-22.5 g/kg). Hydrolyzed guar. An acute oral toxicity study o',\n",
       "   '0 mg/kg body weight at a 2-hour interval. An oral LD50 value of >5000 mg/kg body weight was reported. In a similar test, 10 male and 10 fe',\n",
       "   'ce and rats). None of the ani- mals died, and the LD50 was >6000 mg/kg in both the species. Ceratonia siliqua gum. The ac',\n",
       "   'ity; and generally poor condition. The acute oral LD50 was 12.0 g/kg (95 %confidence limits of 9.2-14.8 g/kg). Carboxymethyl guar. The acute oral toxicity of ',\n",
       "   '/kg), which yielded 90 %mortality. The acute oral LD50 was 15 g/kg (95 %confidence limits of 13-17 g/kg). Hydroxypropyl guar hydroxypropyltrimonium chlor',\n",
       "   ' piloerection. The acute oral median lethal dose (LD50) was 12.5 g/kg (95 %confidence limits of 10.22-14.78 g/kg). The acute oral toxicity of a guar hydroxypropyl',\n",
       "   'zed guar (LD50 > 6 g/kg), cassia gum (LD50 > 5 g/kg), and C siliqua gum (LD50 ¼5 g/kg). The LD50s for C siliqua gum in other species include 13.1 g/kg (mice), 9.1 g/kg (rabbits), and 10.3 g/kg (hamste'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['000 mg/kg body weight',\n",
       "   '0 g/kg',\n",
       "   '2000 mg/kg ',\n",
       "   '5 g/kg',\n",
       "   '5000 mg/kg body weight ',\n",
       "   '6000 mg/kg ',\n",
       "   '8 g/kg',\n",
       "   '17 g/kg',\n",
       "   '78 g/kg',\n",
       "   '13.1 g/kg'],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490d'),\n",
       "  'Nome_comune': 'Ceresin',\n",
       "  'INCI_name': 'Ceresin',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=77345eff-e87a-ec11-8d21-000d3a991547',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b841e05-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 24(Suppl. 1):1-102, 2005',\n",
       "  'pdf_name': 'Published Re-review Not Opened',\n",
       "  'pbc_data': {'page': '', 'valori': '', 'fonti': ''},\n",
       "  'contesti_ld50': '',\n",
       "  'contesti_noael': ['e Panel calculated the MOS of DBP by dividing the NOAEL of 331 mg/kg/day (from a feeding study) by the ex-pected exposure of 9.13 μg/kg/day, yielding an MOS of 36,254. If the more conservat',\n",
       "   'l noted thatthe no observed adverse effect level (NOAEL) of DBP in a gav-age study was 50 mg/kg/day (Mylchreest et al. 2000). However,a feeding study',\n",
       "   'ive NOAEL of 50 mg/kg/day (from a gav-age study) is used, the MOS is 5476. ',\n",
       "   ' reported a NOAEL of 331 mg/kg/day (Ema et al.1998). Overall, the Panel felt that fe'],\n",
       "  'valori_ld50': '',\n",
       "  'valori_noael': ['13 μg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '50 mg/kg/day',\n",
       "   '331 mg/kg/day']},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490e'),\n",
       "  'Nome_comune': 'Ceteareth-10',\n",
       "  'INCI_name': 'Ceteareth-10',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d516cab-a8bb-4599-8256-c2694cfa8ed5',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d729490f'),\n",
       "  'Nome_comune': 'Ceteareth-100',\n",
       "  'INCI_name': 'Ceteareth-100',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=f4251c57-9c28-4a91-8a2f-5b94f8cad60c',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d7294910'),\n",
       "  'Nome_comune': 'Ceteareth-11',\n",
       "  'INCI_name': 'Ceteareth-11',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=92001620-9d0a-460f-92e7-19f2adafd2b2',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c26c1f2275d7294911'),\n",
       "  'Nome_comune': 'Ceteareth-12',\n",
       "  'INCI_name': 'Ceteareth-12',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=3e66b2b7-b3c8-4aa8-9ec8-875d39f66710',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294912'),\n",
       "  'Nome_comune': 'Ceteareth-13',\n",
       "  'INCI_name': 'Ceteareth-13',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=540d6053-90f5-4ab2-977b-3e65a46b88eb',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294913'),\n",
       "  'Nome_comune': 'Ceteareth-14',\n",
       "  'INCI_name': 'Ceteareth-14',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6d40006e-cbdc-4e8a-9771-36335dcd7c57',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294914'),\n",
       "  'Nome_comune': 'Ceteareth-15',\n",
       "  'INCI_name': 'Ceteareth-15',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=8b37ee9e-8956-4831-a670-5da8c72d3e24',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294915'),\n",
       "  'Nome_comune': 'Ceteareth-16',\n",
       "  'INCI_name': 'Ceteareth-16',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=e55b9b5b-b0f2-4395-96c9-2577def23857',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294916'),\n",
       "  'Nome_comune': 'Ceteareth-17',\n",
       "  'INCI_name': 'Ceteareth-17',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=deb5d013-7748-4229-855c-dd05a6fdefc7',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294917'),\n",
       "  'Nome_comune': 'Ceteareth-18',\n",
       "  'INCI_name': 'Ceteareth-18',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6dc7e916-dea3-4336-8c73-480fdb6282ba',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294918'),\n",
       "  'Nome_comune': 'Ceteareth-2',\n",
       "  'INCI_name': 'Ceteareth-2',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=7b1f7973-7acc-482b-8f0f-0299c84c17d0',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c36c1f2275d7294919'),\n",
       "  'Nome_comune': 'Ceteareth-20',\n",
       "  'INCI_name': 'Ceteareth-20',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=6a2a8bf6-5dcc-4ffb-a5fb-5a3b3680896b',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " {'_id': ObjectId('668ed1c46c1f2275d729491a'),\n",
       "  'Nome_comune': 'Ceteareth-22',\n",
       "  'INCI_name': 'Ceteareth-22',\n",
       "  'main_link': 'https://cir-reports.cir-safety.org/cir-ingredient-status-report/?id=a97674f2-8854-447e-ab31-52fa87c9109a',\n",
       "  'pdf_link': 'https://cir-reports.cir-safety.org/view-attachment?id=0b10a771-8e74-ec11-8943-0022482f06a6',\n",
       "  'pdf_date': 'IJT 31(Suppl. 2):169-244, 2012',\n",
       "  'pdf_name': 'Published Report',\n",
       "  'pbc_data': {'page': ''},\n",
       "  'contesti_ld50': ['ups of 10 male albino Swiss Webster mice.42The iv LD 50, after 24 hours and 7 days, was 100 mg/kg. A single intratracheal dose of 100 mL/animal of ',\n",
       "   '50 %solution of the analogs in corn oil, the oral LD 50 ranged from greater than the highest dose tested (2000 mg/kg) to 2500 mg/kg bw for male rats and from 1000 to 2000 mg/kg/ bw for ',\n",
       "   ' stripping and filtration5 Animal toxicology oral LD 50(rats); laneth-5, /C2125 mL/kg; laneth-16, 9.33-12.2 mL/kg, 2.15 g/ kg; laneth-25, >3 g/kg Dermal irritation/sensitization Primary irritation',\n",
       "   'oxicity Studies Ingredient Animals No./Group Dose LD 50(LC 50for inhalation studies) Reference ORAL Laureths Laureth 9 Albino Swiss Webster mice10 M 3300 mg/kg (24 h); 3050 mg/kg (7 day)42 Compounds analogous ',\n",
       "   ' laureth-4, practically nontoxic (rats and mice); LD50: laureth-23, 7.8-9.4 g/kg (rats) and 3.5-4 g/kg (mice); acute dermal LD50: >no mortality w/formul',\n",
       "   'm the GI tract of humans15 Animal toxicology oral LD 50:15-22 g/kg (rodents), higher mol wts less toxic than lower mol wts, i.v. LD 50: 7.3-9.5 g/kg (rodents) 13-wk oral: PEG-8, /C205.6 g/kg/day, no',\n",
       "   'e alcohol Myristyl Alcohol Animal toxicology Oral LD 50(rats): >8 g/kg; formulation w/0.8%, >5 g/kg; dermal LD 50: formulation w/0.8%, >2 g/kg12 Inha',\n",
       "   'erides and phospholipids12 Animal toxicology Oral LD 50(rats): >8.2 g/kg; formulations w/ /C204%, no toxic effects; dermal LD50: >2.6 g/kg; formulation w/5%, 2 g/kg; Inhalation: 6-h exposu',\n",
       "   ' fleece may also be found9 Animal toxicology Oral LD 50: 12.1 to >42.7 g/kg (rats) Dermal irritation/sensitization 50% or 100',\n",
       "   'icity; lethal dose for rhesus monkey: 3 g/kg Oral LD 50: 5.6 g/kg (rat); 7.3-15.3 g/kg (mouse); dermal LD 50: 15.8 g/kg (rabbits); inhalation LC 50: 64 to >145 g/kg (rat',\n",
       "   'sorbed from the GI tract10 Animal toxicology oral LD 50: >8 g/kg; 3 Months dermal study: formulations w/8%,some de',\n",
       "   'xide with stearyl alcohol6 Animal toxicology Oral LD50 (rats):steareth-2, 16 g/kg (unspecified concentration)), /C2121 g/ kg (25% i',\n",
       "   'as used Isostearyl Alcohol Animal toxicology Oral LD 50: >20 g/kg (rats); formulations w/25-27%, >15 g/kg12 Dermal ',\n",
       "   'fe as used Octyl Dodecanol Animal toxicology Oral LD 50(rats): >5 g/kg, undiluted; formulation w/10.2%, >25 g/kg; dermal LD 50: >3 g/kg10 Dermal irritation/sensit',\n",
       "   'ional to PEG concentration Animal toxicology Oral LD 50(rats): ceteth-2, >25 g/kg; ceteth-10, 2.5-3.5 g/kg; ceteth-20, 3.59 g/kg 4-Wk dermal: ceteth-2 (2.5%, rabbits; 3%, rats): n'],\n",
       "  'contesti_noael': '',\n",
       "  'valori_ld50': ['100 mg/kg',\n",
       "   '2500 mg/kg bw ',\n",
       "   '3 g/kg ',\n",
       "   '3300 mg/kg',\n",
       "   '4 g/kg',\n",
       "   '5 g/kg',\n",
       "   '5 g/kg',\n",
       "   '6 g/kg',\n",
       "   '7 g/kg',\n",
       "   '8 g/kg',\n",
       "   '8 g/kg',\n",
       "   '16 g/kg',\n",
       "   '20 g/kg',\n",
       "   '25 g/kg',\n",
       "   '59 g/kg '],\n",
       "  'valori_noael': ''},\n",
       " ...]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "punt = db.Ingredienti.find({})\n",
    "\n",
    "ingredienti = []\n",
    "\n",
    "for el in punt:\n",
    "    ingredienti.append(el)\n",
    "\n",
    "ingredienti"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7230"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(ingredienti)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "for el in ingredienti[10:]:\n",
    "    if el['valori_noael']:\n",
    "        val = el['valori_noael']\n",
    "        cont = el['contesti_noael']\n",
    "        nuova_lista = []\n",
    "        for i in range(len(val)):\n",
    "            nuova_lista.append((val[i],cont[i]))\n",
    "        nuova_lista.sort(key=sorting_func)\n",
    "        n_val = [x[0] for x in nuova_lista]\n",
    "        n_cont = [x[1] for x in nuova_lista]\n",
    "        db.Ingredienti.update_one({\"_id\":el['_id']},{\"$set\":{\"valori_noael\":n_val,\"contesti_noael\":n_cont}})\n",
    "\n",
    "    if el['valori_ld50']:\n",
    "        val = el['valori_ld50']\n",
    "        cont = el['contesti_ld50']\n",
    "        nuova_lista = []\n",
    "        for i in range(len(val)):\n",
    "            nuova_lista.append((val[i],cont[i]))\n",
    "        nuova_lista.sort(key=sorting_func)\n",
    "        n_val = [x[0] for x in nuova_lista]\n",
    "        n_cont = [x[1] for x in nuova_lista]\n",
    "        db.Ingredienti.update_one({\"_id\":el['_id']},{\"$set\":{\"valori_ld50\":n_val,\"contesti_ld50\":n_cont}})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "for el in ingredienti:\n",
    "    try:\n",
    "        page = el[\"pbc_data\"][\"page\"]\n",
    "        valori = el[\"pbc_data\"][\"valori\"]\n",
    "        fonti = el[\"pbc_data\"][\"fonti\"]\n",
    "        db.Ingredienti.update_one({\"_id\":el[\"_id\"]},{\"$set\":{\"pbc_data\":{\"page\":page,\"valori\":valori,\"fonti\":fonti}}})\n",
    "    except:\n",
    "        db.Ingredienti.update_one({\"_id\":el[\"_id\"]},{\"$set\":{\"pbc_data\":{\"page\":'',\"valori\":'',\"fonti\":''}}})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "diz = {\"ciao\":1}\n",
    "diz['bella']"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "pw_01",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
